data_2ozx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ozx _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -147.94 151.93 36.65 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.167 -1.42 . . . . 10.0 107.167 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.41 -23.16 64.15 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.364 0.666 . . . . 10.0 112.713 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.84 -28.62 69.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.474 1.034 . . . . 10.0 112.292 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.5 -29.56 61.46 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.95 0.5 . . . . 10.0 110.769 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.1 mt -75.98 126.0 87.43 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 106.984 -1.488 . . . . 10.0 106.984 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.68 142.07 81.9 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.156 1.904 . . . . 10.0 109.292 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -78.98 -29.86 44.07 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.681 0.753 . . . . 10.0 112.172 -170.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 135.62 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 104.083 -2.562 . . . . 10.0 104.083 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -149.2 107.76 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.609 -1.997 . . . . 10.0 105.609 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.8 pt . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 108.189 -1.041 . . . . 10.0 108.189 -175.422 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -157.57 153.11 26.37 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.64 1.176 . . . . 10.0 109.496 171.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -68.06 150.78 47.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.968 0.907 . . . . 10.0 110.28 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.46 163.65 35.0 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.72 0.808 . . . . 10.0 109.233 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.89 147.35 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.258 1.023 . . . . 10.0 108.705 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 tp -106.31 119.95 40.58 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.4 130.5 71.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.081 -1.452 . . . . 10.0 107.081 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -82.21 134.36 35.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.063 -2.199 . . . . 10.0 105.063 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -119.71 138.93 48.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.255 -1.757 . . . . 10.0 106.255 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -119.4 131.17 55.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.08 -1.822 . . . . 10.0 106.08 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 p -73.51 145.78 45.36 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.867 0.758 . . . . 10.0 110.006 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.27 61.02 3.1 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 106.26 -1.756 . . . . 10.0 106.26 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -56.74 136.9 78.89 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.472 2.781 . . . . 10.0 110.955 -169.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 45.44 26.65 0.31 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.686 1.594 . . . . 10.0 113.829 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 m 55.04 26.01 7.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.27 1.428 . . . . 10.0 113.479 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.93 -1.34 0.03 OUTLIER Glycine 0 CA--C 1.532 1.101 0 N-CA-C 116.843 1.497 . . . . 10.0 116.843 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.11 152.5 84.01 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 120.114 1.957 . . . . 10.0 110.173 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.83 56.88 5.84 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.473 3.449 . . . . 10.0 111.874 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.38 137.37 30.4 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.139 1.376 . . . . 10.0 108.381 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.03 32.46 0.6 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.321 1.449 . . . . 10.0 109.829 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.83 170.09 13.28 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.469 0.708 . . . . 10.0 109.297 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 m -147.03 159.97 42.94 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.622 -0.673 . . . . 10.0 110.417 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -147.59 175.36 10.92 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.087 1.355 . . . . 10.0 108.261 169.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -105.33 150.74 24.94 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.628 -0.879 . . . . 10.0 108.628 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.2 pt -135.86 150.37 28.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.323 1.449 . . . . 10.0 109.49 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.31 126.98 64.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.388 -1.708 . . . . 10.0 106.388 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -132.48 139.15 47.83 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.96 113.88 0.5 Allowed Glycine 0 C--N 1.332 0.321 0 CA-C-N 119.473 1.033 . . . . 10.0 110.941 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -140.75 132.23 26.93 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.114 -0.699 . . . . 10.0 109.114 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -69.49 -14.81 63.07 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.048 1.129 . . . . 10.0 114.048 -171.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -66.58 -23.48 66.2 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.478 1.036 . . . . 10.0 111.943 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.79 127.64 33.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.236 0.926 . . . . 10.0 110.082 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.87 -39.23 73.0 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.541 -0.3 . . . . 10.0 110.284 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -140.5 160.6 39.64 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.663 1.585 . . . . 10.0 108.658 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -56.45 -33.19 65.65 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.323 1.049 . . . . 10.0 112.09 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.7 -31.12 69.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.038 0.935 . . . . 10.0 112.209 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -71.35 -36.07 71.38 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.998 0.817 . . . . 10.0 110.577 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mt -65.49 -50.91 69.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -57.41 -45.1 84.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.418 -0.325 . . . . 10.0 110.554 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.41 -46.3 90.71 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.994 0.518 . . . . 10.0 111.851 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -57.2 -49.49 75.84 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.016 0.371 . . . . 10.0 110.287 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.5 t -68.85 -46.39 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.8 m -58.37 -35.51 72.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.489 1.041 . . . . 10.0 111.509 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.4 -50.68 60.52 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.703 -0.959 . . . . 10.0 110.703 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.66 -44.84 95.24 Favored 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 117.539 0.67 . . . . 10.0 111.204 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -37.22 81.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.673 -0.68 . . . . 10.0 110.887 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.25 -34.96 79.59 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.161 0.891 . . . . 10.0 111.19 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.9 -33.87 77.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.93 0.786 . . . . 10.0 111.658 171.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -70.6 -52.97 17.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.093 0.861 . . . . 10.0 110.165 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.82 43.77 0.23 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.276 1.417 . . . . 10.0 110.204 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.8 m -144.24 172.29 13.13 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.015 1.726 . . . . 10.0 108.655 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -140.27 164.83 29.03 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.692 1.597 . . . . 10.0 108.228 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.0 m -133.3 159.55 39.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.048 0.939 . . . . 10.0 112.429 -169.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -148.48 117.45 6.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.253 1.821 . . . . 10.0 106.61 170.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -62.74 130.59 45.6 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.547 -0.721 . . . . 10.0 109.115 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.0 mt -90.78 -23.04 20.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.576 0.351 . . . . 10.0 110.481 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.77 179.35 29.1 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.43 -1.868 . . . . 10.0 108.43 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.46 -164.14 14.31 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.668 -0.973 . . . . 10.0 110.668 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.69 -139.48 4.28 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 108.508 -1.837 . . . . 10.0 108.508 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -139.87 157.71 45.26 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.985 1.314 . . . . 10.0 108.116 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.42 151.45 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.62 -2.363 . . . . 10.0 104.62 172.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 175.754 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.236 0.367 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -138.14 157.96 45.28 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.745 0.818 . . . . 10.0 109.083 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.5 t -137.48 135.49 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.582 1.153 . . . . 10.0 108.086 -170.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -163.1 -178.53 6.09 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.329 -0.857 . . . . 10.0 111.714 -171.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.77 -163.49 49.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.662 0.649 . . . . 10.0 111.617 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -150.65 178.86 8.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.943 1.297 . . . . 10.0 108.632 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m -103.28 124.79 49.31 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.285 -1.005 . . . . 10.0 108.285 169.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.73 -30.24 67.32 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.081 0.401 . . . . 10.0 110.716 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.46 -30.94 71.78 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.119 0.968 . . . . 10.0 113.475 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.01 -57.9 0.5 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.428 1.013 . . . . 10.0 110.676 -172.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.86 -178.69 35.84 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.596 -1.402 . . . . 10.0 109.596 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.6 138.2 68.66 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.163 1.909 . . . . 10.0 110.167 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.08 161.44 24.47 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.806 -1.183 . . . . 10.0 107.806 168.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -78.82 71.67 5.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.487 -2.042 . . . . 10.0 105.487 169.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -50.33 -30.85 13.0 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.045 1.338 . . . . 10.0 113.494 -169.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.43 74.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.111 0.869 . . . . 10.0 112.061 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.36 -51.22 73.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.404 -1.332 . . . . 10.0 107.404 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -58.06 -46.16 85.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.967 -0.539 . . . . 10.0 112.128 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.4 p -66.28 -41.01 90.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.394 0.997 . . . . 10.0 110.823 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -64.86 -39.96 94.38 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.894 0.77 . . . . 10.0 110.641 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -62.76 -48.22 80.12 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 118.96 -0.543 . . . . 10.0 110.598 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.83 -45.74 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -62.2 -40.45 96.12 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.014 0.926 . . . . 10.0 111.589 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.86 -44.25 77.56 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.033 0.533 . . . . 10.0 110.819 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.9 tptt . . . . . 0 C--O 1.231 0.111 0 N-CA-C 112.669 0.618 . . . . 10.0 112.669 -172.125 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.235 0.325 0 N-CA-C 105.772 -1.936 . . . . 10.0 105.772 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.9 p -134.82 169.91 16.65 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.518 0.727 . . . . 10.0 109.76 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -140.85 166.15 25.57 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.318 0.647 . . . . 10.0 110.467 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 125.526 1.53 . . . . 10.0 108.483 172.792 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 121.138 0.494 . . . . 10.0 111.236 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -152.5 146.64 25.42 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 170.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.46 -25.27 65.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 118.505 -0.759 . . . . 10.0 113.002 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.4 -26.95 68.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.113 0.87 . . . . 10.0 112.034 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -75.76 -27.64 58.15 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.82 0.448 . . . . 10.0 110.709 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.6 mt -74.74 122.09 86.71 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -51.15 139.96 42.09 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.161 2.574 . . . . 10.0 110.594 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.27 -29.47 38.31 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.087 0.946 . . . . 10.0 111.605 -172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -136.65 136.17 48.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 104.323 -2.473 . . . . 10.0 104.323 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -146.32 118.28 8.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.488 -1.301 . . . . 10.0 107.488 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.2 pt . . . . . 0 C--N 1.328 -0.336 0 C-N-CA 126.028 1.731 . . . . 10.0 106.653 -174.757 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 108.118 -1.067 . . . . 10.0 108.118 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -150.17 152.15 34.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.74 0.816 . . . . 10.0 110.766 169.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -70.76 150.11 46.22 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.898 0.879 . . . . 10.0 108.985 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.25 159.36 43.45 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.282 0.492 . . . . 10.0 110.899 172.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.39 145.32 28.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.684 1.594 . . . . 10.0 107.169 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.48 122.04 45.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.971 -2.233 . . . . 10.0 104.971 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.5 mt -124.94 130.15 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.884 -1.525 . . . . 10.0 106.884 -171.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -80.04 129.24 34.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.73 -2.322 . . . . 10.0 104.73 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.73 142.6 32.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -124.62 134.98 52.74 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.182 1.793 . . . . 10.0 106.785 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.9 p -65.79 140.51 58.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 110.048 -0.353 . . . . 10.0 110.048 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.33 46.25 0.48 Allowed Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 125.184 1.393 . . . . 10.0 111.99 168.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.13 159.34 26.54 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.497 2.798 . . . . 10.0 110.785 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.29 20.66 1.43 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.872 1.269 . . . . 10.0 112.141 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 52.1 22.69 1.97 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.582 1.553 . . . . 10.0 113.531 -171.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.34 32.94 0.03 OUTLIER Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.29 -0.881 . . . . 10.0 113.826 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.08 157.74 20.54 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 118.617 1.208 . . . . 10.0 110.475 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.89 57.71 4.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.085 3.19 . . . . 10.0 111.434 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.32 145.54 34.06 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.937 1.695 . . . . 10.0 108.366 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.47 31.11 0.59 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.756 1.222 . . . . 10.0 110.267 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -63.99 153.25 37.8 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.436 -0.95 . . . . 10.0 108.436 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -144.55 161.82 38.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.658 1.183 . . . . 10.0 109.992 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -150.22 176.57 10.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.764 1.226 . . . . 10.0 109.712 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -102.14 146.88 27.33 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.871 -1.159 . . . . 10.0 107.871 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.3 pt -133.67 155.27 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.859 1.264 . . . . 10.0 110.407 172.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.95 130.4 66.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.788 -1.56 . . . . 10.0 106.788 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -132.25 143.91 50.25 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.056 -1.461 . . . . 10.0 107.056 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.56 129.84 1.88 Allowed Glycine 0 C--O 1.226 -0.391 0 CA-C-N 120.489 1.495 . . . . 10.0 113.305 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -151.31 148.27 27.96 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.516 1.126 . . . . 10.0 109.153 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -88.95 -6.72 57.06 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.385 -1.293 . . . . 10.0 114.196 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -63.99 -22.65 67.02 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.019 1.281 . . . . 10.0 111.805 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.85 124.11 22.81 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.345 0.658 . . . . 10.0 109.548 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.26 -35.92 80.52 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.275 0.559 . . . . 10.0 109.642 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -142.74 151.38 41.21 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 126.411 1.885 . . . . 10.0 106.951 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.573 ' CD2' ' HG ' ' A' ' 94' ' ' SER . 73.0 m80 -55.03 -35.7 64.72 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.37 0.668 . . . . 10.0 112.503 -174.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.08 -24.54 58.95 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.429 -0.796 . . . . 10.0 112.445 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.13 -36.64 82.31 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.735 0.698 . . . . 10.0 110.709 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mt -65.25 -49.94 76.2 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 107.787 -1.19 . . . . 10.0 107.787 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -56.1 -46.58 79.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.902 -0.571 . . . . 10.0 111.169 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.02 -45.16 86.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.189 0.595 . . . . 10.0 111.888 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -58.84 -49.4 77.89 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.42 0.688 . . . . 10.0 109.747 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.82 -42.19 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.6 m -58.38 -35.63 72.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.591 1.087 . . . . 10.0 111.333 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.64 -48.33 82.32 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.781 -0.928 . . . . 10.0 110.781 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.34 -46.41 90.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.907 0.853 . . . . 10.0 111.272 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -36.57 83.22 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 118.643 -0.694 . . . . 10.0 110.888 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -64.5 -36.01 82.82 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.828 0.74 . . . . 10.0 110.879 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.46 -32.34 73.13 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 117.982 -1.008 . . . . 10.0 111.71 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -67.85 -57.06 6.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.152 0.887 . . . . 10.0 109.048 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.59 47.04 0.16 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.882 1.706 . . . . 10.0 109.163 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.5 m -146.32 173.62 12.08 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.719 2.008 . . . . 10.0 108.379 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -141.03 162.86 34.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.513 1.525 . . . . 10.0 108.557 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.1 m -134.47 158.75 43.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.425 1.09 . . . . 10.0 112.398 -168.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -148.45 122.21 9.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.954 1.702 . . . . 10.0 106.944 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.7 p -64.56 128.54 36.22 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.772 -1.205 . . . . 10.0 109.368 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.06 -25.97 19.39 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.14 -177.74 35.58 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.548 -1.421 . . . . 10.0 109.548 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.82 -174.67 24.27 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 118.222 1.011 . . . . 10.0 112.015 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.66 -145.96 5.35 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.12 -1.592 . . . . 10.0 109.12 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.8 mtm-85 -137.74 155.31 49.21 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.148 -1.207 . . . . 10.0 108.37 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.9 mt -122.63 148.73 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 105.024 -2.213 . . . . 10.0 105.024 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 125.006 1.322 . . . . 10.0 108.638 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.5 mt . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 107.283 -1.377 . . . . 10.0 107.283 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.465 ' CD2' ' HG1' ' A' ' 119' ' ' THR . 4.8 t-80 -140.47 162.83 34.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.033 0.933 . . . . 10.0 109.672 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.3 144.35 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.12 -1.808 . . . . 10.0 106.12 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -161.19 179.15 8.6 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.283 -0.886 . . . . 10.0 110.218 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.26 -176.21 47.63 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.092 0.377 . . . . 10.0 112.651 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -155.77 134.71 12.01 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.757 0.823 . . . . 10.0 109.958 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.573 ' HG ' ' CD2' ' A' ' 53' ' ' HIS . 19.8 m -74.24 95.55 2.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.912 0.885 . . . . 10.0 109.785 177.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 76.9 mtm -57.62 -14.44 5.4 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.878 0.871 . . . . 10.0 112.602 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.34 -27.7 48.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.691 1.196 . . . . 10.0 113.121 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -47.63 0.33 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.862 0.756 . . . . 10.0 110.882 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.8 173.85 23.35 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.28 1.419 . . . . 10.0 109.862 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.37 134.23 56.32 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.791 2.327 . . . . 10.0 111.071 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.41 162.06 21.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 167.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.99 71.2 5.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.134 -1.432 . . . . 10.0 107.134 169.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -54.42 -26.25 29.64 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.75 1.22 . . . . 10.0 113.376 -170.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.86 92.76 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.476 1.035 . . . . 10.0 111.745 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.6 mt -67.47 -49.87 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.418 -1.327 . . . . 10.0 107.418 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 m -58.84 -44.54 90.98 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.863 -0.589 . . . . 10.0 112.06 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.0 p -64.95 -41.53 95.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.058 -0.972 . . . . 10.0 111.009 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -64.19 -39.33 93.76 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.384 0.993 . . . . 10.0 110.807 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -65.43 -48.22 73.54 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.926 -0.484 . . . . 10.0 110.67 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.24 -42.94 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.298 -1.001 . . . . 10.0 108.298 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -59.49 -45.59 91.23 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.925 0.89 . . . . 10.0 110.41 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.72 95.45 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.552 0.614 . . . . 10.0 111.396 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 tptm . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 118.668 -0.682 . . . . 10.0 110.943 178.576 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.465 ' HG1' ' CD2' ' A' ' 89' ' ' HIS . 8.6 p -139.73 172.24 13.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.208 1.403 . . . . 10.0 108.749 174.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -140.45 163.72 32.05 Favored 'General case' 0 C--O 1.227 -0.114 0 O-C-N 121.543 -0.723 . . . . 10.0 112.406 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 126.5 1.92 . . . . 10.0 108.504 172.6 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 107.118 -1.438 . . . . 10.0 107.118 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -152.17 150.64 30.08 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.389 -1.337 . . . . 10.0 107.389 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.4 -26.66 65.33 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.679 0.792 . . . . 10.0 112.832 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.94 -26.25 68.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.936 0.789 . . . . 10.0 112.159 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.1 mt -75.79 -25.27 56.25 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.034 0.534 . . . . 10.0 110.982 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.4 mt -78.68 122.82 85.29 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -50.74 133.53 39.23 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.499 2.8 . . . . 10.0 110.721 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -82.52 -28.65 30.94 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.504 0.668 . . . . 10.0 112.074 -170.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.08 134.91 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.893 -2.262 . . . . 10.0 104.893 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -150.64 113.82 4.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.056 -1.831 . . . . 10.0 106.056 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 CA--C 1.535 0.39 0 C-N-CA 124.681 1.192 . . . . 10.0 110.258 -169.235 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -146.35 147.06 30.93 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.855 0.862 . . . . 10.0 109.618 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.02 146.89 50.7 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.79 -0.818 . . . . 10.0 108.79 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.01 158.78 43.28 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.599 -0.889 . . . . 10.0 108.599 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.75 150.6 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.171 1.388 . . . . 10.0 107.698 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.6 tp -115.13 115.71 27.21 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.9 138.29 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.759 -1.571 . . . . 10.0 106.759 -169.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -92.86 135.4 34.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.674 -1.602 . . . . 10.0 106.674 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.11 139.99 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 105.824 -1.917 . . . . 10.0 105.824 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -115.11 130.0 56.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.914 -1.884 . . . . 10.0 105.914 173.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 p -70.17 143.51 52.25 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.03 61.44 3.37 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.721 1.208 . . . . 10.0 108.325 169.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -58.93 152.25 59.41 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.247 2.631 . . . . 10.0 111.103 -169.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 65.92 -61.38 0.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 128.122 2.569 . . . . 10.0 112.135 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 p -171.11 -33.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.425 2.29 . . . . 10.0 108.864 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.66 42.63 0.13 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.05 1.31 . . . . 10.0 110.574 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.02 157.23 11.53 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.339 0.656 . . . . 10.0 110.262 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.52 59.46 5.54 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.181 3.254 . . . . 10.0 112.474 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.18 136.36 26.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.074 1.749 . . . . 10.0 107.297 171.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.38 30.21 0.85 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.775 1.23 . . . . 10.0 110.054 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -64.87 161.07 19.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.79 -0.819 . . . . 10.0 108.79 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.5 m -141.08 159.51 42.05 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.233 1.013 . . . . 10.0 110.009 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -149.83 170.19 19.35 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.503 1.121 . . . . 10.0 109.617 171.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -99.95 154.45 18.37 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.211 -0.663 . . . . 10.0 109.211 170.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.0 pt -137.12 154.03 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.291 1.436 . . . . 10.0 109.956 174.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.35 126.84 65.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.453 -1.684 . . . . 10.0 106.453 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -133.94 143.06 47.97 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.738 -1.579 . . . . 10.0 106.738 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.84 129.47 1.65 Allowed Glycine 0 C--O 1.227 -0.295 0 CA-C-N 120.259 1.39 . . . . 10.0 111.378 171.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -145.0 141.5 28.98 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.454 0.702 . . . . 10.0 110.432 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -70.51 -21.98 62.68 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 118.358 -0.83 . . . . 10.0 113.195 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -66.44 -25.13 66.6 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.586 1.085 . . . . 10.0 112.629 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.67 126.32 29.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.252 0.933 . . . . 10.0 110.114 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.49 -31.96 65.81 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 122.621 0.368 . . . . 10.0 110.249 170.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -146.05 152.22 38.99 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.339 1.456 . . . . 10.0 109.13 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -56.93 -31.46 64.98 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.004 1.322 . . . . 10.0 112.626 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.18 -31.55 69.1 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.674 -0.679 . . . . 10.0 112.047 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.74 -41.65 78.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.647 0.658 . . . . 10.0 110.107 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.3 mt -62.78 -50.74 78.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 108.312 -0.996 . . . . 10.0 108.312 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -55.34 -43.7 75.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.834 -0.603 . . . . 10.0 111.295 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.11 -46.59 83.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.609 0.64 . . . . 10.0 111.666 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -57.61 -49.9 74.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.132 0.573 . . . . 10.0 109.643 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.51 -44.31 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 m -56.61 -42.52 78.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.025 0.83 . . . . 10.0 110.9 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.52 -48.37 86.35 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.78 -0.928 . . . . 10.0 110.78 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -62.29 -47.38 84.55 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 118.16 0.98 . . . . 10.0 111.046 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -39.51 87.5 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 119.011 -0.518 . . . . 10.0 110.69 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -65.51 -33.76 76.68 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.567 0.621 . . . . 10.0 110.896 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.08 -34.0 77.08 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 117.239 -1.362 . . . . 10.0 111.21 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -69.47 -65.89 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.292 0.951 . . . . 10.0 108.682 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.79 42.24 0.04 OUTLIER Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.371 1.462 . . . . 10.0 110.491 -169.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.1 m -146.38 176.11 10.03 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.596 1.958 . . . . 10.0 107.935 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -145.21 165.72 27.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.168 0.987 . . . . 10.0 108.764 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.9 m -130.15 155.08 46.81 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.289 0.949 . . . . 10.0 113.019 -169.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -141.57 136.97 31.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.074 1.749 . . . . 10.0 106.774 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.5 t -78.77 141.66 37.62 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.598 -0.689 . . . . 10.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.4 mt -103.48 -20.36 14.07 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.377 0.671 . . . . 10.0 111.146 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.71 -177.96 34.25 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.814 -0.914 . . . . 10.0 110.814 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.15 178.42 32.68 Favored Glycine 0 CA--C 1.521 0.427 0 O-C-N 121.631 -0.923 . . . . 10.0 112.356 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.97 -145.6 5.6 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 109.84 -1.304 . . . . 10.0 109.84 -172.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -142.55 161.72 37.32 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.894 2.078 . . . . 10.0 107.755 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.8 mt -132.29 145.32 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 105.929 -1.878 . . . . 10.0 105.929 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.0 p . . . . . 0 CA--C 1.535 0.385 0 C-N-CA 124.431 1.092 . . . . 10.0 110.747 -175.833 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.3 mm . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 101.676 -3.453 . . . . 10.0 101.676 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -117.53 145.63 44.11 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.5 -0.555 . . . . 10.0 109.5 -167.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 32.1 t -135.17 130.49 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.917 -1.512 . . . . 10.0 106.917 -170.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -166.86 169.46 13.17 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.135 -0.978 . . . . 10.0 109.47 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.03 -174.63 19.84 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 119.272 0.942 . . . . 10.0 114.435 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -140.41 1.31 1.76 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.413 1.264 . . . . 10.0 114.413 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.6 p 50.53 -25.55 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 129.707 3.203 . . . . 10.0 119.007 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 12.3 tmm? 66.58 -48.39 0.45 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.574 2.35 . . . . 10.0 111.009 -168.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.74 70.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.363 1.465 . . . . 10.0 113.016 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -133.93 -50.25 0.82 Allowed 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.643 0.656 . . . . 10.0 111.747 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.02 170.96 12.31 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 109.37 -1.492 . . . . 10.0 109.37 -170.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.05 130.97 40.59 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.029 2.486 . . . . 10.0 111.8 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.66 158.88 28.92 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 168.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -77.1 73.34 3.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -54.61 -26.24 31.52 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.199 0.999 . . . . 10.0 112.835 -170.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.29 -41.06 98.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.261 0.937 . . . . 10.0 112.08 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.2 mt -64.52 -50.24 76.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 107.497 -1.298 . . . . 10.0 107.497 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -60.09 -43.62 95.39 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 119.129 -0.462 . . . . 10.0 111.892 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.9 p -66.58 -37.83 85.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.064 0.847 . . . . 10.0 111.547 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -64.89 -38.97 92.76 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.418 1.008 . . . . 10.0 110.796 175.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -66.66 -45.06 80.17 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 122.042 -0.411 . . . . 10.0 110.626 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.86 -48.72 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -59.03 -40.02 83.75 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.158 0.89 . . . . 10.0 111.567 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.33 72.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.992 0.815 . . . . 10.0 111.977 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 118.534 -0.746 . . . . 10.0 112.822 174.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 107.597 -1.26 . . . . 10.0 107.597 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.0 p -145.53 158.42 43.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.826 1.65 . . . . 10.0 108.926 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -151.22 164.23 37.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.838 0.681 . . . . 10.0 112.838 173.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 126.606 1.962 . . . . 10.0 108.436 170.206 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -151.05 152.05 32.89 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.016 -1.105 . . . . 10.0 108.016 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -59.53 -22.4 61.61 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.937 0.895 . . . . 10.0 113.04 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.94 -24.56 66.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.637 1.108 . . . . 10.0 112.435 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.5 mt -78.96 -17.1 56.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.455 0.702 . . . . 10.0 111.745 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 25.8 mt -100.36 132.35 22.65 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.46 142.33 64.98 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.388 2.058 . . . . 10.0 110.272 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -78.51 -28.88 46.35 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.816 0.847 . . . . 10.0 112.163 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.26 134.38 47.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 106.086 -1.82 . . . . 10.0 106.086 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -152.96 113.42 4.04 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.3 pt . . . . . 0 C--N 1.327 -0.382 0 C-N-CA 124.56 1.144 . . . . 10.0 109.962 -169.548 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -150.37 147.84 28.08 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.986 0.914 . . . . 10.0 109.734 171.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -74.93 157.88 34.25 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.672 -0.862 . . . . 10.0 108.672 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.71 160.35 43.25 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.549 0.34 . . . . 10.0 110.458 173.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 t -133.57 141.89 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.453 1.501 . . . . 10.0 107.383 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 tp -98.63 115.84 29.54 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 104.654 -2.35 . . . . 10.0 104.654 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.3 mt -122.83 124.84 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.625 -1.62 . . . . 10.0 106.625 -167.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -82.53 140.16 33.46 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 168.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.2 t -133.13 142.65 41.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.446 -1.687 . . . . 10.0 106.446 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -126.29 136.96 53.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.509 1.524 . . . . 10.0 107.119 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.9 m -67.56 140.44 56.95 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.36 57.31 2.77 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.399 1.479 . . . . 10.0 107.981 167.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -59.97 135.12 60.88 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.333 2.689 . . . . 10.0 109.834 -169.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 47.34 26.04 0.67 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.028 1.331 . . . . 10.0 112.956 -174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m 48.23 31.28 2.55 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.458 1.503 . . . . 10.0 113.655 -172.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -172.64 -3.39 0.03 OUTLIER Glycine 0 CA--C 1.531 1.051 0 N-CA-C 117.019 1.568 . . . . 10.0 117.019 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.05 151.08 81.76 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 120.433 2.116 . . . . 10.0 110.556 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.03 52.06 3.9 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.315 3.344 . . . . 10.0 111.54 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.53 136.07 30.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.003 1.321 . . . . 10.0 108.723 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.7 31.5 1.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.327 1.451 . . . . 10.0 109.762 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -61.97 151.48 34.91 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.51 -0.922 . . . . 10.0 108.51 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.4 m -139.39 158.49 44.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.799 0.84 . . . . 10.0 110.686 -175.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -152.41 176.78 11.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.807 1.243 . . . . 10.0 109.247 171.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -117.0 142.82 46.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.0 pt -131.17 156.42 42.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.623 1.169 . . . . 10.0 110.067 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.42 125.8 65.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.915 -1.883 . . . . 10.0 105.915 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -130.13 139.17 50.93 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.0 132.76 2.5 Favored Glycine 0 C--O 1.224 -0.527 0 CA-C-N 120.03 1.286 . . . . 10.0 111.817 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -144.75 144.18 31.06 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 122.888 0.475 . . . . 10.0 111.178 -169.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -64.58 -32.45 74.11 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.845 0.858 . . . . 10.0 112.248 -174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -68.59 -16.69 63.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 117.912 -1.042 . . . . 10.0 113.008 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.8 119.31 6.91 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.631 1.105 . . . . 10.0 111.629 -172.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.13 -37.36 81.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.161 0.584 . . . . 10.0 110.18 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -149.67 168.86 22.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 127.142 2.177 . . . . 10.0 107.598 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -59.6 -29.37 67.94 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.135 -0.978 . . . . 10.0 111.805 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.92 68.9 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.838 0.855 . . . . 10.0 112.359 172.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -66.39 -42.6 87.65 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.795 0.807 . . . . 10.0 109.802 -176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.78 -53.84 37.17 Favored 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.214 -1.032 . . . . 10.0 108.214 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -59.14 -39.17 81.55 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 119.027 -0.511 . . . . 10.0 110.992 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.51 -46.02 90.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.445 0.566 . . . . 10.0 111.761 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.83 -49.16 75.99 Favored 'General case' 0 C--N 1.345 0.373 0 O-C-N 121.691 -0.63 . . . . 10.0 109.661 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.79 -43.73 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.301 -0.629 . . . . 10.0 109.301 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.7 p -65.09 -34.05 77.49 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.251 0.932 . . . . 10.0 111.205 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.98 -51.21 60.02 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.393 -1.083 . . . . 10.0 110.393 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.98 -46.25 91.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 117.357 0.579 . . . . 10.0 110.792 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.9 mmt -61.84 -37.75 85.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.702 -0.624 . . . . 10.0 110.812 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -64.86 -36.49 84.52 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.997 0.817 . . . . 10.0 111.14 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -66.61 -34.22 77.41 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.994 -1.003 . . . . 10.0 111.304 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -68.15 -54.22 19.53 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.841 0.746 . . . . 10.0 109.546 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.52 44.04 0.2 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.453 1.502 . . . . 10.0 110.551 -171.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.4 m -144.91 171.68 14.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.229 1.812 . . . . 10.0 109.047 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -139.54 160.92 38.74 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.432 1.493 . . . . 10.0 108.709 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.8 m -127.71 157.59 39.91 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.847 1.259 . . . . 10.0 112.98 -168.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -145.52 111.75 5.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.677 1.991 . . . . 10.0 106.283 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -63.42 118.9 8.75 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.97 -1.081 . . . . 10.0 108.775 171.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 mt -80.7 -29.02 36.49 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 110.171 -0.307 . . . . 10.0 110.171 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.64 -178.43 39.84 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.157 -1.977 . . . . 10.0 108.157 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.99 -168.86 20.19 Favored Glycine 0 CA--C 1.519 0.314 0 O-C-N 121.398 -1.06 . . . . 10.0 110.851 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.17 -151.41 9.07 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.358 -1.897 . . . . 10.0 108.358 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -144.13 165.4 27.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -134.32 151.46 32.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 104.835 -2.283 . . . . 10.0 104.835 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 107.985 -1.117 . . . . 10.0 107.985 177.182 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.7 pt . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 106.865 -1.531 . . . . 10.0 106.865 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -99.79 126.69 45.91 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.199 -1.038 . . . . 10.0 108.199 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.42 145.31 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 106.652 -1.61 . . . . 10.0 106.652 174.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -161.67 178.77 8.71 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.687 0.795 . . . . 10.0 110.182 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.89 -158.26 46.31 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-O 121.328 0.405 . . . . 10.0 112.92 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -158.67 158.03 32.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.557 1.943 . . . . 10.0 107.56 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 t -72.09 130.78 41.71 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 60.4 mtt -73.3 -19.32 61.07 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.604 0.565 . . . . 10.0 110.811 169.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.95 -31.32 22.18 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.536 -0.745 . . . . 10.0 112.077 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -128.17 -54.53 1.28 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.889 0.768 . . . . 10.0 111.297 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.09 179.85 22.58 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.837 1.208 . . . . 10.0 110.165 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.39 133.42 58.0 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.113 2.542 . . . . 10.0 111.673 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.69 165.76 20.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 166.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -80.12 68.22 6.19 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 168.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -49.45 -33.03 13.12 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.463 1.505 . . . . 10.0 113.709 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.5 77.18 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.993 0.815 . . . . 10.0 112.231 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.72 -50.97 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 107.097 -1.445 . . . . 10.0 107.097 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -55.94 -46.52 78.48 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.468 -0.777 . . . . 10.0 112.137 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.6 p -64.99 -42.32 94.63 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 119.721 1.146 . . . . 10.0 111.034 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.87 -39.44 90.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.864 0.756 . . . . 10.0 110.979 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -59.83 -51.66 68.77 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 118.818 -0.61 . . . . 10.0 109.836 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.47 -48.81 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.419 -0.956 . . . . 10.0 108.419 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -60.99 -40.75 94.66 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.693 0.797 . . . . 10.0 111.513 -175.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.12 77.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.122 0.569 . . . . 10.0 110.842 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 118.62 -0.705 . . . . 10.0 112.082 -173.766 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.236 0.346 0 N-CA-C 107.138 -1.43 . . . . 10.0 107.138 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -142.44 170.65 15.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.646 1.178 . . . . 10.0 108.707 173.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -138.75 163.28 32.6 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 122.851 0.46 . . . . 10.0 111.886 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.417 0 C-N-CA 126.164 1.785 . . . . 10.0 108.727 169.939 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -151.16 151.32 31.76 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.931 1.292 . . . . 10.0 107.542 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.13 -24.06 62.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 118.237 -0.887 . . . . 10.0 112.886 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.88 -25.9 67.02 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.605 1.093 . . . . 10.0 112.451 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.2 mt -74.94 -23.77 58.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.123 0.569 . . . . 10.0 111.366 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.9 mt -89.2 128.97 49.51 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 107.071 -1.455 . . . . 10.0 107.071 -173.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.81 147.17 80.48 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.165 1.91 . . . . 10.0 110.67 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.92 -35.61 72.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.779 1.632 . . . . 10.0 111.603 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.64 133.26 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.625 -2.361 . . . . 10.0 104.625 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -150.32 114.3 5.07 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.063 -1.829 . . . . 10.0 106.063 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.3 pt . . . . . 0 N--CA 1.453 -0.323 0 C-N-CA 124.502 1.121 . . . . 10.0 109.525 -170.227 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 108.576 -0.898 . . . . 10.0 108.576 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -146.82 151.16 36.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.694 0.797 . . . . 10.0 109.981 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -55.95 153.46 8.69 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.64 1.176 . . . . 10.0 111.629 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.51 160.9 43.08 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.074 0.95 . . . . 10.0 108.965 168.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.12 147.25 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.703 1.201 . . . . 10.0 108.911 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -107.77 117.99 35.56 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.566 -2.013 . . . . 10.0 105.566 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.3 mt -123.19 132.34 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.522 -1.659 . . . . 10.0 106.522 -170.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -85.32 125.3 32.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.537 -2.023 . . . . 10.0 105.537 167.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.38 141.17 24.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 106.604 -1.628 . . . . 10.0 106.604 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -121.6 130.1 53.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.976 -1.861 . . . . 10.0 105.976 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.6 p -71.03 144.32 50.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.958 -0.386 . . . . 10.0 109.958 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.0 61.83 3.56 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.567 1.547 . . . . 10.0 107.603 166.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -58.08 143.9 95.76 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.944 2.429 . . . . 10.0 110.601 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 48.18 23.72 0.57 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.842 1.257 . . . . 10.0 113.111 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m 49.05 30.95 3.09 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.225 1.41 . . . . 10.0 113.683 -172.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.62 -2.34 0.02 OUTLIER Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.762 1.465 . . . . 10.0 116.762 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.16 152.22 78.94 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 119.937 1.868 . . . . 10.0 110.657 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.78 57.77 6.18 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.285 3.323 . . . . 10.0 112.098 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.24 136.91 30.32 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 125.073 1.349 . . . . 10.0 108.309 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.79 28.53 0.77 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.897 1.279 . . . . 10.0 110.448 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.04 159.94 24.86 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.375 -0.828 . . . . 10.0 109.095 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.0 m -139.76 162.12 35.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.874 0.87 . . . . 10.0 110.694 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -149.29 174.88 11.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.647 1.179 . . . . 10.0 109.351 170.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -99.3 148.85 23.73 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 pt -136.53 148.62 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.604 1.562 . . . . 10.0 109.72 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.7 t -106.94 127.34 62.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -132.68 141.95 48.84 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.618 -1.253 . . . . 10.0 107.618 -176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.06 107.21 0.23 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 110.132 -1.187 . . . . 10.0 110.132 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.97 132.62 42.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 -171.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -59.55 -23.95 63.3 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.791 1.404 . . . . 10.0 114.791 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -67.39 -24.65 65.7 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.315 0.961 . . . . 10.0 112.425 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.98 125.42 29.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.744 1.157 . . . . 10.0 109.799 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -74.29 -33.59 63.28 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.392 0.615 . . . . 10.0 109.855 171.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -143.71 155.91 44.36 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.15 1.38 . . . . 10.0 110.008 -172.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -58.66 -33.87 70.6 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.415 1.486 . . . . 10.0 112.94 -171.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.94 -31.09 70.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.383 -0.818 . . . . 10.0 111.513 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -70.93 -38.54 72.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.86 0.755 . . . . 10.0 110.124 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.4 mt -63.88 -50.34 77.95 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -52.92 -48.26 67.39 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.427 -0.797 . . . . 10.0 111.123 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.2 -47.15 83.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.417 0.553 . . . . 10.0 111.255 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -59.48 -51.42 69.95 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.872 -0.518 . . . . 10.0 110.153 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.1 t -66.98 -41.26 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.678 -0.86 . . . . 10.0 108.678 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 m -62.91 -36.04 82.06 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.629 1.104 . . . . 10.0 111.547 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.77 -51.13 59.45 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.163 -1.175 . . . . 10.0 110.163 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.29 -43.45 98.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.793 0.797 . . . . 10.0 111.016 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.1 mmt -62.32 -37.0 83.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 121.71 -0.619 . . . . 10.0 111.433 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -65.03 -36.17 83.52 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.009 0.822 . . . . 10.0 110.755 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.78 -32.72 74.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.64 -1.172 . . . . 10.0 111.509 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -68.99 -52.16 31.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.718 1.144 . . . . 10.0 109.727 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.08 50.12 0.24 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.766 -1.734 . . . . 10.0 108.766 -169.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.0 m -147.69 170.65 17.08 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.532 1.933 . . . . 10.0 109.216 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -140.2 165.38 27.52 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.276 1.83 . . . . 10.0 108.48 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.1 m -134.48 156.14 49.12 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.582 1.153 . . . . 10.0 112.358 -167.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -149.25 123.23 9.39 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.135 -1.802 . . . . 10.0 106.135 169.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.71 126.98 31.35 Favored 'General case' 0 C--O 1.226 -0.178 0 O-C-N 121.038 -1.039 . . . . 10.0 109.334 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.99 -27.33 35.97 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 122.097 -0.377 . . . . 10.0 110.306 170.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.1 -177.87 38.14 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.966 -1.654 . . . . 10.0 108.966 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.96 -173.01 21.87 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.5 -1.0 . . . . 10.0 111.48 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.51 -146.77 6.4 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.511 -1.836 . . . . 10.0 108.511 -173.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -147.71 159.91 43.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.601 1.161 . . . . 10.0 109.505 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.9 mt -128.7 149.32 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.513 -2.032 . . . . 10.0 105.513 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 C--O 1.237 0.445 0 C-N-CA 124.245 1.018 . . . . 10.0 108.814 170.432 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.0 mt . . . . . 0 C--O 1.238 0.491 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -136.38 147.14 47.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.415 -1.328 . . . . 10.0 107.415 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.69 135.51 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.173 -1.417 . . . . 10.0 107.173 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -164.79 175.29 9.79 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.941 0.897 . . . . 10.0 109.695 -170.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.52 -174.19 20.87 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 121.722 0.624 . . . . 10.0 112.76 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -141.9 24.81 1.99 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.047 0.939 . . . . 10.0 111.862 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.7 p 59.46 -174.89 0.1 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.511 1.924 . . . . 10.0 112.832 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.0 mtt -128.55 21.81 6.01 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.192 1.397 . . . . 10.0 109.039 167.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.24 -28.83 0.45 Allowed 'General case' 0 C--N 1.347 0.488 0 N-CA-C 115.172 1.545 . . . . 10.0 115.172 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.89 -52.54 0.52 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.484 1.493 . . . . 10.0 111.554 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.29 177.79 25.44 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.42 1.486 . . . . 10.0 109.646 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.3 134.45 45.31 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.759 2.306 . . . . 10.0 111.178 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.55 160.93 18.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.963 0.887 . . . . 10.0 109.085 165.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -80.33 75.4 7.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.724 -1.584 . . . . 10.0 106.724 169.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -54.53 -23.74 17.8 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.724 1.209 . . . . 10.0 113.546 -170.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.45 -40.37 94.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.703 1.138 . . . . 10.0 111.675 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.7 mt -65.16 -51.84 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.7 m -57.83 -45.42 86.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.712 -0.661 . . . . 10.0 112.003 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.0 p -68.74 -38.61 80.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 117.775 -1.107 . . . . 10.0 111.654 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.4 -40.29 96.82 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.076 1.307 . . . . 10.0 110.71 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -62.74 -50.43 71.09 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.133 -0.355 . . . . 10.0 110.064 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.2 -39.46 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 120.651 -1.281 . . . . 10.0 109.076 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -62.03 -41.55 98.21 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 119.624 1.102 . . . . 10.0 110.66 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.34 -41.3 96.84 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.315 0.961 . . . . 10.0 111.048 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 118.252 -0.88 . . . . 10.0 110.66 176.224 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 108.644 -0.873 . . . . 10.0 108.644 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.63 169.27 21.97 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.569 1.548 . . . . 10.0 109.96 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.6 p-90 -145.63 166.18 26.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.755 1.162 . . . . 10.0 111.243 172.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 125.98 1.712 . . . . 10.0 108.236 169.22 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 106.753 -1.573 . . . . 10.0 106.753 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -144.89 147.05 32.33 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.382 -1.71 . . . . 10.0 106.382 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -59.05 -26.21 64.39 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.54 -24.92 67.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.704 0.684 . . . . 10.0 112.713 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.83 -27.74 57.99 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.37 0.532 . . . . 10.0 110.61 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 mt -79.94 132.52 60.27 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.11 147.88 80.17 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.453 2.102 . . . . 10.0 109.531 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.49 -28.61 46.41 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.287 0.565 . . . . 10.0 112.131 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -137.96 135.51 45.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.256 1.422 . . . . 10.0 107.173 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -147.84 99.8 3.13 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.541 -1.281 . . . . 10.0 107.541 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.6 pt . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 125.656 1.583 . . . . 10.0 109.736 -169.456 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 108.283 -1.006 . . . . 10.0 108.283 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -141.94 148.67 39.02 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.059 1.344 . . . . 10.0 108.977 173.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -60.43 151.61 27.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.658 0.783 . . . . 10.0 109.187 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.08 162.07 41.66 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.633 -0.667 . . . . 10.0 110.563 170.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.84 152.86 31.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.889 1.276 . . . . 10.0 109.677 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 tp -102.63 114.3 28.41 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.654 -2.351 . . . . 10.0 104.654 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.4 mt -116.58 132.13 67.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.2 -1.778 . . . . 10.0 106.2 -170.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -88.51 139.51 30.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.437 -1.69 . . . . 10.0 106.437 168.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -128.98 142.43 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.076 -1.824 . . . . 10.0 106.076 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -120.6 133.57 55.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.189 -1.782 . . . . 10.0 106.189 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 p -65.8 140.65 58.42 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.766 -0.457 . . . . 10.0 109.766 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.9 60.2 2.89 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.24 1.416 . . . . 10.0 108.676 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.36 143.63 99.49 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.05 2.5 . . . . 10.0 108.941 -174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.0 tpt85 53.12 16.17 0.73 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.637 1.175 . . . . 10.0 113.102 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 m 54.97 24.15 5.67 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.44 1.096 . . . . 10.0 113.222 -170.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.87 1.47 0.03 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.652 1.421 . . . . 10.0 116.652 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.53 153.35 77.67 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 119.984 1.892 . . . . 10.0 110.252 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.95 64.42 7.7 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.315 3.344 . . . . 10.0 111.925 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.32 140.0 35.55 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.378 1.471 . . . . 10.0 108.346 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.36 26.17 0.78 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.806 1.242 . . . . 10.0 110.65 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.88 159.96 27.16 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 169.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -139.45 162.64 34.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.154 0.982 . . . . 10.0 111.135 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -152.43 145.3 24.4 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.318 1.847 . . . . 10.0 107.71 -170.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.2 144.03 28.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 169.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.8 pt -134.74 151.37 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.238 1.015 . . . . 10.0 109.965 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.29 127.12 56.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 105.875 -1.898 . . . . 10.0 105.875 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -130.28 133.63 46.63 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.55 49.51 0.33 Allowed Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.068 -0.813 . . . . 10.0 111.068 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -65.92 132.95 49.84 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -63.1 -27.12 69.17 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.924 1.083 . . . . 10.0 113.924 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -69.39 -20.61 63.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 117.958 -1.02 . . . . 10.0 112.641 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.44 133.93 52.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.29 0.95 . . . . 10.0 111.031 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -79.49 -35.61 39.9 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.509 0.671 . . . . 10.0 109.901 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -143.7 163.42 33.34 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.96 1.304 . . . . 10.0 110.109 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -57.54 -40.87 79.81 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.921 0.888 . . . . 10.0 111.466 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.74 -25.25 66.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.674 -0.679 . . . . 10.0 112.4 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -67.3 -41.49 85.28 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.148 0.975 . . . . 10.0 109.149 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.67 -55.26 23.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.13 -1.063 . . . . 10.0 108.13 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -57.6 -41.02 80.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 119.171 -0.443 . . . . 10.0 111.732 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.68 -44.8 92.64 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.724 0.409 . . . . 10.0 111.612 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.39 -51.35 69.88 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.44 -39.86 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 118.201 -0.904 . . . . 10.0 110.05 -175.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.0 m -61.77 -46.34 90.01 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.275 0.943 . . . . 10.0 110.362 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.51 -44.62 94.91 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.006 -0.838 . . . . 10.0 111.006 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -58.59 -52.8 64.12 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.07 1.348 . . . . 10.0 109.481 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.6 mmt -61.39 -37.81 84.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.253 0.621 . . . . 10.0 111.485 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -64.19 -37.83 88.89 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 119.224 0.92 . . . . 10.0 110.85 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.92 -37.53 87.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 117.702 -1.142 . . . . 10.0 110.942 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -67.55 -51.14 54.22 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.714 0.688 . . . . 10.0 109.727 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.11 41.16 0.29 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.86 1.219 . . . . 10.0 110.789 -169.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.4 m -145.51 171.5 14.57 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.961 1.704 . . . . 10.0 108.742 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -140.11 164.49 29.89 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.81 1.644 . . . . 10.0 108.239 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.6 m -130.58 164.83 24.06 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.506 1.048 . . . . 10.0 113.401 -168.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.98 132.88 16.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.184 2.194 . . . . 10.0 105.203 168.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -80.61 132.05 35.57 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.785 -1.197 . . . . 10.0 108.138 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.5 mt -87.63 -21.54 25.25 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 119.263 -0.399 . . . . 10.0 110.625 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.86 -178.32 26.5 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 109.148 -1.581 . . . . 10.0 109.148 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.08 -171.83 24.49 Favored Glycine 0 C--N 1.329 0.183 0 O-C-N 121.706 -0.879 . . . . 10.0 111.866 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.18 -140.6 4.7 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 107.364 -2.295 . . . . 10.0 107.364 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -139.31 149.44 44.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.883 -1.155 . . . . 10.0 107.883 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.24 146.05 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.871 -2.27 . . . . 10.0 104.871 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.454 -0.23 0 C-N-CA 123.812 0.845 . . . . 10.0 111.173 -168.616 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 C--O 1.234 0.261 0 N-CA-C 105.247 -2.131 . . . . 10.0 105.247 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -132.76 164.71 26.19 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.992 0.808 . . . . 10.0 110.605 -166.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 t -133.51 130.61 56.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.136 1.374 . . . . 10.0 107.767 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.11 178.17 10.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.568 0.747 . . . . 10.0 110.894 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.42 -175.95 45.61 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.661 -0.575 . . . . 10.0 111.661 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.84 152.26 41.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.086 1.354 . . . . 10.0 107.36 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 78.7 p -67.57 142.52 56.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.715 -0.616 . . . . 10.0 109.868 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.1 mtp -70.26 -29.65 66.48 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.759 -0.459 . . . . 10.0 109.759 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.29 -33.52 63.27 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 117.883 -1.056 . . . . 10.0 113.307 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -136.32 -52.2 0.71 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.588 1.085 . . . . 10.0 112.489 -169.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.45 -174.99 23.72 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.855 1.216 . . . . 10.0 110.248 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.81 138.39 57.87 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.716 2.277 . . . . 10.0 111.249 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.2 167.6 20.0 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.996 -1.113 . . . . 10.0 107.996 165.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -80.23 79.06 6.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.368 -1.716 . . . . 10.0 106.368 168.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -56.11 -32.36 64.12 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 124.133 0.973 . . . . 10.0 111.6 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.97 -42.28 97.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.801 0.728 . . . . 10.0 112.214 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.2 mt -63.87 -46.93 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.212 -1.403 . . . . 10.0 107.212 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.5 m -57.12 -44.9 83.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.212 -0.899 . . . . 10.0 111.752 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.1 p -64.95 -38.03 89.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.463 1.483 . . . . 10.0 111.436 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.16 -40.22 95.67 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.317 0.962 . . . . 10.0 110.639 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -65.28 -47.36 76.92 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.611 -0.681 . . . . 10.0 110.451 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.6 mt -60.62 -45.34 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -53.12 -49.97 65.45 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.898 0.879 . . . . 10.0 110.092 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.87 -32.36 73.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.005 0.522 . . . . 10.0 112.399 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.5 tptm . . . . . 0 C--N 1.342 0.271 0 CA-C-N 118.981 0.81 . . . . 10.0 109.981 -176.756 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 103.145 -2.909 . . . . 10.0 103.145 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.9 p -119.06 165.41 14.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.2 0.909 . . . . 10.0 110.76 -170.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -154.48 162.5 41.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 120.901 -1.124 . . . . 10.0 108.453 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 112.8 0.667 . . . . 10.0 112.8 174.039 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.437 0 N-CA-C 106.394 -1.706 . . . . 10.0 106.394 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -150.83 151.22 31.96 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.31 -23.81 64.49 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.566 0.746 . . . . 10.0 112.514 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.12 67.42 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.224 0.92 . . . . 10.0 112.08 173.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.51 -35.53 58.27 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 122.866 0.466 . . . . 10.0 109.837 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mt -63.64 122.59 77.38 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.43 141.94 88.77 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.349 2.032 . . . . 10.0 109.531 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -85.14 -32.18 22.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.192 0.52 . . . . 10.0 112.395 -169.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -139.61 134.06 38.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.599 -2.001 . . . . 10.0 105.599 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -149.61 98.96 2.83 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.599 -1.259 . . . . 10.0 107.599 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.8 pt . . . . . 0 CA--C 1.537 0.443 0 C-N-CA 126.125 1.77 . . . . 10.0 107.959 -174.006 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.574 -0.528 . . . . 10.0 109.574 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -157.32 147.86 21.18 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.287 0.635 . . . . 10.0 109.72 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -67.59 164.48 18.99 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.412 0.625 . . . . 10.0 111.276 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -151.61 166.61 30.69 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.603 0.761 . . . . 10.0 109.196 173.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.88 148.54 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.509 1.124 . . . . 10.0 108.538 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.44 122.35 47.5 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.845 -1.909 . . . . 10.0 105.845 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.4 mt -129.08 136.95 58.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.472 -1.677 . . . . 10.0 106.472 -171.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -93.64 131.86 38.53 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.221 -1.77 . . . . 10.0 106.221 169.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.7 144.06 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.614 -1.254 . . . . 10.0 107.614 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -122.5 122.45 38.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.737 -1.949 . . . . 10.0 105.737 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.1 p -75.85 147.89 38.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.058 0.456 . . . . 10.0 111.475 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.57 65.46 2.29 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 127.31 2.244 . . . . 10.0 106.606 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -54.64 140.7 76.15 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.392 2.728 . . . . 10.0 111.211 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 48.88 21.9 0.5 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.654 1.182 . . . . 10.0 113.295 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.3 m 48.79 35.69 6.84 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.098 1.359 . . . . 10.0 112.923 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.41 -12.03 0.02 OUTLIER Glycine 0 CA--C 1.531 1.047 0 N-CA-C 116.618 1.407 . . . . 10.0 116.618 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.03 150.12 92.48 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 120.006 1.903 . . . . 10.0 110.776 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.41 61.33 7.84 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.325 3.35 . . . . 10.0 111.695 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.86 140.02 34.54 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.886 1.275 . . . . 10.0 108.6 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.97 27.94 0.77 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.89 1.276 . . . . 10.0 110.931 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.84 165.37 19.9 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.426 0.69 . . . . 10.0 109.361 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -139.31 159.93 41.0 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.225 1.01 . . . . 10.0 110.142 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -153.05 175.51 12.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.596 1.158 . . . . 10.0 109.584 170.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -96.43 159.62 14.84 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.06 -0.718 . . . . 10.0 109.06 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.1 pt -138.24 147.55 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.95 1.7 . . . . 10.0 108.425 169.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.27 124.95 64.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.02 -1.845 . . . . 10.0 106.02 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -131.01 136.89 48.9 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.077 0.951 . . . . 10.0 108.637 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.38 47.82 0.34 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 109.687 -1.365 . . . . 10.0 109.687 -172.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -67.77 125.84 27.5 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.063 0.545 . . . . 10.0 111.041 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -59.3 -31.44 69.15 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.626 0.973 . . . . 10.0 113.626 -171.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -69.01 -17.81 63.96 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 118.169 -0.919 . . . . 10.0 112.662 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.78 136.39 57.39 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.142 0.883 . . . . 10.0 111.538 -171.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.69 -38.54 80.39 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.388 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -154.77 169.7 23.33 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.22 1.808 . . . . 10.0 108.791 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -55.65 -32.36 63.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.098 0.959 . . . . 10.0 111.737 169.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.01 80.83 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.121 0.568 . . . . 10.0 111.751 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -69.92 -39.2 76.27 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.03 -57.28 12.88 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 108.458 -0.941 . . . . 10.0 108.458 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -58.93 -40.85 85.84 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.334 -0.365 . . . . 10.0 111.222 -172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.83 -46.72 83.81 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.54 0.336 . . . . 10.0 111.68 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -64.28 -45.22 88.98 Favored 'General case' 0 C--N 1.344 0.327 0 O-C-N 121.785 -0.572 . . . . 10.0 109.907 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.09 -44.22 98.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 123.478 0.711 . . . . 10.0 109.093 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.7 m -60.95 -38.61 86.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.346 0.975 . . . . 10.0 111.092 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.17 -52.2 43.14 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.866 -0.894 . . . . 10.0 110.866 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.27 -42.4 99.13 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 117.48 0.64 . . . . 10.0 111.366 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 25.4 mmt -62.51 -38.07 88.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.4 -0.81 . . . . 10.0 110.768 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -62.9 -36.04 82.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.581 1.082 . . . . 10.0 111.042 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -66.07 -33.43 75.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.098 -0.953 . . . . 10.0 111.685 172.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -70.76 -40.32 72.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.219 0.918 . . . . 10.0 110.679 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.51 53.07 0.73 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 108.768 -1.733 . . . . 10.0 108.768 -168.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.2 m -141.84 165.04 28.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.235 1.814 . . . . 10.0 107.855 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -128.31 161.87 28.4 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.581 1.553 . . . . 10.0 107.668 171.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 73.6 m -127.79 154.28 45.59 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.368 1.067 . . . . 10.0 112.576 -168.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -143.7 116.72 8.87 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.162 -1.792 . . . . 10.0 106.162 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.3 p -61.25 130.46 46.29 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.134 -0.979 . . . . 10.0 108.739 170.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.8 mt -90.66 -24.45 20.47 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.48 0.312 . . . . 10.0 110.21 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.98 179.07 33.55 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.907 -1.677 . . . . 10.0 108.907 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.67 -179.33 22.72 Favored Glycine 0 CA--C 1.522 0.527 0 O-C-N 121.681 -0.894 . . . . 10.0 111.485 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.56 -149.98 7.05 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 109.789 -1.324 . . . . 10.0 109.789 -170.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -147.43 165.13 31.16 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.794 1.238 . . . . 10.0 109.505 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.3 mt -133.82 149.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.484 -2.413 . . . . 10.0 104.484 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 C--N 1.328 -0.349 0 C-N-CA 123.516 0.726 . . . . 10.0 109.582 175.291 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 70.9 mt . . . . . 0 C--O 1.239 0.535 0 CA-C-O 121.526 0.679 . . . . 10.0 109.187 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -134.51 148.8 50.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.007 1.323 . . . . 10.0 108.076 172.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.7 138.62 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.751 1.621 . . . . 10.0 107.286 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -169.31 -167.13 0.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.212 1.405 . . . . 10.0 107.905 -171.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.05 -172.92 38.97 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 121.361 -0.837 . . . . 10.0 112.738 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.69 174.31 11.91 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.951 0.9 . . . . 10.0 109.908 169.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.3 m -131.81 105.89 7.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.219 -2.141 . . . . 10.0 105.219 169.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.3 ttt -54.83 -28.71 51.61 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.303 1.041 . . . . 10.0 113.14 -169.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.0 -25.06 66.62 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.998 0.74 . . . . 10.0 112.998 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -128.87 -49.58 1.23 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.623 0.769 . . . . 10.0 110.407 -170.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.81 174.69 13.75 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.203 1.858 . . . . 10.0 108.917 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -53.94 136.14 65.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.574 2.183 . . . . 10.0 110.895 169.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.93 159.29 25.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.697 0.761 . . . . 10.0 109.164 168.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -78.76 72.01 5.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 169.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -49.52 -32.89 13.27 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.26 1.424 . . . . 10.0 113.551 -169.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.02 -38.03 72.55 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.069 0.85 . . . . 10.0 112.426 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.9 mt -64.8 -51.38 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 106.992 -1.484 . . . . 10.0 106.992 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -59.95 -43.64 94.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.288 -0.863 . . . . 10.0 111.804 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -63.42 -40.42 97.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 119.79 1.177 . . . . 10.0 111.002 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.97 -39.94 90.81 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.275 0.943 . . . . 10.0 110.674 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -66.32 -45.98 78.45 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.986 -0.446 . . . . 10.0 110.045 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.0 mt -59.1 -41.89 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -64.18 -36.56 84.44 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 120.877 -1.14 . . . . 10.0 111.35 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.27 -42.51 93.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.514 0.597 . . . . 10.0 111.037 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.2 tptt . . . . . 0 CA--C 1.541 0.621 0 C-N-CA 123.421 0.689 . . . . 10.0 111.011 173.335 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.234 0.25 0 N-CA-C 106.781 -1.562 . . . . 10.0 106.781 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -147.52 165.45 30.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.388 1.075 . . . . 10.0 109.612 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 40.4 p-90 -145.75 162.09 38.42 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 118.285 0.493 . . . . 10.0 111.181 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.252 0 C-N-CA 126.617 1.967 . . . . 10.0 107.361 169.842 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.95 153.66 35.65 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.651 1.18 . . . . 10.0 108.107 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.86 -20.39 56.82 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.902 0.881 . . . . 10.0 113.036 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.12 -23.59 63.98 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.605 1.093 . . . . 10.0 112.375 173.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -78.36 -7.84 57.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.557 0.743 . . . . 10.0 111.943 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -111.11 126.62 28.31 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 106.168 -1.79 . . . . 10.0 106.168 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -69.88 153.61 68.2 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.927 1.751 . . . . 10.0 109.992 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -81.51 -27.56 34.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.385 1.474 . . . . 10.0 112.642 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.8 t -134.84 133.62 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 124.995 1.318 . . . . 10.0 107.471 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -149.2 103.88 3.36 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.755 -1.572 . . . . 10.0 106.755 169.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.0 pt . . . . . 0 CA--C 1.539 0.546 0 C-N-CA 125.192 1.397 . . . . 10.0 110.108 -169.749 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 108.997 -0.742 . . . . 10.0 108.997 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -151.87 152.38 32.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.139 0.976 . . . . 10.0 109.784 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -74.36 152.3 39.58 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.711 0.805 . . . . 10.0 109.079 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.34 160.39 42.09 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.089 0.471 . . . . 10.0 110.308 173.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.22 141.67 43.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.548 -1.649 . . . . 10.0 106.548 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.7 tp -98.32 121.29 40.06 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.05 -2.204 . . . . 10.0 105.05 169.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.8 mt -129.33 135.57 61.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.582 -1.636 . . . . 10.0 106.582 -168.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -89.33 138.73 31.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.807 -1.923 . . . . 10.0 105.807 168.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 p -122.75 144.23 32.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.62 -1.622 . . . . 10.0 106.62 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -128.62 131.59 48.11 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.178 1.791 . . . . 10.0 106.713 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.5 p -78.17 140.11 38.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.824 0.284 . . . . 10.0 110.564 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.05 66.45 4.41 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.979 1.712 . . . . 10.0 107.182 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.36 -26.4 71.19 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.386 2.724 . . . . 10.0 113.131 -168.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.6 ptt85 -153.11 167.65 28.54 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.795 1.638 . . . . 10.0 107.167 168.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.2 m -58.53 137.76 57.21 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.23 27.54 60.41 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.06 0.838 . . . . 10.0 113.876 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.49 149.81 87.28 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 118.556 1.178 . . . . 10.0 110.884 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.45 35.7 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.987 3.125 . . . . 10.0 111.872 173.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.81 15.34 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.631 1.573 . . . . 10.0 108.516 -174.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.32 28.39 0.57 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.642 1.577 . . . . 10.0 109.547 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -67.21 157.15 34.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.953 0.901 . . . . 10.0 109.098 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 m -141.91 159.63 41.84 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.685 1.194 . . . . 10.0 109.838 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -152.26 176.09 11.95 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.469 1.108 . . . . 10.0 109.807 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -108.24 144.93 35.05 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.512 -0.921 . . . . 10.0 108.512 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.3 pt -137.19 148.78 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.855 1.662 . . . . 10.0 109.629 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.6 t -107.94 122.58 62.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.977 -1.86 . . . . 10.0 105.977 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -127.6 137.47 52.57 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.588 -1.634 . . . . 10.0 106.588 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.51 133.67 2.98 Favored Glycine 0 C--O 1.225 -0.428 0 CA-C-N 119.822 1.192 . . . . 10.0 111.624 174.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -146.01 140.49 26.88 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.019 0.438 . . . . 10.0 110.992 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -65.04 -28.31 69.39 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.242 1.017 . . . . 10.0 113.43 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -69.4 -16.41 63.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.502 -0.761 . . . . 10.0 112.386 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.67 122.35 15.08 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 118.869 0.759 . . . . 10.0 111.244 -173.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -69.55 -32.88 71.94 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.2 0.6 . . . . 10.0 110.201 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -148.47 163.64 36.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.668 1.987 . . . . 10.0 107.617 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -58.92 -38.07 78.12 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.653 -0.655 . . . . 10.0 110.697 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.56 -21.31 66.27 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -67.31 -39.06 85.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.729 0.776 . . . . 10.0 109.477 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.42 -53.1 46.94 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 173.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -58.3 -42.07 85.85 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 119.155 -0.45 . . . . 10.0 111.353 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.72 -45.58 85.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.287 0.494 . . . . 10.0 111.597 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -58.94 -49.55 77.41 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.377 0.671 . . . . 10.0 109.438 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.19 -47.47 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.873 0.869 . . . . 10.0 109.122 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -59.83 -35.09 74.02 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.264 0.938 . . . . 10.0 111.325 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.36 -49.31 75.39 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.646 -0.982 . . . . 10.0 110.646 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.48 -45.87 92.44 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 117.873 0.836 . . . . 10.0 111.329 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -37.43 83.34 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.635 -0.697 . . . . 10.0 110.863 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -64.56 -35.9 82.48 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.049 0.84 . . . . 10.0 110.962 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.97 -32.0 72.94 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.085 -0.959 . . . . 10.0 111.721 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -68.63 -57.99 4.92 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.079 0.854 . . . . 10.0 109.172 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.12 41.8 0.17 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.43 1.49 . . . . 10.0 110.198 -169.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.7 m -142.87 171.69 13.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.679 1.592 . . . . 10.0 109.262 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -140.23 164.07 31.04 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.043 1.737 . . . . 10.0 108.176 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.7 m -130.09 163.82 25.74 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.517 1.127 . . . . 10.0 112.299 -169.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -148.19 118.41 7.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.892 -1.892 . . . . 10.0 105.892 171.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 p -66.03 129.04 38.44 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.929 -1.107 . . . . 10.0 109.119 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 mt -93.13 -23.67 18.52 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.598 0.359 . . . . 10.0 110.461 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.3 -178.22 34.64 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.388 -1.485 . . . . 10.0 109.388 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.2 -177.74 22.78 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 118.233 1.017 . . . . 10.0 112.403 176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.67 -159.35 23.45 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.7 -1.76 . . . . 10.0 108.7 -170.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mtm105 -138.8 161.88 36.14 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.36 -1.082 . . . . 10.0 108.475 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 mt -136.22 146.42 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.66 -1.978 . . . . 10.0 105.66 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.451 -0.384 0 C-N-CA 124.023 0.929 . . . . 10.0 109.41 171.181 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.236 0.382 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -136.91 126.91 25.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.675 -1.602 . . . . 10.0 106.675 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.35 146.33 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 105.639 -1.985 . . . . 10.0 105.639 173.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -154.99 171.53 19.58 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.763 -1.21 . . . . 10.0 111.2 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.74 -160.5 54.07 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 121.535 0.519 . . . . 10.0 112.392 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -148.71 -177.41 5.77 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.625 1.57 . . . . 10.0 108.289 173.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.7 t -109.96 131.17 55.3 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 124.899 1.28 . . . . 10.0 107.865 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.3 mtt -72.58 -18.8 61.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.999 -0.524 . . . . 10.0 111.391 171.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.91 -35.8 72.44 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.909 0.777 . . . . 10.0 110.99 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -132.97 -43.77 0.87 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.9 0.48 . . . . 10.0 112.103 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.22 -178.36 18.84 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.013 -1.635 . . . . 10.0 109.013 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.01 136.65 62.3 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.307 2.005 . . . . 10.0 110.499 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.14 162.14 20.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 166.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -79.41 69.93 5.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.167 -1.79 . . . . 10.0 106.167 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -50.94 -31.0 16.36 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.467 1.507 . . . . 10.0 113.111 -168.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.7 -37.66 73.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.276 0.944 . . . . 10.0 112.326 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.73 -50.43 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 107.293 -1.373 . . . . 10.0 107.293 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -58.56 -45.78 88.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.553 -0.737 . . . . 10.0 111.792 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -63.79 -38.12 89.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 117.754 -1.117 . . . . 10.0 110.976 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.13 -41.39 94.85 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.014 1.279 . . . . 10.0 111.227 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -65.11 -48.1 74.81 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.046 -0.409 . . . . 10.0 109.909 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.7 mt -61.38 -42.32 93.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -58.83 -37.88 77.41 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.328 1.051 . . . . 10.0 111.081 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.76 89.79 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.687 0.676 . . . . 10.0 110.969 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 N--CA 1.47 0.555 0 CA-C-N 118.746 0.703 . . . . 10.0 112.049 175.895 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 C--O 1.236 0.352 0 N-CA-C 105.029 -2.211 . . . . 10.0 105.029 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 p -138.96 167.28 22.39 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.075 0.95 . . . . 10.0 109.928 -172.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -139.06 161.22 37.92 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 123.128 0.571 . . . . 10.0 110.882 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 125.588 1.555 . . . . 10.0 108.587 169.761 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.528 0 CA-C-O 121.109 0.48 . . . . 10.0 111.82 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -154.51 148.84 26.08 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.9 mt -58.13 -28.89 65.09 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.645 -0.659 . . . . 10.0 112.664 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.81 -26.47 68.35 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.93 0.786 . . . . 10.0 112.094 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.23 -24.71 46.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.923 0.489 . . . . 10.0 110.897 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.99 122.18 86.21 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 106.804 -1.554 . . . . 10.0 106.804 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -50.28 133.16 35.84 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.106 2.537 . . . . 10.0 110.169 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.0 -29.25 39.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.677 0.751 . . . . 10.0 111.442 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.3 t -137.74 135.9 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 127.176 2.19 . . . . 10.0 105.733 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -150.78 99.7 2.75 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.149 -1.426 . . . . 10.0 107.149 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 125.055 1.342 . . . . 10.0 110.436 -168.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 105.947 -1.871 . . . . 10.0 105.947 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -135.55 14.66 3.43 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.89 1.811 . . . . 10.0 115.89 -171.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mttp 56.26 159.39 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.646 1.978 . . . . 10.0 112.89 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.52 158.19 28.78 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 120.493 -1.38 . . . . 10.0 109.481 169.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.1 p -138.01 148.8 24.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.735 1.214 . . . . 10.0 107.949 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.73 118.88 37.7 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 105.574 -2.01 . . . . 10.0 105.574 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.0 mt -123.69 125.8 71.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 -169.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -76.97 131.72 38.64 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 168.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 p -119.88 135.22 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.864 -1.532 . . . . 10.0 106.864 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -114.65 150.67 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.448 1.899 . . . . 10.0 107.462 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 p -111.72 142.05 44.55 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -172.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.48 65.97 5.61 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 126.422 1.889 . . . . 10.0 106.594 168.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -41.48 133.27 3.5 Favored 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 125.467 4.111 . . . . 10.0 114.201 -168.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 50.3 23.88 1.34 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.39 1.476 . . . . 10.0 113.073 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m 51.92 32.84 10.52 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.992 1.317 . . . . 10.0 111.871 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.25 26.34 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.455 -0.636 . . . . 10.0 112.827 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.77 131.27 9.93 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 172.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -86.54 32.99 0.44 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 124.594 3.53 . . . . 10.0 112.747 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.01 83.81 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.623 0.769 . . . . 10.0 112.386 -168.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.11 28.46 2.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.543 1.937 . . . . 10.0 114.932 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -78.5 160.41 27.68 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 167.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 m -143.58 156.27 44.54 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.438 -0.789 . . . . 10.0 110.584 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -146.22 -175.47 4.78 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.989 1.316 . . . . 10.0 109.435 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -116.68 147.83 41.6 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.961 -1.126 . . . . 10.0 107.961 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.45 147.62 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.783 1.233 . . . . 10.0 110.111 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.66 125.91 64.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 106.79 -1.559 . . . . 10.0 106.79 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -133.83 141.31 47.37 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 107.125 -1.435 . . . . 10.0 107.125 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.48 124.86 1.14 Allowed Glycine 0 C--O 1.226 -0.382 0 CA-C-N 120.228 1.376 . . . . 10.0 111.52 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -144.72 135.75 24.98 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 117.262 0.531 . . . . 10.0 110.938 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -66.0 -26.24 67.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 118.292 -0.861 . . . . 10.0 113.05 -170.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -63.55 -20.37 65.58 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.111 0.869 . . . . 10.0 112.715 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.98 120.64 14.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.212 0.915 . . . . 10.0 109.691 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.89 -34.24 77.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.01 0.524 . . . . 10.0 110.139 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -147.19 158.29 43.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.724 2.01 . . . . 10.0 107.196 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.527 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 68.5 m80 -58.53 -29.05 66.03 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.918 0.71 . . . . 10.0 112.918 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.67 -28.75 64.05 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 123.203 0.601 . . . . 10.0 112.545 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -74.18 -30.68 62.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.612 0.642 . . . . 10.0 110.973 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -65.76 -52.24 52.42 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 172.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -53.82 -43.27 69.27 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 118.629 -0.7 . . . . 10.0 111.16 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.63 -44.44 93.86 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.728 0.695 . . . . 10.0 111.773 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -60.1 -51.55 69.13 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.141 -0.689 . . . . 10.0 109.141 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.4 t -68.96 -47.8 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 118.904 -0.57 . . . . 10.0 109.912 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.8 p -60.59 -31.63 70.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.472 1.033 . . . . 10.0 111.527 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.34 -50.1 71.3 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.728 -0.949 . . . . 10.0 110.728 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.7 -44.52 93.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.668 0.734 . . . . 10.0 111.5 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -40.01 83.04 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.685 0.675 . . . . 10.0 110.705 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -63.37 -35.66 81.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.16 0.891 . . . . 10.0 111.118 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -65.67 -30.84 71.58 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 117.833 -1.079 . . . . 10.0 111.682 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -74.38 -38.12 63.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.797 1.181 . . . . 10.0 111.055 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.47 57.68 0.83 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 107.202 -2.359 . . . . 10.0 107.202 -168.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.0 m -146.07 169.14 19.29 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.262 1.825 . . . . 10.0 108.102 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -139.61 160.85 38.92 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.39 1.476 . . . . 10.0 108.635 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.0 m -131.19 155.09 47.65 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.496 1.118 . . . . 10.0 112.337 -168.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -149.86 118.86 6.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.884 1.674 . . . . 10.0 106.708 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.9 m -68.03 123.95 22.04 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.005 -1.059 . . . . 10.0 109.153 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.3 mt -81.08 -23.92 38.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.875 0.47 . . . . 10.0 110.726 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.98 176.72 36.92 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.204 -1.559 . . . . 10.0 109.204 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.05 178.5 23.72 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 118.223 1.011 . . . . 10.0 112.109 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.23 -144.74 4.65 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 107.981 -2.048 . . . . 10.0 107.981 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -151.55 149.48 29.23 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 120.898 -1.354 . . . . 10.0 110.44 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.1 mt -108.56 148.04 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 105.121 -2.178 . . . . 10.0 105.121 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.533 0.315 0 C-N-CA 124.311 1.044 . . . . 10.0 109.121 171.892 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.5 pt . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 121.643 0.735 . . . . 10.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -149.13 163.36 37.81 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.105 0.962 . . . . 10.0 109.017 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -136.5 140.55 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.912 0.885 . . . . 10.0 108.66 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -157.5 -175.34 5.34 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.962 0.905 . . . . 10.0 109.98 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.63 -177.64 53.42 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 123.401 0.524 . . . . 10.0 113.012 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.31 -178.98 5.53 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.093 0.957 . . . . 10.0 110.184 169.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.527 ' HG ' ' CE1' ' A' ' 53' ' ' HIS . 22.8 m -133.52 107.43 8.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.212 -1.773 . . . . 10.0 106.212 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 77.2 mtm -59.74 -21.42 60.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.795 0.665 . . . . 10.0 112.795 -172.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.68 -26.36 67.05 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.802 0.841 . . . . 10.0 112.841 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -134.9 -50.68 0.77 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.489 0.716 . . . . 10.0 111.231 -169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.08 175.32 13.79 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.198 1.856 . . . . 10.0 108.981 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -54.81 133.8 59.49 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.467 2.111 . . . . 10.0 110.271 169.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.08 156.07 29.41 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.526 1.155 . . . . 10.0 109.413 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -82.42 65.33 7.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.283 -1.747 . . . . 10.0 106.283 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -51.81 -24.66 6.36 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.374 1.87 . . . . 10.0 114.012 -168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.93 91.08 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.028 1.285 . . . . 10.0 111.392 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.3 mt -63.54 -50.91 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -61.51 -46.5 89.73 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.185 0.594 . . . . 10.0 111.874 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 p -65.37 -38.18 89.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.741 0.701 . . . . 10.0 110.966 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.02 -42.11 76.82 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.149 0.886 . . . . 10.0 110.985 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -59.96 -47.96 83.68 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.671 -0.681 . . . . 10.0 110.143 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.3 mt -56.93 -52.34 56.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 108.112 -1.07 . . . . 10.0 108.112 175.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -56.2 -40.52 74.13 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.324 0.966 . . . . 10.0 111.25 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.43 -50.88 49.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.037 0.535 . . . . 10.0 111.82 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.5 mptt . . . . . 0 N--CA 1.472 0.656 0 CA-C-N 118.93 0.786 . . . . 10.0 112.749 -169.867 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.6 t . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 106.197 -1.779 . . . . 10.0 106.197 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.2 p -138.43 174.52 10.45 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.211 1.004 . . . . 10.0 109.421 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -142.76 159.7 41.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.251 0.62 . . . . 10.0 109.726 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.263 0 C-N-CA 125.433 1.493 . . . . 10.0 107.979 172.251 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -149.21 149.81 31.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.155 1.382 . . . . 10.0 107.872 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.5 mt -58.68 -25.51 62.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.364 1.066 . . . . 10.0 113.024 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.89 -24.23 65.81 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.64 0.655 . . . . 10.0 112.34 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -75.47 -16.67 60.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.271 0.628 . . . . 10.0 111.494 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.5 mt -93.62 120.23 66.43 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.0 -1.482 . . . . 10.0 107.0 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.35 136.24 39.46 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.497 2.798 . . . . 10.0 110.551 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -78.08 -28.16 48.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.392 0.615 . . . . 10.0 111.832 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.2 t -139.22 135.11 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 104.262 -2.496 . . . . 10.0 104.262 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -153.39 119.93 5.58 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.608 -1.627 . . . . 10.0 106.608 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.9 pt . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 124.764 1.226 . . . . 10.0 109.171 -170.036 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 109.756 -0.461 . . . . 10.0 109.756 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -145.35 148.62 33.59 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.488 1.115 . . . . 10.0 109.265 169.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -63.65 150.9 43.18 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.017 0.927 . . . . 10.0 110.319 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.402 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -146.78 168.26 21.83 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.703 1.201 . . . . 10.0 109.037 178.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.74 150.07 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.355 1.062 . . . . 10.0 108.661 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -114.16 121.92 45.25 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.375 -2.084 . . . . 10.0 105.375 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.5 mt -130.32 136.42 58.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.202 -1.406 . . . . 10.0 107.202 -169.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -91.65 139.2 30.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.74 -1.578 . . . . 10.0 106.74 166.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.53 141.33 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.123 -1.806 . . . . 10.0 106.123 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -122.37 135.84 54.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.98 1.712 . . . . 10.0 107.217 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.2 m -63.12 135.17 57.03 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.008 -0.367 . . . . 10.0 110.008 174.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.41 52.7 1.0 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.348 1.459 . . . . 10.0 110.077 168.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.66 -13.07 36.87 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.188 3.258 . . . . 10.0 115.123 -167.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -139.52 13.72 2.55 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.719 -1.238 . . . . 10.0 110.755 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m 48.33 33.98 4.26 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.344 1.058 . . . . 10.0 112.018 -168.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.32 64.82 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 N-CA-C 108.132 -1.987 . . . . 10.0 108.132 -168.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.97 157.12 77.72 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 125.231 1.412 . . . . 10.0 108.964 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.92 39.53 0.66 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 124.309 3.339 . . . . 10.0 112.121 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.93 104.92 3.74 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.978 1.711 . . . . 10.0 107.014 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.81 28.92 1.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.488 1.515 . . . . 10.0 110.28 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.413 ' C ' ' HG ' ' A' ' 40' ' ' SER . 44.0 mt-10 -66.73 174.57 2.82 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.2 1.0 . . . . 10.0 109.911 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.413 ' HG ' ' C ' ' A' ' 39' ' ' GLU . 9.8 m -152.39 159.71 43.38 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 120.193 -1.567 . . . . 10.0 110.423 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -149.63 168.52 23.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.647 1.179 . . . . 10.0 109.565 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -99.9 150.67 22.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.9 pt -138.9 156.04 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 125.795 1.638 . . . . 10.0 109.889 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.39 130.35 62.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -133.35 141.16 47.79 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.02 1.328 . . . . 10.0 107.952 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.72 100.85 0.15 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 110.029 -1.229 . . . . 10.0 110.029 -171.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -130.4 131.87 45.48 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 118.236 1.018 . . . . 10.0 110.371 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -59.56 -25.51 64.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.198 1.184 . . . . 10.0 114.198 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -68.32 -20.62 64.75 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.494 1.043 . . . . 10.0 112.279 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.42 137.68 58.01 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.221 0.919 . . . . 10.0 111.428 -171.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.08 -40.95 87.11 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.679 -0.691 . . . . 10.0 109.231 170.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -155.92 170.67 21.57 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 126.125 1.77 . . . . 10.0 108.922 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -48.66 -36.31 15.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.977 1.311 . . . . 10.0 112.002 167.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.49 -28.02 66.66 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.948 0.721 . . . . 10.0 112.948 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -67.32 -41.94 84.45 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.18 0.991 . . . . 10.0 108.671 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.6 mt -62.0 -51.36 73.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 108.541 -0.911 . . . . 10.0 108.541 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -55.64 -43.49 76.25 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.679 -0.677 . . . . 10.0 111.598 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -62.58 -48.18 80.57 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.369 0.531 . . . . 10.0 111.726 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.54 -49.5 77.29 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.668 -0.645 . . . . 10.0 109.826 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.4 -42.65 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.609 -0.885 . . . . 10.0 108.609 -172.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.7 m -58.58 -36.38 73.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.558 1.072 . . . . 10.0 111.447 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.11 -47.09 91.33 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.803 -0.919 . . . . 10.0 110.803 172.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.09 -47.29 86.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.838 0.819 . . . . 10.0 111.459 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -36.72 82.01 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.338 -0.839 . . . . 10.0 110.74 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -64.35 -36.61 84.68 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.998 0.817 . . . . 10.0 111.004 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -67.96 -31.74 71.68 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.867 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -67.6 -56.79 8.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 119.294 0.952 . . . . 10.0 108.807 175.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.73 41.39 0.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.047 1.308 . . . . 10.0 110.528 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.3 m -144.0 173.63 11.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.837 1.655 . . . . 10.0 109.325 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -139.27 164.24 30.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.421 1.488 . . . . 10.0 108.205 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.2 m -125.22 161.55 26.66 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.567 1.147 . . . . 10.0 112.382 -168.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -149.11 109.8 4.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.817 2.047 . . . . 10.0 105.755 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 p -61.45 136.85 58.18 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.031 -1.043 . . . . 10.0 109.627 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.9 mt -110.19 -12.2 14.5 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.425 0.69 . . . . 10.0 111.235 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.86 -178.51 29.94 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.2 -1.16 . . . . 10.0 110.2 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.05 -179.24 22.97 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.841 -0.904 . . . . 10.0 110.841 168.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.1 -153.48 9.89 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.492 -1.843 . . . . 10.0 108.492 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -134.69 132.74 39.24 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 123.995 0.918 . . . . 10.0 108.61 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.17 119.56 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 104.567 -2.382 . . . . 10.0 104.567 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 105.266 -2.124 . . . . 10.0 105.266 167.071 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 C--O 1.237 0.407 0 N-CA-C 107.919 -1.141 . . . . 10.0 107.919 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -133.51 159.59 39.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.163 -1.421 . . . . 10.0 107.163 169.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 t -140.38 140.69 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 O-C-N 120.749 -1.219 . . . . 10.0 107.939 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -156.32 -177.89 6.92 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.877 0.871 . . . . 10.0 110.908 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.61 -166.4 50.77 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.922 -0.471 . . . . 10.0 111.922 169.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -157.18 173.43 16.99 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.785 1.234 . . . . 10.0 108.972 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.6 m -128.39 104.06 7.5 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.592 -1.262 . . . . 10.0 107.592 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 66.8 mtt -57.24 -24.27 53.59 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.36 1.064 . . . . 10.0 113.565 -170.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.24 -29.94 70.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.6 -0.714 . . . . 10.0 112.427 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -129.17 -45.82 1.24 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.663 0.785 . . . . 10.0 110.716 -171.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.97 174.33 13.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.768 1.651 . . . . 10.0 109.595 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -56.36 124.36 16.06 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.337 2.024 . . . . 10.0 109.631 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.69 159.49 13.34 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.778 0.799 . . . . 10.0 109.178 168.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -84.83 72.04 10.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.953 -1.499 . . . . 10.0 106.953 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.402 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 61.6 m80 -52.37 -25.14 8.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.132 1.373 . . . . 10.0 114.133 -169.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.76 99.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.96 1.255 . . . . 10.0 111.617 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.75 -50.95 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 107.528 -1.286 . . . . 10.0 107.528 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -56.79 -48.47 77.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.29 0.636 . . . . 10.0 111.588 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 p -68.89 -37.25 78.88 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.01 -0.995 . . . . 10.0 111.688 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -65.65 -39.79 91.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.499 1.045 . . . . 10.0 110.404 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -62.65 -48.7 78.17 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 119.16 -0.448 . . . . 10.0 110.103 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.0 mt -57.79 -42.39 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.219 0.918 . . . . 10.0 108.584 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -64.03 -37.63 88.12 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.535 1.062 . . . . 10.0 111.22 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.03 92.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.689 0.677 . . . . 10.0 111.067 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp . . . . . 0 CA--C 1.537 0.456 0 C-N-CA 123.467 0.707 . . . . 10.0 111.073 173.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.232 0.182 0 N-CA-C 107.111 -1.441 . . . . 10.0 107.111 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.2 p -142.55 170.48 15.63 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.514 1.126 . . . . 10.0 109.832 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -147.84 166.67 26.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.236 0.471 . . . . 10.0 111.106 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 127.026 2.13 . . . . 10.0 107.563 169.649 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 107.73 -1.211 . . . . 10.0 107.73 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -148.11 151.9 36.41 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.721 -1.214 . . . . 10.0 107.721 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.13 -30.16 61.73 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.618 0.767 . . . . 10.0 112.837 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.46 -28.45 69.67 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.704 0.683 . . . . 10.0 112.149 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -77.41 -28.82 52.77 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.844 0.458 . . . . 10.0 110.621 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.3 mt -69.91 122.06 84.79 Favored Pre-proline 0 C--O 1.24 0.557 0 N-CA-C 107.519 -1.289 . . . . 10.0 107.519 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.2 135.79 38.22 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.315 2.677 . . . . 10.0 110.341 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.23 -29.54 38.46 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.529 0.681 . . . . 10.0 111.35 -173.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -137.8 136.77 45.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 104.707 -2.331 . . . . 10.0 104.707 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -152.03 122.68 7.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.247 -1.76 . . . . 10.0 106.247 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.5 pt . . . . . 0 C--N 1.328 -0.35 0 C-N-CA 124.65 1.18 . . . . 10.0 109.393 -169.189 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -154.07 154.27 33.37 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.852 0.751 . . . . 10.0 110.66 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -86.96 151.22 23.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.508 1.123 . . . . 10.0 108.32 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.28 159.92 42.29 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.99 0.516 . . . . 10.0 110.479 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.94 140.53 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 125.694 1.598 . . . . 10.0 107.746 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -98.24 119.98 37.85 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 105.513 -2.032 . . . . 10.0 105.513 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.7 mt -124.08 132.99 70.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.52 -1.659 . . . . 10.0 106.52 -171.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -86.78 132.5 33.83 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.16 -1.793 . . . . 10.0 106.16 168.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.67 139.87 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.604 -1.258 . . . . 10.0 107.604 171.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -114.31 123.75 50.28 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.222 -2.14 . . . . 10.0 105.222 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.7 p -68.89 145.24 53.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.794 0.27 . . . . 10.0 110.49 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.35 67.81 3.09 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.206 1.802 . . . . 10.0 106.354 168.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -54.71 127.47 26.29 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.064 2.509 . . . . 10.0 110.872 -170.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 37.03 39.06 0.11 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.582 1.953 . . . . 10.0 113.407 -169.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 m 51.6 30.98 7.12 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.796 1.639 . . . . 10.0 113.696 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.2 -19.54 0.02 OUTLIER Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.242 -1.31 . . . . 10.0 116.26 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.94 149.83 95.99 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 120.277 2.039 . . . . 10.0 110.764 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.63 61.59 8.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.418 3.412 . . . . 10.0 111.657 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.49 139.11 35.06 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.854 1.262 . . . . 10.0 108.536 175.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.06 28.05 0.68 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.752 1.221 . . . . 10.0 110.98 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -67.98 164.51 19.83 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.421 -0.799 . . . . 10.0 109.232 171.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -139.61 159.22 42.67 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.899 0.88 . . . . 10.0 110.802 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -150.19 171.48 16.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.216 1.007 . . . . 10.0 109.907 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.29 150.23 21.77 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.345 -0.983 . . . . 10.0 108.345 172.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.3 pt -137.14 150.76 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 125.461 1.504 . . . . 10.0 109.559 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.09 126.15 63.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -132.92 134.97 45.26 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.29 117.45 0.65 Allowed Glycine 0 C--O 1.225 -0.462 0 CA-C-N 119.46 1.027 . . . . 10.0 110.866 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -138.38 132.03 30.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 -172.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -60.14 -18.16 45.57 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 114.67 1.359 . . . . 10.0 114.67 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -67.1 -28.01 67.81 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.27 1.395 . . . . 10.0 112.139 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.71 153.93 30.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.712 1.142 . . . . 10.0 109.419 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.31 -6.91 2.61 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.553 0.741 . . . . 10.0 111.821 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.92 12.63 3.64 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 118.885 0.766 . . . . 10.0 112.767 -168.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 63.38 -46.57 0.23 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.285 2.634 . . . . 10.0 114.792 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.07 -30.17 67.86 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.024 0.929 . . . . 10.0 111.363 -178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.12 -32.74 74.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 117.938 0.335 . . . . 10.0 111.533 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -67.91 -55.41 16.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 107.326 -1.361 . . . . 10.0 107.326 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.58 -39.42 67.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.256 0.622 . . . . 10.0 111.603 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -61.54 -50.75 71.41 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.304 1.041 . . . . 10.0 111.712 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -45.52 93.12 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.713 -0.617 . . . . 10.0 110.218 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.86 -46.04 93.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -59.1 -36.15 74.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.746 1.157 . . . . 10.0 111.377 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.62 -51.33 54.97 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 174.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.24 -45.21 94.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.525 0.662 . . . . 10.0 111.349 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -34.67 78.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.136 -0.935 . . . . 10.0 110.719 -175.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -65.78 -37.38 86.17 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.613 1.097 . . . . 10.0 110.648 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -62.65 -37.17 85.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 117.681 -1.152 . . . . 10.0 110.919 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -66.78 -52.64 41.7 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.409 1.004 . . . . 10.0 109.646 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.04 51.12 0.25 Allowed Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.475 1.512 . . . . 10.0 109.403 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.3 m -143.68 167.71 21.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.814 1.646 . . . . 10.0 108.486 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -129.62 161.97 29.35 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.03 1.732 . . . . 10.0 107.141 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.2 m -125.34 160.04 30.31 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.669 1.187 . . . . 10.0 112.017 -168.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -148.83 115.38 5.92 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.866 -1.901 . . . . 10.0 105.866 170.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.83 115.11 6.24 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.904 -1.123 . . . . 10.0 108.466 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.7 mt -77.54 -29.26 52.23 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.821 -0.549 . . . . 10.0 110.355 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.76 -177.53 38.82 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.071 -1.611 . . . . 10.0 109.071 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.68 -178.18 29.63 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 118.259 1.029 . . . . 10.0 111.178 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.5 -158.37 17.59 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.531 -1.428 . . . . 10.0 109.531 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 mtm180 -131.8 154.52 49.03 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.54 -0.976 . . . . 10.0 108.476 -177.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.9 mt -134.29 140.55 45.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 104.302 -2.481 . . . . 10.0 104.302 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.329 -0.312 0 O-C-N 120.908 -1.12 . . . . 10.0 110.273 172.76 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.2 pt . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 122.226 1.012 . . . . 10.0 110.848 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -140.2 147.87 40.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.368 -1.345 . . . . 10.0 107.368 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.84 134.77 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.415 -1.328 . . . . 10.0 107.415 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -159.27 -179.69 8.2 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.175 -0.953 . . . . 10.0 111.046 -168.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.8 -158.39 53.08 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.053 0.835 . . . . 10.0 112.981 170.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -150.72 167.82 26.23 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.594 1.158 . . . . 10.0 108.558 172.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.7 p -68.53 -28.67 67.19 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.6 ttm 53.93 29.53 10.13 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.206 0.603 . . . . 10.0 110.159 -167.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.29 -32.42 0.6 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.738 1.215 . . . . 10.0 111.876 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.38 -46.13 0.56 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.215 0.606 . . . . 10.0 110.205 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.41 177.16 31.24 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.111 1.815 . . . . 10.0 109.598 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.99 138.36 56.79 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.511 2.14 . . . . 10.0 110.458 172.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.71 160.97 24.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 166.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -81.31 75.54 8.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.682 -1.599 . . . . 10.0 106.682 169.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -54.48 -24.31 19.89 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.901 1.28 . . . . 10.0 113.528 -169.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.5 99.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.651 1.114 . . . . 10.0 111.705 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.1 mt -64.51 -52.07 59.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 106.988 -1.486 . . . . 10.0 106.988 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 m -57.46 -45.79 84.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.511 -0.757 . . . . 10.0 112.092 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 p -66.24 -37.82 86.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 117.722 -1.132 . . . . 10.0 111.721 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -64.45 -41.21 96.67 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.965 1.257 . . . . 10.0 110.6 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -63.89 -47.55 80.17 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.103 -0.373 . . . . 10.0 110.265 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.31 -38.9 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.415 -0.957 . . . . 10.0 108.415 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -62.32 -38.11 88.17 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 120.556 -1.34 . . . . 10.0 111.239 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.39 -31.02 71.91 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.713 0.688 . . . . 10.0 112.228 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.7 tptt . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 124.327 1.051 . . . . 10.0 111.649 172.241 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.238 0.448 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.5 p -144.7 170.07 16.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.428 1.491 . . . . 10.0 109.041 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -143.98 168.89 18.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.175 0.59 . . . . 10.0 110.754 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.207 0 C-N-CA 124.756 1.223 . . . . 10.0 108.998 173.314 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.308 0 N-CA-C 106.832 -1.544 . . . . 10.0 106.832 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -149.35 150.54 32.64 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.968 -1.123 . . . . 10.0 107.968 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.35 -26.42 60.95 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.372 1.069 . . . . 10.0 112.753 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.91 -25.51 67.62 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.876 0.762 . . . . 10.0 112.792 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -74.2 -25.8 59.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.205 0.457 . . . . 10.0 111.042 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.96 130.68 69.23 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 106.467 -1.679 . . . . 10.0 106.467 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.19 146.14 68.94 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.989 1.792 . . . . 10.0 109.625 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.72 -30.06 59.12 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.605 0.762 . . . . 10.0 112.593 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.4 t -138.28 132.31 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.696 -1.964 . . . . 10.0 105.696 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -149.93 102.72 3.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.47 -2.048 . . . . 10.0 105.47 171.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.2 pt . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 124.672 1.189 . . . . 10.0 110.516 -168.736 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 109.202 -0.666 . . . . 10.0 109.202 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -154.4 148.69 26.02 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.437 1.095 . . . . 10.0 109.592 170.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -72.73 150.71 42.63 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.696 -0.854 . . . . 10.0 108.696 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.33 165.51 29.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.683 0.793 . . . . 10.0 109.561 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.7 143.37 24.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.506 -1.294 . . . . 10.0 107.506 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp -99.8 126.43 45.89 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 105.49 -2.041 . . . . 10.0 105.49 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 98.2 mt -130.34 136.66 58.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -91.56 145.71 24.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.987 -1.486 . . . . 10.0 106.987 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.53 146.0 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.082 -1.821 . . . . 10.0 106.082 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -127.25 132.27 50.41 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.295 -1.742 . . . . 10.0 106.295 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.1 p -71.59 147.43 47.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.827 0.74 . . . . 10.0 110.777 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.93 62.31 3.42 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.621 1.568 . . . . 10.0 107.797 168.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -58.86 145.33 97.14 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.215 2.61 . . . . 10.0 109.664 -172.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 51.66 19.34 0.87 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.291 1.036 . . . . 10.0 112.517 -176.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m 50.44 28.5 3.37 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.865 1.266 . . . . 10.0 113.332 -171.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.62 -0.69 0.02 OUTLIER Glycine 0 CA--C 1.532 1.1 0 N-CA-C 116.497 1.359 . . . . 10.0 116.497 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.72 152.28 75.99 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.879 1.839 . . . . 10.0 110.244 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.46 61.45 7.4 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 124.229 3.286 . . . . 10.0 111.751 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.24 141.74 33.98 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.105 1.362 . . . . 10.0 108.602 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.67 39.5 0.49 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.465 1.506 . . . . 10.0 109.168 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.76 175.14 5.21 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.713 0.805 . . . . 10.0 108.896 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.1 m -151.99 163.2 39.79 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.171 -1.58 . . . . 10.0 111.369 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -154.82 163.53 40.14 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.529 2.332 . . . . 10.0 107.416 -169.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -129.24 141.86 51.01 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.351 -1.351 . . . . 10.0 107.351 174.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.3 pt -138.19 154.9 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.599 1.16 . . . . 10.0 110.822 -169.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.97 125.45 64.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.657 -1.609 . . . . 10.0 106.657 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -132.22 142.99 49.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.27 131.59 1.91 Allowed Glycine 0 C--O 1.22 -0.761 0 CA-C-N 119.878 1.217 . . . . 10.0 111.349 171.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -142.35 138.56 31.31 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 124.174 0.573 . . . . 10.0 109.644 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -68.59 -23.58 64.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.672 0.789 . . . . 10.0 112.362 -171.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -66.18 -20.53 66.16 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 118.444 -0.789 . . . . 10.0 112.422 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 127.67 32.6 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 118.995 0.816 . . . . 10.0 110.75 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -72.31 -35.73 68.72 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.489 0.661 . . . . 10.0 109.648 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -149.01 165.7 30.88 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 126.174 1.79 . . . . 10.0 108.55 -175.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -57.03 -38.75 73.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.988 0.423 . . . . 10.0 110.763 175.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.63 67.47 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 123.925 0.89 . . . . 10.0 113.16 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -66.96 -46.53 74.42 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.3 mt -62.46 -51.43 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -55.36 -41.32 72.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.615 -0.707 . . . . 10.0 111.628 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.7 -47.14 79.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.267 0.485 . . . . 10.0 111.86 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -58.59 -49.85 75.96 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 109.797 -0.446 . . . . 10.0 109.797 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.46 -45.29 93.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.459 -0.781 . . . . 10.0 109.181 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 m -57.58 -43.02 84.27 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.051 0.841 . . . . 10.0 110.821 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.79 -46.59 94.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.969 -0.853 . . . . 10.0 110.969 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.35 -48.55 77.51 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 118.226 1.013 . . . . 10.0 110.951 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -39.09 84.44 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.553 0.615 . . . . 10.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -63.11 -35.88 81.73 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.472 0.578 . . . . 10.0 110.833 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.22 -32.6 72.92 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.513 -1.232 . . . . 10.0 112.188 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 mm-40 -67.26 -53.08 33.19 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.295 0.952 . . . . 10.0 109.327 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.1 44.26 0.22 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.274 1.416 . . . . 10.0 109.607 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.3 m -145.95 175.89 10.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.185 2.194 . . . . 10.0 107.755 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -144.81 164.6 30.55 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.528 0.731 . . . . 10.0 109.04 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.8 m -120.9 162.29 20.11 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.599 1.16 . . . . 10.0 113.313 -168.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -147.57 112.49 5.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.32 2.248 . . . . 10.0 105.741 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 t -64.2 140.47 58.87 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.029 -1.045 . . . . 10.0 109.67 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.9 mt -110.26 -9.67 14.65 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.17 0.988 . . . . 10.0 111.636 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.88 171.75 18.63 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.434 1.016 . . . . 10.0 112.073 169.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.28 161.2 18.78 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.465 1.031 . . . . 10.0 110.828 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.85 -160.89 23.64 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.027 -1.629 . . . . 10.0 109.027 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -146.07 162.84 37.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.34 -1.682 . . . . 10.0 110.337 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -129.12 151.75 36.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 105.64 -1.985 . . . . 10.0 105.64 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.451 -0.404 0 C-N-CA 124.459 1.104 . . . . 10.0 109.292 175.806 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--O 1.238 0.471 0 N-CA-C 107.003 -1.48 . . . . 10.0 107.003 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -135.77 148.97 48.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.598 -0.89 . . . . 10.0 108.598 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.05 128.56 62.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.769 1.228 . . . . 10.0 107.916 -169.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -157.13 -164.97 1.71 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.564 0.746 . . . . 10.0 109.699 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.39 -169.85 54.6 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 111.081 -0.807 . . . . 10.0 111.081 -173.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -161.29 -170.89 2.8 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.4 1.48 . . . . 10.0 107.572 169.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.3 t -135.04 135.54 41.38 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.719 -1.215 . . . . 10.0 107.719 172.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 79.2 mtm -77.26 -16.81 58.84 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.877 -0.583 . . . . 10.0 111.134 169.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.89 -26.07 63.07 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.717 0.69 . . . . 10.0 112.333 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.43 -48.91 0.2 Allowed 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 123.177 0.591 . . . . 10.0 110.53 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.27 179.57 29.67 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.197 -1.561 . . . . 10.0 109.197 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -61.66 150.11 87.0 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.395 2.063 . . . . 10.0 109.902 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.33 27.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.232 1.413 . . . . 10.0 113.924 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 40.21 55.8 2.67 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.425 2.29 . . . . 10.0 109.57 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -43.99 -35.42 2.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.485 2.314 . . . . 10.0 114.603 -166.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.15 -37.12 66.57 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.368 0.986 . . . . 10.0 113.128 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.3 mt -63.66 -53.2 47.88 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 107.247 -1.39 . . . . 10.0 107.247 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.6 m -61.71 -41.73 98.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.178 -0.915 . . . . 10.0 112.267 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 p -65.01 -39.61 93.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.725 1.148 . . . . 10.0 110.602 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -63.77 -40.56 96.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.501 1.046 . . . . 10.0 110.937 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -62.98 -48.92 76.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.674 0.39 . . . . 10.0 110.59 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.8 mt -58.4 -45.75 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -62.41 -38.02 88.06 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 121.225 -0.922 . . . . 10.0 111.547 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.29 75.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.202 0.601 . . . . 10.0 111.763 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt . . . . . 0 CA--C 1.544 0.743 0 CA-C-O 117.718 -1.134 . . . . 10.0 112.433 173.227 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.234 0.249 0 N-CA-C 106.205 -1.776 . . . . 10.0 106.205 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -142.18 170.17 16.22 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.257 1.023 . . . . 10.0 109.996 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -143.7 166.19 25.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.279 0.562 . . . . 10.0 112.474 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 128.787 2.835 . . . . 10.0 107.504 171.374 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 106.5 -1.667 . . . . 10.0 106.5 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -152.41 151.53 30.92 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.85 -25.32 64.93 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.645 0.778 . . . . 10.0 112.859 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.87 72.83 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.162 0.892 . . . . 10.0 111.63 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.59 -34.89 58.41 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.963 0.505 . . . . 10.0 110.032 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mt -64.62 118.81 51.65 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.15 139.51 52.72 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.484 2.789 . . . . 10.0 111.36 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.72 -31.98 25.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.303 0.573 . . . . 10.0 111.915 -173.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.57 139.04 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 105.759 -1.941 . . . . 10.0 105.759 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -146.89 113.26 5.92 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 105.451 -2.055 . . . . 10.0 105.451 171.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.6 pt . . . . . 0 CA--C 1.535 0.399 0 C-N-CA 124.513 1.125 . . . . 10.0 111.877 -168.303 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -145.27 151.34 38.21 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.208 0.603 . . . . 10.0 109.978 171.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -79.98 146.28 32.12 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.335 -1.357 . . . . 10.0 107.335 174.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.86 161.54 38.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.629 0.649 . . . . 10.0 110.962 -177.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.39 145.2 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.571 1.548 . . . . 10.0 107.574 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.3 tp -104.97 123.68 48.21 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.197 -2.149 . . . . 10.0 105.197 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.13 129.47 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 -172.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -83.65 140.09 32.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.525 -1.657 . . . . 10.0 106.525 167.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.69 139.74 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 106.16 -1.793 . . . . 10.0 106.16 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -121.02 138.1 54.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.337 1.855 . . . . 10.0 106.623 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.3 p -97.03 138.42 34.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.247 0.546 . . . . 10.0 112.323 -170.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.37 68.11 7.72 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 125.155 1.382 . . . . 10.0 107.393 168.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.48 149.62 9.5 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.957 3.105 . . . . 10.0 111.917 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 45.86 20.99 0.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.573 1.549 . . . . 10.0 114.632 -171.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.6 m 50.94 39.05 21.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.758 1.223 . . . . 10.0 111.878 -171.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.23 -28.87 0.02 OUTLIER Glycine 0 C--N 1.342 0.871 0 CA-C-O 118.977 -0.902 . . . . 10.0 114.72 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.24 131.2 93.48 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 119.572 1.686 . . . . 10.0 109.231 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -85.55 32.83 0.47 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.353 3.369 . . . . 10.0 112.88 -170.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.25 78.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.637 0.775 . . . . 10.0 111.95 -169.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 48.82 26.74 1.37 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.82 2.048 . . . . 10.0 115.32 174.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.87 159.5 28.89 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 168.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -142.91 158.74 43.33 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.535 -0.728 . . . . 10.0 110.624 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -151.76 176.04 11.8 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.97 1.308 . . . . 10.0 109.356 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.6 mp0 -106.68 153.63 22.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.963 -0.755 . . . . 10.0 108.963 170.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.7 pt -137.75 151.81 26.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 125.338 1.455 . . . . 10.0 110.081 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.45 130.12 58.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 106.233 -1.765 . . . . 10.0 106.233 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -133.83 140.35 46.83 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.082 -1.821 . . . . 10.0 106.082 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.74 139.31 4.98 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 120.455 1.48 . . . . 10.0 113.019 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -149.25 144.85 26.77 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.809 0.843 . . . . 10.0 109.652 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.58 -23.96 61.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 117.956 -1.021 . . . . 10.0 112.936 -172.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -68.03 -17.27 64.36 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.668 0.988 . . . . 10.0 113.668 -174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.24 130.79 46.98 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 119.389 0.995 . . . . 10.0 110.103 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.47 -37.5 77.32 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.925 -0.398 . . . . 10.0 109.925 176.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -149.53 160.38 43.53 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.098 2.159 . . . . 10.0 106.709 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -57.32 -33.13 67.39 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.902 0.881 . . . . 10.0 112.701 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.0 -25.54 65.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.384 0.674 . . . . 10.0 112.586 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.08 -37.92 84.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.579 0.627 . . . . 10.0 110.36 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.7 mt -64.27 -50.85 74.72 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 107.748 -1.204 . . . . 10.0 107.748 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -55.73 -42.6 75.6 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.851 -0.595 . . . . 10.0 111.326 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.09 -43.9 97.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.601 0.637 . . . . 10.0 111.989 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -61.3 -51.34 69.28 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 121.63 -0.669 . . . . 10.0 109.434 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.17 -42.71 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.584 -0.525 . . . . 10.0 109.584 -170.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.4 p -66.45 -33.75 76.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.182 0.901 . . . . 10.0 111.472 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.3 -39.54 96.02 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.364 0.983 . . . . 10.0 111.034 173.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -69.11 -45.38 70.36 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.724 -0.868 . . . . 10.0 111.109 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 27.2 mmt -61.13 -39.5 90.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.186 0.903 . . . . 10.0 110.597 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.55 -39.75 89.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.78 0.718 . . . . 10.0 110.903 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -20.48 59.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 117.874 -1.06 . . . . 10.0 112.887 175.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -72.95 -43.29 62.48 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.714 1.143 . . . . 10.0 110.423 169.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.71 49.71 0.58 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.217 -1.553 . . . . 10.0 109.217 -169.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.7 m -145.74 169.83 17.71 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.046 1.738 . . . . 10.0 108.206 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -136.24 161.51 35.54 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.637 1.575 . . . . 10.0 108.216 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.6 m -125.13 158.05 34.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.542 1.137 . . . . 10.0 112.693 -168.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -146.0 106.41 4.06 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.994 2.118 . . . . 10.0 105.597 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.8 p -61.46 131.51 50.41 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.281 -0.887 . . . . 10.0 109.192 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -102.4 -21.77 14.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.008 0.523 . . . . 10.0 110.909 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.01 -178.48 32.52 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.937 -1.265 . . . . 10.0 109.937 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.94 -173.29 23.56 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 117.944 0.872 . . . . 10.0 111.215 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.23 -148.98 9.87 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.157 -1.577 . . . . 10.0 109.157 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -139.46 160.44 39.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.765 1.226 . . . . 10.0 108.671 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.8 mt -136.58 149.17 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 106.333 -1.728 . . . . 10.0 106.333 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 C--O 1.237 0.413 0 C-N-CA 125.333 1.453 . . . . 10.0 108.435 170.176 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 98.0 mt . . . . . 0 C--O 1.237 0.438 0 N-CA-C 105.546 -2.02 . . . . 10.0 105.546 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -135.76 145.2 46.33 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.847 0.859 . . . . 10.0 108.912 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.81 130.49 55.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 107.326 -1.361 . . . . 10.0 107.326 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -158.66 179.49 9.06 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.346 -0.846 . . . . 10.0 111.714 -168.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.72 -159.01 34.22 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 123.762 0.696 . . . . 10.0 112.359 170.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -155.92 152.38 28.18 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.596 1.959 . . . . 10.0 106.494 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 p -69.82 152.15 44.9 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.017 0.826 . . . . 10.0 111.131 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.5 mtp -77.81 28.73 0.17 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.588 1.155 . . . . 10.0 110.161 169.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.36 -41.5 0.18 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.087 0.955 . . . . 10.0 112.585 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -133.42 -51.28 0.87 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.314 0.961 . . . . 10.0 112.565 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.19 -177.67 23.47 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.806 -0.918 . . . . 10.0 110.806 -171.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.2 144.76 82.34 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.004 2.47 . . . . 10.0 110.725 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.86 21.83 1.5 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -170.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 40.94 53.2 3.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.237 1.415 . . . . 10.0 110.065 -169.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -39.09 -30.91 0.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.95 2.9 . . . . 10.0 116.759 -166.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.65 60.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.814 1.188 . . . . 10.0 112.643 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.0 mt -60.77 -54.22 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -61.59 -41.29 97.22 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 117.915 -1.04 . . . . 10.0 111.867 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.7 p -64.69 -37.31 87.14 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 120.092 1.314 . . . . 10.0 111.431 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.2 -39.98 86.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.906 0.775 . . . . 10.0 110.729 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -64.8 -46.26 82.77 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.834 -0.541 . . . . 10.0 110.527 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.0 mt -57.64 -47.16 86.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -58.42 -42.31 86.96 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.134 0.879 . . . . 10.0 111.239 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.67 89.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.593 0.633 . . . . 10.0 111.559 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 118.085 -0.96 . . . . 10.0 112.99 -176.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.6 p -138.0 167.31 22.04 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.456 1.102 . . . . 10.0 109.429 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -145.01 165.3 28.57 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.41 0 C-N-CA 127.27 2.228 . . . . 10.0 108.286 172.73 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 109.671 -0.492 . . . . 10.0 109.671 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.79 149.64 29.25 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 172.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.01 -23.5 63.71 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.36 -29.29 69.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.139 0.882 . . . . 10.0 111.987 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.9 mt -75.37 -31.88 60.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.159 0.436 . . . . 10.0 110.408 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.0 mt -69.79 123.74 89.21 Favored Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 107.629 -1.248 . . . . 10.0 107.629 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.13 135.05 30.51 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.639 2.893 . . . . 10.0 111.159 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.18 -28.47 27.33 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.299 0.571 . . . . 10.0 112.237 -171.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.19 134.69 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 127.41 2.284 . . . . 10.0 104.895 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -156.2 98.77 1.89 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.208 -1.775 . . . . 10.0 106.208 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.5 pt . . . . . 0 CA--C 1.531 0.234 0 C-N-CA 124.487 1.115 . . . . 10.0 109.633 -169.771 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 110.036 -0.357 . . . . 10.0 110.036 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -139.32 19.57 2.58 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.505 1.122 . . . . 10.0 111.696 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 64.17 146.3 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.594 2.758 . . . . 10.0 113.093 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.47 157.05 43.7 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.749 1.22 . . . . 10.0 108.344 175.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.34 147.96 32.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 125.624 1.569 . . . . 10.0 108.161 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.2 tp -109.46 120.2 41.77 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.666 -1.975 . . . . 10.0 105.666 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.8 mt -131.28 136.36 57.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 -168.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -88.45 143.8 26.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.799 -1.556 . . . . 10.0 106.799 168.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -126.78 141.64 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.565 -1.643 . . . . 10.0 106.565 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -124.83 129.53 50.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.352 1.861 . . . . 10.0 106.048 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.1 p -80.06 146.22 32.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.775 0.322 . . . . 10.0 111.201 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -155.72 62.15 3.08 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.38 1.872 . . . . 10.0 106.702 167.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -55.61 143.63 78.27 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.532 2.821 . . . . 10.0 111.078 -168.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.4 ttt85 47.69 25.38 0.68 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.947 1.299 . . . . 10.0 113.09 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.0 m 53.01 28.82 7.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.523 1.529 . . . . 10.0 113.632 -175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.84 -1.8 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 N-CA-C 116.723 1.449 . . . . 10.0 116.723 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 152.13 82.44 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 120.168 1.984 . . . . 10.0 110.675 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.85 59.14 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.291 3.327 . . . . 10.0 111.917 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.6 140.98 33.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.024 1.33 . . . . 10.0 108.516 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.06 29.77 0.72 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.176 1.391 . . . . 10.0 110.254 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -67.57 162.24 23.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.643 0.777 . . . . 10.0 108.918 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -140.2 160.29 40.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.026 0.93 . . . . 10.0 110.01 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -150.78 176.28 11.19 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.58 1.152 . . . . 10.0 109.627 170.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -99.31 157.09 16.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.347 -0.982 . . . . 10.0 108.347 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.8 pt -141.72 149.35 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 126.387 1.875 . . . . 10.0 108.346 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.76 124.27 66.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.883 -1.895 . . . . 10.0 105.883 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -129.38 148.53 51.31 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.596 -1.261 . . . . 10.0 107.596 -175.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.32 124.08 0.97 Allowed Glycine 0 C--O 1.228 -0.255 0 N-CA-C 109.035 -1.626 . . . . 10.0 109.035 173.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -140.63 134.97 31.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.4 0.6 . . . . 10.0 110.501 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -74.69 -11.95 60.3 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 114.277 1.214 . . . . 10.0 114.277 -169.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -66.11 -24.3 66.66 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.461 1.028 . . . . 10.0 111.575 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.33 163.19 28.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.85 0.75 . . . . 10.0 110.809 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -119.18 -17.65 8.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.449 1.1 . . . . 10.0 110.367 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -146.95 152.49 38.74 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.421 1.488 . . . . 10.0 108.105 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.55 ' CG ' ' HG ' ' A' ' 94' ' ' SER . 55.7 m80 -57.68 -31.85 66.76 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.399 1.079 . . . . 10.0 112.21 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.32 -33.2 72.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.187 -0.911 . . . . 10.0 112.607 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -72.0 -37.08 69.88 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.959 0.799 . . . . 10.0 110.437 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.9 -52.23 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.934 -1.135 . . . . 10.0 107.934 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -56.87 -43.19 80.96 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 119.09 -0.481 . . . . 10.0 111.494 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.32 -45.5 91.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.906 0.482 . . . . 10.0 111.181 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -60.92 -48.25 82.67 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.608 -0.682 . . . . 10.0 109.976 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.97 -43.89 98.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.659 0.783 . . . . 10.0 109.622 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.8 m -61.29 -43.88 98.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.046 0.839 . . . . 10.0 110.406 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.78 -46.92 93.55 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.787 -0.925 . . . . 10.0 110.787 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.05 -44.8 95.92 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.741 0.77 . . . . 10.0 110.668 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.3 mmt -62.01 -37.18 83.91 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.923 -0.56 . . . . 10.0 111.101 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -63.65 -35.64 81.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.274 0.943 . . . . 10.0 110.816 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.55 -31.97 72.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 117.924 -1.036 . . . . 10.0 111.597 171.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.63 -44.43 70.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.527 1.058 . . . . 10.0 110.039 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.86 47.55 0.61 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 108.852 -1.699 . . . . 10.0 108.852 -169.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.5 m -146.66 169.64 18.59 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.321 1.848 . . . . 10.0 108.655 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.57 164.93 28.83 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.064 1.746 . . . . 10.0 108.138 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 78.5 m -126.17 164.89 19.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.199 1.0 . . . . 10.0 112.811 -168.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -149.3 113.08 5.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.317 2.247 . . . . 10.0 105.346 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.8 t -66.47 140.23 58.01 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.637 -1.29 . . . . 10.0 109.479 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.8 mt -108.22 -13.46 14.9 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.614 0.765 . . . . 10.0 111.228 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.06 -174.25 24.48 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.209 1.385 . . . . 10.0 110.573 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.06 -176.23 27.03 Favored Glycine 0 CA--C 1.524 0.647 0 O-C-N 121.44 -1.036 . . . . 10.0 111.495 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.29 -154.5 10.2 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.131 -1.588 . . . . 10.0 109.131 -174.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -139.52 163.65 31.98 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.441 1.896 . . . . 10.0 107.905 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mt -129.23 150.78 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.495 -1.669 . . . . 10.0 106.495 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 p . . . . . 0 CA--C 1.537 0.456 0 C-N-CA 125.257 1.423 . . . . 10.0 108.832 -174.112 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.239 0.528 0 N-CA-C 106.582 -1.636 . . . . 10.0 106.582 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -137.44 157.01 47.49 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.526 0.731 . . . . 10.0 109.366 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.53 140.32 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -159.36 -174.95 4.94 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.761 -1.212 . . . . 10.0 110.06 -171.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.13 -166.07 52.49 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 121.835 0.686 . . . . 10.0 111.641 169.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -148.47 161.8 40.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.512 1.125 . . . . 10.0 108.403 175.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.55 ' HG ' ' CG ' ' A' ' 53' ' ' HIS . 30.1 t -83.17 126.33 32.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -64.63 -26.97 68.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.119 0.568 . . . . 10.0 110.702 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.53 -30.17 46.89 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.529 -0.748 . . . . 10.0 112.487 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -130.15 -58.91 1.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.802 0.728 . . . . 10.0 112.396 -169.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 149.14 176.28 22.28 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 108.902 -1.679 . . . . 10.0 108.902 -170.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -57.13 134.53 64.84 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.572 2.182 . . . . 10.0 110.566 171.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.65 163.44 18.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 166.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -79.79 69.29 6.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.08 -1.822 . . . . 10.0 106.08 167.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -50.78 -30.09 13.25 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.211 1.404 . . . . 10.0 113.518 -168.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.69 70.89 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.289 0.95 . . . . 10.0 112.349 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.9 mt -64.32 -50.28 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.2 m -59.26 -46.5 88.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.61 -0.681 . . . . 10.0 111.96 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.9 p -63.94 -39.98 95.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.356 -0.83 . . . . 10.0 110.876 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.44 -40.17 92.94 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.307 0.958 . . . . 10.0 110.97 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -66.68 -44.23 82.36 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.755 -0.64 . . . . 10.0 110.436 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.7 mt -56.15 -52.44 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.003 -1.11 . . . . 10.0 108.003 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -59.55 -40.59 87.73 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.741 0.816 . . . . 10.0 111.54 -174.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.6 -41.08 98.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.704 0.802 . . . . 10.0 111.288 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 118.233 -0.889 . . . . 10.0 112.923 -177.386 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.235 0.3 0 N-CA-C 107.551 -1.277 . . . . 10.0 107.551 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.17 172.0 13.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.694 1.197 . . . . 10.0 109.163 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 44.0 p-90 -147.04 169.09 19.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.29 0.496 . . . . 10.0 111.179 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 C-N-CA 124.266 1.026 . . . . 10.0 109.997 171.864 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.243 0 N-CA-C 106.549 -1.649 . . . . 10.0 106.549 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -150.21 152.93 35.38 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 172.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.65 -21.8 61.01 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 118.381 -0.818 . . . . 10.0 113.161 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.7 -23.29 64.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.413 1.006 . . . . 10.0 112.688 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.9 mt -77.54 -8.65 58.13 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.661 0.784 . . . . 10.0 111.995 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.9 mt -112.76 128.45 25.56 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 106.479 -1.674 . . . . 10.0 106.479 -172.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.72 151.43 74.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.382 2.055 . . . . 10.0 110.755 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -67.63 -38.16 83.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.05 1.34 . . . . 10.0 112.817 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.55 138.66 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.145 -1.428 . . . . 10.0 107.145 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -155.04 97.7 1.95 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.438 -1.319 . . . . 10.0 107.438 -176.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.1 pt . . . . . 0 CA--C 1.533 0.308 0 C-N-CA 124.895 1.278 . . . . 10.0 108.211 -175.825 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.2 t . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 108.748 -0.834 . . . . 10.0 108.748 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -145.42 146.16 31.42 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.711 -0.848 . . . . 10.0 108.711 172.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -61.84 157.65 17.72 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.367 0.667 . . . . 10.0 110.567 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -151.08 171.9 16.6 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.228 1.411 . . . . 10.0 108.242 169.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.4 152.61 29.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.707 1.203 . . . . 10.0 110.48 174.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.0 tp -102.95 117.68 35.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.086 -2.191 . . . . 10.0 105.086 167.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.78 134.69 62.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 105.731 -1.952 . . . . 10.0 105.731 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -85.79 135.14 33.85 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.381 -1.711 . . . . 10.0 106.381 167.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -120.88 142.3 37.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -122.66 133.21 54.52 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.368 1.867 . . . . 10.0 106.083 -174.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.6 p -66.83 143.55 56.81 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.649 -0.5 . . . . 10.0 109.649 172.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.12 59.35 3.64 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.214 1.006 . . . . 10.0 108.781 168.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -59.18 138.52 85.5 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.871 2.381 . . . . 10.0 109.522 -173.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 45.26 21.19 0.06 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.958 1.703 . . . . 10.0 114.482 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m 47.88 32.14 2.63 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.342 1.457 . . . . 10.0 113.125 -170.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.92 0.11 0.03 OUTLIER Glycine 0 CA--C 1.531 1.059 0 N-CA-C 115.929 1.131 . . . . 10.0 115.929 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.45 152.68 84.85 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 120.529 2.164 . . . . 10.0 110.509 171.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.69 52.63 3.75 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 124.123 3.215 . . . . 10.0 111.651 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.14 136.56 31.98 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.921 1.288 . . . . 10.0 108.333 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.15 30.56 0.7 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.244 1.418 . . . . 10.0 109.595 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -64.34 155.44 32.26 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -140.77 160.45 40.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.981 0.912 . . . . 10.0 110.702 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -149.78 172.64 14.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.177 0.991 . . . . 10.0 109.809 172.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.39 145.8 26.99 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 174.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.5 pt -135.74 148.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.585 1.554 . . . . 10.0 109.02 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.15 126.05 67.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.964 -1.495 . . . . 10.0 106.964 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -131.39 131.11 43.41 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 -174.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.04 55.01 0.36 Allowed Glycine 0 N--CA 1.464 0.527 0 CA-C-N 119.328 0.967 . . . . 10.0 111.398 -168.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -74.05 142.71 45.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.884 0.473 . . . . 10.0 111.15 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -63.53 -37.95 89.29 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 124.037 0.935 . . . . 10.0 112.551 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -66.33 -20.56 66.12 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 118.124 -0.941 . . . . 10.0 113.228 -172.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.37 134.38 51.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.768 0.713 . . . . 10.0 111.439 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -72.78 -34.42 66.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.552 0.691 . . . . 10.0 110.11 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -151.27 165.47 33.9 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 125.173 1.389 . . . . 10.0 109.238 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.455 ' CG ' ' HG ' ' A' ' 94' ' ' SER . 10.3 p-80 -48.88 -40.31 29.23 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.635 1.174 . . . . 10.0 112.516 169.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.24 73.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.52 -0.753 . . . . 10.0 112.184 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -70.19 -38.03 75.27 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.099 0.952 . . . . 10.0 109.793 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.22 -53.72 42.3 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 107.994 -1.113 . . . . 10.0 107.994 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -57.74 -45.24 86.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.323 -0.846 . . . . 10.0 111.504 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.04 -46.94 86.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.433 0.561 . . . . 10.0 111.538 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -63.22 -48.03 79.98 Favored 'General case' 0 C--N 1.342 0.274 0 O-C-N 121.604 -0.685 . . . . 10.0 109.756 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.08 -44.97 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 118.437 -0.792 . . . . 10.0 109.227 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.4 m -57.64 -42.26 83.07 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.497 1.044 . . . . 10.0 110.928 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.21 -45.49 95.9 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.577 -0.609 . . . . 10.0 111.577 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.33 -50.57 73.11 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.399 -1.06 . . . . 10.0 110.81 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -38.87 84.18 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 118.894 -0.574 . . . . 10.0 111.056 -178.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -63.94 -34.14 77.29 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.108 0.413 . . . . 10.0 110.837 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -71.57 -28.45 63.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 117.453 -1.26 . . . . 10.0 112.527 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -69.34 -59.86 2.72 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.727 1.149 . . . . 10.0 108.523 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.06 44.01 0.11 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.979 1.752 . . . . 10.0 109.169 -168.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.0 m -147.09 176.35 10.01 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.441 2.296 . . . . 10.0 107.346 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -148.46 165.9 29.76 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.02 -1.05 . . . . 10.0 108.923 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.8 m -131.04 159.8 36.47 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.602 1.092 . . . . 10.0 112.763 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -145.54 120.18 9.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.007 -1.849 . . . . 10.0 106.007 170.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.9 t -67.33 134.44 51.54 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.643 -1.285 . . . . 10.0 109.056 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 56.0 mt -91.64 -24.2 19.6 Favored 'General case' 0 C--O 1.226 -0.18 0 O-C-N 123.953 0.783 . . . . 10.0 110.646 171.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.92 164.78 21.01 Favored Glycine 0 C--N 1.337 0.587 0 O-C-N 121.216 -0.927 . . . . 10.0 111.233 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -125.61 163.15 19.69 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.263 -1.135 . . . . 10.0 110.263 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.29 -156.11 10.45 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.512 -1.835 . . . . 10.0 108.512 -171.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -139.35 153.59 47.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.059 1.744 . . . . 10.0 109.161 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.0 mm -119.98 145.89 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.327 -2.471 . . . . 10.0 104.327 168.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.4 m . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 168.469 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 mm . . . . . 0 C--O 1.237 0.44 0 N-CA-C 107.343 -1.355 . . . . 10.0 107.343 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -140.37 141.81 35.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.911 -1.144 . . . . 10.0 107.911 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.0 t -131.72 122.77 50.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.832 -1.544 . . . . 10.0 106.832 -169.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -158.28 -164.25 1.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.163 -0.961 . . . . 10.0 108.638 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.51 -173.27 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 118.65 0.659 . . . . 10.0 112.658 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -159.09 167.35 29.45 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.818 -1.178 . . . . 10.0 107.818 167.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.455 ' HG ' ' CG ' ' A' ' 53' ' ' HIS . 58.2 m -133.09 112.62 11.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 172.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -24.56 6.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.68 1.992 . . . . 10.0 114.101 -176.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.35 -25.31 65.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.745 0.818 . . . . 10.0 112.868 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.35 -41.68 0.14 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.0 0.818 . . . . 10.0 112.882 -174.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.29 -175.77 23.89 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.459 1.028 . . . . 10.0 110.765 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.19 148.16 68.12 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.264 2.643 . . . . 10.0 110.397 170.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.87 34.5 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.077 1.351 . . . . 10.0 113.176 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 35.28 59.31 0.77 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.277 2.231 . . . . 10.0 112.156 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -51.4 -25.14 5.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.327 2.251 . . . . 10.0 115.561 -164.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.77 92.47 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.764 1.165 . . . . 10.0 111.663 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.87 -54.01 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.027 -1.471 . . . . 10.0 107.027 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 m -63.34 -41.21 98.85 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.156 0.582 . . . . 10.0 112.516 -173.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.7 p -61.53 -47.14 86.93 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 118.628 0.649 . . . . 10.0 110.419 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -66.68 -36.74 83.25 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.22 0.464 . . . . 10.0 110.271 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -59.68 -50.79 72.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 118.847 -0.597 . . . . 10.0 110.794 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.54 -53.57 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.096 -1.076 . . . . 10.0 108.096 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -60.86 -37.97 83.96 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.039 1.335 . . . . 10.0 112.234 -173.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.48 -50.38 26.43 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.15 0.58 . . . . 10.0 110.389 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 tptt . . . . . 0 C--N 1.341 0.236 0 CA-C-O 118.625 -0.702 . . . . 10.0 111.444 -173.589 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 104.032 -2.581 . . . . 10.0 104.032 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.1 p -111.94 167.15 10.61 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.832 0.853 . . . . 10.0 110.458 -170.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -145.43 166.75 24.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.487 0.921 . . . . 10.0 113.487 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 127.979 2.512 . . . . 10.0 107.93 170.911 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -151.72 149.54 29.18 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.938 -1.504 . . . . 10.0 106.938 171.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.75 -27.91 63.45 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.778 0.831 . . . . 10.0 112.933 -176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -25.96 68.01 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.773 0.715 . . . . 10.0 112.193 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.3 mt -76.34 -23.23 54.22 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.221 0.608 . . . . 10.0 111.191 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.9 mt -83.94 122.08 76.01 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 107.688 -1.227 . . . . 10.0 107.688 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.31 138.55 37.69 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.692 2.928 . . . . 10.0 110.909 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -85.25 -28.42 25.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.438 0.637 . . . . 10.0 112.104 -169.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.8 t -139.16 136.04 41.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 126.185 1.794 . . . . 10.0 106.193 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -149.5 98.79 2.82 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.8 pt . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 125.665 1.586 . . . . 10.0 109.996 -169.647 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -139.68 139.99 36.76 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.901 -1.148 . . . . 10.0 107.901 175.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -67.23 155.82 37.86 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.02 165.41 29.11 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.697 0.761 . . . . 10.0 109.108 172.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.5 140.09 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.318 1.447 . . . . 10.0 107.436 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -100.17 118.93 37.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.695 -2.335 . . . . 10.0 104.695 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.7 mt -123.29 135.97 61.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 -171.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -88.83 133.28 34.32 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.175 -1.787 . . . . 10.0 106.175 168.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -116.25 140.25 39.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.2 -1.778 . . . . 10.0 106.2 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -122.04 136.4 54.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.196 1.798 . . . . 10.0 106.997 -172.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 m -64.12 137.05 57.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.306 -0.628 . . . . 10.0 109.306 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.9 54.95 2.02 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.246 1.018 . . . . 10.0 108.957 166.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.85 131.49 33.25 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.895 2.397 . . . . 10.0 108.523 -169.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.304 4.6 ppt_? 41.12 29.25 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.386 1.874 . . . . 10.0 114.251 -169.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m 46.09 37.87 4.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.758 1.623 . . . . 10.0 113.489 -173.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.99 -1.95 0.03 OUTLIER Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.34 1.296 . . . . 10.0 116.34 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.29 152.38 63.76 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 120.478 2.139 . . . . 10.0 110.55 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.23 49.5 2.85 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.092 3.195 . . . . 10.0 111.892 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.82 128.0 18.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.964 1.306 . . . . 10.0 108.038 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.57 26.61 1.75 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.134 1.374 . . . . 10.0 109.948 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.86 160.05 21.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.6 0.76 . . . . 10.0 109.006 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -138.1 161.39 36.89 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.98 0.912 . . . . 10.0 110.797 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -144.59 173.13 12.08 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.221 1.008 . . . . 10.0 109.578 169.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -98.26 148.95 23.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 pt -137.24 154.17 30.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 125.736 1.615 . . . . 10.0 109.466 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.2 126.97 67.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.217 -1.772 . . . . 10.0 106.217 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -130.54 137.29 49.64 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.91 46.0 0.27 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.944 -0.862 . . . . 10.0 110.944 -169.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -66.16 136.61 56.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.064 0.546 . . . . 10.0 110.406 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -66.72 -27.96 68.05 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 113.667 0.988 . . . . 10.0 113.667 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.6 p-90 -68.3 -23.94 64.8 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.423 -0.798 . . . . 10.0 112.474 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.19 134.28 47.93 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.871 0.76 . . . . 10.0 110.778 -175.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.25 -35.37 71.4 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.366 0.666 . . . . 10.0 110.559 171.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -147.29 157.45 43.59 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.632 1.573 . . . . 10.0 109.084 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.88 -25.67 57.22 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.282 1.033 . . . . 10.0 112.387 172.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.77 -40.24 79.31 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.011 0.823 . . . . 10.0 112.03 169.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -71.54 -33.28 69.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.383 0.611 . . . . 10.0 110.125 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.0 -55.75 20.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 108.35 -0.982 . . . . 10.0 108.35 173.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -54.99 -42.16 72.11 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.956 -0.545 . . . . 10.0 111.305 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.93 -48.7 80.55 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.478 0.711 . . . . 10.0 111.261 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -44.89 72.07 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.486 -0.759 . . . . 10.0 110.29 -175.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.81 -46.06 95.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 C-N-CA 123.89 0.876 . . . . 10.0 109.172 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 m -58.4 -40.47 82.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.09 0.859 . . . . 10.0 111.242 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.09 -50.77 64.02 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.995 -0.842 . . . . 10.0 110.995 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.66 -47.91 84.15 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.073 0.937 . . . . 10.0 111.071 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -39.39 85.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.724 -0.61 . . . . 10.0 110.459 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -68.14 -33.37 74.36 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 118.829 0.741 . . . . 10.0 110.757 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.87 -39.7 94.83 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 116.575 -1.678 . . . . 10.0 111.029 169.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -67.7 -60.15 2.77 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 119.281 0.946 . . . . 10.0 108.788 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.08 44.28 0.08 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.283 1.42 . . . . 10.0 110.447 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.4 m -148.69 177.59 9.37 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.055 2.142 . . . . 10.0 108.052 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -148.21 165.99 29.27 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.503 1.121 . . . . 10.0 109.004 172.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.5 m -134.5 160.1 39.08 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.842 1.201 . . . . 10.0 113.375 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.17 139.32 19.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.512 1.925 . . . . 10.0 106.902 169.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.3 m -75.67 140.82 42.75 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.352 -0.843 . . . . 10.0 110.415 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.7 mt -96.24 -22.99 16.91 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.921 -0.487 . . . . 10.0 110.802 168.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.16 -173.59 39.35 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.979 -1.248 . . . . 10.0 109.979 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.05 -172.16 22.47 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 118.846 1.323 . . . . 10.0 111.911 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.65 -150.85 9.58 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 109.375 -1.49 . . . . 10.0 109.375 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -137.3 160.76 38.11 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.966 1.306 . . . . 10.0 109.117 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.5 mt -132.6 150.18 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 124.608 1.163 . . . . 10.0 109.441 171.619 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.9 mm . . . . . 0 C--O 1.238 0.484 0 N-CA-C 106.719 -1.586 . . . . 10.0 106.719 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -137.23 156.22 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 120.147 -1.596 . . . . 10.0 109.247 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.38 131.87 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.067 -1.457 . . . . 10.0 107.067 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.59 176.72 12.26 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.159 -0.963 . . . . 10.0 112.136 -169.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.71 -159.47 53.03 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.217 -0.753 . . . . 10.0 111.217 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -157.39 157.06 33.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.123 1.369 . . . . 10.0 108.829 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -73.79 127.98 34.28 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.003 -1.061 . . . . 10.0 108.236 170.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 96.7 mtp -75.44 -18.19 59.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.763 -0.637 . . . . 10.0 111.215 169.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.56 -32.01 53.53 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 118.429 0.559 . . . . 10.0 111.688 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -127.37 -49.29 1.42 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.685 0.394 . . . . 10.0 111.264 -171.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.47 177.59 15.76 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.391 -1.484 . . . . 10.0 109.391 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.27 131.15 41.82 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.943 2.429 . . . . 10.0 110.573 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.05 162.58 16.49 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.82 0.819 . . . . 10.0 109.113 166.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -79.17 68.15 5.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.598 -1.63 . . . . 10.0 106.598 167.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -49.81 -32.34 13.86 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.316 1.446 . . . . 10.0 113.321 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.65 -36.89 74.84 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.433 1.015 . . . . 10.0 112.563 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.5 mt -66.62 -49.23 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -58.13 -44.21 87.68 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 117.858 -1.068 . . . . 10.0 111.99 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 p -64.79 -38.06 89.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 120.235 1.38 . . . . 10.0 111.273 -177.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.66 -40.31 88.59 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.58 1.082 . . . . 10.0 110.672 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -65.53 -45.72 82.37 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.793 -0.567 . . . . 10.0 110.337 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.3 mt -59.66 -43.12 90.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 118.017 -0.992 . . . . 10.0 109.213 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -57.95 -41.76 83.52 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 119.024 0.829 . . . . 10.0 110.669 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.69 -44.01 87.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.394 0.543 . . . . 10.0 111.03 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.2 tptp . . . . . 0 CA--C 1.533 0.314 0 O-C-N 121.671 -0.643 . . . . 10.0 111.365 -174.876 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 105.444 -2.058 . . . . 10.0 105.444 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.3 p -133.22 173.43 11.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.61 0.641 . . . . 10.0 109.622 171.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -144.89 165.34 28.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.508 0.323 . . . . 10.0 111.039 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 C-N-CA 126.215 1.806 . . . . 10.0 108.38 171.841 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -149.31 151.16 33.69 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.51 -25.42 62.38 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.399 -0.81 . . . . 10.0 113.07 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.03 -31.93 71.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.992 0.814 . . . . 10.0 112.034 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.06 -35.01 57.06 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.049 0.539 . . . . 10.0 110.118 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -65.61 119.77 62.96 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.271 1.028 . . . . 10.0 108.576 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.7 133.4 38.71 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.748 2.966 . . . . 10.0 111.167 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -84.69 -30.17 25.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.444 0.64 . . . . 10.0 111.929 -170.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -136.57 136.26 48.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 126.266 1.827 . . . . 10.0 106.07 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -149.48 101.54 3.11 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.205 -1.406 . . . . 10.0 107.205 170.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.2 pt . . . . . 0 CA--C 1.533 0.325 0 C-N-CA 125.495 1.518 . . . . 10.0 108.096 -174.944 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -142.53 138.01 30.59 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.668 0.787 . . . . 10.0 108.972 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -59.79 155.03 16.96 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.894 0.878 . . . . 10.0 109.733 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.12 166.47 27.75 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.173 0.989 . . . . 10.0 108.457 174.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.15 148.02 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.012 0.925 . . . . 10.0 108.599 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.9 tp -109.04 114.15 27.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 105.589 -2.004 . . . . 10.0 105.589 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.4 mt -119.18 133.92 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.045 -1.465 . . . . 10.0 107.045 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -88.5 135.05 33.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.93 133.62 53.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.537 -2.023 . . . . 10.0 105.537 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -111.69 128.33 56.04 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.009 -1.848 . . . . 10.0 106.009 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 p -78.66 146.12 34.21 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.009 0.433 . . . . 10.0 111.111 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.86 67.74 3.78 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 126.45 1.9 . . . . 10.0 106.448 167.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.14 -39.55 26.3 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.52 3.48 . . . . 10.0 114.2 -168.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.57 168.8 18.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.79 -1.559 . . . . 10.0 106.79 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -54.43 -21.48 9.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.419 1.888 . . . . 10.0 114.562 -170.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.41 32.12 1.77 Allowed Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.59 1.09 . . . . 10.0 111.699 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.91 146.23 95.53 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.145 0.972 . . . . 10.0 110.766 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -81.64 44.49 1.74 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 124.323 3.348 . . . . 10.0 112.391 -175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.05 138.65 28.47 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.308 1.043 . . . . 10.0 109.572 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.55 27.98 0.64 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.515 1.526 . . . . 10.0 110.358 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.07 164.47 20.13 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.857 0.863 . . . . 10.0 109.527 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -139.54 160.17 40.47 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.909 0.884 . . . . 10.0 110.787 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -149.28 176.07 10.86 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.805 1.242 . . . . 10.0 109.506 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -102.97 154.18 19.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.81 -0.811 . . . . 10.0 108.81 169.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.2 pt -134.04 154.11 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 125.456 1.502 . . . . 10.0 109.583 170.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.42 127.87 62.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.284 -1.747 . . . . 10.0 106.284 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -131.16 134.97 47.03 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 107.863 -1.162 . . . . 10.0 107.863 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.18 49.59 0.31 Allowed Glycine 0 N--CA 1.46 0.258 0 N-CA-C 110.601 -1.0 . . . . 10.0 110.601 -170.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.33 132.5 46.51 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.465 -0.569 . . . . 10.0 109.465 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -65.45 -26.57 68.01 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 113.483 0.92 . . . . 10.0 113.483 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -67.6 -22.83 65.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.46 -0.781 . . . . 10.0 112.774 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.7 128.89 38.02 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.975 0.807 . . . . 10.0 110.462 -174.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -74.58 -24.75 58.96 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.288 0.566 . . . . 10.0 110.412 173.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -147.13 152.64 38.8 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 120.521 -1.362 . . . . 10.0 109.613 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -53.8 -37.39 63.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.133 0.973 . . . . 10.0 111.137 168.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.2 -31.26 71.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.523 -0.751 . . . . 10.0 112.58 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -69.31 -39.04 78.51 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.149 0.976 . . . . 10.0 109.602 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.74 -53.37 47.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 173.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.82 -46.42 74.55 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.727 -0.654 . . . . 10.0 111.135 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.32 -47.26 86.77 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.302 0.376 . . . . 10.0 111.407 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -65.89 -47.26 75.44 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 121.745 -0.597 . . . . 10.0 109.796 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.84 -39.26 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 118.193 -0.908 . . . . 10.0 110.131 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -59.77 -44.65 93.78 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.684 1.129 . . . . 10.0 110.678 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.92 -46.57 93.9 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.884 -0.887 . . . . 10.0 110.884 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.04 -48.24 81.16 Favored 'General case' 0 C--O 1.228 -0.066 0 CA-C-N 117.696 0.748 . . . . 10.0 110.851 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.0 mmt -60.08 -38.7 83.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.227 0.611 . . . . 10.0 111.18 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -63.68 -34.62 78.27 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.645 0.657 . . . . 10.0 110.601 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -70.0 -33.04 71.52 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.78 -1.105 . . . . 10.0 112.033 170.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -66.82 -53.18 35.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.444 1.02 . . . . 10.0 109.491 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 130.35 43.17 0.2 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.34 1.448 . . . . 10.0 110.177 -169.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.5 m -148.28 175.08 11.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.159 1.783 . . . . 10.0 108.461 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -145.27 166.16 26.31 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.265 1.026 . . . . 10.0 108.568 170.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.5 m -133.71 155.79 49.1 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.797 1.036 . . . . 10.0 113.797 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -147.54 142.59 27.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.552 1.941 . . . . 10.0 106.286 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.7 m -83.36 136.48 34.33 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.263 -0.898 . . . . 10.0 110.366 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.9 mt -87.66 -25.17 23.65 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.377 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.09 -178.7 41.68 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.929 -1.269 . . . . 10.0 109.929 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.93 -177.91 21.86 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 118.038 0.919 . . . . 10.0 111.928 170.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.87 -147.91 5.92 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 108.851 -1.7 . . . . 10.0 108.851 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.64 155.22 44.18 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.471 1.508 . . . . 10.0 107.906 170.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.1 155.91 18.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 104.517 -2.401 . . . . 10.0 104.517 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.452 -0.358 0 O-C-N 121.023 -1.048 . . . . 10.0 108.377 173.064 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt . . . . . 0 C--O 1.239 0.513 0 N-CA-C 108.214 -1.032 . . . . 10.0 108.214 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -135.31 155.03 51.28 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.477 1.511 . . . . 10.0 108.893 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.22 139.69 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.429 1.092 . . . . 10.0 108.439 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -159.37 -172.16 3.62 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.272 -0.893 . . . . 10.0 110.564 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.13 -173.42 36.07 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 121.553 0.53 . . . . 10.0 112.125 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -154.08 160.22 41.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.178 -1.415 . . . . 10.0 107.178 169.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.6 m -124.23 107.33 11.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.9 mtt -56.59 -23.64 42.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.989 1.316 . . . . 10.0 113.664 -169.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.75 -25.11 68.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.528 -0.749 . . . . 10.0 112.767 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -135.71 -50.48 0.72 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.712 0.805 . . . . 10.0 111.111 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.7 -177.94 20.09 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.941 1.734 . . . . 10.0 109.604 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.94 132.98 36.69 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.195 1.93 . . . . 10.0 109.175 169.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.18 152.57 37.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 167.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -78.28 73.09 4.84 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -51.1 -31.0 17.73 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 124.631 1.173 . . . . 10.0 113.258 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.66 -35.81 73.15 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.212 0.914 . . . . 10.0 112.405 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.6 mt -65.11 -51.81 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.208 -1.404 . . . . 10.0 107.208 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -57.63 -44.93 85.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.26 -0.876 . . . . 10.0 112.287 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 p -66.85 -38.65 86.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.704 1.138 . . . . 10.0 111.156 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.08 -39.14 89.8 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.941 0.792 . . . . 10.0 110.736 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -64.65 -46.68 81.46 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 122.056 -0.403 . . . . 10.0 110.683 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.43 -44.07 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -60.81 -42.01 96.82 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.256 0.934 . . . . 10.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.42 87.22 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.281 0.632 . . . . 10.0 111.724 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.1 tptp . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 118.089 -0.958 . . . . 10.0 111.57 174.718 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 106.926 -1.509 . . . . 10.0 106.926 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.9 p -139.71 166.95 23.23 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 120.987 -1.07 . . . . 10.0 110.034 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -147.12 164.06 34.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.916 0.326 . . . . 10.0 111.134 169.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.371 0 C-N-CA 126.536 1.934 . . . . 10.0 108.532 174.64 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 121.953 0.883 . . . . 10.0 111.399 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -147.62 151.44 36.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.3 -1.741 . . . . 10.0 106.3 170.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.5 mt -59.88 -22.55 62.49 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 117.602 -1.189 . . . . 10.0 113.947 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.5 -33.58 75.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.034 0.834 . . . . 10.0 111.615 172.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.16 -34.35 43.23 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.989 0.516 . . . . 10.0 110.299 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -65.21 125.03 88.54 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.799 -1.186 . . . . 10.0 107.799 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.35 139.86 61.51 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.326 2.018 . . . . 10.0 109.875 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.92 -31.5 51.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.036 0.935 . . . . 10.0 111.644 -171.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.5 t -140.41 136.17 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 105.129 -2.174 . . . . 10.0 105.129 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -150.77 102.34 2.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 172.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 pt . . . . . 0 CA--C 1.539 0.524 0 C-N-CA 124.967 1.307 . . . . 10.0 109.478 -168.355 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 37.5 t . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 108.025 -1.102 . . . . 10.0 108.025 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -152.49 148.55 27.54 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.575 1.179 . . . . 10.0 111.213 172.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -63.82 145.98 54.79 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.06 160.74 40.36 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.488 0.715 . . . . 10.0 110.159 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.95 146.42 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.576 1.55 . . . . 10.0 108.132 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 tt -106.49 122.22 45.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 105.438 -2.06 . . . . 10.0 105.438 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.8 mt -126.03 133.26 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.997 -1.483 . . . . 10.0 106.997 -171.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 ttm105 -85.47 139.0 31.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 167.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.27 140.58 41.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 124.579 1.152 . . . . 10.0 107.894 175.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -115.54 127.32 55.18 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.692 -1.966 . . . . 10.0 105.692 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.9 p -74.39 144.54 44.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.228 0.537 . . . . 10.0 111.399 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.0 71.07 4.65 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.795 2.038 . . . . 10.0 106.419 167.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.76 -38.92 47.75 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.69 2.927 . . . . 10.0 112.55 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -146.4 162.74 37.57 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 105.257 -2.127 . . . . 10.0 105.257 170.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -55.6 -23.21 26.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.508 1.299 . . . . 10.0 114.508 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -132.5 25.34 3.81 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.69 1.138 . . . . 10.0 111.865 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.86 149.83 89.0 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 118.679 1.24 . . . . 10.0 110.932 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.65 41.66 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.052 3.168 . . . . 10.0 112.03 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.1 135.09 22.59 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.267 1.027 . . . . 10.0 109.001 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.04 27.52 0.77 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.848 1.659 . . . . 10.0 109.579 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.69 166.46 17.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.302 1.041 . . . . 10.0 109.515 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.1 m -136.39 161.19 36.51 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.405 -0.81 . . . . 10.0 110.459 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -146.9 170.7 16.52 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.299 1.439 . . . . 10.0 107.664 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -122.48 140.95 52.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.261 -2.125 . . . . 10.0 105.261 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.2 pt -134.97 154.12 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.347 1.059 . . . . 10.0 110.123 -173.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.97 128.63 69.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -133.75 144.26 48.97 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.041 -1.466 . . . . 10.0 107.041 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.37 131.55 1.96 Allowed Glycine 0 CA--C 1.506 -0.493 0 CA-C-N 120.193 1.361 . . . . 10.0 111.033 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -147.22 139.29 24.43 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -70.84 -17.59 62.73 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 116.885 -1.531 . . . . 10.0 114.277 -173.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -68.52 -17.22 64.12 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 119.994 1.27 . . . . 10.0 112.012 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.81 127.39 31.72 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 119.856 1.207 . . . . 10.0 111.513 -172.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.79 -44.47 85.64 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.802 0.81 . . . . 10.0 109.068 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -146.51 168.83 20.25 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 127.183 2.193 . . . . 10.0 106.898 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.649 ' CD2' ' HG ' ' A' ' 94' ' ' SER . 71.2 m80 -56.98 -36.13 69.97 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.997 -1.064 . . . . 10.0 112.403 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.27 -24.51 63.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.11 -0.947 . . . . 10.0 112.657 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -66.49 -36.34 82.49 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.903 1.335 . . . . 10.0 109.549 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -65.71 -53.78 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 120.471 -1.393 . . . . 10.0 108.505 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -54.73 -40.18 69.02 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.76 -1.114 . . . . 10.0 111.473 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.59 -46.24 90.69 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.347 0.976 . . . . 10.0 111.756 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -65.27 -48.15 74.22 Favored 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 121.002 -1.061 . . . . 10.0 109.718 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.07 -42.48 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.554 -0.535 . . . . 10.0 109.554 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 p -65.06 -34.46 78.47 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.576 1.08 . . . . 10.0 111.362 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.76 -47.93 81.66 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.08 -47.41 84.81 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 117.363 0.582 . . . . 10.0 111.115 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.7 mmt -60.7 -36.8 79.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.137 -0.935 . . . . 10.0 110.57 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.53 -39.85 94.53 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.39 0.996 . . . . 10.0 111.08 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -70.72 -27.19 63.79 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.759 1.163 . . . . 10.0 111.779 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -69.61 -55.64 9.51 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.335 0.97 . . . . 10.0 108.84 175.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.17 42.66 0.14 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.029 1.3 . . . . 10.0 111.553 -173.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 50.9 m -142.17 168.01 20.76 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.278 1.431 . . . . 10.0 109.508 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.73 160.71 30.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.156 1.782 . . . . 10.0 107.138 170.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.3 m -129.7 153.17 48.43 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.443 1.097 . . . . 10.0 112.663 -166.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -142.72 110.65 5.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.907 -1.886 . . . . 10.0 105.907 170.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.5 p -61.26 122.95 16.38 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.248 -0.908 . . . . 10.0 109.103 170.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.1 mt -86.37 -22.55 26.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.163 0.506 . . . . 10.0 110.558 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.84 -177.18 30.66 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 108.239 -1.945 . . . . 10.0 108.239 -172.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.32 -161.2 13.77 Favored Glycine 0 CA--C 1.52 0.371 0 O-C-N 121.016 -1.285 . . . . 10.0 110.714 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.97 -138.63 3.84 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.656 -1.778 . . . . 10.0 108.656 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -136.81 144.43 43.68 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.698 1.199 . . . . 10.0 107.884 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.84 151.55 8.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 104.656 -2.35 . . . . 10.0 104.656 169.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 177.008 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.8 mt . . . . . 0 C--O 1.239 0.518 0 N-CA-C 107.057 -1.46 . . . . 10.0 107.057 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -139.02 159.66 41.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.5 t -141.62 132.53 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.668 -1.234 . . . . 10.0 107.668 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.89 176.69 10.56 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.799 -1.188 . . . . 10.0 111.434 -171.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.27 -166.01 52.28 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 121.732 -0.605 . . . . 10.0 111.59 -176.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -150.52 160.2 43.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.504 1.122 . . . . 10.0 108.05 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.649 ' HG ' ' CD2' ' A' ' 53' ' ' HIS . 70.2 m -86.42 116.7 24.74 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.983 0.811 . . . . 10.0 109.594 172.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -58.56 -25.52 62.62 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 122.877 0.471 . . . . 10.0 110.537 170.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.28 -29.19 70.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.629 -1.177 . . . . 10.0 113.56 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.68 -55.63 0.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.924 1.238 . . . . 10.0 110.884 -176.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.11 -178.79 36.92 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.523 -1.031 . . . . 10.0 110.523 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.43 134.48 41.84 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.818 2.345 . . . . 10.0 109.909 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.09 162.17 28.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.816 0.817 . . . . 10.0 109.796 164.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -80.01 74.84 6.76 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.198 -1.408 . . . . 10.0 107.198 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -48.83 -31.36 6.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.225 1.41 . . . . 10.0 114.487 -170.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.89 72.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.135 0.88 . . . . 10.0 112.408 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.9 mt -63.48 -52.21 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -58.96 -44.77 91.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.305 -0.855 . . . . 10.0 111.355 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.8 p -65.24 -39.17 92.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.702 1.137 . . . . 10.0 111.679 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -65.4 -40.38 93.37 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.648 1.113 . . . . 10.0 109.832 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -66.76 -46.31 75.77 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.03 0.532 . . . . 10.0 110.114 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 72.6 mt -57.51 -45.65 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -61.11 -41.74 97.25 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.158 0.89 . . . . 10.0 110.825 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.77 -39.87 95.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.589 0.631 . . . . 10.0 111.195 174.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.239 0.537 0 CA-C-O 117.296 -1.335 . . . . 10.0 112.181 178.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 106.744 -1.576 . . . . 10.0 106.744 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.1 p -142.86 170.82 14.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.855 1.262 . . . . 10.0 109.128 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -145.6 166.74 24.89 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 119.199 0.909 . . . . 10.0 111.346 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 127.369 2.268 . . . . 10.0 108.124 173.398 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.398 0 CA-C-O 121.382 0.611 . . . . 10.0 111.701 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -152.02 154.63 36.38 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.458 1.503 . . . . 10.0 107.203 173.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.77 -24.79 58.82 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.716 0.806 . . . . 10.0 112.81 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.16 -26.76 66.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.37 0.986 . . . . 10.0 112.368 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.2 mt -75.76 -25.08 56.17 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.033 0.533 . . . . 10.0 111.306 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.6 mt -84.16 127.49 66.39 Favored Pre-proline 0 C--O 1.237 0.436 0 N-CA-C 106.722 -1.584 . . . . 10.0 106.722 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.3 147.17 77.77 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.185 1.923 . . . . 10.0 109.769 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.04 -30.44 55.65 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.535 0.683 . . . . 10.0 112.052 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.83 134.86 45.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.14 -2.171 . . . . 10.0 105.14 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -151.2 114.39 4.79 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.305 -1.369 . . . . 10.0 107.305 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.8 pt . . . . . 0 C--N 1.328 -0.34 0 C-N-CA 126.132 1.773 . . . . 10.0 106.272 -175.601 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -147.6 154.56 40.83 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.197 0.999 . . . . 10.0 110.325 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -79.08 145.92 33.54 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.991 1.316 . . . . 10.0 109.017 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.2 162.25 39.28 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.993 0.425 . . . . 10.0 110.458 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.61 143.19 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 125.261 1.424 . . . . 10.0 107.565 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.72 125.37 47.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.328 -2.101 . . . . 10.0 105.328 171.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.3 mt -128.87 130.17 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.552 -1.647 . . . . 10.0 106.552 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -83.43 135.42 34.69 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.007 -1.849 . . . . 10.0 106.007 168.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 p -124.82 138.4 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.793 -1.558 . . . . 10.0 106.793 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -121.98 131.05 53.8 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.927 1.691 . . . . 10.0 106.647 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 p -67.65 140.23 56.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.783 0.325 . . . . 10.0 110.326 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.42 62.4 4.92 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.803 1.241 . . . . 10.0 108.557 168.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -53.96 -35.29 80.06 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.188 3.259 . . . . 10.0 113.503 -169.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -153.14 161.15 42.79 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.855 2.062 . . . . 10.0 105.738 172.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -55.99 -22.3 26.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.653 1.353 . . . . 10.0 114.653 -172.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.1 26.75 3.37 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.492 1.044 . . . . 10.0 112.045 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.96 148.88 91.52 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 118.039 0.92 . . . . 10.0 110.611 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -79.9 42.96 1.41 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 124.308 3.339 . . . . 10.0 111.999 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.28 139.31 28.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.379 1.072 . . . . 10.0 109.514 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.21 16.79 0.41 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.424 1.49 . . . . 10.0 111.797 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -63.33 160.03 16.8 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.274 1.43 . . . . 10.0 109.722 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.9 m -140.64 161.36 37.95 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.206 1.003 . . . . 10.0 110.66 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -146.99 179.33 7.68 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.967 1.307 . . . . 10.0 108.87 169.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -120.31 143.38 48.39 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.191 -1.041 . . . . 10.0 108.191 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.0 146.97 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.991 1.316 . . . . 10.0 110.289 -171.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.19 125.97 60.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.649 -1.611 . . . . 10.0 106.649 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -131.91 144.18 50.67 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.657 -1.609 . . . . 10.0 106.657 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.71 130.9 1.86 Allowed Glycine 0 C--N 1.329 0.156 0 CA-C-N 120.017 1.281 . . . . 10.0 112.868 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -150.91 142.38 23.46 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.218 1.007 . . . . 10.0 109.293 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -72.49 -16.89 61.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.118 1.155 . . . . 10.0 114.118 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -65.97 -21.37 66.41 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.69 1.132 . . . . 10.0 112.828 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.11 130.7 44.32 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 118.485 0.584 . . . . 10.0 110.804 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -67.8 -41.5 83.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -144.12 158.58 43.63 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 126.319 1.848 . . . . 10.0 107.169 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.532 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 71.7 m80 -56.27 -32.02 64.14 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.525 0.73 . . . . 10.0 112.853 -175.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.09 -27.02 65.16 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.866 -0.588 . . . . 10.0 112.136 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.43 -35.9 78.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.503 0.592 . . . . 10.0 110.795 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.56 -50.85 69.4 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 107.683 -1.229 . . . . 10.0 107.683 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -55.28 -45.59 76.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.928 -0.558 . . . . 10.0 111.171 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.46 -45.27 88.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 118.541 0.61 . . . . 10.0 111.822 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -59.0 -50.1 75.36 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.562 0.745 . . . . 10.0 109.481 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.64 -46.11 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.521 0.728 . . . . 10.0 109.068 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 m -59.08 -36.03 74.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.352 0.978 . . . . 10.0 111.486 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.02 -49.32 76.48 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.531 -1.028 . . . . 10.0 110.531 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.01 -45.87 91.71 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 117.751 0.776 . . . . 10.0 111.283 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -36.43 82.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.776 -0.63 . . . . 10.0 111.057 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -65.05 -35.73 82.09 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.9 0.773 . . . . 10.0 110.942 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -66.36 -32.18 73.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.135 -0.936 . . . . 10.0 111.542 172.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -69.19 -60.47 2.33 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.913 0.779 . . . . 10.0 109.281 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.66 47.38 0.09 OUTLIER Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.826 1.679 . . . . 10.0 109.456 -169.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.9 m -146.79 172.43 13.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.263 1.825 . . . . 10.0 108.734 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -137.87 160.45 39.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.846 1.659 . . . . 10.0 108.361 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.4 m -134.54 154.39 51.48 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.118 0.967 . . . . 10.0 112.894 -168.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -144.78 109.93 5.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.588 1.955 . . . . 10.0 106.857 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -60.04 126.88 29.24 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.114 -0.991 . . . . 10.0 109.544 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.2 mt -91.69 -26.57 18.57 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.698 0.399 . . . . 10.0 110.351 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.33 169.58 31.95 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.641 -0.984 . . . . 10.0 110.641 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.96 166.51 22.01 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.952 1.263 . . . . 10.0 110.883 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.48 -161.56 23.91 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.529 -1.428 . . . . 10.0 109.529 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -138.24 156.66 47.47 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.09 -1.241 . . . . 10.0 108.972 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.9 mt -127.81 146.95 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 104.54 -2.393 . . . . 10.0 104.54 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 C--N 1.33 -0.273 0 N-CA-C 106.903 -1.518 . . . . 10.0 106.903 169.874 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.4 pt . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 108.122 -1.066 . . . . 10.0 108.122 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -149.25 156.6 42.37 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.223 -1.029 . . . . 10.0 108.223 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.31 137.7 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.09 0.956 . . . . 10.0 108.51 -169.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -160.17 -177.11 6.05 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.344 -0.847 . . . . 10.0 110.114 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.64 178.93 37.86 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.244 0.449 . . . . 10.0 112.218 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -153.61 -176.23 5.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.227 1.011 . . . . 10.0 108.815 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.532 ' HG ' ' CE1' ' A' ' 53' ' ' HIS . 14.9 m -137.06 111.14 8.32 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.4 mtt -61.11 -12.87 13.76 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.359 0.664 . . . . 10.0 112.639 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.06 -32.39 54.47 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.124 0.97 . . . . 10.0 112.428 170.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.56 -37.11 0.14 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.377 0.881 . . . . 10.0 113.377 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 141.82 -178.68 20.44 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.612 1.101 . . . . 10.0 110.654 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.22 143.79 78.71 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.219 2.613 . . . . 10.0 110.2 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.44 32.75 0.09 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.182 1.793 . . . . 10.0 113.737 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 37.66 55.45 1.5 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.093 2.557 . . . . 10.0 110.171 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -45.45 -26.84 0.61 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.771 2.428 . . . . 10.0 116.275 -166.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.02 83.2 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.567 1.53 . . . . 10.0 111.899 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.4 -55.03 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -63.93 -39.91 95.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.606 -0.712 . . . . 10.0 112.017 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.0 p -64.85 -38.61 91.56 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 119.417 1.008 . . . . 10.0 110.57 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.59 -41.41 96.27 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.673 1.124 . . . . 10.0 111.241 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -64.08 -47.89 78.34 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.819 -0.55 . . . . 10.0 110.663 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.85 -42.43 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.839 0.855 . . . . 10.0 108.828 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -60.31 -40.15 89.53 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.244 1.018 . . . . 10.0 111.206 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.0 96.43 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.162 0.437 . . . . 10.0 110.936 174.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 117.776 -1.106 . . . . 10.0 113.101 -171.603 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.239 0.546 0 N-CA-C 107.4 -1.333 . . . . 10.0 107.4 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.12 167.07 26.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.432 1.493 . . . . 10.0 107.5 -172.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -144.15 159.67 42.25 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.662 -0.496 . . . . 10.0 109.662 172.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -179.857 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 107.196 -1.409 . . . . 10.0 107.196 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -148.12 152.71 37.78 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.041 -1.096 . . . . 10.0 108.041 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.4 mt -54.91 -31.1 59.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.342 1.057 . . . . 10.0 112.637 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.59 -24.59 66.78 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.7 mt -76.32 -23.74 54.3 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.88 0.472 . . . . 10.0 111.203 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.5 mt -74.48 135.42 75.52 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.001 -1.481 . . . . 10.0 107.001 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.47 138.03 53.24 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.21 1.94 . . . . 10.0 109.062 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.72 -31.79 68.76 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.054 0.761 . . . . 10.0 113.054 -169.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -158.11 136.53 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 105.944 -1.873 . . . . 10.0 105.944 -174.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -157.34 112.72 2.81 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.577 -0.897 . . . . 10.0 108.577 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 CA--C 1.54 0.594 0 C-N-CA 125.487 1.515 . . . . 10.0 109.964 -176.082 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--O 1.24 0.585 0 N-CA-C 108.655 -0.869 . . . . 10.0 108.655 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -154.04 154.85 34.43 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.248 1.019 . . . . 10.0 110.019 168.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -77.75 151.02 34.3 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.112 0.965 . . . . 10.0 109.45 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.53 161.5 38.3 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.507 0.723 . . . . 10.0 109.75 176.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.51 152.69 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.091 1.356 . . . . 10.0 108.988 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -115.35 121.99 44.51 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.58 -2.007 . . . . 10.0 105.58 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 95.2 mt -130.71 134.24 62.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.408 -1.33 . . . . 10.0 107.408 -169.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -85.23 144.56 28.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.533 -1.654 . . . . 10.0 106.533 167.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.99 144.12 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -124.21 132.35 53.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.093 1.757 . . . . 10.0 106.449 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.2 p -64.39 139.86 58.81 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.973 -0.38 . . . . 10.0 109.973 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.48 62.17 2.83 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.854 1.262 . . . . 10.0 108.612 169.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -59.27 135.33 64.85 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.918 2.412 . . . . 10.0 109.499 -172.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 44.76 26.96 0.22 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.925 1.29 . . . . 10.0 113.601 -171.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m 51.54 29.66 5.66 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.22 1.408 . . . . 10.0 113.434 -176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.22 -7.41 0.02 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 116.58 1.392 . . . . 10.0 116.58 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 153.06 80.64 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 120.062 1.931 . . . . 10.0 110.476 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.18 64.06 7.81 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.26 3.306 . . . . 10.0 111.941 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.5 138.21 34.43 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.334 1.453 . . . . 10.0 108.317 172.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.1 25.17 0.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.757 1.223 . . . . 10.0 110.781 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.29 161.14 25.64 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 169.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -139.63 163.51 32.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.291 1.036 . . . . 10.0 110.996 -176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -151.43 166.95 29.49 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.947 2.099 . . . . 10.0 107.862 -170.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.3 mp0 -122.32 143.15 49.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 pt -136.77 155.36 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.441 1.896 . . . . 10.0 109.228 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.48 129.95 74.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -134.68 147.03 50.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.661 -1.607 . . . . 10.0 106.661 -172.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.78 124.17 1.0 Allowed Glycine 0 C--O 1.224 -0.497 0 CA-C-N 119.642 1.11 . . . . 10.0 110.644 172.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -144.52 138.12 27.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 123.846 0.38 . . . . 10.0 110.429 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -61.45 -29.78 70.17 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.22 1.008 . . . . 10.0 112.876 -175.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -64.07 -23.14 67.22 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.957 0.799 . . . . 10.0 112.97 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.37 118.7 14.5 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 119.26 0.936 . . . . 10.0 109.791 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -68.38 -34.16 75.55 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.878 0.471 . . . . 10.0 109.965 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -142.46 151.94 42.24 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.076 1.751 . . . . 10.0 107.894 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.694 ' CD2' ' HG ' ' A' ' 94' ' ' SER . 72.4 m80 -57.17 -36.69 71.09 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.676 0.621 . . . . 10.0 112.676 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.95 -27.06 63.06 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 124.0 0.812 . . . . 10.0 112.175 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.73 -35.36 79.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.26 0.482 . . . . 10.0 110.926 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -66.37 -54.83 22.22 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 N-CA-C 107.399 -1.334 . . . . 10.0 107.399 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -56.93 -41.95 79.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.944 -0.55 . . . . 10.0 111.55 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.33 -47.38 79.61 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.908 0.483 . . . . 10.0 111.632 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -60.97 -47.69 85.29 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 121.872 -0.518 . . . . 10.0 109.695 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.19 -47.57 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 118.475 -0.774 . . . . 10.0 108.996 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 m -57.82 -42.44 84.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.348 0.976 . . . . 10.0 110.897 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.63 -44.29 98.01 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.235 -0.746 . . . . 10.0 111.235 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.87 -48.01 72.99 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.111 0.955 . . . . 10.0 111.504 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -41.07 78.17 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 119.074 0.852 . . . . 10.0 110.121 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -62.69 -36.82 84.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.432 -0.794 . . . . 10.0 110.988 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.1 pttm -74.23 -25.42 59.65 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.468 -1.253 . . . . 10.0 112.652 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -68.31 -56.09 9.81 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.902 1.228 . . . . 10.0 109.151 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.13 45.28 0.14 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.522 1.534 . . . . 10.0 109.896 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.1 m -147.02 175.37 10.74 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.817 2.047 . . . . 10.0 107.875 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -145.64 165.27 29.21 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.892 -0.781 . . . . 10.0 108.892 169.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.94 164.13 19.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.771 1.026 . . . . 10.0 113.771 -168.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -147.07 112.84 5.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.9 2.48 . . . . 10.0 105.734 175.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.9 t -65.2 140.44 58.75 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.916 -1.115 . . . . 10.0 109.48 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.3 mt -106.14 -10.9 16.28 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.732 0.813 . . . . 10.0 111.047 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.31 -177.75 18.74 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.467 1.508 . . . . 10.0 109.723 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.59 -164.23 13.57 Favored Glycine 0 CA--C 1.522 0.519 0 O-C-N 121.472 -1.017 . . . . 10.0 112.04 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.28 -149.71 7.72 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 109.667 -1.373 . . . . 10.0 109.667 -172.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -143.06 155.96 44.72 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.602 1.161 . . . . 10.0 109.275 -174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.1 mt -136.43 153.97 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.529 -2.026 . . . . 10.0 105.529 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 169.879 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 C--O 1.238 0.462 0 CA-C-O 122.826 1.298 . . . . 10.0 110.917 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -134.77 154.45 51.59 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.663 1.985 . . . . 10.0 107.912 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 t -129.57 136.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -150.83 175.7 11.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.728 0.695 . . . . 10.0 111.816 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.84 -153.76 53.05 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.667 0.651 . . . . 10.0 112.981 170.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -150.6 -179.7 7.46 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.381 1.472 . . . . 10.0 109.601 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.694 ' HG ' ' CD2' ' A' ' 53' ' ' HIS . 64.9 m -114.94 122.89 47.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.805 0.842 . . . . 10.0 109.194 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -58.35 -29.23 65.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.352 1.061 . . . . 10.0 111.213 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.75 -25.41 66.48 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.737 1.014 . . . . 10.0 113.737 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -59.03 0.25 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.514 1.052 . . . . 10.0 111.271 -174.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.88 179.66 35.77 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.515 -1.034 . . . . 10.0 110.515 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -56.68 137.41 80.98 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.016 2.477 . . . . 10.0 111.138 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.55 165.81 21.92 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.603 0.715 . . . . 10.0 109.241 167.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -81.59 69.12 8.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.366 -1.716 . . . . 10.0 106.366 167.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -49.24 -30.19 6.82 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.663 1.585 . . . . 10.0 114.196 -169.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.15 -36.28 74.99 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.374 0.988 . . . . 10.0 112.266 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.7 mt -62.81 -50.45 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.052 -1.462 . . . . 10.0 107.052 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -58.55 -47.64 83.54 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.741 0.816 . . . . 10.0 111.822 -177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 p -65.39 -37.85 88.24 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.409 -0.805 . . . . 10.0 111.356 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -64.73 -42.67 95.03 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.362 0.983 . . . . 10.0 110.387 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -62.41 -47.95 81.88 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.682 -0.675 . . . . 10.0 110.085 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.62 -52.19 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -57.52 -38.06 74.04 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.349 1.06 . . . . 10.0 111.971 -174.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 -44.01 81.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.78 0.432 . . . . 10.0 111.309 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.7 mptt . . . . . 0 N--CA 1.469 0.476 0 CA-C-N 118.406 0.548 . . . . 10.0 111.853 -169.656 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 108.637 -0.875 . . . . 10.0 108.637 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.9 p -139.63 167.98 20.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.294 1.037 . . . . 10.0 110.149 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -150.63 167.85 26.07 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.961 -0.462 . . . . 10.0 110.957 170.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.236 0 C-N-CA 125.68 1.592 . . . . 10.0 108.513 169.617 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 106.808 -1.553 . . . . 10.0 106.808 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -150.3 150.69 31.83 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.75 -1.204 . . . . 10.0 107.75 173.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -59.15 -23.47 62.2 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 118.211 -0.9 . . . . 10.0 112.88 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.28 -26.41 67.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.473 1.033 . . . . 10.0 112.473 175.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -73.97 -26.25 60.37 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.111 0.564 . . . . 10.0 111.009 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.38 127.16 62.18 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 106.737 -1.579 . . . . 10.0 106.737 -174.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.62 149.03 79.23 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.226 1.951 . . . . 10.0 110.087 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.66 -33.68 60.43 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.47 1.108 . . . . 10.0 111.958 -178.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -136.92 135.12 48.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 104.843 -2.28 . . . . 10.0 104.843 176.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -150.5 118.07 6.12 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.069 -1.826 . . . . 10.0 106.069 171.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.8 pt . . . . . 0 C--N 1.33 -0.263 0 C-N-CA 124.353 1.061 . . . . 10.0 110.272 -169.806 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 108.966 -0.753 . . . . 10.0 108.966 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -150.69 147.64 27.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.869 1.268 . . . . 10.0 109.104 172.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -67.82 153.94 42.62 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.772 -0.58 . . . . 10.0 109.685 174.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.17 165.6 26.97 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.979 0.912 . . . . 10.0 109.366 170.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.6 147.72 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.428 1.491 . . . . 10.0 107.67 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tt -109.14 121.02 44.27 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 104.777 -2.305 . . . . 10.0 104.777 177.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.5 mt -128.74 140.53 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 -170.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -94.54 131.23 40.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 167.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.91 143.32 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -123.47 130.13 52.24 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.495 1.918 . . . . 10.0 105.857 -175.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.1 p -72.36 142.93 48.77 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.351 -0.241 . . . . 10.0 110.351 175.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.78 59.58 3.54 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.299 1.44 . . . . 10.0 108.205 168.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -58.67 141.41 97.61 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.019 2.48 . . . . 10.0 109.921 -171.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 52.2 16.73 0.61 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.448 1.099 . . . . 10.0 113.058 -177.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m 48.17 31.4 2.55 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.548 1.139 . . . . 10.0 112.897 -169.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.88 -1.71 0.02 OUTLIER Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.43 -1.206 . . . . 10.0 115.954 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 153.32 78.91 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 120.094 1.947 . . . . 10.0 110.448 174.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.87 55.29 5.2 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 124.256 3.304 . . . . 10.0 111.855 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.92 139.51 30.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.045 1.338 . . . . 10.0 108.653 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.75 30.09 0.66 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.188 1.395 . . . . 10.0 109.772 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -66.32 158.4 29.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 174.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 m -140.33 160.27 40.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.138 0.975 . . . . 10.0 110.326 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -150.22 169.57 21.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.132 0.973 . . . . 10.0 109.635 171.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -98.5 149.06 23.12 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.499 -0.926 . . . . 10.0 108.499 172.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.1 pt -138.9 154.43 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.055 1.742 . . . . 10.0 109.924 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.25 128.8 64.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.985 -1.487 . . . . 10.0 106.985 176.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 mmp_? -134.61 138.12 44.26 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.873 -1.529 . . . . 10.0 106.873 -178.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.38 122.91 0.92 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-N 119.725 1.148 . . . . 10.0 110.996 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -142.84 133.93 25.8 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 -172.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -59.55 -21.58 60.48 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 114.515 1.302 . . . . 10.0 114.515 -175.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -65.34 -25.33 67.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.377 1.444 . . . . 10.0 112.276 177.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.85 116.14 11.89 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.854 1.206 . . . . 10.0 110.371 -178.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.7 -29.89 65.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.311 0.645 . . . . 10.0 110.354 173.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -136.03 146.64 47.34 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.79 1.636 . . . . 10.0 107.422 178.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -60.77 -31.88 71.22 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.762 0.825 . . . . 10.0 111.755 -174.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.99 -26.35 67.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.343 0.657 . . . . 10.0 112.165 177.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.62 -32.69 74.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.357 0.598 . . . . 10.0 110.548 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.7 mt -67.48 -51.78 48.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 174.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -55.83 -41.97 75.04 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.462 -0.78 . . . . 10.0 111.141 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.79 -48.74 79.26 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.068 0.547 . . . . 10.0 111.461 177.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -47.27 86.05 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.368 -0.832 . . . . 10.0 110.33 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.56 -43.77 96.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 -177.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 m -62.99 -36.29 83.03 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.479 1.036 . . . . 10.0 111.029 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.33 52.95 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.34 -1.104 . . . . 10.0 110.34 173.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.08 -39.91 91.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.693 0.746 . . . . 10.0 111.686 -177.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.7 mmt -65.31 -39.14 92.09 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.724 -0.655 . . . . 10.0 111.086 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -64.85 -34.76 79.13 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.071 0.85 . . . . 10.0 110.533 176.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.67 -31.92 72.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.359 -1.305 . . . . 10.0 111.612 172.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -73.81 -54.6 7.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.534 1.061 . . . . 10.0 109.014 176.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.95 44.22 0.16 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.39 1.471 . . . . 10.0 109.881 -170.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.6 m -144.07 169.63 17.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.632 1.573 . . . . 10.0 109.308 -177.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -140.04 163.49 32.56 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.357 1.863 . . . . 10.0 108.397 178.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.0 m -139.1 156.38 47.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.67 1.123 . . . . 10.0 113.795 -167.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -139.82 130.15 25.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.872 1.669 . . . . 10.0 106.93 168.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.5 p -68.89 143.31 54.53 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.786 -1.196 . . . . 10.0 109.468 172.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.6 mt -105.1 -18.14 14.25 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.469 0.708 . . . . 10.0 110.906 171.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.96 -173.92 35.24 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.719 -1.352 . . . . 10.0 109.719 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.94 -174.5 28.73 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.248 -1.148 . . . . 10.0 112.006 172.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.44 -149.36 7.81 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.942 -1.663 . . . . 10.0 108.942 -173.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -133.48 154.51 50.75 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.652 1.181 . . . . 10.0 108.874 178.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.4 mt -125.31 152.02 31.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 104.994 -2.224 . . . . 10.0 104.994 173.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 C--N 1.327 -0.392 0 C-N-CA 124.904 1.282 . . . . 10.0 108.837 -176.856 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 C--O 1.236 0.343 0 N-CA-C 106.266 -1.753 . . . . 10.0 106.266 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -141.09 149.71 41.95 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.232 -1.025 . . . . 10.0 108.232 -168.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -135.04 139.42 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.458 -0.942 . . . . 10.0 108.458 -171.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.25 -176.0 3.88 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.457 1.103 . . . . 10.0 109.702 -178.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.08 -167.44 45.59 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 121.653 -0.654 . . . . 10.0 111.866 175.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -152.1 158.2 42.65 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 169.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.9 p -69.07 158.71 34.28 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.637 -0.664 . . . . 10.0 110.601 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 92.8 mtp -82.97 5.57 21.62 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 118.774 -0.632 . . . . 10.0 112.541 -174.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.15 -44.97 0.11 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.465 1.029 . . . . 10.0 113.533 176.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -74.11 -47.12 38.4 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.209 0.913 . . . . 10.0 111.003 -169.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.94 175.76 14.2 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.72 1.629 . . . . 10.0 110.375 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -54.34 130.0 37.59 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.585 2.19 . . . . 10.0 110.105 169.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.89 162.67 13.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.775 0.797 . . . . 10.0 109.244 167.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -79.01 70.01 5.27 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.092 -1.447 . . . . 10.0 107.092 169.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -49.72 -36.37 25.18 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.098 1.359 . . . . 10.0 113.217 -168.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.95 -32.79 73.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.084 0.856 . . . . 10.0 112.504 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.26 -50.59 50.98 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 107.428 -1.323 . . . . 10.0 107.428 175.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.3 m -56.53 -41.89 77.54 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.195 -0.907 . . . . 10.0 111.523 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.5 p -64.38 -43.5 94.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.43 1.014 . . . . 10.0 111.172 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -61.73 -38.88 89.53 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.193 1.36 . . . . 10.0 110.886 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -63.77 -50.24 69.8 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.574 0.35 . . . . 10.0 110.222 176.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.68 -47.15 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.615 -0.883 . . . . 10.0 108.615 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -54.61 -47.43 73.4 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.3 1.04 . . . . 10.0 110.244 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.75 -39.48 88.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.662 0.385 . . . . 10.0 111.572 -178.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 118.12 -0.943 . . . . 10.0 112.457 -175.054 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 105.665 -1.976 . . . . 10.0 105.665 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.7 p -145.58 166.55 25.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.479 1.111 . . . . 10.0 108.893 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -153.41 165.53 35.52 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.548 -0.72 . . . . 10.0 111.075 167.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 125.622 1.569 . . . . 10.0 108.931 174.202 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.5 154.53 50.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.962 1.305 . . . . 10.0 107.762 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 m -63.21 158.16 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.537 0.684 . . . . 10.0 109.602 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.23 172.92 8.69 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.437 1.495 . . . . 10.0 107.722 171.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -147.94 151.93 36.65 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.167 -1.42 . . . . 10.0 107.167 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.41 -23.16 64.15 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.364 0.666 . . . . 10.0 112.713 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.84 -28.62 69.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.474 1.034 . . . . 10.0 112.292 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.5 -29.56 61.46 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.95 0.5 . . . . 10.0 110.769 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.1 mt -75.98 126.0 87.43 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 106.984 -1.488 . . . . 10.0 106.984 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.68 142.07 81.9 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.156 1.904 . . . . 10.0 109.292 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -78.98 -29.86 44.07 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.681 0.753 . . . . 10.0 112.172 -170.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 135.62 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 104.083 -2.562 . . . . 10.0 104.083 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -149.2 107.76 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.609 -1.997 . . . . 10.0 105.609 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.8 pt -135.23 146.21 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.189 -1.041 . . . . 10.0 108.189 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.81 121.01 42.71 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 104.724 -2.325 . . . . 10.0 104.724 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m -139.32 131.28 27.8 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.342 0.497 . . . . 10.0 112.342 -167.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -156.52 16.73 0.32 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.452 1.101 . . . . 10.0 111.815 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.3 -156.18 26.48 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 108.426 -1.87 . . . . 10.0 108.426 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t -75.14 140.03 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 169.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -157.57 153.11 26.37 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.64 1.176 . . . . 10.0 109.496 171.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -68.06 150.78 47.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.968 0.907 . . . . 10.0 110.28 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.46 163.65 35.0 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.72 0.808 . . . . 10.0 109.233 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.89 147.35 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.258 1.023 . . . . 10.0 108.705 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 tp -106.31 119.95 40.58 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.4 130.5 71.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.081 -1.452 . . . . 10.0 107.081 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -82.21 134.36 35.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.063 -2.199 . . . . 10.0 105.063 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -119.71 138.93 48.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.255 -1.757 . . . . 10.0 106.255 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -119.4 131.17 55.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.08 -1.822 . . . . 10.0 106.08 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 p -73.51 145.78 45.36 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.867 0.758 . . . . 10.0 110.006 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.27 61.02 3.1 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 106.26 -1.756 . . . . 10.0 106.26 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -56.74 136.9 78.89 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.472 2.781 . . . . 10.0 110.955 -169.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 45.44 26.65 0.31 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.686 1.594 . . . . 10.0 113.829 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 m 55.04 26.01 7.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.27 1.428 . . . . 10.0 113.479 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.93 -1.34 0.03 OUTLIER Glycine 0 CA--C 1.532 1.101 0 N-CA-C 116.843 1.497 . . . . 10.0 116.843 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.11 152.5 84.01 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 120.114 1.957 . . . . 10.0 110.173 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.83 56.88 5.84 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.473 3.449 . . . . 10.0 111.874 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.38 137.37 30.4 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.139 1.376 . . . . 10.0 108.381 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.03 32.46 0.6 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.321 1.449 . . . . 10.0 109.829 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.83 170.09 13.28 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.469 0.708 . . . . 10.0 109.297 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 m -147.03 159.97 42.94 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.622 -0.673 . . . . 10.0 110.417 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -147.59 175.36 10.92 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.087 1.355 . . . . 10.0 108.261 169.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -105.33 150.74 24.94 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.628 -0.879 . . . . 10.0 108.628 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.2 pt -135.86 150.37 28.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.323 1.449 . . . . 10.0 109.49 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.31 126.98 64.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.388 -1.708 . . . . 10.0 106.388 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -132.48 139.15 47.83 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.96 113.88 0.5 Allowed Glycine 0 C--N 1.332 0.321 0 CA-C-N 119.473 1.033 . . . . 10.0 110.941 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -140.75 132.23 26.93 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.114 -0.699 . . . . 10.0 109.114 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -69.49 -14.81 63.07 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.048 1.129 . . . . 10.0 114.048 -171.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -66.58 -23.48 66.2 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.478 1.036 . . . . 10.0 111.943 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.79 127.64 33.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.236 0.926 . . . . 10.0 110.082 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.87 -39.23 73.0 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.541 -0.3 . . . . 10.0 110.284 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -140.5 160.6 39.64 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.663 1.585 . . . . 10.0 108.658 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -56.45 -33.19 65.65 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.323 1.049 . . . . 10.0 112.09 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.7 -31.12 69.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.038 0.935 . . . . 10.0 112.209 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -71.35 -36.07 71.38 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.998 0.817 . . . . 10.0 110.577 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mt -65.49 -50.91 69.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -57.41 -45.1 84.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.418 -0.325 . . . . 10.0 110.554 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.41 -46.3 90.71 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.994 0.518 . . . . 10.0 111.851 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -57.2 -49.49 75.84 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.016 0.371 . . . . 10.0 110.287 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.5 t -68.85 -46.39 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.8 m -58.37 -35.51 72.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.489 1.041 . . . . 10.0 111.509 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.4 -50.68 60.52 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.703 -0.959 . . . . 10.0 110.703 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.66 -44.84 95.24 Favored 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 117.539 0.67 . . . . 10.0 111.204 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -37.22 81.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.673 -0.68 . . . . 10.0 110.887 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.25 -34.96 79.59 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.161 0.891 . . . . 10.0 111.19 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.9 -33.87 77.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.93 0.786 . . . . 10.0 111.658 171.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -70.6 -52.97 17.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.093 0.861 . . . . 10.0 110.165 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.82 43.77 0.23 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.276 1.417 . . . . 10.0 110.204 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.8 m -144.24 172.29 13.13 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.015 1.726 . . . . 10.0 108.655 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -140.27 164.83 29.03 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.692 1.597 . . . . 10.0 108.228 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.0 m -133.3 159.55 39.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.048 0.939 . . . . 10.0 112.429 -169.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -148.48 117.45 6.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.253 1.821 . . . . 10.0 106.61 170.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -62.74 130.59 45.6 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.547 -0.721 . . . . 10.0 109.115 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.0 mt -90.78 -23.04 20.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.576 0.351 . . . . 10.0 110.481 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.77 179.35 29.1 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.43 -1.868 . . . . 10.0 108.43 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.46 -164.14 14.31 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.668 -0.973 . . . . 10.0 110.668 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.69 -139.48 4.28 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 108.508 -1.837 . . . . 10.0 108.508 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -139.87 157.71 45.26 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.985 1.314 . . . . 10.0 108.116 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.42 151.45 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.62 -2.363 . . . . 10.0 104.62 172.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.8 m -130.82 115.13 16.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -78.7 102.78 8.24 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 104.92 -2.252 . . . . 10.0 104.92 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -30.4 -53.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.126 2.171 . . . . 10.0 116.278 -169.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.1 m 45.52 25.09 0.21 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.179 1.792 . . . . 10.0 114.19 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -164.3 -56.11 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.722 1.209 . . . . 10.0 109.628 -171.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -144.5 110.47 5.4 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.397 1.258 . . . . 10.0 114.397 -169.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 70.84 -79.58 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 119.105 3.002 . . . . 10.0 119.105 168.668 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.89 168.93 25.65 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.325 1.875 . . . . 10.0 115.333 -168.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.7 mt -54.3 137.93 14.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.206 1.402 . . . . 10.0 108.255 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -138.14 157.96 45.28 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.745 0.818 . . . . 10.0 109.083 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.5 t -137.48 135.49 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.582 1.153 . . . . 10.0 108.086 -170.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -163.1 -178.53 6.09 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.329 -0.857 . . . . 10.0 111.714 -171.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.77 -163.49 49.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.662 0.649 . . . . 10.0 111.617 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -150.65 178.86 8.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.943 1.297 . . . . 10.0 108.632 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m -103.28 124.79 49.31 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.285 -1.005 . . . . 10.0 108.285 169.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.73 -30.24 67.32 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.081 0.401 . . . . 10.0 110.716 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.46 -30.94 71.78 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.119 0.968 . . . . 10.0 113.475 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.01 -57.9 0.5 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.428 1.013 . . . . 10.0 110.676 -172.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.86 -178.69 35.84 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.596 -1.402 . . . . 10.0 109.596 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.6 138.2 68.66 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.163 1.909 . . . . 10.0 110.167 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.08 161.44 24.47 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.806 -1.183 . . . . 10.0 107.806 168.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -78.82 71.67 5.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.487 -2.042 . . . . 10.0 105.487 169.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -50.33 -30.85 13.0 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.045 1.338 . . . . 10.0 113.494 -169.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.43 74.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.111 0.869 . . . . 10.0 112.061 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.36 -51.22 73.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.404 -1.332 . . . . 10.0 107.404 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -58.06 -46.16 85.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.967 -0.539 . . . . 10.0 112.128 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.4 p -66.28 -41.01 90.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.394 0.997 . . . . 10.0 110.823 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -64.86 -39.96 94.38 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.894 0.77 . . . . 10.0 110.641 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -62.76 -48.22 80.12 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 118.96 -0.543 . . . . 10.0 110.598 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.83 -45.74 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -62.2 -40.45 96.12 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.014 0.926 . . . . 10.0 111.589 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.86 -44.25 77.56 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.033 0.533 . . . . 10.0 110.819 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -77.06 -38.44 52.61 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 112.669 0.618 . . . . 10.0 112.669 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -110.22 143.98 29.16 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.352 0.661 . . . . 10.0 111.193 -168.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.56 -3.78 13.96 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.96 2.44 . . . . 10.0 113.652 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -56.38 132.76 51.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.697 1.135 . . . . 10.0 109.032 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -58.14 -27.99 64.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.745 1.618 . . . . 10.0 115.196 -168.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -155.95 153.09 29.04 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.979 1.263 . . . . 10.0 110.979 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.06 133.93 17.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.772 -1.936 . . . . 10.0 105.772 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.9 p -134.82 169.91 16.65 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.518 0.727 . . . . 10.0 109.76 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -140.85 166.15 25.57 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.318 0.647 . . . . 10.0 110.467 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.34 172.51 14.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.526 1.53 . . . . 10.0 108.483 172.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -134.94 35.95 3.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.828 1.251 . . . . 10.0 108.606 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.0 -31.01 71.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.397 1.079 . . . . 10.0 113.621 -169.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 176.38 179.91 47.08 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 118.059 0.39 . . . . 10.0 112.563 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 15.3 t80 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.409 1.484 . . . . 10.0 108.489 179.82 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 119.242 -0.408 . . . . 10.0 109.923 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.24 151.52 36.05 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.785 0.434 . . . . 10.0 111.115 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.4 m -67.37 164.71 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.689 0.796 . . . . 10.0 110.672 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.69 164.6 18.94 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.987 0.515 . . . . 10.0 111.236 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -152.5 146.64 25.42 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 170.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.46 -25.27 65.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 118.505 -0.759 . . . . 10.0 113.002 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.4 -26.95 68.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.113 0.87 . . . . 10.0 112.034 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -75.76 -27.64 58.15 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.82 0.448 . . . . 10.0 110.709 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.6 mt -74.74 122.09 86.71 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -51.15 139.96 42.09 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.161 2.574 . . . . 10.0 110.594 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.27 -29.47 38.31 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.087 0.946 . . . . 10.0 111.605 -172.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -136.65 136.17 48.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 104.323 -2.473 . . . . 10.0 104.323 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -146.32 118.28 8.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.488 -1.301 . . . . 10.0 107.488 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.2 pt -142.2 144.96 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.028 1.731 . . . . 10.0 106.653 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -155.92 74.84 0.88 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.886 1.326 . . . . 10.0 108.35 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -156.56 173.37 17.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.987 1.715 . . . . 10.0 108.382 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -144.8 138.71 27.29 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.194 -1.41 . . . . 10.0 107.194 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.75 -153.02 25.48 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.591 -1.403 . . . . 10.0 109.591 -170.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.82 142.09 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.118 -1.067 . . . . 10.0 108.118 169.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -150.17 152.15 34.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.74 0.816 . . . . 10.0 110.766 169.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -70.76 150.11 46.22 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.898 0.879 . . . . 10.0 108.985 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.25 159.36 43.45 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.282 0.492 . . . . 10.0 110.899 172.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.39 145.32 28.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.684 1.594 . . . . 10.0 107.169 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.48 122.04 45.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.971 -2.233 . . . . 10.0 104.971 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.5 mt -124.94 130.15 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.884 -1.525 . . . . 10.0 106.884 -171.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -80.04 129.24 34.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.73 -2.322 . . . . 10.0 104.73 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.73 142.6 32.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -124.62 134.98 52.74 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.182 1.793 . . . . 10.0 106.785 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.9 p -65.79 140.51 58.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 110.048 -0.353 . . . . 10.0 110.048 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.33 46.25 0.48 Allowed Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 125.184 1.393 . . . . 10.0 111.99 168.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.13 159.34 26.54 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.497 2.798 . . . . 10.0 110.785 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.29 20.66 1.43 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.872 1.269 . . . . 10.0 112.141 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 52.1 22.69 1.97 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.582 1.553 . . . . 10.0 113.531 -171.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.34 32.94 0.03 OUTLIER Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.29 -0.881 . . . . 10.0 113.826 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.08 157.74 20.54 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 118.617 1.208 . . . . 10.0 110.475 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.89 57.71 4.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.085 3.19 . . . . 10.0 111.434 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.32 145.54 34.06 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.937 1.695 . . . . 10.0 108.366 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.47 31.11 0.59 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.756 1.222 . . . . 10.0 110.267 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -63.99 153.25 37.8 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.436 -0.95 . . . . 10.0 108.436 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -144.55 161.82 38.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.658 1.183 . . . . 10.0 109.992 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -150.22 176.57 10.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.764 1.226 . . . . 10.0 109.712 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -102.14 146.88 27.33 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.871 -1.159 . . . . 10.0 107.871 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.3 pt -133.67 155.27 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.859 1.264 . . . . 10.0 110.407 172.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.95 130.4 66.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.788 -1.56 . . . . 10.0 106.788 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -132.25 143.91 50.25 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.056 -1.461 . . . . 10.0 107.056 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.56 129.84 1.88 Allowed Glycine 0 C--O 1.226 -0.391 0 CA-C-N 120.489 1.495 . . . . 10.0 113.305 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -151.31 148.27 27.96 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.516 1.126 . . . . 10.0 109.153 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -88.95 -6.72 57.06 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.385 -1.293 . . . . 10.0 114.196 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -63.99 -22.65 67.02 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.019 1.281 . . . . 10.0 111.805 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.85 124.11 22.81 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.345 0.658 . . . . 10.0 109.548 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.26 -35.92 80.52 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.275 0.559 . . . . 10.0 109.642 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -142.74 151.38 41.21 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 126.411 1.885 . . . . 10.0 106.951 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.573 ' CD2' ' HG ' ' A' ' 94' ' ' SER . 73.0 m80 -55.03 -35.7 64.72 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.37 0.668 . . . . 10.0 112.503 -174.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.08 -24.54 58.95 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.429 -0.796 . . . . 10.0 112.445 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.13 -36.64 82.31 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.735 0.698 . . . . 10.0 110.709 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mt -65.25 -49.94 76.2 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 107.787 -1.19 . . . . 10.0 107.787 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -56.1 -46.58 79.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.902 -0.571 . . . . 10.0 111.169 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.02 -45.16 86.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.189 0.595 . . . . 10.0 111.888 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -58.84 -49.4 77.89 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.42 0.688 . . . . 10.0 109.747 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.82 -42.19 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.6 m -58.38 -35.63 72.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.591 1.087 . . . . 10.0 111.333 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.64 -48.33 82.32 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.781 -0.928 . . . . 10.0 110.781 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.34 -46.41 90.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.907 0.853 . . . . 10.0 111.272 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -36.57 83.22 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 118.643 -0.694 . . . . 10.0 110.888 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -64.5 -36.01 82.82 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.828 0.74 . . . . 10.0 110.879 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.46 -32.34 73.13 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 117.982 -1.008 . . . . 10.0 111.71 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -67.85 -57.06 6.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.152 0.887 . . . . 10.0 109.048 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.59 47.04 0.16 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.882 1.706 . . . . 10.0 109.163 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.5 m -146.32 173.62 12.08 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.719 2.008 . . . . 10.0 108.379 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -141.03 162.86 34.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.513 1.525 . . . . 10.0 108.557 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.1 m -134.47 158.75 43.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.425 1.09 . . . . 10.0 112.398 -168.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -148.45 122.21 9.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.954 1.702 . . . . 10.0 106.944 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.7 p -64.56 128.54 36.22 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.772 -1.205 . . . . 10.0 109.368 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.06 -25.97 19.39 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.14 -177.74 35.58 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.548 -1.421 . . . . 10.0 109.548 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.82 -174.67 24.27 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 118.222 1.011 . . . . 10.0 112.015 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.66 -145.96 5.35 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.12 -1.592 . . . . 10.0 109.12 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.8 mtm-85 -137.74 155.31 49.21 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.148 -1.207 . . . . 10.0 108.37 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.9 mt -122.63 148.73 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 105.024 -2.213 . . . . 10.0 105.024 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.9 p -148.71 161.12 42.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.006 1.322 . . . . 10.0 108.638 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -162.0 163.13 29.07 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.224 1.01 . . . . 10.0 108.47 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -150.22 55.42 0.93 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 105.521 -2.029 . . . . 10.0 105.521 171.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.2 m -44.69 -26.41 0.38 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.028 2.531 . . . . 10.0 116.297 -167.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -59.0 -24.61 62.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 173.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -147.24 -25.19 0.39 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.071 0.948 . . . . 10.0 113.458 -170.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -137.18 145.19 43.43 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.361 -1.462 . . . . 10.0 110.519 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 168.42 6.56 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.731 1.212 . . . . 10.0 112.447 176.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.5 mt -68.13 149.42 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.283 -1.377 . . . . 10.0 107.283 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.465 ' CD2' ' HG1' ' A' ' 119' ' ' THR . 4.8 t-80 -140.47 162.83 34.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.033 0.933 . . . . 10.0 109.672 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.3 144.35 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.12 -1.808 . . . . 10.0 106.12 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -161.19 179.15 8.6 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.283 -0.886 . . . . 10.0 110.218 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.26 -176.21 47.63 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.092 0.377 . . . . 10.0 112.651 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -155.77 134.71 12.01 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.757 0.823 . . . . 10.0 109.958 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.573 ' HG ' ' CD2' ' A' ' 53' ' ' HIS . 19.8 m -74.24 95.55 2.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.912 0.885 . . . . 10.0 109.785 177.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 76.9 mtm -57.62 -14.44 5.4 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.878 0.871 . . . . 10.0 112.602 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.34 -27.7 48.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.691 1.196 . . . . 10.0 113.121 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -47.63 0.33 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.862 0.756 . . . . 10.0 110.882 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.8 173.85 23.35 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.28 1.419 . . . . 10.0 109.862 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.37 134.23 56.32 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.791 2.327 . . . . 10.0 111.071 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.41 162.06 21.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 167.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.99 71.2 5.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.134 -1.432 . . . . 10.0 107.134 169.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -54.42 -26.25 29.64 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.75 1.22 . . . . 10.0 113.376 -170.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.86 92.76 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.476 1.035 . . . . 10.0 111.745 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.6 mt -67.47 -49.87 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.418 -1.327 . . . . 10.0 107.418 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 m -58.84 -44.54 90.98 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.863 -0.589 . . . . 10.0 112.06 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.0 p -64.95 -41.53 95.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.058 -0.972 . . . . 10.0 111.009 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -64.19 -39.33 93.76 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.384 0.993 . . . . 10.0 110.807 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -65.43 -48.22 73.54 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.926 -0.484 . . . . 10.0 110.67 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.24 -42.94 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.298 -1.001 . . . . 10.0 108.298 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -59.49 -45.59 91.23 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.925 0.89 . . . . 10.0 110.41 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.72 95.45 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.552 0.614 . . . . 10.0 111.396 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -68.23 -38.18 81.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.668 -0.682 . . . . 10.0 110.943 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -130.99 65.86 77.76 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.112 1.365 . . . . 10.0 109.995 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.45 -10.74 29.59 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.041 2.494 . . . . 10.0 113.569 -171.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.62 -12.38 52.8 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.912 0.885 . . . . 10.0 112.67 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -133.29 150.77 51.89 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 124.347 1.059 . . . . 10.0 109.907 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.1 159.31 31.82 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.899 -1.149 . . . . 10.0 107.899 168.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.04 135.64 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 172.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.465 ' HG1' ' CD2' ' A' ' 89' ' ' HIS . 8.6 p -139.73 172.24 13.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.208 1.403 . . . . 10.0 108.749 174.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -140.45 163.72 32.05 Favored 'General case' 0 C--O 1.227 -0.114 0 O-C-N 121.543 -0.723 . . . . 10.0 112.406 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.27 171.03 15.58 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.5 1.92 . . . . 10.0 108.504 172.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -146.64 27.65 1.09 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.852 1.261 . . . . 10.0 110.993 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.05 -22.27 65.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.818 1.247 . . . . 10.0 113.6 -170.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.74 176.66 37.34 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.623 -1.391 . . . . 10.0 109.623 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 25.2 p90 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 117.701 -1.142 . . . . 10.0 111.385 178.048 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ttt . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.68 -173.87 4.39 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.454 1.102 . . . . 10.0 108.779 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 m -60.56 142.08 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.32 171.24 20.54 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.959 1.704 . . . . 10.0 107.118 -175.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -152.17 150.64 30.08 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.389 -1.337 . . . . 10.0 107.389 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.4 -26.66 65.33 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.679 0.792 . . . . 10.0 112.832 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.94 -26.25 68.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.936 0.789 . . . . 10.0 112.159 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.1 mt -75.79 -25.27 56.25 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.034 0.534 . . . . 10.0 110.982 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.4 mt -78.68 122.82 85.29 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -50.74 133.53 39.23 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.499 2.8 . . . . 10.0 110.721 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -82.52 -28.65 30.94 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.504 0.668 . . . . 10.0 112.074 -170.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.08 134.91 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.893 -2.262 . . . . 10.0 104.893 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -150.64 113.82 4.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.056 -1.831 . . . . 10.0 106.056 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.61 170.88 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.681 1.192 . . . . 10.0 110.258 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -133.43 34.79 3.47 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.582 1.153 . . . . 10.0 111.921 -167.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -49.3 130.85 19.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.95 1.7 . . . . 10.0 112.314 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -165.86 -35.37 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.878 1.671 . . . . 10.0 109.743 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.61 -153.7 6.4 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 106.251 -2.74 . . . . 10.0 106.251 170.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.6 t -61.46 139.27 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 118.649 1.224 . . . . 10.0 108.089 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -146.35 147.06 30.93 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.855 0.862 . . . . 10.0 109.618 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.02 146.89 50.7 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.79 -0.818 . . . . 10.0 108.79 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.01 158.78 43.28 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.599 -0.889 . . . . 10.0 108.599 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.75 150.6 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.171 1.388 . . . . 10.0 107.698 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.6 tp -115.13 115.71 27.21 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.9 138.29 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.759 -1.571 . . . . 10.0 106.759 -169.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -92.86 135.4 34.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.674 -1.602 . . . . 10.0 106.674 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.11 139.99 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 105.824 -1.917 . . . . 10.0 105.824 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -115.11 130.0 56.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.914 -1.884 . . . . 10.0 105.914 173.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 p -70.17 143.51 52.25 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.03 61.44 3.37 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.721 1.208 . . . . 10.0 108.325 169.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -58.93 152.25 59.41 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.247 2.631 . . . . 10.0 111.103 -169.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 65.92 -61.38 0.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 128.122 2.569 . . . . 10.0 112.135 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 p -171.11 -33.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.425 2.29 . . . . 10.0 108.864 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.66 42.63 0.13 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.05 1.31 . . . . 10.0 110.574 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.02 157.23 11.53 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.339 0.656 . . . . 10.0 110.262 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.52 59.46 5.54 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.181 3.254 . . . . 10.0 112.474 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.18 136.36 26.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.074 1.749 . . . . 10.0 107.297 171.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.38 30.21 0.85 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.775 1.23 . . . . 10.0 110.054 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -64.87 161.07 19.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.79 -0.819 . . . . 10.0 108.79 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.5 m -141.08 159.51 42.05 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.233 1.013 . . . . 10.0 110.009 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -149.83 170.19 19.35 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.503 1.121 . . . . 10.0 109.617 171.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -99.95 154.45 18.37 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.211 -0.663 . . . . 10.0 109.211 170.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.0 pt -137.12 154.03 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.291 1.436 . . . . 10.0 109.956 174.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.35 126.84 65.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.453 -1.684 . . . . 10.0 106.453 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -133.94 143.06 47.97 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.738 -1.579 . . . . 10.0 106.738 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.84 129.47 1.65 Allowed Glycine 0 C--O 1.227 -0.295 0 CA-C-N 120.259 1.39 . . . . 10.0 111.378 171.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -145.0 141.5 28.98 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.454 0.702 . . . . 10.0 110.432 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -70.51 -21.98 62.68 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 118.358 -0.83 . . . . 10.0 113.195 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -66.44 -25.13 66.6 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.586 1.085 . . . . 10.0 112.629 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.67 126.32 29.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.252 0.933 . . . . 10.0 110.114 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.49 -31.96 65.81 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 122.621 0.368 . . . . 10.0 110.249 170.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -146.05 152.22 38.99 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.339 1.456 . . . . 10.0 109.13 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -56.93 -31.46 64.98 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.004 1.322 . . . . 10.0 112.626 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.18 -31.55 69.1 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.674 -0.679 . . . . 10.0 112.047 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.74 -41.65 78.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.647 0.658 . . . . 10.0 110.107 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.3 mt -62.78 -50.74 78.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 108.312 -0.996 . . . . 10.0 108.312 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -55.34 -43.7 75.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.834 -0.603 . . . . 10.0 111.295 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.11 -46.59 83.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.609 0.64 . . . . 10.0 111.666 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -57.61 -49.9 74.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.132 0.573 . . . . 10.0 109.643 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.51 -44.31 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 m -56.61 -42.52 78.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.025 0.83 . . . . 10.0 110.9 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.52 -48.37 86.35 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.78 -0.928 . . . . 10.0 110.78 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -62.29 -47.38 84.55 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 118.16 0.98 . . . . 10.0 111.046 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -39.51 87.5 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 119.011 -0.518 . . . . 10.0 110.69 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -65.51 -33.76 76.68 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.567 0.621 . . . . 10.0 110.896 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.08 -34.0 77.08 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 117.239 -1.362 . . . . 10.0 111.21 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -69.47 -65.89 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.292 0.951 . . . . 10.0 108.682 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.79 42.24 0.04 OUTLIER Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.371 1.462 . . . . 10.0 110.491 -169.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.1 m -146.38 176.11 10.03 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.596 1.958 . . . . 10.0 107.935 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -145.21 165.72 27.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.168 0.987 . . . . 10.0 108.764 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.9 m -130.15 155.08 46.81 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.289 0.949 . . . . 10.0 113.019 -169.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -141.57 136.97 31.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.074 1.749 . . . . 10.0 106.774 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.5 t -78.77 141.66 37.62 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.598 -0.689 . . . . 10.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.4 mt -103.48 -20.36 14.07 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.377 0.671 . . . . 10.0 111.146 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.71 -177.96 34.25 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.814 -0.914 . . . . 10.0 110.814 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.15 178.42 32.68 Favored Glycine 0 CA--C 1.521 0.427 0 O-C-N 121.631 -0.923 . . . . 10.0 112.356 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.97 -145.6 5.6 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 109.84 -1.304 . . . . 10.0 109.84 -172.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -142.55 161.72 37.32 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.894 2.078 . . . . 10.0 107.755 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.8 mt -132.29 145.32 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 105.929 -1.878 . . . . 10.0 105.929 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.0 p -154.12 174.52 14.61 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.431 1.092 . . . . 10.0 110.747 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -149.61 152.41 35.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.797 2.039 . . . . 10.0 105.557 169.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -129.05 -12.05 4.68 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.886 0.474 . . . . 10.0 112.076 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 m 57.37 21.89 7.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.084 1.354 . . . . 10.0 113.796 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.33 -17.63 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.637 1.175 . . . . 10.0 113.059 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -159.55 148.02 17.65 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.921 1.688 . . . . 10.0 106.539 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 53.8 -162.66 0.11 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.256 1.022 . . . . 10.0 110.462 -168.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -135.45 -144.81 0.21 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.15 -1.426 . . . . 10.0 107.15 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.3 mm -63.19 113.38 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 101.676 -3.453 . . . . 10.0 101.676 167.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -117.53 145.63 44.11 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.5 -0.555 . . . . 10.0 109.5 -167.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 32.1 t -135.17 130.49 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.917 -1.512 . . . . 10.0 106.917 -170.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -166.86 169.46 13.17 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.135 -0.978 . . . . 10.0 109.47 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.03 -174.63 19.84 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 119.272 0.942 . . . . 10.0 114.435 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -140.41 1.31 1.76 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.413 1.264 . . . . 10.0 114.413 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.6 p 50.53 -25.55 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 129.707 3.203 . . . . 10.0 119.007 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 12.3 tmm? 66.58 -48.39 0.45 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.574 2.35 . . . . 10.0 111.009 -168.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.74 70.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.363 1.465 . . . . 10.0 113.016 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -133.93 -50.25 0.82 Allowed 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.643 0.656 . . . . 10.0 111.747 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.02 170.96 12.31 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 109.37 -1.492 . . . . 10.0 109.37 -170.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.05 130.97 40.59 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.029 2.486 . . . . 10.0 111.8 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.66 158.88 28.92 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 168.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -77.1 73.34 3.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -54.61 -26.24 31.52 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.199 0.999 . . . . 10.0 112.835 -170.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.29 -41.06 98.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.261 0.937 . . . . 10.0 112.08 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.2 mt -64.52 -50.24 76.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 107.497 -1.298 . . . . 10.0 107.497 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -60.09 -43.62 95.39 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 119.129 -0.462 . . . . 10.0 111.892 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.9 p -66.58 -37.83 85.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.064 0.847 . . . . 10.0 111.547 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -64.89 -38.97 92.76 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.418 1.008 . . . . 10.0 110.796 175.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -66.66 -45.06 80.17 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 122.042 -0.411 . . . . 10.0 110.626 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.86 -48.72 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -59.03 -40.02 83.75 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.158 0.89 . . . . 10.0 111.567 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.33 72.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.992 0.815 . . . . 10.0 111.977 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -89.89 -12.6 38.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.534 -0.746 . . . . 10.0 112.822 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.1 p90 38.25 57.59 5.03 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 127.541 2.336 . . . . 10.0 114.558 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -67.63 -16.31 46.48 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.737 1.625 . . . . 10.0 110.671 169.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -142.08 160.15 40.81 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 128.134 2.574 . . . . 10.0 105.681 169.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -76.56 -15.72 59.79 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.539 -0.743 . . . . 10.0 112.456 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.72 153.05 39.81 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.945 1.248 . . . . 10.0 110.588 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.6 t -143.01 154.55 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.382 1.473 . . . . 10.0 107.597 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.0 p -145.53 158.42 43.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.826 1.65 . . . . 10.0 108.926 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -151.22 164.23 37.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.838 0.681 . . . . 10.0 112.838 173.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.21 -174.08 4.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.606 1.962 . . . . 10.0 108.436 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.98 35.04 3.56 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.127 0.971 . . . . 10.0 109.258 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -152.07 157.39 41.57 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.819 1.648 . . . . 10.0 108.021 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.95 -26.84 6.06 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.461 1.505 . . . . 10.0 111.605 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--O 1.25 1.1 0 N-CA-C 104.41 -2.441 . . . . 10.0 104.41 -179.665 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 tpt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.38 150.59 31.6 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.403 1.081 . . . . 10.0 109.221 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.69 176.4 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 128.063 2.545 . . . . 10.0 107.564 -176.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.21 174.61 10.42 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.297 1.439 . . . . 10.0 108.498 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -151.05 152.05 32.89 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.016 -1.105 . . . . 10.0 108.016 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -59.53 -22.4 61.61 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.937 0.895 . . . . 10.0 113.04 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.94 -24.56 66.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.637 1.108 . . . . 10.0 112.435 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.5 mt -78.96 -17.1 56.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.455 0.702 . . . . 10.0 111.745 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 25.8 mt -100.36 132.35 22.65 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.46 142.33 64.98 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.388 2.058 . . . . 10.0 110.272 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -78.51 -28.88 46.35 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.816 0.847 . . . . 10.0 112.163 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.26 134.38 47.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 106.086 -1.82 . . . . 10.0 106.086 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -152.96 113.42 4.04 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.3 pt -139.07 160.78 29.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.56 1.144 . . . . 10.0 109.962 -169.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.13 175.49 2.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.191 0.996 . . . . 10.0 111.572 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -138.82 11.58 2.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.376 1.07 . . . . 10.0 112.55 -169.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -148.81 138.29 21.83 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.152 0.887 . . . . 10.0 110.419 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.24 -163.63 16.29 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.487 1.041 . . . . 10.0 113.139 171.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.84 142.49 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 169.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -150.37 147.84 28.08 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.986 0.914 . . . . 10.0 109.734 171.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -74.93 157.88 34.25 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.672 -0.862 . . . . 10.0 108.672 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.71 160.35 43.25 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.549 0.34 . . . . 10.0 110.458 173.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 t -133.57 141.89 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.453 1.501 . . . . 10.0 107.383 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 tp -98.63 115.84 29.54 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 104.654 -2.35 . . . . 10.0 104.654 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.3 mt -122.83 124.84 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.625 -1.62 . . . . 10.0 106.625 -167.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -82.53 140.16 33.46 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 168.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.2 t -133.13 142.65 41.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.446 -1.687 . . . . 10.0 106.446 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -126.29 136.96 53.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.509 1.524 . . . . 10.0 107.119 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.9 m -67.56 140.44 56.95 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.36 57.31 2.77 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.399 1.479 . . . . 10.0 107.981 167.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -59.97 135.12 60.88 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.333 2.689 . . . . 10.0 109.834 -169.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 47.34 26.04 0.67 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.028 1.331 . . . . 10.0 112.956 -174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m 48.23 31.28 2.55 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.458 1.503 . . . . 10.0 113.655 -172.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -172.64 -3.39 0.03 OUTLIER Glycine 0 CA--C 1.531 1.051 0 N-CA-C 117.019 1.568 . . . . 10.0 117.019 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.05 151.08 81.76 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 120.433 2.116 . . . . 10.0 110.556 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.03 52.06 3.9 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.315 3.344 . . . . 10.0 111.54 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.53 136.07 30.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.003 1.321 . . . . 10.0 108.723 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.7 31.5 1.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.327 1.451 . . . . 10.0 109.762 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -61.97 151.48 34.91 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.51 -0.922 . . . . 10.0 108.51 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.4 m -139.39 158.49 44.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.799 0.84 . . . . 10.0 110.686 -175.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -152.41 176.78 11.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.807 1.243 . . . . 10.0 109.247 171.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -117.0 142.82 46.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.0 pt -131.17 156.42 42.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.623 1.169 . . . . 10.0 110.067 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.42 125.8 65.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.915 -1.883 . . . . 10.0 105.915 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -130.13 139.17 50.93 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.0 132.76 2.5 Favored Glycine 0 C--O 1.224 -0.527 0 CA-C-N 120.03 1.286 . . . . 10.0 111.817 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -144.75 144.18 31.06 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 122.888 0.475 . . . . 10.0 111.178 -169.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -64.58 -32.45 74.11 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.845 0.858 . . . . 10.0 112.248 -174.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -68.59 -16.69 63.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 117.912 -1.042 . . . . 10.0 113.008 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.8 119.31 6.91 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.631 1.105 . . . . 10.0 111.629 -172.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.13 -37.36 81.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.161 0.584 . . . . 10.0 110.18 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -149.67 168.86 22.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 127.142 2.177 . . . . 10.0 107.598 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -59.6 -29.37 67.94 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.135 -0.978 . . . . 10.0 111.805 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.92 68.9 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.838 0.855 . . . . 10.0 112.359 172.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -66.39 -42.6 87.65 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.795 0.807 . . . . 10.0 109.802 -176.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.78 -53.84 37.17 Favored 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.214 -1.032 . . . . 10.0 108.214 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -59.14 -39.17 81.55 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 119.027 -0.511 . . . . 10.0 110.992 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.51 -46.02 90.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.445 0.566 . . . . 10.0 111.761 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.83 -49.16 75.99 Favored 'General case' 0 C--N 1.345 0.373 0 O-C-N 121.691 -0.63 . . . . 10.0 109.661 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.79 -43.73 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.301 -0.629 . . . . 10.0 109.301 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.7 p -65.09 -34.05 77.49 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.251 0.932 . . . . 10.0 111.205 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.98 -51.21 60.02 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.393 -1.083 . . . . 10.0 110.393 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.98 -46.25 91.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 117.357 0.579 . . . . 10.0 110.792 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.9 mmt -61.84 -37.75 85.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.702 -0.624 . . . . 10.0 110.812 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -64.86 -36.49 84.52 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.997 0.817 . . . . 10.0 111.14 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -66.61 -34.22 77.41 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.994 -1.003 . . . . 10.0 111.304 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -68.15 -54.22 19.53 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.841 0.746 . . . . 10.0 109.546 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.52 44.04 0.2 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.453 1.502 . . . . 10.0 110.551 -171.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.4 m -144.91 171.68 14.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.229 1.812 . . . . 10.0 109.047 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -139.54 160.92 38.74 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.432 1.493 . . . . 10.0 108.709 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.8 m -127.71 157.59 39.91 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.847 1.259 . . . . 10.0 112.98 -168.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -145.52 111.75 5.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.677 1.991 . . . . 10.0 106.283 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -63.42 118.9 8.75 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.97 -1.081 . . . . 10.0 108.775 171.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 mt -80.7 -29.02 36.49 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 110.171 -0.307 . . . . 10.0 110.171 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.64 -178.43 39.84 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.157 -1.977 . . . . 10.0 108.157 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.99 -168.86 20.19 Favored Glycine 0 CA--C 1.519 0.314 0 O-C-N 121.398 -1.06 . . . . 10.0 110.851 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.17 -151.41 9.07 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.358 -1.897 . . . . 10.0 108.358 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.433 HH21 ' C ' ' A' ' 125' ' ' TYR . 27.8 ptt180 -144.13 165.4 27.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 173.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -134.32 151.46 32.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 104.835 -2.283 . . . . 10.0 104.835 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.3 p -132.37 118.73 19.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.985 -1.117 . . . . 10.0 107.985 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -78.53 91.0 4.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.091 -1.818 . . . . 10.0 106.091 168.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -82.54 63.7 6.82 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.655 0.741 . . . . 10.0 109.28 -174.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.6 m 49.08 32.19 3.88 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.431 2.292 . . . . 10.0 113.449 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . 0.276 5.5 pt20 51.48 -26.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 130.347 3.459 . . . . 10.0 116.792 -168.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.37 -30.28 62.49 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.721 1.609 . . . . 10.0 112.147 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -124.42 32.18 5.56 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.335 1.054 . . . . 10.0 110.25 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.332 0.0 OUTLIER 54.53 -179.86 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.037 2.935 . . . . 10.0 115.225 172.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.7 pt -86.5 102.48 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.865 -1.531 . . . . 10.0 106.865 169.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -99.79 126.69 45.91 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.199 -1.038 . . . . 10.0 108.199 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.42 145.31 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 106.652 -1.61 . . . . 10.0 106.652 174.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -161.67 178.77 8.71 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.687 0.795 . . . . 10.0 110.182 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.89 -158.26 46.31 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-O 121.328 0.405 . . . . 10.0 112.92 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -158.67 158.03 32.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.557 1.943 . . . . 10.0 107.56 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 t -72.09 130.78 41.71 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 60.4 mtt -73.3 -19.32 61.07 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.604 0.565 . . . . 10.0 110.811 169.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.95 -31.32 22.18 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.536 -0.745 . . . . 10.0 112.077 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -128.17 -54.53 1.28 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.889 0.768 . . . . 10.0 111.297 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.09 179.85 22.58 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.837 1.208 . . . . 10.0 110.165 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.39 133.42 58.0 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.113 2.542 . . . . 10.0 111.673 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.69 165.76 20.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 166.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -80.12 68.22 6.19 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 168.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -49.45 -33.03 13.12 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.463 1.505 . . . . 10.0 113.709 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.5 77.18 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.993 0.815 . . . . 10.0 112.231 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.72 -50.97 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 107.097 -1.445 . . . . 10.0 107.097 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -55.94 -46.52 78.48 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.468 -0.777 . . . . 10.0 112.137 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.6 p -64.99 -42.32 94.63 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 119.721 1.146 . . . . 10.0 111.034 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.87 -39.44 90.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.864 0.756 . . . . 10.0 110.979 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -59.83 -51.66 68.77 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 118.818 -0.61 . . . . 10.0 109.836 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.47 -48.81 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.419 -0.956 . . . . 10.0 108.419 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -60.99 -40.75 94.66 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.693 0.797 . . . . 10.0 111.513 -175.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.12 77.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.122 0.569 . . . . 10.0 110.842 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -79.5 -19.65 49.16 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 118.62 -0.705 . . . . 10.0 112.082 -173.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.84 77.48 72.15 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 126.136 1.774 . . . . 10.0 107.221 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.22 51.4 3.47 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.624 3.549 . . . . 10.0 111.955 -174.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -146.54 166.78 25.45 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.041 1.737 . . . . 10.0 107.953 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 50.78 -140.87 0.8 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.922 1.289 . . . . 10.0 110.029 -169.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -147.54 162.88 38.2 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.98 -1.489 . . . . 10.0 106.98 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.96 132.5 16.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.138 -1.43 . . . . 10.0 107.138 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -142.44 170.65 15.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.646 1.178 . . . . 10.0 108.707 173.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -138.75 163.28 32.6 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 122.851 0.46 . . . . 10.0 111.886 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.47 168.87 20.14 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.164 1.785 . . . . 10.0 108.727 169.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -147.98 23.69 1.07 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.157 0.983 . . . . 10.0 110.164 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.61 -25.88 68.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.106 0.962 . . . . 10.0 112.946 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -169.44 178.54 42.47 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 108.639 -1.784 . . . . 10.0 108.639 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.433 ' C ' HH21 ' A' ' 78' ' ' ARG . 68.2 t80 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.932 -0.556 . . . . 10.0 109.535 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 118.554 -0.736 . . . . 10.0 109.75 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.66 24.04 6.66 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.86 1.264 . . . . 10.0 111.276 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.48 152.19 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 128.904 2.882 . . . . 10.0 105.323 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.43 167.1 20.33 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.479 0.487 . . . . 10.0 109.785 168.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -151.16 151.32 31.76 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.931 1.292 . . . . 10.0 107.542 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.13 -24.06 62.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 118.237 -0.887 . . . . 10.0 112.886 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.88 -25.9 67.02 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.605 1.093 . . . . 10.0 112.451 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.2 mt -74.94 -23.77 58.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.123 0.569 . . . . 10.0 111.366 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.9 mt -89.2 128.97 49.51 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 107.071 -1.455 . . . . 10.0 107.071 -173.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.81 147.17 80.48 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.165 1.91 . . . . 10.0 110.67 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.92 -35.61 72.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.779 1.632 . . . . 10.0 111.603 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.64 133.26 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.625 -2.361 . . . . 10.0 104.625 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -150.32 114.3 5.07 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.063 -1.829 . . . . 10.0 106.063 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.3 pt -141.5 161.06 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.502 1.121 . . . . 10.0 109.525 -170.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -148.28 103.91 3.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.2 m -155.88 155.01 32.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.013 0.925 . . . . 10.0 109.07 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.84 25.41 0.84 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 123.121 1.439 . . . . 10.0 109.717 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.77 -168.55 41.43 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 107.905 -2.078 . . . . 10.0 107.905 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.79 120.64 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 118.06 0.93 . . . . 10.0 108.576 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -146.82 151.16 36.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.694 0.797 . . . . 10.0 109.981 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -55.95 153.46 8.69 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.64 1.176 . . . . 10.0 111.629 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.51 160.9 43.08 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.074 0.95 . . . . 10.0 108.965 168.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.12 147.25 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.703 1.201 . . . . 10.0 108.911 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -107.77 117.99 35.56 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.566 -2.013 . . . . 10.0 105.566 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.3 mt -123.19 132.34 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.522 -1.659 . . . . 10.0 106.522 -170.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -85.32 125.3 32.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.537 -2.023 . . . . 10.0 105.537 167.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.38 141.17 24.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 106.604 -1.628 . . . . 10.0 106.604 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -121.6 130.1 53.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.976 -1.861 . . . . 10.0 105.976 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.6 p -71.03 144.32 50.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.958 -0.386 . . . . 10.0 109.958 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.0 61.83 3.56 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.567 1.547 . . . . 10.0 107.603 166.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -58.08 143.9 95.76 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.944 2.429 . . . . 10.0 110.601 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 48.18 23.72 0.57 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.842 1.257 . . . . 10.0 113.111 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m 49.05 30.95 3.09 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.225 1.41 . . . . 10.0 113.683 -172.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.62 -2.34 0.02 OUTLIER Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.762 1.465 . . . . 10.0 116.762 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.16 152.22 78.94 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 119.937 1.868 . . . . 10.0 110.657 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.78 57.77 6.18 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.285 3.323 . . . . 10.0 112.098 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.24 136.91 30.32 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 125.073 1.349 . . . . 10.0 108.309 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.79 28.53 0.77 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.897 1.279 . . . . 10.0 110.448 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.04 159.94 24.86 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.375 -0.828 . . . . 10.0 109.095 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.0 m -139.76 162.12 35.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.874 0.87 . . . . 10.0 110.694 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -149.29 174.88 11.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.647 1.179 . . . . 10.0 109.351 170.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -99.3 148.85 23.73 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 pt -136.53 148.62 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.604 1.562 . . . . 10.0 109.72 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.7 t -106.94 127.34 62.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -132.68 141.95 48.84 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.618 -1.253 . . . . 10.0 107.618 -176.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.06 107.21 0.23 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 110.132 -1.187 . . . . 10.0 110.132 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.97 132.62 42.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 -171.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -59.55 -23.95 63.3 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.791 1.404 . . . . 10.0 114.791 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -67.39 -24.65 65.7 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.315 0.961 . . . . 10.0 112.425 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.98 125.42 29.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.744 1.157 . . . . 10.0 109.799 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -74.29 -33.59 63.28 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.392 0.615 . . . . 10.0 109.855 171.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -143.71 155.91 44.36 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.15 1.38 . . . . 10.0 110.008 -172.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -58.66 -33.87 70.6 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.415 1.486 . . . . 10.0 112.94 -171.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.94 -31.09 70.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.383 -0.818 . . . . 10.0 111.513 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -70.93 -38.54 72.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.86 0.755 . . . . 10.0 110.124 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.4 mt -63.88 -50.34 77.95 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -52.92 -48.26 67.39 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.427 -0.797 . . . . 10.0 111.123 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.2 -47.15 83.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.417 0.553 . . . . 10.0 111.255 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -59.48 -51.42 69.95 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.872 -0.518 . . . . 10.0 110.153 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.1 t -66.98 -41.26 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.678 -0.86 . . . . 10.0 108.678 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 m -62.91 -36.04 82.06 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.629 1.104 . . . . 10.0 111.547 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.77 -51.13 59.45 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.163 -1.175 . . . . 10.0 110.163 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.29 -43.45 98.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.793 0.797 . . . . 10.0 111.016 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.1 mmt -62.32 -37.0 83.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 121.71 -0.619 . . . . 10.0 111.433 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -65.03 -36.17 83.52 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.009 0.822 . . . . 10.0 110.755 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.78 -32.72 74.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.64 -1.172 . . . . 10.0 111.509 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -68.99 -52.16 31.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.718 1.144 . . . . 10.0 109.727 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.08 50.12 0.24 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.766 -1.734 . . . . 10.0 108.766 -169.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.0 m -147.69 170.65 17.08 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.532 1.933 . . . . 10.0 109.216 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -140.2 165.38 27.52 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.276 1.83 . . . . 10.0 108.48 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.1 m -134.48 156.14 49.12 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.582 1.153 . . . . 10.0 112.358 -167.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -149.25 123.23 9.39 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.135 -1.802 . . . . 10.0 106.135 169.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.71 126.98 31.35 Favored 'General case' 0 C--O 1.226 -0.178 0 O-C-N 121.038 -1.039 . . . . 10.0 109.334 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.99 -27.33 35.97 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 122.097 -0.377 . . . . 10.0 110.306 170.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.1 -177.87 38.14 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.966 -1.654 . . . . 10.0 108.966 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.96 -173.01 21.87 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.5 -1.0 . . . . 10.0 111.48 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.51 -146.77 6.4 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.511 -1.836 . . . . 10.0 108.511 -173.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -147.71 159.91 43.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.601 1.161 . . . . 10.0 109.505 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.9 mt -128.7 149.32 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.513 -2.032 . . . . 10.0 105.513 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.2 p -125.74 164.45 20.62 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.245 1.018 . . . . 10.0 108.814 170.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -139.24 154.17 47.94 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.23 1.412 . . . . 10.0 108.12 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.4 pt20 -70.09 -2.93 14.32 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.216 1.191 . . . . 10.0 114.216 -172.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 m -47.65 -41.35 22.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.756 1.622 . . . . 10.0 112.444 168.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -154.24 14.57 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.75 0.82 . . . . 10.0 111.953 -175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 86' ' ' LYS . 14.8 t70 -144.79 -162.15 1.43 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.978 1.311 . . . . 10.0 108.439 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.426 ' H ' ' CG ' ' A' ' 85' ' ' ASP . 55.2 mtmt -73.99 -176.4 2.5 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.875 -1.14 . . . . 10.0 109.656 174.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 163.66 0.27 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.904 -0.569 . . . . 10.0 110.63 165.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.0 mt -54.73 122.16 3.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 -171.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -136.38 147.14 47.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.415 -1.328 . . . . 10.0 107.415 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.69 135.51 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.173 -1.417 . . . . 10.0 107.173 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -164.79 175.29 9.79 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.941 0.897 . . . . 10.0 109.695 -170.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.52 -174.19 20.87 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 121.722 0.624 . . . . 10.0 112.76 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -141.9 24.81 1.99 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.047 0.939 . . . . 10.0 111.862 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.7 p 59.46 -174.89 0.1 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.511 1.924 . . . . 10.0 112.832 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.0 mtt -128.55 21.81 6.01 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.192 1.397 . . . . 10.0 109.039 167.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.24 -28.83 0.45 Allowed 'General case' 0 C--N 1.347 0.488 0 N-CA-C 115.172 1.545 . . . . 10.0 115.172 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.89 -52.54 0.52 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.484 1.493 . . . . 10.0 111.554 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.29 177.79 25.44 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.42 1.486 . . . . 10.0 109.646 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.3 134.45 45.31 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.759 2.306 . . . . 10.0 111.178 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.55 160.93 18.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.963 0.887 . . . . 10.0 109.085 165.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -80.33 75.4 7.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.724 -1.584 . . . . 10.0 106.724 169.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -54.53 -23.74 17.8 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.724 1.209 . . . . 10.0 113.546 -170.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.45 -40.37 94.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.703 1.138 . . . . 10.0 111.675 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.7 mt -65.16 -51.84 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.7 m -57.83 -45.42 86.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.712 -0.661 . . . . 10.0 112.003 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.0 p -68.74 -38.61 80.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 117.775 -1.107 . . . . 10.0 111.654 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.4 -40.29 96.82 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.076 1.307 . . . . 10.0 110.71 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -62.74 -50.43 71.09 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.133 -0.355 . . . . 10.0 110.064 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.2 -39.46 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 120.651 -1.281 . . . . 10.0 109.076 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -62.03 -41.55 98.21 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 119.624 1.102 . . . . 10.0 110.66 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.34 -41.3 96.84 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.315 0.961 . . . . 10.0 111.048 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -62.98 -33.2 74.89 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 118.252 -0.88 . . . . 10.0 110.66 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.4 t80 41.99 64.63 5.56 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 127.77 2.428 . . . . 10.0 111.764 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -68.03 -24.37 39.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.033 1.822 . . . . 10.0 113.142 -174.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -156.09 -48.19 0.08 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.253 0.933 . . . . 10.0 112.525 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -160.01 -171.31 3.18 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.317 -0.865 . . . . 10.0 111.086 -169.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -47.06 147.97 1.26 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.62 2.368 . . . . 10.0 111.693 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 t -132.51 140.77 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.117 1.367 . . . . 10.0 108.644 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.63 169.27 21.97 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.569 1.548 . . . . 10.0 109.96 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.6 p-90 -145.63 166.18 26.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.755 1.162 . . . . 10.0 111.243 172.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.33 175.23 14.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.98 1.712 . . . . 10.0 108.236 169.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -137.76 36.66 2.41 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.201 1.0 . . . . 10.0 109.567 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.84 -26.3 68.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.354 1.061 . . . . 10.0 112.427 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.48 -174.87 42.43 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.258 -1.537 . . . . 10.0 109.258 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 58.6 t80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.968 -0.539 . . . . 10.0 109.942 173.039 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 118.557 -0.735 . . . . 10.0 110.381 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.53 -177.58 4.81 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.875 0.87 . . . . 10.0 111.613 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.5 m -89.96 146.24 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.239 1.015 . . . . 10.0 109.218 168.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.7 -177.24 5.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.945 2.098 . . . . 10.0 106.753 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -144.89 147.05 32.33 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.382 -1.71 . . . . 10.0 106.382 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -59.05 -26.21 64.39 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.54 -24.92 67.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.704 0.684 . . . . 10.0 112.713 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.83 -27.74 57.99 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.37 0.532 . . . . 10.0 110.61 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 mt -79.94 132.52 60.27 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.11 147.88 80.17 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.453 2.102 . . . . 10.0 109.531 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.49 -28.61 46.41 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.287 0.565 . . . . 10.0 112.131 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -137.96 135.51 45.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.256 1.422 . . . . 10.0 107.173 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -147.84 99.8 3.13 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.541 -1.281 . . . . 10.0 107.541 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.6 pt -143.75 -179.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.656 1.583 . . . . 10.0 109.736 -169.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -138.58 163.5 31.87 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 106.071 -1.826 . . . . 10.0 106.071 167.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.5 m -152.89 22.82 0.58 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.771 1.229 . . . . 10.0 111.198 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.43 -18.21 64.52 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.583 -0.698 . . . . 10.0 112.463 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.04 -174.94 34.42 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.118 1.818 . . . . 10.0 109.101 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.62 130.88 30.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.283 -1.006 . . . . 10.0 108.283 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -141.94 148.67 39.02 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.059 1.344 . . . . 10.0 108.977 173.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -60.43 151.61 27.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.658 0.783 . . . . 10.0 109.187 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.08 162.07 41.66 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.633 -0.667 . . . . 10.0 110.563 170.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.84 152.86 31.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.889 1.276 . . . . 10.0 109.677 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 tp -102.63 114.3 28.41 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.654 -2.351 . . . . 10.0 104.654 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.4 mt -116.58 132.13 67.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.2 -1.778 . . . . 10.0 106.2 -170.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -88.51 139.51 30.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.437 -1.69 . . . . 10.0 106.437 168.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -128.98 142.43 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.076 -1.824 . . . . 10.0 106.076 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -120.6 133.57 55.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.189 -1.782 . . . . 10.0 106.189 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 p -65.8 140.65 58.42 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.766 -0.457 . . . . 10.0 109.766 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.9 60.2 2.89 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.24 1.416 . . . . 10.0 108.676 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.36 143.63 99.49 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.05 2.5 . . . . 10.0 108.941 -174.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.0 tpt85 53.12 16.17 0.73 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.637 1.175 . . . . 10.0 113.102 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 m 54.97 24.15 5.67 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.44 1.096 . . . . 10.0 113.222 -170.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.87 1.47 0.03 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.652 1.421 . . . . 10.0 116.652 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.53 153.35 77.67 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 119.984 1.892 . . . . 10.0 110.252 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.95 64.42 7.7 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.315 3.344 . . . . 10.0 111.925 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.32 140.0 35.55 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.378 1.471 . . . . 10.0 108.346 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.36 26.17 0.78 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.806 1.242 . . . . 10.0 110.65 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.88 159.96 27.16 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 169.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -139.45 162.64 34.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.154 0.982 . . . . 10.0 111.135 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -152.43 145.3 24.4 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.318 1.847 . . . . 10.0 107.71 -170.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.2 144.03 28.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 169.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.8 pt -134.74 151.37 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.238 1.015 . . . . 10.0 109.965 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.29 127.12 56.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 105.875 -1.898 . . . . 10.0 105.875 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -130.28 133.63 46.63 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.55 49.51 0.33 Allowed Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.068 -0.813 . . . . 10.0 111.068 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -65.92 132.95 49.84 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -63.1 -27.12 69.17 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.924 1.083 . . . . 10.0 113.924 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -69.39 -20.61 63.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 117.958 -1.02 . . . . 10.0 112.641 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.44 133.93 52.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.29 0.95 . . . . 10.0 111.031 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -79.49 -35.61 39.9 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.509 0.671 . . . . 10.0 109.901 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -143.7 163.42 33.34 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.96 1.304 . . . . 10.0 110.109 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -57.54 -40.87 79.81 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.921 0.888 . . . . 10.0 111.466 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.74 -25.25 66.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.674 -0.679 . . . . 10.0 112.4 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -67.3 -41.49 85.28 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.148 0.975 . . . . 10.0 109.149 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.67 -55.26 23.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.13 -1.063 . . . . 10.0 108.13 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -57.6 -41.02 80.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 119.171 -0.443 . . . . 10.0 111.732 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.68 -44.8 92.64 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.724 0.409 . . . . 10.0 111.612 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.39 -51.35 69.88 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.44 -39.86 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 118.201 -0.904 . . . . 10.0 110.05 -175.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.0 m -61.77 -46.34 90.01 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.275 0.943 . . . . 10.0 110.362 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.51 -44.62 94.91 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.006 -0.838 . . . . 10.0 111.006 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -58.59 -52.8 64.12 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.07 1.348 . . . . 10.0 109.481 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.6 mmt -61.39 -37.81 84.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.253 0.621 . . . . 10.0 111.485 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -64.19 -37.83 88.89 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 119.224 0.92 . . . . 10.0 110.85 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.92 -37.53 87.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 117.702 -1.142 . . . . 10.0 110.942 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -67.55 -51.14 54.22 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.714 0.688 . . . . 10.0 109.727 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.11 41.16 0.29 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.86 1.219 . . . . 10.0 110.789 -169.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.4 m -145.51 171.5 14.57 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.961 1.704 . . . . 10.0 108.742 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -140.11 164.49 29.89 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.81 1.644 . . . . 10.0 108.239 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.6 m -130.58 164.83 24.06 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.506 1.048 . . . . 10.0 113.401 -168.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.98 132.88 16.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.184 2.194 . . . . 10.0 105.203 168.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -80.61 132.05 35.57 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.785 -1.197 . . . . 10.0 108.138 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.5 mt -87.63 -21.54 25.25 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 119.263 -0.399 . . . . 10.0 110.625 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.86 -178.32 26.5 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 109.148 -1.581 . . . . 10.0 109.148 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.08 -171.83 24.49 Favored Glycine 0 C--N 1.329 0.183 0 O-C-N 121.706 -0.879 . . . . 10.0 111.866 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.18 -140.6 4.7 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 107.364 -2.295 . . . . 10.0 107.364 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -139.31 149.44 44.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.883 -1.155 . . . . 10.0 107.883 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.24 146.05 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.871 -2.27 . . . . 10.0 104.871 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -137.08 154.09 50.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.812 0.845 . . . . 10.0 111.173 -168.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -65.82 164.63 14.4 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.325 1.05 . . . . 10.0 110.703 173.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -71.61 56.26 0.26 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.434 1.894 . . . . 10.0 112.676 172.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.0 p -144.44 -37.17 0.31 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.777 2.031 . . . . 10.0 109.417 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.456 HE22 ' CD2' ' A' ' 89' ' ' HIS . 1.1 tm0? -63.78 -24.52 67.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.976 0.91 . . . . 10.0 110.621 168.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -155.58 171.73 19.46 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.468 2.307 . . . . 10.0 106.63 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -59.27 -18.08 34.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.652 1.181 . . . . 10.0 112.725 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -138.08 170.01 16.78 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.285 1.434 . . . . 10.0 108.72 -175.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.5 mt -55.91 127.88 15.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.247 -2.131 . . . . 10.0 105.247 169.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.456 ' CD2' HE22 ' A' ' 84' ' ' GLN . 12.2 t60 -132.76 164.71 26.19 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.992 0.808 . . . . 10.0 110.605 -166.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 t -133.51 130.61 56.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.136 1.374 . . . . 10.0 107.767 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.11 178.17 10.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.568 0.747 . . . . 10.0 110.894 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.42 -175.95 45.61 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.661 -0.575 . . . . 10.0 111.661 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.84 152.26 41.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.086 1.354 . . . . 10.0 107.36 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 78.7 p -67.57 142.52 56.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.715 -0.616 . . . . 10.0 109.868 -178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.1 mtp -70.26 -29.65 66.48 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.759 -0.459 . . . . 10.0 109.759 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.29 -33.52 63.27 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 117.883 -1.056 . . . . 10.0 113.307 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -136.32 -52.2 0.71 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.588 1.085 . . . . 10.0 112.489 -169.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.45 -174.99 23.72 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.855 1.216 . . . . 10.0 110.248 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.81 138.39 57.87 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.716 2.277 . . . . 10.0 111.249 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.2 167.6 20.0 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.996 -1.113 . . . . 10.0 107.996 165.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -80.23 79.06 6.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.368 -1.716 . . . . 10.0 106.368 168.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -56.11 -32.36 64.12 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 124.133 0.973 . . . . 10.0 111.6 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.97 -42.28 97.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.801 0.728 . . . . 10.0 112.214 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.2 mt -63.87 -46.93 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.212 -1.403 . . . . 10.0 107.212 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.5 m -57.12 -44.9 83.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.212 -0.899 . . . . 10.0 111.752 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.1 p -64.95 -38.03 89.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.463 1.483 . . . . 10.0 111.436 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.16 -40.22 95.67 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.317 0.962 . . . . 10.0 110.639 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -65.28 -47.36 76.92 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.611 -0.681 . . . . 10.0 110.451 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.6 mt -60.62 -45.34 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -53.12 -49.97 65.45 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.898 0.879 . . . . 10.0 110.092 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.87 -32.36 73.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.005 0.522 . . . . 10.0 112.399 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -62.89 -51.87 65.3 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.981 0.81 . . . . 10.0 109.981 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -158.88 -52.62 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.158 -1.401 . . . . 10.0 113.332 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.94 65.64 4.08 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.779 2.986 . . . . 10.0 112.308 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -58.72 -31.03 67.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.723 1.209 . . . . 10.0 112.32 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -58.75 -56.08 26.87 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.049 0.54 . . . . 10.0 110.573 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -169.66 156.48 6.52 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 118.635 0.652 . . . . 10.0 111.247 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 t -147.73 139.95 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 129.099 2.96 . . . . 10.0 103.145 167.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.9 p -119.06 165.41 14.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.2 0.909 . . . . 10.0 110.76 -170.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -154.48 162.5 41.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 120.901 -1.124 . . . . 10.0 108.453 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.93 -32.08 0.2 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.8 0.667 . . . . 10.0 112.8 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 51.4 t30 38.98 62.69 1.04 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.233 1.413 . . . . 10.0 112.579 -171.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -59.19 -35.79 74.21 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.749 -0.66 . . . . 10.0 111.489 172.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.77 173.17 33.99 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.515 1.531 . . . . 10.0 110.282 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 64.0 t80 . . . . . 0 C--O 1.247 0.936 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 169.246 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ttt . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 109.946 -0.39 . . . . 10.0 109.946 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.87 171.2 14.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.237 1.415 . . . . 10.0 109.078 176.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -67.28 165.79 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.647 0.737 . . . . 10.0 110.907 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -149.4 -179.24 6.92 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.451 2.3 . . . . 10.0 106.394 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -150.83 151.22 31.96 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.31 -23.81 64.49 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.566 0.746 . . . . 10.0 112.514 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.12 67.42 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.224 0.92 . . . . 10.0 112.08 173.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.51 -35.53 58.27 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 122.866 0.466 . . . . 10.0 109.837 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mt -63.64 122.59 77.38 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.43 141.94 88.77 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.349 2.032 . . . . 10.0 109.531 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -85.14 -32.18 22.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.192 0.52 . . . . 10.0 112.395 -169.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -139.61 134.06 38.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.599 -2.001 . . . . 10.0 105.599 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -149.61 98.96 2.83 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.599 -1.259 . . . . 10.0 107.599 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.8 pt -140.47 166.28 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.125 1.77 . . . . 10.0 107.959 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -136.01 34.97 2.83 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.699 1.238 . . . . 10.0 109.856 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 m -75.28 41.75 0.19 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.685 1.994 . . . . 10.0 112.979 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.08 -15.92 58.22 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.35 1.06 . . . . 10.0 111.817 169.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.07 -172.99 15.91 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.869 2.652 . . . . 10.0 107.486 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.51 126.0 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 117.854 0.827 . . . . 10.0 109.574 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -157.32 147.86 21.18 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.287 0.635 . . . . 10.0 109.72 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -67.59 164.48 18.99 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.412 0.625 . . . . 10.0 111.276 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -151.61 166.61 30.69 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.603 0.761 . . . . 10.0 109.196 173.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.88 148.54 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.509 1.124 . . . . 10.0 108.538 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.44 122.35 47.5 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.845 -1.909 . . . . 10.0 105.845 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.4 mt -129.08 136.95 58.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.472 -1.677 . . . . 10.0 106.472 -171.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -93.64 131.86 38.53 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.221 -1.77 . . . . 10.0 106.221 169.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.7 144.06 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.614 -1.254 . . . . 10.0 107.614 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -122.5 122.45 38.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.737 -1.949 . . . . 10.0 105.737 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.1 p -75.85 147.89 38.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.058 0.456 . . . . 10.0 111.475 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.57 65.46 2.29 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 127.31 2.244 . . . . 10.0 106.606 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -54.64 140.7 76.15 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.392 2.728 . . . . 10.0 111.211 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 48.88 21.9 0.5 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.654 1.182 . . . . 10.0 113.295 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.3 m 48.79 35.69 6.84 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.098 1.359 . . . . 10.0 112.923 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.41 -12.03 0.02 OUTLIER Glycine 0 CA--C 1.531 1.047 0 N-CA-C 116.618 1.407 . . . . 10.0 116.618 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.03 150.12 92.48 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 120.006 1.903 . . . . 10.0 110.776 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.41 61.33 7.84 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.325 3.35 . . . . 10.0 111.695 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.86 140.02 34.54 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.886 1.275 . . . . 10.0 108.6 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.97 27.94 0.77 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.89 1.276 . . . . 10.0 110.931 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.84 165.37 19.9 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.426 0.69 . . . . 10.0 109.361 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -139.31 159.93 41.0 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.225 1.01 . . . . 10.0 110.142 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -153.05 175.51 12.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.596 1.158 . . . . 10.0 109.584 170.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -96.43 159.62 14.84 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.06 -0.718 . . . . 10.0 109.06 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.1 pt -138.24 147.55 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.95 1.7 . . . . 10.0 108.425 169.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.27 124.95 64.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.02 -1.845 . . . . 10.0 106.02 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -131.01 136.89 48.9 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.077 0.951 . . . . 10.0 108.637 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.38 47.82 0.34 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 109.687 -1.365 . . . . 10.0 109.687 -172.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -67.77 125.84 27.5 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.063 0.545 . . . . 10.0 111.041 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -59.3 -31.44 69.15 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.626 0.973 . . . . 10.0 113.626 -171.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -69.01 -17.81 63.96 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 118.169 -0.919 . . . . 10.0 112.662 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.78 136.39 57.39 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.142 0.883 . . . . 10.0 111.538 -171.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.69 -38.54 80.39 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.388 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -154.77 169.7 23.33 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.22 1.808 . . . . 10.0 108.791 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -55.65 -32.36 63.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.098 0.959 . . . . 10.0 111.737 169.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.01 80.83 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.121 0.568 . . . . 10.0 111.751 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -69.92 -39.2 76.27 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.03 -57.28 12.88 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 108.458 -0.941 . . . . 10.0 108.458 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -58.93 -40.85 85.84 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.334 -0.365 . . . . 10.0 111.222 -172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.83 -46.72 83.81 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.54 0.336 . . . . 10.0 111.68 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -64.28 -45.22 88.98 Favored 'General case' 0 C--N 1.344 0.327 0 O-C-N 121.785 -0.572 . . . . 10.0 109.907 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.09 -44.22 98.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 123.478 0.711 . . . . 10.0 109.093 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.7 m -60.95 -38.61 86.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.346 0.975 . . . . 10.0 111.092 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.17 -52.2 43.14 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.866 -0.894 . . . . 10.0 110.866 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.27 -42.4 99.13 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 117.48 0.64 . . . . 10.0 111.366 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 25.4 mmt -62.51 -38.07 88.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.4 -0.81 . . . . 10.0 110.768 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -62.9 -36.04 82.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.581 1.082 . . . . 10.0 111.042 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -66.07 -33.43 75.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.098 -0.953 . . . . 10.0 111.685 172.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -70.76 -40.32 72.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.219 0.918 . . . . 10.0 110.679 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.51 53.07 0.73 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 108.768 -1.733 . . . . 10.0 108.768 -168.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.2 m -141.84 165.04 28.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.235 1.814 . . . . 10.0 107.855 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -128.31 161.87 28.4 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.581 1.553 . . . . 10.0 107.668 171.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 73.6 m -127.79 154.28 45.59 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.368 1.067 . . . . 10.0 112.576 -168.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -143.7 116.72 8.87 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.162 -1.792 . . . . 10.0 106.162 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.3 p -61.25 130.46 46.29 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.134 -0.979 . . . . 10.0 108.739 170.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.8 mt -90.66 -24.45 20.47 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.48 0.312 . . . . 10.0 110.21 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.98 179.07 33.55 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.907 -1.677 . . . . 10.0 108.907 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.67 -179.33 22.72 Favored Glycine 0 CA--C 1.522 0.527 0 O-C-N 121.681 -0.894 . . . . 10.0 111.485 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.56 -149.98 7.05 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 109.789 -1.324 . . . . 10.0 109.789 -170.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -147.43 165.13 31.16 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.794 1.238 . . . . 10.0 109.505 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.3 mt -133.82 149.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.484 -2.413 . . . . 10.0 104.484 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.1 m -147.0 160.77 41.97 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.516 0.726 . . . . 10.0 109.582 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -158.38 129.69 6.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.252 -2.129 . . . . 10.0 105.252 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 59.67 171.16 0.08 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.07 1.748 . . . . 10.0 111.928 -168.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.6 m 64.1 -20.72 0.07 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.874 2.07 . . . . 10.0 115.922 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -135.83 -29.91 1.01 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.59 1.956 . . . . 10.0 110.459 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -153.66 138.53 17.14 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.491 -1.3 . . . . 10.0 107.491 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -67.55 -13.38 62.0 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.103 -0.951 . . . . 10.0 113.229 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.68 170.37 15.91 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.931 1.292 . . . . 10.0 109.354 176.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.61 136.5 20.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.526 0.679 . . . . 10.0 109.187 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -134.51 148.8 50.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.007 1.323 . . . . 10.0 108.076 172.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.7 138.62 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.751 1.621 . . . . 10.0 107.286 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -169.31 -167.13 0.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.212 1.405 . . . . 10.0 107.905 -171.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.05 -172.92 38.97 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 121.361 -0.837 . . . . 10.0 112.738 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.69 174.31 11.91 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.951 0.9 . . . . 10.0 109.908 169.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.3 m -131.81 105.89 7.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.219 -2.141 . . . . 10.0 105.219 169.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.3 ttt -54.83 -28.71 51.61 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.303 1.041 . . . . 10.0 113.14 -169.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.0 -25.06 66.62 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.998 0.74 . . . . 10.0 112.998 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -128.87 -49.58 1.23 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.623 0.769 . . . . 10.0 110.407 -170.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.81 174.69 13.75 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.203 1.858 . . . . 10.0 108.917 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -53.94 136.14 65.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.574 2.183 . . . . 10.0 110.895 169.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.93 159.29 25.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.697 0.761 . . . . 10.0 109.164 168.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -78.76 72.01 5.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 169.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -49.52 -32.89 13.27 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.26 1.424 . . . . 10.0 113.551 -169.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.02 -38.03 72.55 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.069 0.85 . . . . 10.0 112.426 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.9 mt -64.8 -51.38 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 106.992 -1.484 . . . . 10.0 106.992 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -59.95 -43.64 94.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.288 -0.863 . . . . 10.0 111.804 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -63.42 -40.42 97.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 119.79 1.177 . . . . 10.0 111.002 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.97 -39.94 90.81 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.275 0.943 . . . . 10.0 110.674 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -66.32 -45.98 78.45 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.986 -0.446 . . . . 10.0 110.045 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.0 mt -59.1 -41.89 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -64.18 -36.56 84.44 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 120.877 -1.14 . . . . 10.0 111.35 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.27 -42.51 93.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.514 0.597 . . . . 10.0 111.037 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -62.09 -29.62 70.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.421 0.689 . . . . 10.0 111.011 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 t80 49.45 53.49 14.51 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 127.294 2.238 . . . . 10.0 113.489 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.22 -14.28 25.69 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.151 1.901 . . . . 10.0 112.264 174.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -149.13 164.64 34.11 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.023 1.729 . . . . 10.0 108.292 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -59.88 -31.32 69.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.564 1.546 . . . . 10.0 113.092 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -152.64 156.8 39.94 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.05 0.94 . . . . 10.0 108.553 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.0 139.15 27.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.781 -1.562 . . . . 10.0 106.781 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -147.52 165.45 30.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.388 1.075 . . . . 10.0 109.612 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 40.4 p-90 -145.75 162.09 38.42 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 118.285 0.493 . . . . 10.0 111.181 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -163.18 167.4 22.14 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.617 1.967 . . . . 10.0 107.361 169.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -78.36 48.26 0.75 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.414 0.685 . . . . 10.0 110.409 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.26 -19.25 65.48 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.565 1.146 . . . . 10.0 113.214 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.67 -173.62 41.54 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.51 -1.436 . . . . 10.0 109.51 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 . . . . . 0 C--O 1.257 1.498 0 C-N-CA 125.604 1.561 . . . . 10.0 107.474 -174.703 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 110.24 -0.282 . . . . 10.0 110.24 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.55 165.94 30.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.512 1.525 . . . . 10.0 108.467 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.88 171.22 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 126.11 1.764 . . . . 10.0 109.045 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.0 177.47 8.34 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.343 1.857 . . . . 10.0 108.543 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.95 153.66 35.65 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.651 1.18 . . . . 10.0 108.107 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.86 -20.39 56.82 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.902 0.881 . . . . 10.0 113.036 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.12 -23.59 63.98 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.605 1.093 . . . . 10.0 112.375 173.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -78.36 -7.84 57.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.557 0.743 . . . . 10.0 111.943 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -111.11 126.62 28.31 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 106.168 -1.79 . . . . 10.0 106.168 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -69.88 153.61 68.2 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.927 1.751 . . . . 10.0 109.992 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -81.51 -27.56 34.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.385 1.474 . . . . 10.0 112.642 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.8 t -134.84 133.62 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 124.995 1.318 . . . . 10.0 107.471 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -149.2 103.88 3.36 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.755 -1.572 . . . . 10.0 106.755 169.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.55 34.13 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.192 1.397 . . . . 10.0 110.108 -169.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -61.9 90.3 0.03 OUTLIER 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.441 1.496 . . . . 10.0 111.308 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.3 m -166.21 177.33 6.96 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.545 2.738 . . . . 10.0 108.301 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.19 143.35 30.26 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.87 1.268 . . . . 10.0 108.178 -173.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.57 -155.55 50.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.998 -1.241 . . . . 10.0 109.998 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.29 137.86 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 121.391 -1.064 . . . . 10.0 108.997 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -151.87 152.38 32.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.139 0.976 . . . . 10.0 109.784 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -74.36 152.3 39.58 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.711 0.805 . . . . 10.0 109.079 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.34 160.39 42.09 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.089 0.471 . . . . 10.0 110.308 173.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.22 141.67 43.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.548 -1.649 . . . . 10.0 106.548 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.7 tp -98.32 121.29 40.06 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.05 -2.204 . . . . 10.0 105.05 169.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.8 mt -129.33 135.57 61.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.582 -1.636 . . . . 10.0 106.582 -168.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -89.33 138.73 31.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.807 -1.923 . . . . 10.0 105.807 168.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 p -122.75 144.23 32.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.62 -1.622 . . . . 10.0 106.62 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -128.62 131.59 48.11 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.178 1.791 . . . . 10.0 106.713 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.5 p -78.17 140.11 38.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.824 0.284 . . . . 10.0 110.564 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.05 66.45 4.41 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.979 1.712 . . . . 10.0 107.182 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.36 -26.4 71.19 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.386 2.724 . . . . 10.0 113.131 -168.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.6 ptt85 -153.11 167.65 28.54 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.795 1.638 . . . . 10.0 107.167 168.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.2 m -58.53 137.76 57.21 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.23 27.54 60.41 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.06 0.838 . . . . 10.0 113.876 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.49 149.81 87.28 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 118.556 1.178 . . . . 10.0 110.884 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.45 35.7 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.987 3.125 . . . . 10.0 111.872 173.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.81 15.34 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.631 1.573 . . . . 10.0 108.516 -174.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.32 28.39 0.57 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.642 1.577 . . . . 10.0 109.547 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -67.21 157.15 34.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.953 0.901 . . . . 10.0 109.098 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 m -141.91 159.63 41.84 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.685 1.194 . . . . 10.0 109.838 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -152.26 176.09 11.95 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.469 1.108 . . . . 10.0 109.807 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -108.24 144.93 35.05 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.512 -0.921 . . . . 10.0 108.512 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.3 pt -137.19 148.78 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.855 1.662 . . . . 10.0 109.629 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.6 t -107.94 122.58 62.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.977 -1.86 . . . . 10.0 105.977 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -127.6 137.47 52.57 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.588 -1.634 . . . . 10.0 106.588 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.51 133.67 2.98 Favored Glycine 0 C--O 1.225 -0.428 0 CA-C-N 119.822 1.192 . . . . 10.0 111.624 174.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -146.01 140.49 26.88 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.019 0.438 . . . . 10.0 110.992 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -65.04 -28.31 69.39 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.242 1.017 . . . . 10.0 113.43 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -69.4 -16.41 63.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.502 -0.761 . . . . 10.0 112.386 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.67 122.35 15.08 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 118.869 0.759 . . . . 10.0 111.244 -173.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -69.55 -32.88 71.94 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.2 0.6 . . . . 10.0 110.201 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -148.47 163.64 36.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.668 1.987 . . . . 10.0 107.617 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -58.92 -38.07 78.12 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.653 -0.655 . . . . 10.0 110.697 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.56 -21.31 66.27 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -67.31 -39.06 85.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.729 0.776 . . . . 10.0 109.477 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.42 -53.1 46.94 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 173.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -58.3 -42.07 85.85 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 119.155 -0.45 . . . . 10.0 111.353 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.72 -45.58 85.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.287 0.494 . . . . 10.0 111.597 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -58.94 -49.55 77.41 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.377 0.671 . . . . 10.0 109.438 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.19 -47.47 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.873 0.869 . . . . 10.0 109.122 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -59.83 -35.09 74.02 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.264 0.938 . . . . 10.0 111.325 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.36 -49.31 75.39 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.646 -0.982 . . . . 10.0 110.646 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.48 -45.87 92.44 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 117.873 0.836 . . . . 10.0 111.329 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -37.43 83.34 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.635 -0.697 . . . . 10.0 110.863 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -64.56 -35.9 82.48 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.049 0.84 . . . . 10.0 110.962 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.97 -32.0 72.94 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.085 -0.959 . . . . 10.0 111.721 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -68.63 -57.99 4.92 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.079 0.854 . . . . 10.0 109.172 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.12 41.8 0.17 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.43 1.49 . . . . 10.0 110.198 -169.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.7 m -142.87 171.69 13.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.679 1.592 . . . . 10.0 109.262 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -140.23 164.07 31.04 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.043 1.737 . . . . 10.0 108.176 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.7 m -130.09 163.82 25.74 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.517 1.127 . . . . 10.0 112.299 -169.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -148.19 118.41 7.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.892 -1.892 . . . . 10.0 105.892 171.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 p -66.03 129.04 38.44 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.929 -1.107 . . . . 10.0 109.119 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 mt -93.13 -23.67 18.52 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.598 0.359 . . . . 10.0 110.461 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.3 -178.22 34.64 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.388 -1.485 . . . . 10.0 109.388 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.2 -177.74 22.78 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 118.233 1.017 . . . . 10.0 112.403 176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.67 -159.35 23.45 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.7 -1.76 . . . . 10.0 108.7 -170.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mtm105 -138.8 161.88 36.14 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.36 -1.082 . . . . 10.0 108.475 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 mt -136.22 146.42 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.66 -1.978 . . . . 10.0 105.66 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.1 t -151.64 174.16 13.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.023 0.929 . . . . 10.0 109.41 171.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -158.65 158.01 32.97 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.614 1.966 . . . . 10.0 107.462 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 47.81 45.82 18.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.01 1.324 . . . . 10.0 111.092 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.0 p -150.46 -93.63 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.923 0.889 . . . . 10.0 109.769 -169.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -67.11 -29.3 69.0 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.748 1.219 . . . . 10.0 110.208 172.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -152.44 164.35 37.71 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.679 1.991 . . . . 10.0 106.477 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -72.82 -60.79 2.06 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.05 164.71 17.24 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 123.448 0.468 . . . . 10.0 110.576 176.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.6 mt -57.92 136.94 20.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -136.91 126.91 25.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.675 -1.602 . . . . 10.0 106.675 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.35 146.33 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 105.639 -1.985 . . . . 10.0 105.639 173.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -154.99 171.53 19.58 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.763 -1.21 . . . . 10.0 111.2 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.74 -160.5 54.07 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 121.535 0.519 . . . . 10.0 112.392 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -148.71 -177.41 5.77 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.625 1.57 . . . . 10.0 108.289 173.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.7 t -109.96 131.17 55.3 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 124.899 1.28 . . . . 10.0 107.865 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.3 mtt -72.58 -18.8 61.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.999 -0.524 . . . . 10.0 111.391 171.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.91 -35.8 72.44 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.909 0.777 . . . . 10.0 110.99 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -132.97 -43.77 0.87 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.9 0.48 . . . . 10.0 112.103 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.22 -178.36 18.84 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.013 -1.635 . . . . 10.0 109.013 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.01 136.65 62.3 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.307 2.005 . . . . 10.0 110.499 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.14 162.14 20.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 166.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -79.41 69.93 5.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.167 -1.79 . . . . 10.0 106.167 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -50.94 -31.0 16.36 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.467 1.507 . . . . 10.0 113.111 -168.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.7 -37.66 73.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.276 0.944 . . . . 10.0 112.326 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.73 -50.43 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 107.293 -1.373 . . . . 10.0 107.293 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -58.56 -45.78 88.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.553 -0.737 . . . . 10.0 111.792 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -63.79 -38.12 89.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 117.754 -1.117 . . . . 10.0 110.976 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.13 -41.39 94.85 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.014 1.279 . . . . 10.0 111.227 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -65.11 -48.1 74.81 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.046 -0.409 . . . . 10.0 109.909 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.7 mt -61.38 -42.32 93.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -58.83 -37.88 77.41 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.328 1.051 . . . . 10.0 111.081 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.76 89.79 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.687 0.676 . . . . 10.0 110.969 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -71.84 -44.38 63.94 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.746 0.703 . . . . 10.0 112.049 175.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -60.91 144.31 90.49 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.428 1.091 . . . . 10.0 110.088 -170.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -75.0 -1.8 11.7 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.751 2.301 . . . . 10.0 113.382 -173.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -139.93 153.91 47.07 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.028 1.331 . . . . 10.0 107.669 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -81.93 46.17 0.98 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.081 1.352 . . . . 10.0 111.474 -169.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.23 91.55 2.57 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.879 0.847 . . . . 10.0 110.878 -169.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.1 t -138.24 142.44 35.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.029 -2.211 . . . . 10.0 105.029 169.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 p -138.96 167.28 22.39 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.075 0.95 . . . . 10.0 109.928 -172.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -139.06 161.22 37.92 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 123.128 0.571 . . . . 10.0 110.882 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.72 163.21 38.01 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.588 1.555 . . . . 10.0 108.587 169.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -147.76 46.25 1.1 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.854 0.861 . . . . 10.0 109.617 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.66 -27.06 68.96 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.574 0.75 . . . . 10.0 112.621 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -174.68 179.95 45.67 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.472 1.986 . . . . 10.0 108.384 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.5 t80 . . . . . 0 C--O 1.254 1.309 0 CA-C-O 116.573 -1.679 . . . . 10.0 109.36 176.418 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 118.854 -0.593 . . . . 10.0 110.302 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.27 165.33 36.06 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.495 1.518 . . . . 10.0 108.699 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.75 167.19 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.979 0.912 . . . . 10.0 110.609 172.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.87 169.39 6.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.008 0.523 . . . . 10.0 111.82 177.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -154.51 148.84 26.08 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.9 mt -58.13 -28.89 65.09 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.645 -0.659 . . . . 10.0 112.664 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.81 -26.47 68.35 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.93 0.786 . . . . 10.0 112.094 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.23 -24.71 46.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.923 0.489 . . . . 10.0 110.897 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.99 122.18 86.21 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 106.804 -1.554 . . . . 10.0 106.804 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -50.28 133.16 35.84 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.106 2.537 . . . . 10.0 110.169 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.0 -29.25 39.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.677 0.751 . . . . 10.0 111.442 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.3 t -137.74 135.9 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 127.176 2.19 . . . . 10.0 105.733 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -150.78 99.7 2.75 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.149 -1.426 . . . . 10.0 107.149 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt -131.38 36.59 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.055 1.342 . . . . 10.0 110.436 -168.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -66.56 81.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.471 1.508 . . . . 10.0 112.063 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -164.12 178.38 7.68 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.935 2.494 . . . . 10.0 108.332 174.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -147.98 158.51 44.09 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.602 1.161 . . . . 10.0 108.553 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.31 -162.64 51.32 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 109.587 -1.405 . . . . 10.0 109.587 -169.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.47 123.26 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.947 -1.871 . . . . 10.0 105.947 169.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -135.55 14.66 3.43 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.89 1.811 . . . . 10.0 115.89 -171.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mttp 56.26 159.39 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.646 1.978 . . . . 10.0 112.89 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.52 158.19 28.78 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 120.493 -1.38 . . . . 10.0 109.481 169.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.1 p -138.01 148.8 24.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.735 1.214 . . . . 10.0 107.949 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.73 118.88 37.7 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 105.574 -2.01 . . . . 10.0 105.574 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.0 mt -123.69 125.8 71.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 -169.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -76.97 131.72 38.64 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 168.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 p -119.88 135.22 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.864 -1.532 . . . . 10.0 106.864 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -114.65 150.67 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.448 1.899 . . . . 10.0 107.462 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 p -111.72 142.05 44.55 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -172.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.48 65.97 5.61 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 126.422 1.889 . . . . 10.0 106.594 168.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -41.48 133.27 3.5 Favored 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 125.467 4.111 . . . . 10.0 114.201 -168.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 50.3 23.88 1.34 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.39 1.476 . . . . 10.0 113.073 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m 51.92 32.84 10.52 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.992 1.317 . . . . 10.0 111.871 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.25 26.34 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.455 -0.636 . . . . 10.0 112.827 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.77 131.27 9.93 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 172.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -86.54 32.99 0.44 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 124.594 3.53 . . . . 10.0 112.747 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.01 83.81 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.623 0.769 . . . . 10.0 112.386 -168.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.11 28.46 2.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.543 1.937 . . . . 10.0 114.932 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -78.5 160.41 27.68 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 167.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 m -143.58 156.27 44.54 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.438 -0.789 . . . . 10.0 110.584 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -146.22 -175.47 4.78 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.989 1.316 . . . . 10.0 109.435 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -116.68 147.83 41.6 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.961 -1.126 . . . . 10.0 107.961 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.45 147.62 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.783 1.233 . . . . 10.0 110.111 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.66 125.91 64.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 106.79 -1.559 . . . . 10.0 106.79 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -133.83 141.31 47.37 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 107.125 -1.435 . . . . 10.0 107.125 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.48 124.86 1.14 Allowed Glycine 0 C--O 1.226 -0.382 0 CA-C-N 120.228 1.376 . . . . 10.0 111.52 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -144.72 135.75 24.98 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 117.262 0.531 . . . . 10.0 110.938 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -66.0 -26.24 67.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 118.292 -0.861 . . . . 10.0 113.05 -170.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -63.55 -20.37 65.58 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.111 0.869 . . . . 10.0 112.715 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.98 120.64 14.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.212 0.915 . . . . 10.0 109.691 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.89 -34.24 77.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.01 0.524 . . . . 10.0 110.139 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -147.19 158.29 43.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.724 2.01 . . . . 10.0 107.196 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.527 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 68.5 m80 -58.53 -29.05 66.03 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.918 0.71 . . . . 10.0 112.918 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.67 -28.75 64.05 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 123.203 0.601 . . . . 10.0 112.545 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -74.18 -30.68 62.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.612 0.642 . . . . 10.0 110.973 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -65.76 -52.24 52.42 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 172.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -53.82 -43.27 69.27 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 118.629 -0.7 . . . . 10.0 111.16 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.63 -44.44 93.86 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.728 0.695 . . . . 10.0 111.773 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -60.1 -51.55 69.13 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.141 -0.689 . . . . 10.0 109.141 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.4 t -68.96 -47.8 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 118.904 -0.57 . . . . 10.0 109.912 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.8 p -60.59 -31.63 70.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.472 1.033 . . . . 10.0 111.527 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.34 -50.1 71.3 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.728 -0.949 . . . . 10.0 110.728 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.7 -44.52 93.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.668 0.734 . . . . 10.0 111.5 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -40.01 83.04 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.685 0.675 . . . . 10.0 110.705 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -63.37 -35.66 81.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.16 0.891 . . . . 10.0 111.118 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -65.67 -30.84 71.58 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 117.833 -1.079 . . . . 10.0 111.682 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -74.38 -38.12 63.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.797 1.181 . . . . 10.0 111.055 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.47 57.68 0.83 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 107.202 -2.359 . . . . 10.0 107.202 -168.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.0 m -146.07 169.14 19.29 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.262 1.825 . . . . 10.0 108.102 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -139.61 160.85 38.92 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.39 1.476 . . . . 10.0 108.635 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.0 m -131.19 155.09 47.65 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.496 1.118 . . . . 10.0 112.337 -168.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -149.86 118.86 6.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.884 1.674 . . . . 10.0 106.708 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.9 m -68.03 123.95 22.04 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.005 -1.059 . . . . 10.0 109.153 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.3 mt -81.08 -23.92 38.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.875 0.47 . . . . 10.0 110.726 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.98 176.72 36.92 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.204 -1.559 . . . . 10.0 109.204 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.05 178.5 23.72 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 118.223 1.011 . . . . 10.0 112.109 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.23 -144.74 4.65 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 107.981 -2.048 . . . . 10.0 107.981 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -151.55 149.48 29.23 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 120.898 -1.354 . . . . 10.0 110.44 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.1 mt -108.56 148.04 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 105.121 -2.178 . . . . 10.0 105.121 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -151.65 -179.92 7.84 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.311 1.044 . . . . 10.0 109.121 171.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -114.17 116.56 29.27 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.408 1.483 . . . . 10.0 107.033 175.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -79.21 81.59 5.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.9 m -56.89 -28.66 62.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.465 0.706 . . . . 10.0 112.65 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -58.66 -19.96 43.91 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.585 0.957 . . . . 10.0 113.585 172.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -132.3 11.67 4.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.782 1.633 . . . . 10.0 110.912 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt 39.68 46.73 1.61 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.993 2.517 . . . . 10.0 113.709 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -147.64 159.11 44.14 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 118.688 0.676 . . . . 10.0 111.619 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.5 pt -85.1 148.48 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.643 0.735 . . . . 10.0 110.735 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -149.13 163.36 37.81 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.105 0.962 . . . . 10.0 109.017 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -136.5 140.55 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.912 0.885 . . . . 10.0 108.66 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -157.5 -175.34 5.34 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.962 0.905 . . . . 10.0 109.98 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.63 -177.64 53.42 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 123.401 0.524 . . . . 10.0 113.012 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.31 -178.98 5.53 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.093 0.957 . . . . 10.0 110.184 169.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.527 ' HG ' ' CE1' ' A' ' 53' ' ' HIS . 22.8 m -133.52 107.43 8.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.212 -1.773 . . . . 10.0 106.212 174.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 77.2 mtm -59.74 -21.42 60.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.795 0.665 . . . . 10.0 112.795 -172.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.68 -26.36 67.05 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.802 0.841 . . . . 10.0 112.841 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -134.9 -50.68 0.77 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.489 0.716 . . . . 10.0 111.231 -169.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.08 175.32 13.79 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.198 1.856 . . . . 10.0 108.981 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -54.81 133.8 59.49 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.467 2.111 . . . . 10.0 110.271 169.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.08 156.07 29.41 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.526 1.155 . . . . 10.0 109.413 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -82.42 65.33 7.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.283 -1.747 . . . . 10.0 106.283 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -51.81 -24.66 6.36 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.374 1.87 . . . . 10.0 114.012 -168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.93 91.08 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.028 1.285 . . . . 10.0 111.392 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.3 mt -63.54 -50.91 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -61.51 -46.5 89.73 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.185 0.594 . . . . 10.0 111.874 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 p -65.37 -38.18 89.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.741 0.701 . . . . 10.0 110.966 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.02 -42.11 76.82 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.149 0.886 . . . . 10.0 110.985 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -59.96 -47.96 83.68 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.671 -0.681 . . . . 10.0 110.143 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.3 mt -56.93 -52.34 56.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 108.112 -1.07 . . . . 10.0 108.112 175.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -56.2 -40.52 74.13 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.324 0.966 . . . . 10.0 111.25 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.43 -50.88 49.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.037 0.535 . . . . 10.0 111.82 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -86.94 -26.52 23.83 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.93 0.786 . . . . 10.0 112.749 -169.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -141.1 71.81 27.8 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.666 1.987 . . . . 10.0 107.165 -172.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.4 153.56 65.07 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.218 1.945 . . . . 10.0 111.142 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -149.97 179.89 7.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.878 1.671 . . . . 10.0 107.123 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -59.62 -39.4 84.15 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.192 0.905 . . . . 10.0 110.594 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -159.33 157.44 30.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.189 -1.412 . . . . 10.0 107.189 173.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.86 113.7 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 106.197 -1.779 . . . . 10.0 106.197 172.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.2 p -138.43 174.52 10.45 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.211 1.004 . . . . 10.0 109.421 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -142.76 159.7 41.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.251 0.62 . . . . 10.0 109.726 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.21 162.67 36.28 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.433 1.493 . . . . 10.0 107.979 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.15 52.58 1.83 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.975 -0.75 . . . . 10.0 108.975 169.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.85 -25.7 63.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.36 1.064 . . . . 10.0 111.86 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.36 172.28 38.43 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 127.15 2.31 . . . . 10.0 107.388 169.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 117.862 -1.066 . . . . 10.0 108.865 172.083 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 118.371 -0.824 . . . . 10.0 109.955 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.08 168.86 26.21 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.369 1.868 . . . . 10.0 107.729 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -64.25 160.86 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.032 0.444 . . . . 10.0 110.487 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.34 177.64 10.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.347 1.859 . . . . 10.0 108.787 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -149.21 149.81 31.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.155 1.382 . . . . 10.0 107.872 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.5 mt -58.68 -25.51 62.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.364 1.066 . . . . 10.0 113.024 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.89 -24.23 65.81 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.64 0.655 . . . . 10.0 112.34 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -75.47 -16.67 60.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.271 0.628 . . . . 10.0 111.494 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.5 mt -93.62 120.23 66.43 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.0 -1.482 . . . . 10.0 107.0 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.35 136.24 39.46 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.497 2.798 . . . . 10.0 110.551 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -78.08 -28.16 48.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.392 0.615 . . . . 10.0 111.832 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.2 t -139.22 135.11 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 104.262 -2.496 . . . . 10.0 104.262 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -153.39 119.93 5.58 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.608 -1.627 . . . . 10.0 106.608 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.9 pt -143.72 161.41 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.764 1.226 . . . . 10.0 109.171 -170.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -150.73 107.72 3.57 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.791 -1.559 . . . . 10.0 106.791 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 m -159.06 163.23 36.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.981 1.313 . . . . 10.0 109.536 -173.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -149.68 18.13 0.91 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 123.082 1.42 . . . . 10.0 110.708 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.42 -164.24 35.89 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.168 -1.973 . . . . 10.0 108.168 -171.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.45 120.47 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 117.922 0.861 . . . . 10.0 109.756 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -145.35 148.62 33.59 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.488 1.115 . . . . 10.0 109.265 169.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -63.65 150.9 43.18 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.017 0.927 . . . . 10.0 110.319 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.402 ' HH ' ' CD2' ' A' ' 102' ' ' HIS . 0.2 OUTLIER -146.78 168.26 21.83 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.703 1.201 . . . . 10.0 109.037 178.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.74 150.07 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.355 1.062 . . . . 10.0 108.661 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -114.16 121.92 45.25 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.375 -2.084 . . . . 10.0 105.375 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.5 mt -130.32 136.42 58.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.202 -1.406 . . . . 10.0 107.202 -169.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -91.65 139.2 30.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.74 -1.578 . . . . 10.0 106.74 166.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.53 141.33 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.123 -1.806 . . . . 10.0 106.123 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -122.37 135.84 54.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.98 1.712 . . . . 10.0 107.217 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.2 m -63.12 135.17 57.03 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.008 -0.367 . . . . 10.0 110.008 174.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.41 52.7 1.0 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.348 1.459 . . . . 10.0 110.077 168.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.66 -13.07 36.87 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.188 3.258 . . . . 10.0 115.123 -167.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -139.52 13.72 2.55 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.719 -1.238 . . . . 10.0 110.755 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m 48.33 33.98 4.26 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.344 1.058 . . . . 10.0 112.018 -168.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.32 64.82 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 N-CA-C 108.132 -1.987 . . . . 10.0 108.132 -168.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.97 157.12 77.72 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 125.231 1.412 . . . . 10.0 108.964 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.92 39.53 0.66 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 124.309 3.339 . . . . 10.0 112.121 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.93 104.92 3.74 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.978 1.711 . . . . 10.0 107.014 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.81 28.92 1.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.488 1.515 . . . . 10.0 110.28 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.413 ' C ' ' HG ' ' A' ' 40' ' ' SER . 44.0 mt-10 -66.73 174.57 2.82 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.2 1.0 . . . . 10.0 109.911 173.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.413 ' HG ' ' C ' ' A' ' 39' ' ' GLU . 9.8 m -152.39 159.71 43.38 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 120.193 -1.567 . . . . 10.0 110.423 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -149.63 168.52 23.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.647 1.179 . . . . 10.0 109.565 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -99.9 150.67 22.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.9 pt -138.9 156.04 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 125.795 1.638 . . . . 10.0 109.889 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.39 130.35 62.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -133.35 141.16 47.79 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.02 1.328 . . . . 10.0 107.952 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.72 100.85 0.15 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 110.029 -1.229 . . . . 10.0 110.029 -171.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -130.4 131.87 45.48 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 118.236 1.018 . . . . 10.0 110.371 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -59.56 -25.51 64.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.198 1.184 . . . . 10.0 114.198 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -68.32 -20.62 64.75 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.494 1.043 . . . . 10.0 112.279 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.42 137.68 58.01 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.221 0.919 . . . . 10.0 111.428 -171.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.08 -40.95 87.11 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.679 -0.691 . . . . 10.0 109.231 170.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -155.92 170.67 21.57 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 126.125 1.77 . . . . 10.0 108.922 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -48.66 -36.31 15.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.977 1.311 . . . . 10.0 112.002 167.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.49 -28.02 66.66 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.948 0.721 . . . . 10.0 112.948 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -67.32 -41.94 84.45 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.18 0.991 . . . . 10.0 108.671 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.6 mt -62.0 -51.36 73.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 108.541 -0.911 . . . . 10.0 108.541 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -55.64 -43.49 76.25 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.679 -0.677 . . . . 10.0 111.598 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -62.58 -48.18 80.57 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.369 0.531 . . . . 10.0 111.726 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.54 -49.5 77.29 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.668 -0.645 . . . . 10.0 109.826 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.4 -42.65 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.609 -0.885 . . . . 10.0 108.609 -172.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.7 m -58.58 -36.38 73.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.558 1.072 . . . . 10.0 111.447 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.11 -47.09 91.33 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.803 -0.919 . . . . 10.0 110.803 172.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.09 -47.29 86.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.838 0.819 . . . . 10.0 111.459 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -36.72 82.01 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.338 -0.839 . . . . 10.0 110.74 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -64.35 -36.61 84.68 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.998 0.817 . . . . 10.0 111.004 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -67.96 -31.74 71.68 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.867 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -67.6 -56.79 8.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 119.294 0.952 . . . . 10.0 108.807 175.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.73 41.39 0.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.047 1.308 . . . . 10.0 110.528 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.3 m -144.0 173.63 11.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.837 1.655 . . . . 10.0 109.325 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -139.27 164.24 30.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.421 1.488 . . . . 10.0 108.205 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.2 m -125.22 161.55 26.66 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.567 1.147 . . . . 10.0 112.382 -168.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -149.11 109.8 4.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.817 2.047 . . . . 10.0 105.755 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 p -61.45 136.85 58.18 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.031 -1.043 . . . . 10.0 109.627 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.9 mt -110.19 -12.2 14.5 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.425 0.69 . . . . 10.0 111.235 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.86 -178.51 29.94 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.2 -1.16 . . . . 10.0 110.2 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.05 -179.24 22.97 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.841 -0.904 . . . . 10.0 110.841 168.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.1 -153.48 9.89 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.492 -1.843 . . . . 10.0 108.492 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -134.69 132.74 39.24 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 123.995 0.918 . . . . 10.0 108.61 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.17 119.56 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 104.567 -2.382 . . . . 10.0 104.567 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 m -84.23 83.95 7.79 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.266 -2.124 . . . . 10.0 105.266 167.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -64.61 163.75 13.14 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 122.085 -0.384 . . . . 10.0 110.786 -174.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -53.51 145.8 14.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.716 0.806 . . . . 10.0 109.354 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.4 p -149.61 -58.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.408 0.623 . . . . 10.0 110.911 -169.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -151.68 58.5 0.87 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.644 -1.243 . . . . 10.0 107.644 -173.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t0 53.54 61.3 3.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.38 1.472 . . . . 10.0 111.652 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -125.58 -5.76 7.0 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.101 1.36 . . . . 10.0 112.47 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.332 0.0 OUTLIER 62.76 162.37 0.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.826 2.45 . . . . 10.0 112.934 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.8 mt -74.58 134.78 28.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.919 -1.141 . . . . 10.0 107.919 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -133.51 159.59 39.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.163 -1.421 . . . . 10.0 107.163 169.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 t -140.38 140.69 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 O-C-N 120.749 -1.219 . . . . 10.0 107.939 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -156.32 -177.89 6.92 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.877 0.871 . . . . 10.0 110.908 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.61 -166.4 50.77 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.922 -0.471 . . . . 10.0 111.922 169.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -157.18 173.43 16.99 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.785 1.234 . . . . 10.0 108.972 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.6 m -128.39 104.06 7.5 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.592 -1.262 . . . . 10.0 107.592 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 66.8 mtt -57.24 -24.27 53.59 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.36 1.064 . . . . 10.0 113.565 -170.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.24 -29.94 70.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.6 -0.714 . . . . 10.0 112.427 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -129.17 -45.82 1.24 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.663 0.785 . . . . 10.0 110.716 -171.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.97 174.33 13.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.768 1.651 . . . . 10.0 109.595 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -56.36 124.36 16.06 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.337 2.024 . . . . 10.0 109.631 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.69 159.49 13.34 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.778 0.799 . . . . 10.0 109.178 168.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -84.83 72.04 10.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.953 -1.499 . . . . 10.0 106.953 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.402 ' CD2' ' HH ' ' A' ' 22' ' ' TYR . 61.6 m80 -52.37 -25.14 8.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.132 1.373 . . . . 10.0 114.133 -169.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.76 99.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.96 1.255 . . . . 10.0 111.617 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.75 -50.95 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 107.528 -1.286 . . . . 10.0 107.528 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -56.79 -48.47 77.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.29 0.636 . . . . 10.0 111.588 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 p -68.89 -37.25 78.88 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.01 -0.995 . . . . 10.0 111.688 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -65.65 -39.79 91.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.499 1.045 . . . . 10.0 110.404 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -62.65 -48.7 78.17 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 119.16 -0.448 . . . . 10.0 110.103 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.0 mt -57.79 -42.39 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.219 0.918 . . . . 10.0 108.584 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -64.03 -37.63 88.12 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.535 1.062 . . . . 10.0 111.22 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.03 92.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.689 0.677 . . . . 10.0 111.067 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.16 -30.39 71.02 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.467 0.707 . . . . 10.0 111.073 173.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 t80 49.63 53.23 14.04 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 127.483 2.313 . . . . 10.0 113.426 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.24 -14.42 28.49 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.021 1.814 . . . . 10.0 112.295 174.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -149.62 164.92 33.82 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.198 1.799 . . . . 10.0 108.514 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -58.21 -34.82 70.81 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.433 1.493 . . . . 10.0 113.457 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -151.94 155.72 38.63 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.892 0.769 . . . . 10.0 109.96 -172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 t -141.8 137.07 31.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.111 -1.441 . . . . 10.0 107.111 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.2 p -142.55 170.48 15.63 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.514 1.126 . . . . 10.0 109.832 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -147.84 166.67 26.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.236 0.471 . . . . 10.0 111.106 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.09 176.88 10.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.026 2.13 . . . . 10.0 107.563 169.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.26 37.68 0.7 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.862 -1.149 . . . . 10.0 111.919 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.23 -26.57 64.98 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.392 1.077 . . . . 10.0 113.167 -176.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -174.01 177.97 46.06 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.751 -0.939 . . . . 10.0 110.751 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 60.7 t80 . . . . . 0 C--O 1.246 0.909 0 C-N-CA 124.01 0.924 . . . . 10.0 109.896 173.409 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 118.743 -0.646 . . . . 10.0 109.839 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.28 26.05 2.41 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.282 1.033 . . . . 10.0 112.269 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.9 m -69.94 173.99 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 125.12 1.368 . . . . 10.0 110.632 169.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.62 -178.05 6.04 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.934 1.694 . . . . 10.0 107.73 171.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -148.11 151.9 36.41 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.721 -1.214 . . . . 10.0 107.721 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.13 -30.16 61.73 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.618 0.767 . . . . 10.0 112.837 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.46 -28.45 69.67 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.704 0.683 . . . . 10.0 112.149 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -77.41 -28.82 52.77 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.844 0.458 . . . . 10.0 110.621 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.3 mt -69.91 122.06 84.79 Favored Pre-proline 0 C--O 1.24 0.557 0 N-CA-C 107.519 -1.289 . . . . 10.0 107.519 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.2 135.79 38.22 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.315 2.677 . . . . 10.0 110.341 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.23 -29.54 38.46 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.529 0.681 . . . . 10.0 111.35 -173.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -137.8 136.77 45.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 104.707 -2.331 . . . . 10.0 104.707 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -152.03 122.68 7.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.247 -1.76 . . . . 10.0 106.247 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.5 pt -143.61 160.8 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.65 1.18 . . . . 10.0 109.393 -169.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -141.94 126.3 17.65 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.2 1.0 . . . . 10.0 108.372 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -124.05 176.12 6.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.185 1.394 . . . . 10.0 111.381 -166.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -157.69 -36.71 0.07 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.479 1.512 . . . . 10.0 109.821 168.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.47 -48.18 0.03 OUTLIER Glycine 0 C--N 1.339 0.724 0 N-CA-C 109.896 -1.282 . . . . 10.0 109.896 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -128.37 142.68 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.047 2.139 . . . . 10.0 106.251 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -154.07 154.27 33.37 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.852 0.751 . . . . 10.0 110.66 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -86.96 151.22 23.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.508 1.123 . . . . 10.0 108.32 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.28 159.92 42.29 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.99 0.516 . . . . 10.0 110.479 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.94 140.53 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 125.694 1.598 . . . . 10.0 107.746 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -98.24 119.98 37.85 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 105.513 -2.032 . . . . 10.0 105.513 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.7 mt -124.08 132.99 70.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.52 -1.659 . . . . 10.0 106.52 -171.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -86.78 132.5 33.83 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.16 -1.793 . . . . 10.0 106.16 168.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.67 139.87 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.604 -1.258 . . . . 10.0 107.604 171.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -114.31 123.75 50.28 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.222 -2.14 . . . . 10.0 105.222 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.7 p -68.89 145.24 53.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.794 0.27 . . . . 10.0 110.49 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.35 67.81 3.09 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.206 1.802 . . . . 10.0 106.354 168.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -54.71 127.47 26.29 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.064 2.509 . . . . 10.0 110.872 -170.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 37.03 39.06 0.11 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.582 1.953 . . . . 10.0 113.407 -169.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 m 51.6 30.98 7.12 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.796 1.639 . . . . 10.0 113.696 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.2 -19.54 0.02 OUTLIER Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.242 -1.31 . . . . 10.0 116.26 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.94 149.83 95.99 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 120.277 2.039 . . . . 10.0 110.764 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.63 61.59 8.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.418 3.412 . . . . 10.0 111.657 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.49 139.11 35.06 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.854 1.262 . . . . 10.0 108.536 175.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.06 28.05 0.68 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.752 1.221 . . . . 10.0 110.98 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -67.98 164.51 19.83 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.421 -0.799 . . . . 10.0 109.232 171.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -139.61 159.22 42.67 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.899 0.88 . . . . 10.0 110.802 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -150.19 171.48 16.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.216 1.007 . . . . 10.0 109.907 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.29 150.23 21.77 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.345 -0.983 . . . . 10.0 108.345 172.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.3 pt -137.14 150.76 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 125.461 1.504 . . . . 10.0 109.559 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.09 126.15 63.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -132.92 134.97 45.26 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.29 117.45 0.65 Allowed Glycine 0 C--O 1.225 -0.462 0 CA-C-N 119.46 1.027 . . . . 10.0 110.866 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -138.38 132.03 30.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 -172.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -60.14 -18.16 45.57 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 114.67 1.359 . . . . 10.0 114.67 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -67.1 -28.01 67.81 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.27 1.395 . . . . 10.0 112.139 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.71 153.93 30.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.712 1.142 . . . . 10.0 109.419 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.31 -6.91 2.61 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.553 0.741 . . . . 10.0 111.821 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.92 12.63 3.64 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 118.885 0.766 . . . . 10.0 112.767 -168.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 63.38 -46.57 0.23 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.285 2.634 . . . . 10.0 114.792 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.07 -30.17 67.86 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.024 0.929 . . . . 10.0 111.363 -178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.12 -32.74 74.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 117.938 0.335 . . . . 10.0 111.533 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -67.91 -55.41 16.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 107.326 -1.361 . . . . 10.0 107.326 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.58 -39.42 67.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.256 0.622 . . . . 10.0 111.603 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -61.54 -50.75 71.41 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.304 1.041 . . . . 10.0 111.712 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -45.52 93.12 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.713 -0.617 . . . . 10.0 110.218 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.86 -46.04 93.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -59.1 -36.15 74.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.746 1.157 . . . . 10.0 111.377 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.62 -51.33 54.97 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 174.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.24 -45.21 94.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.525 0.662 . . . . 10.0 111.349 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -34.67 78.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.136 -0.935 . . . . 10.0 110.719 -175.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -65.78 -37.38 86.17 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.613 1.097 . . . . 10.0 110.648 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -62.65 -37.17 85.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 117.681 -1.152 . . . . 10.0 110.919 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -66.78 -52.64 41.7 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.409 1.004 . . . . 10.0 109.646 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.04 51.12 0.25 Allowed Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.475 1.512 . . . . 10.0 109.403 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.3 m -143.68 167.71 21.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.814 1.646 . . . . 10.0 108.486 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -129.62 161.97 29.35 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.03 1.732 . . . . 10.0 107.141 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.2 m -125.34 160.04 30.31 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.669 1.187 . . . . 10.0 112.017 -168.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -148.83 115.38 5.92 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.866 -1.901 . . . . 10.0 105.866 170.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.83 115.11 6.24 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.904 -1.123 . . . . 10.0 108.466 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.7 mt -77.54 -29.26 52.23 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.821 -0.549 . . . . 10.0 110.355 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.76 -177.53 38.82 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.071 -1.611 . . . . 10.0 109.071 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.68 -178.18 29.63 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 118.259 1.029 . . . . 10.0 111.178 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.5 -158.37 17.59 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.531 -1.428 . . . . 10.0 109.531 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 mtm180 -131.8 154.52 49.03 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.54 -0.976 . . . . 10.0 108.476 -177.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.9 mt -134.29 140.55 45.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 104.302 -2.481 . . . . 10.0 104.302 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 m -151.88 151.73 31.66 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.908 -1.12 . . . . 10.0 110.273 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -77.92 123.28 26.58 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.057 -1.831 . . . . 10.0 106.057 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 50.73 54.13 11.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.188 0.995 . . . . 10.0 113.583 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.1 p -56.49 -54.44 45.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.496 0.665 . . . . 10.0 109.905 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -157.68 51.88 0.45 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.403 2.281 . . . . 10.0 105.291 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -150.4 166.45 30.05 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.88 1.272 . . . . 10.0 108.526 -167.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -80.35 -21.59 42.29 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.059 1.344 . . . . 10.0 111.51 171.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.92 -175.27 4.34 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.653 1.581 . . . . 10.0 109.775 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.2 pt -62.28 145.63 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 119.875 1.216 . . . . 10.0 110.848 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -140.2 147.87 40.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.368 -1.345 . . . . 10.0 107.368 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.84 134.77 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.415 -1.328 . . . . 10.0 107.415 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -159.27 -179.69 8.2 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.175 -0.953 . . . . 10.0 111.046 -168.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.8 -158.39 53.08 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.053 0.835 . . . . 10.0 112.981 170.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -150.72 167.82 26.23 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.594 1.158 . . . . 10.0 108.558 172.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.7 p -68.53 -28.67 67.19 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.6 ttm 53.93 29.53 10.13 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.206 0.603 . . . . 10.0 110.159 -167.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.29 -32.42 0.6 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.738 1.215 . . . . 10.0 111.876 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.38 -46.13 0.56 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.215 0.606 . . . . 10.0 110.205 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.41 177.16 31.24 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.111 1.815 . . . . 10.0 109.598 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.99 138.36 56.79 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.511 2.14 . . . . 10.0 110.458 172.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.71 160.97 24.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 166.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -81.31 75.54 8.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.682 -1.599 . . . . 10.0 106.682 169.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -54.48 -24.31 19.89 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.901 1.28 . . . . 10.0 113.528 -169.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.5 99.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.651 1.114 . . . . 10.0 111.705 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.1 mt -64.51 -52.07 59.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 106.988 -1.486 . . . . 10.0 106.988 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 m -57.46 -45.79 84.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.511 -0.757 . . . . 10.0 112.092 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 p -66.24 -37.82 86.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 117.722 -1.132 . . . . 10.0 111.721 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -64.45 -41.21 96.67 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.965 1.257 . . . . 10.0 110.6 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -63.89 -47.55 80.17 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.103 -0.373 . . . . 10.0 110.265 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.31 -38.9 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.415 -0.957 . . . . 10.0 108.415 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -62.32 -38.11 88.17 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 120.556 -1.34 . . . . 10.0 111.239 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.39 -31.02 71.91 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.713 0.688 . . . . 10.0 112.228 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -74.38 -21.93 59.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.327 1.051 . . . . 10.0 111.649 172.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.278 45.0 p90 43.76 48.09 3.85 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 128.318 2.647 . . . . 10.0 116.425 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.28 174.97 9.98 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.485 1.456 . . . . 10.0 109.724 167.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 t70 49.1 -120.91 1.46 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 117.501 -1.238 . . . . 10.0 110.331 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -133.48 -35.48 1.01 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.346 1.43 . . . . 10.0 112.812 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -163.87 164.68 23.35 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 105.78 -1.933 . . . . 10.0 105.78 -173.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.61 135.05 39.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 119.343 0.974 . . . . 10.0 108.984 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.5 p -144.7 170.07 16.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.428 1.491 . . . . 10.0 109.041 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -143.98 168.89 18.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.175 0.59 . . . . 10.0 110.754 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.23 148.89 31.0 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.756 1.223 . . . . 10.0 108.998 173.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -84.17 57.63 4.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.635 1.174 . . . . 10.0 109.676 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -149.49 168.27 23.94 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.131 1.372 . . . . 10.0 109.275 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.35 25.53 63.34 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.147 0.88 . . . . 10.0 113.279 174.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 124.495 1.118 . . . . 10.0 109.459 178.226 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 119.381 -0.343 . . . . 10.0 110.236 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.36 172.31 12.86 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.754 1.222 . . . . 10.0 109.879 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.62 153.54 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.227 0.537 . . . . 10.0 109.966 169.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.45 179.36 9.2 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.906 2.082 . . . . 10.0 106.832 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -149.35 150.54 32.64 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.968 -1.123 . . . . 10.0 107.968 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.35 -26.42 60.95 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.372 1.069 . . . . 10.0 112.753 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.91 -25.51 67.62 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.876 0.762 . . . . 10.0 112.792 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -74.2 -25.8 59.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.205 0.457 . . . . 10.0 111.042 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.96 130.68 69.23 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 106.467 -1.679 . . . . 10.0 106.467 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.19 146.14 68.94 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.989 1.792 . . . . 10.0 109.625 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.72 -30.06 59.12 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.605 0.762 . . . . 10.0 112.593 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.4 t -138.28 132.31 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.696 -1.964 . . . . 10.0 105.696 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -149.93 102.72 3.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.47 -2.048 . . . . 10.0 105.47 171.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.2 pt -136.62 158.83 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.672 1.189 . . . . 10.0 110.516 -168.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.46 173.97 6.31 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.18 0.992 . . . . 10.0 112.391 -176.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -142.65 27.04 1.71 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.556 1.542 . . . . 10.0 111.369 -169.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -131.81 45.65 2.75 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 122.394 1.092 . . . . 10.0 111.078 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.01 -132.85 11.49 Favored Glycine 0 C--N 1.342 0.903 0 O-C-N 120.081 -1.637 . . . . 10.0 110.595 173.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.25 140.12 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.924 -0.75 . . . . 10.0 109.202 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -154.4 148.69 26.02 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.437 1.095 . . . . 10.0 109.592 170.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -72.73 150.71 42.63 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.696 -0.854 . . . . 10.0 108.696 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.33 165.51 29.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.683 0.793 . . . . 10.0 109.561 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.7 143.37 24.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.506 -1.294 . . . . 10.0 107.506 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp -99.8 126.43 45.89 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 105.49 -2.041 . . . . 10.0 105.49 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 98.2 mt -130.34 136.66 58.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -91.56 145.71 24.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.987 -1.486 . . . . 10.0 106.987 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.53 146.0 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.082 -1.821 . . . . 10.0 106.082 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -127.25 132.27 50.41 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.295 -1.742 . . . . 10.0 106.295 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.1 p -71.59 147.43 47.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.827 0.74 . . . . 10.0 110.777 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.93 62.31 3.42 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.621 1.568 . . . . 10.0 107.797 168.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -58.86 145.33 97.14 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.215 2.61 . . . . 10.0 109.664 -172.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 51.66 19.34 0.87 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.291 1.036 . . . . 10.0 112.517 -176.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m 50.44 28.5 3.37 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.865 1.266 . . . . 10.0 113.332 -171.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.62 -0.69 0.02 OUTLIER Glycine 0 CA--C 1.532 1.1 0 N-CA-C 116.497 1.359 . . . . 10.0 116.497 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.72 152.28 75.99 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.879 1.839 . . . . 10.0 110.244 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.46 61.45 7.4 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 124.229 3.286 . . . . 10.0 111.751 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.24 141.74 33.98 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.105 1.362 . . . . 10.0 108.602 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.67 39.5 0.49 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.465 1.506 . . . . 10.0 109.168 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.76 175.14 5.21 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.713 0.805 . . . . 10.0 108.896 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.1 m -151.99 163.2 39.79 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.171 -1.58 . . . . 10.0 111.369 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -154.82 163.53 40.14 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.529 2.332 . . . . 10.0 107.416 -169.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -129.24 141.86 51.01 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.351 -1.351 . . . . 10.0 107.351 174.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.3 pt -138.19 154.9 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.599 1.16 . . . . 10.0 110.822 -169.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.97 125.45 64.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.657 -1.609 . . . . 10.0 106.657 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -132.22 142.99 49.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.27 131.59 1.91 Allowed Glycine 0 C--O 1.22 -0.761 0 CA-C-N 119.878 1.217 . . . . 10.0 111.349 171.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -142.35 138.56 31.31 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 124.174 0.573 . . . . 10.0 109.644 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -68.59 -23.58 64.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.672 0.789 . . . . 10.0 112.362 -171.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -66.18 -20.53 66.16 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 118.444 -0.789 . . . . 10.0 112.422 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 127.67 32.6 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 118.995 0.816 . . . . 10.0 110.75 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -72.31 -35.73 68.72 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.489 0.661 . . . . 10.0 109.648 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -149.01 165.7 30.88 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 126.174 1.79 . . . . 10.0 108.55 -175.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -57.03 -38.75 73.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.988 0.423 . . . . 10.0 110.763 175.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.63 67.47 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 123.925 0.89 . . . . 10.0 113.16 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -66.96 -46.53 74.42 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.3 mt -62.46 -51.43 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -55.36 -41.32 72.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.615 -0.707 . . . . 10.0 111.628 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.7 -47.14 79.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.267 0.485 . . . . 10.0 111.86 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -58.59 -49.85 75.96 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 109.797 -0.446 . . . . 10.0 109.797 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.46 -45.29 93.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.459 -0.781 . . . . 10.0 109.181 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 m -57.58 -43.02 84.27 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.051 0.841 . . . . 10.0 110.821 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.79 -46.59 94.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.969 -0.853 . . . . 10.0 110.969 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.35 -48.55 77.51 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 118.226 1.013 . . . . 10.0 110.951 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -39.09 84.44 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.553 0.615 . . . . 10.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -63.11 -35.88 81.73 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.472 0.578 . . . . 10.0 110.833 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.22 -32.6 72.92 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.513 -1.232 . . . . 10.0 112.188 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 mm-40 -67.26 -53.08 33.19 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.295 0.952 . . . . 10.0 109.327 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.1 44.26 0.22 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.274 1.416 . . . . 10.0 109.607 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.3 m -145.95 175.89 10.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.185 2.194 . . . . 10.0 107.755 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -144.81 164.6 30.55 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.528 0.731 . . . . 10.0 109.04 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.8 m -120.9 162.29 20.11 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.599 1.16 . . . . 10.0 113.313 -168.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -147.57 112.49 5.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.32 2.248 . . . . 10.0 105.741 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 t -64.2 140.47 58.87 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.029 -1.045 . . . . 10.0 109.67 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.9 mt -110.26 -9.67 14.65 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.17 0.988 . . . . 10.0 111.636 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.88 171.75 18.63 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.434 1.016 . . . . 10.0 112.073 169.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.28 161.2 18.78 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.465 1.031 . . . . 10.0 110.828 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.85 -160.89 23.64 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.027 -1.629 . . . . 10.0 109.027 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -146.07 162.84 37.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.34 -1.682 . . . . 10.0 110.337 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -129.12 151.75 36.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 105.64 -1.985 . . . . 10.0 105.64 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 60.1 p -140.69 152.61 45.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.459 1.104 . . . . 10.0 109.292 175.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -160.8 162.76 32.42 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.262 1.825 . . . . 10.0 107.698 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -149.35 162.26 40.42 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.707 2.003 . . . . 10.0 106.576 171.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.5 m -64.21 -28.37 69.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.397 0.888 . . . . 10.0 113.397 -174.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -145.98 163.1 36.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.197 1.399 . . . . 10.0 109.35 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 t70 49.91 34.65 8.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.908 1.683 . . . . 10.0 113.716 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -158.98 163.12 36.75 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.96 1.704 . . . . 10.0 107.184 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 167.39 21.22 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 126.277 1.831 . . . . 10.0 107.197 170.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.1 mt -61.49 128.36 22.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.003 -1.48 . . . . 10.0 107.003 171.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -135.77 148.97 48.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.598 -0.89 . . . . 10.0 108.598 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.05 128.56 62.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.769 1.228 . . . . 10.0 107.916 -169.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -157.13 -164.97 1.71 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.564 0.746 . . . . 10.0 109.699 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.39 -169.85 54.6 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 111.081 -0.807 . . . . 10.0 111.081 -173.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -161.29 -170.89 2.8 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.4 1.48 . . . . 10.0 107.572 169.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.3 t -135.04 135.54 41.38 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.719 -1.215 . . . . 10.0 107.719 172.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 79.2 mtm -77.26 -16.81 58.84 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.877 -0.583 . . . . 10.0 111.134 169.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.89 -26.07 63.07 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.717 0.69 . . . . 10.0 112.333 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.43 -48.91 0.2 Allowed 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 123.177 0.591 . . . . 10.0 110.53 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.27 179.57 29.67 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.197 -1.561 . . . . 10.0 109.197 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -61.66 150.11 87.0 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.395 2.063 . . . . 10.0 109.902 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.33 27.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.232 1.413 . . . . 10.0 113.924 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 40.21 55.8 2.67 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.425 2.29 . . . . 10.0 109.57 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -43.99 -35.42 2.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.485 2.314 . . . . 10.0 114.603 -166.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.15 -37.12 66.57 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.368 0.986 . . . . 10.0 113.128 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.3 mt -63.66 -53.2 47.88 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 107.247 -1.39 . . . . 10.0 107.247 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.6 m -61.71 -41.73 98.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.178 -0.915 . . . . 10.0 112.267 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 p -65.01 -39.61 93.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.725 1.148 . . . . 10.0 110.602 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -63.77 -40.56 96.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.501 1.046 . . . . 10.0 110.937 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -62.98 -48.92 76.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.674 0.39 . . . . 10.0 110.59 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.8 mt -58.4 -45.75 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -62.41 -38.02 88.06 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 121.225 -0.922 . . . . 10.0 111.547 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.29 75.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.202 0.601 . . . . 10.0 111.763 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -80.03 -20.02 46.31 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 117.718 -1.134 . . . . 10.0 112.433 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.4 p90 38.09 58.19 4.9 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.302 2.241 . . . . 10.0 114.597 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.26 -13.78 36.52 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 121.951 1.767 . . . . 10.0 111.969 170.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -144.83 162.77 35.97 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.292 1.837 . . . . 10.0 107.555 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -69.62 -18.24 63.58 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.544 1.138 . . . . 10.0 113.324 -172.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -150.63 153.98 36.65 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.94 0.896 . . . . 10.0 108.911 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t -143.71 135.15 22.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 106.205 -1.776 . . . . 10.0 106.205 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -142.18 170.17 16.22 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.257 1.023 . . . . 10.0 109.996 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -143.7 166.19 25.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.279 0.562 . . . . 10.0 112.474 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.52 -178.46 6.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.787 2.835 . . . . 10.0 107.504 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -144.19 52.98 1.27 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.378 -0.826 . . . . 10.0 109.799 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -149.92 159.49 44.34 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.867 1.267 . . . . 10.0 108.942 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.33 162.21 26.34 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.975 1.75 . . . . 10.0 110.975 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.314 1.446 . . . . 10.0 107.875 170.402 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.68 169.14 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.933 1.293 . . . . 10.0 109.506 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.5 m -71.22 165.52 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 123.636 0.775 . . . . 10.0 111.159 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.54 179.53 8.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.809 2.444 . . . . 10.0 106.5 169.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -152.41 151.53 30.92 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.85 -25.32 64.93 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.645 0.778 . . . . 10.0 112.859 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.87 72.83 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.162 0.892 . . . . 10.0 111.63 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.59 -34.89 58.41 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.963 0.505 . . . . 10.0 110.032 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mt -64.62 118.81 51.65 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.15 139.51 52.72 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.484 2.789 . . . . 10.0 111.36 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.72 -31.98 25.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.303 0.573 . . . . 10.0 111.915 -173.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.57 139.04 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 105.759 -1.941 . . . . 10.0 105.759 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -146.89 113.26 5.92 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 105.451 -2.055 . . . . 10.0 105.451 171.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.6 pt -135.85 174.24 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.513 1.125 . . . . 10.0 111.877 -168.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -137.56 49.96 1.97 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.751 1.22 . . . . 10.0 110.897 -167.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 m -61.76 16.58 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 127.784 2.434 . . . . 10.0 115.751 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.7 -24.85 62.17 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.618 1.567 . . . . 10.0 111.992 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.17 -157.4 14.8 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.76 -2.136 . . . . 10.0 107.76 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t -59.24 141.83 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 169.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -145.27 151.34 38.21 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.208 0.603 . . . . 10.0 109.978 171.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -79.98 146.28 32.12 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.335 -1.357 . . . . 10.0 107.335 174.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.86 161.54 38.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.629 0.649 . . . . 10.0 110.962 -177.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.39 145.2 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.571 1.548 . . . . 10.0 107.574 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.3 tp -104.97 123.68 48.21 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.197 -2.149 . . . . 10.0 105.197 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.13 129.47 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 -172.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -83.65 140.09 32.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.525 -1.657 . . . . 10.0 106.525 167.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.69 139.74 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 106.16 -1.793 . . . . 10.0 106.16 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -121.02 138.1 54.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.337 1.855 . . . . 10.0 106.623 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.3 p -97.03 138.42 34.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.247 0.546 . . . . 10.0 112.323 -170.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.37 68.11 7.72 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 125.155 1.382 . . . . 10.0 107.393 168.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.48 149.62 9.5 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.957 3.105 . . . . 10.0 111.917 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 45.86 20.99 0.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.573 1.549 . . . . 10.0 114.632 -171.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.6 m 50.94 39.05 21.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.758 1.223 . . . . 10.0 111.878 -171.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.23 -28.87 0.02 OUTLIER Glycine 0 C--N 1.342 0.871 0 CA-C-O 118.977 -0.902 . . . . 10.0 114.72 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.24 131.2 93.48 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 119.572 1.686 . . . . 10.0 109.231 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -85.55 32.83 0.47 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.353 3.369 . . . . 10.0 112.88 -170.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.25 78.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.637 0.775 . . . . 10.0 111.95 -169.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 48.82 26.74 1.37 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.82 2.048 . . . . 10.0 115.32 174.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.87 159.5 28.89 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 168.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -142.91 158.74 43.33 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.535 -0.728 . . . . 10.0 110.624 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -151.76 176.04 11.8 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.97 1.308 . . . . 10.0 109.356 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.6 mp0 -106.68 153.63 22.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.963 -0.755 . . . . 10.0 108.963 170.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.7 pt -137.75 151.81 26.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 125.338 1.455 . . . . 10.0 110.081 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.45 130.12 58.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 106.233 -1.765 . . . . 10.0 106.233 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -133.83 140.35 46.83 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.082 -1.821 . . . . 10.0 106.082 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.74 139.31 4.98 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 120.455 1.48 . . . . 10.0 113.019 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -149.25 144.85 26.77 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.809 0.843 . . . . 10.0 109.652 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.58 -23.96 61.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 117.956 -1.021 . . . . 10.0 112.936 -172.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -68.03 -17.27 64.36 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.668 0.988 . . . . 10.0 113.668 -174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.24 130.79 46.98 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 119.389 0.995 . . . . 10.0 110.103 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.47 -37.5 77.32 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.925 -0.398 . . . . 10.0 109.925 176.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -149.53 160.38 43.53 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.098 2.159 . . . . 10.0 106.709 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -57.32 -33.13 67.39 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.902 0.881 . . . . 10.0 112.701 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.0 -25.54 65.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.384 0.674 . . . . 10.0 112.586 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.08 -37.92 84.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.579 0.627 . . . . 10.0 110.36 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.7 mt -64.27 -50.85 74.72 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 107.748 -1.204 . . . . 10.0 107.748 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -55.73 -42.6 75.6 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.851 -0.595 . . . . 10.0 111.326 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.09 -43.9 97.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.601 0.637 . . . . 10.0 111.989 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -61.3 -51.34 69.28 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 121.63 -0.669 . . . . 10.0 109.434 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.17 -42.71 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.584 -0.525 . . . . 10.0 109.584 -170.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.4 p -66.45 -33.75 76.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.182 0.901 . . . . 10.0 111.472 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.3 -39.54 96.02 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.364 0.983 . . . . 10.0 111.034 173.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -69.11 -45.38 70.36 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.724 -0.868 . . . . 10.0 111.109 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 27.2 mmt -61.13 -39.5 90.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.186 0.903 . . . . 10.0 110.597 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.55 -39.75 89.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.78 0.718 . . . . 10.0 110.903 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -20.48 59.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 117.874 -1.06 . . . . 10.0 112.887 175.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -72.95 -43.29 62.48 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.714 1.143 . . . . 10.0 110.423 169.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.71 49.71 0.58 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.217 -1.553 . . . . 10.0 109.217 -169.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.7 m -145.74 169.83 17.71 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.046 1.738 . . . . 10.0 108.206 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -136.24 161.51 35.54 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.637 1.575 . . . . 10.0 108.216 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.6 m -125.13 158.05 34.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.542 1.137 . . . . 10.0 112.693 -168.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -146.0 106.41 4.06 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.994 2.118 . . . . 10.0 105.597 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.8 p -61.46 131.51 50.41 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.281 -0.887 . . . . 10.0 109.192 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -102.4 -21.77 14.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.008 0.523 . . . . 10.0 110.909 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.01 -178.48 32.52 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.937 -1.265 . . . . 10.0 109.937 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.94 -173.29 23.56 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 117.944 0.872 . . . . 10.0 111.215 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.23 -148.98 9.87 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.157 -1.577 . . . . 10.0 109.157 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -139.46 160.44 39.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.765 1.226 . . . . 10.0 108.671 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.8 mt -136.58 149.17 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 106.333 -1.728 . . . . 10.0 106.333 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.3 p -135.41 164.72 27.13 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.333 1.453 . . . . 10.0 108.435 170.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -142.06 143.51 33.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.752 1.221 . . . . 10.0 107.943 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 52.01 35.9 17.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.504 1.522 . . . . 10.0 111.628 -172.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 m -68.75 -25.69 64.86 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.441 1.896 . . . . 10.0 113.119 -169.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -158.33 -33.76 0.07 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.175 1.39 . . . . 10.0 109.819 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -143.56 171.6 13.95 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.706 2.002 . . . . 10.0 106.315 174.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -66.38 73.03 0.08 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.011 1.724 . . . . 10.0 110.789 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -145.08 -172.74 3.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.725 1.61 . . . . 10.0 110.269 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 98.0 mt -127.35 148.17 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.546 -2.02 . . . . 10.0 105.546 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -135.76 145.2 46.33 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.847 0.859 . . . . 10.0 108.912 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.81 130.49 55.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 107.326 -1.361 . . . . 10.0 107.326 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -158.66 179.49 9.06 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.346 -0.846 . . . . 10.0 111.714 -168.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.72 -159.01 34.22 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 123.762 0.696 . . . . 10.0 112.359 170.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -155.92 152.38 28.18 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.596 1.959 . . . . 10.0 106.494 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 p -69.82 152.15 44.9 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.017 0.826 . . . . 10.0 111.131 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.5 mtp -77.81 28.73 0.17 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.588 1.155 . . . . 10.0 110.161 169.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.36 -41.5 0.18 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.087 0.955 . . . . 10.0 112.585 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -133.42 -51.28 0.87 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.314 0.961 . . . . 10.0 112.565 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.19 -177.67 23.47 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.806 -0.918 . . . . 10.0 110.806 -171.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.2 144.76 82.34 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.004 2.47 . . . . 10.0 110.725 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.86 21.83 1.5 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -170.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 40.94 53.2 3.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.237 1.415 . . . . 10.0 110.065 -169.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -39.09 -30.91 0.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.95 2.9 . . . . 10.0 116.759 -166.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.65 60.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.814 1.188 . . . . 10.0 112.643 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.0 mt -60.77 -54.22 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -61.59 -41.29 97.22 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 117.915 -1.04 . . . . 10.0 111.867 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.7 p -64.69 -37.31 87.14 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 120.092 1.314 . . . . 10.0 111.431 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.2 -39.98 86.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.906 0.775 . . . . 10.0 110.729 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -64.8 -46.26 82.77 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.834 -0.541 . . . . 10.0 110.527 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.0 mt -57.64 -47.16 86.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -58.42 -42.31 86.96 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.134 0.879 . . . . 10.0 111.239 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.67 89.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.593 0.633 . . . . 10.0 111.559 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -89.66 -20.21 23.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.085 -0.96 . . . . 10.0 112.99 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -137.05 59.36 22.02 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.384 1.473 . . . . 10.0 109.933 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.83 -11.25 31.39 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.739 2.293 . . . . 10.0 113.29 -175.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -66.29 -12.04 54.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.334 1.053 . . . . 10.0 112.961 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -130.88 150.58 51.97 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 124.526 1.13 . . . . 10.0 109.515 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.38 157.93 36.89 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 t -136.35 139.35 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.6 p -138.0 167.31 22.04 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.456 1.102 . . . . 10.0 109.429 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -145.01 165.3 28.57 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.06 171.37 14.58 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.27 2.228 . . . . 10.0 108.286 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -144.21 37.94 1.27 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.183 0.993 . . . . 10.0 109.681 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -149.38 155.52 40.6 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.369 1.467 . . . . 10.0 108.768 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.97 171.84 38.28 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.443 1.02 . . . . 10.0 111.505 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.244 0.815 0 C-N-CA 124.841 1.256 . . . . 10.0 108.542 176.235 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 tpt . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 119.021 -0.514 . . . . 10.0 109.84 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.85 157.69 43.23 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.899 1.28 . . . . 10.0 108.657 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.83 150.47 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 126.081 1.752 . . . . 10.0 108.149 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.03 170.87 15.14 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.671 -0.492 . . . . 10.0 109.671 169.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.79 149.64 29.25 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 172.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.01 -23.5 63.71 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.36 -29.29 69.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.139 0.882 . . . . 10.0 111.987 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.9 mt -75.37 -31.88 60.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.159 0.436 . . . . 10.0 110.408 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.0 mt -69.79 123.74 89.21 Favored Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 107.629 -1.248 . . . . 10.0 107.629 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.13 135.05 30.51 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.639 2.893 . . . . 10.0 111.159 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.18 -28.47 27.33 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.299 0.571 . . . . 10.0 112.237 -171.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.19 134.69 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 127.41 2.284 . . . . 10.0 104.895 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -156.2 98.77 1.89 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.208 -1.775 . . . . 10.0 106.208 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.5 pt -129.71 87.77 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.487 1.115 . . . . 10.0 109.633 -169.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.2 -26.11 68.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.311 -0.859 . . . . 10.0 110.236 166.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -68.05 60.95 0.08 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.659 1.584 . . . . 10.0 111.359 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -77.04 39.58 0.24 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.32 1.848 . . . . 10.0 110.751 175.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.36 -170.76 42.31 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.034 1.778 . . . . 10.0 109.129 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.4 t -73.41 78.63 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.883 0.873 . . . . 10.0 110.036 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -139.32 19.57 2.58 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.505 1.122 . . . . 10.0 111.696 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 64.17 146.3 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.594 2.758 . . . . 10.0 113.093 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.47 157.05 43.7 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.749 1.22 . . . . 10.0 108.344 175.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.34 147.96 32.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 125.624 1.569 . . . . 10.0 108.161 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.2 tp -109.46 120.2 41.77 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.666 -1.975 . . . . 10.0 105.666 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.8 mt -131.28 136.36 57.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 -168.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -88.45 143.8 26.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.799 -1.556 . . . . 10.0 106.799 168.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -126.78 141.64 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.565 -1.643 . . . . 10.0 106.565 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -124.83 129.53 50.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.352 1.861 . . . . 10.0 106.048 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.1 p -80.06 146.22 32.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.775 0.322 . . . . 10.0 111.201 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -155.72 62.15 3.08 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.38 1.872 . . . . 10.0 106.702 167.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -55.61 143.63 78.27 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.532 2.821 . . . . 10.0 111.078 -168.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.4 ttt85 47.69 25.38 0.68 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.947 1.299 . . . . 10.0 113.09 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.0 m 53.01 28.82 7.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.523 1.529 . . . . 10.0 113.632 -175.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.84 -1.8 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 N-CA-C 116.723 1.449 . . . . 10.0 116.723 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 152.13 82.44 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 120.168 1.984 . . . . 10.0 110.675 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.85 59.14 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.291 3.327 . . . . 10.0 111.917 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.6 140.98 33.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.024 1.33 . . . . 10.0 108.516 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.06 29.77 0.72 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.176 1.391 . . . . 10.0 110.254 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -67.57 162.24 23.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.643 0.777 . . . . 10.0 108.918 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -140.2 160.29 40.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.026 0.93 . . . . 10.0 110.01 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -150.78 176.28 11.19 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.58 1.152 . . . . 10.0 109.627 170.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -99.31 157.09 16.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.347 -0.982 . . . . 10.0 108.347 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.8 pt -141.72 149.35 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 126.387 1.875 . . . . 10.0 108.346 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.76 124.27 66.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.883 -1.895 . . . . 10.0 105.883 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -129.38 148.53 51.31 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.596 -1.261 . . . . 10.0 107.596 -175.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.32 124.08 0.97 Allowed Glycine 0 C--O 1.228 -0.255 0 N-CA-C 109.035 -1.626 . . . . 10.0 109.035 173.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -140.63 134.97 31.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.4 0.6 . . . . 10.0 110.501 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -74.69 -11.95 60.3 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 114.277 1.214 . . . . 10.0 114.277 -169.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -66.11 -24.3 66.66 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.461 1.028 . . . . 10.0 111.575 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.33 163.19 28.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.85 0.75 . . . . 10.0 110.809 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -119.18 -17.65 8.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.449 1.1 . . . . 10.0 110.367 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -146.95 152.49 38.74 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.421 1.488 . . . . 10.0 108.105 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.55 ' CG ' ' HG ' ' A' ' 94' ' ' SER . 55.7 m80 -57.68 -31.85 66.76 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.399 1.079 . . . . 10.0 112.21 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.32 -33.2 72.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.187 -0.911 . . . . 10.0 112.607 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -72.0 -37.08 69.88 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.959 0.799 . . . . 10.0 110.437 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.9 -52.23 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.934 -1.135 . . . . 10.0 107.934 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -56.87 -43.19 80.96 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 119.09 -0.481 . . . . 10.0 111.494 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.32 -45.5 91.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.906 0.482 . . . . 10.0 111.181 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -60.92 -48.25 82.67 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.608 -0.682 . . . . 10.0 109.976 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.97 -43.89 98.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.659 0.783 . . . . 10.0 109.622 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.8 m -61.29 -43.88 98.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.046 0.839 . . . . 10.0 110.406 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.78 -46.92 93.55 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.787 -0.925 . . . . 10.0 110.787 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.05 -44.8 95.92 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.741 0.77 . . . . 10.0 110.668 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.3 mmt -62.01 -37.18 83.91 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.923 -0.56 . . . . 10.0 111.101 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -63.65 -35.64 81.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.274 0.943 . . . . 10.0 110.816 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.55 -31.97 72.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 117.924 -1.036 . . . . 10.0 111.597 171.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.63 -44.43 70.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.527 1.058 . . . . 10.0 110.039 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.86 47.55 0.61 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 108.852 -1.699 . . . . 10.0 108.852 -169.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.5 m -146.66 169.64 18.59 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.321 1.848 . . . . 10.0 108.655 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.57 164.93 28.83 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.064 1.746 . . . . 10.0 108.138 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 78.5 m -126.17 164.89 19.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.199 1.0 . . . . 10.0 112.811 -168.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -149.3 113.08 5.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.317 2.247 . . . . 10.0 105.346 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.8 t -66.47 140.23 58.01 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.637 -1.29 . . . . 10.0 109.479 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.8 mt -108.22 -13.46 14.9 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.614 0.765 . . . . 10.0 111.228 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.06 -174.25 24.48 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.209 1.385 . . . . 10.0 110.573 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.06 -176.23 27.03 Favored Glycine 0 CA--C 1.524 0.647 0 O-C-N 121.44 -1.036 . . . . 10.0 111.495 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.29 -154.5 10.2 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.131 -1.588 . . . . 10.0 109.131 -174.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -139.52 163.65 31.98 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.441 1.896 . . . . 10.0 107.905 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mt -129.23 150.78 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.495 -1.669 . . . . 10.0 106.495 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 p -159.08 -169.66 2.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.257 1.423 . . . . 10.0 108.832 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -132.66 151.93 51.82 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -144.32 164.17 31.56 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.166 0.986 . . . . 10.0 110.286 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.0 m 64.94 166.53 0.17 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.855 2.062 . . . . 10.0 112.656 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -62.14 -28.11 69.42 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.986 -0.446 . . . . 10.0 111.453 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -71.69 -6.25 39.76 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.41 1.084 . . . . 10.0 112.278 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.253 63.5 pttt 42.25 46.23 3.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.428 1.891 . . . . 10.0 112.294 -173.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 155.27 23.08 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 172.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.8 mt -69.47 144.76 13.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.582 -1.636 . . . . 10.0 106.582 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -137.44 157.01 47.49 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.526 0.731 . . . . 10.0 109.366 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.53 140.32 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -159.36 -174.95 4.94 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.761 -1.212 . . . . 10.0 110.06 -171.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.13 -166.07 52.49 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 121.835 0.686 . . . . 10.0 111.641 169.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -148.47 161.8 40.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.512 1.125 . . . . 10.0 108.403 175.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.55 ' HG ' ' CG ' ' A' ' 53' ' ' HIS . 30.1 t -83.17 126.33 32.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -64.63 -26.97 68.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.119 0.568 . . . . 10.0 110.702 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.53 -30.17 46.89 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.529 -0.748 . . . . 10.0 112.487 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -130.15 -58.91 1.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.802 0.728 . . . . 10.0 112.396 -169.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 149.14 176.28 22.28 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 108.902 -1.679 . . . . 10.0 108.902 -170.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -57.13 134.53 64.84 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.572 2.182 . . . . 10.0 110.566 171.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.65 163.44 18.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 166.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -79.79 69.29 6.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.08 -1.822 . . . . 10.0 106.08 167.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -50.78 -30.09 13.25 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.211 1.404 . . . . 10.0 113.518 -168.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.69 70.89 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.289 0.95 . . . . 10.0 112.349 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.9 mt -64.32 -50.28 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.2 m -59.26 -46.5 88.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.61 -0.681 . . . . 10.0 111.96 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.9 p -63.94 -39.98 95.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.356 -0.83 . . . . 10.0 110.876 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.44 -40.17 92.94 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.307 0.958 . . . . 10.0 110.97 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -66.68 -44.23 82.36 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.755 -0.64 . . . . 10.0 110.436 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.7 mt -56.15 -52.44 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.003 -1.11 . . . . 10.0 108.003 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -59.55 -40.59 87.73 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.741 0.816 . . . . 10.0 111.54 -174.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.6 -41.08 98.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.704 0.802 . . . . 10.0 111.288 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -89.93 -19.05 24.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.233 -0.889 . . . . 10.0 112.923 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -130.96 57.75 34.05 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.797 1.239 . . . . 10.0 110.042 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.53 -11.07 30.9 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.108 2.539 . . . . 10.0 113.368 -173.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.18 -12.59 29.22 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.124 0.97 . . . . 10.0 112.33 172.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -126.46 144.18 50.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.594 1.158 . . . . 10.0 109.199 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -78.03 153.33 32.42 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.276 -1.379 . . . . 10.0 107.276 168.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.47 135.54 35.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.551 -1.277 . . . . 10.0 107.551 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.17 172.0 13.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.694 1.197 . . . . 10.0 109.163 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 44.0 p-90 -147.04 169.09 19.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.29 0.496 . . . . 10.0 111.179 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.92 148.93 34.42 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.266 1.026 . . . . 10.0 109.997 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -80.74 48.27 1.05 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.286 1.834 . . . . 10.0 110.406 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -139.99 166.39 24.77 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.741 1.216 . . . . 10.0 110.089 -169.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.42 28.85 73.98 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.959 1.266 . . . . 10.0 112.675 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 . . . . . 0 C--O 1.253 1.285 0 CA-C-O 115.641 -2.123 . . . . 10.0 109.028 178.315 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 118.294 -0.86 . . . . 10.0 109.28 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.91 158.18 33.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.513 0.725 . . . . 10.0 112.227 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.31 161.79 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.692 0.797 . . . . 10.0 110.262 167.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.77 176.65 11.88 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.407 1.883 . . . . 10.0 106.549 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -150.21 152.93 35.38 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 172.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.65 -21.8 61.01 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 118.381 -0.818 . . . . 10.0 113.161 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.7 -23.29 64.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.413 1.006 . . . . 10.0 112.688 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.9 mt -77.54 -8.65 58.13 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.661 0.784 . . . . 10.0 111.995 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.9 mt -112.76 128.45 25.56 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 106.479 -1.674 . . . . 10.0 106.479 -172.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.72 151.43 74.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.382 2.055 . . . . 10.0 110.755 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -67.63 -38.16 83.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.05 1.34 . . . . 10.0 112.817 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.55 138.66 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.145 -1.428 . . . . 10.0 107.145 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -155.04 97.7 1.95 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.438 -1.319 . . . . 10.0 107.438 -176.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.1 pt -131.44 158.4 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.895 1.278 . . . . 10.0 108.211 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -140.25 24.01 2.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 123.339 1.542 . . . . 10.0 110.001 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 m -75.46 70.89 2.37 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.888 2.075 . . . . 10.0 112.528 -170.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.2 -12.73 30.44 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.704 1.201 . . . . 10.0 113.021 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.23 -162.89 11.32 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.328 -1.909 . . . . 10.0 108.328 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.2 t -60.46 113.72 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.183 0.992 . . . . 10.0 108.748 174.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -145.42 146.16 31.42 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.711 -0.848 . . . . 10.0 108.711 172.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -61.84 157.65 17.72 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.367 0.667 . . . . 10.0 110.567 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -151.08 171.9 16.6 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.228 1.411 . . . . 10.0 108.242 169.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.4 152.61 29.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.707 1.203 . . . . 10.0 110.48 174.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.0 tp -102.95 117.68 35.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.086 -2.191 . . . . 10.0 105.086 167.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.78 134.69 62.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 105.731 -1.952 . . . . 10.0 105.731 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -85.79 135.14 33.85 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.381 -1.711 . . . . 10.0 106.381 167.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -120.88 142.3 37.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -122.66 133.21 54.52 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.368 1.867 . . . . 10.0 106.083 -174.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.6 p -66.83 143.55 56.81 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.649 -0.5 . . . . 10.0 109.649 172.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.12 59.35 3.64 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.214 1.006 . . . . 10.0 108.781 168.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -59.18 138.52 85.5 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.871 2.381 . . . . 10.0 109.522 -173.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 45.26 21.19 0.06 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.958 1.703 . . . . 10.0 114.482 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m 47.88 32.14 2.63 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.342 1.457 . . . . 10.0 113.125 -170.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.92 0.11 0.03 OUTLIER Glycine 0 CA--C 1.531 1.059 0 N-CA-C 115.929 1.131 . . . . 10.0 115.929 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.45 152.68 84.85 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 120.529 2.164 . . . . 10.0 110.509 171.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.69 52.63 3.75 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 124.123 3.215 . . . . 10.0 111.651 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.14 136.56 31.98 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.921 1.288 . . . . 10.0 108.333 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.15 30.56 0.7 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.244 1.418 . . . . 10.0 109.595 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -64.34 155.44 32.26 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -140.77 160.45 40.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.981 0.912 . . . . 10.0 110.702 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -149.78 172.64 14.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.177 0.991 . . . . 10.0 109.809 172.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.39 145.8 26.99 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 174.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.5 pt -135.74 148.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.585 1.554 . . . . 10.0 109.02 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.15 126.05 67.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.964 -1.495 . . . . 10.0 106.964 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -131.39 131.11 43.41 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 -174.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.04 55.01 0.36 Allowed Glycine 0 N--CA 1.464 0.527 0 CA-C-N 119.328 0.967 . . . . 10.0 111.398 -168.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -74.05 142.71 45.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.884 0.473 . . . . 10.0 111.15 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -63.53 -37.95 89.29 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 124.037 0.935 . . . . 10.0 112.551 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -66.33 -20.56 66.12 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 118.124 -0.941 . . . . 10.0 113.228 -172.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.37 134.38 51.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.768 0.713 . . . . 10.0 111.439 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -72.78 -34.42 66.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.552 0.691 . . . . 10.0 110.11 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -151.27 165.47 33.9 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 125.173 1.389 . . . . 10.0 109.238 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.455 ' CG ' ' HG ' ' A' ' 94' ' ' SER . 10.3 p-80 -48.88 -40.31 29.23 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.635 1.174 . . . . 10.0 112.516 169.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.24 73.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.52 -0.753 . . . . 10.0 112.184 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -70.19 -38.03 75.27 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.099 0.952 . . . . 10.0 109.793 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.22 -53.72 42.3 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 107.994 -1.113 . . . . 10.0 107.994 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -57.74 -45.24 86.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.323 -0.846 . . . . 10.0 111.504 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.04 -46.94 86.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.433 0.561 . . . . 10.0 111.538 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -63.22 -48.03 79.98 Favored 'General case' 0 C--N 1.342 0.274 0 O-C-N 121.604 -0.685 . . . . 10.0 109.756 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.08 -44.97 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 118.437 -0.792 . . . . 10.0 109.227 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.4 m -57.64 -42.26 83.07 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.497 1.044 . . . . 10.0 110.928 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.21 -45.49 95.9 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.577 -0.609 . . . . 10.0 111.577 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.33 -50.57 73.11 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.399 -1.06 . . . . 10.0 110.81 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -38.87 84.18 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 118.894 -0.574 . . . . 10.0 111.056 -178.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -63.94 -34.14 77.29 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.108 0.413 . . . . 10.0 110.837 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -71.57 -28.45 63.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 117.453 -1.26 . . . . 10.0 112.527 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -69.34 -59.86 2.72 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.727 1.149 . . . . 10.0 108.523 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.06 44.01 0.11 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.979 1.752 . . . . 10.0 109.169 -168.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.0 m -147.09 176.35 10.01 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.441 2.296 . . . . 10.0 107.346 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -148.46 165.9 29.76 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.02 -1.05 . . . . 10.0 108.923 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.8 m -131.04 159.8 36.47 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.602 1.092 . . . . 10.0 112.763 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -145.54 120.18 9.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.007 -1.849 . . . . 10.0 106.007 170.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.9 t -67.33 134.44 51.54 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.643 -1.285 . . . . 10.0 109.056 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 56.0 mt -91.64 -24.2 19.6 Favored 'General case' 0 C--O 1.226 -0.18 0 O-C-N 123.953 0.783 . . . . 10.0 110.646 171.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.92 164.78 21.01 Favored Glycine 0 C--N 1.337 0.587 0 O-C-N 121.216 -0.927 . . . . 10.0 111.233 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -125.61 163.15 19.69 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.263 -1.135 . . . . 10.0 110.263 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.29 -156.11 10.45 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.512 -1.835 . . . . 10.0 108.512 -171.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -139.35 153.59 47.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.059 1.744 . . . . 10.0 109.161 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.0 mm -119.98 145.89 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.327 -2.471 . . . . 10.0 104.327 168.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.4 m -153.51 149.95 28.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 168.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -79.7 -8.35 59.17 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.648 0.981 . . . . 10.0 113.648 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -157.64 154.92 29.18 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 128.678 2.791 . . . . 10.0 105.669 170.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.7 m -162.26 -94.84 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.989 1.316 . . . . 10.0 107.791 169.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.92 -13.07 60.01 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.403 0.681 . . . . 10.0 111.347 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -142.32 160.69 39.75 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 126.453 1.901 . . . . 10.0 106.066 169.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -79.6 46.73 0.78 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.27 1.028 . . . . 10.0 110.57 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -148.35 167.02 26.33 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 124.12 0.968 . . . . 10.0 110.708 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 mm -53.56 127.88 12.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.343 -1.355 . . . . 10.0 107.343 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -140.37 141.81 35.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.911 -1.144 . . . . 10.0 107.911 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.0 t -131.72 122.77 50.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.832 -1.544 . . . . 10.0 106.832 -169.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -158.28 -164.25 1.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.163 -0.961 . . . . 10.0 108.638 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.51 -173.27 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 118.65 0.659 . . . . 10.0 112.658 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -159.09 167.35 29.45 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.818 -1.178 . . . . 10.0 107.818 167.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.455 ' HG ' ' CG ' ' A' ' 53' ' ' HIS . 58.2 m -133.09 112.62 11.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 172.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -24.56 6.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.68 1.992 . . . . 10.0 114.101 -176.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.35 -25.31 65.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.745 0.818 . . . . 10.0 112.868 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.35 -41.68 0.14 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.0 0.818 . . . . 10.0 112.882 -174.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.29 -175.77 23.89 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.459 1.028 . . . . 10.0 110.765 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.19 148.16 68.12 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.264 2.643 . . . . 10.0 110.397 170.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.87 34.5 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.077 1.351 . . . . 10.0 113.176 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 35.28 59.31 0.77 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.277 2.231 . . . . 10.0 112.156 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -51.4 -25.14 5.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.327 2.251 . . . . 10.0 115.561 -164.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.77 92.47 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.764 1.165 . . . . 10.0 111.663 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.87 -54.01 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.027 -1.471 . . . . 10.0 107.027 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 m -63.34 -41.21 98.85 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.156 0.582 . . . . 10.0 112.516 -173.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.7 p -61.53 -47.14 86.93 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 118.628 0.649 . . . . 10.0 110.419 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -66.68 -36.74 83.25 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.22 0.464 . . . . 10.0 110.271 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -59.68 -50.79 72.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 118.847 -0.597 . . . . 10.0 110.794 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.54 -53.57 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.096 -1.076 . . . . 10.0 108.096 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -60.86 -37.97 83.96 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.039 1.335 . . . . 10.0 112.234 -173.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.48 -50.38 26.43 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.15 0.58 . . . . 10.0 110.389 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -69.94 -34.22 73.16 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 118.625 -0.702 . . . . 10.0 111.444 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -128.05 101.3 22.82 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 106.867 -1.531 . . . . 10.0 106.867 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.17 128.4 22.69 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.615 1.543 . . . . 10.0 109.344 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -153.47 155.95 37.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.023 -1.473 . . . . 10.0 107.023 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -60.97 -39.71 90.63 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.405 1.082 . . . . 10.0 111.869 -170.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -160.8 155.59 23.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.923 0.783 . . . . 10.0 109.985 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.39 122.79 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.032 -2.581 . . . . 10.0 104.032 168.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.1 p -111.94 167.15 10.61 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.832 0.853 . . . . 10.0 110.458 -170.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -145.43 166.75 24.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.487 0.921 . . . . 10.0 113.487 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.84 -175.42 4.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.979 2.512 . . . . 10.0 107.93 170.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -140.52 51.42 1.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.174 -0.953 . . . . 10.0 110.105 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -146.89 155.22 42.14 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.52 1.528 . . . . 10.0 107.92 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.65 -150.22 19.23 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.056 -1.618 . . . . 10.0 109.056 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 C--O 1.249 1.058 0 N-CA-C 107.14 -1.43 . . . . 10.0 107.14 169.379 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 118.879 -0.581 . . . . 10.0 110.901 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.31 -176.41 5.29 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.933 1.693 . . . . 10.0 107.278 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.9 m -67.98 143.94 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.25 -1.018 . . . . 10.0 108.25 166.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.78 174.28 15.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.899 1.279 . . . . 10.0 107.857 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -151.72 149.54 29.18 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.938 -1.504 . . . . 10.0 106.938 171.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.75 -27.91 63.45 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.778 0.831 . . . . 10.0 112.933 -176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -25.96 68.01 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.773 0.715 . . . . 10.0 112.193 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.3 mt -76.34 -23.23 54.22 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.221 0.608 . . . . 10.0 111.191 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.9 mt -83.94 122.08 76.01 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 107.688 -1.227 . . . . 10.0 107.688 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.31 138.55 37.69 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.692 2.928 . . . . 10.0 110.909 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -85.25 -28.42 25.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.438 0.637 . . . . 10.0 112.104 -169.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.8 t -139.16 136.04 41.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 126.185 1.794 . . . . 10.0 106.193 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -149.5 98.79 2.82 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.8 pt -143.49 178.96 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.665 1.586 . . . . 10.0 109.996 -169.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -140.58 152.73 45.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 106.175 -1.787 . . . . 10.0 106.175 164.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.3 m -137.05 2.4 2.56 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.841 1.656 . . . . 10.0 111.608 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.47 -19.06 33.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.15 0.976 . . . . 10.0 113.255 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.3 -174.36 22.08 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 107.242 -2.343 . . . . 10.0 107.242 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.2 t -63.72 125.51 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -139.68 139.99 36.76 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.901 -1.148 . . . . 10.0 107.901 175.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -67.23 155.82 37.86 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.02 165.41 29.11 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.697 0.761 . . . . 10.0 109.108 172.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.5 140.09 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.318 1.447 . . . . 10.0 107.436 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -100.17 118.93 37.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.695 -2.335 . . . . 10.0 104.695 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.7 mt -123.29 135.97 61.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 -171.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -88.83 133.28 34.32 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.175 -1.787 . . . . 10.0 106.175 168.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -116.25 140.25 39.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.2 -1.778 . . . . 10.0 106.2 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -122.04 136.4 54.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.196 1.798 . . . . 10.0 106.997 -172.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 m -64.12 137.05 57.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.306 -0.628 . . . . 10.0 109.306 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.9 54.95 2.02 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.246 1.018 . . . . 10.0 108.957 166.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.85 131.49 33.25 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.895 2.397 . . . . 10.0 108.523 -169.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.304 4.6 ppt_? 41.12 29.25 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.386 1.874 . . . . 10.0 114.251 -169.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m 46.09 37.87 4.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.758 1.623 . . . . 10.0 113.489 -173.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.99 -1.95 0.03 OUTLIER Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.34 1.296 . . . . 10.0 116.34 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.29 152.38 63.76 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 120.478 2.139 . . . . 10.0 110.55 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.23 49.5 2.85 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.092 3.195 . . . . 10.0 111.892 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.82 128.0 18.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.964 1.306 . . . . 10.0 108.038 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.57 26.61 1.75 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.134 1.374 . . . . 10.0 109.948 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.86 160.05 21.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.6 0.76 . . . . 10.0 109.006 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -138.1 161.39 36.89 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.98 0.912 . . . . 10.0 110.797 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -144.59 173.13 12.08 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.221 1.008 . . . . 10.0 109.578 169.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -98.26 148.95 23.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 pt -137.24 154.17 30.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 125.736 1.615 . . . . 10.0 109.466 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.2 126.97 67.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.217 -1.772 . . . . 10.0 106.217 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -130.54 137.29 49.64 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.91 46.0 0.27 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.944 -0.862 . . . . 10.0 110.944 -169.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -66.16 136.61 56.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.064 0.546 . . . . 10.0 110.406 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -66.72 -27.96 68.05 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 113.667 0.988 . . . . 10.0 113.667 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.6 p-90 -68.3 -23.94 64.8 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.423 -0.798 . . . . 10.0 112.474 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.19 134.28 47.93 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.871 0.76 . . . . 10.0 110.778 -175.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.25 -35.37 71.4 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.366 0.666 . . . . 10.0 110.559 171.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -147.29 157.45 43.59 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.632 1.573 . . . . 10.0 109.084 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.88 -25.67 57.22 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.282 1.033 . . . . 10.0 112.387 172.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.77 -40.24 79.31 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.011 0.823 . . . . 10.0 112.03 169.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -71.54 -33.28 69.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.383 0.611 . . . . 10.0 110.125 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.0 -55.75 20.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 108.35 -0.982 . . . . 10.0 108.35 173.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -54.99 -42.16 72.11 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.956 -0.545 . . . . 10.0 111.305 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.93 -48.7 80.55 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.478 0.711 . . . . 10.0 111.261 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -44.89 72.07 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.486 -0.759 . . . . 10.0 110.29 -175.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.81 -46.06 95.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 C-N-CA 123.89 0.876 . . . . 10.0 109.172 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 m -58.4 -40.47 82.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.09 0.859 . . . . 10.0 111.242 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.09 -50.77 64.02 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.995 -0.842 . . . . 10.0 110.995 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.66 -47.91 84.15 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.073 0.937 . . . . 10.0 111.071 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -39.39 85.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.724 -0.61 . . . . 10.0 110.459 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -68.14 -33.37 74.36 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 118.829 0.741 . . . . 10.0 110.757 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.87 -39.7 94.83 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 116.575 -1.678 . . . . 10.0 111.029 169.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -67.7 -60.15 2.77 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 119.281 0.946 . . . . 10.0 108.788 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.08 44.28 0.08 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.283 1.42 . . . . 10.0 110.447 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.4 m -148.69 177.59 9.37 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.055 2.142 . . . . 10.0 108.052 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -148.21 165.99 29.27 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.503 1.121 . . . . 10.0 109.004 172.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.5 m -134.5 160.1 39.08 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.842 1.201 . . . . 10.0 113.375 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.17 139.32 19.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.512 1.925 . . . . 10.0 106.902 169.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.3 m -75.67 140.82 42.75 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.352 -0.843 . . . . 10.0 110.415 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.7 mt -96.24 -22.99 16.91 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.921 -0.487 . . . . 10.0 110.802 168.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.16 -173.59 39.35 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.979 -1.248 . . . . 10.0 109.979 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.05 -172.16 22.47 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 118.846 1.323 . . . . 10.0 111.911 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.65 -150.85 9.58 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 109.375 -1.49 . . . . 10.0 109.375 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -137.3 160.76 38.11 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.966 1.306 . . . . 10.0 109.117 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.5 mt -132.6 150.18 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.6 m -155.19 144.5 21.08 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.608 1.163 . . . . 10.0 109.441 171.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -78.37 137.99 38.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 168.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -65.01 145.77 55.9 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.582 -0.699 . . . . 10.0 109.925 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 p -69.9 -22.12 63.25 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -170.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -143.81 22.23 1.78 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.851 0.86 . . . . 10.0 111.28 -170.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -150.34 151.83 33.49 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -56.46 -28.91 60.95 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 117.819 -1.086 . . . . 10.0 113.211 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 164.42 6.31 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.57 1.176 . . . . 10.0 113.468 -168.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.9 mm -115.72 155.04 17.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 125.738 1.615 . . . . 10.0 106.719 173.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -137.23 156.22 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 120.147 -1.596 . . . . 10.0 109.247 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.38 131.87 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.067 -1.457 . . . . 10.0 107.067 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.59 176.72 12.26 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.159 -0.963 . . . . 10.0 112.136 -169.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.71 -159.47 53.03 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.217 -0.753 . . . . 10.0 111.217 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -157.39 157.06 33.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.123 1.369 . . . . 10.0 108.829 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -73.79 127.98 34.28 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.003 -1.061 . . . . 10.0 108.236 170.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 96.7 mtp -75.44 -18.19 59.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.763 -0.637 . . . . 10.0 111.215 169.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.56 -32.01 53.53 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 118.429 0.559 . . . . 10.0 111.688 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -127.37 -49.29 1.42 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.685 0.394 . . . . 10.0 111.264 -171.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.47 177.59 15.76 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.391 -1.484 . . . . 10.0 109.391 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.27 131.15 41.82 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.943 2.429 . . . . 10.0 110.573 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.05 162.58 16.49 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.82 0.819 . . . . 10.0 109.113 166.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -79.17 68.15 5.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.598 -1.63 . . . . 10.0 106.598 167.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -49.81 -32.34 13.86 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.316 1.446 . . . . 10.0 113.321 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.65 -36.89 74.84 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.433 1.015 . . . . 10.0 112.563 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.5 mt -66.62 -49.23 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -58.13 -44.21 87.68 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 117.858 -1.068 . . . . 10.0 111.99 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 p -64.79 -38.06 89.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 120.235 1.38 . . . . 10.0 111.273 -177.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.66 -40.31 88.59 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.58 1.082 . . . . 10.0 110.672 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -65.53 -45.72 82.37 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.793 -0.567 . . . . 10.0 110.337 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.3 mt -59.66 -43.12 90.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 118.017 -0.992 . . . . 10.0 109.213 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -57.95 -41.76 83.52 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 119.024 0.829 . . . . 10.0 110.669 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.69 -44.01 87.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.394 0.543 . . . . 10.0 111.03 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -69.46 -53.86 17.13 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.671 -0.643 . . . . 10.0 111.365 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -69.78 148.97 96.7 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.527 1.131 . . . . 10.0 110.737 -168.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -59.43 -40.46 66.96 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.377 2.052 . . . . 10.0 113.818 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.16 151.61 23.99 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.144 -0.317 . . . . 10.0 110.144 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -111.31 18.09 19.58 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.631 0.772 . . . . 10.0 113.072 -168.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -111.43 121.34 44.94 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 123.252 1.501 . . . . 10.0 109.093 171.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 t -137.99 141.77 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.444 -2.058 . . . . 10.0 105.444 170.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.3 p -133.22 173.43 11.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.61 0.641 . . . . 10.0 109.622 171.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -144.89 165.34 28.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.508 0.323 . . . . 10.0 111.039 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.76 163.17 37.55 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.215 1.806 . . . . 10.0 108.38 171.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -149.3 34.64 0.72 Allowed 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 124.054 0.942 . . . . 10.0 109.199 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.61 -27.26 68.53 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.079 0.951 . . . . 10.0 112.853 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.22 -177.69 44.49 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 108.897 -1.681 . . . . 10.0 108.897 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.6 t80 . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.082 -0.961 . . . . 10.0 109.293 171.836 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 tpp . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 118.217 -0.897 . . . . 10.0 109.741 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.67 166.41 25.91 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.968 0.907 . . . . 10.0 111.122 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.36 161.77 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 128.673 2.789 . . . . 10.0 106.709 174.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.67 -179.23 7.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.174 1.39 . . . . 10.0 108.999 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -149.31 151.16 33.69 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.51 -25.42 62.38 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.399 -0.81 . . . . 10.0 113.07 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.03 -31.93 71.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.992 0.814 . . . . 10.0 112.034 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.06 -35.01 57.06 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.049 0.539 . . . . 10.0 110.118 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -65.61 119.77 62.96 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.271 1.028 . . . . 10.0 108.576 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.7 133.4 38.71 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.748 2.966 . . . . 10.0 111.167 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -84.69 -30.17 25.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.444 0.64 . . . . 10.0 111.929 -170.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -136.57 136.26 48.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 126.266 1.827 . . . . 10.0 106.07 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -149.48 101.54 3.11 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.205 -1.406 . . . . 10.0 107.205 170.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.2 pt -137.13 158.5 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.495 1.518 . . . . 10.0 108.096 -174.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -145.71 35.62 1.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.378 1.085 . . . . 10.0 109.83 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 m -75.17 51.2 0.52 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.527 2.331 . . . . 10.0 113.229 -169.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.23 40.64 0.16 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.318 1.847 . . . . 10.0 111.432 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.24 177.02 39.11 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 128.125 2.774 . . . . 10.0 106.975 -174.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.99 113.59 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 118.878 1.339 . . . . 10.0 107.691 172.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -142.53 138.01 30.59 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.668 0.787 . . . . 10.0 108.972 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -59.79 155.03 16.96 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.894 0.878 . . . . 10.0 109.733 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.12 166.47 27.75 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.173 0.989 . . . . 10.0 108.457 174.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.15 148.02 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.012 0.925 . . . . 10.0 108.599 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.9 tp -109.04 114.15 27.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 105.589 -2.004 . . . . 10.0 105.589 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.4 mt -119.18 133.92 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.045 -1.465 . . . . 10.0 107.045 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -88.5 135.05 33.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.93 133.62 53.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.537 -2.023 . . . . 10.0 105.537 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -111.69 128.33 56.04 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.009 -1.848 . . . . 10.0 106.009 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 p -78.66 146.12 34.21 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.009 0.433 . . . . 10.0 111.111 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.86 67.74 3.78 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 126.45 1.9 . . . . 10.0 106.448 167.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.14 -39.55 26.3 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.52 3.48 . . . . 10.0 114.2 -168.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.57 168.8 18.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.79 -1.559 . . . . 10.0 106.79 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -54.43 -21.48 9.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.419 1.888 . . . . 10.0 114.562 -170.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.41 32.12 1.77 Allowed Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.59 1.09 . . . . 10.0 111.699 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.91 146.23 95.53 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.145 0.972 . . . . 10.0 110.766 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -81.64 44.49 1.74 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 124.323 3.348 . . . . 10.0 112.391 -175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.05 138.65 28.47 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.308 1.043 . . . . 10.0 109.572 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.55 27.98 0.64 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.515 1.526 . . . . 10.0 110.358 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.07 164.47 20.13 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.857 0.863 . . . . 10.0 109.527 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -139.54 160.17 40.47 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.909 0.884 . . . . 10.0 110.787 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -149.28 176.07 10.86 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.805 1.242 . . . . 10.0 109.506 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -102.97 154.18 19.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.81 -0.811 . . . . 10.0 108.81 169.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.2 pt -134.04 154.11 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 125.456 1.502 . . . . 10.0 109.583 170.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.42 127.87 62.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.284 -1.747 . . . . 10.0 106.284 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -131.16 134.97 47.03 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 107.863 -1.162 . . . . 10.0 107.863 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.18 49.59 0.31 Allowed Glycine 0 N--CA 1.46 0.258 0 N-CA-C 110.601 -1.0 . . . . 10.0 110.601 -170.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.33 132.5 46.51 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.465 -0.569 . . . . 10.0 109.465 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -65.45 -26.57 68.01 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 113.483 0.92 . . . . 10.0 113.483 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -67.6 -22.83 65.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.46 -0.781 . . . . 10.0 112.774 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.7 128.89 38.02 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.975 0.807 . . . . 10.0 110.462 -174.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -74.58 -24.75 58.96 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.288 0.566 . . . . 10.0 110.412 173.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -147.13 152.64 38.8 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 120.521 -1.362 . . . . 10.0 109.613 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -53.8 -37.39 63.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.133 0.973 . . . . 10.0 111.137 168.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.2 -31.26 71.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.523 -0.751 . . . . 10.0 112.58 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -69.31 -39.04 78.51 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.149 0.976 . . . . 10.0 109.602 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.74 -53.37 47.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 173.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.82 -46.42 74.55 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.727 -0.654 . . . . 10.0 111.135 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.32 -47.26 86.77 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.302 0.376 . . . . 10.0 111.407 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -65.89 -47.26 75.44 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 121.745 -0.597 . . . . 10.0 109.796 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.84 -39.26 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 118.193 -0.908 . . . . 10.0 110.131 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -59.77 -44.65 93.78 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.684 1.129 . . . . 10.0 110.678 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.92 -46.57 93.9 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.884 -0.887 . . . . 10.0 110.884 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.04 -48.24 81.16 Favored 'General case' 0 C--O 1.228 -0.066 0 CA-C-N 117.696 0.748 . . . . 10.0 110.851 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.0 mmt -60.08 -38.7 83.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.227 0.611 . . . . 10.0 111.18 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -63.68 -34.62 78.27 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.645 0.657 . . . . 10.0 110.601 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -70.0 -33.04 71.52 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.78 -1.105 . . . . 10.0 112.033 170.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -66.82 -53.18 35.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.444 1.02 . . . . 10.0 109.491 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 130.35 43.17 0.2 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.34 1.448 . . . . 10.0 110.177 -169.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.5 m -148.28 175.08 11.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.159 1.783 . . . . 10.0 108.461 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -145.27 166.16 26.31 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.265 1.026 . . . . 10.0 108.568 170.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.5 m -133.71 155.79 49.1 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.797 1.036 . . . . 10.0 113.797 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -147.54 142.59 27.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.552 1.941 . . . . 10.0 106.286 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.7 m -83.36 136.48 34.33 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.263 -0.898 . . . . 10.0 110.366 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.9 mt -87.66 -25.17 23.65 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.377 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.09 -178.7 41.68 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.929 -1.269 . . . . 10.0 109.929 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.93 -177.91 21.86 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 118.038 0.919 . . . . 10.0 111.928 170.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.87 -147.91 5.92 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 108.851 -1.7 . . . . 10.0 108.851 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.64 155.22 44.18 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.471 1.508 . . . . 10.0 107.906 170.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.1 155.91 18.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 104.517 -2.401 . . . . 10.0 104.517 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.6 m -147.81 144.73 28.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.023 -1.048 . . . . 10.0 108.377 173.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -161.99 151.73 16.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.495 1.518 . . . . 10.0 107.281 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -151.42 102.42 2.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.1 -2.556 . . . . 10.0 104.1 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -57.3 -25.83 59.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.044 0.938 . . . . 10.0 113.037 -169.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -77.61 -7.68 56.73 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.398 1.479 . . . . 10.0 112.56 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -143.08 -39.57 0.33 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.76 1.392 . . . . 10.0 114.76 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -150.8 147.93 27.89 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.291 -1.506 . . . . 10.0 112.637 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 169.06 2.32 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.142 0.977 . . . . 10.0 110.942 168.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt -66.85 141.56 17.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.214 -1.032 . . . . 10.0 108.214 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -135.31 155.03 51.28 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.477 1.511 . . . . 10.0 108.893 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.22 139.69 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.429 1.092 . . . . 10.0 108.439 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -159.37 -172.16 3.62 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.272 -0.893 . . . . 10.0 110.564 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.13 -173.42 36.07 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 121.553 0.53 . . . . 10.0 112.125 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -154.08 160.22 41.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.178 -1.415 . . . . 10.0 107.178 169.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.6 m -124.23 107.33 11.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.9 mtt -56.59 -23.64 42.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.989 1.316 . . . . 10.0 113.664 -169.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.75 -25.11 68.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.528 -0.749 . . . . 10.0 112.767 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -135.71 -50.48 0.72 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.712 0.805 . . . . 10.0 111.111 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.7 -177.94 20.09 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.941 1.734 . . . . 10.0 109.604 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.94 132.98 36.69 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.195 1.93 . . . . 10.0 109.175 169.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.18 152.57 37.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 167.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -78.28 73.09 4.84 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -51.1 -31.0 17.73 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 124.631 1.173 . . . . 10.0 113.258 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.66 -35.81 73.15 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.212 0.914 . . . . 10.0 112.405 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.6 mt -65.11 -51.81 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.208 -1.404 . . . . 10.0 107.208 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -57.63 -44.93 85.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.26 -0.876 . . . . 10.0 112.287 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 p -66.85 -38.65 86.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.704 1.138 . . . . 10.0 111.156 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.08 -39.14 89.8 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.941 0.792 . . . . 10.0 110.736 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -64.65 -46.68 81.46 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 122.056 -0.403 . . . . 10.0 110.683 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.43 -44.07 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -60.81 -42.01 96.82 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.256 0.934 . . . . 10.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.42 87.22 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.281 0.632 . . . . 10.0 111.724 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -71.75 -29.99 65.11 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 118.089 -0.958 . . . . 10.0 111.57 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.264 40.9 p90 36.83 60.63 3.55 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 127.804 2.442 . . . . 10.0 113.926 -169.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -62.07 -27.43 79.16 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 121.188 1.259 . . . . 10.0 110.486 168.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -148.74 154.14 39.18 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 128.509 2.723 . . . . 10.0 105.088 166.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -83.3 141.47 31.79 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.99 0.424 . . . . 10.0 110.431 -174.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 65.27 146.43 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.924 2.49 . . . . 10.0 113.286 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.31 148.54 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.533 1.533 . . . . 10.0 106.926 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.9 p -139.71 166.95 23.23 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 120.987 -1.07 . . . . 10.0 110.034 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -147.12 164.06 34.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.916 0.326 . . . . 10.0 111.134 169.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.54 176.54 10.87 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.536 1.934 . . . . 10.0 108.532 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -139.0 41.97 2.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.281 1.032 . . . . 10.0 109.09 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.58 -30.5 70.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.065 0.946 . . . . 10.0 113.063 -174.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.68 -179.46 46.84 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.09 -1.204 . . . . 10.0 110.09 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.6 t80 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 116.651 -1.642 . . . . 10.0 109.74 172.393 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 117.816 -1.088 . . . . 10.0 109.307 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.63 161.06 41.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.933 1.693 . . . . 10.0 107.879 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.37 147.24 11.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 124.294 0.996 . . . . 10.0 109.89 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.49 178.56 8.28 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.953 0.883 . . . . 10.0 111.399 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -147.62 151.44 36.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.3 -1.741 . . . . 10.0 106.3 170.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.5 mt -59.88 -22.55 62.49 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 117.602 -1.189 . . . . 10.0 113.947 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.5 -33.58 75.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.034 0.834 . . . . 10.0 111.615 172.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.16 -34.35 43.23 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.989 0.516 . . . . 10.0 110.299 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -65.21 125.03 88.54 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.799 -1.186 . . . . 10.0 107.799 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.35 139.86 61.51 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.326 2.018 . . . . 10.0 109.875 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.92 -31.5 51.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.036 0.935 . . . . 10.0 111.644 -171.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.5 t -140.41 136.17 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 105.129 -2.174 . . . . 10.0 105.129 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -150.77 102.34 2.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 172.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 pt -131.15 42.78 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.967 1.307 . . . . 10.0 109.478 -168.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -64.46 81.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.447 1.899 . . . . 10.0 111.737 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m -162.64 175.36 11.46 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.314 2.246 . . . . 10.0 108.18 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -147.63 155.39 41.74 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 125.286 1.434 . . . . 10.0 107.613 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.82 -162.15 48.5 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.102 -1.199 . . . . 10.0 110.102 -166.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 37.5 t -72.16 139.64 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.025 -1.102 . . . . 10.0 108.025 167.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -152.49 148.55 27.54 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.575 1.179 . . . . 10.0 111.213 172.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -63.82 145.98 54.79 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.06 160.74 40.36 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.488 0.715 . . . . 10.0 110.159 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.95 146.42 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.576 1.55 . . . . 10.0 108.132 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 tt -106.49 122.22 45.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 105.438 -2.06 . . . . 10.0 105.438 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.8 mt -126.03 133.26 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.997 -1.483 . . . . 10.0 106.997 -171.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 ttm105 -85.47 139.0 31.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 167.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.27 140.58 41.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 124.579 1.152 . . . . 10.0 107.894 175.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -115.54 127.32 55.18 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.692 -1.966 . . . . 10.0 105.692 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.9 p -74.39 144.54 44.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.228 0.537 . . . . 10.0 111.399 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.0 71.07 4.65 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.795 2.038 . . . . 10.0 106.419 167.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.76 -38.92 47.75 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.69 2.927 . . . . 10.0 112.55 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -146.4 162.74 37.57 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 105.257 -2.127 . . . . 10.0 105.257 170.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -55.6 -23.21 26.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.508 1.299 . . . . 10.0 114.508 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -132.5 25.34 3.81 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.69 1.138 . . . . 10.0 111.865 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.86 149.83 89.0 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 118.679 1.24 . . . . 10.0 110.932 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.65 41.66 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.052 3.168 . . . . 10.0 112.03 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.1 135.09 22.59 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.267 1.027 . . . . 10.0 109.001 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.04 27.52 0.77 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.848 1.659 . . . . 10.0 109.579 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.69 166.46 17.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.302 1.041 . . . . 10.0 109.515 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.1 m -136.39 161.19 36.51 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.405 -0.81 . . . . 10.0 110.459 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -146.9 170.7 16.52 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.299 1.439 . . . . 10.0 107.664 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -122.48 140.95 52.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.261 -2.125 . . . . 10.0 105.261 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.2 pt -134.97 154.12 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.347 1.059 . . . . 10.0 110.123 -173.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.97 128.63 69.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -133.75 144.26 48.97 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.041 -1.466 . . . . 10.0 107.041 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.37 131.55 1.96 Allowed Glycine 0 CA--C 1.506 -0.493 0 CA-C-N 120.193 1.361 . . . . 10.0 111.033 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -147.22 139.29 24.43 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -70.84 -17.59 62.73 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 116.885 -1.531 . . . . 10.0 114.277 -173.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -68.52 -17.22 64.12 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 119.994 1.27 . . . . 10.0 112.012 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.81 127.39 31.72 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 119.856 1.207 . . . . 10.0 111.513 -172.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.79 -44.47 85.64 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.802 0.81 . . . . 10.0 109.068 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -146.51 168.83 20.25 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 127.183 2.193 . . . . 10.0 106.898 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.649 ' CD2' ' HG ' ' A' ' 94' ' ' SER . 71.2 m80 -56.98 -36.13 69.97 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.997 -1.064 . . . . 10.0 112.403 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.27 -24.51 63.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.11 -0.947 . . . . 10.0 112.657 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -66.49 -36.34 82.49 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.903 1.335 . . . . 10.0 109.549 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -65.71 -53.78 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 120.471 -1.393 . . . . 10.0 108.505 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -54.73 -40.18 69.02 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.76 -1.114 . . . . 10.0 111.473 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.59 -46.24 90.69 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.347 0.976 . . . . 10.0 111.756 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -65.27 -48.15 74.22 Favored 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 121.002 -1.061 . . . . 10.0 109.718 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.07 -42.48 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.554 -0.535 . . . . 10.0 109.554 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 p -65.06 -34.46 78.47 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.576 1.08 . . . . 10.0 111.362 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.76 -47.93 81.66 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.08 -47.41 84.81 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 117.363 0.582 . . . . 10.0 111.115 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.7 mmt -60.7 -36.8 79.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.137 -0.935 . . . . 10.0 110.57 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.53 -39.85 94.53 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.39 0.996 . . . . 10.0 111.08 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -70.72 -27.19 63.79 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.759 1.163 . . . . 10.0 111.779 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -69.61 -55.64 9.51 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.335 0.97 . . . . 10.0 108.84 175.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.17 42.66 0.14 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.029 1.3 . . . . 10.0 111.553 -173.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 50.9 m -142.17 168.01 20.76 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.278 1.431 . . . . 10.0 109.508 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.73 160.71 30.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.156 1.782 . . . . 10.0 107.138 170.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.3 m -129.7 153.17 48.43 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.443 1.097 . . . . 10.0 112.663 -166.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -142.72 110.65 5.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.907 -1.886 . . . . 10.0 105.907 170.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.5 p -61.26 122.95 16.38 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.248 -0.908 . . . . 10.0 109.103 170.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.1 mt -86.37 -22.55 26.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.163 0.506 . . . . 10.0 110.558 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.84 -177.18 30.66 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 108.239 -1.945 . . . . 10.0 108.239 -172.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.32 -161.2 13.77 Favored Glycine 0 CA--C 1.52 0.371 0 O-C-N 121.016 -1.285 . . . . 10.0 110.714 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.97 -138.63 3.84 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.656 -1.778 . . . . 10.0 108.656 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -136.81 144.43 43.68 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.698 1.199 . . . . 10.0 107.884 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.84 151.55 8.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 104.656 -2.35 . . . . 10.0 104.656 169.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.1 m -131.84 131.39 42.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -141.58 147.35 37.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.444 -1.317 . . . . 10.0 107.444 -171.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -149.12 135.75 19.52 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 104.796 -2.298 . . . . 10.0 104.796 165.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.8 m -67.42 -18.87 65.28 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.838 1.051 . . . . 10.0 113.838 -169.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -145.02 166.62 24.8 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.775 1.63 . . . . 10.0 108.206 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 65.07 -7.45 0.28 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 127.701 2.4 . . . . 10.0 114.912 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -139.86 -179.8 6.15 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 118.991 -2.318 . . . . 10.0 108.235 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.58 169.97 11.94 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.749 1.62 . . . . 10.0 109.059 175.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.72 142.82 13.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.057 -1.46 . . . . 10.0 107.057 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -139.02 159.66 41.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.5 t -141.62 132.53 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.668 -1.234 . . . . 10.0 107.668 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.89 176.69 10.56 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.799 -1.188 . . . . 10.0 111.434 -171.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.27 -166.01 52.28 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 121.732 -0.605 . . . . 10.0 111.59 -176.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -150.52 160.2 43.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.504 1.122 . . . . 10.0 108.05 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.649 ' HG ' ' CD2' ' A' ' 53' ' ' HIS . 70.2 m -86.42 116.7 24.74 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.983 0.811 . . . . 10.0 109.594 172.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -58.56 -25.52 62.62 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 122.877 0.471 . . . . 10.0 110.537 170.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.28 -29.19 70.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.629 -1.177 . . . . 10.0 113.56 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.68 -55.63 0.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.924 1.238 . . . . 10.0 110.884 -176.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.11 -178.79 36.92 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.523 -1.031 . . . . 10.0 110.523 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.43 134.48 41.84 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.818 2.345 . . . . 10.0 109.909 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.09 162.17 28.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.816 0.817 . . . . 10.0 109.796 164.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -80.01 74.84 6.76 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.198 -1.408 . . . . 10.0 107.198 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -48.83 -31.36 6.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.225 1.41 . . . . 10.0 114.487 -170.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.89 72.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.135 0.88 . . . . 10.0 112.408 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.9 mt -63.48 -52.21 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -58.96 -44.77 91.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.305 -0.855 . . . . 10.0 111.355 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.8 p -65.24 -39.17 92.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.702 1.137 . . . . 10.0 111.679 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -65.4 -40.38 93.37 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.648 1.113 . . . . 10.0 109.832 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -66.76 -46.31 75.77 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.03 0.532 . . . . 10.0 110.114 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 72.6 mt -57.51 -45.65 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -61.11 -41.74 97.25 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.158 0.89 . . . . 10.0 110.825 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.77 -39.87 95.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.589 0.631 . . . . 10.0 111.195 174.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -69.29 -31.89 70.69 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 117.296 -1.335 . . . . 10.0 112.181 178.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -134.48 67.25 71.74 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.362 1.065 . . . . 10.0 110.506 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.45 -22.43 50.5 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.846 2.364 . . . . 10.0 114.922 -176.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.43 -12.37 51.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.754 1.222 . . . . 10.0 112.863 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -127.59 146.38 50.55 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.63 -1.294 . . . . 10.0 109.74 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -71.05 153.39 42.64 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.021 -1.104 . . . . 10.0 108.021 165.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 t -135.89 137.05 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 106.744 -1.576 . . . . 10.0 106.744 175.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.1 p -142.86 170.82 14.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.855 1.262 . . . . 10.0 109.128 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -145.6 166.74 24.89 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 119.199 0.909 . . . . 10.0 111.346 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.3 172.32 14.05 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.369 2.268 . . . . 10.0 108.124 173.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -145.33 20.27 1.55 Allowed 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.712 0.805 . . . . 10.0 111.84 -175.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.34 -36.85 71.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.451 1.101 . . . . 10.0 112.615 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 163.52 170.12 27.96 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 51.1 t80 . . . . . 0 C--O 1.254 1.293 0 CA-C-O 116.308 -1.806 . . . . 10.0 108.291 168.8 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.19 164.75 34.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.023 1.329 . . . . 10.0 109.014 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.54 160.92 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.994 0.918 . . . . 10.0 110.563 172.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.71 169.66 12.43 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.382 0.611 . . . . 10.0 111.701 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -152.02 154.63 36.38 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.458 1.503 . . . . 10.0 107.203 173.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.77 -24.79 58.82 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.716 0.806 . . . . 10.0 112.81 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.16 -26.76 66.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.37 0.986 . . . . 10.0 112.368 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.2 mt -75.76 -25.08 56.17 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.033 0.533 . . . . 10.0 111.306 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.6 mt -84.16 127.49 66.39 Favored Pre-proline 0 C--O 1.237 0.436 0 N-CA-C 106.722 -1.584 . . . . 10.0 106.722 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.3 147.17 77.77 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.185 1.923 . . . . 10.0 109.769 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.04 -30.44 55.65 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.535 0.683 . . . . 10.0 112.052 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.83 134.86 45.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.14 -2.171 . . . . 10.0 105.14 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -151.2 114.39 4.79 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.305 -1.369 . . . . 10.0 107.305 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.43 140.13 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.132 1.773 . . . . 10.0 106.272 -175.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -154.55 83.09 1.11 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.81 0.814 . . . . 10.0 108.827 -177.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 m -161.45 175.65 11.94 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.418 1.887 . . . . 10.0 108.572 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -140.76 158.73 43.55 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 125.097 1.359 . . . . 10.0 108.066 177.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.74 -157.65 50.48 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.931 -1.268 . . . . 10.0 109.931 -169.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.18 139.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 169.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -147.6 154.56 40.83 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.197 0.999 . . . . 10.0 110.325 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -79.08 145.92 33.54 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.991 1.316 . . . . 10.0 109.017 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.2 162.25 39.28 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.993 0.425 . . . . 10.0 110.458 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.61 143.19 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 125.261 1.424 . . . . 10.0 107.565 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.72 125.37 47.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.328 -2.101 . . . . 10.0 105.328 171.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.3 mt -128.87 130.17 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.552 -1.647 . . . . 10.0 106.552 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -83.43 135.42 34.69 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.007 -1.849 . . . . 10.0 106.007 168.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 p -124.82 138.4 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.793 -1.558 . . . . 10.0 106.793 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -121.98 131.05 53.8 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.927 1.691 . . . . 10.0 106.647 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 p -67.65 140.23 56.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.783 0.325 . . . . 10.0 110.326 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.42 62.4 4.92 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.803 1.241 . . . . 10.0 108.557 168.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -53.96 -35.29 80.06 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.188 3.259 . . . . 10.0 113.503 -169.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -153.14 161.15 42.79 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.855 2.062 . . . . 10.0 105.738 172.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -55.99 -22.3 26.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.653 1.353 . . . . 10.0 114.653 -172.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.1 26.75 3.37 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.492 1.044 . . . . 10.0 112.045 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.96 148.88 91.52 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 118.039 0.92 . . . . 10.0 110.611 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -79.9 42.96 1.41 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 124.308 3.339 . . . . 10.0 111.999 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.28 139.31 28.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.379 1.072 . . . . 10.0 109.514 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.21 16.79 0.41 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.424 1.49 . . . . 10.0 111.797 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -63.33 160.03 16.8 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.274 1.43 . . . . 10.0 109.722 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.9 m -140.64 161.36 37.95 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.206 1.003 . . . . 10.0 110.66 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -146.99 179.33 7.68 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.967 1.307 . . . . 10.0 108.87 169.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -120.31 143.38 48.39 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.191 -1.041 . . . . 10.0 108.191 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.0 146.97 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.991 1.316 . . . . 10.0 110.289 -171.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.19 125.97 60.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.649 -1.611 . . . . 10.0 106.649 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -131.91 144.18 50.67 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.657 -1.609 . . . . 10.0 106.657 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.71 130.9 1.86 Allowed Glycine 0 C--N 1.329 0.156 0 CA-C-N 120.017 1.281 . . . . 10.0 112.868 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -150.91 142.38 23.46 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.218 1.007 . . . . 10.0 109.293 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -72.49 -16.89 61.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.118 1.155 . . . . 10.0 114.118 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -65.97 -21.37 66.41 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.69 1.132 . . . . 10.0 112.828 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.11 130.7 44.32 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 118.485 0.584 . . . . 10.0 110.804 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -67.8 -41.5 83.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -144.12 158.58 43.63 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 126.319 1.848 . . . . 10.0 107.169 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.532 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 71.7 m80 -56.27 -32.02 64.14 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.525 0.73 . . . . 10.0 112.853 -175.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.09 -27.02 65.16 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.866 -0.588 . . . . 10.0 112.136 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.43 -35.9 78.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.503 0.592 . . . . 10.0 110.795 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.56 -50.85 69.4 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 107.683 -1.229 . . . . 10.0 107.683 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -55.28 -45.59 76.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.928 -0.558 . . . . 10.0 111.171 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.46 -45.27 88.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 118.541 0.61 . . . . 10.0 111.822 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -59.0 -50.1 75.36 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.562 0.745 . . . . 10.0 109.481 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.64 -46.11 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.521 0.728 . . . . 10.0 109.068 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 m -59.08 -36.03 74.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.352 0.978 . . . . 10.0 111.486 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.02 -49.32 76.48 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.531 -1.028 . . . . 10.0 110.531 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.01 -45.87 91.71 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 117.751 0.776 . . . . 10.0 111.283 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -36.43 82.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.776 -0.63 . . . . 10.0 111.057 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -65.05 -35.73 82.09 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.9 0.773 . . . . 10.0 110.942 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -66.36 -32.18 73.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.135 -0.936 . . . . 10.0 111.542 172.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -69.19 -60.47 2.33 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.913 0.779 . . . . 10.0 109.281 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.66 47.38 0.09 OUTLIER Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.826 1.679 . . . . 10.0 109.456 -169.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.9 m -146.79 172.43 13.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.263 1.825 . . . . 10.0 108.734 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -137.87 160.45 39.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.846 1.659 . . . . 10.0 108.361 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.4 m -134.54 154.39 51.48 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.118 0.967 . . . . 10.0 112.894 -168.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -144.78 109.93 5.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.588 1.955 . . . . 10.0 106.857 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -60.04 126.88 29.24 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.114 -0.991 . . . . 10.0 109.544 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.2 mt -91.69 -26.57 18.57 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.698 0.399 . . . . 10.0 110.351 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.33 169.58 31.95 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.641 -0.984 . . . . 10.0 110.641 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.96 166.51 22.01 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.952 1.263 . . . . 10.0 110.883 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.48 -161.56 23.91 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.529 -1.428 . . . . 10.0 109.529 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -138.24 156.66 47.47 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.09 -1.241 . . . . 10.0 108.972 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.9 mt -127.81 146.95 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 104.54 -2.393 . . . . 10.0 104.54 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.2 m -113.44 120.75 42.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.903 -1.518 . . . . 10.0 106.903 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -68.81 156.07 39.04 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.872 0.869 . . . . 10.0 110.845 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -61.86 149.34 40.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.093 1.357 . . . . 10.0 110.157 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.9 m -139.79 25.02 2.38 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.718 1.207 . . . . 10.0 110.926 -176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 51.64 43.88 29.54 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.558 1.543 . . . . 10.0 109.476 -168.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -157.68 -43.3 0.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.408 0.683 . . . . 10.0 112.641 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -145.85 137.09 24.79 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.597 1.159 . . . . 10.0 108.213 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.16 156.17 4.28 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.645 1.178 . . . . 10.0 112.817 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.4 pt -58.47 133.92 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.122 -1.066 . . . . 10.0 108.122 168.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -149.25 156.6 42.37 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.223 -1.029 . . . . 10.0 108.223 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.31 137.7 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.09 0.956 . . . . 10.0 108.51 -169.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -160.17 -177.11 6.05 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.344 -0.847 . . . . 10.0 110.114 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.64 178.93 37.86 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.244 0.449 . . . . 10.0 112.218 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -153.61 -176.23 5.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.227 1.011 . . . . 10.0 108.815 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.532 ' HG ' ' CE1' ' A' ' 53' ' ' HIS . 14.9 m -137.06 111.14 8.32 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -176.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.4 mtt -61.11 -12.87 13.76 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.359 0.664 . . . . 10.0 112.639 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.06 -32.39 54.47 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.124 0.97 . . . . 10.0 112.428 170.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.56 -37.11 0.14 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.377 0.881 . . . . 10.0 113.377 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 141.82 -178.68 20.44 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.612 1.101 . . . . 10.0 110.654 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.22 143.79 78.71 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.219 2.613 . . . . 10.0 110.2 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.44 32.75 0.09 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.182 1.793 . . . . 10.0 113.737 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 37.66 55.45 1.5 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.093 2.557 . . . . 10.0 110.171 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -45.45 -26.84 0.61 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.771 2.428 . . . . 10.0 116.275 -166.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.02 83.2 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.567 1.53 . . . . 10.0 111.899 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.4 -55.03 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -63.93 -39.91 95.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.606 -0.712 . . . . 10.0 112.017 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.0 p -64.85 -38.61 91.56 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 119.417 1.008 . . . . 10.0 110.57 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.59 -41.41 96.27 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.673 1.124 . . . . 10.0 111.241 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -64.08 -47.89 78.34 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.819 -0.55 . . . . 10.0 110.663 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.85 -42.43 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.839 0.855 . . . . 10.0 108.828 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -60.31 -40.15 89.53 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.244 1.018 . . . . 10.0 111.206 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.0 96.43 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.162 0.437 . . . . 10.0 110.936 174.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -77.57 -36.82 51.7 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.776 -1.106 . . . . 10.0 113.101 -171.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.88 148.38 51.02 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 119.942 1.246 . . . . 10.0 112.422 -168.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.25 -10.06 16.35 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.51 2.806 . . . . 10.0 114.111 -172.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -77.76 67.29 3.62 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.283 -1.006 . . . . 10.0 108.283 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -58.89 -16.45 17.61 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.543 1.537 . . . . 10.0 115.025 -168.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -77.94 31.77 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 120.843 1.656 . . . . 10.0 112.144 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.97 127.58 15.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.4 -1.333 . . . . 10.0 107.4 170.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.12 167.07 26.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.432 1.493 . . . . 10.0 107.5 -172.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -144.15 159.67 42.25 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.662 -0.496 . . . . 10.0 109.662 172.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.89 -23.52 0.57 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.0 t30 41.68 53.94 3.85 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.282 1.433 . . . . 10.0 112.46 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.88 -25.72 68.28 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.522 0.934 . . . . 10.0 113.522 -173.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -168.94 171.84 43.05 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.584 1.564 . . . . 10.0 109.403 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.0 t80 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 124.314 1.045 . . . . 10.0 111.844 -174.282 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.484 -0.562 . . . . 10.0 109.484 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.68 167.78 17.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.346 0.658 . . . . 10.0 110.386 170.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.78 166.4 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.306 0.574 . . . . 10.0 110.637 169.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.61 179.19 7.87 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.552 1.941 . . . . 10.0 107.196 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -148.12 152.71 37.78 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.041 -1.096 . . . . 10.0 108.041 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.4 mt -54.91 -31.1 59.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.342 1.057 . . . . 10.0 112.637 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.59 -24.59 66.78 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.7 mt -76.32 -23.74 54.3 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.88 0.472 . . . . 10.0 111.203 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.5 mt -74.48 135.42 75.52 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.001 -1.481 . . . . 10.0 107.001 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.47 138.03 53.24 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.21 1.94 . . . . 10.0 109.062 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.72 -31.79 68.76 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.054 0.761 . . . . 10.0 113.054 -169.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -158.11 136.53 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 105.944 -1.873 . . . . 10.0 105.944 -174.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -157.34 112.72 2.81 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.577 -0.897 . . . . 10.0 108.577 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 pt -134.09 31.83 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.487 1.515 . . . . 10.0 109.964 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.41 101.21 0.12 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.947 0.899 . . . . 10.0 111.467 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -167.55 177.27 6.01 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.949 2.5 . . . . 10.0 108.161 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -140.83 156.39 46.15 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 124.535 1.134 . . . . 10.0 108.796 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.95 -155.97 41.5 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.458 -1.057 . . . . 10.0 110.458 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.28 141.47 17.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.655 -0.869 . . . . 10.0 108.655 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -154.04 154.85 34.43 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.248 1.019 . . . . 10.0 110.019 168.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -77.75 151.02 34.3 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.112 0.965 . . . . 10.0 109.45 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.53 161.5 38.3 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.507 0.723 . . . . 10.0 109.75 176.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.51 152.69 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.091 1.356 . . . . 10.0 108.988 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -115.35 121.99 44.51 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.58 -2.007 . . . . 10.0 105.58 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 95.2 mt -130.71 134.24 62.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.408 -1.33 . . . . 10.0 107.408 -169.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -85.23 144.56 28.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.533 -1.654 . . . . 10.0 106.533 167.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.99 144.12 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -124.21 132.35 53.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.093 1.757 . . . . 10.0 106.449 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.2 p -64.39 139.86 58.81 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.973 -0.38 . . . . 10.0 109.973 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.48 62.17 2.83 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.854 1.262 . . . . 10.0 108.612 169.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -59.27 135.33 64.85 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.918 2.412 . . . . 10.0 109.499 -172.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 44.76 26.96 0.22 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.925 1.29 . . . . 10.0 113.601 -171.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m 51.54 29.66 5.66 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.22 1.408 . . . . 10.0 113.434 -176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.22 -7.41 0.02 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 116.58 1.392 . . . . 10.0 116.58 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 153.06 80.64 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 120.062 1.931 . . . . 10.0 110.476 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.18 64.06 7.81 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.26 3.306 . . . . 10.0 111.941 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.5 138.21 34.43 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.334 1.453 . . . . 10.0 108.317 172.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.1 25.17 0.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.757 1.223 . . . . 10.0 110.781 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.29 161.14 25.64 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 169.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -139.63 163.51 32.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.291 1.036 . . . . 10.0 110.996 -176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -151.43 166.95 29.49 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.947 2.099 . . . . 10.0 107.862 -170.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.3 mp0 -122.32 143.15 49.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 pt -136.77 155.36 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.441 1.896 . . . . 10.0 109.228 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.48 129.95 74.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -134.68 147.03 50.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.661 -1.607 . . . . 10.0 106.661 -172.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.78 124.17 1.0 Allowed Glycine 0 C--O 1.224 -0.497 0 CA-C-N 119.642 1.11 . . . . 10.0 110.644 172.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -144.52 138.12 27.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 123.846 0.38 . . . . 10.0 110.429 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -61.45 -29.78 70.17 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.22 1.008 . . . . 10.0 112.876 -175.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -64.07 -23.14 67.22 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.957 0.799 . . . . 10.0 112.97 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.37 118.7 14.5 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 119.26 0.936 . . . . 10.0 109.791 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -68.38 -34.16 75.55 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.878 0.471 . . . . 10.0 109.965 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -142.46 151.94 42.24 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.076 1.751 . . . . 10.0 107.894 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.694 ' CD2' ' HG ' ' A' ' 94' ' ' SER . 72.4 m80 -57.17 -36.69 71.09 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.676 0.621 . . . . 10.0 112.676 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.95 -27.06 63.06 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 124.0 0.812 . . . . 10.0 112.175 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.73 -35.36 79.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.26 0.482 . . . . 10.0 110.926 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -66.37 -54.83 22.22 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 N-CA-C 107.399 -1.334 . . . . 10.0 107.399 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -56.93 -41.95 79.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.944 -0.55 . . . . 10.0 111.55 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.33 -47.38 79.61 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.908 0.483 . . . . 10.0 111.632 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -60.97 -47.69 85.29 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 121.872 -0.518 . . . . 10.0 109.695 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.19 -47.57 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 118.475 -0.774 . . . . 10.0 108.996 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 m -57.82 -42.44 84.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.348 0.976 . . . . 10.0 110.897 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.63 -44.29 98.01 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.235 -0.746 . . . . 10.0 111.235 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.87 -48.01 72.99 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.111 0.955 . . . . 10.0 111.504 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -41.07 78.17 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 119.074 0.852 . . . . 10.0 110.121 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -62.69 -36.82 84.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.432 -0.794 . . . . 10.0 110.988 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.1 pttm -74.23 -25.42 59.65 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.468 -1.253 . . . . 10.0 112.652 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -68.31 -56.09 9.81 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.902 1.228 . . . . 10.0 109.151 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.13 45.28 0.14 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.522 1.534 . . . . 10.0 109.896 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.1 m -147.02 175.37 10.74 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.817 2.047 . . . . 10.0 107.875 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -145.64 165.27 29.21 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.892 -0.781 . . . . 10.0 108.892 169.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.94 164.13 19.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.771 1.026 . . . . 10.0 113.771 -168.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -147.07 112.84 5.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.9 2.48 . . . . 10.0 105.734 175.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.9 t -65.2 140.44 58.75 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.916 -1.115 . . . . 10.0 109.48 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.3 mt -106.14 -10.9 16.28 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.732 0.813 . . . . 10.0 111.047 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.31 -177.75 18.74 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.467 1.508 . . . . 10.0 109.723 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.59 -164.23 13.57 Favored Glycine 0 CA--C 1.522 0.519 0 O-C-N 121.472 -1.017 . . . . 10.0 112.04 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.28 -149.71 7.72 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 109.667 -1.373 . . . . 10.0 109.667 -172.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -143.06 155.96 44.72 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.602 1.161 . . . . 10.0 109.275 -174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.1 mt -136.43 153.97 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.529 -2.026 . . . . 10.0 105.529 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.6 m -129.24 117.27 20.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 169.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -57.11 133.87 55.37 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 43.58 59.83 2.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.052 1.341 . . . . 10.0 111.258 -172.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -52.61 -36.26 55.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.081 0.552 . . . . 10.0 110.86 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -126.35 170.03 12.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.019 1.727 . . . . 10.0 106.842 168.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.34 -22.86 54.94 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.292 1.219 . . . . 10.0 114.292 -169.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -127.49 -5.72 5.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 117.818 -1.087 . . . . 10.0 113.716 -175.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.38 169.16 24.88 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 120.35 1.432 . . . . 10.0 112.487 -172.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 pt -116.06 166.06 10.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 122.826 1.298 . . . . 10.0 110.917 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -134.77 154.45 51.59 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.663 1.985 . . . . 10.0 107.912 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 t -129.57 136.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -150.83 175.7 11.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.728 0.695 . . . . 10.0 111.816 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.84 -153.76 53.05 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.667 0.651 . . . . 10.0 112.981 170.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -150.6 -179.7 7.46 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.381 1.472 . . . . 10.0 109.601 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.694 ' HG ' ' CD2' ' A' ' 53' ' ' HIS . 64.9 m -114.94 122.89 47.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.805 0.842 . . . . 10.0 109.194 170.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -58.35 -29.23 65.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.352 1.061 . . . . 10.0 111.213 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.75 -25.41 66.48 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.737 1.014 . . . . 10.0 113.737 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -59.03 0.25 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.514 1.052 . . . . 10.0 111.271 -174.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.88 179.66 35.77 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.515 -1.034 . . . . 10.0 110.515 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -56.68 137.41 80.98 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.016 2.477 . . . . 10.0 111.138 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.55 165.81 21.92 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.603 0.715 . . . . 10.0 109.241 167.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -81.59 69.12 8.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.366 -1.716 . . . . 10.0 106.366 167.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -49.24 -30.19 6.82 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.663 1.585 . . . . 10.0 114.196 -169.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.15 -36.28 74.99 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.374 0.988 . . . . 10.0 112.266 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.7 mt -62.81 -50.45 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.052 -1.462 . . . . 10.0 107.052 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -58.55 -47.64 83.54 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.741 0.816 . . . . 10.0 111.822 -177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 p -65.39 -37.85 88.24 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.409 -0.805 . . . . 10.0 111.356 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -64.73 -42.67 95.03 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.362 0.983 . . . . 10.0 110.387 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -62.41 -47.95 81.88 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.682 -0.675 . . . . 10.0 110.085 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.62 -52.19 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -57.52 -38.06 74.04 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.349 1.06 . . . . 10.0 111.971 -174.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 -44.01 81.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.78 0.432 . . . . 10.0 111.309 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -90.99 -49.48 6.39 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.406 0.548 . . . . 10.0 111.853 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -72.49 159.4 85.47 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 123.198 0.599 . . . . 10.0 110.195 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.3 -13.85 30.96 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.716 2.277 . . . . 10.0 112.671 175.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.0 115.76 9.59 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.266 -1.013 . . . . 10.0 108.266 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -107.41 13.63 26.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.48 1.112 . . . . 10.0 111.384 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -140.71 36.49 1.81 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.683 1.193 . . . . 10.0 109.687 -174.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.4 t -56.66 146.08 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.918 1.287 . . . . 10.0 108.637 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.9 p -139.63 167.98 20.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.294 1.037 . . . . 10.0 110.149 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -150.63 167.85 26.07 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.961 -0.462 . . . . 10.0 110.957 170.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.5 153.17 38.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.68 1.592 . . . . 10.0 108.513 169.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -72.37 -27.0 62.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.585 0.354 . . . . 10.0 111.662 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -60.85 165.37 4.08 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.374 1.469 . . . . 10.0 112.327 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.77 31.16 10.38 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.932 0.777 . . . . 10.0 112.309 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 . . . . . 0 C--O 1.245 0.861 0 C-N-CA 124.279 1.032 . . . . 10.0 110.147 174.974 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 tmm? . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 118.297 -0.858 . . . . 10.0 110.11 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.63 -175.76 5.6 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.366 1.467 . . . . 10.0 108.648 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -63.74 155.71 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 122.989 0.515 . . . . 10.0 110.275 169.035 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.16 177.35 11.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.493 2.317 . . . . 10.0 106.808 176.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -150.3 150.69 31.83 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.75 -1.204 . . . . 10.0 107.75 173.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -59.15 -23.47 62.2 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 118.211 -0.9 . . . . 10.0 112.88 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.28 -26.41 67.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.473 1.033 . . . . 10.0 112.473 175.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -73.97 -26.25 60.37 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.111 0.564 . . . . 10.0 111.009 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.38 127.16 62.18 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 106.737 -1.579 . . . . 10.0 106.737 -174.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.62 149.03 79.23 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.226 1.951 . . . . 10.0 110.087 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.66 -33.68 60.43 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.47 1.108 . . . . 10.0 111.958 -178.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -136.92 135.12 48.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 104.843 -2.28 . . . . 10.0 104.843 176.432 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -150.5 118.07 6.12 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.069 -1.826 . . . . 10.0 106.069 171.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.8 pt -142.01 158.04 20.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.353 1.061 . . . . 10.0 110.272 -169.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -144.34 129.39 18.56 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.786 1.235 . . . . 10.0 108.743 174.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.7 p -131.49 177.49 7.45 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.766 1.227 . . . . 10.0 112.297 -166.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -163.92 -35.34 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.363 1.865 . . . . 10.0 108.825 169.305 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.71 -129.23 1.41 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 106.273 -2.731 . . . . 10.0 106.273 170.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.8 t -64.06 144.65 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.418 1.109 . . . . 10.0 108.966 168.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -150.69 147.64 27.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.869 1.268 . . . . 10.0 109.104 172.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -67.82 153.94 42.62 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.772 -0.58 . . . . 10.0 109.685 174.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.17 165.6 26.97 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.979 0.912 . . . . 10.0 109.366 170.549 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.6 147.72 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.428 1.491 . . . . 10.0 107.67 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tt -109.14 121.02 44.27 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 104.777 -2.305 . . . . 10.0 104.777 177.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.5 mt -128.74 140.53 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 -170.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -94.54 131.23 40.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 167.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.91 143.32 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -123.47 130.13 52.24 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.495 1.918 . . . . 10.0 105.857 -175.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.1 p -72.36 142.93 48.77 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.351 -0.241 . . . . 10.0 110.351 175.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.78 59.58 3.54 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.299 1.44 . . . . 10.0 108.205 168.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -58.67 141.41 97.61 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.019 2.48 . . . . 10.0 109.921 -171.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 52.2 16.73 0.61 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.448 1.099 . . . . 10.0 113.058 -177.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m 48.17 31.4 2.55 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.548 1.139 . . . . 10.0 112.897 -169.596 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.88 -1.71 0.02 OUTLIER Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.43 -1.206 . . . . 10.0 115.954 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 153.32 78.91 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 120.094 1.947 . . . . 10.0 110.448 174.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.87 55.29 5.2 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 124.256 3.304 . . . . 10.0 111.855 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.92 139.51 30.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.045 1.338 . . . . 10.0 108.653 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.75 30.09 0.66 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.188 1.395 . . . . 10.0 109.772 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -66.32 158.4 29.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 174.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 m -140.33 160.27 40.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.138 0.975 . . . . 10.0 110.326 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -150.22 169.57 21.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.132 0.973 . . . . 10.0 109.635 171.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -98.5 149.06 23.12 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.499 -0.926 . . . . 10.0 108.499 172.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.1 pt -138.9 154.43 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.055 1.742 . . . . 10.0 109.924 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.25 128.8 64.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.985 -1.487 . . . . 10.0 106.985 176.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 mmp_? -134.61 138.12 44.26 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.873 -1.529 . . . . 10.0 106.873 -178.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.38 122.91 0.92 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-N 119.725 1.148 . . . . 10.0 110.996 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -142.84 133.93 25.8 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 -172.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -59.55 -21.58 60.48 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 114.515 1.302 . . . . 10.0 114.515 -175.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -65.34 -25.33 67.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.377 1.444 . . . . 10.0 112.276 177.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.85 116.14 11.89 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.854 1.206 . . . . 10.0 110.371 -178.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.7 -29.89 65.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.311 0.645 . . . . 10.0 110.354 173.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -136.03 146.64 47.34 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.79 1.636 . . . . 10.0 107.422 178.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -60.77 -31.88 71.22 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.762 0.825 . . . . 10.0 111.755 -174.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.99 -26.35 67.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.343 0.657 . . . . 10.0 112.165 177.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.62 -32.69 74.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.357 0.598 . . . . 10.0 110.548 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.7 mt -67.48 -51.78 48.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 174.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -55.83 -41.97 75.04 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.462 -0.78 . . . . 10.0 111.141 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.79 -48.74 79.26 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.068 0.547 . . . . 10.0 111.461 177.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -47.27 86.05 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.368 -0.832 . . . . 10.0 110.33 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.56 -43.77 96.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 -177.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 m -62.99 -36.29 83.03 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.479 1.036 . . . . 10.0 111.029 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.33 52.95 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.34 -1.104 . . . . 10.0 110.34 173.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.08 -39.91 91.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.693 0.746 . . . . 10.0 111.686 -177.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.7 mmt -65.31 -39.14 92.09 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.724 -0.655 . . . . 10.0 111.086 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -64.85 -34.76 79.13 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.071 0.85 . . . . 10.0 110.533 176.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.67 -31.92 72.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.359 -1.305 . . . . 10.0 111.612 172.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -73.81 -54.6 7.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.534 1.061 . . . . 10.0 109.014 176.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.95 44.22 0.16 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.39 1.471 . . . . 10.0 109.881 -170.18 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.6 m -144.07 169.63 17.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.632 1.573 . . . . 10.0 109.308 -177.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -140.04 163.49 32.56 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.357 1.863 . . . . 10.0 108.397 178.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.0 m -139.1 156.38 47.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.67 1.123 . . . . 10.0 113.795 -167.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -139.82 130.15 25.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.872 1.669 . . . . 10.0 106.93 168.388 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.5 p -68.89 143.31 54.53 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.786 -1.196 . . . . 10.0 109.468 172.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.6 mt -105.1 -18.14 14.25 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.469 0.708 . . . . 10.0 110.906 171.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.96 -173.92 35.24 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.719 -1.352 . . . . 10.0 109.719 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.94 -174.5 28.73 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.248 -1.148 . . . . 10.0 112.006 172.585 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.44 -149.36 7.81 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.942 -1.663 . . . . 10.0 108.942 -173.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -133.48 154.51 50.75 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.652 1.181 . . . . 10.0 108.874 178.416 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.4 mt -125.31 152.02 31.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 104.994 -2.224 . . . . 10.0 104.994 173.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.5 m -143.29 155.5 44.49 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.904 1.282 . . . . 10.0 108.837 -176.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -158.85 144.56 16.52 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.591 -1.633 . . . . 10.0 106.591 171.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -136.91 114.81 11.37 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.216 -2.142 . . . . 10.0 105.216 169.036 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -55.55 -13.6 1.64 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.521 1.928 . . . . 10.0 116.085 -168.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -131.44 9.47 4.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.765 1.226 . . . . 10.0 111.374 -177.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -144.91 -32.93 0.39 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.327 1.232 . . . . 10.0 114.327 -173.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -147.13 124.41 11.55 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.389 -1.444 . . . . 10.0 110.304 -168.278 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -60.75 172.34 0.96 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.228 1.011 . . . . 10.0 111.267 171.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.86 123.61 8.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.266 -1.753 . . . . 10.0 106.266 171.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -141.09 149.71 41.95 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.232 -1.025 . . . . 10.0 108.232 -168.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -135.04 139.42 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.458 -0.942 . . . . 10.0 108.458 -171.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.25 -176.0 3.88 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.457 1.103 . . . . 10.0 109.702 -178.094 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.08 -167.44 45.59 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 121.653 -0.654 . . . . 10.0 111.866 175.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -152.1 158.2 42.65 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 169.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.9 p -69.07 158.71 34.28 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.637 -0.664 . . . . 10.0 110.601 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 92.8 mtp -82.97 5.57 21.62 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 118.774 -0.632 . . . . 10.0 112.541 -174.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.15 -44.97 0.11 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.465 1.029 . . . . 10.0 113.533 176.443 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -74.11 -47.12 38.4 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.209 0.913 . . . . 10.0 111.003 -169.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.94 175.76 14.2 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.72 1.629 . . . . 10.0 110.375 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -54.34 130.0 37.59 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.585 2.19 . . . . 10.0 110.105 169.509 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.89 162.67 13.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.775 0.797 . . . . 10.0 109.244 167.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -79.01 70.01 5.27 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.092 -1.447 . . . . 10.0 107.092 169.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -49.72 -36.37 25.18 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.098 1.359 . . . . 10.0 113.217 -168.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.95 -32.79 73.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.084 0.856 . . . . 10.0 112.504 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.26 -50.59 50.98 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 107.428 -1.323 . . . . 10.0 107.428 175.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.3 m -56.53 -41.89 77.54 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.195 -0.907 . . . . 10.0 111.523 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.5 p -64.38 -43.5 94.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.43 1.014 . . . . 10.0 111.172 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -61.73 -38.88 89.53 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.193 1.36 . . . . 10.0 110.886 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -63.77 -50.24 69.8 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.574 0.35 . . . . 10.0 110.222 176.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.68 -47.15 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.615 -0.883 . . . . 10.0 108.615 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -54.61 -47.43 73.4 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.3 1.04 . . . . 10.0 110.244 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.75 -39.48 88.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.662 0.385 . . . . 10.0 111.572 -178.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -88.05 -32.94 18.51 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 118.12 -0.943 . . . . 10.0 112.457 -175.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -66.12 133.03 94.62 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 119.577 1.081 . . . . 10.0 109.233 -178.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.72 -29.57 42.67 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.789 1.659 . . . . 10.0 113.269 -169.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.75 -2.36 56.12 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.869 0.759 . . . . 10.0 112.401 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 29.7 t80 52.04 54.57 10.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.153 1.381 . . . . 10.0 112.003 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -145.66 160.55 41.53 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.098 -1.001 . . . . 10.0 109.256 170.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.9 p -165.64 166.85 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 127.218 2.207 . . . . 10.0 105.665 178.209 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.7 p -145.58 166.55 25.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.479 1.111 . . . . 10.0 108.893 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -153.41 165.53 35.52 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.548 -0.72 . . . . 10.0 111.075 167.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.88 153.47 40.89 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.622 1.569 . . . . 10.0 108.931 174.202 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -87.39 7.52 28.62 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.585 0.754 . . . . 10.0 112.643 -173.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -57.5 144.58 36.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.25 0.62 . . . . 10.0 111.01 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.59 175.81 54.9 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.21 0.909 . . . . 10.0 113.132 -172.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.2 t80 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 117.42 -1.276 . . . . 10.0 109.255 174.806 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -147.94 151.93 36.65 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.167 -1.42 . . . . 10.0 107.167 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.41 -23.16 64.15 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.364 0.666 . . . . 10.0 112.713 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.84 -28.62 69.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.474 1.034 . . . . 10.0 112.292 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.5 -29.56 61.46 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.95 0.5 . . . . 10.0 110.769 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.1 mt -75.98 126.0 87.43 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 106.984 -1.488 . . . . 10.0 106.984 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.68 142.07 81.9 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.156 1.904 . . . . 10.0 109.292 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -78.98 -29.86 44.07 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.681 0.753 . . . . 10.0 112.172 -170.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 135.62 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 104.083 -2.562 . . . . 10.0 104.083 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -149.2 107.76 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.609 -1.997 . . . . 10.0 105.609 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.8 pt . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 108.189 -1.041 . . . . 10.0 108.189 -175.422 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -157.57 153.11 26.37 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.64 1.176 . . . . 10.0 109.496 171.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -68.06 150.78 47.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.968 0.907 . . . . 10.0 110.28 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.46 163.65 35.0 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.72 0.808 . . . . 10.0 109.233 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.89 147.35 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.258 1.023 . . . . 10.0 108.705 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 tp -106.31 119.95 40.58 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.4 130.5 71.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.081 -1.452 . . . . 10.0 107.081 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -82.21 134.36 35.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.063 -2.199 . . . . 10.0 105.063 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -119.71 138.93 48.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.255 -1.757 . . . . 10.0 106.255 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -119.4 131.17 55.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.08 -1.822 . . . . 10.0 106.08 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 p -73.51 145.78 45.36 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.867 0.758 . . . . 10.0 110.006 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.27 61.02 3.1 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 106.26 -1.756 . . . . 10.0 106.26 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -56.74 136.9 78.89 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.472 2.781 . . . . 10.0 110.955 -169.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 45.44 26.65 0.31 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.686 1.594 . . . . 10.0 113.829 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 m 55.04 26.01 7.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.27 1.428 . . . . 10.0 113.479 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.93 -1.34 0.03 OUTLIER Glycine 0 CA--C 1.532 1.101 0 N-CA-C 116.843 1.497 . . . . 10.0 116.843 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.11 152.5 84.01 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 120.114 1.957 . . . . 10.0 110.173 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.83 56.88 5.84 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.473 3.449 . . . . 10.0 111.874 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.38 137.37 30.4 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.139 1.376 . . . . 10.0 108.381 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.03 32.46 0.6 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.321 1.449 . . . . 10.0 109.829 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.83 170.09 13.28 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.469 0.708 . . . . 10.0 109.297 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 m -147.03 159.97 42.94 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.622 -0.673 . . . . 10.0 110.417 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -147.59 175.36 10.92 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.087 1.355 . . . . 10.0 108.261 169.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -105.33 150.74 24.94 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.628 -0.879 . . . . 10.0 108.628 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.2 pt -135.86 150.37 28.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.323 1.449 . . . . 10.0 109.49 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.31 126.98 64.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.388 -1.708 . . . . 10.0 106.388 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -132.48 139.15 47.83 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.96 113.88 0.5 Allowed Glycine 0 C--N 1.332 0.321 0 CA-C-N 119.473 1.033 . . . . 10.0 110.941 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -140.75 132.23 26.93 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.114 -0.699 . . . . 10.0 109.114 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -69.49 -14.81 63.07 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.048 1.129 . . . . 10.0 114.048 -171.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -66.58 -23.48 66.2 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.478 1.036 . . . . 10.0 111.943 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.79 127.64 33.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.236 0.926 . . . . 10.0 110.082 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.87 -39.23 73.0 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.541 -0.3 . . . . 10.0 110.284 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -140.5 160.6 39.64 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.663 1.585 . . . . 10.0 108.658 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -56.45 -33.19 65.65 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.323 1.049 . . . . 10.0 112.09 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.7 -31.12 69.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.038 0.935 . . . . 10.0 112.209 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -71.35 -36.07 71.38 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.998 0.817 . . . . 10.0 110.577 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mt -65.49 -50.91 69.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -57.41 -45.1 84.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.418 -0.325 . . . . 10.0 110.554 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.41 -46.3 90.71 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.994 0.518 . . . . 10.0 111.851 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -57.2 -49.49 75.84 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.016 0.371 . . . . 10.0 110.287 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.5 t -68.85 -46.39 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.8 m -58.37 -35.51 72.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.489 1.041 . . . . 10.0 111.509 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.4 -50.68 60.52 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.703 -0.959 . . . . 10.0 110.703 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.66 -44.84 95.24 Favored 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 117.539 0.67 . . . . 10.0 111.204 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -37.22 81.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.673 -0.68 . . . . 10.0 110.887 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.25 -34.96 79.59 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.161 0.891 . . . . 10.0 111.19 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.9 -33.87 77.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.93 0.786 . . . . 10.0 111.658 171.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -70.6 -52.97 17.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.093 0.861 . . . . 10.0 110.165 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.82 43.77 0.23 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.276 1.417 . . . . 10.0 110.204 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.8 m -144.24 172.29 13.13 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.015 1.726 . . . . 10.0 108.655 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -140.27 164.83 29.03 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.692 1.597 . . . . 10.0 108.228 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.0 m -133.3 159.55 39.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.048 0.939 . . . . 10.0 112.429 -169.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -148.48 117.45 6.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.253 1.821 . . . . 10.0 106.61 170.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -62.74 130.59 45.6 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.547 -0.721 . . . . 10.0 109.115 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.0 mt -90.78 -23.04 20.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.576 0.351 . . . . 10.0 110.481 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.77 179.35 29.1 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.43 -1.868 . . . . 10.0 108.43 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.46 -164.14 14.31 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.668 -0.973 . . . . 10.0 110.668 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.69 -139.48 4.28 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 108.508 -1.837 . . . . 10.0 108.508 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -139.87 157.71 45.26 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.985 1.314 . . . . 10.0 108.116 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.42 151.45 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.62 -2.363 . . . . 10.0 104.62 172.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 175.754 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.236 0.367 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -138.14 157.96 45.28 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.745 0.818 . . . . 10.0 109.083 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.5 t -137.48 135.49 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.582 1.153 . . . . 10.0 108.086 -170.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -163.1 -178.53 6.09 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.329 -0.857 . . . . 10.0 111.714 -171.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.77 -163.49 49.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.662 0.649 . . . . 10.0 111.617 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -150.65 178.86 8.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.943 1.297 . . . . 10.0 108.632 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m -103.28 124.79 49.31 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.285 -1.005 . . . . 10.0 108.285 169.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.73 -30.24 67.32 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.081 0.401 . . . . 10.0 110.716 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.46 -30.94 71.78 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.119 0.968 . . . . 10.0 113.475 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.01 -57.9 0.5 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.428 1.013 . . . . 10.0 110.676 -172.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.86 -178.69 35.84 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.596 -1.402 . . . . 10.0 109.596 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.6 138.2 68.66 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.163 1.909 . . . . 10.0 110.167 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.08 161.44 24.47 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.806 -1.183 . . . . 10.0 107.806 168.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -78.82 71.67 5.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.487 -2.042 . . . . 10.0 105.487 169.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -50.33 -30.85 13.0 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.045 1.338 . . . . 10.0 113.494 -169.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.43 74.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.111 0.869 . . . . 10.0 112.061 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.36 -51.22 73.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.404 -1.332 . . . . 10.0 107.404 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -58.06 -46.16 85.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.967 -0.539 . . . . 10.0 112.128 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.4 p -66.28 -41.01 90.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.394 0.997 . . . . 10.0 110.823 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -64.86 -39.96 94.38 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.894 0.77 . . . . 10.0 110.641 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -62.76 -48.22 80.12 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 118.96 -0.543 . . . . 10.0 110.598 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.83 -45.74 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -62.2 -40.45 96.12 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.014 0.926 . . . . 10.0 111.589 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.86 -44.25 77.56 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.033 0.533 . . . . 10.0 110.819 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.9 tptt . . . . . 0 C--O 1.231 0.111 0 N-CA-C 112.669 0.618 . . . . 10.0 112.669 -172.125 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.235 0.325 0 N-CA-C 105.772 -1.936 . . . . 10.0 105.772 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.9 p -134.82 169.91 16.65 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.518 0.727 . . . . 10.0 109.76 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -140.85 166.15 25.57 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.318 0.647 . . . . 10.0 110.467 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 125.526 1.53 . . . . 10.0 108.483 172.792 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 121.138 0.494 . . . . 10.0 111.236 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -152.5 146.64 25.42 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 170.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.46 -25.27 65.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 118.505 -0.759 . . . . 10.0 113.002 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.4 -26.95 68.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.113 0.87 . . . . 10.0 112.034 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -75.76 -27.64 58.15 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.82 0.448 . . . . 10.0 110.709 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.6 mt -74.74 122.09 86.71 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -51.15 139.96 42.09 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.161 2.574 . . . . 10.0 110.594 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.27 -29.47 38.31 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.087 0.946 . . . . 10.0 111.605 -172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -136.65 136.17 48.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 104.323 -2.473 . . . . 10.0 104.323 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -146.32 118.28 8.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.488 -1.301 . . . . 10.0 107.488 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.2 pt . . . . . 0 C--N 1.328 -0.336 0 C-N-CA 126.028 1.731 . . . . 10.0 106.653 -174.757 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 108.118 -1.067 . . . . 10.0 108.118 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -150.17 152.15 34.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.74 0.816 . . . . 10.0 110.766 169.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -70.76 150.11 46.22 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.898 0.879 . . . . 10.0 108.985 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.25 159.36 43.45 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.282 0.492 . . . . 10.0 110.899 172.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.39 145.32 28.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.684 1.594 . . . . 10.0 107.169 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.48 122.04 45.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.971 -2.233 . . . . 10.0 104.971 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.5 mt -124.94 130.15 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.884 -1.525 . . . . 10.0 106.884 -171.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -80.04 129.24 34.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.73 -2.322 . . . . 10.0 104.73 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.73 142.6 32.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -124.62 134.98 52.74 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.182 1.793 . . . . 10.0 106.785 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.9 p -65.79 140.51 58.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 110.048 -0.353 . . . . 10.0 110.048 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.33 46.25 0.48 Allowed Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 125.184 1.393 . . . . 10.0 111.99 168.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.13 159.34 26.54 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.497 2.798 . . . . 10.0 110.785 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.29 20.66 1.43 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.872 1.269 . . . . 10.0 112.141 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 52.1 22.69 1.97 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.582 1.553 . . . . 10.0 113.531 -171.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.34 32.94 0.03 OUTLIER Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.29 -0.881 . . . . 10.0 113.826 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.08 157.74 20.54 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 118.617 1.208 . . . . 10.0 110.475 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.89 57.71 4.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.085 3.19 . . . . 10.0 111.434 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.32 145.54 34.06 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.937 1.695 . . . . 10.0 108.366 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.47 31.11 0.59 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.756 1.222 . . . . 10.0 110.267 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -63.99 153.25 37.8 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.436 -0.95 . . . . 10.0 108.436 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -144.55 161.82 38.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.658 1.183 . . . . 10.0 109.992 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -150.22 176.57 10.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.764 1.226 . . . . 10.0 109.712 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -102.14 146.88 27.33 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.871 -1.159 . . . . 10.0 107.871 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.3 pt -133.67 155.27 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.859 1.264 . . . . 10.0 110.407 172.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.95 130.4 66.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.788 -1.56 . . . . 10.0 106.788 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -132.25 143.91 50.25 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.056 -1.461 . . . . 10.0 107.056 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.56 129.84 1.88 Allowed Glycine 0 C--O 1.226 -0.391 0 CA-C-N 120.489 1.495 . . . . 10.0 113.305 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -151.31 148.27 27.96 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.516 1.126 . . . . 10.0 109.153 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -88.95 -6.72 57.06 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.385 -1.293 . . . . 10.0 114.196 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -63.99 -22.65 67.02 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.019 1.281 . . . . 10.0 111.805 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.85 124.11 22.81 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.345 0.658 . . . . 10.0 109.548 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.26 -35.92 80.52 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.275 0.559 . . . . 10.0 109.642 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -142.74 151.38 41.21 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 126.411 1.885 . . . . 10.0 106.951 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -55.03 -35.7 64.72 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.37 0.668 . . . . 10.0 112.503 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.08 -24.54 58.95 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.429 -0.796 . . . . 10.0 112.445 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.13 -36.64 82.31 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.735 0.698 . . . . 10.0 110.709 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mt -65.25 -49.94 76.2 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 107.787 -1.19 . . . . 10.0 107.787 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -56.1 -46.58 79.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.902 -0.571 . . . . 10.0 111.169 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.02 -45.16 86.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.189 0.595 . . . . 10.0 111.888 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -58.84 -49.4 77.89 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.42 0.688 . . . . 10.0 109.747 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.82 -42.19 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.6 m -58.38 -35.63 72.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.591 1.087 . . . . 10.0 111.333 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.64 -48.33 82.32 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.781 -0.928 . . . . 10.0 110.781 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.34 -46.41 90.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.907 0.853 . . . . 10.0 111.272 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -36.57 83.22 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 118.643 -0.694 . . . . 10.0 110.888 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -64.5 -36.01 82.82 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.828 0.74 . . . . 10.0 110.879 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.46 -32.34 73.13 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 117.982 -1.008 . . . . 10.0 111.71 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -67.85 -57.06 6.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.152 0.887 . . . . 10.0 109.048 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.59 47.04 0.16 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.882 1.706 . . . . 10.0 109.163 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.5 m -146.32 173.62 12.08 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.719 2.008 . . . . 10.0 108.379 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -141.03 162.86 34.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.513 1.525 . . . . 10.0 108.557 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.1 m -134.47 158.75 43.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.425 1.09 . . . . 10.0 112.398 -168.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -148.45 122.21 9.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.954 1.702 . . . . 10.0 106.944 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.7 p -64.56 128.54 36.22 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.772 -1.205 . . . . 10.0 109.368 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.06 -25.97 19.39 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.14 -177.74 35.58 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.548 -1.421 . . . . 10.0 109.548 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.82 -174.67 24.27 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 118.222 1.011 . . . . 10.0 112.015 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.66 -145.96 5.35 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.12 -1.592 . . . . 10.0 109.12 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.8 mtm-85 -137.74 155.31 49.21 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.148 -1.207 . . . . 10.0 108.37 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.9 mt -122.63 148.73 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 105.024 -2.213 . . . . 10.0 105.024 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 125.006 1.322 . . . . 10.0 108.638 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.5 mt . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 107.283 -1.377 . . . . 10.0 107.283 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -140.47 162.83 34.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.033 0.933 . . . . 10.0 109.672 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.3 144.35 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.12 -1.808 . . . . 10.0 106.12 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -161.19 179.15 8.6 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.283 -0.886 . . . . 10.0 110.218 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.26 -176.21 47.63 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.092 0.377 . . . . 10.0 112.651 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -155.77 134.71 12.01 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.757 0.823 . . . . 10.0 109.958 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 m -74.24 95.55 2.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.912 0.885 . . . . 10.0 109.785 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 76.9 mtm -57.62 -14.44 5.4 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.878 0.871 . . . . 10.0 112.602 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.34 -27.7 48.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.691 1.196 . . . . 10.0 113.121 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -47.63 0.33 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.862 0.756 . . . . 10.0 110.882 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.8 173.85 23.35 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.28 1.419 . . . . 10.0 109.862 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.37 134.23 56.32 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.791 2.327 . . . . 10.0 111.071 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.41 162.06 21.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 167.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.99 71.2 5.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.134 -1.432 . . . . 10.0 107.134 169.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -54.42 -26.25 29.64 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.75 1.22 . . . . 10.0 113.376 -170.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.86 92.76 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.476 1.035 . . . . 10.0 111.745 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.6 mt -67.47 -49.87 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.418 -1.327 . . . . 10.0 107.418 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 m -58.84 -44.54 90.98 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.863 -0.589 . . . . 10.0 112.06 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.0 p -64.95 -41.53 95.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.058 -0.972 . . . . 10.0 111.009 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -64.19 -39.33 93.76 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.384 0.993 . . . . 10.0 110.807 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -65.43 -48.22 73.54 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.926 -0.484 . . . . 10.0 110.67 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.24 -42.94 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.298 -1.001 . . . . 10.0 108.298 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -59.49 -45.59 91.23 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.925 0.89 . . . . 10.0 110.41 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.72 95.45 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.552 0.614 . . . . 10.0 111.396 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 tptm . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 118.668 -0.682 . . . . 10.0 110.943 178.576 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.6 p -139.73 172.24 13.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.208 1.403 . . . . 10.0 108.749 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -140.45 163.72 32.05 Favored 'General case' 0 C--O 1.227 -0.114 0 O-C-N 121.543 -0.723 . . . . 10.0 112.406 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 126.5 1.92 . . . . 10.0 108.504 172.6 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 107.118 -1.438 . . . . 10.0 107.118 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -152.17 150.64 30.08 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.389 -1.337 . . . . 10.0 107.389 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.4 -26.66 65.33 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.679 0.792 . . . . 10.0 112.832 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.94 -26.25 68.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.936 0.789 . . . . 10.0 112.159 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.1 mt -75.79 -25.27 56.25 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.034 0.534 . . . . 10.0 110.982 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.4 mt -78.68 122.82 85.29 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -50.74 133.53 39.23 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.499 2.8 . . . . 10.0 110.721 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -82.52 -28.65 30.94 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.504 0.668 . . . . 10.0 112.074 -170.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.08 134.91 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.893 -2.262 . . . . 10.0 104.893 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -150.64 113.82 4.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.056 -1.831 . . . . 10.0 106.056 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 CA--C 1.535 0.39 0 C-N-CA 124.681 1.192 . . . . 10.0 110.258 -169.235 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -146.35 147.06 30.93 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.855 0.862 . . . . 10.0 109.618 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.02 146.89 50.7 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.79 -0.818 . . . . 10.0 108.79 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.01 158.78 43.28 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.599 -0.889 . . . . 10.0 108.599 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.75 150.6 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.171 1.388 . . . . 10.0 107.698 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.6 tp -115.13 115.71 27.21 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.9 138.29 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.759 -1.571 . . . . 10.0 106.759 -169.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -92.86 135.4 34.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.674 -1.602 . . . . 10.0 106.674 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.11 139.99 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 105.824 -1.917 . . . . 10.0 105.824 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -115.11 130.0 56.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.914 -1.884 . . . . 10.0 105.914 173.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 p -70.17 143.51 52.25 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.03 61.44 3.37 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.721 1.208 . . . . 10.0 108.325 169.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -58.93 152.25 59.41 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.247 2.631 . . . . 10.0 111.103 -169.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 65.92 -61.38 0.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 128.122 2.569 . . . . 10.0 112.135 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 p -171.11 -33.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.425 2.29 . . . . 10.0 108.864 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.66 42.63 0.13 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.05 1.31 . . . . 10.0 110.574 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.02 157.23 11.53 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.339 0.656 . . . . 10.0 110.262 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.52 59.46 5.54 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.181 3.254 . . . . 10.0 112.474 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.18 136.36 26.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.074 1.749 . . . . 10.0 107.297 171.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.38 30.21 0.85 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.775 1.23 . . . . 10.0 110.054 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -64.87 161.07 19.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.79 -0.819 . . . . 10.0 108.79 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.5 m -141.08 159.51 42.05 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.233 1.013 . . . . 10.0 110.009 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -149.83 170.19 19.35 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.503 1.121 . . . . 10.0 109.617 171.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -99.95 154.45 18.37 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.211 -0.663 . . . . 10.0 109.211 170.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.0 pt -137.12 154.03 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.291 1.436 . . . . 10.0 109.956 174.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.35 126.84 65.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.453 -1.684 . . . . 10.0 106.453 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -133.94 143.06 47.97 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.738 -1.579 . . . . 10.0 106.738 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.84 129.47 1.65 Allowed Glycine 0 C--O 1.227 -0.295 0 CA-C-N 120.259 1.39 . . . . 10.0 111.378 171.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -145.0 141.5 28.98 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.454 0.702 . . . . 10.0 110.432 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -70.51 -21.98 62.68 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 118.358 -0.83 . . . . 10.0 113.195 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -66.44 -25.13 66.6 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.586 1.085 . . . . 10.0 112.629 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.67 126.32 29.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.252 0.933 . . . . 10.0 110.114 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.49 -31.96 65.81 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 122.621 0.368 . . . . 10.0 110.249 170.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -146.05 152.22 38.99 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.339 1.456 . . . . 10.0 109.13 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -56.93 -31.46 64.98 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.004 1.322 . . . . 10.0 112.626 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.18 -31.55 69.1 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.674 -0.679 . . . . 10.0 112.047 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.74 -41.65 78.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.647 0.658 . . . . 10.0 110.107 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.3 mt -62.78 -50.74 78.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 108.312 -0.996 . . . . 10.0 108.312 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -55.34 -43.7 75.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.834 -0.603 . . . . 10.0 111.295 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.11 -46.59 83.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.609 0.64 . . . . 10.0 111.666 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -57.61 -49.9 74.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.132 0.573 . . . . 10.0 109.643 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.51 -44.31 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 m -56.61 -42.52 78.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.025 0.83 . . . . 10.0 110.9 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.52 -48.37 86.35 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.78 -0.928 . . . . 10.0 110.78 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -62.29 -47.38 84.55 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 118.16 0.98 . . . . 10.0 111.046 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -39.51 87.5 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 119.011 -0.518 . . . . 10.0 110.69 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -65.51 -33.76 76.68 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.567 0.621 . . . . 10.0 110.896 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.08 -34.0 77.08 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 117.239 -1.362 . . . . 10.0 111.21 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -69.47 -65.89 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.292 0.951 . . . . 10.0 108.682 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.79 42.24 0.04 OUTLIER Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.371 1.462 . . . . 10.0 110.491 -169.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.1 m -146.38 176.11 10.03 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.596 1.958 . . . . 10.0 107.935 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -145.21 165.72 27.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.168 0.987 . . . . 10.0 108.764 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.9 m -130.15 155.08 46.81 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.289 0.949 . . . . 10.0 113.019 -169.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -141.57 136.97 31.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.074 1.749 . . . . 10.0 106.774 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.5 t -78.77 141.66 37.62 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.598 -0.689 . . . . 10.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.4 mt -103.48 -20.36 14.07 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.377 0.671 . . . . 10.0 111.146 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.71 -177.96 34.25 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.814 -0.914 . . . . 10.0 110.814 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.15 178.42 32.68 Favored Glycine 0 CA--C 1.521 0.427 0 O-C-N 121.631 -0.923 . . . . 10.0 112.356 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.97 -145.6 5.6 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 109.84 -1.304 . . . . 10.0 109.84 -172.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -142.55 161.72 37.32 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.894 2.078 . . . . 10.0 107.755 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.8 mt -132.29 145.32 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 105.929 -1.878 . . . . 10.0 105.929 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.0 p . . . . . 0 CA--C 1.535 0.385 0 C-N-CA 124.431 1.092 . . . . 10.0 110.747 -175.833 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.3 mm . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 101.676 -3.453 . . . . 10.0 101.676 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -117.53 145.63 44.11 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.5 -0.555 . . . . 10.0 109.5 -167.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 32.1 t -135.17 130.49 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.917 -1.512 . . . . 10.0 106.917 -170.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -166.86 169.46 13.17 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.135 -0.978 . . . . 10.0 109.47 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.03 -174.63 19.84 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 119.272 0.942 . . . . 10.0 114.435 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -140.41 1.31 1.76 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.413 1.264 . . . . 10.0 114.413 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.6 p 50.53 -25.55 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 129.707 3.203 . . . . 10.0 119.007 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 12.3 tmm? 66.58 -48.39 0.45 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.574 2.35 . . . . 10.0 111.009 -168.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.74 70.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.363 1.465 . . . . 10.0 113.016 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -133.93 -50.25 0.82 Allowed 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.643 0.656 . . . . 10.0 111.747 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.02 170.96 12.31 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 109.37 -1.492 . . . . 10.0 109.37 -170.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.05 130.97 40.59 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.029 2.486 . . . . 10.0 111.8 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.66 158.88 28.92 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 168.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -77.1 73.34 3.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -54.61 -26.24 31.52 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.199 0.999 . . . . 10.0 112.835 -170.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.29 -41.06 98.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.261 0.937 . . . . 10.0 112.08 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.2 mt -64.52 -50.24 76.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 107.497 -1.298 . . . . 10.0 107.497 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -60.09 -43.62 95.39 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 119.129 -0.462 . . . . 10.0 111.892 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.9 p -66.58 -37.83 85.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.064 0.847 . . . . 10.0 111.547 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -64.89 -38.97 92.76 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.418 1.008 . . . . 10.0 110.796 175.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -66.66 -45.06 80.17 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 122.042 -0.411 . . . . 10.0 110.626 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.86 -48.72 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -59.03 -40.02 83.75 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.158 0.89 . . . . 10.0 111.567 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.33 72.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.992 0.815 . . . . 10.0 111.977 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 118.534 -0.746 . . . . 10.0 112.822 174.997 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 107.597 -1.26 . . . . 10.0 107.597 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.0 p -145.53 158.42 43.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.826 1.65 . . . . 10.0 108.926 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -151.22 164.23 37.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.838 0.681 . . . . 10.0 112.838 173.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 126.606 1.962 . . . . 10.0 108.436 170.206 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -151.05 152.05 32.89 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.016 -1.105 . . . . 10.0 108.016 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -59.53 -22.4 61.61 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.937 0.895 . . . . 10.0 113.04 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.94 -24.56 66.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.637 1.108 . . . . 10.0 112.435 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.5 mt -78.96 -17.1 56.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.455 0.702 . . . . 10.0 111.745 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 25.8 mt -100.36 132.35 22.65 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.46 142.33 64.98 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.388 2.058 . . . . 10.0 110.272 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -78.51 -28.88 46.35 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.816 0.847 . . . . 10.0 112.163 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.26 134.38 47.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 106.086 -1.82 . . . . 10.0 106.086 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -152.96 113.42 4.04 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.3 pt . . . . . 0 C--N 1.327 -0.382 0 C-N-CA 124.56 1.144 . . . . 10.0 109.962 -169.548 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -150.37 147.84 28.08 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.986 0.914 . . . . 10.0 109.734 171.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -74.93 157.88 34.25 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.672 -0.862 . . . . 10.0 108.672 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.71 160.35 43.25 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.549 0.34 . . . . 10.0 110.458 173.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 t -133.57 141.89 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.453 1.501 . . . . 10.0 107.383 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 tp -98.63 115.84 29.54 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 104.654 -2.35 . . . . 10.0 104.654 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.3 mt -122.83 124.84 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.625 -1.62 . . . . 10.0 106.625 -167.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -82.53 140.16 33.46 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 168.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.2 t -133.13 142.65 41.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.446 -1.687 . . . . 10.0 106.446 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -126.29 136.96 53.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.509 1.524 . . . . 10.0 107.119 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.9 m -67.56 140.44 56.95 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.36 57.31 2.77 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.399 1.479 . . . . 10.0 107.981 167.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -59.97 135.12 60.88 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.333 2.689 . . . . 10.0 109.834 -169.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 47.34 26.04 0.67 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.028 1.331 . . . . 10.0 112.956 -174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m 48.23 31.28 2.55 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.458 1.503 . . . . 10.0 113.655 -172.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -172.64 -3.39 0.03 OUTLIER Glycine 0 CA--C 1.531 1.051 0 N-CA-C 117.019 1.568 . . . . 10.0 117.019 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.05 151.08 81.76 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 120.433 2.116 . . . . 10.0 110.556 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.03 52.06 3.9 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.315 3.344 . . . . 10.0 111.54 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.53 136.07 30.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.003 1.321 . . . . 10.0 108.723 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.7 31.5 1.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.327 1.451 . . . . 10.0 109.762 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -61.97 151.48 34.91 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.51 -0.922 . . . . 10.0 108.51 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.4 m -139.39 158.49 44.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.799 0.84 . . . . 10.0 110.686 -175.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -152.41 176.78 11.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.807 1.243 . . . . 10.0 109.247 171.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -117.0 142.82 46.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.0 pt -131.17 156.42 42.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.623 1.169 . . . . 10.0 110.067 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.42 125.8 65.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.915 -1.883 . . . . 10.0 105.915 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -130.13 139.17 50.93 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.0 132.76 2.5 Favored Glycine 0 C--O 1.224 -0.527 0 CA-C-N 120.03 1.286 . . . . 10.0 111.817 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -144.75 144.18 31.06 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 122.888 0.475 . . . . 10.0 111.178 -169.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -64.58 -32.45 74.11 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.845 0.858 . . . . 10.0 112.248 -174.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -68.59 -16.69 63.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 117.912 -1.042 . . . . 10.0 113.008 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.8 119.31 6.91 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.631 1.105 . . . . 10.0 111.629 -172.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.13 -37.36 81.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.161 0.584 . . . . 10.0 110.18 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -149.67 168.86 22.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 127.142 2.177 . . . . 10.0 107.598 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -59.6 -29.37 67.94 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.135 -0.978 . . . . 10.0 111.805 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.92 68.9 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.838 0.855 . . . . 10.0 112.359 172.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -66.39 -42.6 87.65 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.795 0.807 . . . . 10.0 109.802 -176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.78 -53.84 37.17 Favored 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.214 -1.032 . . . . 10.0 108.214 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -59.14 -39.17 81.55 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 119.027 -0.511 . . . . 10.0 110.992 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.51 -46.02 90.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.445 0.566 . . . . 10.0 111.761 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.83 -49.16 75.99 Favored 'General case' 0 C--N 1.345 0.373 0 O-C-N 121.691 -0.63 . . . . 10.0 109.661 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.79 -43.73 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.301 -0.629 . . . . 10.0 109.301 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.7 p -65.09 -34.05 77.49 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.251 0.932 . . . . 10.0 111.205 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.98 -51.21 60.02 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.393 -1.083 . . . . 10.0 110.393 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.98 -46.25 91.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 117.357 0.579 . . . . 10.0 110.792 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.9 mmt -61.84 -37.75 85.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.702 -0.624 . . . . 10.0 110.812 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -64.86 -36.49 84.52 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.997 0.817 . . . . 10.0 111.14 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -66.61 -34.22 77.41 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.994 -1.003 . . . . 10.0 111.304 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -68.15 -54.22 19.53 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.841 0.746 . . . . 10.0 109.546 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.52 44.04 0.2 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.453 1.502 . . . . 10.0 110.551 -171.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.4 m -144.91 171.68 14.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.229 1.812 . . . . 10.0 109.047 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -139.54 160.92 38.74 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.432 1.493 . . . . 10.0 108.709 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.8 m -127.71 157.59 39.91 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.847 1.259 . . . . 10.0 112.98 -168.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -145.52 111.75 5.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.677 1.991 . . . . 10.0 106.283 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -63.42 118.9 8.75 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.97 -1.081 . . . . 10.0 108.775 171.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 mt -80.7 -29.02 36.49 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 110.171 -0.307 . . . . 10.0 110.171 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.64 -178.43 39.84 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.157 -1.977 . . . . 10.0 108.157 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.99 -168.86 20.19 Favored Glycine 0 CA--C 1.519 0.314 0 O-C-N 121.398 -1.06 . . . . 10.0 110.851 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.17 -151.41 9.07 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.358 -1.897 . . . . 10.0 108.358 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -144.13 165.4 27.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -134.32 151.46 32.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 104.835 -2.283 . . . . 10.0 104.835 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 107.985 -1.117 . . . . 10.0 107.985 177.182 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.7 pt . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 106.865 -1.531 . . . . 10.0 106.865 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -99.79 126.69 45.91 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.199 -1.038 . . . . 10.0 108.199 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.42 145.31 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 106.652 -1.61 . . . . 10.0 106.652 174.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -161.67 178.77 8.71 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.687 0.795 . . . . 10.0 110.182 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.89 -158.26 46.31 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-O 121.328 0.405 . . . . 10.0 112.92 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -158.67 158.03 32.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.557 1.943 . . . . 10.0 107.56 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 t -72.09 130.78 41.71 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 60.4 mtt -73.3 -19.32 61.07 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.604 0.565 . . . . 10.0 110.811 169.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.95 -31.32 22.18 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.536 -0.745 . . . . 10.0 112.077 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -128.17 -54.53 1.28 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.889 0.768 . . . . 10.0 111.297 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.09 179.85 22.58 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.837 1.208 . . . . 10.0 110.165 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.39 133.42 58.0 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.113 2.542 . . . . 10.0 111.673 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.69 165.76 20.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 166.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -80.12 68.22 6.19 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 168.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -49.45 -33.03 13.12 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.463 1.505 . . . . 10.0 113.709 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.5 77.18 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.993 0.815 . . . . 10.0 112.231 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.72 -50.97 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 107.097 -1.445 . . . . 10.0 107.097 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -55.94 -46.52 78.48 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.468 -0.777 . . . . 10.0 112.137 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.6 p -64.99 -42.32 94.63 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 119.721 1.146 . . . . 10.0 111.034 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.87 -39.44 90.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.864 0.756 . . . . 10.0 110.979 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -59.83 -51.66 68.77 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 118.818 -0.61 . . . . 10.0 109.836 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.47 -48.81 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.419 -0.956 . . . . 10.0 108.419 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -60.99 -40.75 94.66 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.693 0.797 . . . . 10.0 111.513 -175.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.12 77.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.122 0.569 . . . . 10.0 110.842 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 118.62 -0.705 . . . . 10.0 112.082 -173.766 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.236 0.346 0 N-CA-C 107.138 -1.43 . . . . 10.0 107.138 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -142.44 170.65 15.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.646 1.178 . . . . 10.0 108.707 173.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -138.75 163.28 32.6 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 122.851 0.46 . . . . 10.0 111.886 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.417 0 C-N-CA 126.164 1.785 . . . . 10.0 108.727 169.939 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -151.16 151.32 31.76 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.931 1.292 . . . . 10.0 107.542 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.13 -24.06 62.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 118.237 -0.887 . . . . 10.0 112.886 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.88 -25.9 67.02 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.605 1.093 . . . . 10.0 112.451 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.2 mt -74.94 -23.77 58.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.123 0.569 . . . . 10.0 111.366 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.9 mt -89.2 128.97 49.51 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 107.071 -1.455 . . . . 10.0 107.071 -173.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.81 147.17 80.48 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.165 1.91 . . . . 10.0 110.67 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.92 -35.61 72.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.779 1.632 . . . . 10.0 111.603 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.64 133.26 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.625 -2.361 . . . . 10.0 104.625 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -150.32 114.3 5.07 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.063 -1.829 . . . . 10.0 106.063 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.3 pt . . . . . 0 N--CA 1.453 -0.323 0 C-N-CA 124.502 1.121 . . . . 10.0 109.525 -170.227 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 108.576 -0.898 . . . . 10.0 108.576 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -146.82 151.16 36.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.694 0.797 . . . . 10.0 109.981 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -55.95 153.46 8.69 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.64 1.176 . . . . 10.0 111.629 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.51 160.9 43.08 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.074 0.95 . . . . 10.0 108.965 168.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.12 147.25 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.703 1.201 . . . . 10.0 108.911 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -107.77 117.99 35.56 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.566 -2.013 . . . . 10.0 105.566 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.3 mt -123.19 132.34 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.522 -1.659 . . . . 10.0 106.522 -170.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -85.32 125.3 32.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.537 -2.023 . . . . 10.0 105.537 167.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.38 141.17 24.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 106.604 -1.628 . . . . 10.0 106.604 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -121.6 130.1 53.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.976 -1.861 . . . . 10.0 105.976 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.6 p -71.03 144.32 50.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.958 -0.386 . . . . 10.0 109.958 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.0 61.83 3.56 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.567 1.547 . . . . 10.0 107.603 166.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -58.08 143.9 95.76 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.944 2.429 . . . . 10.0 110.601 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 48.18 23.72 0.57 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.842 1.257 . . . . 10.0 113.111 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m 49.05 30.95 3.09 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.225 1.41 . . . . 10.0 113.683 -172.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.62 -2.34 0.02 OUTLIER Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.762 1.465 . . . . 10.0 116.762 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.16 152.22 78.94 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 119.937 1.868 . . . . 10.0 110.657 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.78 57.77 6.18 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.285 3.323 . . . . 10.0 112.098 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.24 136.91 30.32 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 125.073 1.349 . . . . 10.0 108.309 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.79 28.53 0.77 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.897 1.279 . . . . 10.0 110.448 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.04 159.94 24.86 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.375 -0.828 . . . . 10.0 109.095 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.0 m -139.76 162.12 35.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.874 0.87 . . . . 10.0 110.694 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -149.29 174.88 11.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.647 1.179 . . . . 10.0 109.351 170.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -99.3 148.85 23.73 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 pt -136.53 148.62 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.604 1.562 . . . . 10.0 109.72 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.7 t -106.94 127.34 62.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -132.68 141.95 48.84 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.618 -1.253 . . . . 10.0 107.618 -176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.06 107.21 0.23 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 110.132 -1.187 . . . . 10.0 110.132 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.97 132.62 42.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 -171.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -59.55 -23.95 63.3 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.791 1.404 . . . . 10.0 114.791 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -67.39 -24.65 65.7 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.315 0.961 . . . . 10.0 112.425 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.98 125.42 29.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.744 1.157 . . . . 10.0 109.799 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -74.29 -33.59 63.28 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.392 0.615 . . . . 10.0 109.855 171.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -143.71 155.91 44.36 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.15 1.38 . . . . 10.0 110.008 -172.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -58.66 -33.87 70.6 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.415 1.486 . . . . 10.0 112.94 -171.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.94 -31.09 70.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.383 -0.818 . . . . 10.0 111.513 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -70.93 -38.54 72.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.86 0.755 . . . . 10.0 110.124 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.4 mt -63.88 -50.34 77.95 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -52.92 -48.26 67.39 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.427 -0.797 . . . . 10.0 111.123 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.2 -47.15 83.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.417 0.553 . . . . 10.0 111.255 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -59.48 -51.42 69.95 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.872 -0.518 . . . . 10.0 110.153 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.1 t -66.98 -41.26 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.678 -0.86 . . . . 10.0 108.678 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 m -62.91 -36.04 82.06 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.629 1.104 . . . . 10.0 111.547 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.77 -51.13 59.45 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.163 -1.175 . . . . 10.0 110.163 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.29 -43.45 98.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.793 0.797 . . . . 10.0 111.016 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.1 mmt -62.32 -37.0 83.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 121.71 -0.619 . . . . 10.0 111.433 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -65.03 -36.17 83.52 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.009 0.822 . . . . 10.0 110.755 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.78 -32.72 74.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.64 -1.172 . . . . 10.0 111.509 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -68.99 -52.16 31.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.718 1.144 . . . . 10.0 109.727 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.08 50.12 0.24 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.766 -1.734 . . . . 10.0 108.766 -169.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.0 m -147.69 170.65 17.08 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.532 1.933 . . . . 10.0 109.216 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -140.2 165.38 27.52 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.276 1.83 . . . . 10.0 108.48 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.1 m -134.48 156.14 49.12 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.582 1.153 . . . . 10.0 112.358 -167.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -149.25 123.23 9.39 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.135 -1.802 . . . . 10.0 106.135 169.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.71 126.98 31.35 Favored 'General case' 0 C--O 1.226 -0.178 0 O-C-N 121.038 -1.039 . . . . 10.0 109.334 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.99 -27.33 35.97 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 122.097 -0.377 . . . . 10.0 110.306 170.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.1 -177.87 38.14 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.966 -1.654 . . . . 10.0 108.966 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.96 -173.01 21.87 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.5 -1.0 . . . . 10.0 111.48 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.51 -146.77 6.4 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.511 -1.836 . . . . 10.0 108.511 -173.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -147.71 159.91 43.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.601 1.161 . . . . 10.0 109.505 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.9 mt -128.7 149.32 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.513 -2.032 . . . . 10.0 105.513 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 C--O 1.237 0.445 0 C-N-CA 124.245 1.018 . . . . 10.0 108.814 170.432 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.0 mt . . . . . 0 C--O 1.238 0.491 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -136.38 147.14 47.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.415 -1.328 . . . . 10.0 107.415 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.69 135.51 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.173 -1.417 . . . . 10.0 107.173 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -164.79 175.29 9.79 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.941 0.897 . . . . 10.0 109.695 -170.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.52 -174.19 20.87 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 121.722 0.624 . . . . 10.0 112.76 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -141.9 24.81 1.99 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.047 0.939 . . . . 10.0 111.862 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.7 p 59.46 -174.89 0.1 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.511 1.924 . . . . 10.0 112.832 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.0 mtt -128.55 21.81 6.01 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.192 1.397 . . . . 10.0 109.039 167.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.24 -28.83 0.45 Allowed 'General case' 0 C--N 1.347 0.488 0 N-CA-C 115.172 1.545 . . . . 10.0 115.172 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.89 -52.54 0.52 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.484 1.493 . . . . 10.0 111.554 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.29 177.79 25.44 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.42 1.486 . . . . 10.0 109.646 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.3 134.45 45.31 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.759 2.306 . . . . 10.0 111.178 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.55 160.93 18.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.963 0.887 . . . . 10.0 109.085 165.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -80.33 75.4 7.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.724 -1.584 . . . . 10.0 106.724 169.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -54.53 -23.74 17.8 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.724 1.209 . . . . 10.0 113.546 -170.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.45 -40.37 94.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.703 1.138 . . . . 10.0 111.675 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.7 mt -65.16 -51.84 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.7 m -57.83 -45.42 86.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.712 -0.661 . . . . 10.0 112.003 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.0 p -68.74 -38.61 80.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 117.775 -1.107 . . . . 10.0 111.654 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.4 -40.29 96.82 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.076 1.307 . . . . 10.0 110.71 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -62.74 -50.43 71.09 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.133 -0.355 . . . . 10.0 110.064 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.2 -39.46 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 120.651 -1.281 . . . . 10.0 109.076 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -62.03 -41.55 98.21 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 119.624 1.102 . . . . 10.0 110.66 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.34 -41.3 96.84 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.315 0.961 . . . . 10.0 111.048 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 118.252 -0.88 . . . . 10.0 110.66 176.224 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 108.644 -0.873 . . . . 10.0 108.644 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.63 169.27 21.97 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.569 1.548 . . . . 10.0 109.96 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.6 p-90 -145.63 166.18 26.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.755 1.162 . . . . 10.0 111.243 172.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 125.98 1.712 . . . . 10.0 108.236 169.22 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 106.753 -1.573 . . . . 10.0 106.753 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -144.89 147.05 32.33 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.382 -1.71 . . . . 10.0 106.382 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -59.05 -26.21 64.39 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.54 -24.92 67.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.704 0.684 . . . . 10.0 112.713 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.83 -27.74 57.99 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.37 0.532 . . . . 10.0 110.61 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 mt -79.94 132.52 60.27 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.11 147.88 80.17 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.453 2.102 . . . . 10.0 109.531 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.49 -28.61 46.41 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.287 0.565 . . . . 10.0 112.131 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -137.96 135.51 45.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.256 1.422 . . . . 10.0 107.173 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -147.84 99.8 3.13 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.541 -1.281 . . . . 10.0 107.541 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.6 pt . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 125.656 1.583 . . . . 10.0 109.736 -169.456 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 108.283 -1.006 . . . . 10.0 108.283 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -141.94 148.67 39.02 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.059 1.344 . . . . 10.0 108.977 173.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -60.43 151.61 27.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.658 0.783 . . . . 10.0 109.187 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.08 162.07 41.66 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.633 -0.667 . . . . 10.0 110.563 170.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.84 152.86 31.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.889 1.276 . . . . 10.0 109.677 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 tp -102.63 114.3 28.41 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.654 -2.351 . . . . 10.0 104.654 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.4 mt -116.58 132.13 67.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.2 -1.778 . . . . 10.0 106.2 -170.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -88.51 139.51 30.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.437 -1.69 . . . . 10.0 106.437 168.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -128.98 142.43 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.076 -1.824 . . . . 10.0 106.076 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -120.6 133.57 55.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.189 -1.782 . . . . 10.0 106.189 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 p -65.8 140.65 58.42 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.766 -0.457 . . . . 10.0 109.766 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.9 60.2 2.89 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.24 1.416 . . . . 10.0 108.676 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.36 143.63 99.49 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.05 2.5 . . . . 10.0 108.941 -174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.0 tpt85 53.12 16.17 0.73 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.637 1.175 . . . . 10.0 113.102 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 m 54.97 24.15 5.67 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.44 1.096 . . . . 10.0 113.222 -170.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.87 1.47 0.03 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.652 1.421 . . . . 10.0 116.652 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.53 153.35 77.67 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 119.984 1.892 . . . . 10.0 110.252 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.95 64.42 7.7 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.315 3.344 . . . . 10.0 111.925 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.32 140.0 35.55 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.378 1.471 . . . . 10.0 108.346 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.36 26.17 0.78 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.806 1.242 . . . . 10.0 110.65 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.88 159.96 27.16 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 169.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -139.45 162.64 34.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.154 0.982 . . . . 10.0 111.135 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -152.43 145.3 24.4 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.318 1.847 . . . . 10.0 107.71 -170.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.2 144.03 28.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 169.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.8 pt -134.74 151.37 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.238 1.015 . . . . 10.0 109.965 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.29 127.12 56.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 105.875 -1.898 . . . . 10.0 105.875 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.412 ' HG3' HG21 ' A' ' 60' ' ' VAL . 6.2 mmp_? -130.28 133.63 46.63 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.55 49.51 0.33 Allowed Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.068 -0.813 . . . . 10.0 111.068 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -65.92 132.95 49.84 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -63.1 -27.12 69.17 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.924 1.083 . . . . 10.0 113.924 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -69.39 -20.61 63.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 117.958 -1.02 . . . . 10.0 112.641 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.44 133.93 52.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.29 0.95 . . . . 10.0 111.031 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -79.49 -35.61 39.9 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.509 0.671 . . . . 10.0 109.901 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -143.7 163.42 33.34 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.96 1.304 . . . . 10.0 110.109 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 94' ' ' SER . 53.2 m80 -57.54 -40.87 79.81 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.921 0.888 . . . . 10.0 111.466 175.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.74 -25.25 66.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.674 -0.679 . . . . 10.0 112.4 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -67.3 -41.49 85.28 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.148 0.975 . . . . 10.0 109.149 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.67 -55.26 23.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.13 -1.063 . . . . 10.0 108.13 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -57.6 -41.02 80.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 119.171 -0.443 . . . . 10.0 111.732 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.68 -44.8 92.64 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.724 0.409 . . . . 10.0 111.612 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.39 -51.35 69.88 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.412 HG21 ' HG3' ' A' ' 45' ' ' ARG . 93.4 t -62.44 -39.86 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 118.201 -0.904 . . . . 10.0 110.05 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.0 m -61.77 -46.34 90.01 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.275 0.943 . . . . 10.0 110.362 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.51 -44.62 94.91 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.006 -0.838 . . . . 10.0 111.006 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -58.59 -52.8 64.12 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.07 1.348 . . . . 10.0 109.481 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.6 mmt -61.39 -37.81 84.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.253 0.621 . . . . 10.0 111.485 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -64.19 -37.83 88.89 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 119.224 0.92 . . . . 10.0 110.85 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.92 -37.53 87.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 117.702 -1.142 . . . . 10.0 110.942 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -67.55 -51.14 54.22 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.714 0.688 . . . . 10.0 109.727 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.11 41.16 0.29 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.86 1.219 . . . . 10.0 110.789 -169.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.4 m -145.51 171.5 14.57 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.961 1.704 . . . . 10.0 108.742 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -140.11 164.49 29.89 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.81 1.644 . . . . 10.0 108.239 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.6 m -130.58 164.83 24.06 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.506 1.048 . . . . 10.0 113.401 -168.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.98 132.88 16.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.184 2.194 . . . . 10.0 105.203 168.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -80.61 132.05 35.57 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.785 -1.197 . . . . 10.0 108.138 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.5 mt -87.63 -21.54 25.25 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 119.263 -0.399 . . . . 10.0 110.625 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.86 -178.32 26.5 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 109.148 -1.581 . . . . 10.0 109.148 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.08 -171.83 24.49 Favored Glycine 0 C--N 1.329 0.183 0 O-C-N 121.706 -0.879 . . . . 10.0 111.866 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.18 -140.6 4.7 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 107.364 -2.295 . . . . 10.0 107.364 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -139.31 149.44 44.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.883 -1.155 . . . . 10.0 107.883 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.24 146.05 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.871 -2.27 . . . . 10.0 104.871 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.454 -0.23 0 C-N-CA 123.812 0.845 . . . . 10.0 111.173 -168.616 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 C--O 1.234 0.261 0 N-CA-C 105.247 -2.131 . . . . 10.0 105.247 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -132.76 164.71 26.19 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.992 0.808 . . . . 10.0 110.605 -166.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 t -133.51 130.61 56.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.136 1.374 . . . . 10.0 107.767 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.11 178.17 10.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.568 0.747 . . . . 10.0 110.894 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.42 -175.95 45.61 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.661 -0.575 . . . . 10.0 111.661 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.84 152.26 41.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.086 1.354 . . . . 10.0 107.36 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.408 ' HA ' ' CE1' ' A' ' 53' ' ' HIS . 78.7 p -67.57 142.52 56.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.715 -0.616 . . . . 10.0 109.868 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.1 mtp -70.26 -29.65 66.48 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.759 -0.459 . . . . 10.0 109.759 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.29 -33.52 63.27 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 117.883 -1.056 . . . . 10.0 113.307 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -136.32 -52.2 0.71 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.588 1.085 . . . . 10.0 112.489 -169.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.45 -174.99 23.72 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.855 1.216 . . . . 10.0 110.248 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.81 138.39 57.87 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.716 2.277 . . . . 10.0 111.249 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.2 167.6 20.0 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.996 -1.113 . . . . 10.0 107.996 165.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -80.23 79.06 6.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.368 -1.716 . . . . 10.0 106.368 168.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -56.11 -32.36 64.12 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 124.133 0.973 . . . . 10.0 111.6 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.97 -42.28 97.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.801 0.728 . . . . 10.0 112.214 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.2 mt -63.87 -46.93 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.212 -1.403 . . . . 10.0 107.212 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.5 m -57.12 -44.9 83.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.212 -0.899 . . . . 10.0 111.752 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.1 p -64.95 -38.03 89.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.463 1.483 . . . . 10.0 111.436 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.16 -40.22 95.67 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.317 0.962 . . . . 10.0 110.639 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -65.28 -47.36 76.92 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.611 -0.681 . . . . 10.0 110.451 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.6 mt -60.62 -45.34 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -53.12 -49.97 65.45 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.898 0.879 . . . . 10.0 110.092 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.87 -32.36 73.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.005 0.522 . . . . 10.0 112.399 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.5 tptm . . . . . 0 C--N 1.342 0.271 0 CA-C-N 118.981 0.81 . . . . 10.0 109.981 -176.756 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 103.145 -2.909 . . . . 10.0 103.145 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.9 p -119.06 165.41 14.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.2 0.909 . . . . 10.0 110.76 -170.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -154.48 162.5 41.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 120.901 -1.124 . . . . 10.0 108.453 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 112.8 0.667 . . . . 10.0 112.8 174.039 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.437 0 N-CA-C 106.394 -1.706 . . . . 10.0 106.394 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -150.83 151.22 31.96 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.31 -23.81 64.49 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.566 0.746 . . . . 10.0 112.514 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.12 67.42 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.224 0.92 . . . . 10.0 112.08 173.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.51 -35.53 58.27 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 122.866 0.466 . . . . 10.0 109.837 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mt -63.64 122.59 77.38 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.43 141.94 88.77 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.349 2.032 . . . . 10.0 109.531 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -85.14 -32.18 22.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.192 0.52 . . . . 10.0 112.395 -169.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -139.61 134.06 38.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.599 -2.001 . . . . 10.0 105.599 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -149.61 98.96 2.83 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.599 -1.259 . . . . 10.0 107.599 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.8 pt . . . . . 0 CA--C 1.537 0.443 0 C-N-CA 126.125 1.77 . . . . 10.0 107.959 -174.006 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.574 -0.528 . . . . 10.0 109.574 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -157.32 147.86 21.18 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.287 0.635 . . . . 10.0 109.72 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -67.59 164.48 18.99 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.412 0.625 . . . . 10.0 111.276 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -151.61 166.61 30.69 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.603 0.761 . . . . 10.0 109.196 173.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.88 148.54 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.509 1.124 . . . . 10.0 108.538 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.44 122.35 47.5 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.845 -1.909 . . . . 10.0 105.845 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.4 mt -129.08 136.95 58.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.472 -1.677 . . . . 10.0 106.472 -171.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -93.64 131.86 38.53 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.221 -1.77 . . . . 10.0 106.221 169.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.7 144.06 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.614 -1.254 . . . . 10.0 107.614 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -122.5 122.45 38.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.737 -1.949 . . . . 10.0 105.737 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.1 p -75.85 147.89 38.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.058 0.456 . . . . 10.0 111.475 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.57 65.46 2.29 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 127.31 2.244 . . . . 10.0 106.606 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -54.64 140.7 76.15 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.392 2.728 . . . . 10.0 111.211 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 48.88 21.9 0.5 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.654 1.182 . . . . 10.0 113.295 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.3 m 48.79 35.69 6.84 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.098 1.359 . . . . 10.0 112.923 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.41 -12.03 0.02 OUTLIER Glycine 0 CA--C 1.531 1.047 0 N-CA-C 116.618 1.407 . . . . 10.0 116.618 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.03 150.12 92.48 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 120.006 1.903 . . . . 10.0 110.776 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.41 61.33 7.84 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.325 3.35 . . . . 10.0 111.695 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.86 140.02 34.54 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.886 1.275 . . . . 10.0 108.6 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.97 27.94 0.77 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.89 1.276 . . . . 10.0 110.931 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.84 165.37 19.9 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.426 0.69 . . . . 10.0 109.361 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -139.31 159.93 41.0 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.225 1.01 . . . . 10.0 110.142 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -153.05 175.51 12.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.596 1.158 . . . . 10.0 109.584 170.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -96.43 159.62 14.84 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.06 -0.718 . . . . 10.0 109.06 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.1 pt -138.24 147.55 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.95 1.7 . . . . 10.0 108.425 169.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.27 124.95 64.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.02 -1.845 . . . . 10.0 106.02 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -131.01 136.89 48.9 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.077 0.951 . . . . 10.0 108.637 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.38 47.82 0.34 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 109.687 -1.365 . . . . 10.0 109.687 -172.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -67.77 125.84 27.5 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.063 0.545 . . . . 10.0 111.041 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -59.3 -31.44 69.15 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.626 0.973 . . . . 10.0 113.626 -171.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -69.01 -17.81 63.96 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 118.169 -0.919 . . . . 10.0 112.662 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.78 136.39 57.39 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.142 0.883 . . . . 10.0 111.538 -171.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.69 -38.54 80.39 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.388 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -154.77 169.7 23.33 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.22 1.808 . . . . 10.0 108.791 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -55.65 -32.36 63.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.098 0.959 . . . . 10.0 111.737 169.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.01 80.83 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.121 0.568 . . . . 10.0 111.751 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -69.92 -39.2 76.27 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.03 -57.28 12.88 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 108.458 -0.941 . . . . 10.0 108.458 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -58.93 -40.85 85.84 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.334 -0.365 . . . . 10.0 111.222 -172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.83 -46.72 83.81 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.54 0.336 . . . . 10.0 111.68 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -64.28 -45.22 88.98 Favored 'General case' 0 C--N 1.344 0.327 0 O-C-N 121.785 -0.572 . . . . 10.0 109.907 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.09 -44.22 98.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 123.478 0.711 . . . . 10.0 109.093 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.7 m -60.95 -38.61 86.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.346 0.975 . . . . 10.0 111.092 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.17 -52.2 43.14 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.866 -0.894 . . . . 10.0 110.866 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.27 -42.4 99.13 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 117.48 0.64 . . . . 10.0 111.366 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 25.4 mmt -62.51 -38.07 88.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.4 -0.81 . . . . 10.0 110.768 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -62.9 -36.04 82.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.581 1.082 . . . . 10.0 111.042 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -66.07 -33.43 75.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.098 -0.953 . . . . 10.0 111.685 172.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -70.76 -40.32 72.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.219 0.918 . . . . 10.0 110.679 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.51 53.07 0.73 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 108.768 -1.733 . . . . 10.0 108.768 -168.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.2 m -141.84 165.04 28.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.235 1.814 . . . . 10.0 107.855 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -128.31 161.87 28.4 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.581 1.553 . . . . 10.0 107.668 171.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 73.6 m -127.79 154.28 45.59 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.368 1.067 . . . . 10.0 112.576 -168.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -143.7 116.72 8.87 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.162 -1.792 . . . . 10.0 106.162 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.3 p -61.25 130.46 46.29 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.134 -0.979 . . . . 10.0 108.739 170.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.8 mt -90.66 -24.45 20.47 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.48 0.312 . . . . 10.0 110.21 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.98 179.07 33.55 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.907 -1.677 . . . . 10.0 108.907 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.67 -179.33 22.72 Favored Glycine 0 CA--C 1.522 0.527 0 O-C-N 121.681 -0.894 . . . . 10.0 111.485 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.56 -149.98 7.05 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 109.789 -1.324 . . . . 10.0 109.789 -170.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -147.43 165.13 31.16 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.794 1.238 . . . . 10.0 109.505 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.3 mt -133.82 149.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.484 -2.413 . . . . 10.0 104.484 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 C--N 1.328 -0.349 0 C-N-CA 123.516 0.726 . . . . 10.0 109.582 175.291 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 70.9 mt . . . . . 0 C--O 1.239 0.535 0 CA-C-O 121.526 0.679 . . . . 10.0 109.187 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -134.51 148.8 50.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.007 1.323 . . . . 10.0 108.076 172.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.7 138.62 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.751 1.621 . . . . 10.0 107.286 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -169.31 -167.13 0.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.212 1.405 . . . . 10.0 107.905 -171.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.05 -172.92 38.97 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 121.361 -0.837 . . . . 10.0 112.738 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.69 174.31 11.91 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.951 0.9 . . . . 10.0 109.908 169.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.3 m -131.81 105.89 7.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.219 -2.141 . . . . 10.0 105.219 169.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.3 ttt -54.83 -28.71 51.61 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.303 1.041 . . . . 10.0 113.14 -169.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.0 -25.06 66.62 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.998 0.74 . . . . 10.0 112.998 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -128.87 -49.58 1.23 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.623 0.769 . . . . 10.0 110.407 -170.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.81 174.69 13.75 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.203 1.858 . . . . 10.0 108.917 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -53.94 136.14 65.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.574 2.183 . . . . 10.0 110.895 169.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.93 159.29 25.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.697 0.761 . . . . 10.0 109.164 168.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -78.76 72.01 5.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 169.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -49.52 -32.89 13.27 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.26 1.424 . . . . 10.0 113.551 -169.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.02 -38.03 72.55 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.069 0.85 . . . . 10.0 112.426 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.9 mt -64.8 -51.38 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 106.992 -1.484 . . . . 10.0 106.992 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -59.95 -43.64 94.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.288 -0.863 . . . . 10.0 111.804 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -63.42 -40.42 97.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 119.79 1.177 . . . . 10.0 111.002 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.97 -39.94 90.81 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.275 0.943 . . . . 10.0 110.674 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -66.32 -45.98 78.45 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.986 -0.446 . . . . 10.0 110.045 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.0 mt -59.1 -41.89 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 173.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -64.18 -36.56 84.44 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 120.877 -1.14 . . . . 10.0 111.35 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.27 -42.51 93.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.514 0.597 . . . . 10.0 111.037 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.2 tptt . . . . . 0 CA--C 1.541 0.621 0 C-N-CA 123.421 0.689 . . . . 10.0 111.011 173.335 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.234 0.25 0 N-CA-C 106.781 -1.562 . . . . 10.0 106.781 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -147.52 165.45 30.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.388 1.075 . . . . 10.0 109.612 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 40.4 p-90 -145.75 162.09 38.42 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 118.285 0.493 . . . . 10.0 111.181 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.252 0 C-N-CA 126.617 1.967 . . . . 10.0 107.361 169.842 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.95 153.66 35.65 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.651 1.18 . . . . 10.0 108.107 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.86 -20.39 56.82 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.902 0.881 . . . . 10.0 113.036 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.12 -23.59 63.98 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.605 1.093 . . . . 10.0 112.375 173.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -78.36 -7.84 57.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.557 0.743 . . . . 10.0 111.943 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -111.11 126.62 28.31 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 106.168 -1.79 . . . . 10.0 106.168 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -69.88 153.61 68.2 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.927 1.751 . . . . 10.0 109.992 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -81.51 -27.56 34.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.385 1.474 . . . . 10.0 112.642 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.8 t -134.84 133.62 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 124.995 1.318 . . . . 10.0 107.471 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -149.2 103.88 3.36 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.755 -1.572 . . . . 10.0 106.755 169.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.0 pt . . . . . 0 CA--C 1.539 0.546 0 C-N-CA 125.192 1.397 . . . . 10.0 110.108 -169.749 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 108.997 -0.742 . . . . 10.0 108.997 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -151.87 152.38 32.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.139 0.976 . . . . 10.0 109.784 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -74.36 152.3 39.58 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.711 0.805 . . . . 10.0 109.079 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.34 160.39 42.09 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.089 0.471 . . . . 10.0 110.308 173.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.22 141.67 43.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.548 -1.649 . . . . 10.0 106.548 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.7 tp -98.32 121.29 40.06 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.05 -2.204 . . . . 10.0 105.05 169.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.8 mt -129.33 135.57 61.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.582 -1.636 . . . . 10.0 106.582 -168.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -89.33 138.73 31.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.807 -1.923 . . . . 10.0 105.807 168.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 p -122.75 144.23 32.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.62 -1.622 . . . . 10.0 106.62 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -128.62 131.59 48.11 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.178 1.791 . . . . 10.0 106.713 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.5 p -78.17 140.11 38.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.824 0.284 . . . . 10.0 110.564 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.05 66.45 4.41 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.979 1.712 . . . . 10.0 107.182 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.36 -26.4 71.19 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.386 2.724 . . . . 10.0 113.131 -168.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.6 ptt85 -153.11 167.65 28.54 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.795 1.638 . . . . 10.0 107.167 168.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.2 m -58.53 137.76 57.21 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.23 27.54 60.41 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.06 0.838 . . . . 10.0 113.876 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.49 149.81 87.28 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 118.556 1.178 . . . . 10.0 110.884 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.45 35.7 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.987 3.125 . . . . 10.0 111.872 173.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.81 15.34 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.631 1.573 . . . . 10.0 108.516 -174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.32 28.39 0.57 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.642 1.577 . . . . 10.0 109.547 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -67.21 157.15 34.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.953 0.901 . . . . 10.0 109.098 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 m -141.91 159.63 41.84 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.685 1.194 . . . . 10.0 109.838 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -152.26 176.09 11.95 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.469 1.108 . . . . 10.0 109.807 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -108.24 144.93 35.05 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.512 -0.921 . . . . 10.0 108.512 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.3 pt -137.19 148.78 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.855 1.662 . . . . 10.0 109.629 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.6 t -107.94 122.58 62.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.977 -1.86 . . . . 10.0 105.977 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -127.6 137.47 52.57 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.588 -1.634 . . . . 10.0 106.588 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.51 133.67 2.98 Favored Glycine 0 C--O 1.225 -0.428 0 CA-C-N 119.822 1.192 . . . . 10.0 111.624 174.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -146.01 140.49 26.88 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.019 0.438 . . . . 10.0 110.992 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -65.04 -28.31 69.39 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.242 1.017 . . . . 10.0 113.43 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -69.4 -16.41 63.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.502 -0.761 . . . . 10.0 112.386 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.67 122.35 15.08 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 118.869 0.759 . . . . 10.0 111.244 -173.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -69.55 -32.88 71.94 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.2 0.6 . . . . 10.0 110.201 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -148.47 163.64 36.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.668 1.987 . . . . 10.0 107.617 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -58.92 -38.07 78.12 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.653 -0.655 . . . . 10.0 110.697 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.56 -21.31 66.27 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -67.31 -39.06 85.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.729 0.776 . . . . 10.0 109.477 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.42 -53.1 46.94 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 173.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -58.3 -42.07 85.85 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 119.155 -0.45 . . . . 10.0 111.353 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.72 -45.58 85.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.287 0.494 . . . . 10.0 111.597 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -58.94 -49.55 77.41 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.377 0.671 . . . . 10.0 109.438 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.19 -47.47 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.873 0.869 . . . . 10.0 109.122 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -59.83 -35.09 74.02 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.264 0.938 . . . . 10.0 111.325 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.36 -49.31 75.39 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.646 -0.982 . . . . 10.0 110.646 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.48 -45.87 92.44 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 117.873 0.836 . . . . 10.0 111.329 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -37.43 83.34 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.635 -0.697 . . . . 10.0 110.863 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -64.56 -35.9 82.48 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.049 0.84 . . . . 10.0 110.962 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.97 -32.0 72.94 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.085 -0.959 . . . . 10.0 111.721 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -68.63 -57.99 4.92 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.079 0.854 . . . . 10.0 109.172 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.12 41.8 0.17 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.43 1.49 . . . . 10.0 110.198 -169.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.7 m -142.87 171.69 13.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.679 1.592 . . . . 10.0 109.262 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -140.23 164.07 31.04 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.043 1.737 . . . . 10.0 108.176 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.7 m -130.09 163.82 25.74 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.517 1.127 . . . . 10.0 112.299 -169.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -148.19 118.41 7.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.892 -1.892 . . . . 10.0 105.892 171.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 p -66.03 129.04 38.44 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.929 -1.107 . . . . 10.0 109.119 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 mt -93.13 -23.67 18.52 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.598 0.359 . . . . 10.0 110.461 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.3 -178.22 34.64 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.388 -1.485 . . . . 10.0 109.388 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.2 -177.74 22.78 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 118.233 1.017 . . . . 10.0 112.403 176.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.67 -159.35 23.45 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.7 -1.76 . . . . 10.0 108.7 -170.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mtm105 -138.8 161.88 36.14 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.36 -1.082 . . . . 10.0 108.475 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 mt -136.22 146.42 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.66 -1.978 . . . . 10.0 105.66 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.451 -0.384 0 C-N-CA 124.023 0.929 . . . . 10.0 109.41 171.181 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.236 0.382 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -136.91 126.91 25.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.675 -1.602 . . . . 10.0 106.675 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.35 146.33 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 105.639 -1.985 . . . . 10.0 105.639 173.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -154.99 171.53 19.58 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.763 -1.21 . . . . 10.0 111.2 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.74 -160.5 54.07 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 121.535 0.519 . . . . 10.0 112.392 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -148.71 -177.41 5.77 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.625 1.57 . . . . 10.0 108.289 173.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.7 t -109.96 131.17 55.3 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 124.899 1.28 . . . . 10.0 107.865 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.3 mtt -72.58 -18.8 61.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.999 -0.524 . . . . 10.0 111.391 171.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.91 -35.8 72.44 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.909 0.777 . . . . 10.0 110.99 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -132.97 -43.77 0.87 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.9 0.48 . . . . 10.0 112.103 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.22 -178.36 18.84 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.013 -1.635 . . . . 10.0 109.013 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.01 136.65 62.3 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.307 2.005 . . . . 10.0 110.499 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.14 162.14 20.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 166.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -79.41 69.93 5.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.167 -1.79 . . . . 10.0 106.167 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -50.94 -31.0 16.36 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.467 1.507 . . . . 10.0 113.111 -168.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.7 -37.66 73.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.276 0.944 . . . . 10.0 112.326 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.73 -50.43 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 107.293 -1.373 . . . . 10.0 107.293 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -58.56 -45.78 88.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.553 -0.737 . . . . 10.0 111.792 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -63.79 -38.12 89.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 117.754 -1.117 . . . . 10.0 110.976 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.13 -41.39 94.85 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.014 1.279 . . . . 10.0 111.227 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -65.11 -48.1 74.81 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.046 -0.409 . . . . 10.0 109.909 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.7 mt -61.38 -42.32 93.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -58.83 -37.88 77.41 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.328 1.051 . . . . 10.0 111.081 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.76 89.79 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.687 0.676 . . . . 10.0 110.969 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 N--CA 1.47 0.555 0 CA-C-N 118.746 0.703 . . . . 10.0 112.049 175.895 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 C--O 1.236 0.352 0 N-CA-C 105.029 -2.211 . . . . 10.0 105.029 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 p -138.96 167.28 22.39 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.075 0.95 . . . . 10.0 109.928 -172.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -139.06 161.22 37.92 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 123.128 0.571 . . . . 10.0 110.882 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 125.588 1.555 . . . . 10.0 108.587 169.761 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.528 0 CA-C-O 121.109 0.48 . . . . 10.0 111.82 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -154.51 148.84 26.08 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.9 mt -58.13 -28.89 65.09 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.645 -0.659 . . . . 10.0 112.664 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.81 -26.47 68.35 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.93 0.786 . . . . 10.0 112.094 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.23 -24.71 46.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.923 0.489 . . . . 10.0 110.897 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.99 122.18 86.21 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 106.804 -1.554 . . . . 10.0 106.804 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -50.28 133.16 35.84 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.106 2.537 . . . . 10.0 110.169 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.0 -29.25 39.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.677 0.751 . . . . 10.0 111.442 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.3 t -137.74 135.9 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 127.176 2.19 . . . . 10.0 105.733 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -150.78 99.7 2.75 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.149 -1.426 . . . . 10.0 107.149 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 125.055 1.342 . . . . 10.0 110.436 -168.97 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 105.947 -1.871 . . . . 10.0 105.947 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -135.55 14.66 3.43 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.89 1.811 . . . . 10.0 115.89 -171.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mttp 56.26 159.39 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.646 1.978 . . . . 10.0 112.89 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.52 158.19 28.78 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 120.493 -1.38 . . . . 10.0 109.481 169.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.1 p -138.01 148.8 24.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.735 1.214 . . . . 10.0 107.949 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.73 118.88 37.7 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 105.574 -2.01 . . . . 10.0 105.574 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.0 mt -123.69 125.8 71.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 -169.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -76.97 131.72 38.64 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 168.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 p -119.88 135.22 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.864 -1.532 . . . . 10.0 106.864 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -114.65 150.67 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.448 1.899 . . . . 10.0 107.462 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 p -111.72 142.05 44.55 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -172.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.48 65.97 5.61 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 126.422 1.889 . . . . 10.0 106.594 168.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -41.48 133.27 3.5 Favored 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 125.467 4.111 . . . . 10.0 114.201 -168.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 50.3 23.88 1.34 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.39 1.476 . . . . 10.0 113.073 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m 51.92 32.84 10.52 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.992 1.317 . . . . 10.0 111.871 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.25 26.34 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.455 -0.636 . . . . 10.0 112.827 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.77 131.27 9.93 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 172.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -86.54 32.99 0.44 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 124.594 3.53 . . . . 10.0 112.747 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.01 83.81 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.623 0.769 . . . . 10.0 112.386 -168.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.11 28.46 2.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.543 1.937 . . . . 10.0 114.932 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -78.5 160.41 27.68 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 167.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 m -143.58 156.27 44.54 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.438 -0.789 . . . . 10.0 110.584 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -146.22 -175.47 4.78 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.989 1.316 . . . . 10.0 109.435 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -116.68 147.83 41.6 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.961 -1.126 . . . . 10.0 107.961 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.45 147.62 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.783 1.233 . . . . 10.0 110.111 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.66 125.91 64.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 106.79 -1.559 . . . . 10.0 106.79 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -133.83 141.31 47.37 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 107.125 -1.435 . . . . 10.0 107.125 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.48 124.86 1.14 Allowed Glycine 0 C--O 1.226 -0.382 0 CA-C-N 120.228 1.376 . . . . 10.0 111.52 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -144.72 135.75 24.98 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 117.262 0.531 . . . . 10.0 110.938 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -66.0 -26.24 67.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 118.292 -0.861 . . . . 10.0 113.05 -170.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -63.55 -20.37 65.58 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.111 0.869 . . . . 10.0 112.715 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.98 120.64 14.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.212 0.915 . . . . 10.0 109.691 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.89 -34.24 77.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.01 0.524 . . . . 10.0 110.139 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -147.19 158.29 43.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.724 2.01 . . . . 10.0 107.196 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -58.53 -29.05 66.03 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.918 0.71 . . . . 10.0 112.918 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.67 -28.75 64.05 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 123.203 0.601 . . . . 10.0 112.545 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -74.18 -30.68 62.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.612 0.642 . . . . 10.0 110.973 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -65.76 -52.24 52.42 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 172.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -53.82 -43.27 69.27 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 118.629 -0.7 . . . . 10.0 111.16 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.63 -44.44 93.86 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.728 0.695 . . . . 10.0 111.773 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -60.1 -51.55 69.13 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.141 -0.689 . . . . 10.0 109.141 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.4 t -68.96 -47.8 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 118.904 -0.57 . . . . 10.0 109.912 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.8 p -60.59 -31.63 70.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.472 1.033 . . . . 10.0 111.527 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.34 -50.1 71.3 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.728 -0.949 . . . . 10.0 110.728 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.7 -44.52 93.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.668 0.734 . . . . 10.0 111.5 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -40.01 83.04 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.685 0.675 . . . . 10.0 110.705 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -63.37 -35.66 81.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.16 0.891 . . . . 10.0 111.118 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -65.67 -30.84 71.58 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 117.833 -1.079 . . . . 10.0 111.682 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -74.38 -38.12 63.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.797 1.181 . . . . 10.0 111.055 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.47 57.68 0.83 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 107.202 -2.359 . . . . 10.0 107.202 -168.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.0 m -146.07 169.14 19.29 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.262 1.825 . . . . 10.0 108.102 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -139.61 160.85 38.92 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.39 1.476 . . . . 10.0 108.635 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.0 m -131.19 155.09 47.65 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.496 1.118 . . . . 10.0 112.337 -168.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -149.86 118.86 6.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.884 1.674 . . . . 10.0 106.708 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.9 m -68.03 123.95 22.04 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.005 -1.059 . . . . 10.0 109.153 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.3 mt -81.08 -23.92 38.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.875 0.47 . . . . 10.0 110.726 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.98 176.72 36.92 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.204 -1.559 . . . . 10.0 109.204 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.05 178.5 23.72 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 118.223 1.011 . . . . 10.0 112.109 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.23 -144.74 4.65 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 107.981 -2.048 . . . . 10.0 107.981 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -151.55 149.48 29.23 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 120.898 -1.354 . . . . 10.0 110.44 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.1 mt -108.56 148.04 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 105.121 -2.178 . . . . 10.0 105.121 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.533 0.315 0 C-N-CA 124.311 1.044 . . . . 10.0 109.121 171.892 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.5 pt . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 121.643 0.735 . . . . 10.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -149.13 163.36 37.81 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.105 0.962 . . . . 10.0 109.017 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -136.5 140.55 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.912 0.885 . . . . 10.0 108.66 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -157.5 -175.34 5.34 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.962 0.905 . . . . 10.0 109.98 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.63 -177.64 53.42 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 123.401 0.524 . . . . 10.0 113.012 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.31 -178.98 5.53 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.093 0.957 . . . . 10.0 110.184 169.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.8 m -133.52 107.43 8.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.212 -1.773 . . . . 10.0 106.212 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 77.2 mtm -59.74 -21.42 60.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.795 0.665 . . . . 10.0 112.795 -172.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.68 -26.36 67.05 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.802 0.841 . . . . 10.0 112.841 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -134.9 -50.68 0.77 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.489 0.716 . . . . 10.0 111.231 -169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.08 175.32 13.79 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.198 1.856 . . . . 10.0 108.981 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -54.81 133.8 59.49 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.467 2.111 . . . . 10.0 110.271 169.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.08 156.07 29.41 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.526 1.155 . . . . 10.0 109.413 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -82.42 65.33 7.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.283 -1.747 . . . . 10.0 106.283 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -51.81 -24.66 6.36 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.374 1.87 . . . . 10.0 114.012 -168.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.93 91.08 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.028 1.285 . . . . 10.0 111.392 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.3 mt -63.54 -50.91 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -61.51 -46.5 89.73 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.185 0.594 . . . . 10.0 111.874 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 p -65.37 -38.18 89.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.741 0.701 . . . . 10.0 110.966 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.02 -42.11 76.82 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.149 0.886 . . . . 10.0 110.985 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -59.96 -47.96 83.68 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.671 -0.681 . . . . 10.0 110.143 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.3 mt -56.93 -52.34 56.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 108.112 -1.07 . . . . 10.0 108.112 175.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -56.2 -40.52 74.13 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.324 0.966 . . . . 10.0 111.25 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.43 -50.88 49.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.037 0.535 . . . . 10.0 111.82 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.5 mptt . . . . . 0 N--CA 1.472 0.656 0 CA-C-N 118.93 0.786 . . . . 10.0 112.749 -169.867 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.6 t . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 106.197 -1.779 . . . . 10.0 106.197 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.2 p -138.43 174.52 10.45 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.211 1.004 . . . . 10.0 109.421 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -142.76 159.7 41.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.251 0.62 . . . . 10.0 109.726 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.263 0 C-N-CA 125.433 1.493 . . . . 10.0 107.979 172.251 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -149.21 149.81 31.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.155 1.382 . . . . 10.0 107.872 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.5 mt -58.68 -25.51 62.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.364 1.066 . . . . 10.0 113.024 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.89 -24.23 65.81 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.64 0.655 . . . . 10.0 112.34 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -75.47 -16.67 60.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.271 0.628 . . . . 10.0 111.494 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.5 mt -93.62 120.23 66.43 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.0 -1.482 . . . . 10.0 107.0 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.35 136.24 39.46 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.497 2.798 . . . . 10.0 110.551 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -78.08 -28.16 48.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.392 0.615 . . . . 10.0 111.832 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.2 t -139.22 135.11 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 104.262 -2.496 . . . . 10.0 104.262 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -153.39 119.93 5.58 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.608 -1.627 . . . . 10.0 106.608 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.9 pt . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 124.764 1.226 . . . . 10.0 109.171 -170.036 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 109.756 -0.461 . . . . 10.0 109.756 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -145.35 148.62 33.59 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.488 1.115 . . . . 10.0 109.265 169.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -63.65 150.9 43.18 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.017 0.927 . . . . 10.0 110.319 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.78 168.26 21.83 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.703 1.201 . . . . 10.0 109.037 178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.74 150.07 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.355 1.062 . . . . 10.0 108.661 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -114.16 121.92 45.25 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.375 -2.084 . . . . 10.0 105.375 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.5 mt -130.32 136.42 58.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.202 -1.406 . . . . 10.0 107.202 -169.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -91.65 139.2 30.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.74 -1.578 . . . . 10.0 106.74 166.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.53 141.33 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.123 -1.806 . . . . 10.0 106.123 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -122.37 135.84 54.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.98 1.712 . . . . 10.0 107.217 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.2 m -63.12 135.17 57.03 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.008 -0.367 . . . . 10.0 110.008 174.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.41 52.7 1.0 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.348 1.459 . . . . 10.0 110.077 168.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.66 -13.07 36.87 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.188 3.258 . . . . 10.0 115.123 -167.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -139.52 13.72 2.55 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.719 -1.238 . . . . 10.0 110.755 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m 48.33 33.98 4.26 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.344 1.058 . . . . 10.0 112.018 -168.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.32 64.82 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 N-CA-C 108.132 -1.987 . . . . 10.0 108.132 -168.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.97 157.12 77.72 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 125.231 1.412 . . . . 10.0 108.964 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.92 39.53 0.66 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 124.309 3.339 . . . . 10.0 112.121 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.93 104.92 3.74 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.978 1.711 . . . . 10.0 107.014 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.81 28.92 1.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.488 1.515 . . . . 10.0 110.28 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.73 174.57 2.82 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.2 1.0 . . . . 10.0 109.911 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -152.39 159.71 43.38 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 120.193 -1.567 . . . . 10.0 110.423 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -149.63 168.52 23.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.647 1.179 . . . . 10.0 109.565 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -99.9 150.67 22.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.9 pt -138.9 156.04 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 125.795 1.638 . . . . 10.0 109.889 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.39 130.35 62.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -133.35 141.16 47.79 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.02 1.328 . . . . 10.0 107.952 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.72 100.85 0.15 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 110.029 -1.229 . . . . 10.0 110.029 -171.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -130.4 131.87 45.48 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 118.236 1.018 . . . . 10.0 110.371 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -59.56 -25.51 64.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.198 1.184 . . . . 10.0 114.198 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -68.32 -20.62 64.75 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.494 1.043 . . . . 10.0 112.279 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.42 137.68 58.01 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.221 0.919 . . . . 10.0 111.428 -171.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.08 -40.95 87.11 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.679 -0.691 . . . . 10.0 109.231 170.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -155.92 170.67 21.57 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 126.125 1.77 . . . . 10.0 108.922 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -48.66 -36.31 15.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.977 1.311 . . . . 10.0 112.002 167.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.49 -28.02 66.66 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.948 0.721 . . . . 10.0 112.948 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -67.32 -41.94 84.45 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.18 0.991 . . . . 10.0 108.671 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.6 mt -62.0 -51.36 73.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 108.541 -0.911 . . . . 10.0 108.541 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -55.64 -43.49 76.25 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.679 -0.677 . . . . 10.0 111.598 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -62.58 -48.18 80.57 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.369 0.531 . . . . 10.0 111.726 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.54 -49.5 77.29 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.668 -0.645 . . . . 10.0 109.826 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.4 -42.65 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.609 -0.885 . . . . 10.0 108.609 -172.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.7 m -58.58 -36.38 73.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.558 1.072 . . . . 10.0 111.447 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.11 -47.09 91.33 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.803 -0.919 . . . . 10.0 110.803 172.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.09 -47.29 86.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.838 0.819 . . . . 10.0 111.459 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -36.72 82.01 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.338 -0.839 . . . . 10.0 110.74 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -64.35 -36.61 84.68 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.998 0.817 . . . . 10.0 111.004 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -67.96 -31.74 71.68 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.867 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -67.6 -56.79 8.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 119.294 0.952 . . . . 10.0 108.807 175.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.73 41.39 0.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.047 1.308 . . . . 10.0 110.528 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.3 m -144.0 173.63 11.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.837 1.655 . . . . 10.0 109.325 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -139.27 164.24 30.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.421 1.488 . . . . 10.0 108.205 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.2 m -125.22 161.55 26.66 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.567 1.147 . . . . 10.0 112.382 -168.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -149.11 109.8 4.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.817 2.047 . . . . 10.0 105.755 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 p -61.45 136.85 58.18 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.031 -1.043 . . . . 10.0 109.627 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.9 mt -110.19 -12.2 14.5 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.425 0.69 . . . . 10.0 111.235 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.86 -178.51 29.94 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.2 -1.16 . . . . 10.0 110.2 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.05 -179.24 22.97 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.841 -0.904 . . . . 10.0 110.841 168.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.1 -153.48 9.89 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.492 -1.843 . . . . 10.0 108.492 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -134.69 132.74 39.24 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 123.995 0.918 . . . . 10.0 108.61 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.17 119.56 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 104.567 -2.382 . . . . 10.0 104.567 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 105.266 -2.124 . . . . 10.0 105.266 167.071 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 C--O 1.237 0.407 0 N-CA-C 107.919 -1.141 . . . . 10.0 107.919 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -133.51 159.59 39.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.163 -1.421 . . . . 10.0 107.163 169.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 t -140.38 140.69 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 O-C-N 120.749 -1.219 . . . . 10.0 107.939 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -156.32 -177.89 6.92 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.877 0.871 . . . . 10.0 110.908 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.61 -166.4 50.77 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.922 -0.471 . . . . 10.0 111.922 169.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -157.18 173.43 16.99 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.785 1.234 . . . . 10.0 108.972 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.6 m -128.39 104.06 7.5 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.592 -1.262 . . . . 10.0 107.592 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 66.8 mtt -57.24 -24.27 53.59 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.36 1.064 . . . . 10.0 113.565 -170.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.24 -29.94 70.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.6 -0.714 . . . . 10.0 112.427 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -129.17 -45.82 1.24 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.663 0.785 . . . . 10.0 110.716 -171.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.97 174.33 13.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.768 1.651 . . . . 10.0 109.595 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -56.36 124.36 16.06 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.337 2.024 . . . . 10.0 109.631 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.69 159.49 13.34 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.778 0.799 . . . . 10.0 109.178 168.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -84.83 72.04 10.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.953 -1.499 . . . . 10.0 106.953 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -52.37 -25.14 8.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.132 1.373 . . . . 10.0 114.133 -169.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.76 99.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.96 1.255 . . . . 10.0 111.617 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.75 -50.95 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 107.528 -1.286 . . . . 10.0 107.528 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -56.79 -48.47 77.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.29 0.636 . . . . 10.0 111.588 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 p -68.89 -37.25 78.88 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.01 -0.995 . . . . 10.0 111.688 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -65.65 -39.79 91.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.499 1.045 . . . . 10.0 110.404 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -62.65 -48.7 78.17 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 119.16 -0.448 . . . . 10.0 110.103 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.0 mt -57.79 -42.39 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.219 0.918 . . . . 10.0 108.584 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -64.03 -37.63 88.12 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.535 1.062 . . . . 10.0 111.22 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.03 92.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.689 0.677 . . . . 10.0 111.067 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp . . . . . 0 CA--C 1.537 0.456 0 C-N-CA 123.467 0.707 . . . . 10.0 111.073 173.838 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.232 0.182 0 N-CA-C 107.111 -1.441 . . . . 10.0 107.111 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.2 p -142.55 170.48 15.63 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.514 1.126 . . . . 10.0 109.832 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -147.84 166.67 26.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.236 0.471 . . . . 10.0 111.106 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 127.026 2.13 . . . . 10.0 107.563 169.649 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 107.73 -1.211 . . . . 10.0 107.73 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -148.11 151.9 36.41 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.721 -1.214 . . . . 10.0 107.721 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.13 -30.16 61.73 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.618 0.767 . . . . 10.0 112.837 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.46 -28.45 69.67 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.704 0.683 . . . . 10.0 112.149 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -77.41 -28.82 52.77 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.844 0.458 . . . . 10.0 110.621 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.3 mt -69.91 122.06 84.79 Favored Pre-proline 0 C--O 1.24 0.557 0 N-CA-C 107.519 -1.289 . . . . 10.0 107.519 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.2 135.79 38.22 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.315 2.677 . . . . 10.0 110.341 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.23 -29.54 38.46 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.529 0.681 . . . . 10.0 111.35 -173.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -137.8 136.77 45.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 104.707 -2.331 . . . . 10.0 104.707 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -152.03 122.68 7.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.247 -1.76 . . . . 10.0 106.247 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.5 pt . . . . . 0 C--N 1.328 -0.35 0 C-N-CA 124.65 1.18 . . . . 10.0 109.393 -169.189 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -154.07 154.27 33.37 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.852 0.751 . . . . 10.0 110.66 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -86.96 151.22 23.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.508 1.123 . . . . 10.0 108.32 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.28 159.92 42.29 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.99 0.516 . . . . 10.0 110.479 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.94 140.53 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 125.694 1.598 . . . . 10.0 107.746 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -98.24 119.98 37.85 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 105.513 -2.032 . . . . 10.0 105.513 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.7 mt -124.08 132.99 70.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.52 -1.659 . . . . 10.0 106.52 -171.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -86.78 132.5 33.83 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.16 -1.793 . . . . 10.0 106.16 168.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.67 139.87 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.604 -1.258 . . . . 10.0 107.604 171.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -114.31 123.75 50.28 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.222 -2.14 . . . . 10.0 105.222 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.7 p -68.89 145.24 53.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.794 0.27 . . . . 10.0 110.49 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.35 67.81 3.09 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.206 1.802 . . . . 10.0 106.354 168.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -54.71 127.47 26.29 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.064 2.509 . . . . 10.0 110.872 -170.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 37.03 39.06 0.11 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.582 1.953 . . . . 10.0 113.407 -169.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 m 51.6 30.98 7.12 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.796 1.639 . . . . 10.0 113.696 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.2 -19.54 0.02 OUTLIER Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.242 -1.31 . . . . 10.0 116.26 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.94 149.83 95.99 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 120.277 2.039 . . . . 10.0 110.764 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.63 61.59 8.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.418 3.412 . . . . 10.0 111.657 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.49 139.11 35.06 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.854 1.262 . . . . 10.0 108.536 175.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.06 28.05 0.68 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.752 1.221 . . . . 10.0 110.98 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -67.98 164.51 19.83 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.421 -0.799 . . . . 10.0 109.232 171.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -139.61 159.22 42.67 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.899 0.88 . . . . 10.0 110.802 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -150.19 171.48 16.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.216 1.007 . . . . 10.0 109.907 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.29 150.23 21.77 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.345 -0.983 . . . . 10.0 108.345 172.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.3 pt -137.14 150.76 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 125.461 1.504 . . . . 10.0 109.559 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.09 126.15 63.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -132.92 134.97 45.26 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.29 117.45 0.65 Allowed Glycine 0 C--O 1.225 -0.462 0 CA-C-N 119.46 1.027 . . . . 10.0 110.866 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -138.38 132.03 30.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 -172.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -60.14 -18.16 45.57 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 114.67 1.359 . . . . 10.0 114.67 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -67.1 -28.01 67.81 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.27 1.395 . . . . 10.0 112.139 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.71 153.93 30.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.712 1.142 . . . . 10.0 109.419 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.31 -6.91 2.61 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.553 0.741 . . . . 10.0 111.821 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.92 12.63 3.64 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 118.885 0.766 . . . . 10.0 112.767 -168.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 63.38 -46.57 0.23 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.285 2.634 . . . . 10.0 114.792 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.07 -30.17 67.86 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.024 0.929 . . . . 10.0 111.363 -178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.12 -32.74 74.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 117.938 0.335 . . . . 10.0 111.533 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -67.91 -55.41 16.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 107.326 -1.361 . . . . 10.0 107.326 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.58 -39.42 67.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.256 0.622 . . . . 10.0 111.603 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -61.54 -50.75 71.41 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.304 1.041 . . . . 10.0 111.712 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -45.52 93.12 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.713 -0.617 . . . . 10.0 110.218 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.86 -46.04 93.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -59.1 -36.15 74.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.746 1.157 . . . . 10.0 111.377 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.62 -51.33 54.97 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 174.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.24 -45.21 94.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.525 0.662 . . . . 10.0 111.349 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -34.67 78.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.136 -0.935 . . . . 10.0 110.719 -175.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -65.78 -37.38 86.17 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.613 1.097 . . . . 10.0 110.648 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -62.65 -37.17 85.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 117.681 -1.152 . . . . 10.0 110.919 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -66.78 -52.64 41.7 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.409 1.004 . . . . 10.0 109.646 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.04 51.12 0.25 Allowed Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.475 1.512 . . . . 10.0 109.403 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.3 m -143.68 167.71 21.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.814 1.646 . . . . 10.0 108.486 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -129.62 161.97 29.35 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.03 1.732 . . . . 10.0 107.141 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.2 m -125.34 160.04 30.31 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.669 1.187 . . . . 10.0 112.017 -168.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -148.83 115.38 5.92 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.866 -1.901 . . . . 10.0 105.866 170.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.83 115.11 6.24 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.904 -1.123 . . . . 10.0 108.466 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.7 mt -77.54 -29.26 52.23 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.821 -0.549 . . . . 10.0 110.355 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.76 -177.53 38.82 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.071 -1.611 . . . . 10.0 109.071 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.68 -178.18 29.63 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 118.259 1.029 . . . . 10.0 111.178 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.5 -158.37 17.59 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.531 -1.428 . . . . 10.0 109.531 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 mtm180 -131.8 154.52 49.03 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.54 -0.976 . . . . 10.0 108.476 -177.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.9 mt -134.29 140.55 45.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 104.302 -2.481 . . . . 10.0 104.302 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.329 -0.312 0 O-C-N 120.908 -1.12 . . . . 10.0 110.273 172.76 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.2 pt . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 122.226 1.012 . . . . 10.0 110.848 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -140.2 147.87 40.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.368 -1.345 . . . . 10.0 107.368 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.84 134.77 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.415 -1.328 . . . . 10.0 107.415 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -159.27 -179.69 8.2 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.175 -0.953 . . . . 10.0 111.046 -168.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.8 -158.39 53.08 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.053 0.835 . . . . 10.0 112.981 170.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -150.72 167.82 26.23 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.594 1.158 . . . . 10.0 108.558 172.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.7 p -68.53 -28.67 67.19 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.6 ttm 53.93 29.53 10.13 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.206 0.603 . . . . 10.0 110.159 -167.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.29 -32.42 0.6 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.738 1.215 . . . . 10.0 111.876 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.38 -46.13 0.56 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.215 0.606 . . . . 10.0 110.205 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.41 177.16 31.24 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.111 1.815 . . . . 10.0 109.598 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.99 138.36 56.79 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.511 2.14 . . . . 10.0 110.458 172.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.71 160.97 24.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 166.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -81.31 75.54 8.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.682 -1.599 . . . . 10.0 106.682 169.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -54.48 -24.31 19.89 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.901 1.28 . . . . 10.0 113.528 -169.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.5 99.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.651 1.114 . . . . 10.0 111.705 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.1 mt -64.51 -52.07 59.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 106.988 -1.486 . . . . 10.0 106.988 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 m -57.46 -45.79 84.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.511 -0.757 . . . . 10.0 112.092 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 p -66.24 -37.82 86.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 117.722 -1.132 . . . . 10.0 111.721 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -64.45 -41.21 96.67 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.965 1.257 . . . . 10.0 110.6 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -63.89 -47.55 80.17 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.103 -0.373 . . . . 10.0 110.265 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.31 -38.9 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.415 -0.957 . . . . 10.0 108.415 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -62.32 -38.11 88.17 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 120.556 -1.34 . . . . 10.0 111.239 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.39 -31.02 71.91 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.713 0.688 . . . . 10.0 112.228 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.7 tptt . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 124.327 1.051 . . . . 10.0 111.649 172.241 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.238 0.448 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.5 p -144.7 170.07 16.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.428 1.491 . . . . 10.0 109.041 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -143.98 168.89 18.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.175 0.59 . . . . 10.0 110.754 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.207 0 C-N-CA 124.756 1.223 . . . . 10.0 108.998 173.314 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.308 0 N-CA-C 106.832 -1.544 . . . . 10.0 106.832 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -149.35 150.54 32.64 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.968 -1.123 . . . . 10.0 107.968 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.35 -26.42 60.95 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.372 1.069 . . . . 10.0 112.753 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.91 -25.51 67.62 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.876 0.762 . . . . 10.0 112.792 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -74.2 -25.8 59.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.205 0.457 . . . . 10.0 111.042 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.96 130.68 69.23 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 106.467 -1.679 . . . . 10.0 106.467 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.19 146.14 68.94 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.989 1.792 . . . . 10.0 109.625 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.72 -30.06 59.12 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.605 0.762 . . . . 10.0 112.593 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.4 t -138.28 132.31 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.696 -1.964 . . . . 10.0 105.696 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -149.93 102.72 3.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.47 -2.048 . . . . 10.0 105.47 171.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.2 pt . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 124.672 1.189 . . . . 10.0 110.516 -168.736 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 109.202 -0.666 . . . . 10.0 109.202 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -154.4 148.69 26.02 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.437 1.095 . . . . 10.0 109.592 170.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -72.73 150.71 42.63 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.696 -0.854 . . . . 10.0 108.696 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.33 165.51 29.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.683 0.793 . . . . 10.0 109.561 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.7 143.37 24.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.506 -1.294 . . . . 10.0 107.506 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp -99.8 126.43 45.89 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 105.49 -2.041 . . . . 10.0 105.49 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 98.2 mt -130.34 136.66 58.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -91.56 145.71 24.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.987 -1.486 . . . . 10.0 106.987 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.53 146.0 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.082 -1.821 . . . . 10.0 106.082 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -127.25 132.27 50.41 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.295 -1.742 . . . . 10.0 106.295 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.1 p -71.59 147.43 47.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.827 0.74 . . . . 10.0 110.777 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.93 62.31 3.42 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.621 1.568 . . . . 10.0 107.797 168.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -58.86 145.33 97.14 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.215 2.61 . . . . 10.0 109.664 -172.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 51.66 19.34 0.87 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.291 1.036 . . . . 10.0 112.517 -176.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m 50.44 28.5 3.37 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.865 1.266 . . . . 10.0 113.332 -171.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.62 -0.69 0.02 OUTLIER Glycine 0 CA--C 1.532 1.1 0 N-CA-C 116.497 1.359 . . . . 10.0 116.497 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.72 152.28 75.99 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.879 1.839 . . . . 10.0 110.244 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.46 61.45 7.4 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 124.229 3.286 . . . . 10.0 111.751 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.24 141.74 33.98 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.105 1.362 . . . . 10.0 108.602 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.67 39.5 0.49 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.465 1.506 . . . . 10.0 109.168 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.76 175.14 5.21 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.713 0.805 . . . . 10.0 108.896 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.1 m -151.99 163.2 39.79 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.171 -1.58 . . . . 10.0 111.369 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -154.82 163.53 40.14 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.529 2.332 . . . . 10.0 107.416 -169.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -129.24 141.86 51.01 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.351 -1.351 . . . . 10.0 107.351 174.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.3 pt -138.19 154.9 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.599 1.16 . . . . 10.0 110.822 -169.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.97 125.45 64.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.657 -1.609 . . . . 10.0 106.657 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -132.22 142.99 49.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.27 131.59 1.91 Allowed Glycine 0 C--O 1.22 -0.761 0 CA-C-N 119.878 1.217 . . . . 10.0 111.349 171.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -142.35 138.56 31.31 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 124.174 0.573 . . . . 10.0 109.644 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -68.59 -23.58 64.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.672 0.789 . . . . 10.0 112.362 -171.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -66.18 -20.53 66.16 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 118.444 -0.789 . . . . 10.0 112.422 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 127.67 32.6 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 118.995 0.816 . . . . 10.0 110.75 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -72.31 -35.73 68.72 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.489 0.661 . . . . 10.0 109.648 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -149.01 165.7 30.88 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 126.174 1.79 . . . . 10.0 108.55 -175.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -57.03 -38.75 73.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.988 0.423 . . . . 10.0 110.763 175.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.63 67.47 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 123.925 0.89 . . . . 10.0 113.16 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -66.96 -46.53 74.42 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.3 mt -62.46 -51.43 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -55.36 -41.32 72.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.615 -0.707 . . . . 10.0 111.628 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.7 -47.14 79.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.267 0.485 . . . . 10.0 111.86 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -58.59 -49.85 75.96 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 109.797 -0.446 . . . . 10.0 109.797 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.46 -45.29 93.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.459 -0.781 . . . . 10.0 109.181 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 m -57.58 -43.02 84.27 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.051 0.841 . . . . 10.0 110.821 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.79 -46.59 94.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.969 -0.853 . . . . 10.0 110.969 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.35 -48.55 77.51 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 118.226 1.013 . . . . 10.0 110.951 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -39.09 84.44 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.553 0.615 . . . . 10.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -63.11 -35.88 81.73 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.472 0.578 . . . . 10.0 110.833 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.22 -32.6 72.92 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.513 -1.232 . . . . 10.0 112.188 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 mm-40 -67.26 -53.08 33.19 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.295 0.952 . . . . 10.0 109.327 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.1 44.26 0.22 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.274 1.416 . . . . 10.0 109.607 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.3 m -145.95 175.89 10.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.185 2.194 . . . . 10.0 107.755 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -144.81 164.6 30.55 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.528 0.731 . . . . 10.0 109.04 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.8 m -120.9 162.29 20.11 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.599 1.16 . . . . 10.0 113.313 -168.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -147.57 112.49 5.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.32 2.248 . . . . 10.0 105.741 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 t -64.2 140.47 58.87 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.029 -1.045 . . . . 10.0 109.67 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.9 mt -110.26 -9.67 14.65 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.17 0.988 . . . . 10.0 111.636 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.88 171.75 18.63 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.434 1.016 . . . . 10.0 112.073 169.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.28 161.2 18.78 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.465 1.031 . . . . 10.0 110.828 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.85 -160.89 23.64 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.027 -1.629 . . . . 10.0 109.027 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -146.07 162.84 37.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.34 -1.682 . . . . 10.0 110.337 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -129.12 151.75 36.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 105.64 -1.985 . . . . 10.0 105.64 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.451 -0.404 0 C-N-CA 124.459 1.104 . . . . 10.0 109.292 175.806 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--O 1.238 0.471 0 N-CA-C 107.003 -1.48 . . . . 10.0 107.003 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -135.77 148.97 48.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.598 -0.89 . . . . 10.0 108.598 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.05 128.56 62.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.769 1.228 . . . . 10.0 107.916 -169.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -157.13 -164.97 1.71 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.564 0.746 . . . . 10.0 109.699 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.39 -169.85 54.6 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 111.081 -0.807 . . . . 10.0 111.081 -173.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -161.29 -170.89 2.8 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.4 1.48 . . . . 10.0 107.572 169.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.3 t -135.04 135.54 41.38 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.719 -1.215 . . . . 10.0 107.719 172.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 79.2 mtm -77.26 -16.81 58.84 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.877 -0.583 . . . . 10.0 111.134 169.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.89 -26.07 63.07 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.717 0.69 . . . . 10.0 112.333 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.43 -48.91 0.2 Allowed 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 123.177 0.591 . . . . 10.0 110.53 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.27 179.57 29.67 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.197 -1.561 . . . . 10.0 109.197 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -61.66 150.11 87.0 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.395 2.063 . . . . 10.0 109.902 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.33 27.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.232 1.413 . . . . 10.0 113.924 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 40.21 55.8 2.67 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.425 2.29 . . . . 10.0 109.57 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -43.99 -35.42 2.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.485 2.314 . . . . 10.0 114.603 -166.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.15 -37.12 66.57 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.368 0.986 . . . . 10.0 113.128 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.3 mt -63.66 -53.2 47.88 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 107.247 -1.39 . . . . 10.0 107.247 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.6 m -61.71 -41.73 98.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.178 -0.915 . . . . 10.0 112.267 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 p -65.01 -39.61 93.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.725 1.148 . . . . 10.0 110.602 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -63.77 -40.56 96.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.501 1.046 . . . . 10.0 110.937 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -62.98 -48.92 76.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.674 0.39 . . . . 10.0 110.59 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.8 mt -58.4 -45.75 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -62.41 -38.02 88.06 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 121.225 -0.922 . . . . 10.0 111.547 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.29 75.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.202 0.601 . . . . 10.0 111.763 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt . . . . . 0 CA--C 1.544 0.743 0 CA-C-O 117.718 -1.134 . . . . 10.0 112.433 173.227 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.234 0.249 0 N-CA-C 106.205 -1.776 . . . . 10.0 106.205 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -142.18 170.17 16.22 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.257 1.023 . . . . 10.0 109.996 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -143.7 166.19 25.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.279 0.562 . . . . 10.0 112.474 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 128.787 2.835 . . . . 10.0 107.504 171.374 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 106.5 -1.667 . . . . 10.0 106.5 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -152.41 151.53 30.92 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.85 -25.32 64.93 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.645 0.778 . . . . 10.0 112.859 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.87 72.83 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.162 0.892 . . . . 10.0 111.63 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.59 -34.89 58.41 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.963 0.505 . . . . 10.0 110.032 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mt -64.62 118.81 51.65 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.15 139.51 52.72 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.484 2.789 . . . . 10.0 111.36 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.72 -31.98 25.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.303 0.573 . . . . 10.0 111.915 -173.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.57 139.04 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 105.759 -1.941 . . . . 10.0 105.759 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -146.89 113.26 5.92 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 105.451 -2.055 . . . . 10.0 105.451 171.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.6 pt . . . . . 0 CA--C 1.535 0.399 0 C-N-CA 124.513 1.125 . . . . 10.0 111.877 -168.303 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -145.27 151.34 38.21 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.208 0.603 . . . . 10.0 109.978 171.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -79.98 146.28 32.12 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.335 -1.357 . . . . 10.0 107.335 174.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.86 161.54 38.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.629 0.649 . . . . 10.0 110.962 -177.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.39 145.2 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.571 1.548 . . . . 10.0 107.574 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.3 tp -104.97 123.68 48.21 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.197 -2.149 . . . . 10.0 105.197 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.13 129.47 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 -172.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -83.65 140.09 32.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.525 -1.657 . . . . 10.0 106.525 167.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.69 139.74 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 106.16 -1.793 . . . . 10.0 106.16 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -121.02 138.1 54.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.337 1.855 . . . . 10.0 106.623 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.3 p -97.03 138.42 34.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.247 0.546 . . . . 10.0 112.323 -170.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.37 68.11 7.72 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 125.155 1.382 . . . . 10.0 107.393 168.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.48 149.62 9.5 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.957 3.105 . . . . 10.0 111.917 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 45.86 20.99 0.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.573 1.549 . . . . 10.0 114.632 -171.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.6 m 50.94 39.05 21.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.758 1.223 . . . . 10.0 111.878 -171.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.23 -28.87 0.02 OUTLIER Glycine 0 C--N 1.342 0.871 0 CA-C-O 118.977 -0.902 . . . . 10.0 114.72 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.24 131.2 93.48 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 119.572 1.686 . . . . 10.0 109.231 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -85.55 32.83 0.47 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.353 3.369 . . . . 10.0 112.88 -170.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.25 78.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.637 0.775 . . . . 10.0 111.95 -169.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 48.82 26.74 1.37 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.82 2.048 . . . . 10.0 115.32 174.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.87 159.5 28.89 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 168.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -142.91 158.74 43.33 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.535 -0.728 . . . . 10.0 110.624 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -151.76 176.04 11.8 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.97 1.308 . . . . 10.0 109.356 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.6 mp0 -106.68 153.63 22.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.963 -0.755 . . . . 10.0 108.963 170.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.7 pt -137.75 151.81 26.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 125.338 1.455 . . . . 10.0 110.081 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.45 130.12 58.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 106.233 -1.765 . . . . 10.0 106.233 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -133.83 140.35 46.83 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.082 -1.821 . . . . 10.0 106.082 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.74 139.31 4.98 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 120.455 1.48 . . . . 10.0 113.019 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -149.25 144.85 26.77 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.809 0.843 . . . . 10.0 109.652 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.58 -23.96 61.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 117.956 -1.021 . . . . 10.0 112.936 -172.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -68.03 -17.27 64.36 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.668 0.988 . . . . 10.0 113.668 -174.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.24 130.79 46.98 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 119.389 0.995 . . . . 10.0 110.103 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.47 -37.5 77.32 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.925 -0.398 . . . . 10.0 109.925 176.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -149.53 160.38 43.53 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.098 2.159 . . . . 10.0 106.709 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -57.32 -33.13 67.39 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.902 0.881 . . . . 10.0 112.701 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.0 -25.54 65.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.384 0.674 . . . . 10.0 112.586 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.08 -37.92 84.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.579 0.627 . . . . 10.0 110.36 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.7 mt -64.27 -50.85 74.72 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 107.748 -1.204 . . . . 10.0 107.748 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -55.73 -42.6 75.6 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.851 -0.595 . . . . 10.0 111.326 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.09 -43.9 97.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.601 0.637 . . . . 10.0 111.989 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -61.3 -51.34 69.28 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 121.63 -0.669 . . . . 10.0 109.434 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.17 -42.71 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.584 -0.525 . . . . 10.0 109.584 -170.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.4 p -66.45 -33.75 76.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.182 0.901 . . . . 10.0 111.472 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.3 -39.54 96.02 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.364 0.983 . . . . 10.0 111.034 173.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -69.11 -45.38 70.36 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.724 -0.868 . . . . 10.0 111.109 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 27.2 mmt -61.13 -39.5 90.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.186 0.903 . . . . 10.0 110.597 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.55 -39.75 89.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.78 0.718 . . . . 10.0 110.903 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -20.48 59.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 117.874 -1.06 . . . . 10.0 112.887 175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -72.95 -43.29 62.48 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.714 1.143 . . . . 10.0 110.423 169.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.71 49.71 0.58 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.217 -1.553 . . . . 10.0 109.217 -169.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.7 m -145.74 169.83 17.71 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.046 1.738 . . . . 10.0 108.206 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -136.24 161.51 35.54 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.637 1.575 . . . . 10.0 108.216 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.6 m -125.13 158.05 34.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.542 1.137 . . . . 10.0 112.693 -168.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -146.0 106.41 4.06 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.994 2.118 . . . . 10.0 105.597 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.8 p -61.46 131.51 50.41 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.281 -0.887 . . . . 10.0 109.192 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -102.4 -21.77 14.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.008 0.523 . . . . 10.0 110.909 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.01 -178.48 32.52 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.937 -1.265 . . . . 10.0 109.937 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.94 -173.29 23.56 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 117.944 0.872 . . . . 10.0 111.215 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.23 -148.98 9.87 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.157 -1.577 . . . . 10.0 109.157 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -139.46 160.44 39.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.765 1.226 . . . . 10.0 108.671 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.8 mt -136.58 149.17 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 106.333 -1.728 . . . . 10.0 106.333 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 C--O 1.237 0.413 0 C-N-CA 125.333 1.453 . . . . 10.0 108.435 170.176 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 98.0 mt . . . . . 0 C--O 1.237 0.438 0 N-CA-C 105.546 -2.02 . . . . 10.0 105.546 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -135.76 145.2 46.33 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.847 0.859 . . . . 10.0 108.912 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.81 130.49 55.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 107.326 -1.361 . . . . 10.0 107.326 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -158.66 179.49 9.06 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.346 -0.846 . . . . 10.0 111.714 -168.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.72 -159.01 34.22 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 123.762 0.696 . . . . 10.0 112.359 170.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -155.92 152.38 28.18 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.596 1.959 . . . . 10.0 106.494 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 p -69.82 152.15 44.9 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.017 0.826 . . . . 10.0 111.131 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.5 mtp -77.81 28.73 0.17 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.588 1.155 . . . . 10.0 110.161 169.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.36 -41.5 0.18 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.087 0.955 . . . . 10.0 112.585 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -133.42 -51.28 0.87 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.314 0.961 . . . . 10.0 112.565 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.19 -177.67 23.47 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.806 -0.918 . . . . 10.0 110.806 -171.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.2 144.76 82.34 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.004 2.47 . . . . 10.0 110.725 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.86 21.83 1.5 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -170.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 40.94 53.2 3.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.237 1.415 . . . . 10.0 110.065 -169.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -39.09 -30.91 0.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.95 2.9 . . . . 10.0 116.759 -166.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.65 60.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.814 1.188 . . . . 10.0 112.643 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.0 mt -60.77 -54.22 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -61.59 -41.29 97.22 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 117.915 -1.04 . . . . 10.0 111.867 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.7 p -64.69 -37.31 87.14 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 120.092 1.314 . . . . 10.0 111.431 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.2 -39.98 86.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.906 0.775 . . . . 10.0 110.729 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -64.8 -46.26 82.77 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.834 -0.541 . . . . 10.0 110.527 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.0 mt -57.64 -47.16 86.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -58.42 -42.31 86.96 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.134 0.879 . . . . 10.0 111.239 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.67 89.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.593 0.633 . . . . 10.0 111.559 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 118.085 -0.96 . . . . 10.0 112.99 -176.998 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.6 p -138.0 167.31 22.04 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.456 1.102 . . . . 10.0 109.429 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -145.01 165.3 28.57 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.41 0 C-N-CA 127.27 2.228 . . . . 10.0 108.286 172.73 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 109.671 -0.492 . . . . 10.0 109.671 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.79 149.64 29.25 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 172.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.01 -23.5 63.71 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.36 -29.29 69.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.139 0.882 . . . . 10.0 111.987 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.9 mt -75.37 -31.88 60.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.159 0.436 . . . . 10.0 110.408 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.0 mt -69.79 123.74 89.21 Favored Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 107.629 -1.248 . . . . 10.0 107.629 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.13 135.05 30.51 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.639 2.893 . . . . 10.0 111.159 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.18 -28.47 27.33 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.299 0.571 . . . . 10.0 112.237 -171.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.19 134.69 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 127.41 2.284 . . . . 10.0 104.895 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -156.2 98.77 1.89 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.208 -1.775 . . . . 10.0 106.208 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.5 pt . . . . . 0 CA--C 1.531 0.234 0 C-N-CA 124.487 1.115 . . . . 10.0 109.633 -169.771 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 110.036 -0.357 . . . . 10.0 110.036 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -139.32 19.57 2.58 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.505 1.122 . . . . 10.0 111.696 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 64.17 146.3 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.594 2.758 . . . . 10.0 113.093 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.47 157.05 43.7 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.749 1.22 . . . . 10.0 108.344 175.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.34 147.96 32.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 125.624 1.569 . . . . 10.0 108.161 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.2 tp -109.46 120.2 41.77 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.666 -1.975 . . . . 10.0 105.666 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.8 mt -131.28 136.36 57.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 -168.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -88.45 143.8 26.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.799 -1.556 . . . . 10.0 106.799 168.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -126.78 141.64 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.565 -1.643 . . . . 10.0 106.565 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -124.83 129.53 50.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.352 1.861 . . . . 10.0 106.048 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.1 p -80.06 146.22 32.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.775 0.322 . . . . 10.0 111.201 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -155.72 62.15 3.08 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.38 1.872 . . . . 10.0 106.702 167.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -55.61 143.63 78.27 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.532 2.821 . . . . 10.0 111.078 -168.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.4 ttt85 47.69 25.38 0.68 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.947 1.299 . . . . 10.0 113.09 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.0 m 53.01 28.82 7.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.523 1.529 . . . . 10.0 113.632 -175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.84 -1.8 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 N-CA-C 116.723 1.449 . . . . 10.0 116.723 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 152.13 82.44 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 120.168 1.984 . . . . 10.0 110.675 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.85 59.14 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.291 3.327 . . . . 10.0 111.917 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.6 140.98 33.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.024 1.33 . . . . 10.0 108.516 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.06 29.77 0.72 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.176 1.391 . . . . 10.0 110.254 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -67.57 162.24 23.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.643 0.777 . . . . 10.0 108.918 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -140.2 160.29 40.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.026 0.93 . . . . 10.0 110.01 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -150.78 176.28 11.19 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.58 1.152 . . . . 10.0 109.627 170.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -99.31 157.09 16.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.347 -0.982 . . . . 10.0 108.347 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.8 pt -141.72 149.35 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 126.387 1.875 . . . . 10.0 108.346 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.76 124.27 66.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.883 -1.895 . . . . 10.0 105.883 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -129.38 148.53 51.31 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.596 -1.261 . . . . 10.0 107.596 -175.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.32 124.08 0.97 Allowed Glycine 0 C--O 1.228 -0.255 0 N-CA-C 109.035 -1.626 . . . . 10.0 109.035 173.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -140.63 134.97 31.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.4 0.6 . . . . 10.0 110.501 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -74.69 -11.95 60.3 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 114.277 1.214 . . . . 10.0 114.277 -169.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -66.11 -24.3 66.66 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.461 1.028 . . . . 10.0 111.575 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.33 163.19 28.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.85 0.75 . . . . 10.0 110.809 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -119.18 -17.65 8.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.449 1.1 . . . . 10.0 110.367 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -146.95 152.49 38.74 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.421 1.488 . . . . 10.0 108.105 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 94' ' ' SER . 55.7 m80 -57.68 -31.85 66.76 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.399 1.079 . . . . 10.0 112.21 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.32 -33.2 72.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.187 -0.911 . . . . 10.0 112.607 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -72.0 -37.08 69.88 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.959 0.799 . . . . 10.0 110.437 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.9 -52.23 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.934 -1.135 . . . . 10.0 107.934 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -56.87 -43.19 80.96 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 119.09 -0.481 . . . . 10.0 111.494 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.32 -45.5 91.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.906 0.482 . . . . 10.0 111.181 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -60.92 -48.25 82.67 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.608 -0.682 . . . . 10.0 109.976 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.97 -43.89 98.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.659 0.783 . . . . 10.0 109.622 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.8 m -61.29 -43.88 98.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.046 0.839 . . . . 10.0 110.406 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.78 -46.92 93.55 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.787 -0.925 . . . . 10.0 110.787 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.05 -44.8 95.92 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.741 0.77 . . . . 10.0 110.668 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.3 mmt -62.01 -37.18 83.91 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.923 -0.56 . . . . 10.0 111.101 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -63.65 -35.64 81.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.274 0.943 . . . . 10.0 110.816 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.55 -31.97 72.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 117.924 -1.036 . . . . 10.0 111.597 171.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.63 -44.43 70.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.527 1.058 . . . . 10.0 110.039 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.86 47.55 0.61 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 108.852 -1.699 . . . . 10.0 108.852 -169.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.5 m -146.66 169.64 18.59 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.321 1.848 . . . . 10.0 108.655 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.57 164.93 28.83 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.064 1.746 . . . . 10.0 108.138 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 78.5 m -126.17 164.89 19.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.199 1.0 . . . . 10.0 112.811 -168.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -149.3 113.08 5.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.317 2.247 . . . . 10.0 105.346 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.8 t -66.47 140.23 58.01 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.637 -1.29 . . . . 10.0 109.479 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.8 mt -108.22 -13.46 14.9 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.614 0.765 . . . . 10.0 111.228 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.06 -174.25 24.48 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.209 1.385 . . . . 10.0 110.573 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.06 -176.23 27.03 Favored Glycine 0 CA--C 1.524 0.647 0 O-C-N 121.44 -1.036 . . . . 10.0 111.495 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.29 -154.5 10.2 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.131 -1.588 . . . . 10.0 109.131 -174.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -139.52 163.65 31.98 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.441 1.896 . . . . 10.0 107.905 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mt -129.23 150.78 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.495 -1.669 . . . . 10.0 106.495 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 p . . . . . 0 CA--C 1.537 0.456 0 C-N-CA 125.257 1.423 . . . . 10.0 108.832 -174.112 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.239 0.528 0 N-CA-C 106.582 -1.636 . . . . 10.0 106.582 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -137.44 157.01 47.49 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.526 0.731 . . . . 10.0 109.366 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.53 140.32 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -159.36 -174.95 4.94 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.761 -1.212 . . . . 10.0 110.06 -171.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.13 -166.07 52.49 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 121.835 0.686 . . . . 10.0 111.641 169.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -148.47 161.8 40.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.512 1.125 . . . . 10.0 108.403 175.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.408 ' HA ' ' CE1' ' A' ' 53' ' ' HIS . 30.1 t -83.17 126.33 32.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -64.63 -26.97 68.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.119 0.568 . . . . 10.0 110.702 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.53 -30.17 46.89 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.529 -0.748 . . . . 10.0 112.487 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -130.15 -58.91 1.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.802 0.728 . . . . 10.0 112.396 -169.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 149.14 176.28 22.28 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 108.902 -1.679 . . . . 10.0 108.902 -170.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -57.13 134.53 64.84 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.572 2.182 . . . . 10.0 110.566 171.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.65 163.44 18.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 166.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -79.79 69.29 6.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.08 -1.822 . . . . 10.0 106.08 167.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -50.78 -30.09 13.25 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.211 1.404 . . . . 10.0 113.518 -168.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.69 70.89 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.289 0.95 . . . . 10.0 112.349 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.9 mt -64.32 -50.28 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.2 m -59.26 -46.5 88.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.61 -0.681 . . . . 10.0 111.96 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.9 p -63.94 -39.98 95.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.356 -0.83 . . . . 10.0 110.876 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.44 -40.17 92.94 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.307 0.958 . . . . 10.0 110.97 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -66.68 -44.23 82.36 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.755 -0.64 . . . . 10.0 110.436 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.7 mt -56.15 -52.44 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.003 -1.11 . . . . 10.0 108.003 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -59.55 -40.59 87.73 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.741 0.816 . . . . 10.0 111.54 -174.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.6 -41.08 98.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.704 0.802 . . . . 10.0 111.288 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 118.233 -0.889 . . . . 10.0 112.923 -177.386 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.235 0.3 0 N-CA-C 107.551 -1.277 . . . . 10.0 107.551 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.17 172.0 13.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.694 1.197 . . . . 10.0 109.163 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 44.0 p-90 -147.04 169.09 19.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.29 0.496 . . . . 10.0 111.179 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 C-N-CA 124.266 1.026 . . . . 10.0 109.997 171.864 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.243 0 N-CA-C 106.549 -1.649 . . . . 10.0 106.549 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -150.21 152.93 35.38 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 172.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.65 -21.8 61.01 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 118.381 -0.818 . . . . 10.0 113.161 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.7 -23.29 64.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.413 1.006 . . . . 10.0 112.688 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.9 mt -77.54 -8.65 58.13 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.661 0.784 . . . . 10.0 111.995 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.9 mt -112.76 128.45 25.56 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 106.479 -1.674 . . . . 10.0 106.479 -172.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.72 151.43 74.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.382 2.055 . . . . 10.0 110.755 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -67.63 -38.16 83.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.05 1.34 . . . . 10.0 112.817 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.55 138.66 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.145 -1.428 . . . . 10.0 107.145 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -155.04 97.7 1.95 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.438 -1.319 . . . . 10.0 107.438 -176.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.1 pt . . . . . 0 CA--C 1.533 0.308 0 C-N-CA 124.895 1.278 . . . . 10.0 108.211 -175.825 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.2 t . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 108.748 -0.834 . . . . 10.0 108.748 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -145.42 146.16 31.42 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.711 -0.848 . . . . 10.0 108.711 172.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -61.84 157.65 17.72 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.367 0.667 . . . . 10.0 110.567 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -151.08 171.9 16.6 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.228 1.411 . . . . 10.0 108.242 169.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.4 152.61 29.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.707 1.203 . . . . 10.0 110.48 174.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.0 tp -102.95 117.68 35.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.086 -2.191 . . . . 10.0 105.086 167.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.78 134.69 62.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 105.731 -1.952 . . . . 10.0 105.731 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -85.79 135.14 33.85 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.381 -1.711 . . . . 10.0 106.381 167.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -120.88 142.3 37.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -122.66 133.21 54.52 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.368 1.867 . . . . 10.0 106.083 -174.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.6 p -66.83 143.55 56.81 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.649 -0.5 . . . . 10.0 109.649 172.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.12 59.35 3.64 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.214 1.006 . . . . 10.0 108.781 168.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -59.18 138.52 85.5 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.871 2.381 . . . . 10.0 109.522 -173.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 45.26 21.19 0.06 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.958 1.703 . . . . 10.0 114.482 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m 47.88 32.14 2.63 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.342 1.457 . . . . 10.0 113.125 -170.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.92 0.11 0.03 OUTLIER Glycine 0 CA--C 1.531 1.059 0 N-CA-C 115.929 1.131 . . . . 10.0 115.929 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.45 152.68 84.85 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 120.529 2.164 . . . . 10.0 110.509 171.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.69 52.63 3.75 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 124.123 3.215 . . . . 10.0 111.651 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.14 136.56 31.98 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.921 1.288 . . . . 10.0 108.333 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.15 30.56 0.7 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.244 1.418 . . . . 10.0 109.595 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -64.34 155.44 32.26 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -140.77 160.45 40.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.981 0.912 . . . . 10.0 110.702 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -149.78 172.64 14.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.177 0.991 . . . . 10.0 109.809 172.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.39 145.8 26.99 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 174.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.5 pt -135.74 148.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.585 1.554 . . . . 10.0 109.02 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.15 126.05 67.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.964 -1.495 . . . . 10.0 106.964 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -131.39 131.11 43.41 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 -174.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.04 55.01 0.36 Allowed Glycine 0 N--CA 1.464 0.527 0 CA-C-N 119.328 0.967 . . . . 10.0 111.398 -168.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -74.05 142.71 45.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.884 0.473 . . . . 10.0 111.15 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -63.53 -37.95 89.29 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 124.037 0.935 . . . . 10.0 112.551 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -66.33 -20.56 66.12 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 118.124 -0.941 . . . . 10.0 113.228 -172.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.37 134.38 51.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.768 0.713 . . . . 10.0 111.439 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -72.78 -34.42 66.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.552 0.691 . . . . 10.0 110.11 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -151.27 165.47 33.9 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 125.173 1.389 . . . . 10.0 109.238 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -48.88 -40.31 29.23 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.635 1.174 . . . . 10.0 112.516 169.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.24 73.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.52 -0.753 . . . . 10.0 112.184 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -70.19 -38.03 75.27 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.099 0.952 . . . . 10.0 109.793 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.22 -53.72 42.3 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 107.994 -1.113 . . . . 10.0 107.994 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -57.74 -45.24 86.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.323 -0.846 . . . . 10.0 111.504 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.04 -46.94 86.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.433 0.561 . . . . 10.0 111.538 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -63.22 -48.03 79.98 Favored 'General case' 0 C--N 1.342 0.274 0 O-C-N 121.604 -0.685 . . . . 10.0 109.756 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.08 -44.97 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 118.437 -0.792 . . . . 10.0 109.227 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.4 m -57.64 -42.26 83.07 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.497 1.044 . . . . 10.0 110.928 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.21 -45.49 95.9 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.577 -0.609 . . . . 10.0 111.577 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.33 -50.57 73.11 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.399 -1.06 . . . . 10.0 110.81 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -38.87 84.18 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 118.894 -0.574 . . . . 10.0 111.056 -178.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -63.94 -34.14 77.29 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.108 0.413 . . . . 10.0 110.837 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -71.57 -28.45 63.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 117.453 -1.26 . . . . 10.0 112.527 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -69.34 -59.86 2.72 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.727 1.149 . . . . 10.0 108.523 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.06 44.01 0.11 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.979 1.752 . . . . 10.0 109.169 -168.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.0 m -147.09 176.35 10.01 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.441 2.296 . . . . 10.0 107.346 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -148.46 165.9 29.76 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.02 -1.05 . . . . 10.0 108.923 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.8 m -131.04 159.8 36.47 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.602 1.092 . . . . 10.0 112.763 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -145.54 120.18 9.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.007 -1.849 . . . . 10.0 106.007 170.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.9 t -67.33 134.44 51.54 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.643 -1.285 . . . . 10.0 109.056 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 56.0 mt -91.64 -24.2 19.6 Favored 'General case' 0 C--O 1.226 -0.18 0 O-C-N 123.953 0.783 . . . . 10.0 110.646 171.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.92 164.78 21.01 Favored Glycine 0 C--N 1.337 0.587 0 O-C-N 121.216 -0.927 . . . . 10.0 111.233 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -125.61 163.15 19.69 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.263 -1.135 . . . . 10.0 110.263 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.29 -156.11 10.45 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.512 -1.835 . . . . 10.0 108.512 -171.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -139.35 153.59 47.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.059 1.744 . . . . 10.0 109.161 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.0 mm -119.98 145.89 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.327 -2.471 . . . . 10.0 104.327 168.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.4 m . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 168.469 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 mm . . . . . 0 C--O 1.237 0.44 0 N-CA-C 107.343 -1.355 . . . . 10.0 107.343 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -140.37 141.81 35.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.911 -1.144 . . . . 10.0 107.911 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.0 t -131.72 122.77 50.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.832 -1.544 . . . . 10.0 106.832 -169.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -158.28 -164.25 1.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.163 -0.961 . . . . 10.0 108.638 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.51 -173.27 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 118.65 0.659 . . . . 10.0 112.658 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -159.09 167.35 29.45 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.818 -1.178 . . . . 10.0 107.818 167.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.2 m -133.09 112.62 11.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 172.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -24.56 6.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.68 1.992 . . . . 10.0 114.101 -176.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.35 -25.31 65.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.745 0.818 . . . . 10.0 112.868 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.35 -41.68 0.14 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.0 0.818 . . . . 10.0 112.882 -174.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.29 -175.77 23.89 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.459 1.028 . . . . 10.0 110.765 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.19 148.16 68.12 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.264 2.643 . . . . 10.0 110.397 170.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.87 34.5 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.077 1.351 . . . . 10.0 113.176 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 35.28 59.31 0.77 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.277 2.231 . . . . 10.0 112.156 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -51.4 -25.14 5.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.327 2.251 . . . . 10.0 115.561 -164.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.77 92.47 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.764 1.165 . . . . 10.0 111.663 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.87 -54.01 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.027 -1.471 . . . . 10.0 107.027 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 m -63.34 -41.21 98.85 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.156 0.582 . . . . 10.0 112.516 -173.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.7 p -61.53 -47.14 86.93 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 118.628 0.649 . . . . 10.0 110.419 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -66.68 -36.74 83.25 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.22 0.464 . . . . 10.0 110.271 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -59.68 -50.79 72.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 118.847 -0.597 . . . . 10.0 110.794 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.54 -53.57 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.096 -1.076 . . . . 10.0 108.096 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -60.86 -37.97 83.96 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.039 1.335 . . . . 10.0 112.234 -173.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.48 -50.38 26.43 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.15 0.58 . . . . 10.0 110.389 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 tptt . . . . . 0 C--N 1.341 0.236 0 CA-C-O 118.625 -0.702 . . . . 10.0 111.444 -173.589 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 104.032 -2.581 . . . . 10.0 104.032 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.1 p -111.94 167.15 10.61 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.832 0.853 . . . . 10.0 110.458 -170.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -145.43 166.75 24.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.487 0.921 . . . . 10.0 113.487 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 127.979 2.512 . . . . 10.0 107.93 170.911 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -151.72 149.54 29.18 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.938 -1.504 . . . . 10.0 106.938 171.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.75 -27.91 63.45 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.778 0.831 . . . . 10.0 112.933 -176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -25.96 68.01 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.773 0.715 . . . . 10.0 112.193 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.3 mt -76.34 -23.23 54.22 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.221 0.608 . . . . 10.0 111.191 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.9 mt -83.94 122.08 76.01 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 107.688 -1.227 . . . . 10.0 107.688 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.31 138.55 37.69 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.692 2.928 . . . . 10.0 110.909 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -85.25 -28.42 25.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.438 0.637 . . . . 10.0 112.104 -169.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.8 t -139.16 136.04 41.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 126.185 1.794 . . . . 10.0 106.193 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -149.5 98.79 2.82 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.8 pt . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 125.665 1.586 . . . . 10.0 109.996 -169.647 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -139.68 139.99 36.76 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.901 -1.148 . . . . 10.0 107.901 175.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -67.23 155.82 37.86 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.02 165.41 29.11 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.697 0.761 . . . . 10.0 109.108 172.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.5 140.09 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.318 1.447 . . . . 10.0 107.436 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -100.17 118.93 37.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.695 -2.335 . . . . 10.0 104.695 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.7 mt -123.29 135.97 61.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 -171.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -88.83 133.28 34.32 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.175 -1.787 . . . . 10.0 106.175 168.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -116.25 140.25 39.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.2 -1.778 . . . . 10.0 106.2 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -122.04 136.4 54.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.196 1.798 . . . . 10.0 106.997 -172.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 m -64.12 137.05 57.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.306 -0.628 . . . . 10.0 109.306 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.9 54.95 2.02 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.246 1.018 . . . . 10.0 108.957 166.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.85 131.49 33.25 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.895 2.397 . . . . 10.0 108.523 -169.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.304 4.6 ppt_? 41.12 29.25 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.386 1.874 . . . . 10.0 114.251 -169.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m 46.09 37.87 4.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.758 1.623 . . . . 10.0 113.489 -173.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.99 -1.95 0.03 OUTLIER Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.34 1.296 . . . . 10.0 116.34 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.29 152.38 63.76 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 120.478 2.139 . . . . 10.0 110.55 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.23 49.5 2.85 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.092 3.195 . . . . 10.0 111.892 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.82 128.0 18.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.964 1.306 . . . . 10.0 108.038 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.57 26.61 1.75 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.134 1.374 . . . . 10.0 109.948 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.86 160.05 21.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.6 0.76 . . . . 10.0 109.006 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -138.1 161.39 36.89 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.98 0.912 . . . . 10.0 110.797 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -144.59 173.13 12.08 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.221 1.008 . . . . 10.0 109.578 169.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -98.26 148.95 23.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 pt -137.24 154.17 30.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 125.736 1.615 . . . . 10.0 109.466 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.2 126.97 67.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.217 -1.772 . . . . 10.0 106.217 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -130.54 137.29 49.64 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.91 46.0 0.27 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.944 -0.862 . . . . 10.0 110.944 -169.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -66.16 136.61 56.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.064 0.546 . . . . 10.0 110.406 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -66.72 -27.96 68.05 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 113.667 0.988 . . . . 10.0 113.667 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.6 p-90 -68.3 -23.94 64.8 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.423 -0.798 . . . . 10.0 112.474 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.19 134.28 47.93 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.871 0.76 . . . . 10.0 110.778 -175.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.25 -35.37 71.4 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.366 0.666 . . . . 10.0 110.559 171.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -147.29 157.45 43.59 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.632 1.573 . . . . 10.0 109.084 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.88 -25.67 57.22 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.282 1.033 . . . . 10.0 112.387 172.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.77 -40.24 79.31 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.011 0.823 . . . . 10.0 112.03 169.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -71.54 -33.28 69.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.383 0.611 . . . . 10.0 110.125 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.0 -55.75 20.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 108.35 -0.982 . . . . 10.0 108.35 173.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -54.99 -42.16 72.11 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.956 -0.545 . . . . 10.0 111.305 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.93 -48.7 80.55 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.478 0.711 . . . . 10.0 111.261 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -44.89 72.07 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.486 -0.759 . . . . 10.0 110.29 -175.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.81 -46.06 95.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 C-N-CA 123.89 0.876 . . . . 10.0 109.172 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 m -58.4 -40.47 82.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.09 0.859 . . . . 10.0 111.242 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.09 -50.77 64.02 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.995 -0.842 . . . . 10.0 110.995 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.66 -47.91 84.15 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.073 0.937 . . . . 10.0 111.071 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -39.39 85.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.724 -0.61 . . . . 10.0 110.459 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -68.14 -33.37 74.36 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 118.829 0.741 . . . . 10.0 110.757 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.87 -39.7 94.83 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 116.575 -1.678 . . . . 10.0 111.029 169.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -67.7 -60.15 2.77 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 119.281 0.946 . . . . 10.0 108.788 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.08 44.28 0.08 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.283 1.42 . . . . 10.0 110.447 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.4 m -148.69 177.59 9.37 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.055 2.142 . . . . 10.0 108.052 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -148.21 165.99 29.27 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.503 1.121 . . . . 10.0 109.004 172.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.5 m -134.5 160.1 39.08 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.842 1.201 . . . . 10.0 113.375 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.17 139.32 19.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.512 1.925 . . . . 10.0 106.902 169.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.3 m -75.67 140.82 42.75 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.352 -0.843 . . . . 10.0 110.415 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.7 mt -96.24 -22.99 16.91 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.921 -0.487 . . . . 10.0 110.802 168.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.16 -173.59 39.35 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.979 -1.248 . . . . 10.0 109.979 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.05 -172.16 22.47 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 118.846 1.323 . . . . 10.0 111.911 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.65 -150.85 9.58 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 109.375 -1.49 . . . . 10.0 109.375 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -137.3 160.76 38.11 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.966 1.306 . . . . 10.0 109.117 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.5 mt -132.6 150.18 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 124.608 1.163 . . . . 10.0 109.441 171.619 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.9 mm . . . . . 0 C--O 1.238 0.484 0 N-CA-C 106.719 -1.586 . . . . 10.0 106.719 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -137.23 156.22 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 120.147 -1.596 . . . . 10.0 109.247 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.38 131.87 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.067 -1.457 . . . . 10.0 107.067 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.59 176.72 12.26 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.159 -0.963 . . . . 10.0 112.136 -169.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.71 -159.47 53.03 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.217 -0.753 . . . . 10.0 111.217 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -157.39 157.06 33.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.123 1.369 . . . . 10.0 108.829 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -73.79 127.98 34.28 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.003 -1.061 . . . . 10.0 108.236 170.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 96.7 mtp -75.44 -18.19 59.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.763 -0.637 . . . . 10.0 111.215 169.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.56 -32.01 53.53 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 118.429 0.559 . . . . 10.0 111.688 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -127.37 -49.29 1.42 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.685 0.394 . . . . 10.0 111.264 -171.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.47 177.59 15.76 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.391 -1.484 . . . . 10.0 109.391 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.27 131.15 41.82 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.943 2.429 . . . . 10.0 110.573 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.05 162.58 16.49 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.82 0.819 . . . . 10.0 109.113 166.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -79.17 68.15 5.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.598 -1.63 . . . . 10.0 106.598 167.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -49.81 -32.34 13.86 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.316 1.446 . . . . 10.0 113.321 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.65 -36.89 74.84 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.433 1.015 . . . . 10.0 112.563 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.5 mt -66.62 -49.23 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -58.13 -44.21 87.68 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 117.858 -1.068 . . . . 10.0 111.99 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 p -64.79 -38.06 89.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 120.235 1.38 . . . . 10.0 111.273 -177.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.66 -40.31 88.59 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.58 1.082 . . . . 10.0 110.672 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -65.53 -45.72 82.37 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.793 -0.567 . . . . 10.0 110.337 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.3 mt -59.66 -43.12 90.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 118.017 -0.992 . . . . 10.0 109.213 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -57.95 -41.76 83.52 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 119.024 0.829 . . . . 10.0 110.669 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.69 -44.01 87.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.394 0.543 . . . . 10.0 111.03 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.2 tptp . . . . . 0 CA--C 1.533 0.314 0 O-C-N 121.671 -0.643 . . . . 10.0 111.365 -174.876 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 105.444 -2.058 . . . . 10.0 105.444 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.3 p -133.22 173.43 11.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.61 0.641 . . . . 10.0 109.622 171.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -144.89 165.34 28.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.508 0.323 . . . . 10.0 111.039 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 C-N-CA 126.215 1.806 . . . . 10.0 108.38 171.841 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -149.31 151.16 33.69 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.51 -25.42 62.38 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.399 -0.81 . . . . 10.0 113.07 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.03 -31.93 71.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.992 0.814 . . . . 10.0 112.034 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.06 -35.01 57.06 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.049 0.539 . . . . 10.0 110.118 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -65.61 119.77 62.96 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.271 1.028 . . . . 10.0 108.576 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.7 133.4 38.71 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.748 2.966 . . . . 10.0 111.167 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -84.69 -30.17 25.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.444 0.64 . . . . 10.0 111.929 -170.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -136.57 136.26 48.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 126.266 1.827 . . . . 10.0 106.07 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -149.48 101.54 3.11 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.205 -1.406 . . . . 10.0 107.205 170.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.2 pt . . . . . 0 CA--C 1.533 0.325 0 C-N-CA 125.495 1.518 . . . . 10.0 108.096 -174.944 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -142.53 138.01 30.59 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.668 0.787 . . . . 10.0 108.972 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -59.79 155.03 16.96 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.894 0.878 . . . . 10.0 109.733 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.12 166.47 27.75 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.173 0.989 . . . . 10.0 108.457 174.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.15 148.02 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.012 0.925 . . . . 10.0 108.599 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.9 tp -109.04 114.15 27.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 105.589 -2.004 . . . . 10.0 105.589 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.4 mt -119.18 133.92 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.045 -1.465 . . . . 10.0 107.045 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -88.5 135.05 33.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.93 133.62 53.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.537 -2.023 . . . . 10.0 105.537 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -111.69 128.33 56.04 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.009 -1.848 . . . . 10.0 106.009 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 p -78.66 146.12 34.21 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.009 0.433 . . . . 10.0 111.111 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.86 67.74 3.78 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 126.45 1.9 . . . . 10.0 106.448 167.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.14 -39.55 26.3 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.52 3.48 . . . . 10.0 114.2 -168.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.57 168.8 18.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.79 -1.559 . . . . 10.0 106.79 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -54.43 -21.48 9.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.419 1.888 . . . . 10.0 114.562 -170.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.41 32.12 1.77 Allowed Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.59 1.09 . . . . 10.0 111.699 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.91 146.23 95.53 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.145 0.972 . . . . 10.0 110.766 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -81.64 44.49 1.74 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 124.323 3.348 . . . . 10.0 112.391 -175.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.05 138.65 28.47 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.308 1.043 . . . . 10.0 109.572 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.55 27.98 0.64 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.515 1.526 . . . . 10.0 110.358 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.07 164.47 20.13 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.857 0.863 . . . . 10.0 109.527 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -139.54 160.17 40.47 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.909 0.884 . . . . 10.0 110.787 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -149.28 176.07 10.86 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.805 1.242 . . . . 10.0 109.506 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -102.97 154.18 19.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.81 -0.811 . . . . 10.0 108.81 169.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.2 pt -134.04 154.11 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 125.456 1.502 . . . . 10.0 109.583 170.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.42 127.87 62.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.284 -1.747 . . . . 10.0 106.284 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -131.16 134.97 47.03 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 107.863 -1.162 . . . . 10.0 107.863 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.18 49.59 0.31 Allowed Glycine 0 N--CA 1.46 0.258 0 N-CA-C 110.601 -1.0 . . . . 10.0 110.601 -170.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.33 132.5 46.51 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.465 -0.569 . . . . 10.0 109.465 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -65.45 -26.57 68.01 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 113.483 0.92 . . . . 10.0 113.483 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -67.6 -22.83 65.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.46 -0.781 . . . . 10.0 112.774 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.7 128.89 38.02 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.975 0.807 . . . . 10.0 110.462 -174.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -74.58 -24.75 58.96 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.288 0.566 . . . . 10.0 110.412 173.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -147.13 152.64 38.8 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 120.521 -1.362 . . . . 10.0 109.613 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -53.8 -37.39 63.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.133 0.973 . . . . 10.0 111.137 168.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.2 -31.26 71.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.523 -0.751 . . . . 10.0 112.58 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -69.31 -39.04 78.51 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.149 0.976 . . . . 10.0 109.602 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.74 -53.37 47.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 173.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.82 -46.42 74.55 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.727 -0.654 . . . . 10.0 111.135 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.32 -47.26 86.77 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.302 0.376 . . . . 10.0 111.407 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -65.89 -47.26 75.44 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 121.745 -0.597 . . . . 10.0 109.796 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.84 -39.26 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 118.193 -0.908 . . . . 10.0 110.131 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -59.77 -44.65 93.78 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.684 1.129 . . . . 10.0 110.678 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.92 -46.57 93.9 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.884 -0.887 . . . . 10.0 110.884 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.04 -48.24 81.16 Favored 'General case' 0 C--O 1.228 -0.066 0 CA-C-N 117.696 0.748 . . . . 10.0 110.851 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.0 mmt -60.08 -38.7 83.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.227 0.611 . . . . 10.0 111.18 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -63.68 -34.62 78.27 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.645 0.657 . . . . 10.0 110.601 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -70.0 -33.04 71.52 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.78 -1.105 . . . . 10.0 112.033 170.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -66.82 -53.18 35.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.444 1.02 . . . . 10.0 109.491 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 130.35 43.17 0.2 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.34 1.448 . . . . 10.0 110.177 -169.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.5 m -148.28 175.08 11.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.159 1.783 . . . . 10.0 108.461 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -145.27 166.16 26.31 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.265 1.026 . . . . 10.0 108.568 170.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.5 m -133.71 155.79 49.1 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.797 1.036 . . . . 10.0 113.797 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -147.54 142.59 27.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.552 1.941 . . . . 10.0 106.286 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.7 m -83.36 136.48 34.33 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.263 -0.898 . . . . 10.0 110.366 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.9 mt -87.66 -25.17 23.65 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.377 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.09 -178.7 41.68 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.929 -1.269 . . . . 10.0 109.929 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.93 -177.91 21.86 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 118.038 0.919 . . . . 10.0 111.928 170.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.87 -147.91 5.92 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 108.851 -1.7 . . . . 10.0 108.851 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.64 155.22 44.18 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.471 1.508 . . . . 10.0 107.906 170.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.1 155.91 18.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 104.517 -2.401 . . . . 10.0 104.517 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.452 -0.358 0 O-C-N 121.023 -1.048 . . . . 10.0 108.377 173.064 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt . . . . . 0 C--O 1.239 0.513 0 N-CA-C 108.214 -1.032 . . . . 10.0 108.214 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -135.31 155.03 51.28 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.477 1.511 . . . . 10.0 108.893 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.22 139.69 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.429 1.092 . . . . 10.0 108.439 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -159.37 -172.16 3.62 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.272 -0.893 . . . . 10.0 110.564 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.13 -173.42 36.07 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 121.553 0.53 . . . . 10.0 112.125 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -154.08 160.22 41.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.178 -1.415 . . . . 10.0 107.178 169.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.6 m -124.23 107.33 11.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.9 mtt -56.59 -23.64 42.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.989 1.316 . . . . 10.0 113.664 -169.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.75 -25.11 68.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.528 -0.749 . . . . 10.0 112.767 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -135.71 -50.48 0.72 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.712 0.805 . . . . 10.0 111.111 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.7 -177.94 20.09 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.941 1.734 . . . . 10.0 109.604 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.94 132.98 36.69 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.195 1.93 . . . . 10.0 109.175 169.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.18 152.57 37.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 167.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -78.28 73.09 4.84 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -51.1 -31.0 17.73 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 124.631 1.173 . . . . 10.0 113.258 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.66 -35.81 73.15 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.212 0.914 . . . . 10.0 112.405 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.6 mt -65.11 -51.81 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.208 -1.404 . . . . 10.0 107.208 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -57.63 -44.93 85.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.26 -0.876 . . . . 10.0 112.287 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 p -66.85 -38.65 86.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.704 1.138 . . . . 10.0 111.156 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.08 -39.14 89.8 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.941 0.792 . . . . 10.0 110.736 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -64.65 -46.68 81.46 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 122.056 -0.403 . . . . 10.0 110.683 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.43 -44.07 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -60.81 -42.01 96.82 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.256 0.934 . . . . 10.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.42 87.22 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.281 0.632 . . . . 10.0 111.724 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.1 tptp . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 118.089 -0.958 . . . . 10.0 111.57 174.718 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 106.926 -1.509 . . . . 10.0 106.926 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.9 p -139.71 166.95 23.23 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 120.987 -1.07 . . . . 10.0 110.034 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -147.12 164.06 34.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.916 0.326 . . . . 10.0 111.134 169.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.371 0 C-N-CA 126.536 1.934 . . . . 10.0 108.532 174.64 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 121.953 0.883 . . . . 10.0 111.399 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -147.62 151.44 36.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.3 -1.741 . . . . 10.0 106.3 170.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.5 mt -59.88 -22.55 62.49 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 117.602 -1.189 . . . . 10.0 113.947 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.5 -33.58 75.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.034 0.834 . . . . 10.0 111.615 172.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.16 -34.35 43.23 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.989 0.516 . . . . 10.0 110.299 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -65.21 125.03 88.54 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.799 -1.186 . . . . 10.0 107.799 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.35 139.86 61.51 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.326 2.018 . . . . 10.0 109.875 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.92 -31.5 51.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.036 0.935 . . . . 10.0 111.644 -171.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.5 t -140.41 136.17 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 105.129 -2.174 . . . . 10.0 105.129 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -150.77 102.34 2.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 172.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 pt . . . . . 0 CA--C 1.539 0.524 0 C-N-CA 124.967 1.307 . . . . 10.0 109.478 -168.355 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 37.5 t . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 108.025 -1.102 . . . . 10.0 108.025 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -152.49 148.55 27.54 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.575 1.179 . . . . 10.0 111.213 172.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -63.82 145.98 54.79 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.06 160.74 40.36 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.488 0.715 . . . . 10.0 110.159 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.95 146.42 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.576 1.55 . . . . 10.0 108.132 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 tt -106.49 122.22 45.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 105.438 -2.06 . . . . 10.0 105.438 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.8 mt -126.03 133.26 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.997 -1.483 . . . . 10.0 106.997 -171.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 ttm105 -85.47 139.0 31.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 167.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.27 140.58 41.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 124.579 1.152 . . . . 10.0 107.894 175.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -115.54 127.32 55.18 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.692 -1.966 . . . . 10.0 105.692 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.9 p -74.39 144.54 44.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.228 0.537 . . . . 10.0 111.399 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.0 71.07 4.65 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.795 2.038 . . . . 10.0 106.419 167.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.76 -38.92 47.75 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.69 2.927 . . . . 10.0 112.55 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -146.4 162.74 37.57 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 105.257 -2.127 . . . . 10.0 105.257 170.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -55.6 -23.21 26.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.508 1.299 . . . . 10.0 114.508 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -132.5 25.34 3.81 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.69 1.138 . . . . 10.0 111.865 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.86 149.83 89.0 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 118.679 1.24 . . . . 10.0 110.932 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.65 41.66 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.052 3.168 . . . . 10.0 112.03 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.1 135.09 22.59 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.267 1.027 . . . . 10.0 109.001 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.04 27.52 0.77 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.848 1.659 . . . . 10.0 109.579 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.69 166.46 17.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.302 1.041 . . . . 10.0 109.515 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.1 m -136.39 161.19 36.51 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.405 -0.81 . . . . 10.0 110.459 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -146.9 170.7 16.52 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.299 1.439 . . . . 10.0 107.664 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -122.48 140.95 52.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.261 -2.125 . . . . 10.0 105.261 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.2 pt -134.97 154.12 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.347 1.059 . . . . 10.0 110.123 -173.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.97 128.63 69.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -133.75 144.26 48.97 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.041 -1.466 . . . . 10.0 107.041 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.37 131.55 1.96 Allowed Glycine 0 CA--C 1.506 -0.493 0 CA-C-N 120.193 1.361 . . . . 10.0 111.033 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -147.22 139.29 24.43 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -70.84 -17.59 62.73 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 116.885 -1.531 . . . . 10.0 114.277 -173.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -68.52 -17.22 64.12 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 119.994 1.27 . . . . 10.0 112.012 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.81 127.39 31.72 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 119.856 1.207 . . . . 10.0 111.513 -172.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.79 -44.47 85.64 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.802 0.81 . . . . 10.0 109.068 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -146.51 168.83 20.25 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 127.183 2.193 . . . . 10.0 106.898 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -56.98 -36.13 69.97 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.997 -1.064 . . . . 10.0 112.403 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.27 -24.51 63.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.11 -0.947 . . . . 10.0 112.657 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -66.49 -36.34 82.49 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.903 1.335 . . . . 10.0 109.549 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -65.71 -53.78 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 120.471 -1.393 . . . . 10.0 108.505 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -54.73 -40.18 69.02 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.76 -1.114 . . . . 10.0 111.473 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.59 -46.24 90.69 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.347 0.976 . . . . 10.0 111.756 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -65.27 -48.15 74.22 Favored 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 121.002 -1.061 . . . . 10.0 109.718 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.07 -42.48 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.554 -0.535 . . . . 10.0 109.554 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 p -65.06 -34.46 78.47 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.576 1.08 . . . . 10.0 111.362 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.76 -47.93 81.66 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.08 -47.41 84.81 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 117.363 0.582 . . . . 10.0 111.115 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.7 mmt -60.7 -36.8 79.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.137 -0.935 . . . . 10.0 110.57 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.53 -39.85 94.53 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.39 0.996 . . . . 10.0 111.08 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -70.72 -27.19 63.79 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.759 1.163 . . . . 10.0 111.779 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -69.61 -55.64 9.51 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.335 0.97 . . . . 10.0 108.84 175.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.17 42.66 0.14 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.029 1.3 . . . . 10.0 111.553 -173.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 50.9 m -142.17 168.01 20.76 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.278 1.431 . . . . 10.0 109.508 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.73 160.71 30.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.156 1.782 . . . . 10.0 107.138 170.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.3 m -129.7 153.17 48.43 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.443 1.097 . . . . 10.0 112.663 -166.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -142.72 110.65 5.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.907 -1.886 . . . . 10.0 105.907 170.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.5 p -61.26 122.95 16.38 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.248 -0.908 . . . . 10.0 109.103 170.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.1 mt -86.37 -22.55 26.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.163 0.506 . . . . 10.0 110.558 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.84 -177.18 30.66 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 108.239 -1.945 . . . . 10.0 108.239 -172.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.32 -161.2 13.77 Favored Glycine 0 CA--C 1.52 0.371 0 O-C-N 121.016 -1.285 . . . . 10.0 110.714 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.97 -138.63 3.84 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.656 -1.778 . . . . 10.0 108.656 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -136.81 144.43 43.68 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.698 1.199 . . . . 10.0 107.884 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.84 151.55 8.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 104.656 -2.35 . . . . 10.0 104.656 169.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 177.008 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.8 mt . . . . . 0 C--O 1.239 0.518 0 N-CA-C 107.057 -1.46 . . . . 10.0 107.057 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -139.02 159.66 41.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.5 t -141.62 132.53 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.668 -1.234 . . . . 10.0 107.668 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.89 176.69 10.56 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.799 -1.188 . . . . 10.0 111.434 -171.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.27 -166.01 52.28 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 121.732 -0.605 . . . . 10.0 111.59 -176.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -150.52 160.2 43.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.504 1.122 . . . . 10.0 108.05 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.2 m -86.42 116.7 24.74 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.983 0.811 . . . . 10.0 109.594 172.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -58.56 -25.52 62.62 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 122.877 0.471 . . . . 10.0 110.537 170.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.28 -29.19 70.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.629 -1.177 . . . . 10.0 113.56 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.68 -55.63 0.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.924 1.238 . . . . 10.0 110.884 -176.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.11 -178.79 36.92 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.523 -1.031 . . . . 10.0 110.523 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.43 134.48 41.84 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.818 2.345 . . . . 10.0 109.909 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.09 162.17 28.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.816 0.817 . . . . 10.0 109.796 164.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -80.01 74.84 6.76 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.198 -1.408 . . . . 10.0 107.198 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -48.83 -31.36 6.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.225 1.41 . . . . 10.0 114.487 -170.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.89 72.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.135 0.88 . . . . 10.0 112.408 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.9 mt -63.48 -52.21 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -58.96 -44.77 91.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.305 -0.855 . . . . 10.0 111.355 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.8 p -65.24 -39.17 92.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.702 1.137 . . . . 10.0 111.679 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -65.4 -40.38 93.37 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.648 1.113 . . . . 10.0 109.832 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -66.76 -46.31 75.77 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.03 0.532 . . . . 10.0 110.114 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 72.6 mt -57.51 -45.65 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -61.11 -41.74 97.25 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.158 0.89 . . . . 10.0 110.825 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.77 -39.87 95.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.589 0.631 . . . . 10.0 111.195 174.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.239 0.537 0 CA-C-O 117.296 -1.335 . . . . 10.0 112.181 178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 106.744 -1.576 . . . . 10.0 106.744 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.1 p -142.86 170.82 14.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.855 1.262 . . . . 10.0 109.128 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -145.6 166.74 24.89 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 119.199 0.909 . . . . 10.0 111.346 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 127.369 2.268 . . . . 10.0 108.124 173.398 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.398 0 CA-C-O 121.382 0.611 . . . . 10.0 111.701 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -152.02 154.63 36.38 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.458 1.503 . . . . 10.0 107.203 173.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.77 -24.79 58.82 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.716 0.806 . . . . 10.0 112.81 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.16 -26.76 66.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.37 0.986 . . . . 10.0 112.368 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.2 mt -75.76 -25.08 56.17 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.033 0.533 . . . . 10.0 111.306 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.6 mt -84.16 127.49 66.39 Favored Pre-proline 0 C--O 1.237 0.436 0 N-CA-C 106.722 -1.584 . . . . 10.0 106.722 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.3 147.17 77.77 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.185 1.923 . . . . 10.0 109.769 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.04 -30.44 55.65 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.535 0.683 . . . . 10.0 112.052 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.83 134.86 45.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.14 -2.171 . . . . 10.0 105.14 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -151.2 114.39 4.79 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.305 -1.369 . . . . 10.0 107.305 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.8 pt . . . . . 0 C--N 1.328 -0.34 0 C-N-CA 126.132 1.773 . . . . 10.0 106.272 -175.601 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -147.6 154.56 40.83 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.197 0.999 . . . . 10.0 110.325 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -79.08 145.92 33.54 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.991 1.316 . . . . 10.0 109.017 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.2 162.25 39.28 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.993 0.425 . . . . 10.0 110.458 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.61 143.19 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 125.261 1.424 . . . . 10.0 107.565 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.72 125.37 47.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.328 -2.101 . . . . 10.0 105.328 171.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.3 mt -128.87 130.17 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.552 -1.647 . . . . 10.0 106.552 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -83.43 135.42 34.69 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.007 -1.849 . . . . 10.0 106.007 168.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 p -124.82 138.4 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.793 -1.558 . . . . 10.0 106.793 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -121.98 131.05 53.8 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.927 1.691 . . . . 10.0 106.647 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 p -67.65 140.23 56.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.783 0.325 . . . . 10.0 110.326 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.42 62.4 4.92 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.803 1.241 . . . . 10.0 108.557 168.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -53.96 -35.29 80.06 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.188 3.259 . . . . 10.0 113.503 -169.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -153.14 161.15 42.79 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.855 2.062 . . . . 10.0 105.738 172.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -55.99 -22.3 26.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.653 1.353 . . . . 10.0 114.653 -172.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.1 26.75 3.37 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.492 1.044 . . . . 10.0 112.045 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.96 148.88 91.52 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 118.039 0.92 . . . . 10.0 110.611 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -79.9 42.96 1.41 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 124.308 3.339 . . . . 10.0 111.999 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.28 139.31 28.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.379 1.072 . . . . 10.0 109.514 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.21 16.79 0.41 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.424 1.49 . . . . 10.0 111.797 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -63.33 160.03 16.8 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.274 1.43 . . . . 10.0 109.722 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.9 m -140.64 161.36 37.95 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.206 1.003 . . . . 10.0 110.66 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -146.99 179.33 7.68 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.967 1.307 . . . . 10.0 108.87 169.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -120.31 143.38 48.39 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.191 -1.041 . . . . 10.0 108.191 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.0 146.97 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.991 1.316 . . . . 10.0 110.289 -171.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.19 125.97 60.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.649 -1.611 . . . . 10.0 106.649 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -131.91 144.18 50.67 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.657 -1.609 . . . . 10.0 106.657 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.71 130.9 1.86 Allowed Glycine 0 C--N 1.329 0.156 0 CA-C-N 120.017 1.281 . . . . 10.0 112.868 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -150.91 142.38 23.46 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.218 1.007 . . . . 10.0 109.293 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -72.49 -16.89 61.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.118 1.155 . . . . 10.0 114.118 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -65.97 -21.37 66.41 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.69 1.132 . . . . 10.0 112.828 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.11 130.7 44.32 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 118.485 0.584 . . . . 10.0 110.804 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -67.8 -41.5 83.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -144.12 158.58 43.63 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 126.319 1.848 . . . . 10.0 107.169 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -56.27 -32.02 64.14 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.525 0.73 . . . . 10.0 112.853 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.09 -27.02 65.16 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.866 -0.588 . . . . 10.0 112.136 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.43 -35.9 78.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.503 0.592 . . . . 10.0 110.795 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.56 -50.85 69.4 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 107.683 -1.229 . . . . 10.0 107.683 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -55.28 -45.59 76.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.928 -0.558 . . . . 10.0 111.171 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.46 -45.27 88.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 118.541 0.61 . . . . 10.0 111.822 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -59.0 -50.1 75.36 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.562 0.745 . . . . 10.0 109.481 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.64 -46.11 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.521 0.728 . . . . 10.0 109.068 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 m -59.08 -36.03 74.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.352 0.978 . . . . 10.0 111.486 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.02 -49.32 76.48 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.531 -1.028 . . . . 10.0 110.531 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.01 -45.87 91.71 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 117.751 0.776 . . . . 10.0 111.283 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -36.43 82.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.776 -0.63 . . . . 10.0 111.057 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -65.05 -35.73 82.09 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.9 0.773 . . . . 10.0 110.942 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -66.36 -32.18 73.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.135 -0.936 . . . . 10.0 111.542 172.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -69.19 -60.47 2.33 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.913 0.779 . . . . 10.0 109.281 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.66 47.38 0.09 OUTLIER Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.826 1.679 . . . . 10.0 109.456 -169.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.9 m -146.79 172.43 13.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.263 1.825 . . . . 10.0 108.734 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -137.87 160.45 39.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.846 1.659 . . . . 10.0 108.361 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.4 m -134.54 154.39 51.48 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.118 0.967 . . . . 10.0 112.894 -168.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -144.78 109.93 5.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.588 1.955 . . . . 10.0 106.857 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -60.04 126.88 29.24 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.114 -0.991 . . . . 10.0 109.544 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.2 mt -91.69 -26.57 18.57 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.698 0.399 . . . . 10.0 110.351 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.33 169.58 31.95 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.641 -0.984 . . . . 10.0 110.641 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.96 166.51 22.01 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.952 1.263 . . . . 10.0 110.883 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.48 -161.56 23.91 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.529 -1.428 . . . . 10.0 109.529 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -138.24 156.66 47.47 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.09 -1.241 . . . . 10.0 108.972 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.9 mt -127.81 146.95 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 104.54 -2.393 . . . . 10.0 104.54 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 C--N 1.33 -0.273 0 N-CA-C 106.903 -1.518 . . . . 10.0 106.903 169.874 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.4 pt . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 108.122 -1.066 . . . . 10.0 108.122 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -149.25 156.6 42.37 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.223 -1.029 . . . . 10.0 108.223 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.31 137.7 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.09 0.956 . . . . 10.0 108.51 -169.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -160.17 -177.11 6.05 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.344 -0.847 . . . . 10.0 110.114 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.64 178.93 37.86 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.244 0.449 . . . . 10.0 112.218 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -153.61 -176.23 5.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.227 1.011 . . . . 10.0 108.815 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -137.06 111.14 8.32 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.4 mtt -61.11 -12.87 13.76 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.359 0.664 . . . . 10.0 112.639 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.06 -32.39 54.47 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.124 0.97 . . . . 10.0 112.428 170.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.56 -37.11 0.14 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.377 0.881 . . . . 10.0 113.377 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 141.82 -178.68 20.44 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.612 1.101 . . . . 10.0 110.654 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.22 143.79 78.71 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.219 2.613 . . . . 10.0 110.2 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.44 32.75 0.09 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.182 1.793 . . . . 10.0 113.737 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 37.66 55.45 1.5 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.093 2.557 . . . . 10.0 110.171 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -45.45 -26.84 0.61 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.771 2.428 . . . . 10.0 116.275 -166.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.02 83.2 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.567 1.53 . . . . 10.0 111.899 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.4 -55.03 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -63.93 -39.91 95.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.606 -0.712 . . . . 10.0 112.017 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.0 p -64.85 -38.61 91.56 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 119.417 1.008 . . . . 10.0 110.57 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.59 -41.41 96.27 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.673 1.124 . . . . 10.0 111.241 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -64.08 -47.89 78.34 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.819 -0.55 . . . . 10.0 110.663 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.85 -42.43 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.839 0.855 . . . . 10.0 108.828 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -60.31 -40.15 89.53 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.244 1.018 . . . . 10.0 111.206 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.0 96.43 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.162 0.437 . . . . 10.0 110.936 174.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 117.776 -1.106 . . . . 10.0 113.101 -171.603 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.239 0.546 0 N-CA-C 107.4 -1.333 . . . . 10.0 107.4 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.12 167.07 26.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.432 1.493 . . . . 10.0 107.5 -172.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -144.15 159.67 42.25 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.662 -0.496 . . . . 10.0 109.662 172.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -179.857 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 107.196 -1.409 . . . . 10.0 107.196 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -148.12 152.71 37.78 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.041 -1.096 . . . . 10.0 108.041 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.4 mt -54.91 -31.1 59.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.342 1.057 . . . . 10.0 112.637 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.59 -24.59 66.78 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.7 mt -76.32 -23.74 54.3 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.88 0.472 . . . . 10.0 111.203 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.5 mt -74.48 135.42 75.52 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.001 -1.481 . . . . 10.0 107.001 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.47 138.03 53.24 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.21 1.94 . . . . 10.0 109.062 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.72 -31.79 68.76 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.054 0.761 . . . . 10.0 113.054 -169.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -158.11 136.53 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 105.944 -1.873 . . . . 10.0 105.944 -174.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -157.34 112.72 2.81 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.577 -0.897 . . . . 10.0 108.577 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 CA--C 1.54 0.594 0 C-N-CA 125.487 1.515 . . . . 10.0 109.964 -176.082 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--O 1.24 0.585 0 N-CA-C 108.655 -0.869 . . . . 10.0 108.655 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -154.04 154.85 34.43 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.248 1.019 . . . . 10.0 110.019 168.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -77.75 151.02 34.3 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.112 0.965 . . . . 10.0 109.45 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.53 161.5 38.3 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.507 0.723 . . . . 10.0 109.75 176.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.51 152.69 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.091 1.356 . . . . 10.0 108.988 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -115.35 121.99 44.51 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.58 -2.007 . . . . 10.0 105.58 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 95.2 mt -130.71 134.24 62.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.408 -1.33 . . . . 10.0 107.408 -169.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -85.23 144.56 28.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.533 -1.654 . . . . 10.0 106.533 167.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.99 144.12 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -124.21 132.35 53.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.093 1.757 . . . . 10.0 106.449 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.2 p -64.39 139.86 58.81 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.973 -0.38 . . . . 10.0 109.973 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.48 62.17 2.83 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.854 1.262 . . . . 10.0 108.612 169.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -59.27 135.33 64.85 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.918 2.412 . . . . 10.0 109.499 -172.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 44.76 26.96 0.22 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.925 1.29 . . . . 10.0 113.601 -171.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m 51.54 29.66 5.66 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.22 1.408 . . . . 10.0 113.434 -176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.22 -7.41 0.02 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 116.58 1.392 . . . . 10.0 116.58 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 153.06 80.64 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 120.062 1.931 . . . . 10.0 110.476 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.18 64.06 7.81 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.26 3.306 . . . . 10.0 111.941 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.5 138.21 34.43 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.334 1.453 . . . . 10.0 108.317 172.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.1 25.17 0.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.757 1.223 . . . . 10.0 110.781 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.29 161.14 25.64 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 169.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -139.63 163.51 32.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.291 1.036 . . . . 10.0 110.996 -176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -151.43 166.95 29.49 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.947 2.099 . . . . 10.0 107.862 -170.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.3 mp0 -122.32 143.15 49.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 pt -136.77 155.36 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.441 1.896 . . . . 10.0 109.228 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.48 129.95 74.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -134.68 147.03 50.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.661 -1.607 . . . . 10.0 106.661 -172.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.78 124.17 1.0 Allowed Glycine 0 C--O 1.224 -0.497 0 CA-C-N 119.642 1.11 . . . . 10.0 110.644 172.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -144.52 138.12 27.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 123.846 0.38 . . . . 10.0 110.429 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -61.45 -29.78 70.17 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.22 1.008 . . . . 10.0 112.876 -175.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -64.07 -23.14 67.22 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.957 0.799 . . . . 10.0 112.97 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.37 118.7 14.5 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 119.26 0.936 . . . . 10.0 109.791 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -68.38 -34.16 75.55 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.878 0.471 . . . . 10.0 109.965 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -142.46 151.94 42.24 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.076 1.751 . . . . 10.0 107.894 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -57.17 -36.69 71.09 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.676 0.621 . . . . 10.0 112.676 -171.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.95 -27.06 63.06 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 124.0 0.812 . . . . 10.0 112.175 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.73 -35.36 79.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.26 0.482 . . . . 10.0 110.926 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -66.37 -54.83 22.22 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 N-CA-C 107.399 -1.334 . . . . 10.0 107.399 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -56.93 -41.95 79.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.944 -0.55 . . . . 10.0 111.55 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.33 -47.38 79.61 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.908 0.483 . . . . 10.0 111.632 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -60.97 -47.69 85.29 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 121.872 -0.518 . . . . 10.0 109.695 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.19 -47.57 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 118.475 -0.774 . . . . 10.0 108.996 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 m -57.82 -42.44 84.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.348 0.976 . . . . 10.0 110.897 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.63 -44.29 98.01 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.235 -0.746 . . . . 10.0 111.235 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.87 -48.01 72.99 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.111 0.955 . . . . 10.0 111.504 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -41.07 78.17 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 119.074 0.852 . . . . 10.0 110.121 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -62.69 -36.82 84.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.432 -0.794 . . . . 10.0 110.988 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.1 pttm -74.23 -25.42 59.65 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.468 -1.253 . . . . 10.0 112.652 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -68.31 -56.09 9.81 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.902 1.228 . . . . 10.0 109.151 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.13 45.28 0.14 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.522 1.534 . . . . 10.0 109.896 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.1 m -147.02 175.37 10.74 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.817 2.047 . . . . 10.0 107.875 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -145.64 165.27 29.21 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.892 -0.781 . . . . 10.0 108.892 169.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.94 164.13 19.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.771 1.026 . . . . 10.0 113.771 -168.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -147.07 112.84 5.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.9 2.48 . . . . 10.0 105.734 175.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.9 t -65.2 140.44 58.75 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.916 -1.115 . . . . 10.0 109.48 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.3 mt -106.14 -10.9 16.28 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.732 0.813 . . . . 10.0 111.047 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.31 -177.75 18.74 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.467 1.508 . . . . 10.0 109.723 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.59 -164.23 13.57 Favored Glycine 0 CA--C 1.522 0.519 0 O-C-N 121.472 -1.017 . . . . 10.0 112.04 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.28 -149.71 7.72 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 109.667 -1.373 . . . . 10.0 109.667 -172.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -143.06 155.96 44.72 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.602 1.161 . . . . 10.0 109.275 -174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.1 mt -136.43 153.97 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.529 -2.026 . . . . 10.0 105.529 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 169.879 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 C--O 1.238 0.462 0 CA-C-O 122.826 1.298 . . . . 10.0 110.917 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -134.77 154.45 51.59 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.663 1.985 . . . . 10.0 107.912 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 t -129.57 136.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -150.83 175.7 11.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.728 0.695 . . . . 10.0 111.816 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.84 -153.76 53.05 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.667 0.651 . . . . 10.0 112.981 170.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -150.6 -179.7 7.46 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.381 1.472 . . . . 10.0 109.601 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.9 m -114.94 122.89 47.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.805 0.842 . . . . 10.0 109.194 170.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -58.35 -29.23 65.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.352 1.061 . . . . 10.0 111.213 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.75 -25.41 66.48 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.737 1.014 . . . . 10.0 113.737 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -59.03 0.25 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.514 1.052 . . . . 10.0 111.271 -174.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.88 179.66 35.77 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.515 -1.034 . . . . 10.0 110.515 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -56.68 137.41 80.98 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.016 2.477 . . . . 10.0 111.138 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.55 165.81 21.92 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.603 0.715 . . . . 10.0 109.241 167.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -81.59 69.12 8.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.366 -1.716 . . . . 10.0 106.366 167.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -49.24 -30.19 6.82 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.663 1.585 . . . . 10.0 114.196 -169.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.15 -36.28 74.99 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.374 0.988 . . . . 10.0 112.266 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.7 mt -62.81 -50.45 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.052 -1.462 . . . . 10.0 107.052 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -58.55 -47.64 83.54 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.741 0.816 . . . . 10.0 111.822 -177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 p -65.39 -37.85 88.24 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.409 -0.805 . . . . 10.0 111.356 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -64.73 -42.67 95.03 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.362 0.983 . . . . 10.0 110.387 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -62.41 -47.95 81.88 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.682 -0.675 . . . . 10.0 110.085 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.62 -52.19 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -57.52 -38.06 74.04 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.349 1.06 . . . . 10.0 111.971 -174.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 -44.01 81.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.78 0.432 . . . . 10.0 111.309 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.7 mptt . . . . . 0 N--CA 1.469 0.476 0 CA-C-N 118.406 0.548 . . . . 10.0 111.853 -169.656 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 108.637 -0.875 . . . . 10.0 108.637 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.9 p -139.63 167.98 20.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.294 1.037 . . . . 10.0 110.149 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -150.63 167.85 26.07 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.961 -0.462 . . . . 10.0 110.957 170.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.236 0 C-N-CA 125.68 1.592 . . . . 10.0 108.513 169.617 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 106.808 -1.553 . . . . 10.0 106.808 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -150.3 150.69 31.83 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.75 -1.204 . . . . 10.0 107.75 173.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -59.15 -23.47 62.2 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 118.211 -0.9 . . . . 10.0 112.88 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.28 -26.41 67.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.473 1.033 . . . . 10.0 112.473 175.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -73.97 -26.25 60.37 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.111 0.564 . . . . 10.0 111.009 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.38 127.16 62.18 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 106.737 -1.579 . . . . 10.0 106.737 -174.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.62 149.03 79.23 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.226 1.951 . . . . 10.0 110.087 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.66 -33.68 60.43 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.47 1.108 . . . . 10.0 111.958 -178.073 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -136.92 135.12 48.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 104.843 -2.28 . . . . 10.0 104.843 176.432 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -150.5 118.07 6.12 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.069 -1.826 . . . . 10.0 106.069 171.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.8 pt . . . . . 0 C--N 1.33 -0.263 0 C-N-CA 124.353 1.061 . . . . 10.0 110.272 -169.806 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 108.966 -0.753 . . . . 10.0 108.966 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -150.69 147.64 27.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.869 1.268 . . . . 10.0 109.104 172.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -67.82 153.94 42.62 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.772 -0.58 . . . . 10.0 109.685 174.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.17 165.6 26.97 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.979 0.912 . . . . 10.0 109.366 170.549 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.6 147.72 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.428 1.491 . . . . 10.0 107.67 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tt -109.14 121.02 44.27 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 104.777 -2.305 . . . . 10.0 104.777 177.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.5 mt -128.74 140.53 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 -170.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -94.54 131.23 40.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 167.036 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.91 143.32 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -123.47 130.13 52.24 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.495 1.918 . . . . 10.0 105.857 -175.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.1 p -72.36 142.93 48.77 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.351 -0.241 . . . . 10.0 110.351 175.684 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.78 59.58 3.54 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.299 1.44 . . . . 10.0 108.205 168.095 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -58.67 141.41 97.61 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.019 2.48 . . . . 10.0 109.921 -171.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 52.2 16.73 0.61 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.448 1.099 . . . . 10.0 113.058 -177.209 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m 48.17 31.4 2.55 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.548 1.139 . . . . 10.0 112.897 -169.596 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.88 -1.71 0.02 OUTLIER Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.43 -1.206 . . . . 10.0 115.954 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 153.32 78.91 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 120.094 1.947 . . . . 10.0 110.448 174.212 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.87 55.29 5.2 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 124.256 3.304 . . . . 10.0 111.855 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.92 139.51 30.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.045 1.338 . . . . 10.0 108.653 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.75 30.09 0.66 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.188 1.395 . . . . 10.0 109.772 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -66.32 158.4 29.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 174.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 m -140.33 160.27 40.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.138 0.975 . . . . 10.0 110.326 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -150.22 169.57 21.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.132 0.973 . . . . 10.0 109.635 171.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -98.5 149.06 23.12 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.499 -0.926 . . . . 10.0 108.499 172.13 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.1 pt -138.9 154.43 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.055 1.742 . . . . 10.0 109.924 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.25 128.8 64.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.985 -1.487 . . . . 10.0 106.985 176.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 mmp_? -134.61 138.12 44.26 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.873 -1.529 . . . . 10.0 106.873 -178.162 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.38 122.91 0.92 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-N 119.725 1.148 . . . . 10.0 110.996 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -142.84 133.93 25.8 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 -172.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -59.55 -21.58 60.48 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 114.515 1.302 . . . . 10.0 114.515 -175.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -65.34 -25.33 67.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.377 1.444 . . . . 10.0 112.276 177.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.85 116.14 11.89 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.854 1.206 . . . . 10.0 110.371 -178.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.7 -29.89 65.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.311 0.645 . . . . 10.0 110.354 173.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -136.03 146.64 47.34 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.79 1.636 . . . . 10.0 107.422 178.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -60.77 -31.88 71.22 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.762 0.825 . . . . 10.0 111.755 -174.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.99 -26.35 67.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.343 0.657 . . . . 10.0 112.165 177.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.62 -32.69 74.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.357 0.598 . . . . 10.0 110.548 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.7 mt -67.48 -51.78 48.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 174.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -55.83 -41.97 75.04 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.462 -0.78 . . . . 10.0 111.141 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.79 -48.74 79.26 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.068 0.547 . . . . 10.0 111.461 177.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -47.27 86.05 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.368 -0.832 . . . . 10.0 110.33 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.56 -43.77 96.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 -177.587 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 m -62.99 -36.29 83.03 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.479 1.036 . . . . 10.0 111.029 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.33 52.95 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.34 -1.104 . . . . 10.0 110.34 173.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.08 -39.91 91.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.693 0.746 . . . . 10.0 111.686 -177.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.7 mmt -65.31 -39.14 92.09 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.724 -0.655 . . . . 10.0 111.086 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -64.85 -34.76 79.13 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.071 0.85 . . . . 10.0 110.533 176.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.67 -31.92 72.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.359 -1.305 . . . . 10.0 111.612 172.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -73.81 -54.6 7.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.534 1.061 . . . . 10.0 109.014 176.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.95 44.22 0.16 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.39 1.471 . . . . 10.0 109.881 -170.18 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.6 m -144.07 169.63 17.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.632 1.573 . . . . 10.0 109.308 -177.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -140.04 163.49 32.56 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.357 1.863 . . . . 10.0 108.397 178.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.0 m -139.1 156.38 47.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.67 1.123 . . . . 10.0 113.795 -167.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -139.82 130.15 25.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.872 1.669 . . . . 10.0 106.93 168.388 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.5 p -68.89 143.31 54.53 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.786 -1.196 . . . . 10.0 109.468 172.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.6 mt -105.1 -18.14 14.25 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.469 0.708 . . . . 10.0 110.906 171.019 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.96 -173.92 35.24 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.719 -1.352 . . . . 10.0 109.719 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.94 -174.5 28.73 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.248 -1.148 . . . . 10.0 112.006 172.585 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.44 -149.36 7.81 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.942 -1.663 . . . . 10.0 108.942 -173.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -133.48 154.51 50.75 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.652 1.181 . . . . 10.0 108.874 178.416 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.4 mt -125.31 152.02 31.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 104.994 -2.224 . . . . 10.0 104.994 173.377 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 C--N 1.327 -0.392 0 C-N-CA 124.904 1.282 . . . . 10.0 108.837 -176.856 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 C--O 1.236 0.343 0 N-CA-C 106.266 -1.753 . . . . 10.0 106.266 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -141.09 149.71 41.95 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.232 -1.025 . . . . 10.0 108.232 -168.455 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -135.04 139.42 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.458 -0.942 . . . . 10.0 108.458 -171.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.25 -176.0 3.88 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.457 1.103 . . . . 10.0 109.702 -178.094 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.08 -167.44 45.59 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 121.653 -0.654 . . . . 10.0 111.866 175.032 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -152.1 158.2 42.65 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 169.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.9 p -69.07 158.71 34.28 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.637 -0.664 . . . . 10.0 110.601 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 92.8 mtp -82.97 5.57 21.62 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 118.774 -0.632 . . . . 10.0 112.541 -174.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.15 -44.97 0.11 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.465 1.029 . . . . 10.0 113.533 176.443 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -74.11 -47.12 38.4 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.209 0.913 . . . . 10.0 111.003 -169.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.94 175.76 14.2 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.72 1.629 . . . . 10.0 110.375 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -54.34 130.0 37.59 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.585 2.19 . . . . 10.0 110.105 169.509 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.89 162.67 13.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.775 0.797 . . . . 10.0 109.244 167.252 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -79.01 70.01 5.27 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.092 -1.447 . . . . 10.0 107.092 169.408 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -49.72 -36.37 25.18 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.098 1.359 . . . . 10.0 113.217 -168.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.95 -32.79 73.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.084 0.856 . . . . 10.0 112.504 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.26 -50.59 50.98 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 107.428 -1.323 . . . . 10.0 107.428 175.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.3 m -56.53 -41.89 77.54 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.195 -0.907 . . . . 10.0 111.523 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.5 p -64.38 -43.5 94.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.43 1.014 . . . . 10.0 111.172 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -61.73 -38.88 89.53 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.193 1.36 . . . . 10.0 110.886 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -63.77 -50.24 69.8 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.574 0.35 . . . . 10.0 110.222 176.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.68 -47.15 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.615 -0.883 . . . . 10.0 108.615 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -54.61 -47.43 73.4 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.3 1.04 . . . . 10.0 110.244 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.75 -39.48 88.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.662 0.385 . . . . 10.0 111.572 -178.041 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 118.12 -0.943 . . . . 10.0 112.457 -175.054 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 105.665 -1.976 . . . . 10.0 105.665 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.7 p -145.58 166.55 25.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.479 1.111 . . . . 10.0 108.893 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -153.41 165.53 35.52 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.548 -0.72 . . . . 10.0 111.075 167.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 125.622 1.569 . . . . 10.0 108.931 174.202 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.5 154.53 50.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.962 1.305 . . . . 10.0 107.762 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 m -63.21 158.16 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.537 0.684 . . . . 10.0 109.602 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.23 172.92 8.69 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.437 1.495 . . . . 10.0 107.722 171.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -147.94 151.93 36.65 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.167 -1.42 . . . . 10.0 107.167 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.41 -23.16 64.15 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.364 0.666 . . . . 10.0 112.713 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.84 -28.62 69.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.474 1.034 . . . . 10.0 112.292 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.5 -29.56 61.46 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.95 0.5 . . . . 10.0 110.769 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.1 mt -75.98 126.0 87.43 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 106.984 -1.488 . . . . 10.0 106.984 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.68 142.07 81.9 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.156 1.904 . . . . 10.0 109.292 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -78.98 -29.86 44.07 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.681 0.753 . . . . 10.0 112.172 -170.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 135.62 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 104.083 -2.562 . . . . 10.0 104.083 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -149.2 107.76 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.609 -1.997 . . . . 10.0 105.609 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.8 pt -135.23 146.21 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.189 -1.041 . . . . 10.0 108.189 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.81 121.01 42.71 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 104.724 -2.325 . . . . 10.0 104.724 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m -139.32 131.28 27.8 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.342 0.497 . . . . 10.0 112.342 -167.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -156.52 16.73 0.32 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.452 1.101 . . . . 10.0 111.815 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.3 -156.18 26.48 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 108.426 -1.87 . . . . 10.0 108.426 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t -75.14 140.03 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 169.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -157.57 153.11 26.37 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.64 1.176 . . . . 10.0 109.496 171.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -68.06 150.78 47.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.968 0.907 . . . . 10.0 110.28 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.46 163.65 35.0 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.72 0.808 . . . . 10.0 109.233 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.89 147.35 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.258 1.023 . . . . 10.0 108.705 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 tp -106.31 119.95 40.58 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.4 130.5 71.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.081 -1.452 . . . . 10.0 107.081 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -82.21 134.36 35.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.063 -2.199 . . . . 10.0 105.063 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -119.71 138.93 48.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.255 -1.757 . . . . 10.0 106.255 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -119.4 131.17 55.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.08 -1.822 . . . . 10.0 106.08 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 p -73.51 145.78 45.36 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.867 0.758 . . . . 10.0 110.006 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.27 61.02 3.1 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 106.26 -1.756 . . . . 10.0 106.26 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -56.74 136.9 78.89 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.472 2.781 . . . . 10.0 110.955 -169.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 45.44 26.65 0.31 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.686 1.594 . . . . 10.0 113.829 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 m 55.04 26.01 7.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.27 1.428 . . . . 10.0 113.479 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.93 -1.34 0.03 OUTLIER Glycine 0 CA--C 1.532 1.101 0 N-CA-C 116.843 1.497 . . . . 10.0 116.843 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.11 152.5 84.01 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 120.114 1.957 . . . . 10.0 110.173 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.83 56.88 5.84 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.473 3.449 . . . . 10.0 111.874 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.38 137.37 30.4 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.139 1.376 . . . . 10.0 108.381 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.03 32.46 0.6 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.321 1.449 . . . . 10.0 109.829 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.83 170.09 13.28 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.469 0.708 . . . . 10.0 109.297 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 m -147.03 159.97 42.94 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.622 -0.673 . . . . 10.0 110.417 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -147.59 175.36 10.92 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.087 1.355 . . . . 10.0 108.261 169.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -105.33 150.74 24.94 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.628 -0.879 . . . . 10.0 108.628 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.2 pt -135.86 150.37 28.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.323 1.449 . . . . 10.0 109.49 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.31 126.98 64.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.388 -1.708 . . . . 10.0 106.388 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -132.48 139.15 47.83 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.96 113.88 0.5 Allowed Glycine 0 C--N 1.332 0.321 0 CA-C-N 119.473 1.033 . . . . 10.0 110.941 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -140.75 132.23 26.93 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.114 -0.699 . . . . 10.0 109.114 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -69.49 -14.81 63.07 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.048 1.129 . . . . 10.0 114.048 -171.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -66.58 -23.48 66.2 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.478 1.036 . . . . 10.0 111.943 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.79 127.64 33.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.236 0.926 . . . . 10.0 110.082 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.87 -39.23 73.0 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.541 -0.3 . . . . 10.0 110.284 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -140.5 160.6 39.64 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.663 1.585 . . . . 10.0 108.658 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -56.45 -33.19 65.65 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.323 1.049 . . . . 10.0 112.09 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.7 -31.12 69.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.038 0.935 . . . . 10.0 112.209 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -71.35 -36.07 71.38 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.998 0.817 . . . . 10.0 110.577 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mt -65.49 -50.91 69.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -57.41 -45.1 84.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.418 -0.325 . . . . 10.0 110.554 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.41 -46.3 90.71 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.994 0.518 . . . . 10.0 111.851 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -57.2 -49.49 75.84 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.016 0.371 . . . . 10.0 110.287 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.5 t -68.85 -46.39 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.8 m -58.37 -35.51 72.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.489 1.041 . . . . 10.0 111.509 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.4 -50.68 60.52 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.703 -0.959 . . . . 10.0 110.703 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.66 -44.84 95.24 Favored 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 117.539 0.67 . . . . 10.0 111.204 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -37.22 81.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.673 -0.68 . . . . 10.0 110.887 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.25 -34.96 79.59 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.161 0.891 . . . . 10.0 111.19 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.9 -33.87 77.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.93 0.786 . . . . 10.0 111.658 171.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -70.6 -52.97 17.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.093 0.861 . . . . 10.0 110.165 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.82 43.77 0.23 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.276 1.417 . . . . 10.0 110.204 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.8 m -144.24 172.29 13.13 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.015 1.726 . . . . 10.0 108.655 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -140.27 164.83 29.03 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.692 1.597 . . . . 10.0 108.228 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.0 m -133.3 159.55 39.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.048 0.939 . . . . 10.0 112.429 -169.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -148.48 117.45 6.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.253 1.821 . . . . 10.0 106.61 170.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -62.74 130.59 45.6 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.547 -0.721 . . . . 10.0 109.115 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.0 mt -90.78 -23.04 20.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.576 0.351 . . . . 10.0 110.481 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.77 179.35 29.1 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.43 -1.868 . . . . 10.0 108.43 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.46 -164.14 14.31 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.668 -0.973 . . . . 10.0 110.668 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.69 -139.48 4.28 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 108.508 -1.837 . . . . 10.0 108.508 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -139.87 157.71 45.26 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.985 1.314 . . . . 10.0 108.116 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.42 151.45 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.62 -2.363 . . . . 10.0 104.62 172.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.8 m -130.82 115.13 16.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -78.7 102.78 8.24 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 104.92 -2.252 . . . . 10.0 104.92 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -30.4 -53.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.126 2.171 . . . . 10.0 116.278 -169.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.1 m 45.52 25.09 0.21 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.179 1.792 . . . . 10.0 114.19 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -164.3 -56.11 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.722 1.209 . . . . 10.0 109.628 -171.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -144.5 110.47 5.4 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.397 1.258 . . . . 10.0 114.397 -169.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 70.84 -79.58 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 119.105 3.002 . . . . 10.0 119.105 168.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.89 168.93 25.65 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.325 1.875 . . . . 10.0 115.333 -168.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.7 mt -54.3 137.93 14.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.206 1.402 . . . . 10.0 108.255 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -138.14 157.96 45.28 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.745 0.818 . . . . 10.0 109.083 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.5 t -137.48 135.49 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.582 1.153 . . . . 10.0 108.086 -170.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -163.1 -178.53 6.09 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.329 -0.857 . . . . 10.0 111.714 -171.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.77 -163.49 49.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.662 0.649 . . . . 10.0 111.617 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -150.65 178.86 8.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.943 1.297 . . . . 10.0 108.632 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m -103.28 124.79 49.31 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.285 -1.005 . . . . 10.0 108.285 169.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.73 -30.24 67.32 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.081 0.401 . . . . 10.0 110.716 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.46 -30.94 71.78 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.119 0.968 . . . . 10.0 113.475 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.01 -57.9 0.5 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.428 1.013 . . . . 10.0 110.676 -172.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.86 -178.69 35.84 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.596 -1.402 . . . . 10.0 109.596 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.6 138.2 68.66 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.163 1.909 . . . . 10.0 110.167 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.08 161.44 24.47 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.806 -1.183 . . . . 10.0 107.806 168.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -78.82 71.67 5.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.487 -2.042 . . . . 10.0 105.487 169.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -50.33 -30.85 13.0 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.045 1.338 . . . . 10.0 113.494 -169.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.43 74.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.111 0.869 . . . . 10.0 112.061 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.36 -51.22 73.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.404 -1.332 . . . . 10.0 107.404 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -58.06 -46.16 85.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.967 -0.539 . . . . 10.0 112.128 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.4 p -66.28 -41.01 90.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.394 0.997 . . . . 10.0 110.823 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -64.86 -39.96 94.38 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.894 0.77 . . . . 10.0 110.641 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -62.76 -48.22 80.12 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 118.96 -0.543 . . . . 10.0 110.598 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.83 -45.74 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -62.2 -40.45 96.12 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.014 0.926 . . . . 10.0 111.589 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.86 -44.25 77.56 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.033 0.533 . . . . 10.0 110.819 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -77.06 -38.44 52.61 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 112.669 0.618 . . . . 10.0 112.669 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -110.22 143.98 29.16 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.352 0.661 . . . . 10.0 111.193 -168.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.56 -3.78 13.96 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.96 2.44 . . . . 10.0 113.652 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -56.38 132.76 51.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.697 1.135 . . . . 10.0 109.032 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -58.14 -27.99 64.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.745 1.618 . . . . 10.0 115.196 -168.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -155.95 153.09 29.04 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.979 1.263 . . . . 10.0 110.979 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.06 133.93 17.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.772 -1.936 . . . . 10.0 105.772 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.9 p -134.82 169.91 16.65 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.518 0.727 . . . . 10.0 109.76 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -140.85 166.15 25.57 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.318 0.647 . . . . 10.0 110.467 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.34 172.51 14.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.526 1.53 . . . . 10.0 108.483 172.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -134.94 35.95 3.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.828 1.251 . . . . 10.0 108.606 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.0 -31.01 71.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.397 1.079 . . . . 10.0 113.621 -169.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 176.38 179.91 47.08 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 118.059 0.39 . . . . 10.0 112.563 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 15.3 t80 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.409 1.484 . . . . 10.0 108.489 179.82 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 119.242 -0.408 . . . . 10.0 109.923 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.24 151.52 36.05 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.785 0.434 . . . . 10.0 111.115 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.4 m -67.37 164.71 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.689 0.796 . . . . 10.0 110.672 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.69 164.6 18.94 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.987 0.515 . . . . 10.0 111.236 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -152.5 146.64 25.42 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 170.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.46 -25.27 65.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 118.505 -0.759 . . . . 10.0 113.002 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.4 -26.95 68.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.113 0.87 . . . . 10.0 112.034 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -75.76 -27.64 58.15 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.82 0.448 . . . . 10.0 110.709 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.6 mt -74.74 122.09 86.71 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -51.15 139.96 42.09 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.161 2.574 . . . . 10.0 110.594 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.27 -29.47 38.31 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.087 0.946 . . . . 10.0 111.605 -172.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -136.65 136.17 48.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 104.323 -2.473 . . . . 10.0 104.323 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -146.32 118.28 8.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.488 -1.301 . . . . 10.0 107.488 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.2 pt -142.2 144.96 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.028 1.731 . . . . 10.0 106.653 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -155.92 74.84 0.88 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.886 1.326 . . . . 10.0 108.35 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -156.56 173.37 17.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.987 1.715 . . . . 10.0 108.382 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -144.8 138.71 27.29 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.194 -1.41 . . . . 10.0 107.194 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.75 -153.02 25.48 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.591 -1.403 . . . . 10.0 109.591 -170.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.82 142.09 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.118 -1.067 . . . . 10.0 108.118 169.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -150.17 152.15 34.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.74 0.816 . . . . 10.0 110.766 169.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -70.76 150.11 46.22 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.898 0.879 . . . . 10.0 108.985 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.25 159.36 43.45 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.282 0.492 . . . . 10.0 110.899 172.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.39 145.32 28.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.684 1.594 . . . . 10.0 107.169 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.48 122.04 45.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.971 -2.233 . . . . 10.0 104.971 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.5 mt -124.94 130.15 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.884 -1.525 . . . . 10.0 106.884 -171.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -80.04 129.24 34.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.73 -2.322 . . . . 10.0 104.73 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.73 142.6 32.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -124.62 134.98 52.74 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.182 1.793 . . . . 10.0 106.785 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.9 p -65.79 140.51 58.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 110.048 -0.353 . . . . 10.0 110.048 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.33 46.25 0.48 Allowed Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 125.184 1.393 . . . . 10.0 111.99 168.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.13 159.34 26.54 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.497 2.798 . . . . 10.0 110.785 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.29 20.66 1.43 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.872 1.269 . . . . 10.0 112.141 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 52.1 22.69 1.97 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.582 1.553 . . . . 10.0 113.531 -171.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.34 32.94 0.03 OUTLIER Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.29 -0.881 . . . . 10.0 113.826 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.08 157.74 20.54 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 118.617 1.208 . . . . 10.0 110.475 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.89 57.71 4.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.085 3.19 . . . . 10.0 111.434 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.32 145.54 34.06 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.937 1.695 . . . . 10.0 108.366 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.47 31.11 0.59 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.756 1.222 . . . . 10.0 110.267 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -63.99 153.25 37.8 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.436 -0.95 . . . . 10.0 108.436 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -144.55 161.82 38.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.658 1.183 . . . . 10.0 109.992 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -150.22 176.57 10.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.764 1.226 . . . . 10.0 109.712 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -102.14 146.88 27.33 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.871 -1.159 . . . . 10.0 107.871 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.3 pt -133.67 155.27 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.859 1.264 . . . . 10.0 110.407 172.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.95 130.4 66.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.788 -1.56 . . . . 10.0 106.788 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -132.25 143.91 50.25 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.056 -1.461 . . . . 10.0 107.056 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.56 129.84 1.88 Allowed Glycine 0 C--O 1.226 -0.391 0 CA-C-N 120.489 1.495 . . . . 10.0 113.305 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -151.31 148.27 27.96 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.516 1.126 . . . . 10.0 109.153 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -88.95 -6.72 57.06 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.385 -1.293 . . . . 10.0 114.196 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -63.99 -22.65 67.02 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.019 1.281 . . . . 10.0 111.805 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.85 124.11 22.81 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.345 0.658 . . . . 10.0 109.548 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.26 -35.92 80.52 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.275 0.559 . . . . 10.0 109.642 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -142.74 151.38 41.21 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 126.411 1.885 . . . . 10.0 106.951 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -55.03 -35.7 64.72 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.37 0.668 . . . . 10.0 112.503 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.08 -24.54 58.95 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.429 -0.796 . . . . 10.0 112.445 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.13 -36.64 82.31 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.735 0.698 . . . . 10.0 110.709 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mt -65.25 -49.94 76.2 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 107.787 -1.19 . . . . 10.0 107.787 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -56.1 -46.58 79.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.902 -0.571 . . . . 10.0 111.169 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.02 -45.16 86.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.189 0.595 . . . . 10.0 111.888 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -58.84 -49.4 77.89 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.42 0.688 . . . . 10.0 109.747 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.82 -42.19 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.6 m -58.38 -35.63 72.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.591 1.087 . . . . 10.0 111.333 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.64 -48.33 82.32 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.781 -0.928 . . . . 10.0 110.781 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.34 -46.41 90.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.907 0.853 . . . . 10.0 111.272 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -36.57 83.22 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 118.643 -0.694 . . . . 10.0 110.888 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -64.5 -36.01 82.82 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.828 0.74 . . . . 10.0 110.879 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.46 -32.34 73.13 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 117.982 -1.008 . . . . 10.0 111.71 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -67.85 -57.06 6.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.152 0.887 . . . . 10.0 109.048 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.59 47.04 0.16 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.882 1.706 . . . . 10.0 109.163 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.5 m -146.32 173.62 12.08 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.719 2.008 . . . . 10.0 108.379 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -141.03 162.86 34.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.513 1.525 . . . . 10.0 108.557 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.1 m -134.47 158.75 43.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.425 1.09 . . . . 10.0 112.398 -168.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -148.45 122.21 9.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.954 1.702 . . . . 10.0 106.944 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.7 p -64.56 128.54 36.22 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.772 -1.205 . . . . 10.0 109.368 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.06 -25.97 19.39 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.14 -177.74 35.58 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.548 -1.421 . . . . 10.0 109.548 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.82 -174.67 24.27 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 118.222 1.011 . . . . 10.0 112.015 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.66 -145.96 5.35 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.12 -1.592 . . . . 10.0 109.12 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.8 mtm-85 -137.74 155.31 49.21 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.148 -1.207 . . . . 10.0 108.37 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.9 mt -122.63 148.73 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 105.024 -2.213 . . . . 10.0 105.024 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.9 p -148.71 161.12 42.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.006 1.322 . . . . 10.0 108.638 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -162.0 163.13 29.07 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.224 1.01 . . . . 10.0 108.47 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -150.22 55.42 0.93 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 105.521 -2.029 . . . . 10.0 105.521 171.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.2 m -44.69 -26.41 0.38 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.028 2.531 . . . . 10.0 116.297 -167.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -59.0 -24.61 62.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 173.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -147.24 -25.19 0.39 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.071 0.948 . . . . 10.0 113.458 -170.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -137.18 145.19 43.43 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.361 -1.462 . . . . 10.0 110.519 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 168.42 6.56 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.731 1.212 . . . . 10.0 112.447 176.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.5 mt -68.13 149.42 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.283 -1.377 . . . . 10.0 107.283 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -140.47 162.83 34.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.033 0.933 . . . . 10.0 109.672 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.3 144.35 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.12 -1.808 . . . . 10.0 106.12 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -161.19 179.15 8.6 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.283 -0.886 . . . . 10.0 110.218 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.26 -176.21 47.63 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.092 0.377 . . . . 10.0 112.651 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -155.77 134.71 12.01 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.757 0.823 . . . . 10.0 109.958 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 m -74.24 95.55 2.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.912 0.885 . . . . 10.0 109.785 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 76.9 mtm -57.62 -14.44 5.4 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.878 0.871 . . . . 10.0 112.602 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.34 -27.7 48.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.691 1.196 . . . . 10.0 113.121 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -47.63 0.33 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.862 0.756 . . . . 10.0 110.882 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.8 173.85 23.35 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.28 1.419 . . . . 10.0 109.862 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.37 134.23 56.32 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.791 2.327 . . . . 10.0 111.071 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.41 162.06 21.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 167.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.99 71.2 5.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.134 -1.432 . . . . 10.0 107.134 169.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -54.42 -26.25 29.64 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.75 1.22 . . . . 10.0 113.376 -170.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.86 92.76 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.476 1.035 . . . . 10.0 111.745 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.6 mt -67.47 -49.87 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.418 -1.327 . . . . 10.0 107.418 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 m -58.84 -44.54 90.98 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.863 -0.589 . . . . 10.0 112.06 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.0 p -64.95 -41.53 95.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.058 -0.972 . . . . 10.0 111.009 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -64.19 -39.33 93.76 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.384 0.993 . . . . 10.0 110.807 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -65.43 -48.22 73.54 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.926 -0.484 . . . . 10.0 110.67 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.24 -42.94 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.298 -1.001 . . . . 10.0 108.298 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -59.49 -45.59 91.23 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.925 0.89 . . . . 10.0 110.41 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.72 95.45 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.552 0.614 . . . . 10.0 111.396 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -68.23 -38.18 81.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.668 -0.682 . . . . 10.0 110.943 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -130.99 65.86 77.76 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.112 1.365 . . . . 10.0 109.995 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.45 -10.74 29.59 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.041 2.494 . . . . 10.0 113.569 -171.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.62 -12.38 52.8 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.912 0.885 . . . . 10.0 112.67 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -133.29 150.77 51.89 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 124.347 1.059 . . . . 10.0 109.907 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.1 159.31 31.82 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.899 -1.149 . . . . 10.0 107.899 168.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.04 135.64 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 172.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.6 p -139.73 172.24 13.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.208 1.403 . . . . 10.0 108.749 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -140.45 163.72 32.05 Favored 'General case' 0 C--O 1.227 -0.114 0 O-C-N 121.543 -0.723 . . . . 10.0 112.406 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.27 171.03 15.58 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.5 1.92 . . . . 10.0 108.504 172.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -146.64 27.65 1.09 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.852 1.261 . . . . 10.0 110.993 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.05 -22.27 65.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.818 1.247 . . . . 10.0 113.6 -170.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.74 176.66 37.34 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.623 -1.391 . . . . 10.0 109.623 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 25.2 p90 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 117.701 -1.142 . . . . 10.0 111.385 178.048 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ttt . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.68 -173.87 4.39 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.454 1.102 . . . . 10.0 108.779 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 m -60.56 142.08 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.32 171.24 20.54 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.959 1.704 . . . . 10.0 107.118 -175.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -152.17 150.64 30.08 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.389 -1.337 . . . . 10.0 107.389 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.4 -26.66 65.33 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.679 0.792 . . . . 10.0 112.832 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.94 -26.25 68.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.936 0.789 . . . . 10.0 112.159 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.1 mt -75.79 -25.27 56.25 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.034 0.534 . . . . 10.0 110.982 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.4 mt -78.68 122.82 85.29 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -50.74 133.53 39.23 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.499 2.8 . . . . 10.0 110.721 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -82.52 -28.65 30.94 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.504 0.668 . . . . 10.0 112.074 -170.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.08 134.91 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.893 -2.262 . . . . 10.0 104.893 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -150.64 113.82 4.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.056 -1.831 . . . . 10.0 106.056 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.61 170.88 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.681 1.192 . . . . 10.0 110.258 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -133.43 34.79 3.47 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.582 1.153 . . . . 10.0 111.921 -167.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -49.3 130.85 19.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.95 1.7 . . . . 10.0 112.314 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -165.86 -35.37 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.878 1.671 . . . . 10.0 109.743 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.61 -153.7 6.4 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 106.251 -2.74 . . . . 10.0 106.251 170.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.6 t -61.46 139.27 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 118.649 1.224 . . . . 10.0 108.089 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -146.35 147.06 30.93 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.855 0.862 . . . . 10.0 109.618 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.02 146.89 50.7 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.79 -0.818 . . . . 10.0 108.79 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.01 158.78 43.28 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.599 -0.889 . . . . 10.0 108.599 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.75 150.6 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.171 1.388 . . . . 10.0 107.698 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.6 tp -115.13 115.71 27.21 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.9 138.29 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.759 -1.571 . . . . 10.0 106.759 -169.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -92.86 135.4 34.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.674 -1.602 . . . . 10.0 106.674 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.11 139.99 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 105.824 -1.917 . . . . 10.0 105.824 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -115.11 130.0 56.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.914 -1.884 . . . . 10.0 105.914 173.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 p -70.17 143.51 52.25 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.03 61.44 3.37 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.721 1.208 . . . . 10.0 108.325 169.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -58.93 152.25 59.41 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.247 2.631 . . . . 10.0 111.103 -169.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 65.92 -61.38 0.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 128.122 2.569 . . . . 10.0 112.135 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 p -171.11 -33.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.425 2.29 . . . . 10.0 108.864 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.66 42.63 0.13 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.05 1.31 . . . . 10.0 110.574 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.02 157.23 11.53 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.339 0.656 . . . . 10.0 110.262 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.52 59.46 5.54 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.181 3.254 . . . . 10.0 112.474 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.18 136.36 26.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.074 1.749 . . . . 10.0 107.297 171.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.38 30.21 0.85 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.775 1.23 . . . . 10.0 110.054 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -64.87 161.07 19.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.79 -0.819 . . . . 10.0 108.79 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.5 m -141.08 159.51 42.05 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.233 1.013 . . . . 10.0 110.009 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -149.83 170.19 19.35 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.503 1.121 . . . . 10.0 109.617 171.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -99.95 154.45 18.37 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.211 -0.663 . . . . 10.0 109.211 170.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.0 pt -137.12 154.03 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.291 1.436 . . . . 10.0 109.956 174.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.35 126.84 65.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.453 -1.684 . . . . 10.0 106.453 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -133.94 143.06 47.97 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.738 -1.579 . . . . 10.0 106.738 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.84 129.47 1.65 Allowed Glycine 0 C--O 1.227 -0.295 0 CA-C-N 120.259 1.39 . . . . 10.0 111.378 171.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -145.0 141.5 28.98 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.454 0.702 . . . . 10.0 110.432 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -70.51 -21.98 62.68 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 118.358 -0.83 . . . . 10.0 113.195 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -66.44 -25.13 66.6 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.586 1.085 . . . . 10.0 112.629 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.67 126.32 29.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.252 0.933 . . . . 10.0 110.114 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.49 -31.96 65.81 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 122.621 0.368 . . . . 10.0 110.249 170.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -146.05 152.22 38.99 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.339 1.456 . . . . 10.0 109.13 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -56.93 -31.46 64.98 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.004 1.322 . . . . 10.0 112.626 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.18 -31.55 69.1 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.674 -0.679 . . . . 10.0 112.047 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.74 -41.65 78.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.647 0.658 . . . . 10.0 110.107 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.3 mt -62.78 -50.74 78.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 108.312 -0.996 . . . . 10.0 108.312 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -55.34 -43.7 75.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.834 -0.603 . . . . 10.0 111.295 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.11 -46.59 83.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.609 0.64 . . . . 10.0 111.666 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -57.61 -49.9 74.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.132 0.573 . . . . 10.0 109.643 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.51 -44.31 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 m -56.61 -42.52 78.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.025 0.83 . . . . 10.0 110.9 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.52 -48.37 86.35 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.78 -0.928 . . . . 10.0 110.78 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -62.29 -47.38 84.55 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 118.16 0.98 . . . . 10.0 111.046 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -39.51 87.5 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 119.011 -0.518 . . . . 10.0 110.69 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -65.51 -33.76 76.68 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.567 0.621 . . . . 10.0 110.896 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.08 -34.0 77.08 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 117.239 -1.362 . . . . 10.0 111.21 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -69.47 -65.89 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.292 0.951 . . . . 10.0 108.682 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.79 42.24 0.04 OUTLIER Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.371 1.462 . . . . 10.0 110.491 -169.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.1 m -146.38 176.11 10.03 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.596 1.958 . . . . 10.0 107.935 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -145.21 165.72 27.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.168 0.987 . . . . 10.0 108.764 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.9 m -130.15 155.08 46.81 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.289 0.949 . . . . 10.0 113.019 -169.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -141.57 136.97 31.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.074 1.749 . . . . 10.0 106.774 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.5 t -78.77 141.66 37.62 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.598 -0.689 . . . . 10.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.4 mt -103.48 -20.36 14.07 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.377 0.671 . . . . 10.0 111.146 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.71 -177.96 34.25 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.814 -0.914 . . . . 10.0 110.814 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.15 178.42 32.68 Favored Glycine 0 CA--C 1.521 0.427 0 O-C-N 121.631 -0.923 . . . . 10.0 112.356 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.97 -145.6 5.6 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 109.84 -1.304 . . . . 10.0 109.84 -172.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -142.55 161.72 37.32 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.894 2.078 . . . . 10.0 107.755 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.8 mt -132.29 145.32 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 105.929 -1.878 . . . . 10.0 105.929 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.0 p -154.12 174.52 14.61 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.431 1.092 . . . . 10.0 110.747 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -149.61 152.41 35.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.797 2.039 . . . . 10.0 105.557 169.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -129.05 -12.05 4.68 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.886 0.474 . . . . 10.0 112.076 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 m 57.37 21.89 7.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.084 1.354 . . . . 10.0 113.796 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.33 -17.63 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.637 1.175 . . . . 10.0 113.059 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -159.55 148.02 17.65 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.921 1.688 . . . . 10.0 106.539 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 53.8 -162.66 0.11 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.256 1.022 . . . . 10.0 110.462 -168.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -135.45 -144.81 0.21 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.15 -1.426 . . . . 10.0 107.15 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.3 mm -63.19 113.38 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 101.676 -3.453 . . . . 10.0 101.676 167.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -117.53 145.63 44.11 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.5 -0.555 . . . . 10.0 109.5 -167.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 32.1 t -135.17 130.49 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.917 -1.512 . . . . 10.0 106.917 -170.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -166.86 169.46 13.17 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.135 -0.978 . . . . 10.0 109.47 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.03 -174.63 19.84 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 119.272 0.942 . . . . 10.0 114.435 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -140.41 1.31 1.76 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.413 1.264 . . . . 10.0 114.413 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.6 p 50.53 -25.55 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 129.707 3.203 . . . . 10.0 119.007 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 12.3 tmm? 66.58 -48.39 0.45 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.574 2.35 . . . . 10.0 111.009 -168.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.74 70.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.363 1.465 . . . . 10.0 113.016 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -133.93 -50.25 0.82 Allowed 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.643 0.656 . . . . 10.0 111.747 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.02 170.96 12.31 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 109.37 -1.492 . . . . 10.0 109.37 -170.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.05 130.97 40.59 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.029 2.486 . . . . 10.0 111.8 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.66 158.88 28.92 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 168.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -77.1 73.34 3.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -54.61 -26.24 31.52 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.199 0.999 . . . . 10.0 112.835 -170.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.29 -41.06 98.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.261 0.937 . . . . 10.0 112.08 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.2 mt -64.52 -50.24 76.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 107.497 -1.298 . . . . 10.0 107.497 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -60.09 -43.62 95.39 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 119.129 -0.462 . . . . 10.0 111.892 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.9 p -66.58 -37.83 85.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.064 0.847 . . . . 10.0 111.547 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -64.89 -38.97 92.76 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.418 1.008 . . . . 10.0 110.796 175.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -66.66 -45.06 80.17 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 122.042 -0.411 . . . . 10.0 110.626 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.86 -48.72 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -59.03 -40.02 83.75 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.158 0.89 . . . . 10.0 111.567 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.33 72.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.992 0.815 . . . . 10.0 111.977 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -89.89 -12.6 38.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.534 -0.746 . . . . 10.0 112.822 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.1 p90 38.25 57.59 5.03 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 127.541 2.336 . . . . 10.0 114.558 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -67.63 -16.31 46.48 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.737 1.625 . . . . 10.0 110.671 169.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -142.08 160.15 40.81 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 128.134 2.574 . . . . 10.0 105.681 169.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -76.56 -15.72 59.79 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.539 -0.743 . . . . 10.0 112.456 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.72 153.05 39.81 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.945 1.248 . . . . 10.0 110.588 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.6 t -143.01 154.55 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.382 1.473 . . . . 10.0 107.597 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.0 p -145.53 158.42 43.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.826 1.65 . . . . 10.0 108.926 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -151.22 164.23 37.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.838 0.681 . . . . 10.0 112.838 173.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.21 -174.08 4.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.606 1.962 . . . . 10.0 108.436 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.98 35.04 3.56 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.127 0.971 . . . . 10.0 109.258 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -152.07 157.39 41.57 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.819 1.648 . . . . 10.0 108.021 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.95 -26.84 6.06 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.461 1.505 . . . . 10.0 111.605 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--O 1.25 1.1 0 N-CA-C 104.41 -2.441 . . . . 10.0 104.41 -179.665 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 tpt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.38 150.59 31.6 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.403 1.081 . . . . 10.0 109.221 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.69 176.4 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 128.063 2.545 . . . . 10.0 107.564 -176.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.21 174.61 10.42 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.297 1.439 . . . . 10.0 108.498 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -151.05 152.05 32.89 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.016 -1.105 . . . . 10.0 108.016 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -59.53 -22.4 61.61 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.937 0.895 . . . . 10.0 113.04 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.94 -24.56 66.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.637 1.108 . . . . 10.0 112.435 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.5 mt -78.96 -17.1 56.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.455 0.702 . . . . 10.0 111.745 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 25.8 mt -100.36 132.35 22.65 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.46 142.33 64.98 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.388 2.058 . . . . 10.0 110.272 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -78.51 -28.88 46.35 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.816 0.847 . . . . 10.0 112.163 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.26 134.38 47.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 106.086 -1.82 . . . . 10.0 106.086 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -152.96 113.42 4.04 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.3 pt -139.07 160.78 29.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.56 1.144 . . . . 10.0 109.962 -169.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.13 175.49 2.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.191 0.996 . . . . 10.0 111.572 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -138.82 11.58 2.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.376 1.07 . . . . 10.0 112.55 -169.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -148.81 138.29 21.83 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.152 0.887 . . . . 10.0 110.419 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.24 -163.63 16.29 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.487 1.041 . . . . 10.0 113.139 171.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.84 142.49 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 169.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -150.37 147.84 28.08 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.986 0.914 . . . . 10.0 109.734 171.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -74.93 157.88 34.25 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.672 -0.862 . . . . 10.0 108.672 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.71 160.35 43.25 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.549 0.34 . . . . 10.0 110.458 173.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 t -133.57 141.89 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.453 1.501 . . . . 10.0 107.383 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 tp -98.63 115.84 29.54 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 104.654 -2.35 . . . . 10.0 104.654 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.3 mt -122.83 124.84 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.625 -1.62 . . . . 10.0 106.625 -167.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -82.53 140.16 33.46 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 168.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.2 t -133.13 142.65 41.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.446 -1.687 . . . . 10.0 106.446 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -126.29 136.96 53.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.509 1.524 . . . . 10.0 107.119 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.9 m -67.56 140.44 56.95 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.36 57.31 2.77 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.399 1.479 . . . . 10.0 107.981 167.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -59.97 135.12 60.88 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.333 2.689 . . . . 10.0 109.834 -169.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 47.34 26.04 0.67 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.028 1.331 . . . . 10.0 112.956 -174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m 48.23 31.28 2.55 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.458 1.503 . . . . 10.0 113.655 -172.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -172.64 -3.39 0.03 OUTLIER Glycine 0 CA--C 1.531 1.051 0 N-CA-C 117.019 1.568 . . . . 10.0 117.019 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.05 151.08 81.76 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 120.433 2.116 . . . . 10.0 110.556 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.03 52.06 3.9 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.315 3.344 . . . . 10.0 111.54 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.53 136.07 30.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.003 1.321 . . . . 10.0 108.723 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.7 31.5 1.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.327 1.451 . . . . 10.0 109.762 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -61.97 151.48 34.91 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.51 -0.922 . . . . 10.0 108.51 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.4 m -139.39 158.49 44.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.799 0.84 . . . . 10.0 110.686 -175.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -152.41 176.78 11.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.807 1.243 . . . . 10.0 109.247 171.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -117.0 142.82 46.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.0 pt -131.17 156.42 42.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.623 1.169 . . . . 10.0 110.067 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.42 125.8 65.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.915 -1.883 . . . . 10.0 105.915 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -130.13 139.17 50.93 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.0 132.76 2.5 Favored Glycine 0 C--O 1.224 -0.527 0 CA-C-N 120.03 1.286 . . . . 10.0 111.817 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -144.75 144.18 31.06 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 122.888 0.475 . . . . 10.0 111.178 -169.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -64.58 -32.45 74.11 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.845 0.858 . . . . 10.0 112.248 -174.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -68.59 -16.69 63.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 117.912 -1.042 . . . . 10.0 113.008 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.8 119.31 6.91 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.631 1.105 . . . . 10.0 111.629 -172.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.13 -37.36 81.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.161 0.584 . . . . 10.0 110.18 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -149.67 168.86 22.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 127.142 2.177 . . . . 10.0 107.598 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -59.6 -29.37 67.94 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.135 -0.978 . . . . 10.0 111.805 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.92 68.9 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.838 0.855 . . . . 10.0 112.359 172.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -66.39 -42.6 87.65 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.795 0.807 . . . . 10.0 109.802 -176.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.78 -53.84 37.17 Favored 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.214 -1.032 . . . . 10.0 108.214 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -59.14 -39.17 81.55 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 119.027 -0.511 . . . . 10.0 110.992 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.51 -46.02 90.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.445 0.566 . . . . 10.0 111.761 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.83 -49.16 75.99 Favored 'General case' 0 C--N 1.345 0.373 0 O-C-N 121.691 -0.63 . . . . 10.0 109.661 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.79 -43.73 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.301 -0.629 . . . . 10.0 109.301 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.7 p -65.09 -34.05 77.49 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.251 0.932 . . . . 10.0 111.205 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.98 -51.21 60.02 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.393 -1.083 . . . . 10.0 110.393 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.98 -46.25 91.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 117.357 0.579 . . . . 10.0 110.792 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.9 mmt -61.84 -37.75 85.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.702 -0.624 . . . . 10.0 110.812 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -64.86 -36.49 84.52 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.997 0.817 . . . . 10.0 111.14 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -66.61 -34.22 77.41 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.994 -1.003 . . . . 10.0 111.304 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -68.15 -54.22 19.53 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.841 0.746 . . . . 10.0 109.546 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.52 44.04 0.2 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.453 1.502 . . . . 10.0 110.551 -171.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.4 m -144.91 171.68 14.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.229 1.812 . . . . 10.0 109.047 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -139.54 160.92 38.74 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.432 1.493 . . . . 10.0 108.709 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.8 m -127.71 157.59 39.91 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.847 1.259 . . . . 10.0 112.98 -168.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -145.52 111.75 5.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.677 1.991 . . . . 10.0 106.283 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -63.42 118.9 8.75 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.97 -1.081 . . . . 10.0 108.775 171.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 mt -80.7 -29.02 36.49 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 110.171 -0.307 . . . . 10.0 110.171 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.64 -178.43 39.84 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.157 -1.977 . . . . 10.0 108.157 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.99 -168.86 20.19 Favored Glycine 0 CA--C 1.519 0.314 0 O-C-N 121.398 -1.06 . . . . 10.0 110.851 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.17 -151.41 9.07 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.358 -1.897 . . . . 10.0 108.358 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -144.13 165.4 27.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -134.32 151.46 32.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 104.835 -2.283 . . . . 10.0 104.835 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.3 p -132.37 118.73 19.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.985 -1.117 . . . . 10.0 107.985 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -78.53 91.0 4.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.091 -1.818 . . . . 10.0 106.091 168.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -82.54 63.7 6.82 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.655 0.741 . . . . 10.0 109.28 -174.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.6 m 49.08 32.19 3.88 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.431 2.292 . . . . 10.0 113.449 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . 0.276 5.5 pt20 51.48 -26.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 130.347 3.459 . . . . 10.0 116.792 -168.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.37 -30.28 62.49 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.721 1.609 . . . . 10.0 112.147 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -124.42 32.18 5.56 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.335 1.054 . . . . 10.0 110.25 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.332 0.0 OUTLIER 54.53 -179.86 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.037 2.935 . . . . 10.0 115.225 172.695 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.7 pt -86.5 102.48 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.865 -1.531 . . . . 10.0 106.865 169.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -99.79 126.69 45.91 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.199 -1.038 . . . . 10.0 108.199 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.42 145.31 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 106.652 -1.61 . . . . 10.0 106.652 174.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -161.67 178.77 8.71 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.687 0.795 . . . . 10.0 110.182 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.89 -158.26 46.31 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-O 121.328 0.405 . . . . 10.0 112.92 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -158.67 158.03 32.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.557 1.943 . . . . 10.0 107.56 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 t -72.09 130.78 41.71 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 60.4 mtt -73.3 -19.32 61.07 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.604 0.565 . . . . 10.0 110.811 169.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.95 -31.32 22.18 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.536 -0.745 . . . . 10.0 112.077 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -128.17 -54.53 1.28 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.889 0.768 . . . . 10.0 111.297 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.09 179.85 22.58 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.837 1.208 . . . . 10.0 110.165 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.39 133.42 58.0 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.113 2.542 . . . . 10.0 111.673 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.69 165.76 20.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 166.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -80.12 68.22 6.19 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 168.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -49.45 -33.03 13.12 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.463 1.505 . . . . 10.0 113.709 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.5 77.18 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.993 0.815 . . . . 10.0 112.231 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.72 -50.97 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 107.097 -1.445 . . . . 10.0 107.097 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -55.94 -46.52 78.48 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.468 -0.777 . . . . 10.0 112.137 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.6 p -64.99 -42.32 94.63 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 119.721 1.146 . . . . 10.0 111.034 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.87 -39.44 90.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.864 0.756 . . . . 10.0 110.979 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -59.83 -51.66 68.77 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 118.818 -0.61 . . . . 10.0 109.836 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.47 -48.81 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.419 -0.956 . . . . 10.0 108.419 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -60.99 -40.75 94.66 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.693 0.797 . . . . 10.0 111.513 -175.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.12 77.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.122 0.569 . . . . 10.0 110.842 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -79.5 -19.65 49.16 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 118.62 -0.705 . . . . 10.0 112.082 -173.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.84 77.48 72.15 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 126.136 1.774 . . . . 10.0 107.221 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.22 51.4 3.47 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.624 3.549 . . . . 10.0 111.955 -174.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -146.54 166.78 25.45 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.041 1.737 . . . . 10.0 107.953 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 50.78 -140.87 0.8 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.922 1.289 . . . . 10.0 110.029 -169.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -147.54 162.88 38.2 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.98 -1.489 . . . . 10.0 106.98 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.96 132.5 16.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.138 -1.43 . . . . 10.0 107.138 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -142.44 170.65 15.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.646 1.178 . . . . 10.0 108.707 173.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -138.75 163.28 32.6 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 122.851 0.46 . . . . 10.0 111.886 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.47 168.87 20.14 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.164 1.785 . . . . 10.0 108.727 169.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -147.98 23.69 1.07 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.157 0.983 . . . . 10.0 110.164 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.61 -25.88 68.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.106 0.962 . . . . 10.0 112.946 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -169.44 178.54 42.47 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 108.639 -1.784 . . . . 10.0 108.639 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 68.2 t80 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.932 -0.556 . . . . 10.0 109.535 176.11 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 118.554 -0.736 . . . . 10.0 109.75 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.66 24.04 6.66 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.86 1.264 . . . . 10.0 111.276 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.48 152.19 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 128.904 2.882 . . . . 10.0 105.323 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.43 167.1 20.33 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.479 0.487 . . . . 10.0 109.785 168.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -151.16 151.32 31.76 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.931 1.292 . . . . 10.0 107.542 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.13 -24.06 62.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 118.237 -0.887 . . . . 10.0 112.886 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.88 -25.9 67.02 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.605 1.093 . . . . 10.0 112.451 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.2 mt -74.94 -23.77 58.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.123 0.569 . . . . 10.0 111.366 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.9 mt -89.2 128.97 49.51 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 107.071 -1.455 . . . . 10.0 107.071 -173.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.81 147.17 80.48 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.165 1.91 . . . . 10.0 110.67 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.92 -35.61 72.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.779 1.632 . . . . 10.0 111.603 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.64 133.26 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.625 -2.361 . . . . 10.0 104.625 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -150.32 114.3 5.07 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.063 -1.829 . . . . 10.0 106.063 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.3 pt -141.5 161.06 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.502 1.121 . . . . 10.0 109.525 -170.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -148.28 103.91 3.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.2 m -155.88 155.01 32.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.013 0.925 . . . . 10.0 109.07 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.84 25.41 0.84 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 123.121 1.439 . . . . 10.0 109.717 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.77 -168.55 41.43 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 107.905 -2.078 . . . . 10.0 107.905 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.79 120.64 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 118.06 0.93 . . . . 10.0 108.576 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -146.82 151.16 36.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.694 0.797 . . . . 10.0 109.981 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -55.95 153.46 8.69 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.64 1.176 . . . . 10.0 111.629 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.51 160.9 43.08 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.074 0.95 . . . . 10.0 108.965 168.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.12 147.25 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.703 1.201 . . . . 10.0 108.911 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -107.77 117.99 35.56 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.566 -2.013 . . . . 10.0 105.566 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.3 mt -123.19 132.34 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.522 -1.659 . . . . 10.0 106.522 -170.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -85.32 125.3 32.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.537 -2.023 . . . . 10.0 105.537 167.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.38 141.17 24.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 106.604 -1.628 . . . . 10.0 106.604 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -121.6 130.1 53.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.976 -1.861 . . . . 10.0 105.976 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.6 p -71.03 144.32 50.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.958 -0.386 . . . . 10.0 109.958 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.0 61.83 3.56 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.567 1.547 . . . . 10.0 107.603 166.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -58.08 143.9 95.76 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.944 2.429 . . . . 10.0 110.601 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 48.18 23.72 0.57 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.842 1.257 . . . . 10.0 113.111 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m 49.05 30.95 3.09 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.225 1.41 . . . . 10.0 113.683 -172.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.62 -2.34 0.02 OUTLIER Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.762 1.465 . . . . 10.0 116.762 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.16 152.22 78.94 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 119.937 1.868 . . . . 10.0 110.657 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.78 57.77 6.18 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.285 3.323 . . . . 10.0 112.098 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.24 136.91 30.32 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 125.073 1.349 . . . . 10.0 108.309 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.79 28.53 0.77 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.897 1.279 . . . . 10.0 110.448 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.04 159.94 24.86 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.375 -0.828 . . . . 10.0 109.095 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.0 m -139.76 162.12 35.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.874 0.87 . . . . 10.0 110.694 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -149.29 174.88 11.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.647 1.179 . . . . 10.0 109.351 170.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -99.3 148.85 23.73 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 pt -136.53 148.62 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.604 1.562 . . . . 10.0 109.72 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.7 t -106.94 127.34 62.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -132.68 141.95 48.84 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.618 -1.253 . . . . 10.0 107.618 -176.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.06 107.21 0.23 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 110.132 -1.187 . . . . 10.0 110.132 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.97 132.62 42.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 -171.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -59.55 -23.95 63.3 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.791 1.404 . . . . 10.0 114.791 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -67.39 -24.65 65.7 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.315 0.961 . . . . 10.0 112.425 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.98 125.42 29.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.744 1.157 . . . . 10.0 109.799 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -74.29 -33.59 63.28 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.392 0.615 . . . . 10.0 109.855 171.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -143.71 155.91 44.36 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.15 1.38 . . . . 10.0 110.008 -172.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -58.66 -33.87 70.6 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.415 1.486 . . . . 10.0 112.94 -171.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.94 -31.09 70.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.383 -0.818 . . . . 10.0 111.513 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -70.93 -38.54 72.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.86 0.755 . . . . 10.0 110.124 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.4 mt -63.88 -50.34 77.95 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -52.92 -48.26 67.39 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.427 -0.797 . . . . 10.0 111.123 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.2 -47.15 83.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.417 0.553 . . . . 10.0 111.255 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -59.48 -51.42 69.95 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.872 -0.518 . . . . 10.0 110.153 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.1 t -66.98 -41.26 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.678 -0.86 . . . . 10.0 108.678 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 m -62.91 -36.04 82.06 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.629 1.104 . . . . 10.0 111.547 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.77 -51.13 59.45 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.163 -1.175 . . . . 10.0 110.163 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.29 -43.45 98.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.793 0.797 . . . . 10.0 111.016 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.1 mmt -62.32 -37.0 83.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 121.71 -0.619 . . . . 10.0 111.433 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -65.03 -36.17 83.52 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.009 0.822 . . . . 10.0 110.755 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.78 -32.72 74.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.64 -1.172 . . . . 10.0 111.509 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -68.99 -52.16 31.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.718 1.144 . . . . 10.0 109.727 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.08 50.12 0.24 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.766 -1.734 . . . . 10.0 108.766 -169.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.0 m -147.69 170.65 17.08 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.532 1.933 . . . . 10.0 109.216 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -140.2 165.38 27.52 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.276 1.83 . . . . 10.0 108.48 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.1 m -134.48 156.14 49.12 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.582 1.153 . . . . 10.0 112.358 -167.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -149.25 123.23 9.39 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.135 -1.802 . . . . 10.0 106.135 169.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.71 126.98 31.35 Favored 'General case' 0 C--O 1.226 -0.178 0 O-C-N 121.038 -1.039 . . . . 10.0 109.334 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.99 -27.33 35.97 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 122.097 -0.377 . . . . 10.0 110.306 170.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.1 -177.87 38.14 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.966 -1.654 . . . . 10.0 108.966 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.96 -173.01 21.87 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.5 -1.0 . . . . 10.0 111.48 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.51 -146.77 6.4 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.511 -1.836 . . . . 10.0 108.511 -173.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -147.71 159.91 43.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.601 1.161 . . . . 10.0 109.505 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.9 mt -128.7 149.32 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.513 -2.032 . . . . 10.0 105.513 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.2 p -125.74 164.45 20.62 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.245 1.018 . . . . 10.0 108.814 170.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -139.24 154.17 47.94 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.23 1.412 . . . . 10.0 108.12 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.4 pt20 -70.09 -2.93 14.32 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.216 1.191 . . . . 10.0 114.216 -172.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 m -47.65 -41.35 22.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.756 1.622 . . . . 10.0 112.444 168.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -154.24 14.57 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.75 0.82 . . . . 10.0 111.953 -175.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -144.79 -162.15 1.43 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.978 1.311 . . . . 10.0 108.439 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -73.99 -176.4 2.5 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.875 -1.14 . . . . 10.0 109.656 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 163.66 0.27 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.904 -0.569 . . . . 10.0 110.63 165.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.0 mt -54.73 122.16 3.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 -171.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -136.38 147.14 47.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.415 -1.328 . . . . 10.0 107.415 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.69 135.51 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.173 -1.417 . . . . 10.0 107.173 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -164.79 175.29 9.79 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.941 0.897 . . . . 10.0 109.695 -170.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.52 -174.19 20.87 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 121.722 0.624 . . . . 10.0 112.76 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -141.9 24.81 1.99 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.047 0.939 . . . . 10.0 111.862 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.7 p 59.46 -174.89 0.1 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.511 1.924 . . . . 10.0 112.832 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.0 mtt -128.55 21.81 6.01 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.192 1.397 . . . . 10.0 109.039 167.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.24 -28.83 0.45 Allowed 'General case' 0 C--N 1.347 0.488 0 N-CA-C 115.172 1.545 . . . . 10.0 115.172 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.89 -52.54 0.52 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.484 1.493 . . . . 10.0 111.554 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.29 177.79 25.44 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.42 1.486 . . . . 10.0 109.646 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.3 134.45 45.31 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.759 2.306 . . . . 10.0 111.178 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.55 160.93 18.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.963 0.887 . . . . 10.0 109.085 165.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -80.33 75.4 7.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.724 -1.584 . . . . 10.0 106.724 169.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -54.53 -23.74 17.8 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.724 1.209 . . . . 10.0 113.546 -170.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.45 -40.37 94.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.703 1.138 . . . . 10.0 111.675 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.7 mt -65.16 -51.84 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.7 m -57.83 -45.42 86.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.712 -0.661 . . . . 10.0 112.003 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.0 p -68.74 -38.61 80.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 117.775 -1.107 . . . . 10.0 111.654 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.4 -40.29 96.82 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.076 1.307 . . . . 10.0 110.71 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -62.74 -50.43 71.09 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.133 -0.355 . . . . 10.0 110.064 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.2 -39.46 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 120.651 -1.281 . . . . 10.0 109.076 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -62.03 -41.55 98.21 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 119.624 1.102 . . . . 10.0 110.66 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.34 -41.3 96.84 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.315 0.961 . . . . 10.0 111.048 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -62.98 -33.2 74.89 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 118.252 -0.88 . . . . 10.0 110.66 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.4 t80 41.99 64.63 5.56 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 127.77 2.428 . . . . 10.0 111.764 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -68.03 -24.37 39.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.033 1.822 . . . . 10.0 113.142 -174.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -156.09 -48.19 0.08 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.253 0.933 . . . . 10.0 112.525 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -160.01 -171.31 3.18 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.317 -0.865 . . . . 10.0 111.086 -169.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -47.06 147.97 1.26 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.62 2.368 . . . . 10.0 111.693 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 t -132.51 140.77 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.117 1.367 . . . . 10.0 108.644 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.63 169.27 21.97 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.569 1.548 . . . . 10.0 109.96 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.6 p-90 -145.63 166.18 26.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.755 1.162 . . . . 10.0 111.243 172.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.33 175.23 14.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.98 1.712 . . . . 10.0 108.236 169.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -137.76 36.66 2.41 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.201 1.0 . . . . 10.0 109.567 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.84 -26.3 68.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.354 1.061 . . . . 10.0 112.427 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.48 -174.87 42.43 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.258 -1.537 . . . . 10.0 109.258 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 58.6 t80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.968 -0.539 . . . . 10.0 109.942 173.039 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 118.557 -0.735 . . . . 10.0 110.381 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.53 -177.58 4.81 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.875 0.87 . . . . 10.0 111.613 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.5 m -89.96 146.24 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.239 1.015 . . . . 10.0 109.218 168.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.7 -177.24 5.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.945 2.098 . . . . 10.0 106.753 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -144.89 147.05 32.33 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.382 -1.71 . . . . 10.0 106.382 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -59.05 -26.21 64.39 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.54 -24.92 67.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.704 0.684 . . . . 10.0 112.713 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.83 -27.74 57.99 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.37 0.532 . . . . 10.0 110.61 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 mt -79.94 132.52 60.27 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.11 147.88 80.17 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.453 2.102 . . . . 10.0 109.531 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.49 -28.61 46.41 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.287 0.565 . . . . 10.0 112.131 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -137.96 135.51 45.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.256 1.422 . . . . 10.0 107.173 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -147.84 99.8 3.13 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.541 -1.281 . . . . 10.0 107.541 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.6 pt -143.75 -179.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.656 1.583 . . . . 10.0 109.736 -169.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -138.58 163.5 31.87 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 106.071 -1.826 . . . . 10.0 106.071 167.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.5 m -152.89 22.82 0.58 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.771 1.229 . . . . 10.0 111.198 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.43 -18.21 64.52 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.583 -0.698 . . . . 10.0 112.463 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.04 -174.94 34.42 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.118 1.818 . . . . 10.0 109.101 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.62 130.88 30.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.283 -1.006 . . . . 10.0 108.283 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -141.94 148.67 39.02 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.059 1.344 . . . . 10.0 108.977 173.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -60.43 151.61 27.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.658 0.783 . . . . 10.0 109.187 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.08 162.07 41.66 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.633 -0.667 . . . . 10.0 110.563 170.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.84 152.86 31.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.889 1.276 . . . . 10.0 109.677 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 tp -102.63 114.3 28.41 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.654 -2.351 . . . . 10.0 104.654 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.4 mt -116.58 132.13 67.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.2 -1.778 . . . . 10.0 106.2 -170.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -88.51 139.51 30.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.437 -1.69 . . . . 10.0 106.437 168.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -128.98 142.43 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.076 -1.824 . . . . 10.0 106.076 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -120.6 133.57 55.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.189 -1.782 . . . . 10.0 106.189 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 p -65.8 140.65 58.42 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.766 -0.457 . . . . 10.0 109.766 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.9 60.2 2.89 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.24 1.416 . . . . 10.0 108.676 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.36 143.63 99.49 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.05 2.5 . . . . 10.0 108.941 -174.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.0 tpt85 53.12 16.17 0.73 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.637 1.175 . . . . 10.0 113.102 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 m 54.97 24.15 5.67 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.44 1.096 . . . . 10.0 113.222 -170.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.87 1.47 0.03 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.652 1.421 . . . . 10.0 116.652 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.53 153.35 77.67 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 119.984 1.892 . . . . 10.0 110.252 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.95 64.42 7.7 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.315 3.344 . . . . 10.0 111.925 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.32 140.0 35.55 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.378 1.471 . . . . 10.0 108.346 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.36 26.17 0.78 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.806 1.242 . . . . 10.0 110.65 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.88 159.96 27.16 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 169.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -139.45 162.64 34.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.154 0.982 . . . . 10.0 111.135 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -152.43 145.3 24.4 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.318 1.847 . . . . 10.0 107.71 -170.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.2 144.03 28.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 169.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.8 pt -134.74 151.37 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.238 1.015 . . . . 10.0 109.965 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.29 127.12 56.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 105.875 -1.898 . . . . 10.0 105.875 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.412 ' HG3' HG21 ' A' ' 60' ' ' VAL . 6.2 mmp_? -130.28 133.63 46.63 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.55 49.51 0.33 Allowed Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.068 -0.813 . . . . 10.0 111.068 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -65.92 132.95 49.84 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -63.1 -27.12 69.17 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.924 1.083 . . . . 10.0 113.924 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -69.39 -20.61 63.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 117.958 -1.02 . . . . 10.0 112.641 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.44 133.93 52.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.29 0.95 . . . . 10.0 111.031 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -79.49 -35.61 39.9 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.509 0.671 . . . . 10.0 109.901 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -143.7 163.42 33.34 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.96 1.304 . . . . 10.0 110.109 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 94' ' ' SER . 53.2 m80 -57.54 -40.87 79.81 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.921 0.888 . . . . 10.0 111.466 175.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.74 -25.25 66.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.674 -0.679 . . . . 10.0 112.4 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -67.3 -41.49 85.28 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.148 0.975 . . . . 10.0 109.149 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.67 -55.26 23.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.13 -1.063 . . . . 10.0 108.13 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -57.6 -41.02 80.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 119.171 -0.443 . . . . 10.0 111.732 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.68 -44.8 92.64 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.724 0.409 . . . . 10.0 111.612 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.39 -51.35 69.88 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.412 HG21 ' HG3' ' A' ' 45' ' ' ARG . 93.4 t -62.44 -39.86 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 118.201 -0.904 . . . . 10.0 110.05 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.0 m -61.77 -46.34 90.01 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.275 0.943 . . . . 10.0 110.362 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.51 -44.62 94.91 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.006 -0.838 . . . . 10.0 111.006 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -58.59 -52.8 64.12 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.07 1.348 . . . . 10.0 109.481 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.6 mmt -61.39 -37.81 84.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.253 0.621 . . . . 10.0 111.485 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -64.19 -37.83 88.89 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 119.224 0.92 . . . . 10.0 110.85 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.92 -37.53 87.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 117.702 -1.142 . . . . 10.0 110.942 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -67.55 -51.14 54.22 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.714 0.688 . . . . 10.0 109.727 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.11 41.16 0.29 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.86 1.219 . . . . 10.0 110.789 -169.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.4 m -145.51 171.5 14.57 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.961 1.704 . . . . 10.0 108.742 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -140.11 164.49 29.89 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.81 1.644 . . . . 10.0 108.239 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.6 m -130.58 164.83 24.06 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.506 1.048 . . . . 10.0 113.401 -168.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.98 132.88 16.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.184 2.194 . . . . 10.0 105.203 168.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -80.61 132.05 35.57 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.785 -1.197 . . . . 10.0 108.138 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.5 mt -87.63 -21.54 25.25 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 119.263 -0.399 . . . . 10.0 110.625 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.86 -178.32 26.5 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 109.148 -1.581 . . . . 10.0 109.148 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.08 -171.83 24.49 Favored Glycine 0 C--N 1.329 0.183 0 O-C-N 121.706 -0.879 . . . . 10.0 111.866 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.18 -140.6 4.7 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 107.364 -2.295 . . . . 10.0 107.364 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -139.31 149.44 44.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.883 -1.155 . . . . 10.0 107.883 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.24 146.05 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.871 -2.27 . . . . 10.0 104.871 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -137.08 154.09 50.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.812 0.845 . . . . 10.0 111.173 -168.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -65.82 164.63 14.4 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.325 1.05 . . . . 10.0 110.703 173.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -71.61 56.26 0.26 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.434 1.894 . . . . 10.0 112.676 172.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.0 p -144.44 -37.17 0.31 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.777 2.031 . . . . 10.0 109.417 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.461 HE22 ' CD2' ' A' ' 89' ' ' HIS . 1.1 tm0? -63.78 -24.52 67.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.976 0.91 . . . . 10.0 110.621 168.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -155.58 171.73 19.46 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.468 2.307 . . . . 10.0 106.63 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -59.27 -18.08 34.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.652 1.181 . . . . 10.0 112.725 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -138.08 170.01 16.78 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.285 1.434 . . . . 10.0 108.72 -175.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.5 mt -55.91 127.88 15.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.247 -2.131 . . . . 10.0 105.247 169.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.461 ' CD2' HE22 ' A' ' 84' ' ' GLN . 12.2 t60 -132.76 164.71 26.19 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.992 0.808 . . . . 10.0 110.605 -166.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 t -133.51 130.61 56.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.136 1.374 . . . . 10.0 107.767 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.11 178.17 10.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.568 0.747 . . . . 10.0 110.894 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.42 -175.95 45.61 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.661 -0.575 . . . . 10.0 111.661 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.84 152.26 41.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.086 1.354 . . . . 10.0 107.36 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.408 ' HA ' ' CE1' ' A' ' 53' ' ' HIS . 78.7 p -67.57 142.52 56.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.715 -0.616 . . . . 10.0 109.868 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.1 mtp -70.26 -29.65 66.48 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.759 -0.459 . . . . 10.0 109.759 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.29 -33.52 63.27 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 117.883 -1.056 . . . . 10.0 113.307 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -136.32 -52.2 0.71 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.588 1.085 . . . . 10.0 112.489 -169.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.45 -174.99 23.72 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.855 1.216 . . . . 10.0 110.248 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.81 138.39 57.87 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.716 2.277 . . . . 10.0 111.249 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.2 167.6 20.0 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.996 -1.113 . . . . 10.0 107.996 165.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -80.23 79.06 6.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.368 -1.716 . . . . 10.0 106.368 168.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -56.11 -32.36 64.12 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 124.133 0.973 . . . . 10.0 111.6 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.97 -42.28 97.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.801 0.728 . . . . 10.0 112.214 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.2 mt -63.87 -46.93 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.212 -1.403 . . . . 10.0 107.212 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.5 m -57.12 -44.9 83.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.212 -0.899 . . . . 10.0 111.752 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.1 p -64.95 -38.03 89.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.463 1.483 . . . . 10.0 111.436 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.16 -40.22 95.67 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.317 0.962 . . . . 10.0 110.639 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -65.28 -47.36 76.92 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.611 -0.681 . . . . 10.0 110.451 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.6 mt -60.62 -45.34 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -53.12 -49.97 65.45 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.898 0.879 . . . . 10.0 110.092 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.87 -32.36 73.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.005 0.522 . . . . 10.0 112.399 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -62.89 -51.87 65.3 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.981 0.81 . . . . 10.0 109.981 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -158.88 -52.62 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.158 -1.401 . . . . 10.0 113.332 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.94 65.64 4.08 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.779 2.986 . . . . 10.0 112.308 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -58.72 -31.03 67.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.723 1.209 . . . . 10.0 112.32 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -58.75 -56.08 26.87 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.049 0.54 . . . . 10.0 110.573 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -169.66 156.48 6.52 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 118.635 0.652 . . . . 10.0 111.247 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 t -147.73 139.95 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 129.099 2.96 . . . . 10.0 103.145 167.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.9 p -119.06 165.41 14.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.2 0.909 . . . . 10.0 110.76 -170.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -154.48 162.5 41.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 120.901 -1.124 . . . . 10.0 108.453 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.93 -32.08 0.2 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.8 0.667 . . . . 10.0 112.8 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 51.4 t30 38.98 62.69 1.04 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.233 1.413 . . . . 10.0 112.579 -171.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -59.19 -35.79 74.21 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.749 -0.66 . . . . 10.0 111.489 172.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.77 173.17 33.99 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.515 1.531 . . . . 10.0 110.282 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 64.0 t80 . . . . . 0 C--O 1.247 0.936 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 169.246 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ttt . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 109.946 -0.39 . . . . 10.0 109.946 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.87 171.2 14.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.237 1.415 . . . . 10.0 109.078 176.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -67.28 165.79 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.647 0.737 . . . . 10.0 110.907 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -149.4 -179.24 6.92 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.451 2.3 . . . . 10.0 106.394 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -150.83 151.22 31.96 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.31 -23.81 64.49 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.566 0.746 . . . . 10.0 112.514 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.12 67.42 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.224 0.92 . . . . 10.0 112.08 173.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.51 -35.53 58.27 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 122.866 0.466 . . . . 10.0 109.837 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mt -63.64 122.59 77.38 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.43 141.94 88.77 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.349 2.032 . . . . 10.0 109.531 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -85.14 -32.18 22.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.192 0.52 . . . . 10.0 112.395 -169.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -139.61 134.06 38.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.599 -2.001 . . . . 10.0 105.599 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -149.61 98.96 2.83 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.599 -1.259 . . . . 10.0 107.599 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.8 pt -140.47 166.28 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.125 1.77 . . . . 10.0 107.959 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -136.01 34.97 2.83 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.699 1.238 . . . . 10.0 109.856 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 m -75.28 41.75 0.19 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.685 1.994 . . . . 10.0 112.979 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.08 -15.92 58.22 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.35 1.06 . . . . 10.0 111.817 169.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.07 -172.99 15.91 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.869 2.652 . . . . 10.0 107.486 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.51 126.0 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 117.854 0.827 . . . . 10.0 109.574 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -157.32 147.86 21.18 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.287 0.635 . . . . 10.0 109.72 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -67.59 164.48 18.99 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.412 0.625 . . . . 10.0 111.276 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -151.61 166.61 30.69 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.603 0.761 . . . . 10.0 109.196 173.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.88 148.54 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.509 1.124 . . . . 10.0 108.538 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.44 122.35 47.5 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.845 -1.909 . . . . 10.0 105.845 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.4 mt -129.08 136.95 58.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.472 -1.677 . . . . 10.0 106.472 -171.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -93.64 131.86 38.53 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.221 -1.77 . . . . 10.0 106.221 169.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.7 144.06 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.614 -1.254 . . . . 10.0 107.614 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -122.5 122.45 38.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.737 -1.949 . . . . 10.0 105.737 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.1 p -75.85 147.89 38.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.058 0.456 . . . . 10.0 111.475 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.57 65.46 2.29 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 127.31 2.244 . . . . 10.0 106.606 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -54.64 140.7 76.15 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.392 2.728 . . . . 10.0 111.211 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 48.88 21.9 0.5 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.654 1.182 . . . . 10.0 113.295 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.3 m 48.79 35.69 6.84 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.098 1.359 . . . . 10.0 112.923 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.41 -12.03 0.02 OUTLIER Glycine 0 CA--C 1.531 1.047 0 N-CA-C 116.618 1.407 . . . . 10.0 116.618 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.03 150.12 92.48 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 120.006 1.903 . . . . 10.0 110.776 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.41 61.33 7.84 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.325 3.35 . . . . 10.0 111.695 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.86 140.02 34.54 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.886 1.275 . . . . 10.0 108.6 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.97 27.94 0.77 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.89 1.276 . . . . 10.0 110.931 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.84 165.37 19.9 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.426 0.69 . . . . 10.0 109.361 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -139.31 159.93 41.0 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.225 1.01 . . . . 10.0 110.142 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -153.05 175.51 12.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.596 1.158 . . . . 10.0 109.584 170.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -96.43 159.62 14.84 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.06 -0.718 . . . . 10.0 109.06 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.1 pt -138.24 147.55 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.95 1.7 . . . . 10.0 108.425 169.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.27 124.95 64.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.02 -1.845 . . . . 10.0 106.02 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -131.01 136.89 48.9 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.077 0.951 . . . . 10.0 108.637 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.38 47.82 0.34 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 109.687 -1.365 . . . . 10.0 109.687 -172.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -67.77 125.84 27.5 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.063 0.545 . . . . 10.0 111.041 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -59.3 -31.44 69.15 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.626 0.973 . . . . 10.0 113.626 -171.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -69.01 -17.81 63.96 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 118.169 -0.919 . . . . 10.0 112.662 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.78 136.39 57.39 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.142 0.883 . . . . 10.0 111.538 -171.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.69 -38.54 80.39 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.388 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -154.77 169.7 23.33 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.22 1.808 . . . . 10.0 108.791 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -55.65 -32.36 63.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.098 0.959 . . . . 10.0 111.737 169.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.01 80.83 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.121 0.568 . . . . 10.0 111.751 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -69.92 -39.2 76.27 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.03 -57.28 12.88 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 108.458 -0.941 . . . . 10.0 108.458 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -58.93 -40.85 85.84 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.334 -0.365 . . . . 10.0 111.222 -172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.83 -46.72 83.81 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.54 0.336 . . . . 10.0 111.68 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -64.28 -45.22 88.98 Favored 'General case' 0 C--N 1.344 0.327 0 O-C-N 121.785 -0.572 . . . . 10.0 109.907 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.09 -44.22 98.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 123.478 0.711 . . . . 10.0 109.093 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.7 m -60.95 -38.61 86.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.346 0.975 . . . . 10.0 111.092 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.17 -52.2 43.14 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.866 -0.894 . . . . 10.0 110.866 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.27 -42.4 99.13 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 117.48 0.64 . . . . 10.0 111.366 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 25.4 mmt -62.51 -38.07 88.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.4 -0.81 . . . . 10.0 110.768 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -62.9 -36.04 82.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.581 1.082 . . . . 10.0 111.042 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -66.07 -33.43 75.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.098 -0.953 . . . . 10.0 111.685 172.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -70.76 -40.32 72.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.219 0.918 . . . . 10.0 110.679 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.51 53.07 0.73 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 108.768 -1.733 . . . . 10.0 108.768 -168.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.2 m -141.84 165.04 28.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.235 1.814 . . . . 10.0 107.855 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -128.31 161.87 28.4 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.581 1.553 . . . . 10.0 107.668 171.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 73.6 m -127.79 154.28 45.59 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.368 1.067 . . . . 10.0 112.576 -168.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -143.7 116.72 8.87 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.162 -1.792 . . . . 10.0 106.162 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.3 p -61.25 130.46 46.29 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.134 -0.979 . . . . 10.0 108.739 170.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.8 mt -90.66 -24.45 20.47 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.48 0.312 . . . . 10.0 110.21 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.98 179.07 33.55 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.907 -1.677 . . . . 10.0 108.907 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.67 -179.33 22.72 Favored Glycine 0 CA--C 1.522 0.527 0 O-C-N 121.681 -0.894 . . . . 10.0 111.485 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.56 -149.98 7.05 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 109.789 -1.324 . . . . 10.0 109.789 -170.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -147.43 165.13 31.16 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.794 1.238 . . . . 10.0 109.505 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.3 mt -133.82 149.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.484 -2.413 . . . . 10.0 104.484 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.1 m -147.0 160.77 41.97 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.516 0.726 . . . . 10.0 109.582 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -158.38 129.69 6.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.252 -2.129 . . . . 10.0 105.252 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 59.67 171.16 0.08 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.07 1.748 . . . . 10.0 111.928 -168.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.6 m 64.1 -20.72 0.07 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.874 2.07 . . . . 10.0 115.922 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -135.83 -29.91 1.01 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.59 1.956 . . . . 10.0 110.459 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -153.66 138.53 17.14 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.491 -1.3 . . . . 10.0 107.491 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -67.55 -13.38 62.0 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.103 -0.951 . . . . 10.0 113.229 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.68 170.37 15.91 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.931 1.292 . . . . 10.0 109.354 176.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.61 136.5 20.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.526 0.679 . . . . 10.0 109.187 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -134.51 148.8 50.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.007 1.323 . . . . 10.0 108.076 172.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.7 138.62 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.751 1.621 . . . . 10.0 107.286 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -169.31 -167.13 0.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.212 1.405 . . . . 10.0 107.905 -171.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.05 -172.92 38.97 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 121.361 -0.837 . . . . 10.0 112.738 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.69 174.31 11.91 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.951 0.9 . . . . 10.0 109.908 169.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.3 m -131.81 105.89 7.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.219 -2.141 . . . . 10.0 105.219 169.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.3 ttt -54.83 -28.71 51.61 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.303 1.041 . . . . 10.0 113.14 -169.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.0 -25.06 66.62 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.998 0.74 . . . . 10.0 112.998 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -128.87 -49.58 1.23 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.623 0.769 . . . . 10.0 110.407 -170.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.81 174.69 13.75 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.203 1.858 . . . . 10.0 108.917 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -53.94 136.14 65.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.574 2.183 . . . . 10.0 110.895 169.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.93 159.29 25.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.697 0.761 . . . . 10.0 109.164 168.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -78.76 72.01 5.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 169.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -49.52 -32.89 13.27 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.26 1.424 . . . . 10.0 113.551 -169.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.02 -38.03 72.55 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.069 0.85 . . . . 10.0 112.426 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.9 mt -64.8 -51.38 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 106.992 -1.484 . . . . 10.0 106.992 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -59.95 -43.64 94.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.288 -0.863 . . . . 10.0 111.804 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -63.42 -40.42 97.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 119.79 1.177 . . . . 10.0 111.002 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.97 -39.94 90.81 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.275 0.943 . . . . 10.0 110.674 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -66.32 -45.98 78.45 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.986 -0.446 . . . . 10.0 110.045 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.0 mt -59.1 -41.89 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 173.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -64.18 -36.56 84.44 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 120.877 -1.14 . . . . 10.0 111.35 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.27 -42.51 93.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.514 0.597 . . . . 10.0 111.037 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -62.09 -29.62 70.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.421 0.689 . . . . 10.0 111.011 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 t80 49.45 53.49 14.51 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 127.294 2.238 . . . . 10.0 113.489 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.22 -14.28 25.69 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.151 1.901 . . . . 10.0 112.264 174.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -149.13 164.64 34.11 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.023 1.729 . . . . 10.0 108.292 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -59.88 -31.32 69.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.564 1.546 . . . . 10.0 113.092 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -152.64 156.8 39.94 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.05 0.94 . . . . 10.0 108.553 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.0 139.15 27.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.781 -1.562 . . . . 10.0 106.781 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -147.52 165.45 30.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.388 1.075 . . . . 10.0 109.612 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 40.4 p-90 -145.75 162.09 38.42 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 118.285 0.493 . . . . 10.0 111.181 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -163.18 167.4 22.14 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.617 1.967 . . . . 10.0 107.361 169.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -78.36 48.26 0.75 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.414 0.685 . . . . 10.0 110.409 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.26 -19.25 65.48 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.565 1.146 . . . . 10.0 113.214 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.67 -173.62 41.54 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.51 -1.436 . . . . 10.0 109.51 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 . . . . . 0 C--O 1.257 1.498 0 C-N-CA 125.604 1.561 . . . . 10.0 107.474 -174.703 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 110.24 -0.282 . . . . 10.0 110.24 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.55 165.94 30.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.512 1.525 . . . . 10.0 108.467 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.88 171.22 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 126.11 1.764 . . . . 10.0 109.045 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.0 177.47 8.34 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.343 1.857 . . . . 10.0 108.543 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.95 153.66 35.65 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.651 1.18 . . . . 10.0 108.107 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.86 -20.39 56.82 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.902 0.881 . . . . 10.0 113.036 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.12 -23.59 63.98 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.605 1.093 . . . . 10.0 112.375 173.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -78.36 -7.84 57.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.557 0.743 . . . . 10.0 111.943 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -111.11 126.62 28.31 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 106.168 -1.79 . . . . 10.0 106.168 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -69.88 153.61 68.2 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.927 1.751 . . . . 10.0 109.992 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -81.51 -27.56 34.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.385 1.474 . . . . 10.0 112.642 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.8 t -134.84 133.62 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 124.995 1.318 . . . . 10.0 107.471 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -149.2 103.88 3.36 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.755 -1.572 . . . . 10.0 106.755 169.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.55 34.13 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.192 1.397 . . . . 10.0 110.108 -169.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -61.9 90.3 0.03 OUTLIER 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.441 1.496 . . . . 10.0 111.308 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.3 m -166.21 177.33 6.96 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.545 2.738 . . . . 10.0 108.301 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.19 143.35 30.26 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.87 1.268 . . . . 10.0 108.178 -173.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.57 -155.55 50.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.998 -1.241 . . . . 10.0 109.998 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.29 137.86 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 121.391 -1.064 . . . . 10.0 108.997 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -151.87 152.38 32.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.139 0.976 . . . . 10.0 109.784 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -74.36 152.3 39.58 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.711 0.805 . . . . 10.0 109.079 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.34 160.39 42.09 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.089 0.471 . . . . 10.0 110.308 173.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.22 141.67 43.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.548 -1.649 . . . . 10.0 106.548 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.7 tp -98.32 121.29 40.06 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.05 -2.204 . . . . 10.0 105.05 169.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.8 mt -129.33 135.57 61.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.582 -1.636 . . . . 10.0 106.582 -168.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -89.33 138.73 31.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.807 -1.923 . . . . 10.0 105.807 168.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 p -122.75 144.23 32.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.62 -1.622 . . . . 10.0 106.62 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -128.62 131.59 48.11 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.178 1.791 . . . . 10.0 106.713 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.5 p -78.17 140.11 38.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.824 0.284 . . . . 10.0 110.564 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.05 66.45 4.41 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.979 1.712 . . . . 10.0 107.182 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.36 -26.4 71.19 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.386 2.724 . . . . 10.0 113.131 -168.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.6 ptt85 -153.11 167.65 28.54 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.795 1.638 . . . . 10.0 107.167 168.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.2 m -58.53 137.76 57.21 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.23 27.54 60.41 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.06 0.838 . . . . 10.0 113.876 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.49 149.81 87.28 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 118.556 1.178 . . . . 10.0 110.884 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.45 35.7 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.987 3.125 . . . . 10.0 111.872 173.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.81 15.34 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.631 1.573 . . . . 10.0 108.516 -174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.32 28.39 0.57 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.642 1.577 . . . . 10.0 109.547 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -67.21 157.15 34.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.953 0.901 . . . . 10.0 109.098 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 m -141.91 159.63 41.84 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.685 1.194 . . . . 10.0 109.838 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -152.26 176.09 11.95 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.469 1.108 . . . . 10.0 109.807 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -108.24 144.93 35.05 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.512 -0.921 . . . . 10.0 108.512 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.3 pt -137.19 148.78 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.855 1.662 . . . . 10.0 109.629 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.6 t -107.94 122.58 62.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.977 -1.86 . . . . 10.0 105.977 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -127.6 137.47 52.57 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.588 -1.634 . . . . 10.0 106.588 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.51 133.67 2.98 Favored Glycine 0 C--O 1.225 -0.428 0 CA-C-N 119.822 1.192 . . . . 10.0 111.624 174.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -146.01 140.49 26.88 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.019 0.438 . . . . 10.0 110.992 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -65.04 -28.31 69.39 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.242 1.017 . . . . 10.0 113.43 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -69.4 -16.41 63.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.502 -0.761 . . . . 10.0 112.386 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.67 122.35 15.08 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 118.869 0.759 . . . . 10.0 111.244 -173.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -69.55 -32.88 71.94 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.2 0.6 . . . . 10.0 110.201 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -148.47 163.64 36.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.668 1.987 . . . . 10.0 107.617 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -58.92 -38.07 78.12 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.653 -0.655 . . . . 10.0 110.697 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.56 -21.31 66.27 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -67.31 -39.06 85.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.729 0.776 . . . . 10.0 109.477 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.42 -53.1 46.94 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 173.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -58.3 -42.07 85.85 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 119.155 -0.45 . . . . 10.0 111.353 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.72 -45.58 85.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.287 0.494 . . . . 10.0 111.597 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -58.94 -49.55 77.41 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.377 0.671 . . . . 10.0 109.438 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.19 -47.47 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.873 0.869 . . . . 10.0 109.122 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -59.83 -35.09 74.02 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.264 0.938 . . . . 10.0 111.325 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.36 -49.31 75.39 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.646 -0.982 . . . . 10.0 110.646 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.48 -45.87 92.44 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 117.873 0.836 . . . . 10.0 111.329 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -37.43 83.34 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.635 -0.697 . . . . 10.0 110.863 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -64.56 -35.9 82.48 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.049 0.84 . . . . 10.0 110.962 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.97 -32.0 72.94 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.085 -0.959 . . . . 10.0 111.721 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -68.63 -57.99 4.92 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.079 0.854 . . . . 10.0 109.172 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.12 41.8 0.17 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.43 1.49 . . . . 10.0 110.198 -169.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.7 m -142.87 171.69 13.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.679 1.592 . . . . 10.0 109.262 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -140.23 164.07 31.04 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.043 1.737 . . . . 10.0 108.176 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.7 m -130.09 163.82 25.74 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.517 1.127 . . . . 10.0 112.299 -169.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -148.19 118.41 7.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.892 -1.892 . . . . 10.0 105.892 171.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 p -66.03 129.04 38.44 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.929 -1.107 . . . . 10.0 109.119 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 mt -93.13 -23.67 18.52 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.598 0.359 . . . . 10.0 110.461 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.3 -178.22 34.64 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.388 -1.485 . . . . 10.0 109.388 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.2 -177.74 22.78 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 118.233 1.017 . . . . 10.0 112.403 176.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.67 -159.35 23.45 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.7 -1.76 . . . . 10.0 108.7 -170.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mtm105 -138.8 161.88 36.14 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.36 -1.082 . . . . 10.0 108.475 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 mt -136.22 146.42 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.66 -1.978 . . . . 10.0 105.66 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.1 t -151.64 174.16 13.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.023 0.929 . . . . 10.0 109.41 171.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -158.65 158.01 32.97 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.614 1.966 . . . . 10.0 107.462 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 47.81 45.82 18.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.01 1.324 . . . . 10.0 111.092 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.0 p -150.46 -93.63 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.923 0.889 . . . . 10.0 109.769 -169.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -67.11 -29.3 69.0 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.748 1.219 . . . . 10.0 110.208 172.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -152.44 164.35 37.71 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.679 1.991 . . . . 10.0 106.477 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -72.82 -60.79 2.06 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.05 164.71 17.24 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 123.448 0.468 . . . . 10.0 110.576 176.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.6 mt -57.92 136.94 20.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -136.91 126.91 25.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.675 -1.602 . . . . 10.0 106.675 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.35 146.33 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 105.639 -1.985 . . . . 10.0 105.639 173.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -154.99 171.53 19.58 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.763 -1.21 . . . . 10.0 111.2 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.74 -160.5 54.07 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 121.535 0.519 . . . . 10.0 112.392 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -148.71 -177.41 5.77 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.625 1.57 . . . . 10.0 108.289 173.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.7 t -109.96 131.17 55.3 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 124.899 1.28 . . . . 10.0 107.865 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.3 mtt -72.58 -18.8 61.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.999 -0.524 . . . . 10.0 111.391 171.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.91 -35.8 72.44 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.909 0.777 . . . . 10.0 110.99 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -132.97 -43.77 0.87 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.9 0.48 . . . . 10.0 112.103 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.22 -178.36 18.84 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.013 -1.635 . . . . 10.0 109.013 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.01 136.65 62.3 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.307 2.005 . . . . 10.0 110.499 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.14 162.14 20.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 166.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -79.41 69.93 5.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.167 -1.79 . . . . 10.0 106.167 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -50.94 -31.0 16.36 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.467 1.507 . . . . 10.0 113.111 -168.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.7 -37.66 73.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.276 0.944 . . . . 10.0 112.326 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.73 -50.43 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 107.293 -1.373 . . . . 10.0 107.293 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -58.56 -45.78 88.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.553 -0.737 . . . . 10.0 111.792 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -63.79 -38.12 89.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 117.754 -1.117 . . . . 10.0 110.976 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.13 -41.39 94.85 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.014 1.279 . . . . 10.0 111.227 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -65.11 -48.1 74.81 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.046 -0.409 . . . . 10.0 109.909 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.7 mt -61.38 -42.32 93.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -58.83 -37.88 77.41 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.328 1.051 . . . . 10.0 111.081 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.76 89.79 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.687 0.676 . . . . 10.0 110.969 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -71.84 -44.38 63.94 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.746 0.703 . . . . 10.0 112.049 175.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.415 ' CD1' ' HD2' ' A' ' 114' ' ' PRO . 4.7 t80 -60.91 144.31 90.49 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.428 1.091 . . . . 10.0 110.088 -170.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HD2' ' CD1' ' A' ' 113' ' ' TYR . 93.8 Cg_endo -75.0 -1.8 11.7 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.751 2.301 . . . . 10.0 113.382 -173.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -139.93 153.91 47.07 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.028 1.331 . . . . 10.0 107.669 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -81.93 46.17 0.98 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.081 1.352 . . . . 10.0 111.474 -169.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.23 91.55 2.57 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.879 0.847 . . . . 10.0 110.878 -169.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.1 t -138.24 142.44 35.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.029 -2.211 . . . . 10.0 105.029 169.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 p -138.96 167.28 22.39 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.075 0.95 . . . . 10.0 109.928 -172.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -139.06 161.22 37.92 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 123.128 0.571 . . . . 10.0 110.882 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.72 163.21 38.01 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.588 1.555 . . . . 10.0 108.587 169.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -147.76 46.25 1.1 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.854 0.861 . . . . 10.0 109.617 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.66 -27.06 68.96 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.574 0.75 . . . . 10.0 112.621 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -174.68 179.95 45.67 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.472 1.986 . . . . 10.0 108.384 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.5 t80 . . . . . 0 C--O 1.254 1.309 0 CA-C-O 116.573 -1.679 . . . . 10.0 109.36 176.418 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 118.854 -0.593 . . . . 10.0 110.302 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.27 165.33 36.06 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.495 1.518 . . . . 10.0 108.699 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.75 167.19 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.979 0.912 . . . . 10.0 110.609 172.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.87 169.39 6.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.008 0.523 . . . . 10.0 111.82 177.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -154.51 148.84 26.08 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.9 mt -58.13 -28.89 65.09 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.645 -0.659 . . . . 10.0 112.664 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.81 -26.47 68.35 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.93 0.786 . . . . 10.0 112.094 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.23 -24.71 46.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.923 0.489 . . . . 10.0 110.897 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.99 122.18 86.21 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 106.804 -1.554 . . . . 10.0 106.804 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -50.28 133.16 35.84 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.106 2.537 . . . . 10.0 110.169 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.0 -29.25 39.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.677 0.751 . . . . 10.0 111.442 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.3 t -137.74 135.9 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 127.176 2.19 . . . . 10.0 105.733 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -150.78 99.7 2.75 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.149 -1.426 . . . . 10.0 107.149 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt -131.38 36.59 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.055 1.342 . . . . 10.0 110.436 -168.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -66.56 81.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.471 1.508 . . . . 10.0 112.063 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -164.12 178.38 7.68 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.935 2.494 . . . . 10.0 108.332 174.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -147.98 158.51 44.09 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.602 1.161 . . . . 10.0 108.553 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.31 -162.64 51.32 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 109.587 -1.405 . . . . 10.0 109.587 -169.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.47 123.26 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.947 -1.871 . . . . 10.0 105.947 169.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -135.55 14.66 3.43 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.89 1.811 . . . . 10.0 115.89 -171.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mttp 56.26 159.39 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.646 1.978 . . . . 10.0 112.89 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.52 158.19 28.78 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 120.493 -1.38 . . . . 10.0 109.481 169.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.1 p -138.01 148.8 24.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.735 1.214 . . . . 10.0 107.949 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.73 118.88 37.7 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 105.574 -2.01 . . . . 10.0 105.574 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.0 mt -123.69 125.8 71.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 -169.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -76.97 131.72 38.64 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 168.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 p -119.88 135.22 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.864 -1.532 . . . . 10.0 106.864 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -114.65 150.67 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.448 1.899 . . . . 10.0 107.462 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 p -111.72 142.05 44.55 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -172.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.48 65.97 5.61 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 126.422 1.889 . . . . 10.0 106.594 168.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -41.48 133.27 3.5 Favored 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 125.467 4.111 . . . . 10.0 114.201 -168.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 50.3 23.88 1.34 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.39 1.476 . . . . 10.0 113.073 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m 51.92 32.84 10.52 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.992 1.317 . . . . 10.0 111.871 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.25 26.34 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.455 -0.636 . . . . 10.0 112.827 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.77 131.27 9.93 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 172.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -86.54 32.99 0.44 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 124.594 3.53 . . . . 10.0 112.747 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.01 83.81 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.623 0.769 . . . . 10.0 112.386 -168.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.11 28.46 2.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.543 1.937 . . . . 10.0 114.932 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -78.5 160.41 27.68 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 167.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 m -143.58 156.27 44.54 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.438 -0.789 . . . . 10.0 110.584 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -146.22 -175.47 4.78 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.989 1.316 . . . . 10.0 109.435 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -116.68 147.83 41.6 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.961 -1.126 . . . . 10.0 107.961 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.45 147.62 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.783 1.233 . . . . 10.0 110.111 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.66 125.91 64.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 106.79 -1.559 . . . . 10.0 106.79 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -133.83 141.31 47.37 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 107.125 -1.435 . . . . 10.0 107.125 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.48 124.86 1.14 Allowed Glycine 0 C--O 1.226 -0.382 0 CA-C-N 120.228 1.376 . . . . 10.0 111.52 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -144.72 135.75 24.98 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 117.262 0.531 . . . . 10.0 110.938 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -66.0 -26.24 67.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 118.292 -0.861 . . . . 10.0 113.05 -170.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -63.55 -20.37 65.58 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.111 0.869 . . . . 10.0 112.715 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.98 120.64 14.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.212 0.915 . . . . 10.0 109.691 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.89 -34.24 77.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.01 0.524 . . . . 10.0 110.139 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -147.19 158.29 43.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.724 2.01 . . . . 10.0 107.196 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -58.53 -29.05 66.03 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.918 0.71 . . . . 10.0 112.918 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.67 -28.75 64.05 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 123.203 0.601 . . . . 10.0 112.545 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -74.18 -30.68 62.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.612 0.642 . . . . 10.0 110.973 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -65.76 -52.24 52.42 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 172.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -53.82 -43.27 69.27 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 118.629 -0.7 . . . . 10.0 111.16 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.63 -44.44 93.86 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.728 0.695 . . . . 10.0 111.773 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -60.1 -51.55 69.13 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.141 -0.689 . . . . 10.0 109.141 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.4 t -68.96 -47.8 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 118.904 -0.57 . . . . 10.0 109.912 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.8 p -60.59 -31.63 70.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.472 1.033 . . . . 10.0 111.527 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.34 -50.1 71.3 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.728 -0.949 . . . . 10.0 110.728 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.7 -44.52 93.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.668 0.734 . . . . 10.0 111.5 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -40.01 83.04 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.685 0.675 . . . . 10.0 110.705 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -63.37 -35.66 81.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.16 0.891 . . . . 10.0 111.118 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -65.67 -30.84 71.58 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 117.833 -1.079 . . . . 10.0 111.682 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -74.38 -38.12 63.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.797 1.181 . . . . 10.0 111.055 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.47 57.68 0.83 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 107.202 -2.359 . . . . 10.0 107.202 -168.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.0 m -146.07 169.14 19.29 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.262 1.825 . . . . 10.0 108.102 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -139.61 160.85 38.92 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.39 1.476 . . . . 10.0 108.635 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.0 m -131.19 155.09 47.65 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.496 1.118 . . . . 10.0 112.337 -168.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -149.86 118.86 6.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.884 1.674 . . . . 10.0 106.708 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.9 m -68.03 123.95 22.04 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.005 -1.059 . . . . 10.0 109.153 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.3 mt -81.08 -23.92 38.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.875 0.47 . . . . 10.0 110.726 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.98 176.72 36.92 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.204 -1.559 . . . . 10.0 109.204 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.05 178.5 23.72 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 118.223 1.011 . . . . 10.0 112.109 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.23 -144.74 4.65 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 107.981 -2.048 . . . . 10.0 107.981 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -151.55 149.48 29.23 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 120.898 -1.354 . . . . 10.0 110.44 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.1 mt -108.56 148.04 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 105.121 -2.178 . . . . 10.0 105.121 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -151.65 -179.92 7.84 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.311 1.044 . . . . 10.0 109.121 171.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -114.17 116.56 29.27 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.408 1.483 . . . . 10.0 107.033 175.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -79.21 81.59 5.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.9 m -56.89 -28.66 62.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.465 0.706 . . . . 10.0 112.65 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -58.66 -19.96 43.91 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.585 0.957 . . . . 10.0 113.585 172.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -132.3 11.67 4.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.782 1.633 . . . . 10.0 110.912 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt 39.68 46.73 1.61 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.993 2.517 . . . . 10.0 113.709 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -147.64 159.11 44.14 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 118.688 0.676 . . . . 10.0 111.619 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.5 pt -85.1 148.48 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.643 0.735 . . . . 10.0 110.735 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -149.13 163.36 37.81 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.105 0.962 . . . . 10.0 109.017 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -136.5 140.55 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.912 0.885 . . . . 10.0 108.66 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -157.5 -175.34 5.34 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.962 0.905 . . . . 10.0 109.98 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.63 -177.64 53.42 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 123.401 0.524 . . . . 10.0 113.012 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.31 -178.98 5.53 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.093 0.957 . . . . 10.0 110.184 169.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.8 m -133.52 107.43 8.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.212 -1.773 . . . . 10.0 106.212 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 77.2 mtm -59.74 -21.42 60.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.795 0.665 . . . . 10.0 112.795 -172.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.68 -26.36 67.05 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.802 0.841 . . . . 10.0 112.841 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -134.9 -50.68 0.77 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.489 0.716 . . . . 10.0 111.231 -169.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.08 175.32 13.79 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.198 1.856 . . . . 10.0 108.981 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -54.81 133.8 59.49 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.467 2.111 . . . . 10.0 110.271 169.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.08 156.07 29.41 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.526 1.155 . . . . 10.0 109.413 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -82.42 65.33 7.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.283 -1.747 . . . . 10.0 106.283 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -51.81 -24.66 6.36 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.374 1.87 . . . . 10.0 114.012 -168.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.93 91.08 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.028 1.285 . . . . 10.0 111.392 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.3 mt -63.54 -50.91 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -61.51 -46.5 89.73 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.185 0.594 . . . . 10.0 111.874 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 p -65.37 -38.18 89.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.741 0.701 . . . . 10.0 110.966 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.02 -42.11 76.82 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.149 0.886 . . . . 10.0 110.985 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -59.96 -47.96 83.68 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.671 -0.681 . . . . 10.0 110.143 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.3 mt -56.93 -52.34 56.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 108.112 -1.07 . . . . 10.0 108.112 175.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -56.2 -40.52 74.13 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.324 0.966 . . . . 10.0 111.25 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.43 -50.88 49.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.037 0.535 . . . . 10.0 111.82 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -86.94 -26.52 23.83 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.93 0.786 . . . . 10.0 112.749 -169.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -141.1 71.81 27.8 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.666 1.987 . . . . 10.0 107.165 -172.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.4 153.56 65.07 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.218 1.945 . . . . 10.0 111.142 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -149.97 179.89 7.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.878 1.671 . . . . 10.0 107.123 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -59.62 -39.4 84.15 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.192 0.905 . . . . 10.0 110.594 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -159.33 157.44 30.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.189 -1.412 . . . . 10.0 107.189 173.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.86 113.7 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 106.197 -1.779 . . . . 10.0 106.197 172.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.2 p -138.43 174.52 10.45 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.211 1.004 . . . . 10.0 109.421 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -142.76 159.7 41.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.251 0.62 . . . . 10.0 109.726 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.21 162.67 36.28 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.433 1.493 . . . . 10.0 107.979 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.15 52.58 1.83 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.975 -0.75 . . . . 10.0 108.975 169.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.85 -25.7 63.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.36 1.064 . . . . 10.0 111.86 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.36 172.28 38.43 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 127.15 2.31 . . . . 10.0 107.388 169.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 117.862 -1.066 . . . . 10.0 108.865 172.083 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 118.371 -0.824 . . . . 10.0 109.955 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.08 168.86 26.21 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.369 1.868 . . . . 10.0 107.729 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -64.25 160.86 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.032 0.444 . . . . 10.0 110.487 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.34 177.64 10.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.347 1.859 . . . . 10.0 108.787 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -149.21 149.81 31.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.155 1.382 . . . . 10.0 107.872 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.5 mt -58.68 -25.51 62.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.364 1.066 . . . . 10.0 113.024 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.89 -24.23 65.81 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.64 0.655 . . . . 10.0 112.34 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -75.47 -16.67 60.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.271 0.628 . . . . 10.0 111.494 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.5 mt -93.62 120.23 66.43 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.0 -1.482 . . . . 10.0 107.0 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.35 136.24 39.46 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.497 2.798 . . . . 10.0 110.551 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -78.08 -28.16 48.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.392 0.615 . . . . 10.0 111.832 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.2 t -139.22 135.11 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 104.262 -2.496 . . . . 10.0 104.262 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -153.39 119.93 5.58 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.608 -1.627 . . . . 10.0 106.608 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.9 pt -143.72 161.41 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.764 1.226 . . . . 10.0 109.171 -170.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -150.73 107.72 3.57 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.791 -1.559 . . . . 10.0 106.791 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 m -159.06 163.23 36.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.981 1.313 . . . . 10.0 109.536 -173.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -149.68 18.13 0.91 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 123.082 1.42 . . . . 10.0 110.708 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.42 -164.24 35.89 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.168 -1.973 . . . . 10.0 108.168 -171.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.45 120.47 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 117.922 0.861 . . . . 10.0 109.756 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -145.35 148.62 33.59 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.488 1.115 . . . . 10.0 109.265 169.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -63.65 150.9 43.18 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.017 0.927 . . . . 10.0 110.319 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.78 168.26 21.83 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.703 1.201 . . . . 10.0 109.037 178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.74 150.07 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.355 1.062 . . . . 10.0 108.661 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -114.16 121.92 45.25 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.375 -2.084 . . . . 10.0 105.375 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.5 mt -130.32 136.42 58.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.202 -1.406 . . . . 10.0 107.202 -169.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -91.65 139.2 30.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.74 -1.578 . . . . 10.0 106.74 166.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.53 141.33 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.123 -1.806 . . . . 10.0 106.123 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -122.37 135.84 54.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.98 1.712 . . . . 10.0 107.217 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.2 m -63.12 135.17 57.03 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.008 -0.367 . . . . 10.0 110.008 174.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.41 52.7 1.0 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.348 1.459 . . . . 10.0 110.077 168.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.66 -13.07 36.87 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.188 3.258 . . . . 10.0 115.123 -167.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -139.52 13.72 2.55 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.719 -1.238 . . . . 10.0 110.755 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m 48.33 33.98 4.26 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.344 1.058 . . . . 10.0 112.018 -168.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.32 64.82 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 N-CA-C 108.132 -1.987 . . . . 10.0 108.132 -168.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.97 157.12 77.72 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 125.231 1.412 . . . . 10.0 108.964 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.92 39.53 0.66 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 124.309 3.339 . . . . 10.0 112.121 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.93 104.92 3.74 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.978 1.711 . . . . 10.0 107.014 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.81 28.92 1.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.488 1.515 . . . . 10.0 110.28 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.73 174.57 2.82 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.2 1.0 . . . . 10.0 109.911 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -152.39 159.71 43.38 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 120.193 -1.567 . . . . 10.0 110.423 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -149.63 168.52 23.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.647 1.179 . . . . 10.0 109.565 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -99.9 150.67 22.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.9 pt -138.9 156.04 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 125.795 1.638 . . . . 10.0 109.889 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.39 130.35 62.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -133.35 141.16 47.79 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.02 1.328 . . . . 10.0 107.952 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.72 100.85 0.15 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 110.029 -1.229 . . . . 10.0 110.029 -171.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -130.4 131.87 45.48 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 118.236 1.018 . . . . 10.0 110.371 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -59.56 -25.51 64.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.198 1.184 . . . . 10.0 114.198 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -68.32 -20.62 64.75 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.494 1.043 . . . . 10.0 112.279 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.42 137.68 58.01 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.221 0.919 . . . . 10.0 111.428 -171.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.08 -40.95 87.11 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.679 -0.691 . . . . 10.0 109.231 170.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -155.92 170.67 21.57 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 126.125 1.77 . . . . 10.0 108.922 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -48.66 -36.31 15.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.977 1.311 . . . . 10.0 112.002 167.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.49 -28.02 66.66 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.948 0.721 . . . . 10.0 112.948 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -67.32 -41.94 84.45 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.18 0.991 . . . . 10.0 108.671 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.6 mt -62.0 -51.36 73.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 108.541 -0.911 . . . . 10.0 108.541 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -55.64 -43.49 76.25 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.679 -0.677 . . . . 10.0 111.598 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -62.58 -48.18 80.57 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.369 0.531 . . . . 10.0 111.726 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.54 -49.5 77.29 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.668 -0.645 . . . . 10.0 109.826 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.4 -42.65 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.609 -0.885 . . . . 10.0 108.609 -172.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.7 m -58.58 -36.38 73.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.558 1.072 . . . . 10.0 111.447 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.11 -47.09 91.33 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.803 -0.919 . . . . 10.0 110.803 172.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.09 -47.29 86.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.838 0.819 . . . . 10.0 111.459 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -36.72 82.01 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.338 -0.839 . . . . 10.0 110.74 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -64.35 -36.61 84.68 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.998 0.817 . . . . 10.0 111.004 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -67.96 -31.74 71.68 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.867 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -67.6 -56.79 8.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 119.294 0.952 . . . . 10.0 108.807 175.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.73 41.39 0.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.047 1.308 . . . . 10.0 110.528 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.3 m -144.0 173.63 11.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.837 1.655 . . . . 10.0 109.325 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -139.27 164.24 30.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.421 1.488 . . . . 10.0 108.205 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.2 m -125.22 161.55 26.66 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.567 1.147 . . . . 10.0 112.382 -168.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -149.11 109.8 4.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.817 2.047 . . . . 10.0 105.755 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 p -61.45 136.85 58.18 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.031 -1.043 . . . . 10.0 109.627 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.9 mt -110.19 -12.2 14.5 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.425 0.69 . . . . 10.0 111.235 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.86 -178.51 29.94 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.2 -1.16 . . . . 10.0 110.2 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.05 -179.24 22.97 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.841 -0.904 . . . . 10.0 110.841 168.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.1 -153.48 9.89 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.492 -1.843 . . . . 10.0 108.492 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -134.69 132.74 39.24 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 123.995 0.918 . . . . 10.0 108.61 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.17 119.56 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 104.567 -2.382 . . . . 10.0 104.567 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 m -84.23 83.95 7.79 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.266 -2.124 . . . . 10.0 105.266 167.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -64.61 163.75 13.14 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 122.085 -0.384 . . . . 10.0 110.786 -174.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -53.51 145.8 14.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.716 0.806 . . . . 10.0 109.354 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.4 p -149.61 -58.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.408 0.623 . . . . 10.0 110.911 -169.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -151.68 58.5 0.87 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.644 -1.243 . . . . 10.0 107.644 -173.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t0 53.54 61.3 3.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.38 1.472 . . . . 10.0 111.652 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -125.58 -5.76 7.0 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.101 1.36 . . . . 10.0 112.47 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.332 0.0 OUTLIER 62.76 162.37 0.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.826 2.45 . . . . 10.0 112.934 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.8 mt -74.58 134.78 28.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.919 -1.141 . . . . 10.0 107.919 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -133.51 159.59 39.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.163 -1.421 . . . . 10.0 107.163 169.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 t -140.38 140.69 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 O-C-N 120.749 -1.219 . . . . 10.0 107.939 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -156.32 -177.89 6.92 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.877 0.871 . . . . 10.0 110.908 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.61 -166.4 50.77 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.922 -0.471 . . . . 10.0 111.922 169.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -157.18 173.43 16.99 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.785 1.234 . . . . 10.0 108.972 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.6 m -128.39 104.06 7.5 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.592 -1.262 . . . . 10.0 107.592 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 66.8 mtt -57.24 -24.27 53.59 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.36 1.064 . . . . 10.0 113.565 -170.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.24 -29.94 70.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.6 -0.714 . . . . 10.0 112.427 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -129.17 -45.82 1.24 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.663 0.785 . . . . 10.0 110.716 -171.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.97 174.33 13.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.768 1.651 . . . . 10.0 109.595 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -56.36 124.36 16.06 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.337 2.024 . . . . 10.0 109.631 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.69 159.49 13.34 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.778 0.799 . . . . 10.0 109.178 168.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -84.83 72.04 10.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.953 -1.499 . . . . 10.0 106.953 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -52.37 -25.14 8.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.132 1.373 . . . . 10.0 114.133 -169.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.76 99.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.96 1.255 . . . . 10.0 111.617 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.75 -50.95 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 107.528 -1.286 . . . . 10.0 107.528 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -56.79 -48.47 77.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.29 0.636 . . . . 10.0 111.588 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 p -68.89 -37.25 78.88 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.01 -0.995 . . . . 10.0 111.688 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -65.65 -39.79 91.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.499 1.045 . . . . 10.0 110.404 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -62.65 -48.7 78.17 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 119.16 -0.448 . . . . 10.0 110.103 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.0 mt -57.79 -42.39 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.219 0.918 . . . . 10.0 108.584 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -64.03 -37.63 88.12 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.535 1.062 . . . . 10.0 111.22 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.03 92.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.689 0.677 . . . . 10.0 111.067 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.16 -30.39 71.02 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.467 0.707 . . . . 10.0 111.073 173.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 t80 49.63 53.23 14.04 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 127.483 2.313 . . . . 10.0 113.426 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.24 -14.42 28.49 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.021 1.814 . . . . 10.0 112.295 174.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -149.62 164.92 33.82 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.198 1.799 . . . . 10.0 108.514 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -58.21 -34.82 70.81 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.433 1.493 . . . . 10.0 113.457 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -151.94 155.72 38.63 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.892 0.769 . . . . 10.0 109.96 -172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 t -141.8 137.07 31.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.111 -1.441 . . . . 10.0 107.111 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.2 p -142.55 170.48 15.63 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.514 1.126 . . . . 10.0 109.832 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -147.84 166.67 26.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.236 0.471 . . . . 10.0 111.106 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.09 176.88 10.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.026 2.13 . . . . 10.0 107.563 169.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.26 37.68 0.7 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.862 -1.149 . . . . 10.0 111.919 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.23 -26.57 64.98 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.392 1.077 . . . . 10.0 113.167 -176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -174.01 177.97 46.06 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.751 -0.939 . . . . 10.0 110.751 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 60.7 t80 . . . . . 0 C--O 1.246 0.909 0 C-N-CA 124.01 0.924 . . . . 10.0 109.896 173.409 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 118.743 -0.646 . . . . 10.0 109.839 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.28 26.05 2.41 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.282 1.033 . . . . 10.0 112.269 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.9 m -69.94 173.99 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 125.12 1.368 . . . . 10.0 110.632 169.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.62 -178.05 6.04 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.934 1.694 . . . . 10.0 107.73 171.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -148.11 151.9 36.41 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.721 -1.214 . . . . 10.0 107.721 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.13 -30.16 61.73 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.618 0.767 . . . . 10.0 112.837 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.46 -28.45 69.67 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.704 0.683 . . . . 10.0 112.149 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -77.41 -28.82 52.77 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.844 0.458 . . . . 10.0 110.621 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.3 mt -69.91 122.06 84.79 Favored Pre-proline 0 C--O 1.24 0.557 0 N-CA-C 107.519 -1.289 . . . . 10.0 107.519 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.2 135.79 38.22 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.315 2.677 . . . . 10.0 110.341 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.23 -29.54 38.46 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.529 0.681 . . . . 10.0 111.35 -173.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -137.8 136.77 45.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 104.707 -2.331 . . . . 10.0 104.707 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -152.03 122.68 7.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.247 -1.76 . . . . 10.0 106.247 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.5 pt -143.61 160.8 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.65 1.18 . . . . 10.0 109.393 -169.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -141.94 126.3 17.65 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.2 1.0 . . . . 10.0 108.372 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -124.05 176.12 6.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.185 1.394 . . . . 10.0 111.381 -166.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -157.69 -36.71 0.07 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.479 1.512 . . . . 10.0 109.821 168.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.47 -48.18 0.03 OUTLIER Glycine 0 C--N 1.339 0.724 0 N-CA-C 109.896 -1.282 . . . . 10.0 109.896 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -128.37 142.68 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.047 2.139 . . . . 10.0 106.251 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -154.07 154.27 33.37 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.852 0.751 . . . . 10.0 110.66 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -86.96 151.22 23.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.508 1.123 . . . . 10.0 108.32 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.28 159.92 42.29 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.99 0.516 . . . . 10.0 110.479 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.94 140.53 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 125.694 1.598 . . . . 10.0 107.746 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -98.24 119.98 37.85 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 105.513 -2.032 . . . . 10.0 105.513 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.7 mt -124.08 132.99 70.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.52 -1.659 . . . . 10.0 106.52 -171.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -86.78 132.5 33.83 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.16 -1.793 . . . . 10.0 106.16 168.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.67 139.87 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.604 -1.258 . . . . 10.0 107.604 171.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -114.31 123.75 50.28 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.222 -2.14 . . . . 10.0 105.222 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.7 p -68.89 145.24 53.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.794 0.27 . . . . 10.0 110.49 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.35 67.81 3.09 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.206 1.802 . . . . 10.0 106.354 168.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -54.71 127.47 26.29 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.064 2.509 . . . . 10.0 110.872 -170.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 37.03 39.06 0.11 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.582 1.953 . . . . 10.0 113.407 -169.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 m 51.6 30.98 7.12 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.796 1.639 . . . . 10.0 113.696 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.2 -19.54 0.02 OUTLIER Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.242 -1.31 . . . . 10.0 116.26 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.94 149.83 95.99 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 120.277 2.039 . . . . 10.0 110.764 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.63 61.59 8.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.418 3.412 . . . . 10.0 111.657 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.49 139.11 35.06 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.854 1.262 . . . . 10.0 108.536 175.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.06 28.05 0.68 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.752 1.221 . . . . 10.0 110.98 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -67.98 164.51 19.83 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.421 -0.799 . . . . 10.0 109.232 171.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -139.61 159.22 42.67 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.899 0.88 . . . . 10.0 110.802 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -150.19 171.48 16.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.216 1.007 . . . . 10.0 109.907 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.29 150.23 21.77 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.345 -0.983 . . . . 10.0 108.345 172.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.3 pt -137.14 150.76 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 125.461 1.504 . . . . 10.0 109.559 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.09 126.15 63.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -132.92 134.97 45.26 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.29 117.45 0.65 Allowed Glycine 0 C--O 1.225 -0.462 0 CA-C-N 119.46 1.027 . . . . 10.0 110.866 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -138.38 132.03 30.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 -172.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -60.14 -18.16 45.57 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 114.67 1.359 . . . . 10.0 114.67 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -67.1 -28.01 67.81 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.27 1.395 . . . . 10.0 112.139 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.71 153.93 30.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.712 1.142 . . . . 10.0 109.419 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.31 -6.91 2.61 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.553 0.741 . . . . 10.0 111.821 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.92 12.63 3.64 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 118.885 0.766 . . . . 10.0 112.767 -168.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 63.38 -46.57 0.23 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.285 2.634 . . . . 10.0 114.792 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.07 -30.17 67.86 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.024 0.929 . . . . 10.0 111.363 -178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.12 -32.74 74.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 117.938 0.335 . . . . 10.0 111.533 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -67.91 -55.41 16.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 107.326 -1.361 . . . . 10.0 107.326 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.58 -39.42 67.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.256 0.622 . . . . 10.0 111.603 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -61.54 -50.75 71.41 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.304 1.041 . . . . 10.0 111.712 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -45.52 93.12 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.713 -0.617 . . . . 10.0 110.218 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.86 -46.04 93.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -59.1 -36.15 74.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.746 1.157 . . . . 10.0 111.377 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.62 -51.33 54.97 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 174.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.24 -45.21 94.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.525 0.662 . . . . 10.0 111.349 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -34.67 78.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.136 -0.935 . . . . 10.0 110.719 -175.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -65.78 -37.38 86.17 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.613 1.097 . . . . 10.0 110.648 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -62.65 -37.17 85.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 117.681 -1.152 . . . . 10.0 110.919 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -66.78 -52.64 41.7 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.409 1.004 . . . . 10.0 109.646 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.04 51.12 0.25 Allowed Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.475 1.512 . . . . 10.0 109.403 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.3 m -143.68 167.71 21.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.814 1.646 . . . . 10.0 108.486 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -129.62 161.97 29.35 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.03 1.732 . . . . 10.0 107.141 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.2 m -125.34 160.04 30.31 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.669 1.187 . . . . 10.0 112.017 -168.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -148.83 115.38 5.92 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.866 -1.901 . . . . 10.0 105.866 170.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.83 115.11 6.24 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.904 -1.123 . . . . 10.0 108.466 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.7 mt -77.54 -29.26 52.23 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.821 -0.549 . . . . 10.0 110.355 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.76 -177.53 38.82 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.071 -1.611 . . . . 10.0 109.071 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.68 -178.18 29.63 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 118.259 1.029 . . . . 10.0 111.178 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.5 -158.37 17.59 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.531 -1.428 . . . . 10.0 109.531 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 mtm180 -131.8 154.52 49.03 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.54 -0.976 . . . . 10.0 108.476 -177.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.9 mt -134.29 140.55 45.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 104.302 -2.481 . . . . 10.0 104.302 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 m -151.88 151.73 31.66 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.908 -1.12 . . . . 10.0 110.273 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -77.92 123.28 26.58 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.057 -1.831 . . . . 10.0 106.057 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 50.73 54.13 11.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.188 0.995 . . . . 10.0 113.583 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.1 p -56.49 -54.44 45.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.496 0.665 . . . . 10.0 109.905 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -157.68 51.88 0.45 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.403 2.281 . . . . 10.0 105.291 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -150.4 166.45 30.05 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.88 1.272 . . . . 10.0 108.526 -167.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -80.35 -21.59 42.29 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.059 1.344 . . . . 10.0 111.51 171.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.92 -175.27 4.34 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.653 1.581 . . . . 10.0 109.775 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.2 pt -62.28 145.63 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 119.875 1.216 . . . . 10.0 110.848 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -140.2 147.87 40.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.368 -1.345 . . . . 10.0 107.368 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.84 134.77 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.415 -1.328 . . . . 10.0 107.415 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -159.27 -179.69 8.2 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.175 -0.953 . . . . 10.0 111.046 -168.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.8 -158.39 53.08 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.053 0.835 . . . . 10.0 112.981 170.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -150.72 167.82 26.23 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.594 1.158 . . . . 10.0 108.558 172.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.7 p -68.53 -28.67 67.19 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.6 ttm 53.93 29.53 10.13 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.206 0.603 . . . . 10.0 110.159 -167.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.29 -32.42 0.6 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.738 1.215 . . . . 10.0 111.876 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.38 -46.13 0.56 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.215 0.606 . . . . 10.0 110.205 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.41 177.16 31.24 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.111 1.815 . . . . 10.0 109.598 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.99 138.36 56.79 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.511 2.14 . . . . 10.0 110.458 172.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.71 160.97 24.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 166.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -81.31 75.54 8.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.682 -1.599 . . . . 10.0 106.682 169.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -54.48 -24.31 19.89 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.901 1.28 . . . . 10.0 113.528 -169.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.5 99.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.651 1.114 . . . . 10.0 111.705 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.1 mt -64.51 -52.07 59.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 106.988 -1.486 . . . . 10.0 106.988 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 m -57.46 -45.79 84.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.511 -0.757 . . . . 10.0 112.092 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 p -66.24 -37.82 86.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 117.722 -1.132 . . . . 10.0 111.721 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -64.45 -41.21 96.67 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.965 1.257 . . . . 10.0 110.6 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -63.89 -47.55 80.17 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.103 -0.373 . . . . 10.0 110.265 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.31 -38.9 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.415 -0.957 . . . . 10.0 108.415 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -62.32 -38.11 88.17 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 120.556 -1.34 . . . . 10.0 111.239 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.39 -31.02 71.91 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.713 0.688 . . . . 10.0 112.228 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -74.38 -21.93 59.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.327 1.051 . . . . 10.0 111.649 172.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.278 45.0 p90 43.76 48.09 3.85 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 128.318 2.647 . . . . 10.0 116.425 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.28 174.97 9.98 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.485 1.456 . . . . 10.0 109.724 167.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 t70 49.1 -120.91 1.46 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 117.501 -1.238 . . . . 10.0 110.331 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -133.48 -35.48 1.01 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.346 1.43 . . . . 10.0 112.812 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -163.87 164.68 23.35 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 105.78 -1.933 . . . . 10.0 105.78 -173.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.61 135.05 39.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 119.343 0.974 . . . . 10.0 108.984 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.5 p -144.7 170.07 16.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.428 1.491 . . . . 10.0 109.041 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -143.98 168.89 18.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.175 0.59 . . . . 10.0 110.754 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.23 148.89 31.0 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.756 1.223 . . . . 10.0 108.998 173.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -84.17 57.63 4.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.635 1.174 . . . . 10.0 109.676 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -149.49 168.27 23.94 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.131 1.372 . . . . 10.0 109.275 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.35 25.53 63.34 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.147 0.88 . . . . 10.0 113.279 174.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 124.495 1.118 . . . . 10.0 109.459 178.226 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 119.381 -0.343 . . . . 10.0 110.236 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.36 172.31 12.86 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.754 1.222 . . . . 10.0 109.879 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.62 153.54 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.227 0.537 . . . . 10.0 109.966 169.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.45 179.36 9.2 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.906 2.082 . . . . 10.0 106.832 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -149.35 150.54 32.64 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.968 -1.123 . . . . 10.0 107.968 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.35 -26.42 60.95 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.372 1.069 . . . . 10.0 112.753 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.91 -25.51 67.62 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.876 0.762 . . . . 10.0 112.792 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -74.2 -25.8 59.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.205 0.457 . . . . 10.0 111.042 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.96 130.68 69.23 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 106.467 -1.679 . . . . 10.0 106.467 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.19 146.14 68.94 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.989 1.792 . . . . 10.0 109.625 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.72 -30.06 59.12 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.605 0.762 . . . . 10.0 112.593 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.4 t -138.28 132.31 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.696 -1.964 . . . . 10.0 105.696 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -149.93 102.72 3.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.47 -2.048 . . . . 10.0 105.47 171.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.2 pt -136.62 158.83 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.672 1.189 . . . . 10.0 110.516 -168.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.46 173.97 6.31 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.18 0.992 . . . . 10.0 112.391 -176.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -142.65 27.04 1.71 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.556 1.542 . . . . 10.0 111.369 -169.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -131.81 45.65 2.75 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 122.394 1.092 . . . . 10.0 111.078 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.01 -132.85 11.49 Favored Glycine 0 C--N 1.342 0.903 0 O-C-N 120.081 -1.637 . . . . 10.0 110.595 173.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.25 140.12 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.924 -0.75 . . . . 10.0 109.202 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -154.4 148.69 26.02 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.437 1.095 . . . . 10.0 109.592 170.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -72.73 150.71 42.63 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.696 -0.854 . . . . 10.0 108.696 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.33 165.51 29.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.683 0.793 . . . . 10.0 109.561 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.7 143.37 24.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.506 -1.294 . . . . 10.0 107.506 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp -99.8 126.43 45.89 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 105.49 -2.041 . . . . 10.0 105.49 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 98.2 mt -130.34 136.66 58.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -91.56 145.71 24.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.987 -1.486 . . . . 10.0 106.987 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.53 146.0 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.082 -1.821 . . . . 10.0 106.082 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -127.25 132.27 50.41 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.295 -1.742 . . . . 10.0 106.295 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.1 p -71.59 147.43 47.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.827 0.74 . . . . 10.0 110.777 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.93 62.31 3.42 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.621 1.568 . . . . 10.0 107.797 168.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -58.86 145.33 97.14 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.215 2.61 . . . . 10.0 109.664 -172.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 51.66 19.34 0.87 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.291 1.036 . . . . 10.0 112.517 -176.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m 50.44 28.5 3.37 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.865 1.266 . . . . 10.0 113.332 -171.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.62 -0.69 0.02 OUTLIER Glycine 0 CA--C 1.532 1.1 0 N-CA-C 116.497 1.359 . . . . 10.0 116.497 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.72 152.28 75.99 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.879 1.839 . . . . 10.0 110.244 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.46 61.45 7.4 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 124.229 3.286 . . . . 10.0 111.751 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.24 141.74 33.98 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.105 1.362 . . . . 10.0 108.602 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.67 39.5 0.49 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.465 1.506 . . . . 10.0 109.168 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.76 175.14 5.21 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.713 0.805 . . . . 10.0 108.896 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.1 m -151.99 163.2 39.79 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.171 -1.58 . . . . 10.0 111.369 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -154.82 163.53 40.14 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.529 2.332 . . . . 10.0 107.416 -169.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -129.24 141.86 51.01 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.351 -1.351 . . . . 10.0 107.351 174.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.3 pt -138.19 154.9 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.599 1.16 . . . . 10.0 110.822 -169.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.97 125.45 64.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.657 -1.609 . . . . 10.0 106.657 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -132.22 142.99 49.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.27 131.59 1.91 Allowed Glycine 0 C--O 1.22 -0.761 0 CA-C-N 119.878 1.217 . . . . 10.0 111.349 171.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -142.35 138.56 31.31 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 124.174 0.573 . . . . 10.0 109.644 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -68.59 -23.58 64.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.672 0.789 . . . . 10.0 112.362 -171.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -66.18 -20.53 66.16 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 118.444 -0.789 . . . . 10.0 112.422 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 127.67 32.6 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 118.995 0.816 . . . . 10.0 110.75 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -72.31 -35.73 68.72 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.489 0.661 . . . . 10.0 109.648 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -149.01 165.7 30.88 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 126.174 1.79 . . . . 10.0 108.55 -175.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -57.03 -38.75 73.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.988 0.423 . . . . 10.0 110.763 175.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.63 67.47 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 123.925 0.89 . . . . 10.0 113.16 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -66.96 -46.53 74.42 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.3 mt -62.46 -51.43 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -55.36 -41.32 72.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.615 -0.707 . . . . 10.0 111.628 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.7 -47.14 79.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.267 0.485 . . . . 10.0 111.86 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -58.59 -49.85 75.96 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 109.797 -0.446 . . . . 10.0 109.797 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.46 -45.29 93.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.459 -0.781 . . . . 10.0 109.181 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 m -57.58 -43.02 84.27 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.051 0.841 . . . . 10.0 110.821 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.79 -46.59 94.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.969 -0.853 . . . . 10.0 110.969 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.35 -48.55 77.51 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 118.226 1.013 . . . . 10.0 110.951 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -39.09 84.44 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.553 0.615 . . . . 10.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -63.11 -35.88 81.73 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.472 0.578 . . . . 10.0 110.833 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.22 -32.6 72.92 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.513 -1.232 . . . . 10.0 112.188 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 mm-40 -67.26 -53.08 33.19 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.295 0.952 . . . . 10.0 109.327 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.1 44.26 0.22 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.274 1.416 . . . . 10.0 109.607 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.3 m -145.95 175.89 10.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.185 2.194 . . . . 10.0 107.755 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -144.81 164.6 30.55 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.528 0.731 . . . . 10.0 109.04 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.8 m -120.9 162.29 20.11 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.599 1.16 . . . . 10.0 113.313 -168.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -147.57 112.49 5.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.32 2.248 . . . . 10.0 105.741 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 t -64.2 140.47 58.87 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.029 -1.045 . . . . 10.0 109.67 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.9 mt -110.26 -9.67 14.65 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.17 0.988 . . . . 10.0 111.636 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.88 171.75 18.63 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.434 1.016 . . . . 10.0 112.073 169.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.28 161.2 18.78 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.465 1.031 . . . . 10.0 110.828 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.85 -160.89 23.64 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.027 -1.629 . . . . 10.0 109.027 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -146.07 162.84 37.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.34 -1.682 . . . . 10.0 110.337 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -129.12 151.75 36.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 105.64 -1.985 . . . . 10.0 105.64 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 60.1 p -140.69 152.61 45.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.459 1.104 . . . . 10.0 109.292 175.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -160.8 162.76 32.42 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.262 1.825 . . . . 10.0 107.698 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -149.35 162.26 40.42 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.707 2.003 . . . . 10.0 106.576 171.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.5 m -64.21 -28.37 69.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.397 0.888 . . . . 10.0 113.397 -174.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -145.98 163.1 36.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.197 1.399 . . . . 10.0 109.35 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 t70 49.91 34.65 8.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.908 1.683 . . . . 10.0 113.716 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -158.98 163.12 36.75 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.96 1.704 . . . . 10.0 107.184 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 167.39 21.22 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 126.277 1.831 . . . . 10.0 107.197 170.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.1 mt -61.49 128.36 22.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.003 -1.48 . . . . 10.0 107.003 171.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -135.77 148.97 48.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.598 -0.89 . . . . 10.0 108.598 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.05 128.56 62.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.769 1.228 . . . . 10.0 107.916 -169.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -157.13 -164.97 1.71 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.564 0.746 . . . . 10.0 109.699 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.39 -169.85 54.6 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 111.081 -0.807 . . . . 10.0 111.081 -173.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -161.29 -170.89 2.8 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.4 1.48 . . . . 10.0 107.572 169.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.3 t -135.04 135.54 41.38 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.719 -1.215 . . . . 10.0 107.719 172.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 79.2 mtm -77.26 -16.81 58.84 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.877 -0.583 . . . . 10.0 111.134 169.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.89 -26.07 63.07 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.717 0.69 . . . . 10.0 112.333 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.43 -48.91 0.2 Allowed 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 123.177 0.591 . . . . 10.0 110.53 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.27 179.57 29.67 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.197 -1.561 . . . . 10.0 109.197 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -61.66 150.11 87.0 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.395 2.063 . . . . 10.0 109.902 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.33 27.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.232 1.413 . . . . 10.0 113.924 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 40.21 55.8 2.67 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.425 2.29 . . . . 10.0 109.57 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -43.99 -35.42 2.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.485 2.314 . . . . 10.0 114.603 -166.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.15 -37.12 66.57 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.368 0.986 . . . . 10.0 113.128 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.3 mt -63.66 -53.2 47.88 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 107.247 -1.39 . . . . 10.0 107.247 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.6 m -61.71 -41.73 98.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.178 -0.915 . . . . 10.0 112.267 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 p -65.01 -39.61 93.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.725 1.148 . . . . 10.0 110.602 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -63.77 -40.56 96.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.501 1.046 . . . . 10.0 110.937 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -62.98 -48.92 76.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.674 0.39 . . . . 10.0 110.59 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.8 mt -58.4 -45.75 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -62.41 -38.02 88.06 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 121.225 -0.922 . . . . 10.0 111.547 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.29 75.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.202 0.601 . . . . 10.0 111.763 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -80.03 -20.02 46.31 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 117.718 -1.134 . . . . 10.0 112.433 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.4 p90 38.09 58.19 4.9 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.302 2.241 . . . . 10.0 114.597 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.26 -13.78 36.52 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 121.951 1.767 . . . . 10.0 111.969 170.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -144.83 162.77 35.97 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.292 1.837 . . . . 10.0 107.555 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -69.62 -18.24 63.58 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.544 1.138 . . . . 10.0 113.324 -172.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -150.63 153.98 36.65 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.94 0.896 . . . . 10.0 108.911 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t -143.71 135.15 22.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 106.205 -1.776 . . . . 10.0 106.205 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -142.18 170.17 16.22 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.257 1.023 . . . . 10.0 109.996 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -143.7 166.19 25.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.279 0.562 . . . . 10.0 112.474 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.52 -178.46 6.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.787 2.835 . . . . 10.0 107.504 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -144.19 52.98 1.27 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.378 -0.826 . . . . 10.0 109.799 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -149.92 159.49 44.34 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.867 1.267 . . . . 10.0 108.942 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.33 162.21 26.34 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.975 1.75 . . . . 10.0 110.975 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.314 1.446 . . . . 10.0 107.875 170.402 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.68 169.14 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.933 1.293 . . . . 10.0 109.506 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.5 m -71.22 165.52 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 123.636 0.775 . . . . 10.0 111.159 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.54 179.53 8.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.809 2.444 . . . . 10.0 106.5 169.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -152.41 151.53 30.92 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.85 -25.32 64.93 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.645 0.778 . . . . 10.0 112.859 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.87 72.83 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.162 0.892 . . . . 10.0 111.63 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.59 -34.89 58.41 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.963 0.505 . . . . 10.0 110.032 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mt -64.62 118.81 51.65 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.15 139.51 52.72 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.484 2.789 . . . . 10.0 111.36 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.72 -31.98 25.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.303 0.573 . . . . 10.0 111.915 -173.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.57 139.04 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 105.759 -1.941 . . . . 10.0 105.759 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -146.89 113.26 5.92 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 105.451 -2.055 . . . . 10.0 105.451 171.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.6 pt -135.85 174.24 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.513 1.125 . . . . 10.0 111.877 -168.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -137.56 49.96 1.97 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.751 1.22 . . . . 10.0 110.897 -167.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 m -61.76 16.58 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 127.784 2.434 . . . . 10.0 115.751 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.7 -24.85 62.17 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.618 1.567 . . . . 10.0 111.992 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.17 -157.4 14.8 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.76 -2.136 . . . . 10.0 107.76 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t -59.24 141.83 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 169.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -145.27 151.34 38.21 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.208 0.603 . . . . 10.0 109.978 171.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -79.98 146.28 32.12 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.335 -1.357 . . . . 10.0 107.335 174.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.86 161.54 38.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.629 0.649 . . . . 10.0 110.962 -177.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.39 145.2 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.571 1.548 . . . . 10.0 107.574 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.3 tp -104.97 123.68 48.21 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.197 -2.149 . . . . 10.0 105.197 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.13 129.47 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 -172.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -83.65 140.09 32.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.525 -1.657 . . . . 10.0 106.525 167.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.69 139.74 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 106.16 -1.793 . . . . 10.0 106.16 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -121.02 138.1 54.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.337 1.855 . . . . 10.0 106.623 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.3 p -97.03 138.42 34.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.247 0.546 . . . . 10.0 112.323 -170.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.37 68.11 7.72 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 125.155 1.382 . . . . 10.0 107.393 168.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.48 149.62 9.5 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.957 3.105 . . . . 10.0 111.917 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 45.86 20.99 0.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.573 1.549 . . . . 10.0 114.632 -171.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.6 m 50.94 39.05 21.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.758 1.223 . . . . 10.0 111.878 -171.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.23 -28.87 0.02 OUTLIER Glycine 0 C--N 1.342 0.871 0 CA-C-O 118.977 -0.902 . . . . 10.0 114.72 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.24 131.2 93.48 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 119.572 1.686 . . . . 10.0 109.231 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -85.55 32.83 0.47 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.353 3.369 . . . . 10.0 112.88 -170.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.25 78.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.637 0.775 . . . . 10.0 111.95 -169.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 48.82 26.74 1.37 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.82 2.048 . . . . 10.0 115.32 174.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.87 159.5 28.89 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 168.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -142.91 158.74 43.33 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.535 -0.728 . . . . 10.0 110.624 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -151.76 176.04 11.8 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.97 1.308 . . . . 10.0 109.356 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.6 mp0 -106.68 153.63 22.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.963 -0.755 . . . . 10.0 108.963 170.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.7 pt -137.75 151.81 26.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 125.338 1.455 . . . . 10.0 110.081 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.45 130.12 58.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 106.233 -1.765 . . . . 10.0 106.233 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -133.83 140.35 46.83 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.082 -1.821 . . . . 10.0 106.082 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.74 139.31 4.98 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 120.455 1.48 . . . . 10.0 113.019 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -149.25 144.85 26.77 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.809 0.843 . . . . 10.0 109.652 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.58 -23.96 61.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 117.956 -1.021 . . . . 10.0 112.936 -172.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -68.03 -17.27 64.36 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.668 0.988 . . . . 10.0 113.668 -174.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.24 130.79 46.98 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 119.389 0.995 . . . . 10.0 110.103 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.47 -37.5 77.32 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.925 -0.398 . . . . 10.0 109.925 176.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -149.53 160.38 43.53 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.098 2.159 . . . . 10.0 106.709 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -57.32 -33.13 67.39 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.902 0.881 . . . . 10.0 112.701 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.0 -25.54 65.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.384 0.674 . . . . 10.0 112.586 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.08 -37.92 84.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.579 0.627 . . . . 10.0 110.36 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.7 mt -64.27 -50.85 74.72 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 107.748 -1.204 . . . . 10.0 107.748 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -55.73 -42.6 75.6 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.851 -0.595 . . . . 10.0 111.326 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.09 -43.9 97.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.601 0.637 . . . . 10.0 111.989 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -61.3 -51.34 69.28 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 121.63 -0.669 . . . . 10.0 109.434 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.17 -42.71 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.584 -0.525 . . . . 10.0 109.584 -170.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.4 p -66.45 -33.75 76.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.182 0.901 . . . . 10.0 111.472 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.3 -39.54 96.02 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.364 0.983 . . . . 10.0 111.034 173.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -69.11 -45.38 70.36 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.724 -0.868 . . . . 10.0 111.109 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 27.2 mmt -61.13 -39.5 90.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.186 0.903 . . . . 10.0 110.597 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.55 -39.75 89.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.78 0.718 . . . . 10.0 110.903 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -20.48 59.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 117.874 -1.06 . . . . 10.0 112.887 175.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -72.95 -43.29 62.48 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.714 1.143 . . . . 10.0 110.423 169.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.71 49.71 0.58 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.217 -1.553 . . . . 10.0 109.217 -169.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.7 m -145.74 169.83 17.71 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.046 1.738 . . . . 10.0 108.206 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -136.24 161.51 35.54 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.637 1.575 . . . . 10.0 108.216 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.6 m -125.13 158.05 34.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.542 1.137 . . . . 10.0 112.693 -168.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -146.0 106.41 4.06 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.994 2.118 . . . . 10.0 105.597 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.8 p -61.46 131.51 50.41 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.281 -0.887 . . . . 10.0 109.192 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -102.4 -21.77 14.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.008 0.523 . . . . 10.0 110.909 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.01 -178.48 32.52 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.937 -1.265 . . . . 10.0 109.937 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.94 -173.29 23.56 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 117.944 0.872 . . . . 10.0 111.215 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.23 -148.98 9.87 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.157 -1.577 . . . . 10.0 109.157 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -139.46 160.44 39.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.765 1.226 . . . . 10.0 108.671 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.8 mt -136.58 149.17 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 106.333 -1.728 . . . . 10.0 106.333 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.3 p -135.41 164.72 27.13 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.333 1.453 . . . . 10.0 108.435 170.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -142.06 143.51 33.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.752 1.221 . . . . 10.0 107.943 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 52.01 35.9 17.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.504 1.522 . . . . 10.0 111.628 -172.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 m -68.75 -25.69 64.86 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.441 1.896 . . . . 10.0 113.119 -169.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -158.33 -33.76 0.07 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.175 1.39 . . . . 10.0 109.819 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -143.56 171.6 13.95 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.706 2.002 . . . . 10.0 106.315 174.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -66.38 73.03 0.08 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.011 1.724 . . . . 10.0 110.789 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -145.08 -172.74 3.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.725 1.61 . . . . 10.0 110.269 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 98.0 mt -127.35 148.17 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.546 -2.02 . . . . 10.0 105.546 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -135.76 145.2 46.33 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.847 0.859 . . . . 10.0 108.912 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.81 130.49 55.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 107.326 -1.361 . . . . 10.0 107.326 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -158.66 179.49 9.06 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.346 -0.846 . . . . 10.0 111.714 -168.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.72 -159.01 34.22 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 123.762 0.696 . . . . 10.0 112.359 170.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -155.92 152.38 28.18 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.596 1.959 . . . . 10.0 106.494 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 p -69.82 152.15 44.9 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.017 0.826 . . . . 10.0 111.131 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.5 mtp -77.81 28.73 0.17 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.588 1.155 . . . . 10.0 110.161 169.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.36 -41.5 0.18 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.087 0.955 . . . . 10.0 112.585 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -133.42 -51.28 0.87 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.314 0.961 . . . . 10.0 112.565 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.19 -177.67 23.47 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.806 -0.918 . . . . 10.0 110.806 -171.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.2 144.76 82.34 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.004 2.47 . . . . 10.0 110.725 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.86 21.83 1.5 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -170.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 40.94 53.2 3.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.237 1.415 . . . . 10.0 110.065 -169.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -39.09 -30.91 0.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.95 2.9 . . . . 10.0 116.759 -166.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.65 60.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.814 1.188 . . . . 10.0 112.643 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.0 mt -60.77 -54.22 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -61.59 -41.29 97.22 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 117.915 -1.04 . . . . 10.0 111.867 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.7 p -64.69 -37.31 87.14 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 120.092 1.314 . . . . 10.0 111.431 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.2 -39.98 86.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.906 0.775 . . . . 10.0 110.729 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -64.8 -46.26 82.77 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.834 -0.541 . . . . 10.0 110.527 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.0 mt -57.64 -47.16 86.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -58.42 -42.31 86.96 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.134 0.879 . . . . 10.0 111.239 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.67 89.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.593 0.633 . . . . 10.0 111.559 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -89.66 -20.21 23.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.085 -0.96 . . . . 10.0 112.99 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -137.05 59.36 22.02 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.384 1.473 . . . . 10.0 109.933 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.83 -11.25 31.39 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.739 2.293 . . . . 10.0 113.29 -175.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -66.29 -12.04 54.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.334 1.053 . . . . 10.0 112.961 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -130.88 150.58 51.97 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 124.526 1.13 . . . . 10.0 109.515 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.38 157.93 36.89 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 t -136.35 139.35 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.6 p -138.0 167.31 22.04 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.456 1.102 . . . . 10.0 109.429 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -145.01 165.3 28.57 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.06 171.37 14.58 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.27 2.228 . . . . 10.0 108.286 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -144.21 37.94 1.27 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.183 0.993 . . . . 10.0 109.681 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -149.38 155.52 40.6 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.369 1.467 . . . . 10.0 108.768 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.97 171.84 38.28 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.443 1.02 . . . . 10.0 111.505 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.244 0.815 0 C-N-CA 124.841 1.256 . . . . 10.0 108.542 176.235 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 tpt . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 119.021 -0.514 . . . . 10.0 109.84 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.85 157.69 43.23 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.899 1.28 . . . . 10.0 108.657 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.83 150.47 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 126.081 1.752 . . . . 10.0 108.149 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.03 170.87 15.14 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.671 -0.492 . . . . 10.0 109.671 169.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.79 149.64 29.25 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 172.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.01 -23.5 63.71 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.36 -29.29 69.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.139 0.882 . . . . 10.0 111.987 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.9 mt -75.37 -31.88 60.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.159 0.436 . . . . 10.0 110.408 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.0 mt -69.79 123.74 89.21 Favored Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 107.629 -1.248 . . . . 10.0 107.629 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.13 135.05 30.51 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.639 2.893 . . . . 10.0 111.159 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.18 -28.47 27.33 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.299 0.571 . . . . 10.0 112.237 -171.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.19 134.69 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 127.41 2.284 . . . . 10.0 104.895 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -156.2 98.77 1.89 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.208 -1.775 . . . . 10.0 106.208 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.5 pt -129.71 87.77 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.487 1.115 . . . . 10.0 109.633 -169.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.2 -26.11 68.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.311 -0.859 . . . . 10.0 110.236 166.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -68.05 60.95 0.08 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.659 1.584 . . . . 10.0 111.359 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -77.04 39.58 0.24 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.32 1.848 . . . . 10.0 110.751 175.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.36 -170.76 42.31 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.034 1.778 . . . . 10.0 109.129 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.4 t -73.41 78.63 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.883 0.873 . . . . 10.0 110.036 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -139.32 19.57 2.58 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.505 1.122 . . . . 10.0 111.696 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 64.17 146.3 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.594 2.758 . . . . 10.0 113.093 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.47 157.05 43.7 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.749 1.22 . . . . 10.0 108.344 175.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.34 147.96 32.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 125.624 1.569 . . . . 10.0 108.161 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.2 tp -109.46 120.2 41.77 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.666 -1.975 . . . . 10.0 105.666 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.8 mt -131.28 136.36 57.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 -168.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -88.45 143.8 26.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.799 -1.556 . . . . 10.0 106.799 168.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -126.78 141.64 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.565 -1.643 . . . . 10.0 106.565 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -124.83 129.53 50.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.352 1.861 . . . . 10.0 106.048 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.1 p -80.06 146.22 32.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.775 0.322 . . . . 10.0 111.201 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -155.72 62.15 3.08 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.38 1.872 . . . . 10.0 106.702 167.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -55.61 143.63 78.27 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.532 2.821 . . . . 10.0 111.078 -168.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.4 ttt85 47.69 25.38 0.68 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.947 1.299 . . . . 10.0 113.09 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.0 m 53.01 28.82 7.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.523 1.529 . . . . 10.0 113.632 -175.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.84 -1.8 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 N-CA-C 116.723 1.449 . . . . 10.0 116.723 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 152.13 82.44 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 120.168 1.984 . . . . 10.0 110.675 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.85 59.14 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.291 3.327 . . . . 10.0 111.917 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.6 140.98 33.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.024 1.33 . . . . 10.0 108.516 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.06 29.77 0.72 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.176 1.391 . . . . 10.0 110.254 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -67.57 162.24 23.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.643 0.777 . . . . 10.0 108.918 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -140.2 160.29 40.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.026 0.93 . . . . 10.0 110.01 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -150.78 176.28 11.19 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.58 1.152 . . . . 10.0 109.627 170.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -99.31 157.09 16.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.347 -0.982 . . . . 10.0 108.347 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.8 pt -141.72 149.35 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 126.387 1.875 . . . . 10.0 108.346 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.76 124.27 66.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.883 -1.895 . . . . 10.0 105.883 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -129.38 148.53 51.31 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.596 -1.261 . . . . 10.0 107.596 -175.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.32 124.08 0.97 Allowed Glycine 0 C--O 1.228 -0.255 0 N-CA-C 109.035 -1.626 . . . . 10.0 109.035 173.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -140.63 134.97 31.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.4 0.6 . . . . 10.0 110.501 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -74.69 -11.95 60.3 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 114.277 1.214 . . . . 10.0 114.277 -169.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -66.11 -24.3 66.66 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.461 1.028 . . . . 10.0 111.575 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.33 163.19 28.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.85 0.75 . . . . 10.0 110.809 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -119.18 -17.65 8.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.449 1.1 . . . . 10.0 110.367 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -146.95 152.49 38.74 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.421 1.488 . . . . 10.0 108.105 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 94' ' ' SER . 55.7 m80 -57.68 -31.85 66.76 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.399 1.079 . . . . 10.0 112.21 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.32 -33.2 72.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.187 -0.911 . . . . 10.0 112.607 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -72.0 -37.08 69.88 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.959 0.799 . . . . 10.0 110.437 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.9 -52.23 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.934 -1.135 . . . . 10.0 107.934 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -56.87 -43.19 80.96 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 119.09 -0.481 . . . . 10.0 111.494 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.32 -45.5 91.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.906 0.482 . . . . 10.0 111.181 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -60.92 -48.25 82.67 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.608 -0.682 . . . . 10.0 109.976 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.97 -43.89 98.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.659 0.783 . . . . 10.0 109.622 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.8 m -61.29 -43.88 98.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.046 0.839 . . . . 10.0 110.406 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.78 -46.92 93.55 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.787 -0.925 . . . . 10.0 110.787 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.05 -44.8 95.92 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.741 0.77 . . . . 10.0 110.668 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.3 mmt -62.01 -37.18 83.91 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.923 -0.56 . . . . 10.0 111.101 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -63.65 -35.64 81.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.274 0.943 . . . . 10.0 110.816 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.55 -31.97 72.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 117.924 -1.036 . . . . 10.0 111.597 171.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.63 -44.43 70.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.527 1.058 . . . . 10.0 110.039 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.86 47.55 0.61 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 108.852 -1.699 . . . . 10.0 108.852 -169.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.5 m -146.66 169.64 18.59 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.321 1.848 . . . . 10.0 108.655 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.57 164.93 28.83 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.064 1.746 . . . . 10.0 108.138 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 78.5 m -126.17 164.89 19.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.199 1.0 . . . . 10.0 112.811 -168.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -149.3 113.08 5.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.317 2.247 . . . . 10.0 105.346 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.8 t -66.47 140.23 58.01 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.637 -1.29 . . . . 10.0 109.479 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.8 mt -108.22 -13.46 14.9 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.614 0.765 . . . . 10.0 111.228 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.06 -174.25 24.48 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.209 1.385 . . . . 10.0 110.573 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.06 -176.23 27.03 Favored Glycine 0 CA--C 1.524 0.647 0 O-C-N 121.44 -1.036 . . . . 10.0 111.495 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.29 -154.5 10.2 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.131 -1.588 . . . . 10.0 109.131 -174.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -139.52 163.65 31.98 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.441 1.896 . . . . 10.0 107.905 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mt -129.23 150.78 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.495 -1.669 . . . . 10.0 106.495 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 p -159.08 -169.66 2.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.257 1.423 . . . . 10.0 108.832 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -132.66 151.93 51.82 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -144.32 164.17 31.56 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.166 0.986 . . . . 10.0 110.286 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.0 m 64.94 166.53 0.17 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.855 2.062 . . . . 10.0 112.656 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -62.14 -28.11 69.42 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.986 -0.446 . . . . 10.0 111.453 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -71.69 -6.25 39.76 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.41 1.084 . . . . 10.0 112.278 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.253 63.5 pttt 42.25 46.23 3.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.428 1.891 . . . . 10.0 112.294 -173.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 155.27 23.08 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 172.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.8 mt -69.47 144.76 13.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.582 -1.636 . . . . 10.0 106.582 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -137.44 157.01 47.49 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.526 0.731 . . . . 10.0 109.366 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.53 140.32 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -159.36 -174.95 4.94 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.761 -1.212 . . . . 10.0 110.06 -171.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.13 -166.07 52.49 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 121.835 0.686 . . . . 10.0 111.641 169.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -148.47 161.8 40.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.512 1.125 . . . . 10.0 108.403 175.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.408 ' HA ' ' CE1' ' A' ' 53' ' ' HIS . 30.1 t -83.17 126.33 32.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -64.63 -26.97 68.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.119 0.568 . . . . 10.0 110.702 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.53 -30.17 46.89 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.529 -0.748 . . . . 10.0 112.487 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -130.15 -58.91 1.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.802 0.728 . . . . 10.0 112.396 -169.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 149.14 176.28 22.28 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 108.902 -1.679 . . . . 10.0 108.902 -170.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -57.13 134.53 64.84 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.572 2.182 . . . . 10.0 110.566 171.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.65 163.44 18.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 166.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -79.79 69.29 6.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.08 -1.822 . . . . 10.0 106.08 167.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -50.78 -30.09 13.25 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.211 1.404 . . . . 10.0 113.518 -168.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.69 70.89 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.289 0.95 . . . . 10.0 112.349 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.9 mt -64.32 -50.28 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.2 m -59.26 -46.5 88.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.61 -0.681 . . . . 10.0 111.96 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.9 p -63.94 -39.98 95.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.356 -0.83 . . . . 10.0 110.876 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.44 -40.17 92.94 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.307 0.958 . . . . 10.0 110.97 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -66.68 -44.23 82.36 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.755 -0.64 . . . . 10.0 110.436 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.7 mt -56.15 -52.44 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.003 -1.11 . . . . 10.0 108.003 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -59.55 -40.59 87.73 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.741 0.816 . . . . 10.0 111.54 -174.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.6 -41.08 98.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.704 0.802 . . . . 10.0 111.288 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -89.93 -19.05 24.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.233 -0.889 . . . . 10.0 112.923 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -130.96 57.75 34.05 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.797 1.239 . . . . 10.0 110.042 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.53 -11.07 30.9 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.108 2.539 . . . . 10.0 113.368 -173.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.18 -12.59 29.22 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.124 0.97 . . . . 10.0 112.33 172.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -126.46 144.18 50.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.594 1.158 . . . . 10.0 109.199 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -78.03 153.33 32.42 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.276 -1.379 . . . . 10.0 107.276 168.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.47 135.54 35.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.551 -1.277 . . . . 10.0 107.551 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.17 172.0 13.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.694 1.197 . . . . 10.0 109.163 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 44.0 p-90 -147.04 169.09 19.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.29 0.496 . . . . 10.0 111.179 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.92 148.93 34.42 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.266 1.026 . . . . 10.0 109.997 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -80.74 48.27 1.05 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.286 1.834 . . . . 10.0 110.406 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -139.99 166.39 24.77 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.741 1.216 . . . . 10.0 110.089 -169.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.42 28.85 73.98 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.959 1.266 . . . . 10.0 112.675 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 . . . . . 0 C--O 1.253 1.285 0 CA-C-O 115.641 -2.123 . . . . 10.0 109.028 178.315 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 118.294 -0.86 . . . . 10.0 109.28 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.91 158.18 33.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.513 0.725 . . . . 10.0 112.227 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.31 161.79 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.692 0.797 . . . . 10.0 110.262 167.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.77 176.65 11.88 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.407 1.883 . . . . 10.0 106.549 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -150.21 152.93 35.38 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 172.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.65 -21.8 61.01 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 118.381 -0.818 . . . . 10.0 113.161 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.7 -23.29 64.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.413 1.006 . . . . 10.0 112.688 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.9 mt -77.54 -8.65 58.13 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.661 0.784 . . . . 10.0 111.995 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.9 mt -112.76 128.45 25.56 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 106.479 -1.674 . . . . 10.0 106.479 -172.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.72 151.43 74.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.382 2.055 . . . . 10.0 110.755 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -67.63 -38.16 83.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.05 1.34 . . . . 10.0 112.817 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.55 138.66 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.145 -1.428 . . . . 10.0 107.145 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -155.04 97.7 1.95 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.438 -1.319 . . . . 10.0 107.438 -176.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.1 pt -131.44 158.4 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.895 1.278 . . . . 10.0 108.211 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -140.25 24.01 2.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 123.339 1.542 . . . . 10.0 110.001 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 m -75.46 70.89 2.37 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.888 2.075 . . . . 10.0 112.528 -170.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.2 -12.73 30.44 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.704 1.201 . . . . 10.0 113.021 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.23 -162.89 11.32 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.328 -1.909 . . . . 10.0 108.328 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.2 t -60.46 113.72 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.183 0.992 . . . . 10.0 108.748 174.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -145.42 146.16 31.42 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.711 -0.848 . . . . 10.0 108.711 172.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -61.84 157.65 17.72 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.367 0.667 . . . . 10.0 110.567 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -151.08 171.9 16.6 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.228 1.411 . . . . 10.0 108.242 169.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.4 152.61 29.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.707 1.203 . . . . 10.0 110.48 174.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.0 tp -102.95 117.68 35.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.086 -2.191 . . . . 10.0 105.086 167.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.78 134.69 62.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 105.731 -1.952 . . . . 10.0 105.731 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -85.79 135.14 33.85 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.381 -1.711 . . . . 10.0 106.381 167.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -120.88 142.3 37.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -122.66 133.21 54.52 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.368 1.867 . . . . 10.0 106.083 -174.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.6 p -66.83 143.55 56.81 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.649 -0.5 . . . . 10.0 109.649 172.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.12 59.35 3.64 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.214 1.006 . . . . 10.0 108.781 168.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -59.18 138.52 85.5 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.871 2.381 . . . . 10.0 109.522 -173.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 45.26 21.19 0.06 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.958 1.703 . . . . 10.0 114.482 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m 47.88 32.14 2.63 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.342 1.457 . . . . 10.0 113.125 -170.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.92 0.11 0.03 OUTLIER Glycine 0 CA--C 1.531 1.059 0 N-CA-C 115.929 1.131 . . . . 10.0 115.929 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.45 152.68 84.85 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 120.529 2.164 . . . . 10.0 110.509 171.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.69 52.63 3.75 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 124.123 3.215 . . . . 10.0 111.651 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.14 136.56 31.98 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.921 1.288 . . . . 10.0 108.333 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.15 30.56 0.7 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.244 1.418 . . . . 10.0 109.595 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -64.34 155.44 32.26 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -140.77 160.45 40.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.981 0.912 . . . . 10.0 110.702 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -149.78 172.64 14.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.177 0.991 . . . . 10.0 109.809 172.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.39 145.8 26.99 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 174.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.5 pt -135.74 148.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.585 1.554 . . . . 10.0 109.02 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.15 126.05 67.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.964 -1.495 . . . . 10.0 106.964 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -131.39 131.11 43.41 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 -174.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.04 55.01 0.36 Allowed Glycine 0 N--CA 1.464 0.527 0 CA-C-N 119.328 0.967 . . . . 10.0 111.398 -168.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -74.05 142.71 45.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.884 0.473 . . . . 10.0 111.15 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -63.53 -37.95 89.29 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 124.037 0.935 . . . . 10.0 112.551 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -66.33 -20.56 66.12 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 118.124 -0.941 . . . . 10.0 113.228 -172.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.37 134.38 51.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.768 0.713 . . . . 10.0 111.439 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -72.78 -34.42 66.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.552 0.691 . . . . 10.0 110.11 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -151.27 165.47 33.9 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 125.173 1.389 . . . . 10.0 109.238 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -48.88 -40.31 29.23 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.635 1.174 . . . . 10.0 112.516 169.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.24 73.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.52 -0.753 . . . . 10.0 112.184 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -70.19 -38.03 75.27 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.099 0.952 . . . . 10.0 109.793 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.22 -53.72 42.3 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 107.994 -1.113 . . . . 10.0 107.994 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -57.74 -45.24 86.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.323 -0.846 . . . . 10.0 111.504 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.04 -46.94 86.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.433 0.561 . . . . 10.0 111.538 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -63.22 -48.03 79.98 Favored 'General case' 0 C--N 1.342 0.274 0 O-C-N 121.604 -0.685 . . . . 10.0 109.756 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.08 -44.97 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 118.437 -0.792 . . . . 10.0 109.227 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.4 m -57.64 -42.26 83.07 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.497 1.044 . . . . 10.0 110.928 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.21 -45.49 95.9 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.577 -0.609 . . . . 10.0 111.577 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.33 -50.57 73.11 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.399 -1.06 . . . . 10.0 110.81 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -38.87 84.18 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 118.894 -0.574 . . . . 10.0 111.056 -178.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -63.94 -34.14 77.29 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.108 0.413 . . . . 10.0 110.837 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -71.57 -28.45 63.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 117.453 -1.26 . . . . 10.0 112.527 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -69.34 -59.86 2.72 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.727 1.149 . . . . 10.0 108.523 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.06 44.01 0.11 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.979 1.752 . . . . 10.0 109.169 -168.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.0 m -147.09 176.35 10.01 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.441 2.296 . . . . 10.0 107.346 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -148.46 165.9 29.76 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.02 -1.05 . . . . 10.0 108.923 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.8 m -131.04 159.8 36.47 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.602 1.092 . . . . 10.0 112.763 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -145.54 120.18 9.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.007 -1.849 . . . . 10.0 106.007 170.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.9 t -67.33 134.44 51.54 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.643 -1.285 . . . . 10.0 109.056 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 56.0 mt -91.64 -24.2 19.6 Favored 'General case' 0 C--O 1.226 -0.18 0 O-C-N 123.953 0.783 . . . . 10.0 110.646 171.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.92 164.78 21.01 Favored Glycine 0 C--N 1.337 0.587 0 O-C-N 121.216 -0.927 . . . . 10.0 111.233 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -125.61 163.15 19.69 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.263 -1.135 . . . . 10.0 110.263 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.29 -156.11 10.45 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.512 -1.835 . . . . 10.0 108.512 -171.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -139.35 153.59 47.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.059 1.744 . . . . 10.0 109.161 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.0 mm -119.98 145.89 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.327 -2.471 . . . . 10.0 104.327 168.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.4 m -153.51 149.95 28.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 168.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -79.7 -8.35 59.17 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.648 0.981 . . . . 10.0 113.648 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -157.64 154.92 29.18 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 128.678 2.791 . . . . 10.0 105.669 170.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.7 m -162.26 -94.84 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.989 1.316 . . . . 10.0 107.791 169.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.92 -13.07 60.01 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.403 0.681 . . . . 10.0 111.347 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -142.32 160.69 39.75 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 126.453 1.901 . . . . 10.0 106.066 169.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -79.6 46.73 0.78 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.27 1.028 . . . . 10.0 110.57 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -148.35 167.02 26.33 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 124.12 0.968 . . . . 10.0 110.708 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 mm -53.56 127.88 12.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.343 -1.355 . . . . 10.0 107.343 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -140.37 141.81 35.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.911 -1.144 . . . . 10.0 107.911 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.0 t -131.72 122.77 50.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.832 -1.544 . . . . 10.0 106.832 -169.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -158.28 -164.25 1.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.163 -0.961 . . . . 10.0 108.638 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.51 -173.27 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 118.65 0.659 . . . . 10.0 112.658 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -159.09 167.35 29.45 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.818 -1.178 . . . . 10.0 107.818 167.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.2 m -133.09 112.62 11.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 172.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -24.56 6.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.68 1.992 . . . . 10.0 114.101 -176.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.35 -25.31 65.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.745 0.818 . . . . 10.0 112.868 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.35 -41.68 0.14 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.0 0.818 . . . . 10.0 112.882 -174.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.29 -175.77 23.89 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.459 1.028 . . . . 10.0 110.765 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.19 148.16 68.12 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.264 2.643 . . . . 10.0 110.397 170.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.87 34.5 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.077 1.351 . . . . 10.0 113.176 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 35.28 59.31 0.77 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.277 2.231 . . . . 10.0 112.156 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -51.4 -25.14 5.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.327 2.251 . . . . 10.0 115.561 -164.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.77 92.47 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.764 1.165 . . . . 10.0 111.663 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.87 -54.01 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.027 -1.471 . . . . 10.0 107.027 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 m -63.34 -41.21 98.85 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.156 0.582 . . . . 10.0 112.516 -173.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.7 p -61.53 -47.14 86.93 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 118.628 0.649 . . . . 10.0 110.419 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -66.68 -36.74 83.25 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.22 0.464 . . . . 10.0 110.271 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -59.68 -50.79 72.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 118.847 -0.597 . . . . 10.0 110.794 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.54 -53.57 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.096 -1.076 . . . . 10.0 108.096 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -60.86 -37.97 83.96 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.039 1.335 . . . . 10.0 112.234 -173.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.48 -50.38 26.43 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.15 0.58 . . . . 10.0 110.389 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -69.94 -34.22 73.16 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 118.625 -0.702 . . . . 10.0 111.444 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -128.05 101.3 22.82 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 106.867 -1.531 . . . . 10.0 106.867 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.17 128.4 22.69 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.615 1.543 . . . . 10.0 109.344 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -153.47 155.95 37.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.023 -1.473 . . . . 10.0 107.023 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -60.97 -39.71 90.63 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.405 1.082 . . . . 10.0 111.869 -170.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -160.8 155.59 23.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.923 0.783 . . . . 10.0 109.985 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.39 122.79 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.032 -2.581 . . . . 10.0 104.032 168.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.1 p -111.94 167.15 10.61 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.832 0.853 . . . . 10.0 110.458 -170.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -145.43 166.75 24.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.487 0.921 . . . . 10.0 113.487 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.84 -175.42 4.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.979 2.512 . . . . 10.0 107.93 170.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -140.52 51.42 1.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.174 -0.953 . . . . 10.0 110.105 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -146.89 155.22 42.14 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.52 1.528 . . . . 10.0 107.92 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.65 -150.22 19.23 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.056 -1.618 . . . . 10.0 109.056 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 C--O 1.249 1.058 0 N-CA-C 107.14 -1.43 . . . . 10.0 107.14 169.379 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 118.879 -0.581 . . . . 10.0 110.901 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.31 -176.41 5.29 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.933 1.693 . . . . 10.0 107.278 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.9 m -67.98 143.94 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.25 -1.018 . . . . 10.0 108.25 166.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.78 174.28 15.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.899 1.279 . . . . 10.0 107.857 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -151.72 149.54 29.18 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.938 -1.504 . . . . 10.0 106.938 171.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.75 -27.91 63.45 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.778 0.831 . . . . 10.0 112.933 -176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -25.96 68.01 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.773 0.715 . . . . 10.0 112.193 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.3 mt -76.34 -23.23 54.22 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.221 0.608 . . . . 10.0 111.191 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.9 mt -83.94 122.08 76.01 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 107.688 -1.227 . . . . 10.0 107.688 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.31 138.55 37.69 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.692 2.928 . . . . 10.0 110.909 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -85.25 -28.42 25.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.438 0.637 . . . . 10.0 112.104 -169.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.8 t -139.16 136.04 41.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 126.185 1.794 . . . . 10.0 106.193 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -149.5 98.79 2.82 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.8 pt -143.49 178.96 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.665 1.586 . . . . 10.0 109.996 -169.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -140.58 152.73 45.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 106.175 -1.787 . . . . 10.0 106.175 164.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.3 m -137.05 2.4 2.56 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.841 1.656 . . . . 10.0 111.608 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.47 -19.06 33.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.15 0.976 . . . . 10.0 113.255 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.3 -174.36 22.08 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 107.242 -2.343 . . . . 10.0 107.242 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.2 t -63.72 125.51 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -139.68 139.99 36.76 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.901 -1.148 . . . . 10.0 107.901 175.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -67.23 155.82 37.86 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.02 165.41 29.11 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.697 0.761 . . . . 10.0 109.108 172.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.5 140.09 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.318 1.447 . . . . 10.0 107.436 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -100.17 118.93 37.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.695 -2.335 . . . . 10.0 104.695 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.7 mt -123.29 135.97 61.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 -171.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -88.83 133.28 34.32 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.175 -1.787 . . . . 10.0 106.175 168.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -116.25 140.25 39.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.2 -1.778 . . . . 10.0 106.2 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -122.04 136.4 54.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.196 1.798 . . . . 10.0 106.997 -172.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 m -64.12 137.05 57.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.306 -0.628 . . . . 10.0 109.306 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.9 54.95 2.02 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.246 1.018 . . . . 10.0 108.957 166.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.85 131.49 33.25 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.895 2.397 . . . . 10.0 108.523 -169.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.304 4.6 ppt_? 41.12 29.25 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.386 1.874 . . . . 10.0 114.251 -169.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m 46.09 37.87 4.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.758 1.623 . . . . 10.0 113.489 -173.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.99 -1.95 0.03 OUTLIER Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.34 1.296 . . . . 10.0 116.34 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.29 152.38 63.76 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 120.478 2.139 . . . . 10.0 110.55 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.23 49.5 2.85 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.092 3.195 . . . . 10.0 111.892 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.82 128.0 18.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.964 1.306 . . . . 10.0 108.038 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.57 26.61 1.75 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.134 1.374 . . . . 10.0 109.948 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.86 160.05 21.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.6 0.76 . . . . 10.0 109.006 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -138.1 161.39 36.89 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.98 0.912 . . . . 10.0 110.797 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -144.59 173.13 12.08 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.221 1.008 . . . . 10.0 109.578 169.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -98.26 148.95 23.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 pt -137.24 154.17 30.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 125.736 1.615 . . . . 10.0 109.466 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.2 126.97 67.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.217 -1.772 . . . . 10.0 106.217 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -130.54 137.29 49.64 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.91 46.0 0.27 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.944 -0.862 . . . . 10.0 110.944 -169.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -66.16 136.61 56.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.064 0.546 . . . . 10.0 110.406 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -66.72 -27.96 68.05 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 113.667 0.988 . . . . 10.0 113.667 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.6 p-90 -68.3 -23.94 64.8 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.423 -0.798 . . . . 10.0 112.474 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.19 134.28 47.93 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.871 0.76 . . . . 10.0 110.778 -175.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.25 -35.37 71.4 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.366 0.666 . . . . 10.0 110.559 171.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -147.29 157.45 43.59 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.632 1.573 . . . . 10.0 109.084 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.88 -25.67 57.22 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.282 1.033 . . . . 10.0 112.387 172.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.77 -40.24 79.31 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.011 0.823 . . . . 10.0 112.03 169.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -71.54 -33.28 69.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.383 0.611 . . . . 10.0 110.125 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.0 -55.75 20.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 108.35 -0.982 . . . . 10.0 108.35 173.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -54.99 -42.16 72.11 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.956 -0.545 . . . . 10.0 111.305 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.93 -48.7 80.55 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.478 0.711 . . . . 10.0 111.261 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -44.89 72.07 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.486 -0.759 . . . . 10.0 110.29 -175.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.81 -46.06 95.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 C-N-CA 123.89 0.876 . . . . 10.0 109.172 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 m -58.4 -40.47 82.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.09 0.859 . . . . 10.0 111.242 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.09 -50.77 64.02 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.995 -0.842 . . . . 10.0 110.995 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.66 -47.91 84.15 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.073 0.937 . . . . 10.0 111.071 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -39.39 85.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.724 -0.61 . . . . 10.0 110.459 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -68.14 -33.37 74.36 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 118.829 0.741 . . . . 10.0 110.757 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.87 -39.7 94.83 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 116.575 -1.678 . . . . 10.0 111.029 169.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -67.7 -60.15 2.77 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 119.281 0.946 . . . . 10.0 108.788 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.08 44.28 0.08 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.283 1.42 . . . . 10.0 110.447 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.4 m -148.69 177.59 9.37 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.055 2.142 . . . . 10.0 108.052 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -148.21 165.99 29.27 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.503 1.121 . . . . 10.0 109.004 172.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.5 m -134.5 160.1 39.08 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.842 1.201 . . . . 10.0 113.375 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.17 139.32 19.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.512 1.925 . . . . 10.0 106.902 169.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.3 m -75.67 140.82 42.75 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.352 -0.843 . . . . 10.0 110.415 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.7 mt -96.24 -22.99 16.91 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.921 -0.487 . . . . 10.0 110.802 168.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.16 -173.59 39.35 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.979 -1.248 . . . . 10.0 109.979 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.05 -172.16 22.47 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 118.846 1.323 . . . . 10.0 111.911 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.65 -150.85 9.58 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 109.375 -1.49 . . . . 10.0 109.375 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -137.3 160.76 38.11 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.966 1.306 . . . . 10.0 109.117 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.5 mt -132.6 150.18 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.6 m -155.19 144.5 21.08 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.608 1.163 . . . . 10.0 109.441 171.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -78.37 137.99 38.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 168.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -65.01 145.77 55.9 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.582 -0.699 . . . . 10.0 109.925 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 p -69.9 -22.12 63.25 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -170.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -143.81 22.23 1.78 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.851 0.86 . . . . 10.0 111.28 -170.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -150.34 151.83 33.49 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -56.46 -28.91 60.95 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 117.819 -1.086 . . . . 10.0 113.211 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 164.42 6.31 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.57 1.176 . . . . 10.0 113.468 -168.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.9 mm -115.72 155.04 17.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 125.738 1.615 . . . . 10.0 106.719 173.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -137.23 156.22 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 120.147 -1.596 . . . . 10.0 109.247 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.38 131.87 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.067 -1.457 . . . . 10.0 107.067 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.59 176.72 12.26 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.159 -0.963 . . . . 10.0 112.136 -169.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.71 -159.47 53.03 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.217 -0.753 . . . . 10.0 111.217 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -157.39 157.06 33.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.123 1.369 . . . . 10.0 108.829 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -73.79 127.98 34.28 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.003 -1.061 . . . . 10.0 108.236 170.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 96.7 mtp -75.44 -18.19 59.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.763 -0.637 . . . . 10.0 111.215 169.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.56 -32.01 53.53 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 118.429 0.559 . . . . 10.0 111.688 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -127.37 -49.29 1.42 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.685 0.394 . . . . 10.0 111.264 -171.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.47 177.59 15.76 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.391 -1.484 . . . . 10.0 109.391 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.27 131.15 41.82 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.943 2.429 . . . . 10.0 110.573 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.05 162.58 16.49 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.82 0.819 . . . . 10.0 109.113 166.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -79.17 68.15 5.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.598 -1.63 . . . . 10.0 106.598 167.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -49.81 -32.34 13.86 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.316 1.446 . . . . 10.0 113.321 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.65 -36.89 74.84 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.433 1.015 . . . . 10.0 112.563 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.5 mt -66.62 -49.23 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -58.13 -44.21 87.68 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 117.858 -1.068 . . . . 10.0 111.99 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 p -64.79 -38.06 89.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 120.235 1.38 . . . . 10.0 111.273 -177.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.66 -40.31 88.59 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.58 1.082 . . . . 10.0 110.672 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -65.53 -45.72 82.37 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.793 -0.567 . . . . 10.0 110.337 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.3 mt -59.66 -43.12 90.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 118.017 -0.992 . . . . 10.0 109.213 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -57.95 -41.76 83.52 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 119.024 0.829 . . . . 10.0 110.669 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.69 -44.01 87.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.394 0.543 . . . . 10.0 111.03 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -69.46 -53.86 17.13 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.671 -0.643 . . . . 10.0 111.365 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -69.78 148.97 96.7 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.527 1.131 . . . . 10.0 110.737 -168.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -59.43 -40.46 66.96 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.377 2.052 . . . . 10.0 113.818 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.16 151.61 23.99 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.144 -0.317 . . . . 10.0 110.144 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -111.31 18.09 19.58 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.631 0.772 . . . . 10.0 113.072 -168.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -111.43 121.34 44.94 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 123.252 1.501 . . . . 10.0 109.093 171.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 t -137.99 141.77 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.444 -2.058 . . . . 10.0 105.444 170.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.3 p -133.22 173.43 11.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.61 0.641 . . . . 10.0 109.622 171.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -144.89 165.34 28.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.508 0.323 . . . . 10.0 111.039 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.76 163.17 37.55 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.215 1.806 . . . . 10.0 108.38 171.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -149.3 34.64 0.72 Allowed 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 124.054 0.942 . . . . 10.0 109.199 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.61 -27.26 68.53 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.079 0.951 . . . . 10.0 112.853 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.22 -177.69 44.49 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 108.897 -1.681 . . . . 10.0 108.897 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.6 t80 . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.082 -0.961 . . . . 10.0 109.293 171.836 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 tpp . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 118.217 -0.897 . . . . 10.0 109.741 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.67 166.41 25.91 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.968 0.907 . . . . 10.0 111.122 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.36 161.77 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 128.673 2.789 . . . . 10.0 106.709 174.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.67 -179.23 7.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.174 1.39 . . . . 10.0 108.999 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -149.31 151.16 33.69 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.51 -25.42 62.38 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.399 -0.81 . . . . 10.0 113.07 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.03 -31.93 71.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.992 0.814 . . . . 10.0 112.034 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.06 -35.01 57.06 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.049 0.539 . . . . 10.0 110.118 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -65.61 119.77 62.96 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.271 1.028 . . . . 10.0 108.576 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.7 133.4 38.71 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.748 2.966 . . . . 10.0 111.167 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -84.69 -30.17 25.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.444 0.64 . . . . 10.0 111.929 -170.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -136.57 136.26 48.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 126.266 1.827 . . . . 10.0 106.07 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -149.48 101.54 3.11 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.205 -1.406 . . . . 10.0 107.205 170.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.2 pt -137.13 158.5 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.495 1.518 . . . . 10.0 108.096 -174.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -145.71 35.62 1.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.378 1.085 . . . . 10.0 109.83 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 m -75.17 51.2 0.52 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.527 2.331 . . . . 10.0 113.229 -169.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.23 40.64 0.16 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.318 1.847 . . . . 10.0 111.432 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.24 177.02 39.11 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 128.125 2.774 . . . . 10.0 106.975 -174.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.99 113.59 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 118.878 1.339 . . . . 10.0 107.691 172.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -142.53 138.01 30.59 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.668 0.787 . . . . 10.0 108.972 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -59.79 155.03 16.96 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.894 0.878 . . . . 10.0 109.733 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.12 166.47 27.75 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.173 0.989 . . . . 10.0 108.457 174.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.15 148.02 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.012 0.925 . . . . 10.0 108.599 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.9 tp -109.04 114.15 27.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 105.589 -2.004 . . . . 10.0 105.589 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.4 mt -119.18 133.92 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.045 -1.465 . . . . 10.0 107.045 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -88.5 135.05 33.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.93 133.62 53.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.537 -2.023 . . . . 10.0 105.537 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -111.69 128.33 56.04 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.009 -1.848 . . . . 10.0 106.009 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 p -78.66 146.12 34.21 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.009 0.433 . . . . 10.0 111.111 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.86 67.74 3.78 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 126.45 1.9 . . . . 10.0 106.448 167.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.14 -39.55 26.3 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.52 3.48 . . . . 10.0 114.2 -168.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.57 168.8 18.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.79 -1.559 . . . . 10.0 106.79 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -54.43 -21.48 9.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.419 1.888 . . . . 10.0 114.562 -170.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.41 32.12 1.77 Allowed Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.59 1.09 . . . . 10.0 111.699 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.91 146.23 95.53 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.145 0.972 . . . . 10.0 110.766 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -81.64 44.49 1.74 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 124.323 3.348 . . . . 10.0 112.391 -175.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.05 138.65 28.47 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.308 1.043 . . . . 10.0 109.572 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.55 27.98 0.64 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.515 1.526 . . . . 10.0 110.358 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.07 164.47 20.13 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.857 0.863 . . . . 10.0 109.527 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -139.54 160.17 40.47 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.909 0.884 . . . . 10.0 110.787 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -149.28 176.07 10.86 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.805 1.242 . . . . 10.0 109.506 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -102.97 154.18 19.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.81 -0.811 . . . . 10.0 108.81 169.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.2 pt -134.04 154.11 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 125.456 1.502 . . . . 10.0 109.583 170.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.42 127.87 62.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.284 -1.747 . . . . 10.0 106.284 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -131.16 134.97 47.03 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 107.863 -1.162 . . . . 10.0 107.863 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.18 49.59 0.31 Allowed Glycine 0 N--CA 1.46 0.258 0 N-CA-C 110.601 -1.0 . . . . 10.0 110.601 -170.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.33 132.5 46.51 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.465 -0.569 . . . . 10.0 109.465 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -65.45 -26.57 68.01 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 113.483 0.92 . . . . 10.0 113.483 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -67.6 -22.83 65.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.46 -0.781 . . . . 10.0 112.774 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.7 128.89 38.02 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.975 0.807 . . . . 10.0 110.462 -174.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -74.58 -24.75 58.96 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.288 0.566 . . . . 10.0 110.412 173.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -147.13 152.64 38.8 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 120.521 -1.362 . . . . 10.0 109.613 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -53.8 -37.39 63.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.133 0.973 . . . . 10.0 111.137 168.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.2 -31.26 71.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.523 -0.751 . . . . 10.0 112.58 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -69.31 -39.04 78.51 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.149 0.976 . . . . 10.0 109.602 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.74 -53.37 47.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 173.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.82 -46.42 74.55 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.727 -0.654 . . . . 10.0 111.135 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.32 -47.26 86.77 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.302 0.376 . . . . 10.0 111.407 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -65.89 -47.26 75.44 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 121.745 -0.597 . . . . 10.0 109.796 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.84 -39.26 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 118.193 -0.908 . . . . 10.0 110.131 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -59.77 -44.65 93.78 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.684 1.129 . . . . 10.0 110.678 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.92 -46.57 93.9 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.884 -0.887 . . . . 10.0 110.884 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.04 -48.24 81.16 Favored 'General case' 0 C--O 1.228 -0.066 0 CA-C-N 117.696 0.748 . . . . 10.0 110.851 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.0 mmt -60.08 -38.7 83.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.227 0.611 . . . . 10.0 111.18 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -63.68 -34.62 78.27 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.645 0.657 . . . . 10.0 110.601 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -70.0 -33.04 71.52 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.78 -1.105 . . . . 10.0 112.033 170.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -66.82 -53.18 35.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.444 1.02 . . . . 10.0 109.491 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 130.35 43.17 0.2 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.34 1.448 . . . . 10.0 110.177 -169.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.5 m -148.28 175.08 11.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.159 1.783 . . . . 10.0 108.461 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -145.27 166.16 26.31 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.265 1.026 . . . . 10.0 108.568 170.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.5 m -133.71 155.79 49.1 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.797 1.036 . . . . 10.0 113.797 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -147.54 142.59 27.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.552 1.941 . . . . 10.0 106.286 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.7 m -83.36 136.48 34.33 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.263 -0.898 . . . . 10.0 110.366 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.9 mt -87.66 -25.17 23.65 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.377 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.09 -178.7 41.68 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.929 -1.269 . . . . 10.0 109.929 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.93 -177.91 21.86 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 118.038 0.919 . . . . 10.0 111.928 170.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.87 -147.91 5.92 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 108.851 -1.7 . . . . 10.0 108.851 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.64 155.22 44.18 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.471 1.508 . . . . 10.0 107.906 170.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.1 155.91 18.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 104.517 -2.401 . . . . 10.0 104.517 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.6 m -147.81 144.73 28.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.023 -1.048 . . . . 10.0 108.377 173.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -161.99 151.73 16.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.495 1.518 . . . . 10.0 107.281 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -151.42 102.42 2.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.1 -2.556 . . . . 10.0 104.1 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -57.3 -25.83 59.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.044 0.938 . . . . 10.0 113.037 -169.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -77.61 -7.68 56.73 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.398 1.479 . . . . 10.0 112.56 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -143.08 -39.57 0.33 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.76 1.392 . . . . 10.0 114.76 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -150.8 147.93 27.89 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.291 -1.506 . . . . 10.0 112.637 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 169.06 2.32 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.142 0.977 . . . . 10.0 110.942 168.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt -66.85 141.56 17.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.214 -1.032 . . . . 10.0 108.214 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -135.31 155.03 51.28 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.477 1.511 . . . . 10.0 108.893 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.22 139.69 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.429 1.092 . . . . 10.0 108.439 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -159.37 -172.16 3.62 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.272 -0.893 . . . . 10.0 110.564 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.13 -173.42 36.07 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 121.553 0.53 . . . . 10.0 112.125 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -154.08 160.22 41.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.178 -1.415 . . . . 10.0 107.178 169.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.6 m -124.23 107.33 11.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.9 mtt -56.59 -23.64 42.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.989 1.316 . . . . 10.0 113.664 -169.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.75 -25.11 68.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.528 -0.749 . . . . 10.0 112.767 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -135.71 -50.48 0.72 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.712 0.805 . . . . 10.0 111.111 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.7 -177.94 20.09 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.941 1.734 . . . . 10.0 109.604 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.94 132.98 36.69 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.195 1.93 . . . . 10.0 109.175 169.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.18 152.57 37.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 167.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -78.28 73.09 4.84 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -51.1 -31.0 17.73 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 124.631 1.173 . . . . 10.0 113.258 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.66 -35.81 73.15 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.212 0.914 . . . . 10.0 112.405 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.6 mt -65.11 -51.81 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.208 -1.404 . . . . 10.0 107.208 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -57.63 -44.93 85.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.26 -0.876 . . . . 10.0 112.287 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 p -66.85 -38.65 86.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.704 1.138 . . . . 10.0 111.156 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.08 -39.14 89.8 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.941 0.792 . . . . 10.0 110.736 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -64.65 -46.68 81.46 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 122.056 -0.403 . . . . 10.0 110.683 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.43 -44.07 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -60.81 -42.01 96.82 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.256 0.934 . . . . 10.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.42 87.22 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.281 0.632 . . . . 10.0 111.724 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -71.75 -29.99 65.11 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 118.089 -0.958 . . . . 10.0 111.57 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.264 40.9 p90 36.83 60.63 3.55 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 127.804 2.442 . . . . 10.0 113.926 -169.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -62.07 -27.43 79.16 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 121.188 1.259 . . . . 10.0 110.486 168.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -148.74 154.14 39.18 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 128.509 2.723 . . . . 10.0 105.088 166.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -83.3 141.47 31.79 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.99 0.424 . . . . 10.0 110.431 -174.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 65.27 146.43 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.924 2.49 . . . . 10.0 113.286 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.31 148.54 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.533 1.533 . . . . 10.0 106.926 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.9 p -139.71 166.95 23.23 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 120.987 -1.07 . . . . 10.0 110.034 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -147.12 164.06 34.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.916 0.326 . . . . 10.0 111.134 169.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.54 176.54 10.87 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.536 1.934 . . . . 10.0 108.532 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -139.0 41.97 2.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.281 1.032 . . . . 10.0 109.09 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.58 -30.5 70.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.065 0.946 . . . . 10.0 113.063 -174.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.68 -179.46 46.84 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.09 -1.204 . . . . 10.0 110.09 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.6 t80 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 116.651 -1.642 . . . . 10.0 109.74 172.393 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 117.816 -1.088 . . . . 10.0 109.307 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.63 161.06 41.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.933 1.693 . . . . 10.0 107.879 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.37 147.24 11.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 124.294 0.996 . . . . 10.0 109.89 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.49 178.56 8.28 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.953 0.883 . . . . 10.0 111.399 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -147.62 151.44 36.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.3 -1.741 . . . . 10.0 106.3 170.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.5 mt -59.88 -22.55 62.49 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 117.602 -1.189 . . . . 10.0 113.947 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.5 -33.58 75.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.034 0.834 . . . . 10.0 111.615 172.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.16 -34.35 43.23 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.989 0.516 . . . . 10.0 110.299 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -65.21 125.03 88.54 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.799 -1.186 . . . . 10.0 107.799 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.35 139.86 61.51 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.326 2.018 . . . . 10.0 109.875 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.92 -31.5 51.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.036 0.935 . . . . 10.0 111.644 -171.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.5 t -140.41 136.17 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 105.129 -2.174 . . . . 10.0 105.129 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -150.77 102.34 2.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 172.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 pt -131.15 42.78 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.967 1.307 . . . . 10.0 109.478 -168.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -64.46 81.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.447 1.899 . . . . 10.0 111.737 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m -162.64 175.36 11.46 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.314 2.246 . . . . 10.0 108.18 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -147.63 155.39 41.74 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 125.286 1.434 . . . . 10.0 107.613 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.82 -162.15 48.5 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.102 -1.199 . . . . 10.0 110.102 -166.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 37.5 t -72.16 139.64 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.025 -1.102 . . . . 10.0 108.025 167.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -152.49 148.55 27.54 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.575 1.179 . . . . 10.0 111.213 172.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -63.82 145.98 54.79 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.06 160.74 40.36 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.488 0.715 . . . . 10.0 110.159 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.95 146.42 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.576 1.55 . . . . 10.0 108.132 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 tt -106.49 122.22 45.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 105.438 -2.06 . . . . 10.0 105.438 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.8 mt -126.03 133.26 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.997 -1.483 . . . . 10.0 106.997 -171.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 ttm105 -85.47 139.0 31.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 167.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.27 140.58 41.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 124.579 1.152 . . . . 10.0 107.894 175.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -115.54 127.32 55.18 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.692 -1.966 . . . . 10.0 105.692 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.9 p -74.39 144.54 44.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.228 0.537 . . . . 10.0 111.399 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.0 71.07 4.65 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.795 2.038 . . . . 10.0 106.419 167.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.76 -38.92 47.75 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.69 2.927 . . . . 10.0 112.55 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -146.4 162.74 37.57 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 105.257 -2.127 . . . . 10.0 105.257 170.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -55.6 -23.21 26.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.508 1.299 . . . . 10.0 114.508 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -132.5 25.34 3.81 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.69 1.138 . . . . 10.0 111.865 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.86 149.83 89.0 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 118.679 1.24 . . . . 10.0 110.932 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.65 41.66 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.052 3.168 . . . . 10.0 112.03 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.1 135.09 22.59 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.267 1.027 . . . . 10.0 109.001 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.04 27.52 0.77 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.848 1.659 . . . . 10.0 109.579 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.69 166.46 17.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.302 1.041 . . . . 10.0 109.515 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.1 m -136.39 161.19 36.51 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.405 -0.81 . . . . 10.0 110.459 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -146.9 170.7 16.52 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.299 1.439 . . . . 10.0 107.664 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -122.48 140.95 52.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.261 -2.125 . . . . 10.0 105.261 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.2 pt -134.97 154.12 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.347 1.059 . . . . 10.0 110.123 -173.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.97 128.63 69.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -133.75 144.26 48.97 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.041 -1.466 . . . . 10.0 107.041 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.37 131.55 1.96 Allowed Glycine 0 CA--C 1.506 -0.493 0 CA-C-N 120.193 1.361 . . . . 10.0 111.033 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -147.22 139.29 24.43 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -70.84 -17.59 62.73 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 116.885 -1.531 . . . . 10.0 114.277 -173.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -68.52 -17.22 64.12 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 119.994 1.27 . . . . 10.0 112.012 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.81 127.39 31.72 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 119.856 1.207 . . . . 10.0 111.513 -172.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.79 -44.47 85.64 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.802 0.81 . . . . 10.0 109.068 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -146.51 168.83 20.25 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 127.183 2.193 . . . . 10.0 106.898 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -56.98 -36.13 69.97 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.997 -1.064 . . . . 10.0 112.403 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.27 -24.51 63.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.11 -0.947 . . . . 10.0 112.657 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -66.49 -36.34 82.49 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.903 1.335 . . . . 10.0 109.549 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -65.71 -53.78 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 120.471 -1.393 . . . . 10.0 108.505 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -54.73 -40.18 69.02 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.76 -1.114 . . . . 10.0 111.473 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.59 -46.24 90.69 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.347 0.976 . . . . 10.0 111.756 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -65.27 -48.15 74.22 Favored 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 121.002 -1.061 . . . . 10.0 109.718 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.07 -42.48 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.554 -0.535 . . . . 10.0 109.554 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 p -65.06 -34.46 78.47 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.576 1.08 . . . . 10.0 111.362 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.76 -47.93 81.66 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.08 -47.41 84.81 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 117.363 0.582 . . . . 10.0 111.115 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.7 mmt -60.7 -36.8 79.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.137 -0.935 . . . . 10.0 110.57 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.53 -39.85 94.53 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.39 0.996 . . . . 10.0 111.08 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -70.72 -27.19 63.79 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.759 1.163 . . . . 10.0 111.779 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -69.61 -55.64 9.51 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.335 0.97 . . . . 10.0 108.84 175.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.17 42.66 0.14 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.029 1.3 . . . . 10.0 111.553 -173.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 50.9 m -142.17 168.01 20.76 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.278 1.431 . . . . 10.0 109.508 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.73 160.71 30.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.156 1.782 . . . . 10.0 107.138 170.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.3 m -129.7 153.17 48.43 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.443 1.097 . . . . 10.0 112.663 -166.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -142.72 110.65 5.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.907 -1.886 . . . . 10.0 105.907 170.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.5 p -61.26 122.95 16.38 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.248 -0.908 . . . . 10.0 109.103 170.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.1 mt -86.37 -22.55 26.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.163 0.506 . . . . 10.0 110.558 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.84 -177.18 30.66 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 108.239 -1.945 . . . . 10.0 108.239 -172.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.32 -161.2 13.77 Favored Glycine 0 CA--C 1.52 0.371 0 O-C-N 121.016 -1.285 . . . . 10.0 110.714 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.97 -138.63 3.84 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.656 -1.778 . . . . 10.0 108.656 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -136.81 144.43 43.68 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.698 1.199 . . . . 10.0 107.884 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.84 151.55 8.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 104.656 -2.35 . . . . 10.0 104.656 169.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.1 m -131.84 131.39 42.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -141.58 147.35 37.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.444 -1.317 . . . . 10.0 107.444 -171.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -149.12 135.75 19.52 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 104.796 -2.298 . . . . 10.0 104.796 165.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.8 m -67.42 -18.87 65.28 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.838 1.051 . . . . 10.0 113.838 -169.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -145.02 166.62 24.8 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.775 1.63 . . . . 10.0 108.206 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 65.07 -7.45 0.28 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 127.701 2.4 . . . . 10.0 114.912 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -139.86 -179.8 6.15 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 118.991 -2.318 . . . . 10.0 108.235 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.58 169.97 11.94 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.749 1.62 . . . . 10.0 109.059 175.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.72 142.82 13.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.057 -1.46 . . . . 10.0 107.057 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -139.02 159.66 41.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.5 t -141.62 132.53 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.668 -1.234 . . . . 10.0 107.668 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.89 176.69 10.56 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.799 -1.188 . . . . 10.0 111.434 -171.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.27 -166.01 52.28 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 121.732 -0.605 . . . . 10.0 111.59 -176.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -150.52 160.2 43.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.504 1.122 . . . . 10.0 108.05 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.2 m -86.42 116.7 24.74 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.983 0.811 . . . . 10.0 109.594 172.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -58.56 -25.52 62.62 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 122.877 0.471 . . . . 10.0 110.537 170.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.28 -29.19 70.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.629 -1.177 . . . . 10.0 113.56 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.68 -55.63 0.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.924 1.238 . . . . 10.0 110.884 -176.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.11 -178.79 36.92 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.523 -1.031 . . . . 10.0 110.523 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.43 134.48 41.84 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.818 2.345 . . . . 10.0 109.909 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.09 162.17 28.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.816 0.817 . . . . 10.0 109.796 164.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -80.01 74.84 6.76 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.198 -1.408 . . . . 10.0 107.198 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -48.83 -31.36 6.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.225 1.41 . . . . 10.0 114.487 -170.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.89 72.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.135 0.88 . . . . 10.0 112.408 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.9 mt -63.48 -52.21 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -58.96 -44.77 91.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.305 -0.855 . . . . 10.0 111.355 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.8 p -65.24 -39.17 92.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.702 1.137 . . . . 10.0 111.679 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -65.4 -40.38 93.37 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.648 1.113 . . . . 10.0 109.832 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -66.76 -46.31 75.77 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.03 0.532 . . . . 10.0 110.114 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 72.6 mt -57.51 -45.65 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -61.11 -41.74 97.25 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.158 0.89 . . . . 10.0 110.825 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.77 -39.87 95.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.589 0.631 . . . . 10.0 111.195 174.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -69.29 -31.89 70.69 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 117.296 -1.335 . . . . 10.0 112.181 178.329 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -134.48 67.25 71.74 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.362 1.065 . . . . 10.0 110.506 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.45 -22.43 50.5 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.846 2.364 . . . . 10.0 114.922 -176.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.43 -12.37 51.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.754 1.222 . . . . 10.0 112.863 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -127.59 146.38 50.55 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.63 -1.294 . . . . 10.0 109.74 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -71.05 153.39 42.64 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.021 -1.104 . . . . 10.0 108.021 165.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 t -135.89 137.05 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 106.744 -1.576 . . . . 10.0 106.744 175.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.1 p -142.86 170.82 14.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.855 1.262 . . . . 10.0 109.128 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -145.6 166.74 24.89 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 119.199 0.909 . . . . 10.0 111.346 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.3 172.32 14.05 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.369 2.268 . . . . 10.0 108.124 173.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -145.33 20.27 1.55 Allowed 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.712 0.805 . . . . 10.0 111.84 -175.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.34 -36.85 71.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.451 1.101 . . . . 10.0 112.615 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 163.52 170.12 27.96 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 51.1 t80 . . . . . 0 C--O 1.254 1.293 0 CA-C-O 116.308 -1.806 . . . . 10.0 108.291 168.8 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.19 164.75 34.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.023 1.329 . . . . 10.0 109.014 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.54 160.92 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.994 0.918 . . . . 10.0 110.563 172.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.71 169.66 12.43 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.382 0.611 . . . . 10.0 111.701 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -152.02 154.63 36.38 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.458 1.503 . . . . 10.0 107.203 173.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.77 -24.79 58.82 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.716 0.806 . . . . 10.0 112.81 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.16 -26.76 66.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.37 0.986 . . . . 10.0 112.368 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.2 mt -75.76 -25.08 56.17 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.033 0.533 . . . . 10.0 111.306 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.6 mt -84.16 127.49 66.39 Favored Pre-proline 0 C--O 1.237 0.436 0 N-CA-C 106.722 -1.584 . . . . 10.0 106.722 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.3 147.17 77.77 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.185 1.923 . . . . 10.0 109.769 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.04 -30.44 55.65 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.535 0.683 . . . . 10.0 112.052 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.83 134.86 45.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.14 -2.171 . . . . 10.0 105.14 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -151.2 114.39 4.79 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.305 -1.369 . . . . 10.0 107.305 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.43 140.13 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.132 1.773 . . . . 10.0 106.272 -175.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -154.55 83.09 1.11 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.81 0.814 . . . . 10.0 108.827 -177.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 m -161.45 175.65 11.94 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.418 1.887 . . . . 10.0 108.572 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -140.76 158.73 43.55 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 125.097 1.359 . . . . 10.0 108.066 177.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.74 -157.65 50.48 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.931 -1.268 . . . . 10.0 109.931 -169.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.18 139.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 169.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -147.6 154.56 40.83 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.197 0.999 . . . . 10.0 110.325 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -79.08 145.92 33.54 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.991 1.316 . . . . 10.0 109.017 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.2 162.25 39.28 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.993 0.425 . . . . 10.0 110.458 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.61 143.19 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 125.261 1.424 . . . . 10.0 107.565 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.72 125.37 47.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.328 -2.101 . . . . 10.0 105.328 171.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.3 mt -128.87 130.17 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.552 -1.647 . . . . 10.0 106.552 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -83.43 135.42 34.69 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.007 -1.849 . . . . 10.0 106.007 168.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 p -124.82 138.4 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.793 -1.558 . . . . 10.0 106.793 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -121.98 131.05 53.8 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.927 1.691 . . . . 10.0 106.647 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 p -67.65 140.23 56.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.783 0.325 . . . . 10.0 110.326 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.42 62.4 4.92 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.803 1.241 . . . . 10.0 108.557 168.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -53.96 -35.29 80.06 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.188 3.259 . . . . 10.0 113.503 -169.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -153.14 161.15 42.79 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.855 2.062 . . . . 10.0 105.738 172.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -55.99 -22.3 26.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.653 1.353 . . . . 10.0 114.653 -172.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.1 26.75 3.37 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.492 1.044 . . . . 10.0 112.045 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.96 148.88 91.52 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 118.039 0.92 . . . . 10.0 110.611 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -79.9 42.96 1.41 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 124.308 3.339 . . . . 10.0 111.999 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.28 139.31 28.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.379 1.072 . . . . 10.0 109.514 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.21 16.79 0.41 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.424 1.49 . . . . 10.0 111.797 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -63.33 160.03 16.8 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.274 1.43 . . . . 10.0 109.722 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.9 m -140.64 161.36 37.95 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.206 1.003 . . . . 10.0 110.66 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -146.99 179.33 7.68 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.967 1.307 . . . . 10.0 108.87 169.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -120.31 143.38 48.39 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.191 -1.041 . . . . 10.0 108.191 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.0 146.97 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.991 1.316 . . . . 10.0 110.289 -171.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.19 125.97 60.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.649 -1.611 . . . . 10.0 106.649 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -131.91 144.18 50.67 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.657 -1.609 . . . . 10.0 106.657 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.71 130.9 1.86 Allowed Glycine 0 C--N 1.329 0.156 0 CA-C-N 120.017 1.281 . . . . 10.0 112.868 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -150.91 142.38 23.46 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.218 1.007 . . . . 10.0 109.293 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -72.49 -16.89 61.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.118 1.155 . . . . 10.0 114.118 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -65.97 -21.37 66.41 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.69 1.132 . . . . 10.0 112.828 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.11 130.7 44.32 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 118.485 0.584 . . . . 10.0 110.804 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -67.8 -41.5 83.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -144.12 158.58 43.63 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 126.319 1.848 . . . . 10.0 107.169 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -56.27 -32.02 64.14 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.525 0.73 . . . . 10.0 112.853 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.09 -27.02 65.16 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.866 -0.588 . . . . 10.0 112.136 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.43 -35.9 78.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.503 0.592 . . . . 10.0 110.795 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.56 -50.85 69.4 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 107.683 -1.229 . . . . 10.0 107.683 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -55.28 -45.59 76.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.928 -0.558 . . . . 10.0 111.171 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.46 -45.27 88.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 118.541 0.61 . . . . 10.0 111.822 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -59.0 -50.1 75.36 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.562 0.745 . . . . 10.0 109.481 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.64 -46.11 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.521 0.728 . . . . 10.0 109.068 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 m -59.08 -36.03 74.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.352 0.978 . . . . 10.0 111.486 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.02 -49.32 76.48 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.531 -1.028 . . . . 10.0 110.531 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.01 -45.87 91.71 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 117.751 0.776 . . . . 10.0 111.283 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -36.43 82.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.776 -0.63 . . . . 10.0 111.057 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -65.05 -35.73 82.09 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.9 0.773 . . . . 10.0 110.942 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -66.36 -32.18 73.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.135 -0.936 . . . . 10.0 111.542 172.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -69.19 -60.47 2.33 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.913 0.779 . . . . 10.0 109.281 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.66 47.38 0.09 OUTLIER Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.826 1.679 . . . . 10.0 109.456 -169.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.9 m -146.79 172.43 13.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.263 1.825 . . . . 10.0 108.734 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -137.87 160.45 39.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.846 1.659 . . . . 10.0 108.361 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.4 m -134.54 154.39 51.48 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.118 0.967 . . . . 10.0 112.894 -168.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -144.78 109.93 5.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.588 1.955 . . . . 10.0 106.857 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -60.04 126.88 29.24 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.114 -0.991 . . . . 10.0 109.544 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.2 mt -91.69 -26.57 18.57 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.698 0.399 . . . . 10.0 110.351 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.33 169.58 31.95 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.641 -0.984 . . . . 10.0 110.641 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.96 166.51 22.01 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.952 1.263 . . . . 10.0 110.883 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.48 -161.56 23.91 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.529 -1.428 . . . . 10.0 109.529 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -138.24 156.66 47.47 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.09 -1.241 . . . . 10.0 108.972 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.9 mt -127.81 146.95 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 104.54 -2.393 . . . . 10.0 104.54 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.2 m -113.44 120.75 42.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.903 -1.518 . . . . 10.0 106.903 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -68.81 156.07 39.04 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.872 0.869 . . . . 10.0 110.845 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -61.86 149.34 40.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.093 1.357 . . . . 10.0 110.157 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.9 m -139.79 25.02 2.38 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.718 1.207 . . . . 10.0 110.926 -176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 51.64 43.88 29.54 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.558 1.543 . . . . 10.0 109.476 -168.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -157.68 -43.3 0.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.408 0.683 . . . . 10.0 112.641 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -145.85 137.09 24.79 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.597 1.159 . . . . 10.0 108.213 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.16 156.17 4.28 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.645 1.178 . . . . 10.0 112.817 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.4 pt -58.47 133.92 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.122 -1.066 . . . . 10.0 108.122 168.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -149.25 156.6 42.37 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.223 -1.029 . . . . 10.0 108.223 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.31 137.7 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.09 0.956 . . . . 10.0 108.51 -169.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -160.17 -177.11 6.05 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.344 -0.847 . . . . 10.0 110.114 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.64 178.93 37.86 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.244 0.449 . . . . 10.0 112.218 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -153.61 -176.23 5.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.227 1.011 . . . . 10.0 108.815 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -137.06 111.14 8.32 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.4 mtt -61.11 -12.87 13.76 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.359 0.664 . . . . 10.0 112.639 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.06 -32.39 54.47 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.124 0.97 . . . . 10.0 112.428 170.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.56 -37.11 0.14 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.377 0.881 . . . . 10.0 113.377 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 141.82 -178.68 20.44 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.612 1.101 . . . . 10.0 110.654 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.22 143.79 78.71 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.219 2.613 . . . . 10.0 110.2 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.44 32.75 0.09 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.182 1.793 . . . . 10.0 113.737 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 37.66 55.45 1.5 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.093 2.557 . . . . 10.0 110.171 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -45.45 -26.84 0.61 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.771 2.428 . . . . 10.0 116.275 -166.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.02 83.2 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.567 1.53 . . . . 10.0 111.899 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.4 -55.03 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -63.93 -39.91 95.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.606 -0.712 . . . . 10.0 112.017 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.0 p -64.85 -38.61 91.56 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 119.417 1.008 . . . . 10.0 110.57 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.59 -41.41 96.27 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.673 1.124 . . . . 10.0 111.241 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -64.08 -47.89 78.34 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.819 -0.55 . . . . 10.0 110.663 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.85 -42.43 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.839 0.855 . . . . 10.0 108.828 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -60.31 -40.15 89.53 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.244 1.018 . . . . 10.0 111.206 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.0 96.43 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.162 0.437 . . . . 10.0 110.936 174.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -77.57 -36.82 51.7 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.776 -1.106 . . . . 10.0 113.101 -171.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.88 148.38 51.02 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 119.942 1.246 . . . . 10.0 112.422 -168.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.25 -10.06 16.35 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.51 2.806 . . . . 10.0 114.111 -172.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -77.76 67.29 3.62 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.283 -1.006 . . . . 10.0 108.283 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -58.89 -16.45 17.61 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.543 1.537 . . . . 10.0 115.025 -168.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -77.94 31.77 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 120.843 1.656 . . . . 10.0 112.144 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.97 127.58 15.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.4 -1.333 . . . . 10.0 107.4 170.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.12 167.07 26.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.432 1.493 . . . . 10.0 107.5 -172.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -144.15 159.67 42.25 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.662 -0.496 . . . . 10.0 109.662 172.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.89 -23.52 0.57 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.0 t30 41.68 53.94 3.85 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.282 1.433 . . . . 10.0 112.46 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.88 -25.72 68.28 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.522 0.934 . . . . 10.0 113.522 -173.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -168.94 171.84 43.05 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.584 1.564 . . . . 10.0 109.403 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.0 t80 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 124.314 1.045 . . . . 10.0 111.844 -174.282 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.484 -0.562 . . . . 10.0 109.484 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.68 167.78 17.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.346 0.658 . . . . 10.0 110.386 170.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.78 166.4 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.306 0.574 . . . . 10.0 110.637 169.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.61 179.19 7.87 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.552 1.941 . . . . 10.0 107.196 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -148.12 152.71 37.78 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.041 -1.096 . . . . 10.0 108.041 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.4 mt -54.91 -31.1 59.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.342 1.057 . . . . 10.0 112.637 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.59 -24.59 66.78 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.7 mt -76.32 -23.74 54.3 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.88 0.472 . . . . 10.0 111.203 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.5 mt -74.48 135.42 75.52 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.001 -1.481 . . . . 10.0 107.001 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.47 138.03 53.24 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.21 1.94 . . . . 10.0 109.062 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.72 -31.79 68.76 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.054 0.761 . . . . 10.0 113.054 -169.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -158.11 136.53 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 105.944 -1.873 . . . . 10.0 105.944 -174.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -157.34 112.72 2.81 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.577 -0.897 . . . . 10.0 108.577 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 pt -134.09 31.83 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.487 1.515 . . . . 10.0 109.964 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.41 101.21 0.12 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.947 0.899 . . . . 10.0 111.467 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -167.55 177.27 6.01 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.949 2.5 . . . . 10.0 108.161 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -140.83 156.39 46.15 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 124.535 1.134 . . . . 10.0 108.796 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.95 -155.97 41.5 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.458 -1.057 . . . . 10.0 110.458 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.28 141.47 17.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.655 -0.869 . . . . 10.0 108.655 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -154.04 154.85 34.43 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.248 1.019 . . . . 10.0 110.019 168.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -77.75 151.02 34.3 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.112 0.965 . . . . 10.0 109.45 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.53 161.5 38.3 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.507 0.723 . . . . 10.0 109.75 176.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.51 152.69 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.091 1.356 . . . . 10.0 108.988 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -115.35 121.99 44.51 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.58 -2.007 . . . . 10.0 105.58 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 95.2 mt -130.71 134.24 62.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.408 -1.33 . . . . 10.0 107.408 -169.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -85.23 144.56 28.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.533 -1.654 . . . . 10.0 106.533 167.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.99 144.12 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -124.21 132.35 53.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.093 1.757 . . . . 10.0 106.449 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.2 p -64.39 139.86 58.81 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.973 -0.38 . . . . 10.0 109.973 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.48 62.17 2.83 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.854 1.262 . . . . 10.0 108.612 169.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -59.27 135.33 64.85 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.918 2.412 . . . . 10.0 109.499 -172.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 44.76 26.96 0.22 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.925 1.29 . . . . 10.0 113.601 -171.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m 51.54 29.66 5.66 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.22 1.408 . . . . 10.0 113.434 -176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.22 -7.41 0.02 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 116.58 1.392 . . . . 10.0 116.58 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 153.06 80.64 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 120.062 1.931 . . . . 10.0 110.476 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.18 64.06 7.81 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.26 3.306 . . . . 10.0 111.941 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.5 138.21 34.43 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.334 1.453 . . . . 10.0 108.317 172.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.1 25.17 0.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.757 1.223 . . . . 10.0 110.781 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.29 161.14 25.64 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 169.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -139.63 163.51 32.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.291 1.036 . . . . 10.0 110.996 -176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -151.43 166.95 29.49 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.947 2.099 . . . . 10.0 107.862 -170.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.3 mp0 -122.32 143.15 49.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 pt -136.77 155.36 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.441 1.896 . . . . 10.0 109.228 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.48 129.95 74.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -134.68 147.03 50.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.661 -1.607 . . . . 10.0 106.661 -172.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.78 124.17 1.0 Allowed Glycine 0 C--O 1.224 -0.497 0 CA-C-N 119.642 1.11 . . . . 10.0 110.644 172.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -144.52 138.12 27.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 123.846 0.38 . . . . 10.0 110.429 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -61.45 -29.78 70.17 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.22 1.008 . . . . 10.0 112.876 -175.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -64.07 -23.14 67.22 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.957 0.799 . . . . 10.0 112.97 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.37 118.7 14.5 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 119.26 0.936 . . . . 10.0 109.791 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -68.38 -34.16 75.55 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.878 0.471 . . . . 10.0 109.965 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -142.46 151.94 42.24 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.076 1.751 . . . . 10.0 107.894 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -57.17 -36.69 71.09 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.676 0.621 . . . . 10.0 112.676 -171.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.95 -27.06 63.06 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 124.0 0.812 . . . . 10.0 112.175 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.73 -35.36 79.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.26 0.482 . . . . 10.0 110.926 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -66.37 -54.83 22.22 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 N-CA-C 107.399 -1.334 . . . . 10.0 107.399 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -56.93 -41.95 79.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.944 -0.55 . . . . 10.0 111.55 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.33 -47.38 79.61 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.908 0.483 . . . . 10.0 111.632 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -60.97 -47.69 85.29 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 121.872 -0.518 . . . . 10.0 109.695 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.19 -47.57 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 118.475 -0.774 . . . . 10.0 108.996 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 m -57.82 -42.44 84.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.348 0.976 . . . . 10.0 110.897 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.63 -44.29 98.01 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.235 -0.746 . . . . 10.0 111.235 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.87 -48.01 72.99 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.111 0.955 . . . . 10.0 111.504 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -41.07 78.17 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 119.074 0.852 . . . . 10.0 110.121 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -62.69 -36.82 84.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.432 -0.794 . . . . 10.0 110.988 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.1 pttm -74.23 -25.42 59.65 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.468 -1.253 . . . . 10.0 112.652 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -68.31 -56.09 9.81 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.902 1.228 . . . . 10.0 109.151 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.13 45.28 0.14 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.522 1.534 . . . . 10.0 109.896 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.1 m -147.02 175.37 10.74 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.817 2.047 . . . . 10.0 107.875 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -145.64 165.27 29.21 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.892 -0.781 . . . . 10.0 108.892 169.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.94 164.13 19.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.771 1.026 . . . . 10.0 113.771 -168.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -147.07 112.84 5.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.9 2.48 . . . . 10.0 105.734 175.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.9 t -65.2 140.44 58.75 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.916 -1.115 . . . . 10.0 109.48 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.3 mt -106.14 -10.9 16.28 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.732 0.813 . . . . 10.0 111.047 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.31 -177.75 18.74 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.467 1.508 . . . . 10.0 109.723 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.59 -164.23 13.57 Favored Glycine 0 CA--C 1.522 0.519 0 O-C-N 121.472 -1.017 . . . . 10.0 112.04 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.28 -149.71 7.72 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 109.667 -1.373 . . . . 10.0 109.667 -172.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -143.06 155.96 44.72 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.602 1.161 . . . . 10.0 109.275 -174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.1 mt -136.43 153.97 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.529 -2.026 . . . . 10.0 105.529 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.6 m -129.24 117.27 20.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 169.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -57.11 133.87 55.37 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 43.58 59.83 2.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.052 1.341 . . . . 10.0 111.258 -172.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -52.61 -36.26 55.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.081 0.552 . . . . 10.0 110.86 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -126.35 170.03 12.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.019 1.727 . . . . 10.0 106.842 168.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.34 -22.86 54.94 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.292 1.219 . . . . 10.0 114.292 -169.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -127.49 -5.72 5.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 117.818 -1.087 . . . . 10.0 113.716 -175.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.38 169.16 24.88 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 120.35 1.432 . . . . 10.0 112.487 -172.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 pt -116.06 166.06 10.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 122.826 1.298 . . . . 10.0 110.917 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -134.77 154.45 51.59 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.663 1.985 . . . . 10.0 107.912 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 t -129.57 136.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -150.83 175.7 11.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.728 0.695 . . . . 10.0 111.816 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.84 -153.76 53.05 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.667 0.651 . . . . 10.0 112.981 170.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -150.6 -179.7 7.46 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.381 1.472 . . . . 10.0 109.601 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.9 m -114.94 122.89 47.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.805 0.842 . . . . 10.0 109.194 170.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -58.35 -29.23 65.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.352 1.061 . . . . 10.0 111.213 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.75 -25.41 66.48 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.737 1.014 . . . . 10.0 113.737 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -59.03 0.25 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.514 1.052 . . . . 10.0 111.271 -174.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.88 179.66 35.77 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.515 -1.034 . . . . 10.0 110.515 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -56.68 137.41 80.98 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.016 2.477 . . . . 10.0 111.138 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.55 165.81 21.92 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.603 0.715 . . . . 10.0 109.241 167.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -81.59 69.12 8.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.366 -1.716 . . . . 10.0 106.366 167.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -49.24 -30.19 6.82 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.663 1.585 . . . . 10.0 114.196 -169.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.15 -36.28 74.99 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.374 0.988 . . . . 10.0 112.266 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.7 mt -62.81 -50.45 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.052 -1.462 . . . . 10.0 107.052 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -58.55 -47.64 83.54 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.741 0.816 . . . . 10.0 111.822 -177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 p -65.39 -37.85 88.24 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.409 -0.805 . . . . 10.0 111.356 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -64.73 -42.67 95.03 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.362 0.983 . . . . 10.0 110.387 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -62.41 -47.95 81.88 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.682 -0.675 . . . . 10.0 110.085 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.62 -52.19 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -57.52 -38.06 74.04 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.349 1.06 . . . . 10.0 111.971 -174.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 -44.01 81.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.78 0.432 . . . . 10.0 111.309 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -90.99 -49.48 6.39 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.406 0.548 . . . . 10.0 111.853 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -72.49 159.4 85.47 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 123.198 0.599 . . . . 10.0 110.195 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.3 -13.85 30.96 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.716 2.277 . . . . 10.0 112.671 175.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.0 115.76 9.59 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.266 -1.013 . . . . 10.0 108.266 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -107.41 13.63 26.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.48 1.112 . . . . 10.0 111.384 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -140.71 36.49 1.81 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.683 1.193 . . . . 10.0 109.687 -174.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.4 t -56.66 146.08 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.918 1.287 . . . . 10.0 108.637 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.9 p -139.63 167.98 20.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.294 1.037 . . . . 10.0 110.149 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -150.63 167.85 26.07 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.961 -0.462 . . . . 10.0 110.957 170.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.5 153.17 38.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.68 1.592 . . . . 10.0 108.513 169.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -72.37 -27.0 62.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.585 0.354 . . . . 10.0 111.662 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -60.85 165.37 4.08 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.374 1.469 . . . . 10.0 112.327 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.77 31.16 10.38 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.932 0.777 . . . . 10.0 112.309 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 . . . . . 0 C--O 1.245 0.861 0 C-N-CA 124.279 1.032 . . . . 10.0 110.147 174.974 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 tmm? . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 118.297 -0.858 . . . . 10.0 110.11 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.63 -175.76 5.6 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.366 1.467 . . . . 10.0 108.648 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -63.74 155.71 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 122.989 0.515 . . . . 10.0 110.275 169.035 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.45 ' H ' ' HB3' ' A' ' 31' ' ' PRO . . . -158.16 177.35 11.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.493 2.317 . . . . 10.0 106.808 176.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -150.3 150.69 31.83 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.75 -1.204 . . . . 10.0 107.75 173.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -59.15 -23.47 62.2 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 118.211 -0.9 . . . . 10.0 112.88 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.28 -26.41 67.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.473 1.033 . . . . 10.0 112.473 175.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -73.97 -26.25 60.37 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.111 0.564 . . . . 10.0 111.009 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.38 127.16 62.18 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 106.737 -1.579 . . . . 10.0 106.737 -174.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.62 149.03 79.23 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.226 1.951 . . . . 10.0 110.087 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.66 -33.68 60.43 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.47 1.108 . . . . 10.0 111.958 -178.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -136.92 135.12 48.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 104.843 -2.28 . . . . 10.0 104.843 176.432 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -150.5 118.07 6.12 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.069 -1.826 . . . . 10.0 106.069 171.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.8 pt -142.01 158.04 20.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.353 1.061 . . . . 10.0 110.272 -169.806 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -144.34 129.39 18.56 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.786 1.235 . . . . 10.0 108.743 174.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.416 ' HB3' ' CE1' ' A' ' 20' ' ' PHE . 58.7 p -131.49 177.49 7.45 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.766 1.227 . . . . 10.0 112.297 -166.313 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -163.92 -35.34 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.363 1.865 . . . . 10.0 108.825 169.305 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.71 -129.23 1.41 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 106.273 -2.731 . . . . 10.0 106.273 170.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.8 t -64.06 144.65 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.418 1.109 . . . . 10.0 108.966 168.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 16' ' ' SER . 24.8 p90 -150.69 147.64 27.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.869 1.268 . . . . 10.0 109.104 172.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -67.82 153.94 42.62 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.772 -0.58 . . . . 10.0 109.685 174.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.17 165.6 26.97 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.979 0.912 . . . . 10.0 109.366 170.549 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.6 147.72 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.428 1.491 . . . . 10.0 107.67 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tt -109.14 121.02 44.27 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 104.777 -2.305 . . . . 10.0 104.777 177.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.5 mt -128.74 140.53 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 -170.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -94.54 131.23 40.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 167.036 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.91 143.32 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -123.47 130.13 52.24 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.495 1.918 . . . . 10.0 105.857 -175.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.1 p -72.36 142.93 48.77 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.351 -0.241 . . . . 10.0 110.351 175.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.78 59.58 3.54 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.299 1.44 . . . . 10.0 108.205 168.095 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HB3' ' H ' ' A' ' 4' ' ' ALA . 10.1 Cg_exo -58.67 141.41 97.61 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.019 2.48 . . . . 10.0 109.921 -171.338 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 52.2 16.73 0.61 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.448 1.099 . . . . 10.0 113.058 -177.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m 48.17 31.4 2.55 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.548 1.139 . . . . 10.0 112.897 -169.596 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.88 -1.71 0.02 OUTLIER Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.43 -1.206 . . . . 10.0 115.954 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 153.32 78.91 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 120.094 1.947 . . . . 10.0 110.448 174.212 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.87 55.29 5.2 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 124.256 3.304 . . . . 10.0 111.855 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.92 139.51 30.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.045 1.338 . . . . 10.0 108.653 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.75 30.09 0.66 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.188 1.395 . . . . 10.0 109.772 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -66.32 158.4 29.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 174.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 m -140.33 160.27 40.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.138 0.975 . . . . 10.0 110.326 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -150.22 169.57 21.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.132 0.973 . . . . 10.0 109.635 171.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -98.5 149.06 23.12 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.499 -0.926 . . . . 10.0 108.499 172.13 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.1 pt -138.9 154.43 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.055 1.742 . . . . 10.0 109.924 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.25 128.8 64.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.985 -1.487 . . . . 10.0 106.985 176.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 mmp_? -134.61 138.12 44.26 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.873 -1.529 . . . . 10.0 106.873 -178.162 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.38 122.91 0.92 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-N 119.725 1.148 . . . . 10.0 110.996 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -142.84 133.93 25.8 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 -172.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -59.55 -21.58 60.48 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 114.515 1.302 . . . . 10.0 114.515 -175.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -65.34 -25.33 67.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.377 1.444 . . . . 10.0 112.276 177.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.85 116.14 11.89 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.854 1.206 . . . . 10.0 110.371 -178.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.7 -29.89 65.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.311 0.645 . . . . 10.0 110.354 173.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -136.03 146.64 47.34 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.79 1.636 . . . . 10.0 107.422 178.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -60.77 -31.88 71.22 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.762 0.825 . . . . 10.0 111.755 -174.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.99 -26.35 67.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.343 0.657 . . . . 10.0 112.165 177.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.62 -32.69 74.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.357 0.598 . . . . 10.0 110.548 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.7 mt -67.48 -51.78 48.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 174.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -55.83 -41.97 75.04 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.462 -0.78 . . . . 10.0 111.141 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.79 -48.74 79.26 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.068 0.547 . . . . 10.0 111.461 177.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -47.27 86.05 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.368 -0.832 . . . . 10.0 110.33 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.56 -43.77 96.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 -177.587 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 m -62.99 -36.29 83.03 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.479 1.036 . . . . 10.0 111.029 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.33 52.95 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.34 -1.104 . . . . 10.0 110.34 173.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.08 -39.91 91.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.693 0.746 . . . . 10.0 111.686 -177.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.7 mmt -65.31 -39.14 92.09 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.724 -0.655 . . . . 10.0 111.086 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -64.85 -34.76 79.13 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.071 0.85 . . . . 10.0 110.533 176.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.67 -31.92 72.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.359 -1.305 . . . . 10.0 111.612 172.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -73.81 -54.6 7.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.534 1.061 . . . . 10.0 109.014 176.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.95 44.22 0.16 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.39 1.471 . . . . 10.0 109.881 -170.18 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.6 m -144.07 169.63 17.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.632 1.573 . . . . 10.0 109.308 -177.125 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -140.04 163.49 32.56 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.357 1.863 . . . . 10.0 108.397 178.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.0 m -139.1 156.38 47.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.67 1.123 . . . . 10.0 113.795 -167.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -139.82 130.15 25.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.872 1.669 . . . . 10.0 106.93 168.388 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.5 p -68.89 143.31 54.53 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.786 -1.196 . . . . 10.0 109.468 172.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.6 mt -105.1 -18.14 14.25 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.469 0.708 . . . . 10.0 110.906 171.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.96 -173.92 35.24 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.719 -1.352 . . . . 10.0 109.719 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.94 -174.5 28.73 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.248 -1.148 . . . . 10.0 112.006 172.585 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.44 -149.36 7.81 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.942 -1.663 . . . . 10.0 108.942 -173.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -133.48 154.51 50.75 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.652 1.181 . . . . 10.0 108.874 178.416 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.4 mt -125.31 152.02 31.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 104.994 -2.224 . . . . 10.0 104.994 173.377 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.5 m -143.29 155.5 44.49 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.904 1.282 . . . . 10.0 108.837 -176.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -158.85 144.56 16.52 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.591 -1.633 . . . . 10.0 106.591 171.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -136.91 114.81 11.37 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.216 -2.142 . . . . 10.0 105.216 169.036 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -55.55 -13.6 1.64 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.521 1.928 . . . . 10.0 116.085 -168.258 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -131.44 9.47 4.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.765 1.226 . . . . 10.0 111.374 -177.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -144.91 -32.93 0.39 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.327 1.232 . . . . 10.0 114.327 -173.052 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -147.13 124.41 11.55 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.389 -1.444 . . . . 10.0 110.304 -168.278 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -60.75 172.34 0.96 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.228 1.011 . . . . 10.0 111.267 171.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.86 123.61 8.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.266 -1.753 . . . . 10.0 106.266 171.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -141.09 149.71 41.95 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.232 -1.025 . . . . 10.0 108.232 -168.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -135.04 139.42 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.458 -0.942 . . . . 10.0 108.458 -171.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.25 -176.0 3.88 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.457 1.103 . . . . 10.0 109.702 -178.094 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.08 -167.44 45.59 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 121.653 -0.654 . . . . 10.0 111.866 175.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -152.1 158.2 42.65 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 169.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.9 p -69.07 158.71 34.28 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.637 -0.664 . . . . 10.0 110.601 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 92.8 mtp -82.97 5.57 21.62 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 118.774 -0.632 . . . . 10.0 112.541 -174.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.15 -44.97 0.11 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.465 1.029 . . . . 10.0 113.533 176.443 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -74.11 -47.12 38.4 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.209 0.913 . . . . 10.0 111.003 -169.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.94 175.76 14.2 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.72 1.629 . . . . 10.0 110.375 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -54.34 130.0 37.59 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.585 2.19 . . . . 10.0 110.105 169.509 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.89 162.67 13.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.775 0.797 . . . . 10.0 109.244 167.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -79.01 70.01 5.27 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.092 -1.447 . . . . 10.0 107.092 169.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -49.72 -36.37 25.18 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.098 1.359 . . . . 10.0 113.217 -168.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.95 -32.79 73.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.084 0.856 . . . . 10.0 112.504 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.26 -50.59 50.98 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 107.428 -1.323 . . . . 10.0 107.428 175.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.3 m -56.53 -41.89 77.54 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.195 -0.907 . . . . 10.0 111.523 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.5 p -64.38 -43.5 94.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.43 1.014 . . . . 10.0 111.172 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -61.73 -38.88 89.53 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.193 1.36 . . . . 10.0 110.886 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -63.77 -50.24 69.8 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.574 0.35 . . . . 10.0 110.222 176.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.68 -47.15 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.615 -0.883 . . . . 10.0 108.615 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -54.61 -47.43 73.4 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.3 1.04 . . . . 10.0 110.244 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.75 -39.48 88.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.662 0.385 . . . . 10.0 111.572 -178.041 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -88.05 -32.94 18.51 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 118.12 -0.943 . . . . 10.0 112.457 -175.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -66.12 133.03 94.62 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 119.577 1.081 . . . . 10.0 109.233 -178.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.72 -29.57 42.67 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.789 1.659 . . . . 10.0 113.269 -169.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.75 -2.36 56.12 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.869 0.759 . . . . 10.0 112.401 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 29.7 t80 52.04 54.57 10.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.153 1.381 . . . . 10.0 112.003 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -145.66 160.55 41.53 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.098 -1.001 . . . . 10.0 109.256 170.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.9 p -165.64 166.85 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 127.218 2.207 . . . . 10.0 105.665 178.209 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.7 p -145.58 166.55 25.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.479 1.111 . . . . 10.0 108.893 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -153.41 165.53 35.52 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.548 -0.72 . . . . 10.0 111.075 167.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.88 153.47 40.89 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.622 1.569 . . . . 10.0 108.931 174.202 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -87.39 7.52 28.62 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.585 0.754 . . . . 10.0 112.643 -173.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -57.5 144.58 36.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.25 0.62 . . . . 10.0 111.01 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.59 175.81 54.9 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.21 0.909 . . . . 10.0 113.132 -172.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.2 t80 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 117.42 -1.276 . . . . 10.0 109.255 174.806 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -147.94 151.93 36.65 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.167 -1.42 . . . . 10.0 107.167 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.41 -23.16 64.15 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.364 0.666 . . . . 10.0 112.713 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.84 -28.62 69.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.474 1.034 . . . . 10.0 112.292 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.5 -29.56 61.46 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.95 0.5 . . . . 10.0 110.769 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.1 mt -75.98 126.0 87.43 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 106.984 -1.488 . . . . 10.0 106.984 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.68 142.07 81.9 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.156 1.904 . . . . 10.0 109.292 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -78.98 -29.86 44.07 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.681 0.753 . . . . 10.0 112.172 -170.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 135.62 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 104.083 -2.562 . . . . 10.0 104.083 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -149.2 107.76 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.609 -1.997 . . . . 10.0 105.609 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.8 pt . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 108.189 -1.041 . . . . 10.0 108.189 -175.422 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -157.57 153.11 26.37 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.64 1.176 . . . . 10.0 109.496 171.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -68.06 150.78 47.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.968 0.907 . . . . 10.0 110.28 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.46 163.65 35.0 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.72 0.808 . . . . 10.0 109.233 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.89 147.35 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.258 1.023 . . . . 10.0 108.705 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 tp -106.31 119.95 40.58 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.4 130.5 71.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.081 -1.452 . . . . 10.0 107.081 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -82.21 134.36 35.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.063 -2.199 . . . . 10.0 105.063 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -119.71 138.93 48.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.255 -1.757 . . . . 10.0 106.255 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -119.4 131.17 55.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.08 -1.822 . . . . 10.0 106.08 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 p -73.51 145.78 45.36 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.867 0.758 . . . . 10.0 110.006 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.27 61.02 3.1 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 106.26 -1.756 . . . . 10.0 106.26 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -56.74 136.9 78.89 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.472 2.781 . . . . 10.0 110.955 -169.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 45.44 26.65 0.31 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.686 1.594 . . . . 10.0 113.829 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 m 55.04 26.01 7.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.27 1.428 . . . . 10.0 113.479 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.93 -1.34 0.03 OUTLIER Glycine 0 CA--C 1.532 1.101 0 N-CA-C 116.843 1.497 . . . . 10.0 116.843 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.11 152.5 84.01 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 120.114 1.957 . . . . 10.0 110.173 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.83 56.88 5.84 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.473 3.449 . . . . 10.0 111.874 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.38 137.37 30.4 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.139 1.376 . . . . 10.0 108.381 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.03 32.46 0.6 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.321 1.449 . . . . 10.0 109.829 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.83 170.09 13.28 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.469 0.708 . . . . 10.0 109.297 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 m -147.03 159.97 42.94 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.622 -0.673 . . . . 10.0 110.417 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -147.59 175.36 10.92 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.087 1.355 . . . . 10.0 108.261 169.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -105.33 150.74 24.94 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.628 -0.879 . . . . 10.0 108.628 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.2 pt -135.86 150.37 28.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.323 1.449 . . . . 10.0 109.49 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.31 126.98 64.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.388 -1.708 . . . . 10.0 106.388 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -132.48 139.15 47.83 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.96 113.88 0.5 Allowed Glycine 0 C--N 1.332 0.321 0 CA-C-N 119.473 1.033 . . . . 10.0 110.941 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -140.75 132.23 26.93 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.114 -0.699 . . . . 10.0 109.114 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -69.49 -14.81 63.07 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.048 1.129 . . . . 10.0 114.048 -171.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -66.58 -23.48 66.2 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.478 1.036 . . . . 10.0 111.943 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.79 127.64 33.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.236 0.926 . . . . 10.0 110.082 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.87 -39.23 73.0 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.541 -0.3 . . . . 10.0 110.284 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -140.5 160.6 39.64 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.663 1.585 . . . . 10.0 108.658 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -56.45 -33.19 65.65 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.323 1.049 . . . . 10.0 112.09 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.7 -31.12 69.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.038 0.935 . . . . 10.0 112.209 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -71.35 -36.07 71.38 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.998 0.817 . . . . 10.0 110.577 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mt -65.49 -50.91 69.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -57.41 -45.1 84.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.418 -0.325 . . . . 10.0 110.554 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.41 -46.3 90.71 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.994 0.518 . . . . 10.0 111.851 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -57.2 -49.49 75.84 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.016 0.371 . . . . 10.0 110.287 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.5 t -68.85 -46.39 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.8 m -58.37 -35.51 72.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.489 1.041 . . . . 10.0 111.509 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.4 -50.68 60.52 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.703 -0.959 . . . . 10.0 110.703 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.66 -44.84 95.24 Favored 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 117.539 0.67 . . . . 10.0 111.204 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -37.22 81.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.673 -0.68 . . . . 10.0 110.887 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.25 -34.96 79.59 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.161 0.891 . . . . 10.0 111.19 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.9 -33.87 77.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.93 0.786 . . . . 10.0 111.658 171.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -70.6 -52.97 17.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.093 0.861 . . . . 10.0 110.165 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.82 43.77 0.23 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.276 1.417 . . . . 10.0 110.204 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.8 m -144.24 172.29 13.13 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.015 1.726 . . . . 10.0 108.655 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -140.27 164.83 29.03 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.692 1.597 . . . . 10.0 108.228 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.0 m -133.3 159.55 39.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.048 0.939 . . . . 10.0 112.429 -169.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -148.48 117.45 6.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.253 1.821 . . . . 10.0 106.61 170.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -62.74 130.59 45.6 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.547 -0.721 . . . . 10.0 109.115 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.0 mt -90.78 -23.04 20.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.576 0.351 . . . . 10.0 110.481 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.77 179.35 29.1 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.43 -1.868 . . . . 10.0 108.43 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.46 -164.14 14.31 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.668 -0.973 . . . . 10.0 110.668 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.69 -139.48 4.28 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 108.508 -1.837 . . . . 10.0 108.508 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -139.87 157.71 45.26 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.985 1.314 . . . . 10.0 108.116 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.42 151.45 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.62 -2.363 . . . . 10.0 104.62 172.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.8 m . . . . . 0 N--CA 1.45 -0.462 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 175.754 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.236 0.367 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -138.14 157.96 45.28 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.745 0.818 . . . . 10.0 109.083 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.5 t -137.48 135.49 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.582 1.153 . . . . 10.0 108.086 -170.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -163.1 -178.53 6.09 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.329 -0.857 . . . . 10.0 111.714 -171.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.77 -163.49 49.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.662 0.649 . . . . 10.0 111.617 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -150.65 178.86 8.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.943 1.297 . . . . 10.0 108.632 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m -103.28 124.79 49.31 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.285 -1.005 . . . . 10.0 108.285 169.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.73 -30.24 67.32 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.081 0.401 . . . . 10.0 110.716 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.46 -30.94 71.78 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.119 0.968 . . . . 10.0 113.475 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.01 -57.9 0.5 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.428 1.013 . . . . 10.0 110.676 -172.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.86 -178.69 35.84 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.596 -1.402 . . . . 10.0 109.596 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.6 138.2 68.66 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.163 1.909 . . . . 10.0 110.167 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.08 161.44 24.47 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.806 -1.183 . . . . 10.0 107.806 168.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -78.82 71.67 5.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.487 -2.042 . . . . 10.0 105.487 169.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -50.33 -30.85 13.0 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.045 1.338 . . . . 10.0 113.494 -169.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.43 74.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.111 0.869 . . . . 10.0 112.061 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.36 -51.22 73.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.404 -1.332 . . . . 10.0 107.404 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -58.06 -46.16 85.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.967 -0.539 . . . . 10.0 112.128 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.4 p -66.28 -41.01 90.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.394 0.997 . . . . 10.0 110.823 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -64.86 -39.96 94.38 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.894 0.77 . . . . 10.0 110.641 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -62.76 -48.22 80.12 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 118.96 -0.543 . . . . 10.0 110.598 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.83 -45.74 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -62.2 -40.45 96.12 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.014 0.926 . . . . 10.0 111.589 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.86 -44.25 77.56 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.033 0.533 . . . . 10.0 110.819 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.9 tptt . . . . . 0 C--O 1.231 0.111 0 N-CA-C 112.669 0.618 . . . . 10.0 112.669 -172.125 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.235 0.325 0 N-CA-C 105.772 -1.936 . . . . 10.0 105.772 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.9 p -134.82 169.91 16.65 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.518 0.727 . . . . 10.0 109.76 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -140.85 166.15 25.57 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.318 0.647 . . . . 10.0 110.467 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 125.526 1.53 . . . . 10.0 108.483 172.792 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.373 0 CA-C-O 121.138 0.494 . . . . 10.0 111.236 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -152.5 146.64 25.42 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 170.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.46 -25.27 65.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 118.505 -0.759 . . . . 10.0 113.002 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.4 -26.95 68.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.113 0.87 . . . . 10.0 112.034 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -75.76 -27.64 58.15 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.82 0.448 . . . . 10.0 110.709 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.6 mt -74.74 122.09 86.71 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -51.15 139.96 42.09 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.161 2.574 . . . . 10.0 110.594 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.27 -29.47 38.31 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.087 0.946 . . . . 10.0 111.605 -172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -136.65 136.17 48.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 104.323 -2.473 . . . . 10.0 104.323 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -146.32 118.28 8.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.488 -1.301 . . . . 10.0 107.488 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.2 pt . . . . . 0 C--N 1.328 -0.336 0 C-N-CA 126.028 1.731 . . . . 10.0 106.653 -174.757 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.1 t . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 108.118 -1.067 . . . . 10.0 108.118 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -150.17 152.15 34.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.74 0.816 . . . . 10.0 110.766 169.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -70.76 150.11 46.22 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.898 0.879 . . . . 10.0 108.985 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.25 159.36 43.45 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.282 0.492 . . . . 10.0 110.899 172.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.39 145.32 28.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.684 1.594 . . . . 10.0 107.169 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.48 122.04 45.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.971 -2.233 . . . . 10.0 104.971 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.5 mt -124.94 130.15 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.884 -1.525 . . . . 10.0 106.884 -171.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -80.04 129.24 34.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.73 -2.322 . . . . 10.0 104.73 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.73 142.6 32.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -124.62 134.98 52.74 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.182 1.793 . . . . 10.0 106.785 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.9 p -65.79 140.51 58.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 110.048 -0.353 . . . . 10.0 110.048 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.33 46.25 0.48 Allowed Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 125.184 1.393 . . . . 10.0 111.99 168.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.13 159.34 26.54 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.497 2.798 . . . . 10.0 110.785 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.29 20.66 1.43 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.872 1.269 . . . . 10.0 112.141 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 52.1 22.69 1.97 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.582 1.553 . . . . 10.0 113.531 -171.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.34 32.94 0.03 OUTLIER Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.29 -0.881 . . . . 10.0 113.826 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.08 157.74 20.54 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 118.617 1.208 . . . . 10.0 110.475 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.89 57.71 4.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.085 3.19 . . . . 10.0 111.434 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.32 145.54 34.06 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.937 1.695 . . . . 10.0 108.366 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.47 31.11 0.59 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.756 1.222 . . . . 10.0 110.267 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -63.99 153.25 37.8 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.436 -0.95 . . . . 10.0 108.436 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -144.55 161.82 38.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.658 1.183 . . . . 10.0 109.992 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -150.22 176.57 10.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.764 1.226 . . . . 10.0 109.712 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -102.14 146.88 27.33 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.871 -1.159 . . . . 10.0 107.871 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.3 pt -133.67 155.27 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.859 1.264 . . . . 10.0 110.407 172.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.95 130.4 66.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.788 -1.56 . . . . 10.0 106.788 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -132.25 143.91 50.25 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.056 -1.461 . . . . 10.0 107.056 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.56 129.84 1.88 Allowed Glycine 0 C--O 1.226 -0.391 0 CA-C-N 120.489 1.495 . . . . 10.0 113.305 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -151.31 148.27 27.96 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.516 1.126 . . . . 10.0 109.153 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -88.95 -6.72 57.06 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.385 -1.293 . . . . 10.0 114.196 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -63.99 -22.65 67.02 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.019 1.281 . . . . 10.0 111.805 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.85 124.11 22.81 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.345 0.658 . . . . 10.0 109.548 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.26 -35.92 80.52 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.275 0.559 . . . . 10.0 109.642 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -142.74 151.38 41.21 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 126.411 1.885 . . . . 10.0 106.951 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -55.03 -35.7 64.72 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.37 0.668 . . . . 10.0 112.503 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.08 -24.54 58.95 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.429 -0.796 . . . . 10.0 112.445 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.13 -36.64 82.31 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.735 0.698 . . . . 10.0 110.709 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mt -65.25 -49.94 76.2 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 107.787 -1.19 . . . . 10.0 107.787 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -56.1 -46.58 79.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.902 -0.571 . . . . 10.0 111.169 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.02 -45.16 86.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.189 0.595 . . . . 10.0 111.888 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -58.84 -49.4 77.89 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.42 0.688 . . . . 10.0 109.747 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.82 -42.19 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.6 m -58.38 -35.63 72.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.591 1.087 . . . . 10.0 111.333 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.64 -48.33 82.32 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.781 -0.928 . . . . 10.0 110.781 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.34 -46.41 90.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.907 0.853 . . . . 10.0 111.272 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -36.57 83.22 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 118.643 -0.694 . . . . 10.0 110.888 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -64.5 -36.01 82.82 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.828 0.74 . . . . 10.0 110.879 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.46 -32.34 73.13 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 117.982 -1.008 . . . . 10.0 111.71 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -67.85 -57.06 6.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.152 0.887 . . . . 10.0 109.048 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.59 47.04 0.16 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.882 1.706 . . . . 10.0 109.163 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.5 m -146.32 173.62 12.08 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.719 2.008 . . . . 10.0 108.379 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -141.03 162.86 34.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.513 1.525 . . . . 10.0 108.557 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.1 m -134.47 158.75 43.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.425 1.09 . . . . 10.0 112.398 -168.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -148.45 122.21 9.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.954 1.702 . . . . 10.0 106.944 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.7 p -64.56 128.54 36.22 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.772 -1.205 . . . . 10.0 109.368 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.06 -25.97 19.39 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.14 -177.74 35.58 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.548 -1.421 . . . . 10.0 109.548 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.82 -174.67 24.27 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 118.222 1.011 . . . . 10.0 112.015 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.66 -145.96 5.35 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.12 -1.592 . . . . 10.0 109.12 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.8 mtm-85 -137.74 155.31 49.21 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.148 -1.207 . . . . 10.0 108.37 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.9 mt -122.63 148.73 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 105.024 -2.213 . . . . 10.0 105.024 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 125.006 1.322 . . . . 10.0 108.638 -179.96 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.5 mt . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 107.283 -1.377 . . . . 10.0 107.283 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -140.47 162.83 34.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.033 0.933 . . . . 10.0 109.672 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.3 144.35 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.12 -1.808 . . . . 10.0 106.12 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -161.19 179.15 8.6 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.283 -0.886 . . . . 10.0 110.218 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.26 -176.21 47.63 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.092 0.377 . . . . 10.0 112.651 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -155.77 134.71 12.01 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.757 0.823 . . . . 10.0 109.958 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 m -74.24 95.55 2.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.912 0.885 . . . . 10.0 109.785 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 76.9 mtm -57.62 -14.44 5.4 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.878 0.871 . . . . 10.0 112.602 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.34 -27.7 48.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.691 1.196 . . . . 10.0 113.121 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -47.63 0.33 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.862 0.756 . . . . 10.0 110.882 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.8 173.85 23.35 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.28 1.419 . . . . 10.0 109.862 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.37 134.23 56.32 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.791 2.327 . . . . 10.0 111.071 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.41 162.06 21.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 167.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.99 71.2 5.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.134 -1.432 . . . . 10.0 107.134 169.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -54.42 -26.25 29.64 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.75 1.22 . . . . 10.0 113.376 -170.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.86 92.76 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.476 1.035 . . . . 10.0 111.745 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.6 mt -67.47 -49.87 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.418 -1.327 . . . . 10.0 107.418 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 m -58.84 -44.54 90.98 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.863 -0.589 . . . . 10.0 112.06 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.0 p -64.95 -41.53 95.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.058 -0.972 . . . . 10.0 111.009 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -64.19 -39.33 93.76 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.384 0.993 . . . . 10.0 110.807 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -65.43 -48.22 73.54 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.926 -0.484 . . . . 10.0 110.67 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.24 -42.94 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.298 -1.001 . . . . 10.0 108.298 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -59.49 -45.59 91.23 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.925 0.89 . . . . 10.0 110.41 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.72 95.45 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.552 0.614 . . . . 10.0 111.396 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 tptm . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 118.668 -0.682 . . . . 10.0 110.943 178.576 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.6 p -139.73 172.24 13.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.208 1.403 . . . . 10.0 108.749 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -140.45 163.72 32.05 Favored 'General case' 0 C--O 1.227 -0.114 0 O-C-N 121.543 -0.723 . . . . 10.0 112.406 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 126.5 1.92 . . . . 10.0 108.504 172.6 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 107.118 -1.438 . . . . 10.0 107.118 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -152.17 150.64 30.08 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.389 -1.337 . . . . 10.0 107.389 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.4 -26.66 65.33 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.679 0.792 . . . . 10.0 112.832 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.94 -26.25 68.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.936 0.789 . . . . 10.0 112.159 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.1 mt -75.79 -25.27 56.25 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.034 0.534 . . . . 10.0 110.982 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.4 mt -78.68 122.82 85.29 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -50.74 133.53 39.23 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.499 2.8 . . . . 10.0 110.721 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -82.52 -28.65 30.94 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.504 0.668 . . . . 10.0 112.074 -170.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.08 134.91 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.893 -2.262 . . . . 10.0 104.893 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -150.64 113.82 4.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.056 -1.831 . . . . 10.0 106.056 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt . . . . . 0 CA--C 1.535 0.39 0 C-N-CA 124.681 1.192 . . . . 10.0 110.258 -169.235 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -146.35 147.06 30.93 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.855 0.862 . . . . 10.0 109.618 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.02 146.89 50.7 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.79 -0.818 . . . . 10.0 108.79 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.01 158.78 43.28 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.599 -0.889 . . . . 10.0 108.599 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.75 150.6 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.171 1.388 . . . . 10.0 107.698 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.6 tp -115.13 115.71 27.21 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.9 138.29 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.759 -1.571 . . . . 10.0 106.759 -169.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -92.86 135.4 34.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.674 -1.602 . . . . 10.0 106.674 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.11 139.99 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 105.824 -1.917 . . . . 10.0 105.824 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -115.11 130.0 56.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.914 -1.884 . . . . 10.0 105.914 173.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 p -70.17 143.51 52.25 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.03 61.44 3.37 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.721 1.208 . . . . 10.0 108.325 169.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -58.93 152.25 59.41 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.247 2.631 . . . . 10.0 111.103 -169.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 65.92 -61.38 0.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 128.122 2.569 . . . . 10.0 112.135 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 p -171.11 -33.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.425 2.29 . . . . 10.0 108.864 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.66 42.63 0.13 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.05 1.31 . . . . 10.0 110.574 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.02 157.23 11.53 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.339 0.656 . . . . 10.0 110.262 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.52 59.46 5.54 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.181 3.254 . . . . 10.0 112.474 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.18 136.36 26.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.074 1.749 . . . . 10.0 107.297 171.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.38 30.21 0.85 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.775 1.23 . . . . 10.0 110.054 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -64.87 161.07 19.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.79 -0.819 . . . . 10.0 108.79 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.5 m -141.08 159.51 42.05 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.233 1.013 . . . . 10.0 110.009 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -149.83 170.19 19.35 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.503 1.121 . . . . 10.0 109.617 171.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -99.95 154.45 18.37 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.211 -0.663 . . . . 10.0 109.211 170.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.0 pt -137.12 154.03 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.291 1.436 . . . . 10.0 109.956 174.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.35 126.84 65.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.453 -1.684 . . . . 10.0 106.453 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -133.94 143.06 47.97 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.738 -1.579 . . . . 10.0 106.738 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.84 129.47 1.65 Allowed Glycine 0 C--O 1.227 -0.295 0 CA-C-N 120.259 1.39 . . . . 10.0 111.378 171.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -145.0 141.5 28.98 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.454 0.702 . . . . 10.0 110.432 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -70.51 -21.98 62.68 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 118.358 -0.83 . . . . 10.0 113.195 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -66.44 -25.13 66.6 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.586 1.085 . . . . 10.0 112.629 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.67 126.32 29.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.252 0.933 . . . . 10.0 110.114 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.49 -31.96 65.81 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 122.621 0.368 . . . . 10.0 110.249 170.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -146.05 152.22 38.99 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.339 1.456 . . . . 10.0 109.13 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -56.93 -31.46 64.98 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.004 1.322 . . . . 10.0 112.626 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.18 -31.55 69.1 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.674 -0.679 . . . . 10.0 112.047 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.74 -41.65 78.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.647 0.658 . . . . 10.0 110.107 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.3 mt -62.78 -50.74 78.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 108.312 -0.996 . . . . 10.0 108.312 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -55.34 -43.7 75.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.834 -0.603 . . . . 10.0 111.295 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.11 -46.59 83.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.609 0.64 . . . . 10.0 111.666 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -57.61 -49.9 74.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.132 0.573 . . . . 10.0 109.643 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.51 -44.31 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 m -56.61 -42.52 78.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.025 0.83 . . . . 10.0 110.9 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.52 -48.37 86.35 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.78 -0.928 . . . . 10.0 110.78 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -62.29 -47.38 84.55 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 118.16 0.98 . . . . 10.0 111.046 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -39.51 87.5 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 119.011 -0.518 . . . . 10.0 110.69 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -65.51 -33.76 76.68 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.567 0.621 . . . . 10.0 110.896 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.08 -34.0 77.08 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 117.239 -1.362 . . . . 10.0 111.21 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -69.47 -65.89 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.292 0.951 . . . . 10.0 108.682 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.79 42.24 0.04 OUTLIER Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.371 1.462 . . . . 10.0 110.491 -169.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.1 m -146.38 176.11 10.03 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.596 1.958 . . . . 10.0 107.935 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -145.21 165.72 27.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.168 0.987 . . . . 10.0 108.764 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.9 m -130.15 155.08 46.81 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.289 0.949 . . . . 10.0 113.019 -169.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -141.57 136.97 31.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.074 1.749 . . . . 10.0 106.774 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.5 t -78.77 141.66 37.62 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.598 -0.689 . . . . 10.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.4 mt -103.48 -20.36 14.07 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.377 0.671 . . . . 10.0 111.146 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.71 -177.96 34.25 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.814 -0.914 . . . . 10.0 110.814 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.15 178.42 32.68 Favored Glycine 0 CA--C 1.521 0.427 0 O-C-N 121.631 -0.923 . . . . 10.0 112.356 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.97 -145.6 5.6 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 109.84 -1.304 . . . . 10.0 109.84 -172.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -142.55 161.72 37.32 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.894 2.078 . . . . 10.0 107.755 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.8 mt -132.29 145.32 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 105.929 -1.878 . . . . 10.0 105.929 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.0 p . . . . . 0 CA--C 1.535 0.385 0 C-N-CA 124.431 1.092 . . . . 10.0 110.747 -175.833 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.3 mm . . . . . 0 N--CA 1.464 0.268 0 N-CA-C 101.676 -3.453 . . . . 10.0 101.676 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -117.53 145.63 44.11 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.5 -0.555 . . . . 10.0 109.5 -167.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 32.1 t -135.17 130.49 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.917 -1.512 . . . . 10.0 106.917 -170.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -166.86 169.46 13.17 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.135 -0.978 . . . . 10.0 109.47 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.03 -174.63 19.84 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 119.272 0.942 . . . . 10.0 114.435 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -140.41 1.31 1.76 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.413 1.264 . . . . 10.0 114.413 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.6 p 50.53 -25.55 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 129.707 3.203 . . . . 10.0 119.007 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 12.3 tmm? 66.58 -48.39 0.45 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.574 2.35 . . . . 10.0 111.009 -168.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.74 70.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.363 1.465 . . . . 10.0 113.016 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -133.93 -50.25 0.82 Allowed 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.643 0.656 . . . . 10.0 111.747 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.02 170.96 12.31 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 109.37 -1.492 . . . . 10.0 109.37 -170.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.05 130.97 40.59 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.029 2.486 . . . . 10.0 111.8 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.66 158.88 28.92 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 168.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -77.1 73.34 3.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -54.61 -26.24 31.52 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.199 0.999 . . . . 10.0 112.835 -170.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.29 -41.06 98.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.261 0.937 . . . . 10.0 112.08 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.2 mt -64.52 -50.24 76.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 107.497 -1.298 . . . . 10.0 107.497 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -60.09 -43.62 95.39 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 119.129 -0.462 . . . . 10.0 111.892 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.9 p -66.58 -37.83 85.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.064 0.847 . . . . 10.0 111.547 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -64.89 -38.97 92.76 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.418 1.008 . . . . 10.0 110.796 175.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -66.66 -45.06 80.17 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 122.042 -0.411 . . . . 10.0 110.626 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.86 -48.72 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -59.03 -40.02 83.75 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.158 0.89 . . . . 10.0 111.567 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.33 72.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.992 0.815 . . . . 10.0 111.977 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt . . . . . 0 CA--C 1.538 0.516 0 CA-C-O 118.534 -0.746 . . . . 10.0 112.822 174.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 107.597 -1.26 . . . . 10.0 107.597 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.0 p -145.53 158.42 43.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.826 1.65 . . . . 10.0 108.926 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -151.22 164.23 37.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.838 0.681 . . . . 10.0 112.838 173.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 126.606 1.962 . . . . 10.0 108.436 170.206 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -151.05 152.05 32.89 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.016 -1.105 . . . . 10.0 108.016 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -59.53 -22.4 61.61 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.937 0.895 . . . . 10.0 113.04 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.94 -24.56 66.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.637 1.108 . . . . 10.0 112.435 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.5 mt -78.96 -17.1 56.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.455 0.702 . . . . 10.0 111.745 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 25.8 mt -100.36 132.35 22.65 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.46 142.33 64.98 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.388 2.058 . . . . 10.0 110.272 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -78.51 -28.88 46.35 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.816 0.847 . . . . 10.0 112.163 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.26 134.38 47.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 106.086 -1.82 . . . . 10.0 106.086 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -152.96 113.42 4.04 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.3 pt . . . . . 0 C--N 1.327 -0.382 0 C-N-CA 124.56 1.144 . . . . 10.0 109.962 -169.548 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 CA--C 1.537 0.444 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -150.37 147.84 28.08 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.986 0.914 . . . . 10.0 109.734 171.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -74.93 157.88 34.25 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.672 -0.862 . . . . 10.0 108.672 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.71 160.35 43.25 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.549 0.34 . . . . 10.0 110.458 173.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 t -133.57 141.89 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.453 1.501 . . . . 10.0 107.383 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 tp -98.63 115.84 29.54 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 104.654 -2.35 . . . . 10.0 104.654 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.3 mt -122.83 124.84 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.625 -1.62 . . . . 10.0 106.625 -167.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -82.53 140.16 33.46 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 168.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.2 t -133.13 142.65 41.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.446 -1.687 . . . . 10.0 106.446 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -126.29 136.96 53.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.509 1.524 . . . . 10.0 107.119 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.9 m -67.56 140.44 56.95 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.36 57.31 2.77 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.399 1.479 . . . . 10.0 107.981 167.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -59.97 135.12 60.88 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.333 2.689 . . . . 10.0 109.834 -169.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 47.34 26.04 0.67 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.028 1.331 . . . . 10.0 112.956 -174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m 48.23 31.28 2.55 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.458 1.503 . . . . 10.0 113.655 -172.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -172.64 -3.39 0.03 OUTLIER Glycine 0 CA--C 1.531 1.051 0 N-CA-C 117.019 1.568 . . . . 10.0 117.019 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.05 151.08 81.76 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 120.433 2.116 . . . . 10.0 110.556 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.03 52.06 3.9 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.315 3.344 . . . . 10.0 111.54 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.53 136.07 30.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.003 1.321 . . . . 10.0 108.723 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.7 31.5 1.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.327 1.451 . . . . 10.0 109.762 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -61.97 151.48 34.91 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.51 -0.922 . . . . 10.0 108.51 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.4 m -139.39 158.49 44.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.799 0.84 . . . . 10.0 110.686 -175.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -152.41 176.78 11.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.807 1.243 . . . . 10.0 109.247 171.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -117.0 142.82 46.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.0 pt -131.17 156.42 42.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.623 1.169 . . . . 10.0 110.067 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.42 125.8 65.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.915 -1.883 . . . . 10.0 105.915 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -130.13 139.17 50.93 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.0 132.76 2.5 Favored Glycine 0 C--O 1.224 -0.527 0 CA-C-N 120.03 1.286 . . . . 10.0 111.817 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -144.75 144.18 31.06 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 122.888 0.475 . . . . 10.0 111.178 -169.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -64.58 -32.45 74.11 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.845 0.858 . . . . 10.0 112.248 -174.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -68.59 -16.69 63.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 117.912 -1.042 . . . . 10.0 113.008 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.8 119.31 6.91 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.631 1.105 . . . . 10.0 111.629 -172.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.13 -37.36 81.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.161 0.584 . . . . 10.0 110.18 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -149.67 168.86 22.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 127.142 2.177 . . . . 10.0 107.598 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -59.6 -29.37 67.94 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.135 -0.978 . . . . 10.0 111.805 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.92 68.9 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.838 0.855 . . . . 10.0 112.359 172.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -66.39 -42.6 87.65 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.795 0.807 . . . . 10.0 109.802 -176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.78 -53.84 37.17 Favored 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.214 -1.032 . . . . 10.0 108.214 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -59.14 -39.17 81.55 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 119.027 -0.511 . . . . 10.0 110.992 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.51 -46.02 90.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.445 0.566 . . . . 10.0 111.761 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.83 -49.16 75.99 Favored 'General case' 0 C--N 1.345 0.373 0 O-C-N 121.691 -0.63 . . . . 10.0 109.661 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.79 -43.73 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.301 -0.629 . . . . 10.0 109.301 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.7 p -65.09 -34.05 77.49 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.251 0.932 . . . . 10.0 111.205 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.98 -51.21 60.02 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.393 -1.083 . . . . 10.0 110.393 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.98 -46.25 91.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 117.357 0.579 . . . . 10.0 110.792 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.9 mmt -61.84 -37.75 85.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.702 -0.624 . . . . 10.0 110.812 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -64.86 -36.49 84.52 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.997 0.817 . . . . 10.0 111.14 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -66.61 -34.22 77.41 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.994 -1.003 . . . . 10.0 111.304 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -68.15 -54.22 19.53 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.841 0.746 . . . . 10.0 109.546 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.52 44.04 0.2 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.453 1.502 . . . . 10.0 110.551 -171.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.4 m -144.91 171.68 14.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.229 1.812 . . . . 10.0 109.047 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -139.54 160.92 38.74 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.432 1.493 . . . . 10.0 108.709 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.8 m -127.71 157.59 39.91 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.847 1.259 . . . . 10.0 112.98 -168.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -145.52 111.75 5.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.677 1.991 . . . . 10.0 106.283 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -63.42 118.9 8.75 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.97 -1.081 . . . . 10.0 108.775 171.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 mt -80.7 -29.02 36.49 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 110.171 -0.307 . . . . 10.0 110.171 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.64 -178.43 39.84 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.157 -1.977 . . . . 10.0 108.157 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.99 -168.86 20.19 Favored Glycine 0 CA--C 1.519 0.314 0 O-C-N 121.398 -1.06 . . . . 10.0 110.851 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.17 -151.41 9.07 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.358 -1.897 . . . . 10.0 108.358 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -144.13 165.4 27.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -134.32 151.46 32.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 104.835 -2.283 . . . . 10.0 104.835 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 107.985 -1.117 . . . . 10.0 107.985 177.182 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.7 pt . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 106.865 -1.531 . . . . 10.0 106.865 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -99.79 126.69 45.91 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.199 -1.038 . . . . 10.0 108.199 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.42 145.31 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 106.652 -1.61 . . . . 10.0 106.652 174.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -161.67 178.77 8.71 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.687 0.795 . . . . 10.0 110.182 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.89 -158.26 46.31 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-O 121.328 0.405 . . . . 10.0 112.92 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -158.67 158.03 32.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.557 1.943 . . . . 10.0 107.56 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 t -72.09 130.78 41.71 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 60.4 mtt -73.3 -19.32 61.07 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.604 0.565 . . . . 10.0 110.811 169.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.95 -31.32 22.18 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.536 -0.745 . . . . 10.0 112.077 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -128.17 -54.53 1.28 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.889 0.768 . . . . 10.0 111.297 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.09 179.85 22.58 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.837 1.208 . . . . 10.0 110.165 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.39 133.42 58.0 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.113 2.542 . . . . 10.0 111.673 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.69 165.76 20.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 166.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -80.12 68.22 6.19 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 168.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -49.45 -33.03 13.12 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.463 1.505 . . . . 10.0 113.709 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.5 77.18 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.993 0.815 . . . . 10.0 112.231 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.72 -50.97 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 107.097 -1.445 . . . . 10.0 107.097 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -55.94 -46.52 78.48 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.468 -0.777 . . . . 10.0 112.137 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.6 p -64.99 -42.32 94.63 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 119.721 1.146 . . . . 10.0 111.034 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.87 -39.44 90.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.864 0.756 . . . . 10.0 110.979 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -59.83 -51.66 68.77 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 118.818 -0.61 . . . . 10.0 109.836 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.47 -48.81 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.419 -0.956 . . . . 10.0 108.419 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -60.99 -40.75 94.66 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.693 0.797 . . . . 10.0 111.513 -175.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.12 77.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.122 0.569 . . . . 10.0 110.842 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 118.62 -0.705 . . . . 10.0 112.082 -173.766 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.236 0.346 0 N-CA-C 107.138 -1.43 . . . . 10.0 107.138 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -142.44 170.65 15.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.646 1.178 . . . . 10.0 108.707 173.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -138.75 163.28 32.6 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 122.851 0.46 . . . . 10.0 111.886 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.417 0 C-N-CA 126.164 1.785 . . . . 10.0 108.727 169.939 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 109.785 -0.45 . . . . 10.0 109.785 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -151.16 151.32 31.76 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.931 1.292 . . . . 10.0 107.542 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.13 -24.06 62.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 118.237 -0.887 . . . . 10.0 112.886 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.88 -25.9 67.02 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.605 1.093 . . . . 10.0 112.451 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.2 mt -74.94 -23.77 58.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.123 0.569 . . . . 10.0 111.366 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.9 mt -89.2 128.97 49.51 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 107.071 -1.455 . . . . 10.0 107.071 -173.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.81 147.17 80.48 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.165 1.91 . . . . 10.0 110.67 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.92 -35.61 72.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.779 1.632 . . . . 10.0 111.603 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.64 133.26 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.625 -2.361 . . . . 10.0 104.625 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -150.32 114.3 5.07 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.063 -1.829 . . . . 10.0 106.063 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.3 pt . . . . . 0 N--CA 1.453 -0.323 0 C-N-CA 124.502 1.121 . . . . 10.0 109.525 -170.227 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 108.576 -0.898 . . . . 10.0 108.576 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -146.82 151.16 36.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.694 0.797 . . . . 10.0 109.981 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -55.95 153.46 8.69 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.64 1.176 . . . . 10.0 111.629 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.51 160.9 43.08 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.074 0.95 . . . . 10.0 108.965 168.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.12 147.25 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.703 1.201 . . . . 10.0 108.911 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -107.77 117.99 35.56 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.566 -2.013 . . . . 10.0 105.566 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.3 mt -123.19 132.34 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.522 -1.659 . . . . 10.0 106.522 -170.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -85.32 125.3 32.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.537 -2.023 . . . . 10.0 105.537 167.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.38 141.17 24.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 106.604 -1.628 . . . . 10.0 106.604 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -121.6 130.1 53.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.976 -1.861 . . . . 10.0 105.976 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.6 p -71.03 144.32 50.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.958 -0.386 . . . . 10.0 109.958 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.0 61.83 3.56 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.567 1.547 . . . . 10.0 107.603 166.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -58.08 143.9 95.76 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.944 2.429 . . . . 10.0 110.601 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 48.18 23.72 0.57 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.842 1.257 . . . . 10.0 113.111 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m 49.05 30.95 3.09 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.225 1.41 . . . . 10.0 113.683 -172.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.62 -2.34 0.02 OUTLIER Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.762 1.465 . . . . 10.0 116.762 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.16 152.22 78.94 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 119.937 1.868 . . . . 10.0 110.657 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.78 57.77 6.18 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.285 3.323 . . . . 10.0 112.098 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.24 136.91 30.32 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 125.073 1.349 . . . . 10.0 108.309 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.79 28.53 0.77 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.897 1.279 . . . . 10.0 110.448 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.04 159.94 24.86 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.375 -0.828 . . . . 10.0 109.095 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.0 m -139.76 162.12 35.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.874 0.87 . . . . 10.0 110.694 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -149.29 174.88 11.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.647 1.179 . . . . 10.0 109.351 170.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -99.3 148.85 23.73 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 pt -136.53 148.62 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.604 1.562 . . . . 10.0 109.72 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.7 t -106.94 127.34 62.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -132.68 141.95 48.84 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.618 -1.253 . . . . 10.0 107.618 -176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.06 107.21 0.23 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 110.132 -1.187 . . . . 10.0 110.132 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.97 132.62 42.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 -171.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -59.55 -23.95 63.3 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.791 1.404 . . . . 10.0 114.791 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -67.39 -24.65 65.7 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.315 0.961 . . . . 10.0 112.425 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.98 125.42 29.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.744 1.157 . . . . 10.0 109.799 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -74.29 -33.59 63.28 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.392 0.615 . . . . 10.0 109.855 171.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -143.71 155.91 44.36 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.15 1.38 . . . . 10.0 110.008 -172.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -58.66 -33.87 70.6 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.415 1.486 . . . . 10.0 112.94 -171.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.94 -31.09 70.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.383 -0.818 . . . . 10.0 111.513 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -70.93 -38.54 72.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.86 0.755 . . . . 10.0 110.124 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.4 mt -63.88 -50.34 77.95 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -52.92 -48.26 67.39 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.427 -0.797 . . . . 10.0 111.123 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.2 -47.15 83.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.417 0.553 . . . . 10.0 111.255 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -59.48 -51.42 69.95 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.872 -0.518 . . . . 10.0 110.153 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.1 t -66.98 -41.26 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.678 -0.86 . . . . 10.0 108.678 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 m -62.91 -36.04 82.06 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.629 1.104 . . . . 10.0 111.547 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.77 -51.13 59.45 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.163 -1.175 . . . . 10.0 110.163 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.29 -43.45 98.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.793 0.797 . . . . 10.0 111.016 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.1 mmt -62.32 -37.0 83.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 121.71 -0.619 . . . . 10.0 111.433 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -65.03 -36.17 83.52 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.009 0.822 . . . . 10.0 110.755 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.78 -32.72 74.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.64 -1.172 . . . . 10.0 111.509 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -68.99 -52.16 31.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.718 1.144 . . . . 10.0 109.727 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.08 50.12 0.24 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.766 -1.734 . . . . 10.0 108.766 -169.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.0 m -147.69 170.65 17.08 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.532 1.933 . . . . 10.0 109.216 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -140.2 165.38 27.52 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.276 1.83 . . . . 10.0 108.48 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.1 m -134.48 156.14 49.12 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.582 1.153 . . . . 10.0 112.358 -167.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -149.25 123.23 9.39 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.135 -1.802 . . . . 10.0 106.135 169.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.71 126.98 31.35 Favored 'General case' 0 C--O 1.226 -0.178 0 O-C-N 121.038 -1.039 . . . . 10.0 109.334 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.99 -27.33 35.97 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 122.097 -0.377 . . . . 10.0 110.306 170.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.1 -177.87 38.14 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.966 -1.654 . . . . 10.0 108.966 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.96 -173.01 21.87 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.5 -1.0 . . . . 10.0 111.48 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.51 -146.77 6.4 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.511 -1.836 . . . . 10.0 108.511 -173.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -147.71 159.91 43.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.601 1.161 . . . . 10.0 109.505 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.9 mt -128.7 149.32 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.513 -2.032 . . . . 10.0 105.513 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.2 p . . . . . 0 C--O 1.237 0.445 0 C-N-CA 124.245 1.018 . . . . 10.0 108.814 170.432 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.0 mt . . . . . 0 C--O 1.238 0.491 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -136.38 147.14 47.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.415 -1.328 . . . . 10.0 107.415 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.69 135.51 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.173 -1.417 . . . . 10.0 107.173 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -164.79 175.29 9.79 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.941 0.897 . . . . 10.0 109.695 -170.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.52 -174.19 20.87 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 121.722 0.624 . . . . 10.0 112.76 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -141.9 24.81 1.99 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.047 0.939 . . . . 10.0 111.862 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.7 p 59.46 -174.89 0.1 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.511 1.924 . . . . 10.0 112.832 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.0 mtt -128.55 21.81 6.01 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.192 1.397 . . . . 10.0 109.039 167.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.24 -28.83 0.45 Allowed 'General case' 0 C--N 1.347 0.488 0 N-CA-C 115.172 1.545 . . . . 10.0 115.172 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.89 -52.54 0.52 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.484 1.493 . . . . 10.0 111.554 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.29 177.79 25.44 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.42 1.486 . . . . 10.0 109.646 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.3 134.45 45.31 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.759 2.306 . . . . 10.0 111.178 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.55 160.93 18.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.963 0.887 . . . . 10.0 109.085 165.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -80.33 75.4 7.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.724 -1.584 . . . . 10.0 106.724 169.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -54.53 -23.74 17.8 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.724 1.209 . . . . 10.0 113.546 -170.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.45 -40.37 94.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.703 1.138 . . . . 10.0 111.675 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.7 mt -65.16 -51.84 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.7 m -57.83 -45.42 86.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.712 -0.661 . . . . 10.0 112.003 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.0 p -68.74 -38.61 80.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 117.775 -1.107 . . . . 10.0 111.654 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.4 -40.29 96.82 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.076 1.307 . . . . 10.0 110.71 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -62.74 -50.43 71.09 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.133 -0.355 . . . . 10.0 110.064 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.2 -39.46 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 120.651 -1.281 . . . . 10.0 109.076 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -62.03 -41.55 98.21 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 119.624 1.102 . . . . 10.0 110.66 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.34 -41.3 96.84 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.315 0.961 . . . . 10.0 111.048 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 118.252 -0.88 . . . . 10.0 110.66 176.224 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 108.644 -0.873 . . . . 10.0 108.644 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.63 169.27 21.97 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.569 1.548 . . . . 10.0 109.96 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.6 p-90 -145.63 166.18 26.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.755 1.162 . . . . 10.0 111.243 172.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 125.98 1.712 . . . . 10.0 108.236 169.22 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 106.753 -1.573 . . . . 10.0 106.753 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -144.89 147.05 32.33 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.382 -1.71 . . . . 10.0 106.382 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -59.05 -26.21 64.39 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.54 -24.92 67.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.704 0.684 . . . . 10.0 112.713 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.83 -27.74 57.99 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.37 0.532 . . . . 10.0 110.61 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 mt -79.94 132.52 60.27 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.11 147.88 80.17 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.453 2.102 . . . . 10.0 109.531 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.49 -28.61 46.41 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.287 0.565 . . . . 10.0 112.131 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -137.96 135.51 45.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.256 1.422 . . . . 10.0 107.173 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -147.84 99.8 3.13 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.541 -1.281 . . . . 10.0 107.541 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.6 pt . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 125.656 1.583 . . . . 10.0 109.736 -169.456 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 108.283 -1.006 . . . . 10.0 108.283 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -141.94 148.67 39.02 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.059 1.344 . . . . 10.0 108.977 173.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -60.43 151.61 27.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.658 0.783 . . . . 10.0 109.187 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.08 162.07 41.66 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.633 -0.667 . . . . 10.0 110.563 170.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.84 152.86 31.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.889 1.276 . . . . 10.0 109.677 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 tp -102.63 114.3 28.41 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.654 -2.351 . . . . 10.0 104.654 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.4 mt -116.58 132.13 67.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.2 -1.778 . . . . 10.0 106.2 -170.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -88.51 139.51 30.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.437 -1.69 . . . . 10.0 106.437 168.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -128.98 142.43 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.076 -1.824 . . . . 10.0 106.076 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -120.6 133.57 55.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.189 -1.782 . . . . 10.0 106.189 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 p -65.8 140.65 58.42 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.766 -0.457 . . . . 10.0 109.766 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.9 60.2 2.89 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.24 1.416 . . . . 10.0 108.676 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.36 143.63 99.49 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.05 2.5 . . . . 10.0 108.941 -174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.0 tpt85 53.12 16.17 0.73 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.637 1.175 . . . . 10.0 113.102 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 m 54.97 24.15 5.67 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.44 1.096 . . . . 10.0 113.222 -170.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.87 1.47 0.03 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.652 1.421 . . . . 10.0 116.652 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.53 153.35 77.67 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 119.984 1.892 . . . . 10.0 110.252 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.95 64.42 7.7 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.315 3.344 . . . . 10.0 111.925 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.32 140.0 35.55 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.378 1.471 . . . . 10.0 108.346 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.36 26.17 0.78 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.806 1.242 . . . . 10.0 110.65 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.88 159.96 27.16 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 169.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -139.45 162.64 34.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.154 0.982 . . . . 10.0 111.135 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -152.43 145.3 24.4 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.318 1.847 . . . . 10.0 107.71 -170.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.2 144.03 28.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 169.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.8 pt -134.74 151.37 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.238 1.015 . . . . 10.0 109.965 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.29 127.12 56.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 105.875 -1.898 . . . . 10.0 105.875 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.412 ' HG3' HG21 ' A' ' 60' ' ' VAL . 6.2 mmp_? -130.28 133.63 46.63 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.55 49.51 0.33 Allowed Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.068 -0.813 . . . . 10.0 111.068 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -65.92 132.95 49.84 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -63.1 -27.12 69.17 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.924 1.083 . . . . 10.0 113.924 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -69.39 -20.61 63.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 117.958 -1.02 . . . . 10.0 112.641 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.44 133.93 52.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.29 0.95 . . . . 10.0 111.031 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -79.49 -35.61 39.9 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.509 0.671 . . . . 10.0 109.901 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -143.7 163.42 33.34 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.96 1.304 . . . . 10.0 110.109 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 94' ' ' SER . 53.2 m80 -57.54 -40.87 79.81 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.921 0.888 . . . . 10.0 111.466 175.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.74 -25.25 66.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.674 -0.679 . . . . 10.0 112.4 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -67.3 -41.49 85.28 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.148 0.975 . . . . 10.0 109.149 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.67 -55.26 23.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.13 -1.063 . . . . 10.0 108.13 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -57.6 -41.02 80.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 119.171 -0.443 . . . . 10.0 111.732 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.68 -44.8 92.64 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.724 0.409 . . . . 10.0 111.612 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.39 -51.35 69.88 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.412 HG21 ' HG3' ' A' ' 45' ' ' ARG . 93.4 t -62.44 -39.86 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 118.201 -0.904 . . . . 10.0 110.05 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.0 m -61.77 -46.34 90.01 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.275 0.943 . . . . 10.0 110.362 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.51 -44.62 94.91 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.006 -0.838 . . . . 10.0 111.006 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -58.59 -52.8 64.12 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.07 1.348 . . . . 10.0 109.481 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.6 mmt -61.39 -37.81 84.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.253 0.621 . . . . 10.0 111.485 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -64.19 -37.83 88.89 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 119.224 0.92 . . . . 10.0 110.85 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.92 -37.53 87.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 117.702 -1.142 . . . . 10.0 110.942 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -67.55 -51.14 54.22 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.714 0.688 . . . . 10.0 109.727 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.11 41.16 0.29 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.86 1.219 . . . . 10.0 110.789 -169.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.4 m -145.51 171.5 14.57 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.961 1.704 . . . . 10.0 108.742 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -140.11 164.49 29.89 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.81 1.644 . . . . 10.0 108.239 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.6 m -130.58 164.83 24.06 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.506 1.048 . . . . 10.0 113.401 -168.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.98 132.88 16.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.184 2.194 . . . . 10.0 105.203 168.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -80.61 132.05 35.57 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.785 -1.197 . . . . 10.0 108.138 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.5 mt -87.63 -21.54 25.25 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 119.263 -0.399 . . . . 10.0 110.625 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.86 -178.32 26.5 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 109.148 -1.581 . . . . 10.0 109.148 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.08 -171.83 24.49 Favored Glycine 0 C--N 1.329 0.183 0 O-C-N 121.706 -0.879 . . . . 10.0 111.866 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.18 -140.6 4.7 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 107.364 -2.295 . . . . 10.0 107.364 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -139.31 149.44 44.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.883 -1.155 . . . . 10.0 107.883 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.24 146.05 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.871 -2.27 . . . . 10.0 104.871 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.454 -0.23 0 C-N-CA 123.812 0.845 . . . . 10.0 111.173 -168.616 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.5 mt . . . . . 0 C--O 1.234 0.261 0 N-CA-C 105.247 -2.131 . . . . 10.0 105.247 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.2 t60 -132.76 164.71 26.19 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.992 0.808 . . . . 10.0 110.605 -166.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 t -133.51 130.61 56.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.136 1.374 . . . . 10.0 107.767 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.11 178.17 10.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.568 0.747 . . . . 10.0 110.894 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.42 -175.95 45.61 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.661 -0.575 . . . . 10.0 111.661 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.84 152.26 41.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.086 1.354 . . . . 10.0 107.36 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.408 ' HA ' ' CE1' ' A' ' 53' ' ' HIS . 78.7 p -67.57 142.52 56.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.715 -0.616 . . . . 10.0 109.868 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.1 mtp -70.26 -29.65 66.48 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.759 -0.459 . . . . 10.0 109.759 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.29 -33.52 63.27 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 117.883 -1.056 . . . . 10.0 113.307 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -136.32 -52.2 0.71 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.588 1.085 . . . . 10.0 112.489 -169.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.45 -174.99 23.72 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.855 1.216 . . . . 10.0 110.248 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.81 138.39 57.87 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.716 2.277 . . . . 10.0 111.249 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.2 167.6 20.0 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.996 -1.113 . . . . 10.0 107.996 165.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -80.23 79.06 6.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.368 -1.716 . . . . 10.0 106.368 168.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -56.11 -32.36 64.12 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 124.133 0.973 . . . . 10.0 111.6 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.97 -42.28 97.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.801 0.728 . . . . 10.0 112.214 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.2 mt -63.87 -46.93 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.212 -1.403 . . . . 10.0 107.212 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.5 m -57.12 -44.9 83.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.212 -0.899 . . . . 10.0 111.752 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.1 p -64.95 -38.03 89.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.463 1.483 . . . . 10.0 111.436 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.16 -40.22 95.67 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.317 0.962 . . . . 10.0 110.639 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -65.28 -47.36 76.92 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.611 -0.681 . . . . 10.0 110.451 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.6 mt -60.62 -45.34 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -53.12 -49.97 65.45 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.898 0.879 . . . . 10.0 110.092 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.87 -32.36 73.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.005 0.522 . . . . 10.0 112.399 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.5 tptm . . . . . 0 C--N 1.342 0.271 0 CA-C-N 118.981 0.81 . . . . 10.0 109.981 -176.756 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 CA--C 1.538 0.512 0 N-CA-C 103.145 -2.909 . . . . 10.0 103.145 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.9 p -119.06 165.41 14.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.2 0.909 . . . . 10.0 110.76 -170.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -154.48 162.5 41.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 120.901 -1.124 . . . . 10.0 108.453 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 112.8 0.667 . . . . 10.0 112.8 174.039 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.437 0 N-CA-C 106.394 -1.706 . . . . 10.0 106.394 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -150.83 151.22 31.96 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.31 -23.81 64.49 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.566 0.746 . . . . 10.0 112.514 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.12 67.42 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.224 0.92 . . . . 10.0 112.08 173.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.51 -35.53 58.27 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 122.866 0.466 . . . . 10.0 109.837 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mt -63.64 122.59 77.38 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.43 141.94 88.77 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.349 2.032 . . . . 10.0 109.531 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -85.14 -32.18 22.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.192 0.52 . . . . 10.0 112.395 -169.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -139.61 134.06 38.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.599 -2.001 . . . . 10.0 105.599 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -149.61 98.96 2.83 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.599 -1.259 . . . . 10.0 107.599 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.8 pt . . . . . 0 CA--C 1.537 0.443 0 C-N-CA 126.125 1.77 . . . . 10.0 107.959 -174.006 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 CA--C 1.533 0.317 0 N-CA-C 109.574 -0.528 . . . . 10.0 109.574 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -157.32 147.86 21.18 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.287 0.635 . . . . 10.0 109.72 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -67.59 164.48 18.99 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.412 0.625 . . . . 10.0 111.276 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -151.61 166.61 30.69 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.603 0.761 . . . . 10.0 109.196 173.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.88 148.54 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.509 1.124 . . . . 10.0 108.538 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.44 122.35 47.5 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.845 -1.909 . . . . 10.0 105.845 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.4 mt -129.08 136.95 58.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.472 -1.677 . . . . 10.0 106.472 -171.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -93.64 131.86 38.53 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.221 -1.77 . . . . 10.0 106.221 169.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.7 144.06 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.614 -1.254 . . . . 10.0 107.614 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -122.5 122.45 38.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.737 -1.949 . . . . 10.0 105.737 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.1 p -75.85 147.89 38.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.058 0.456 . . . . 10.0 111.475 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.57 65.46 2.29 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 127.31 2.244 . . . . 10.0 106.606 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -54.64 140.7 76.15 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.392 2.728 . . . . 10.0 111.211 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 48.88 21.9 0.5 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.654 1.182 . . . . 10.0 113.295 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.3 m 48.79 35.69 6.84 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.098 1.359 . . . . 10.0 112.923 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.41 -12.03 0.02 OUTLIER Glycine 0 CA--C 1.531 1.047 0 N-CA-C 116.618 1.407 . . . . 10.0 116.618 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.03 150.12 92.48 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 120.006 1.903 . . . . 10.0 110.776 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.41 61.33 7.84 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.325 3.35 . . . . 10.0 111.695 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.86 140.02 34.54 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.886 1.275 . . . . 10.0 108.6 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.97 27.94 0.77 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.89 1.276 . . . . 10.0 110.931 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.84 165.37 19.9 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.426 0.69 . . . . 10.0 109.361 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -139.31 159.93 41.0 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.225 1.01 . . . . 10.0 110.142 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -153.05 175.51 12.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.596 1.158 . . . . 10.0 109.584 170.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -96.43 159.62 14.84 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.06 -0.718 . . . . 10.0 109.06 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.1 pt -138.24 147.55 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.95 1.7 . . . . 10.0 108.425 169.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.27 124.95 64.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.02 -1.845 . . . . 10.0 106.02 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -131.01 136.89 48.9 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.077 0.951 . . . . 10.0 108.637 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.38 47.82 0.34 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 109.687 -1.365 . . . . 10.0 109.687 -172.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -67.77 125.84 27.5 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.063 0.545 . . . . 10.0 111.041 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -59.3 -31.44 69.15 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.626 0.973 . . . . 10.0 113.626 -171.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -69.01 -17.81 63.96 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 118.169 -0.919 . . . . 10.0 112.662 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.78 136.39 57.39 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.142 0.883 . . . . 10.0 111.538 -171.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.69 -38.54 80.39 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.388 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -154.77 169.7 23.33 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.22 1.808 . . . . 10.0 108.791 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -55.65 -32.36 63.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.098 0.959 . . . . 10.0 111.737 169.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.01 80.83 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.121 0.568 . . . . 10.0 111.751 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -69.92 -39.2 76.27 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.03 -57.28 12.88 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 108.458 -0.941 . . . . 10.0 108.458 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -58.93 -40.85 85.84 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.334 -0.365 . . . . 10.0 111.222 -172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.83 -46.72 83.81 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.54 0.336 . . . . 10.0 111.68 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -64.28 -45.22 88.98 Favored 'General case' 0 C--N 1.344 0.327 0 O-C-N 121.785 -0.572 . . . . 10.0 109.907 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.09 -44.22 98.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 123.478 0.711 . . . . 10.0 109.093 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.7 m -60.95 -38.61 86.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.346 0.975 . . . . 10.0 111.092 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.17 -52.2 43.14 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.866 -0.894 . . . . 10.0 110.866 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.27 -42.4 99.13 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 117.48 0.64 . . . . 10.0 111.366 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 25.4 mmt -62.51 -38.07 88.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.4 -0.81 . . . . 10.0 110.768 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -62.9 -36.04 82.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.581 1.082 . . . . 10.0 111.042 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -66.07 -33.43 75.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.098 -0.953 . . . . 10.0 111.685 172.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -70.76 -40.32 72.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.219 0.918 . . . . 10.0 110.679 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.51 53.07 0.73 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 108.768 -1.733 . . . . 10.0 108.768 -168.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.2 m -141.84 165.04 28.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.235 1.814 . . . . 10.0 107.855 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -128.31 161.87 28.4 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.581 1.553 . . . . 10.0 107.668 171.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 73.6 m -127.79 154.28 45.59 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.368 1.067 . . . . 10.0 112.576 -168.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -143.7 116.72 8.87 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.162 -1.792 . . . . 10.0 106.162 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.3 p -61.25 130.46 46.29 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.134 -0.979 . . . . 10.0 108.739 170.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.8 mt -90.66 -24.45 20.47 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.48 0.312 . . . . 10.0 110.21 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.98 179.07 33.55 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.907 -1.677 . . . . 10.0 108.907 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.67 -179.33 22.72 Favored Glycine 0 CA--C 1.522 0.527 0 O-C-N 121.681 -0.894 . . . . 10.0 111.485 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.56 -149.98 7.05 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 109.789 -1.324 . . . . 10.0 109.789 -170.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -147.43 165.13 31.16 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.794 1.238 . . . . 10.0 109.505 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.3 mt -133.82 149.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.484 -2.413 . . . . 10.0 104.484 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 C--N 1.328 -0.349 0 C-N-CA 123.516 0.726 . . . . 10.0 109.582 175.291 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 70.9 mt . . . . . 0 C--O 1.239 0.535 0 CA-C-O 121.526 0.679 . . . . 10.0 109.187 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -134.51 148.8 50.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.007 1.323 . . . . 10.0 108.076 172.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.7 138.62 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.751 1.621 . . . . 10.0 107.286 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -169.31 -167.13 0.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.212 1.405 . . . . 10.0 107.905 -171.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.05 -172.92 38.97 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 121.361 -0.837 . . . . 10.0 112.738 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.69 174.31 11.91 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.951 0.9 . . . . 10.0 109.908 169.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.3 m -131.81 105.89 7.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.219 -2.141 . . . . 10.0 105.219 169.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.3 ttt -54.83 -28.71 51.61 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.303 1.041 . . . . 10.0 113.14 -169.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.0 -25.06 66.62 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.998 0.74 . . . . 10.0 112.998 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -128.87 -49.58 1.23 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.623 0.769 . . . . 10.0 110.407 -170.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.81 174.69 13.75 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.203 1.858 . . . . 10.0 108.917 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -53.94 136.14 65.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.574 2.183 . . . . 10.0 110.895 169.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.93 159.29 25.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.697 0.761 . . . . 10.0 109.164 168.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -78.76 72.01 5.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 169.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -49.52 -32.89 13.27 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.26 1.424 . . . . 10.0 113.551 -169.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.02 -38.03 72.55 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.069 0.85 . . . . 10.0 112.426 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.9 mt -64.8 -51.38 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 106.992 -1.484 . . . . 10.0 106.992 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -59.95 -43.64 94.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.288 -0.863 . . . . 10.0 111.804 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -63.42 -40.42 97.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 119.79 1.177 . . . . 10.0 111.002 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.97 -39.94 90.81 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.275 0.943 . . . . 10.0 110.674 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -66.32 -45.98 78.45 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.986 -0.446 . . . . 10.0 110.045 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.0 mt -59.1 -41.89 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 173.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -64.18 -36.56 84.44 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 120.877 -1.14 . . . . 10.0 111.35 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.27 -42.51 93.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.514 0.597 . . . . 10.0 111.037 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.2 tptt . . . . . 0 CA--C 1.541 0.621 0 C-N-CA 123.421 0.689 . . . . 10.0 111.011 173.335 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.234 0.25 0 N-CA-C 106.781 -1.562 . . . . 10.0 106.781 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -147.52 165.45 30.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.388 1.075 . . . . 10.0 109.612 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 40.4 p-90 -145.75 162.09 38.42 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 118.285 0.493 . . . . 10.0 111.181 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.252 0 C-N-CA 126.617 1.967 . . . . 10.0 107.361 169.842 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.95 153.66 35.65 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.651 1.18 . . . . 10.0 108.107 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.86 -20.39 56.82 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.902 0.881 . . . . 10.0 113.036 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.12 -23.59 63.98 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.605 1.093 . . . . 10.0 112.375 173.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -78.36 -7.84 57.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.557 0.743 . . . . 10.0 111.943 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -111.11 126.62 28.31 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 106.168 -1.79 . . . . 10.0 106.168 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -69.88 153.61 68.2 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.927 1.751 . . . . 10.0 109.992 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -81.51 -27.56 34.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.385 1.474 . . . . 10.0 112.642 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.8 t -134.84 133.62 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 124.995 1.318 . . . . 10.0 107.471 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -149.2 103.88 3.36 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.755 -1.572 . . . . 10.0 106.755 169.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.0 pt . . . . . 0 CA--C 1.539 0.546 0 C-N-CA 125.192 1.397 . . . . 10.0 110.108 -169.749 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 108.997 -0.742 . . . . 10.0 108.997 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -151.87 152.38 32.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.139 0.976 . . . . 10.0 109.784 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -74.36 152.3 39.58 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.711 0.805 . . . . 10.0 109.079 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.34 160.39 42.09 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.089 0.471 . . . . 10.0 110.308 173.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.22 141.67 43.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.548 -1.649 . . . . 10.0 106.548 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.7 tp -98.32 121.29 40.06 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.05 -2.204 . . . . 10.0 105.05 169.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.8 mt -129.33 135.57 61.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.582 -1.636 . . . . 10.0 106.582 -168.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -89.33 138.73 31.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.807 -1.923 . . . . 10.0 105.807 168.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 p -122.75 144.23 32.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.62 -1.622 . . . . 10.0 106.62 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -128.62 131.59 48.11 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.178 1.791 . . . . 10.0 106.713 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.5 p -78.17 140.11 38.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.824 0.284 . . . . 10.0 110.564 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.05 66.45 4.41 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.979 1.712 . . . . 10.0 107.182 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.36 -26.4 71.19 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.386 2.724 . . . . 10.0 113.131 -168.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.6 ptt85 -153.11 167.65 28.54 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.795 1.638 . . . . 10.0 107.167 168.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.2 m -58.53 137.76 57.21 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.23 27.54 60.41 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.06 0.838 . . . . 10.0 113.876 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.49 149.81 87.28 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 118.556 1.178 . . . . 10.0 110.884 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.45 35.7 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.987 3.125 . . . . 10.0 111.872 173.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.81 15.34 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.631 1.573 . . . . 10.0 108.516 -174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.32 28.39 0.57 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.642 1.577 . . . . 10.0 109.547 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -67.21 157.15 34.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.953 0.901 . . . . 10.0 109.098 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 m -141.91 159.63 41.84 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.685 1.194 . . . . 10.0 109.838 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -152.26 176.09 11.95 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.469 1.108 . . . . 10.0 109.807 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -108.24 144.93 35.05 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.512 -0.921 . . . . 10.0 108.512 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.3 pt -137.19 148.78 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.855 1.662 . . . . 10.0 109.629 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.6 t -107.94 122.58 62.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.977 -1.86 . . . . 10.0 105.977 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -127.6 137.47 52.57 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.588 -1.634 . . . . 10.0 106.588 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.51 133.67 2.98 Favored Glycine 0 C--O 1.225 -0.428 0 CA-C-N 119.822 1.192 . . . . 10.0 111.624 174.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -146.01 140.49 26.88 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.019 0.438 . . . . 10.0 110.992 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -65.04 -28.31 69.39 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.242 1.017 . . . . 10.0 113.43 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -69.4 -16.41 63.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.502 -0.761 . . . . 10.0 112.386 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.67 122.35 15.08 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 118.869 0.759 . . . . 10.0 111.244 -173.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -69.55 -32.88 71.94 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.2 0.6 . . . . 10.0 110.201 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -148.47 163.64 36.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.668 1.987 . . . . 10.0 107.617 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -58.92 -38.07 78.12 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.653 -0.655 . . . . 10.0 110.697 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.56 -21.31 66.27 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -67.31 -39.06 85.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.729 0.776 . . . . 10.0 109.477 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.42 -53.1 46.94 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 173.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -58.3 -42.07 85.85 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 119.155 -0.45 . . . . 10.0 111.353 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.72 -45.58 85.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.287 0.494 . . . . 10.0 111.597 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -58.94 -49.55 77.41 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.377 0.671 . . . . 10.0 109.438 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.19 -47.47 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.873 0.869 . . . . 10.0 109.122 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -59.83 -35.09 74.02 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.264 0.938 . . . . 10.0 111.325 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.36 -49.31 75.39 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.646 -0.982 . . . . 10.0 110.646 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.48 -45.87 92.44 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 117.873 0.836 . . . . 10.0 111.329 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -37.43 83.34 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.635 -0.697 . . . . 10.0 110.863 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -64.56 -35.9 82.48 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.049 0.84 . . . . 10.0 110.962 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.97 -32.0 72.94 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.085 -0.959 . . . . 10.0 111.721 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -68.63 -57.99 4.92 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.079 0.854 . . . . 10.0 109.172 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.12 41.8 0.17 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.43 1.49 . . . . 10.0 110.198 -169.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.7 m -142.87 171.69 13.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.679 1.592 . . . . 10.0 109.262 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -140.23 164.07 31.04 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.043 1.737 . . . . 10.0 108.176 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.7 m -130.09 163.82 25.74 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.517 1.127 . . . . 10.0 112.299 -169.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -148.19 118.41 7.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.892 -1.892 . . . . 10.0 105.892 171.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 p -66.03 129.04 38.44 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.929 -1.107 . . . . 10.0 109.119 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 mt -93.13 -23.67 18.52 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.598 0.359 . . . . 10.0 110.461 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.3 -178.22 34.64 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.388 -1.485 . . . . 10.0 109.388 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.2 -177.74 22.78 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 118.233 1.017 . . . . 10.0 112.403 176.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.67 -159.35 23.45 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.7 -1.76 . . . . 10.0 108.7 -170.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mtm105 -138.8 161.88 36.14 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.36 -1.082 . . . . 10.0 108.475 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 mt -136.22 146.42 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.66 -1.978 . . . . 10.0 105.66 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.451 -0.384 0 C-N-CA 124.023 0.929 . . . . 10.0 109.41 171.181 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.236 0.382 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -136.91 126.91 25.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.675 -1.602 . . . . 10.0 106.675 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.35 146.33 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 105.639 -1.985 . . . . 10.0 105.639 173.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -154.99 171.53 19.58 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.763 -1.21 . . . . 10.0 111.2 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.74 -160.5 54.07 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 121.535 0.519 . . . . 10.0 112.392 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -148.71 -177.41 5.77 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.625 1.57 . . . . 10.0 108.289 173.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.7 t -109.96 131.17 55.3 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 124.899 1.28 . . . . 10.0 107.865 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.3 mtt -72.58 -18.8 61.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.999 -0.524 . . . . 10.0 111.391 171.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.91 -35.8 72.44 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.909 0.777 . . . . 10.0 110.99 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -132.97 -43.77 0.87 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.9 0.48 . . . . 10.0 112.103 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.22 -178.36 18.84 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.013 -1.635 . . . . 10.0 109.013 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.01 136.65 62.3 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.307 2.005 . . . . 10.0 110.499 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.14 162.14 20.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 166.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -79.41 69.93 5.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.167 -1.79 . . . . 10.0 106.167 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -50.94 -31.0 16.36 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.467 1.507 . . . . 10.0 113.111 -168.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.7 -37.66 73.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.276 0.944 . . . . 10.0 112.326 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.73 -50.43 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 107.293 -1.373 . . . . 10.0 107.293 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -58.56 -45.78 88.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.553 -0.737 . . . . 10.0 111.792 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -63.79 -38.12 89.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 117.754 -1.117 . . . . 10.0 110.976 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.13 -41.39 94.85 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.014 1.279 . . . . 10.0 111.227 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -65.11 -48.1 74.81 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.046 -0.409 . . . . 10.0 109.909 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.7 mt -61.38 -42.32 93.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -58.83 -37.88 77.41 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.328 1.051 . . . . 10.0 111.081 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.76 89.79 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.687 0.676 . . . . 10.0 110.969 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt . . . . . 0 N--CA 1.47 0.555 0 CA-C-N 118.746 0.703 . . . . 10.0 112.049 175.895 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 C--O 1.236 0.352 0 N-CA-C 105.029 -2.211 . . . . 10.0 105.029 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 p -138.96 167.28 22.39 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.075 0.95 . . . . 10.0 109.928 -172.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -139.06 161.22 37.92 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 123.128 0.571 . . . . 10.0 110.882 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.263 0 C-N-CA 125.588 1.555 . . . . 10.0 108.587 169.761 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.528 0 CA-C-O 121.109 0.48 . . . . 10.0 111.82 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -154.51 148.84 26.08 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.9 mt -58.13 -28.89 65.09 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.645 -0.659 . . . . 10.0 112.664 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.81 -26.47 68.35 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.93 0.786 . . . . 10.0 112.094 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.23 -24.71 46.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.923 0.489 . . . . 10.0 110.897 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.99 122.18 86.21 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 106.804 -1.554 . . . . 10.0 106.804 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -50.28 133.16 35.84 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.106 2.537 . . . . 10.0 110.169 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.0 -29.25 39.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.677 0.751 . . . . 10.0 111.442 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.3 t -137.74 135.9 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 127.176 2.19 . . . . 10.0 105.733 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -150.78 99.7 2.75 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.149 -1.426 . . . . 10.0 107.149 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt . . . . . 0 CA--C 1.541 0.632 0 C-N-CA 125.055 1.342 . . . . 10.0 110.436 -168.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.534 0.337 0 N-CA-C 105.947 -1.871 . . . . 10.0 105.947 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -135.55 14.66 3.43 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.89 1.811 . . . . 10.0 115.89 -171.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mttp 56.26 159.39 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.646 1.978 . . . . 10.0 112.89 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.52 158.19 28.78 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 120.493 -1.38 . . . . 10.0 109.481 169.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.1 p -138.01 148.8 24.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.735 1.214 . . . . 10.0 107.949 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.73 118.88 37.7 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 105.574 -2.01 . . . . 10.0 105.574 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.0 mt -123.69 125.8 71.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 -169.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -76.97 131.72 38.64 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 168.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 p -119.88 135.22 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.864 -1.532 . . . . 10.0 106.864 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -114.65 150.67 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.448 1.899 . . . . 10.0 107.462 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 p -111.72 142.05 44.55 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -172.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.48 65.97 5.61 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 126.422 1.889 . . . . 10.0 106.594 168.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -41.48 133.27 3.5 Favored 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 125.467 4.111 . . . . 10.0 114.201 -168.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 50.3 23.88 1.34 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.39 1.476 . . . . 10.0 113.073 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m 51.92 32.84 10.52 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.992 1.317 . . . . 10.0 111.871 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.25 26.34 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.455 -0.636 . . . . 10.0 112.827 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.77 131.27 9.93 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 172.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -86.54 32.99 0.44 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 124.594 3.53 . . . . 10.0 112.747 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.01 83.81 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.623 0.769 . . . . 10.0 112.386 -168.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.11 28.46 2.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.543 1.937 . . . . 10.0 114.932 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -78.5 160.41 27.68 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 167.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 m -143.58 156.27 44.54 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.438 -0.789 . . . . 10.0 110.584 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -146.22 -175.47 4.78 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.989 1.316 . . . . 10.0 109.435 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -116.68 147.83 41.6 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.961 -1.126 . . . . 10.0 107.961 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.45 147.62 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.783 1.233 . . . . 10.0 110.111 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.66 125.91 64.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 106.79 -1.559 . . . . 10.0 106.79 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -133.83 141.31 47.37 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 107.125 -1.435 . . . . 10.0 107.125 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.48 124.86 1.14 Allowed Glycine 0 C--O 1.226 -0.382 0 CA-C-N 120.228 1.376 . . . . 10.0 111.52 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -144.72 135.75 24.98 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 117.262 0.531 . . . . 10.0 110.938 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -66.0 -26.24 67.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 118.292 -0.861 . . . . 10.0 113.05 -170.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -63.55 -20.37 65.58 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.111 0.869 . . . . 10.0 112.715 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.98 120.64 14.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.212 0.915 . . . . 10.0 109.691 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.89 -34.24 77.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.01 0.524 . . . . 10.0 110.139 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -147.19 158.29 43.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.724 2.01 . . . . 10.0 107.196 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -58.53 -29.05 66.03 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.918 0.71 . . . . 10.0 112.918 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.67 -28.75 64.05 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 123.203 0.601 . . . . 10.0 112.545 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -74.18 -30.68 62.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.612 0.642 . . . . 10.0 110.973 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -65.76 -52.24 52.42 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 172.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -53.82 -43.27 69.27 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 118.629 -0.7 . . . . 10.0 111.16 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.63 -44.44 93.86 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.728 0.695 . . . . 10.0 111.773 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -60.1 -51.55 69.13 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.141 -0.689 . . . . 10.0 109.141 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.4 t -68.96 -47.8 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 118.904 -0.57 . . . . 10.0 109.912 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.8 p -60.59 -31.63 70.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.472 1.033 . . . . 10.0 111.527 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.34 -50.1 71.3 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.728 -0.949 . . . . 10.0 110.728 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.7 -44.52 93.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.668 0.734 . . . . 10.0 111.5 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -40.01 83.04 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.685 0.675 . . . . 10.0 110.705 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -63.37 -35.66 81.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.16 0.891 . . . . 10.0 111.118 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -65.67 -30.84 71.58 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 117.833 -1.079 . . . . 10.0 111.682 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -74.38 -38.12 63.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.797 1.181 . . . . 10.0 111.055 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.47 57.68 0.83 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 107.202 -2.359 . . . . 10.0 107.202 -168.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.0 m -146.07 169.14 19.29 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.262 1.825 . . . . 10.0 108.102 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -139.61 160.85 38.92 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.39 1.476 . . . . 10.0 108.635 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.0 m -131.19 155.09 47.65 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.496 1.118 . . . . 10.0 112.337 -168.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -149.86 118.86 6.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.884 1.674 . . . . 10.0 106.708 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.9 m -68.03 123.95 22.04 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.005 -1.059 . . . . 10.0 109.153 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.3 mt -81.08 -23.92 38.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.875 0.47 . . . . 10.0 110.726 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.98 176.72 36.92 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.204 -1.559 . . . . 10.0 109.204 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.05 178.5 23.72 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 118.223 1.011 . . . . 10.0 112.109 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.23 -144.74 4.65 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 107.981 -2.048 . . . . 10.0 107.981 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -151.55 149.48 29.23 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 120.898 -1.354 . . . . 10.0 110.44 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.1 mt -108.56 148.04 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 105.121 -2.178 . . . . 10.0 105.121 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.533 0.315 0 C-N-CA 124.311 1.044 . . . . 10.0 109.121 171.892 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.5 pt . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 121.643 0.735 . . . . 10.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -149.13 163.36 37.81 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.105 0.962 . . . . 10.0 109.017 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -136.5 140.55 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.912 0.885 . . . . 10.0 108.66 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -157.5 -175.34 5.34 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.962 0.905 . . . . 10.0 109.98 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.63 -177.64 53.42 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 123.401 0.524 . . . . 10.0 113.012 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.31 -178.98 5.53 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.093 0.957 . . . . 10.0 110.184 169.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.8 m -133.52 107.43 8.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.212 -1.773 . . . . 10.0 106.212 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 77.2 mtm -59.74 -21.42 60.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.795 0.665 . . . . 10.0 112.795 -172.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.68 -26.36 67.05 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.802 0.841 . . . . 10.0 112.841 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -134.9 -50.68 0.77 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.489 0.716 . . . . 10.0 111.231 -169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.08 175.32 13.79 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.198 1.856 . . . . 10.0 108.981 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -54.81 133.8 59.49 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.467 2.111 . . . . 10.0 110.271 169.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.08 156.07 29.41 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.526 1.155 . . . . 10.0 109.413 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -82.42 65.33 7.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.283 -1.747 . . . . 10.0 106.283 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -51.81 -24.66 6.36 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.374 1.87 . . . . 10.0 114.012 -168.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.93 91.08 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.028 1.285 . . . . 10.0 111.392 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.3 mt -63.54 -50.91 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -61.51 -46.5 89.73 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.185 0.594 . . . . 10.0 111.874 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 p -65.37 -38.18 89.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.741 0.701 . . . . 10.0 110.966 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.02 -42.11 76.82 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.149 0.886 . . . . 10.0 110.985 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -59.96 -47.96 83.68 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.671 -0.681 . . . . 10.0 110.143 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.3 mt -56.93 -52.34 56.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 108.112 -1.07 . . . . 10.0 108.112 175.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -56.2 -40.52 74.13 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.324 0.966 . . . . 10.0 111.25 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.43 -50.88 49.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.037 0.535 . . . . 10.0 111.82 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.5 mptt . . . . . 0 N--CA 1.472 0.656 0 CA-C-N 118.93 0.786 . . . . 10.0 112.749 -169.867 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.6 t . . . . . 0 CA--C 1.531 0.225 0 N-CA-C 106.197 -1.779 . . . . 10.0 106.197 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.2 p -138.43 174.52 10.45 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.211 1.004 . . . . 10.0 109.421 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -142.76 159.7 41.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.251 0.62 . . . . 10.0 109.726 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.263 0 C-N-CA 125.433 1.493 . . . . 10.0 107.979 172.251 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 108.787 -0.82 . . . . 10.0 108.787 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -149.21 149.81 31.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.155 1.382 . . . . 10.0 107.872 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.5 mt -58.68 -25.51 62.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.364 1.066 . . . . 10.0 113.024 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.89 -24.23 65.81 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.64 0.655 . . . . 10.0 112.34 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -75.47 -16.67 60.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.271 0.628 . . . . 10.0 111.494 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.5 mt -93.62 120.23 66.43 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.0 -1.482 . . . . 10.0 107.0 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.35 136.24 39.46 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.497 2.798 . . . . 10.0 110.551 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -78.08 -28.16 48.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.392 0.615 . . . . 10.0 111.832 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.2 t -139.22 135.11 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 104.262 -2.496 . . . . 10.0 104.262 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -153.39 119.93 5.58 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.608 -1.627 . . . . 10.0 106.608 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.9 pt . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 124.764 1.226 . . . . 10.0 109.171 -170.036 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 N--CA 1.465 0.312 0 N-CA-C 109.756 -0.461 . . . . 10.0 109.756 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -145.35 148.62 33.59 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.488 1.115 . . . . 10.0 109.265 169.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -63.65 150.9 43.18 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.017 0.927 . . . . 10.0 110.319 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.78 168.26 21.83 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.703 1.201 . . . . 10.0 109.037 178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.74 150.07 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.355 1.062 . . . . 10.0 108.661 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -114.16 121.92 45.25 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.375 -2.084 . . . . 10.0 105.375 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.5 mt -130.32 136.42 58.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.202 -1.406 . . . . 10.0 107.202 -169.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -91.65 139.2 30.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.74 -1.578 . . . . 10.0 106.74 166.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.53 141.33 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.123 -1.806 . . . . 10.0 106.123 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -122.37 135.84 54.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.98 1.712 . . . . 10.0 107.217 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.2 m -63.12 135.17 57.03 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.008 -0.367 . . . . 10.0 110.008 174.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.41 52.7 1.0 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.348 1.459 . . . . 10.0 110.077 168.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.66 -13.07 36.87 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.188 3.258 . . . . 10.0 115.123 -167.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -139.52 13.72 2.55 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.719 -1.238 . . . . 10.0 110.755 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m 48.33 33.98 4.26 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.344 1.058 . . . . 10.0 112.018 -168.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.32 64.82 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 N-CA-C 108.132 -1.987 . . . . 10.0 108.132 -168.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.97 157.12 77.72 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 125.231 1.412 . . . . 10.0 108.964 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.92 39.53 0.66 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 124.309 3.339 . . . . 10.0 112.121 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.93 104.92 3.74 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.978 1.711 . . . . 10.0 107.014 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.81 28.92 1.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.488 1.515 . . . . 10.0 110.28 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.73 174.57 2.82 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.2 1.0 . . . . 10.0 109.911 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -152.39 159.71 43.38 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 120.193 -1.567 . . . . 10.0 110.423 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -149.63 168.52 23.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.647 1.179 . . . . 10.0 109.565 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -99.9 150.67 22.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.9 pt -138.9 156.04 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 125.795 1.638 . . . . 10.0 109.889 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.39 130.35 62.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -133.35 141.16 47.79 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.02 1.328 . . . . 10.0 107.952 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.72 100.85 0.15 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 110.029 -1.229 . . . . 10.0 110.029 -171.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -130.4 131.87 45.48 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 118.236 1.018 . . . . 10.0 110.371 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -59.56 -25.51 64.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.198 1.184 . . . . 10.0 114.198 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -68.32 -20.62 64.75 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.494 1.043 . . . . 10.0 112.279 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.42 137.68 58.01 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.221 0.919 . . . . 10.0 111.428 -171.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.08 -40.95 87.11 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.679 -0.691 . . . . 10.0 109.231 170.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -155.92 170.67 21.57 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 126.125 1.77 . . . . 10.0 108.922 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -48.66 -36.31 15.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.977 1.311 . . . . 10.0 112.002 167.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.49 -28.02 66.66 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.948 0.721 . . . . 10.0 112.948 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -67.32 -41.94 84.45 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.18 0.991 . . . . 10.0 108.671 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.6 mt -62.0 -51.36 73.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 108.541 -0.911 . . . . 10.0 108.541 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -55.64 -43.49 76.25 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.679 -0.677 . . . . 10.0 111.598 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -62.58 -48.18 80.57 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.369 0.531 . . . . 10.0 111.726 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.54 -49.5 77.29 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.668 -0.645 . . . . 10.0 109.826 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.4 -42.65 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.609 -0.885 . . . . 10.0 108.609 -172.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.7 m -58.58 -36.38 73.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.558 1.072 . . . . 10.0 111.447 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.11 -47.09 91.33 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.803 -0.919 . . . . 10.0 110.803 172.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.09 -47.29 86.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.838 0.819 . . . . 10.0 111.459 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -36.72 82.01 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.338 -0.839 . . . . 10.0 110.74 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -64.35 -36.61 84.68 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.998 0.817 . . . . 10.0 111.004 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -67.96 -31.74 71.68 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.867 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -67.6 -56.79 8.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 119.294 0.952 . . . . 10.0 108.807 175.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.73 41.39 0.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.047 1.308 . . . . 10.0 110.528 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.3 m -144.0 173.63 11.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.837 1.655 . . . . 10.0 109.325 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -139.27 164.24 30.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.421 1.488 . . . . 10.0 108.205 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.2 m -125.22 161.55 26.66 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.567 1.147 . . . . 10.0 112.382 -168.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -149.11 109.8 4.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.817 2.047 . . . . 10.0 105.755 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 p -61.45 136.85 58.18 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.031 -1.043 . . . . 10.0 109.627 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.9 mt -110.19 -12.2 14.5 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.425 0.69 . . . . 10.0 111.235 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.86 -178.51 29.94 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.2 -1.16 . . . . 10.0 110.2 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.05 -179.24 22.97 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.841 -0.904 . . . . 10.0 110.841 168.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.1 -153.48 9.89 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.492 -1.843 . . . . 10.0 108.492 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -134.69 132.74 39.24 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 123.995 0.918 . . . . 10.0 108.61 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.17 119.56 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 104.567 -2.382 . . . . 10.0 104.567 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 C--N 1.323 -0.569 0 N-CA-C 105.266 -2.124 . . . . 10.0 105.266 167.071 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 C--O 1.237 0.407 0 N-CA-C 107.919 -1.141 . . . . 10.0 107.919 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -133.51 159.59 39.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.163 -1.421 . . . . 10.0 107.163 169.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 t -140.38 140.69 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 O-C-N 120.749 -1.219 . . . . 10.0 107.939 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -156.32 -177.89 6.92 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.877 0.871 . . . . 10.0 110.908 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.61 -166.4 50.77 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.922 -0.471 . . . . 10.0 111.922 169.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -157.18 173.43 16.99 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.785 1.234 . . . . 10.0 108.972 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.6 m -128.39 104.06 7.5 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.592 -1.262 . . . . 10.0 107.592 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 66.8 mtt -57.24 -24.27 53.59 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.36 1.064 . . . . 10.0 113.565 -170.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.24 -29.94 70.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.6 -0.714 . . . . 10.0 112.427 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -129.17 -45.82 1.24 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.663 0.785 . . . . 10.0 110.716 -171.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.97 174.33 13.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.768 1.651 . . . . 10.0 109.595 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -56.36 124.36 16.06 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.337 2.024 . . . . 10.0 109.631 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.69 159.49 13.34 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.778 0.799 . . . . 10.0 109.178 168.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -84.83 72.04 10.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.953 -1.499 . . . . 10.0 106.953 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -52.37 -25.14 8.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.132 1.373 . . . . 10.0 114.133 -169.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.76 99.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.96 1.255 . . . . 10.0 111.617 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.75 -50.95 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 107.528 -1.286 . . . . 10.0 107.528 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -56.79 -48.47 77.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.29 0.636 . . . . 10.0 111.588 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 p -68.89 -37.25 78.88 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.01 -0.995 . . . . 10.0 111.688 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -65.65 -39.79 91.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.499 1.045 . . . . 10.0 110.404 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -62.65 -48.7 78.17 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 119.16 -0.448 . . . . 10.0 110.103 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.0 mt -57.79 -42.39 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.219 0.918 . . . . 10.0 108.584 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -64.03 -37.63 88.12 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.535 1.062 . . . . 10.0 111.22 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.03 92.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.689 0.677 . . . . 10.0 111.067 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp . . . . . 0 CA--C 1.537 0.456 0 C-N-CA 123.467 0.707 . . . . 10.0 111.073 173.838 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.232 0.182 0 N-CA-C 107.111 -1.441 . . . . 10.0 107.111 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.2 p -142.55 170.48 15.63 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.514 1.126 . . . . 10.0 109.832 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -147.84 166.67 26.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.236 0.471 . . . . 10.0 111.106 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.305 0 C-N-CA 127.026 2.13 . . . . 10.0 107.563 169.649 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 107.73 -1.211 . . . . 10.0 107.73 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -148.11 151.9 36.41 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.721 -1.214 . . . . 10.0 107.721 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.13 -30.16 61.73 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.618 0.767 . . . . 10.0 112.837 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.46 -28.45 69.67 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.704 0.683 . . . . 10.0 112.149 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -77.41 -28.82 52.77 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.844 0.458 . . . . 10.0 110.621 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.3 mt -69.91 122.06 84.79 Favored Pre-proline 0 C--O 1.24 0.557 0 N-CA-C 107.519 -1.289 . . . . 10.0 107.519 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.2 135.79 38.22 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.315 2.677 . . . . 10.0 110.341 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.23 -29.54 38.46 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.529 0.681 . . . . 10.0 111.35 -173.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -137.8 136.77 45.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 104.707 -2.331 . . . . 10.0 104.707 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -152.03 122.68 7.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.247 -1.76 . . . . 10.0 106.247 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.5 pt . . . . . 0 C--N 1.328 -0.35 0 C-N-CA 124.65 1.18 . . . . 10.0 109.393 -169.189 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -154.07 154.27 33.37 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.852 0.751 . . . . 10.0 110.66 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -86.96 151.22 23.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.508 1.123 . . . . 10.0 108.32 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.28 159.92 42.29 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.99 0.516 . . . . 10.0 110.479 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.94 140.53 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 125.694 1.598 . . . . 10.0 107.746 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -98.24 119.98 37.85 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 105.513 -2.032 . . . . 10.0 105.513 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.7 mt -124.08 132.99 70.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.52 -1.659 . . . . 10.0 106.52 -171.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -86.78 132.5 33.83 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.16 -1.793 . . . . 10.0 106.16 168.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.67 139.87 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.604 -1.258 . . . . 10.0 107.604 171.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -114.31 123.75 50.28 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.222 -2.14 . . . . 10.0 105.222 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.7 p -68.89 145.24 53.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.794 0.27 . . . . 10.0 110.49 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.35 67.81 3.09 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.206 1.802 . . . . 10.0 106.354 168.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -54.71 127.47 26.29 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.064 2.509 . . . . 10.0 110.872 -170.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 37.03 39.06 0.11 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.582 1.953 . . . . 10.0 113.407 -169.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 m 51.6 30.98 7.12 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.796 1.639 . . . . 10.0 113.696 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.2 -19.54 0.02 OUTLIER Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.242 -1.31 . . . . 10.0 116.26 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.94 149.83 95.99 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 120.277 2.039 . . . . 10.0 110.764 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.63 61.59 8.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.418 3.412 . . . . 10.0 111.657 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.49 139.11 35.06 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.854 1.262 . . . . 10.0 108.536 175.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.06 28.05 0.68 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.752 1.221 . . . . 10.0 110.98 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -67.98 164.51 19.83 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.421 -0.799 . . . . 10.0 109.232 171.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -139.61 159.22 42.67 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.899 0.88 . . . . 10.0 110.802 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -150.19 171.48 16.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.216 1.007 . . . . 10.0 109.907 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.29 150.23 21.77 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.345 -0.983 . . . . 10.0 108.345 172.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.3 pt -137.14 150.76 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 125.461 1.504 . . . . 10.0 109.559 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.09 126.15 63.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -132.92 134.97 45.26 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.29 117.45 0.65 Allowed Glycine 0 C--O 1.225 -0.462 0 CA-C-N 119.46 1.027 . . . . 10.0 110.866 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -138.38 132.03 30.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 -172.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -60.14 -18.16 45.57 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 114.67 1.359 . . . . 10.0 114.67 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -67.1 -28.01 67.81 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.27 1.395 . . . . 10.0 112.139 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.71 153.93 30.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.712 1.142 . . . . 10.0 109.419 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.31 -6.91 2.61 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.553 0.741 . . . . 10.0 111.821 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.92 12.63 3.64 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 118.885 0.766 . . . . 10.0 112.767 -168.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 63.38 -46.57 0.23 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.285 2.634 . . . . 10.0 114.792 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.07 -30.17 67.86 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.024 0.929 . . . . 10.0 111.363 -178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.12 -32.74 74.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 117.938 0.335 . . . . 10.0 111.533 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -67.91 -55.41 16.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 107.326 -1.361 . . . . 10.0 107.326 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.58 -39.42 67.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.256 0.622 . . . . 10.0 111.603 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -61.54 -50.75 71.41 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.304 1.041 . . . . 10.0 111.712 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -45.52 93.12 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.713 -0.617 . . . . 10.0 110.218 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.86 -46.04 93.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -59.1 -36.15 74.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.746 1.157 . . . . 10.0 111.377 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.62 -51.33 54.97 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 174.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.24 -45.21 94.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.525 0.662 . . . . 10.0 111.349 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -34.67 78.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.136 -0.935 . . . . 10.0 110.719 -175.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -65.78 -37.38 86.17 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.613 1.097 . . . . 10.0 110.648 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -62.65 -37.17 85.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 117.681 -1.152 . . . . 10.0 110.919 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -66.78 -52.64 41.7 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.409 1.004 . . . . 10.0 109.646 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.04 51.12 0.25 Allowed Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.475 1.512 . . . . 10.0 109.403 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.3 m -143.68 167.71 21.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.814 1.646 . . . . 10.0 108.486 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -129.62 161.97 29.35 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.03 1.732 . . . . 10.0 107.141 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.2 m -125.34 160.04 30.31 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.669 1.187 . . . . 10.0 112.017 -168.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -148.83 115.38 5.92 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.866 -1.901 . . . . 10.0 105.866 170.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.83 115.11 6.24 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.904 -1.123 . . . . 10.0 108.466 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.7 mt -77.54 -29.26 52.23 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.821 -0.549 . . . . 10.0 110.355 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.76 -177.53 38.82 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.071 -1.611 . . . . 10.0 109.071 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.68 -178.18 29.63 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 118.259 1.029 . . . . 10.0 111.178 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.5 -158.37 17.59 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.531 -1.428 . . . . 10.0 109.531 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 mtm180 -131.8 154.52 49.03 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.54 -0.976 . . . . 10.0 108.476 -177.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.9 mt -134.29 140.55 45.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 104.302 -2.481 . . . . 10.0 104.302 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.329 -0.312 0 O-C-N 120.908 -1.12 . . . . 10.0 110.273 172.76 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.2 pt . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 122.226 1.012 . . . . 10.0 110.848 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -140.2 147.87 40.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.368 -1.345 . . . . 10.0 107.368 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.84 134.77 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.415 -1.328 . . . . 10.0 107.415 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -159.27 -179.69 8.2 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.175 -0.953 . . . . 10.0 111.046 -168.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.8 -158.39 53.08 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.053 0.835 . . . . 10.0 112.981 170.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -150.72 167.82 26.23 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.594 1.158 . . . . 10.0 108.558 172.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.7 p -68.53 -28.67 67.19 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.6 ttm 53.93 29.53 10.13 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.206 0.603 . . . . 10.0 110.159 -167.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.29 -32.42 0.6 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.738 1.215 . . . . 10.0 111.876 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.38 -46.13 0.56 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.215 0.606 . . . . 10.0 110.205 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.41 177.16 31.24 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.111 1.815 . . . . 10.0 109.598 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.99 138.36 56.79 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.511 2.14 . . . . 10.0 110.458 172.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.71 160.97 24.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 166.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -81.31 75.54 8.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.682 -1.599 . . . . 10.0 106.682 169.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -54.48 -24.31 19.89 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.901 1.28 . . . . 10.0 113.528 -169.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.5 99.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.651 1.114 . . . . 10.0 111.705 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.1 mt -64.51 -52.07 59.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 106.988 -1.486 . . . . 10.0 106.988 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 m -57.46 -45.79 84.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.511 -0.757 . . . . 10.0 112.092 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 p -66.24 -37.82 86.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 117.722 -1.132 . . . . 10.0 111.721 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -64.45 -41.21 96.67 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.965 1.257 . . . . 10.0 110.6 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -63.89 -47.55 80.17 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.103 -0.373 . . . . 10.0 110.265 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.31 -38.9 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.415 -0.957 . . . . 10.0 108.415 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -62.32 -38.11 88.17 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 120.556 -1.34 . . . . 10.0 111.239 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.39 -31.02 71.91 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.713 0.688 . . . . 10.0 112.228 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.7 tptt . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 124.327 1.051 . . . . 10.0 111.649 172.241 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.238 0.448 0 N-CA-C 108.984 -0.747 . . . . 10.0 108.984 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.5 p -144.7 170.07 16.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.428 1.491 . . . . 10.0 109.041 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -143.98 168.89 18.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.175 0.59 . . . . 10.0 110.754 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.207 0 C-N-CA 124.756 1.223 . . . . 10.0 108.998 173.314 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.308 0 N-CA-C 106.832 -1.544 . . . . 10.0 106.832 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -149.35 150.54 32.64 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.968 -1.123 . . . . 10.0 107.968 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.35 -26.42 60.95 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.372 1.069 . . . . 10.0 112.753 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.91 -25.51 67.62 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.876 0.762 . . . . 10.0 112.792 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -74.2 -25.8 59.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.205 0.457 . . . . 10.0 111.042 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.96 130.68 69.23 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 106.467 -1.679 . . . . 10.0 106.467 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.19 146.14 68.94 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.989 1.792 . . . . 10.0 109.625 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.72 -30.06 59.12 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.605 0.762 . . . . 10.0 112.593 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.4 t -138.28 132.31 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.696 -1.964 . . . . 10.0 105.696 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -149.93 102.72 3.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.47 -2.048 . . . . 10.0 105.47 171.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.2 pt . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 124.672 1.189 . . . . 10.0 110.516 -168.736 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 109.202 -0.666 . . . . 10.0 109.202 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -154.4 148.69 26.02 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.437 1.095 . . . . 10.0 109.592 170.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -72.73 150.71 42.63 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.696 -0.854 . . . . 10.0 108.696 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.33 165.51 29.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.683 0.793 . . . . 10.0 109.561 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.7 143.37 24.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.506 -1.294 . . . . 10.0 107.506 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp -99.8 126.43 45.89 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 105.49 -2.041 . . . . 10.0 105.49 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 98.2 mt -130.34 136.66 58.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -91.56 145.71 24.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.987 -1.486 . . . . 10.0 106.987 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.53 146.0 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.082 -1.821 . . . . 10.0 106.082 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -127.25 132.27 50.41 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.295 -1.742 . . . . 10.0 106.295 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.1 p -71.59 147.43 47.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.827 0.74 . . . . 10.0 110.777 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.93 62.31 3.42 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.621 1.568 . . . . 10.0 107.797 168.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -58.86 145.33 97.14 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.215 2.61 . . . . 10.0 109.664 -172.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 51.66 19.34 0.87 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.291 1.036 . . . . 10.0 112.517 -176.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m 50.44 28.5 3.37 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.865 1.266 . . . . 10.0 113.332 -171.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.62 -0.69 0.02 OUTLIER Glycine 0 CA--C 1.532 1.1 0 N-CA-C 116.497 1.359 . . . . 10.0 116.497 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.72 152.28 75.99 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.879 1.839 . . . . 10.0 110.244 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.46 61.45 7.4 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 124.229 3.286 . . . . 10.0 111.751 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.24 141.74 33.98 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.105 1.362 . . . . 10.0 108.602 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.67 39.5 0.49 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.465 1.506 . . . . 10.0 109.168 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.76 175.14 5.21 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.713 0.805 . . . . 10.0 108.896 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.1 m -151.99 163.2 39.79 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.171 -1.58 . . . . 10.0 111.369 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -154.82 163.53 40.14 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.529 2.332 . . . . 10.0 107.416 -169.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -129.24 141.86 51.01 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.351 -1.351 . . . . 10.0 107.351 174.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.3 pt -138.19 154.9 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.599 1.16 . . . . 10.0 110.822 -169.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.97 125.45 64.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.657 -1.609 . . . . 10.0 106.657 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -132.22 142.99 49.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.27 131.59 1.91 Allowed Glycine 0 C--O 1.22 -0.761 0 CA-C-N 119.878 1.217 . . . . 10.0 111.349 171.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -142.35 138.56 31.31 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 124.174 0.573 . . . . 10.0 109.644 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -68.59 -23.58 64.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.672 0.789 . . . . 10.0 112.362 -171.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -66.18 -20.53 66.16 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 118.444 -0.789 . . . . 10.0 112.422 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 127.67 32.6 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 118.995 0.816 . . . . 10.0 110.75 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -72.31 -35.73 68.72 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.489 0.661 . . . . 10.0 109.648 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -149.01 165.7 30.88 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 126.174 1.79 . . . . 10.0 108.55 -175.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -57.03 -38.75 73.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.988 0.423 . . . . 10.0 110.763 175.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.63 67.47 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 123.925 0.89 . . . . 10.0 113.16 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -66.96 -46.53 74.42 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.3 mt -62.46 -51.43 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -55.36 -41.32 72.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.615 -0.707 . . . . 10.0 111.628 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.7 -47.14 79.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.267 0.485 . . . . 10.0 111.86 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -58.59 -49.85 75.96 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 109.797 -0.446 . . . . 10.0 109.797 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.46 -45.29 93.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.459 -0.781 . . . . 10.0 109.181 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 m -57.58 -43.02 84.27 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.051 0.841 . . . . 10.0 110.821 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.79 -46.59 94.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.969 -0.853 . . . . 10.0 110.969 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.35 -48.55 77.51 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 118.226 1.013 . . . . 10.0 110.951 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -39.09 84.44 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.553 0.615 . . . . 10.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -63.11 -35.88 81.73 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.472 0.578 . . . . 10.0 110.833 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.22 -32.6 72.92 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.513 -1.232 . . . . 10.0 112.188 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 mm-40 -67.26 -53.08 33.19 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.295 0.952 . . . . 10.0 109.327 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.1 44.26 0.22 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.274 1.416 . . . . 10.0 109.607 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.3 m -145.95 175.89 10.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.185 2.194 . . . . 10.0 107.755 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -144.81 164.6 30.55 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.528 0.731 . . . . 10.0 109.04 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.8 m -120.9 162.29 20.11 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.599 1.16 . . . . 10.0 113.313 -168.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -147.57 112.49 5.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.32 2.248 . . . . 10.0 105.741 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 t -64.2 140.47 58.87 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.029 -1.045 . . . . 10.0 109.67 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.9 mt -110.26 -9.67 14.65 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.17 0.988 . . . . 10.0 111.636 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.88 171.75 18.63 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.434 1.016 . . . . 10.0 112.073 169.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.28 161.2 18.78 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.465 1.031 . . . . 10.0 110.828 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.85 -160.89 23.64 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.027 -1.629 . . . . 10.0 109.027 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -146.07 162.84 37.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.34 -1.682 . . . . 10.0 110.337 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -129.12 151.75 36.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 105.64 -1.985 . . . . 10.0 105.64 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.451 -0.404 0 C-N-CA 124.459 1.104 . . . . 10.0 109.292 175.806 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.1 mt . . . . . 0 C--O 1.238 0.471 0 N-CA-C 107.003 -1.48 . . . . 10.0 107.003 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -135.77 148.97 48.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.598 -0.89 . . . . 10.0 108.598 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.05 128.56 62.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.769 1.228 . . . . 10.0 107.916 -169.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -157.13 -164.97 1.71 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.564 0.746 . . . . 10.0 109.699 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.39 -169.85 54.6 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 111.081 -0.807 . . . . 10.0 111.081 -173.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -161.29 -170.89 2.8 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.4 1.48 . . . . 10.0 107.572 169.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.3 t -135.04 135.54 41.38 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.719 -1.215 . . . . 10.0 107.719 172.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 79.2 mtm -77.26 -16.81 58.84 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.877 -0.583 . . . . 10.0 111.134 169.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.89 -26.07 63.07 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.717 0.69 . . . . 10.0 112.333 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.43 -48.91 0.2 Allowed 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 123.177 0.591 . . . . 10.0 110.53 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.27 179.57 29.67 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.197 -1.561 . . . . 10.0 109.197 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -61.66 150.11 87.0 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.395 2.063 . . . . 10.0 109.902 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.33 27.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.232 1.413 . . . . 10.0 113.924 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 40.21 55.8 2.67 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.425 2.29 . . . . 10.0 109.57 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -43.99 -35.42 2.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.485 2.314 . . . . 10.0 114.603 -166.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.15 -37.12 66.57 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.368 0.986 . . . . 10.0 113.128 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.3 mt -63.66 -53.2 47.88 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 107.247 -1.39 . . . . 10.0 107.247 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.6 m -61.71 -41.73 98.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.178 -0.915 . . . . 10.0 112.267 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 p -65.01 -39.61 93.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.725 1.148 . . . . 10.0 110.602 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -63.77 -40.56 96.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.501 1.046 . . . . 10.0 110.937 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -62.98 -48.92 76.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.674 0.39 . . . . 10.0 110.59 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.8 mt -58.4 -45.75 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -62.41 -38.02 88.06 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 121.225 -0.922 . . . . 10.0 111.547 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.29 75.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.202 0.601 . . . . 10.0 111.763 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt . . . . . 0 CA--C 1.544 0.743 0 CA-C-O 117.718 -1.134 . . . . 10.0 112.433 173.227 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.234 0.249 0 N-CA-C 106.205 -1.776 . . . . 10.0 106.205 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -142.18 170.17 16.22 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.257 1.023 . . . . 10.0 109.996 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -143.7 166.19 25.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.279 0.562 . . . . 10.0 112.474 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 128.787 2.835 . . . . 10.0 107.504 171.374 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 106.5 -1.667 . . . . 10.0 106.5 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -152.41 151.53 30.92 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.85 -25.32 64.93 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.645 0.778 . . . . 10.0 112.859 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.87 72.83 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.162 0.892 . . . . 10.0 111.63 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.59 -34.89 58.41 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.963 0.505 . . . . 10.0 110.032 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mt -64.62 118.81 51.65 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.15 139.51 52.72 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.484 2.789 . . . . 10.0 111.36 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.72 -31.98 25.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.303 0.573 . . . . 10.0 111.915 -173.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.57 139.04 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 105.759 -1.941 . . . . 10.0 105.759 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -146.89 113.26 5.92 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 105.451 -2.055 . . . . 10.0 105.451 171.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.6 pt . . . . . 0 CA--C 1.535 0.399 0 C-N-CA 124.513 1.125 . . . . 10.0 111.877 -168.303 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 CA--C 1.536 0.432 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -145.27 151.34 38.21 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.208 0.603 . . . . 10.0 109.978 171.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -79.98 146.28 32.12 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.335 -1.357 . . . . 10.0 107.335 174.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.86 161.54 38.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.629 0.649 . . . . 10.0 110.962 -177.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.39 145.2 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.571 1.548 . . . . 10.0 107.574 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.3 tp -104.97 123.68 48.21 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.197 -2.149 . . . . 10.0 105.197 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.13 129.47 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 -172.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -83.65 140.09 32.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.525 -1.657 . . . . 10.0 106.525 167.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.69 139.74 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 106.16 -1.793 . . . . 10.0 106.16 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -121.02 138.1 54.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.337 1.855 . . . . 10.0 106.623 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.3 p -97.03 138.42 34.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.247 0.546 . . . . 10.0 112.323 -170.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.37 68.11 7.72 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 125.155 1.382 . . . . 10.0 107.393 168.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.48 149.62 9.5 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.957 3.105 . . . . 10.0 111.917 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 45.86 20.99 0.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.573 1.549 . . . . 10.0 114.632 -171.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.6 m 50.94 39.05 21.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.758 1.223 . . . . 10.0 111.878 -171.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.23 -28.87 0.02 OUTLIER Glycine 0 C--N 1.342 0.871 0 CA-C-O 118.977 -0.902 . . . . 10.0 114.72 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.24 131.2 93.48 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 119.572 1.686 . . . . 10.0 109.231 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -85.55 32.83 0.47 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.353 3.369 . . . . 10.0 112.88 -170.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.25 78.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.637 0.775 . . . . 10.0 111.95 -169.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 48.82 26.74 1.37 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.82 2.048 . . . . 10.0 115.32 174.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.87 159.5 28.89 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 168.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -142.91 158.74 43.33 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.535 -0.728 . . . . 10.0 110.624 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -151.76 176.04 11.8 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.97 1.308 . . . . 10.0 109.356 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.6 mp0 -106.68 153.63 22.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.963 -0.755 . . . . 10.0 108.963 170.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.7 pt -137.75 151.81 26.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 125.338 1.455 . . . . 10.0 110.081 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.45 130.12 58.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 106.233 -1.765 . . . . 10.0 106.233 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -133.83 140.35 46.83 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.082 -1.821 . . . . 10.0 106.082 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.74 139.31 4.98 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 120.455 1.48 . . . . 10.0 113.019 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -149.25 144.85 26.77 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.809 0.843 . . . . 10.0 109.652 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.58 -23.96 61.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 117.956 -1.021 . . . . 10.0 112.936 -172.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -68.03 -17.27 64.36 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.668 0.988 . . . . 10.0 113.668 -174.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.24 130.79 46.98 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 119.389 0.995 . . . . 10.0 110.103 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.47 -37.5 77.32 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.925 -0.398 . . . . 10.0 109.925 176.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -149.53 160.38 43.53 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.098 2.159 . . . . 10.0 106.709 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -57.32 -33.13 67.39 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.902 0.881 . . . . 10.0 112.701 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.0 -25.54 65.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.384 0.674 . . . . 10.0 112.586 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.08 -37.92 84.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.579 0.627 . . . . 10.0 110.36 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.7 mt -64.27 -50.85 74.72 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 107.748 -1.204 . . . . 10.0 107.748 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -55.73 -42.6 75.6 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.851 -0.595 . . . . 10.0 111.326 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.09 -43.9 97.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.601 0.637 . . . . 10.0 111.989 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -61.3 -51.34 69.28 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 121.63 -0.669 . . . . 10.0 109.434 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.17 -42.71 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.584 -0.525 . . . . 10.0 109.584 -170.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.4 p -66.45 -33.75 76.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.182 0.901 . . . . 10.0 111.472 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.3 -39.54 96.02 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.364 0.983 . . . . 10.0 111.034 173.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -69.11 -45.38 70.36 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.724 -0.868 . . . . 10.0 111.109 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 27.2 mmt -61.13 -39.5 90.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.186 0.903 . . . . 10.0 110.597 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.55 -39.75 89.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.78 0.718 . . . . 10.0 110.903 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -20.48 59.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 117.874 -1.06 . . . . 10.0 112.887 175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -72.95 -43.29 62.48 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.714 1.143 . . . . 10.0 110.423 169.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.71 49.71 0.58 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.217 -1.553 . . . . 10.0 109.217 -169.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.7 m -145.74 169.83 17.71 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.046 1.738 . . . . 10.0 108.206 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -136.24 161.51 35.54 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.637 1.575 . . . . 10.0 108.216 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.6 m -125.13 158.05 34.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.542 1.137 . . . . 10.0 112.693 -168.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -146.0 106.41 4.06 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.994 2.118 . . . . 10.0 105.597 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.8 p -61.46 131.51 50.41 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.281 -0.887 . . . . 10.0 109.192 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -102.4 -21.77 14.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.008 0.523 . . . . 10.0 110.909 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.01 -178.48 32.52 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.937 -1.265 . . . . 10.0 109.937 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.94 -173.29 23.56 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 117.944 0.872 . . . . 10.0 111.215 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.23 -148.98 9.87 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.157 -1.577 . . . . 10.0 109.157 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -139.46 160.44 39.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.765 1.226 . . . . 10.0 108.671 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.8 mt -136.58 149.17 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 106.333 -1.728 . . . . 10.0 106.333 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 C--O 1.237 0.413 0 C-N-CA 125.333 1.453 . . . . 10.0 108.435 170.176 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 98.0 mt . . . . . 0 C--O 1.237 0.438 0 N-CA-C 105.546 -2.02 . . . . 10.0 105.546 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -135.76 145.2 46.33 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.847 0.859 . . . . 10.0 108.912 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.81 130.49 55.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 107.326 -1.361 . . . . 10.0 107.326 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -158.66 179.49 9.06 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.346 -0.846 . . . . 10.0 111.714 -168.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.72 -159.01 34.22 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 123.762 0.696 . . . . 10.0 112.359 170.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -155.92 152.38 28.18 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.596 1.959 . . . . 10.0 106.494 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 p -69.82 152.15 44.9 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.017 0.826 . . . . 10.0 111.131 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.5 mtp -77.81 28.73 0.17 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.588 1.155 . . . . 10.0 110.161 169.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.36 -41.5 0.18 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.087 0.955 . . . . 10.0 112.585 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -133.42 -51.28 0.87 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.314 0.961 . . . . 10.0 112.565 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.19 -177.67 23.47 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.806 -0.918 . . . . 10.0 110.806 -171.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.2 144.76 82.34 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.004 2.47 . . . . 10.0 110.725 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.86 21.83 1.5 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -170.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 40.94 53.2 3.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.237 1.415 . . . . 10.0 110.065 -169.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -39.09 -30.91 0.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.95 2.9 . . . . 10.0 116.759 -166.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.65 60.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.814 1.188 . . . . 10.0 112.643 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.0 mt -60.77 -54.22 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -61.59 -41.29 97.22 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 117.915 -1.04 . . . . 10.0 111.867 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.7 p -64.69 -37.31 87.14 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 120.092 1.314 . . . . 10.0 111.431 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.2 -39.98 86.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.906 0.775 . . . . 10.0 110.729 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -64.8 -46.26 82.77 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.834 -0.541 . . . . 10.0 110.527 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.0 mt -57.64 -47.16 86.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -58.42 -42.31 86.96 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.134 0.879 . . . . 10.0 111.239 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.67 89.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.593 0.633 . . . . 10.0 111.559 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 118.085 -0.96 . . . . 10.0 112.99 -176.998 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 t . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.6 p -138.0 167.31 22.04 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.456 1.102 . . . . 10.0 109.429 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -145.01 165.3 28.57 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.41 0 C-N-CA 127.27 2.228 . . . . 10.0 108.286 172.73 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.367 0 N-CA-C 109.671 -0.492 . . . . 10.0 109.671 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.79 149.64 29.25 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 172.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.01 -23.5 63.71 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.36 -29.29 69.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.139 0.882 . . . . 10.0 111.987 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.9 mt -75.37 -31.88 60.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.159 0.436 . . . . 10.0 110.408 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.0 mt -69.79 123.74 89.21 Favored Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 107.629 -1.248 . . . . 10.0 107.629 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.13 135.05 30.51 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.639 2.893 . . . . 10.0 111.159 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.18 -28.47 27.33 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.299 0.571 . . . . 10.0 112.237 -171.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.19 134.69 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 127.41 2.284 . . . . 10.0 104.895 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -156.2 98.77 1.89 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.208 -1.775 . . . . 10.0 106.208 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.5 pt . . . . . 0 CA--C 1.531 0.234 0 C-N-CA 124.487 1.115 . . . . 10.0 109.633 -169.771 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.4 t . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 110.036 -0.357 . . . . 10.0 110.036 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -139.32 19.57 2.58 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.505 1.122 . . . . 10.0 111.696 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 64.17 146.3 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.594 2.758 . . . . 10.0 113.093 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.47 157.05 43.7 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.749 1.22 . . . . 10.0 108.344 175.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.34 147.96 32.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 125.624 1.569 . . . . 10.0 108.161 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.2 tp -109.46 120.2 41.77 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.666 -1.975 . . . . 10.0 105.666 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.8 mt -131.28 136.36 57.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 -168.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -88.45 143.8 26.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.799 -1.556 . . . . 10.0 106.799 168.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -126.78 141.64 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.565 -1.643 . . . . 10.0 106.565 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -124.83 129.53 50.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.352 1.861 . . . . 10.0 106.048 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.1 p -80.06 146.22 32.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.775 0.322 . . . . 10.0 111.201 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -155.72 62.15 3.08 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.38 1.872 . . . . 10.0 106.702 167.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -55.61 143.63 78.27 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.532 2.821 . . . . 10.0 111.078 -168.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.4 ttt85 47.69 25.38 0.68 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.947 1.299 . . . . 10.0 113.09 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.0 m 53.01 28.82 7.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.523 1.529 . . . . 10.0 113.632 -175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.84 -1.8 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 N-CA-C 116.723 1.449 . . . . 10.0 116.723 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 152.13 82.44 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 120.168 1.984 . . . . 10.0 110.675 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.85 59.14 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.291 3.327 . . . . 10.0 111.917 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.6 140.98 33.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.024 1.33 . . . . 10.0 108.516 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.06 29.77 0.72 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.176 1.391 . . . . 10.0 110.254 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -67.57 162.24 23.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.643 0.777 . . . . 10.0 108.918 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -140.2 160.29 40.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.026 0.93 . . . . 10.0 110.01 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -150.78 176.28 11.19 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.58 1.152 . . . . 10.0 109.627 170.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -99.31 157.09 16.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.347 -0.982 . . . . 10.0 108.347 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.8 pt -141.72 149.35 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 126.387 1.875 . . . . 10.0 108.346 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.76 124.27 66.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.883 -1.895 . . . . 10.0 105.883 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -129.38 148.53 51.31 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.596 -1.261 . . . . 10.0 107.596 -175.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.32 124.08 0.97 Allowed Glycine 0 C--O 1.228 -0.255 0 N-CA-C 109.035 -1.626 . . . . 10.0 109.035 173.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -140.63 134.97 31.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.4 0.6 . . . . 10.0 110.501 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -74.69 -11.95 60.3 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 114.277 1.214 . . . . 10.0 114.277 -169.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -66.11 -24.3 66.66 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.461 1.028 . . . . 10.0 111.575 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.33 163.19 28.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.85 0.75 . . . . 10.0 110.809 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -119.18 -17.65 8.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.449 1.1 . . . . 10.0 110.367 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -146.95 152.49 38.74 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.421 1.488 . . . . 10.0 108.105 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 94' ' ' SER . 55.7 m80 -57.68 -31.85 66.76 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.399 1.079 . . . . 10.0 112.21 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.32 -33.2 72.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.187 -0.911 . . . . 10.0 112.607 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -72.0 -37.08 69.88 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.959 0.799 . . . . 10.0 110.437 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.9 -52.23 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.934 -1.135 . . . . 10.0 107.934 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -56.87 -43.19 80.96 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 119.09 -0.481 . . . . 10.0 111.494 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.32 -45.5 91.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.906 0.482 . . . . 10.0 111.181 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -60.92 -48.25 82.67 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.608 -0.682 . . . . 10.0 109.976 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.97 -43.89 98.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.659 0.783 . . . . 10.0 109.622 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.8 m -61.29 -43.88 98.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.046 0.839 . . . . 10.0 110.406 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.78 -46.92 93.55 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.787 -0.925 . . . . 10.0 110.787 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.05 -44.8 95.92 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.741 0.77 . . . . 10.0 110.668 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.3 mmt -62.01 -37.18 83.91 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.923 -0.56 . . . . 10.0 111.101 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -63.65 -35.64 81.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.274 0.943 . . . . 10.0 110.816 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.55 -31.97 72.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 117.924 -1.036 . . . . 10.0 111.597 171.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.63 -44.43 70.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.527 1.058 . . . . 10.0 110.039 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.86 47.55 0.61 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 108.852 -1.699 . . . . 10.0 108.852 -169.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.5 m -146.66 169.64 18.59 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.321 1.848 . . . . 10.0 108.655 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.57 164.93 28.83 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.064 1.746 . . . . 10.0 108.138 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 78.5 m -126.17 164.89 19.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.199 1.0 . . . . 10.0 112.811 -168.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -149.3 113.08 5.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.317 2.247 . . . . 10.0 105.346 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.8 t -66.47 140.23 58.01 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.637 -1.29 . . . . 10.0 109.479 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.8 mt -108.22 -13.46 14.9 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.614 0.765 . . . . 10.0 111.228 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.06 -174.25 24.48 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.209 1.385 . . . . 10.0 110.573 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.06 -176.23 27.03 Favored Glycine 0 CA--C 1.524 0.647 0 O-C-N 121.44 -1.036 . . . . 10.0 111.495 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.29 -154.5 10.2 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.131 -1.588 . . . . 10.0 109.131 -174.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -139.52 163.65 31.98 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.441 1.896 . . . . 10.0 107.905 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mt -129.23 150.78 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.495 -1.669 . . . . 10.0 106.495 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 p . . . . . 0 CA--C 1.537 0.456 0 C-N-CA 125.257 1.423 . . . . 10.0 108.832 -174.112 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.8 mt . . . . . 0 C--O 1.239 0.528 0 N-CA-C 106.582 -1.636 . . . . 10.0 106.582 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -137.44 157.01 47.49 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.526 0.731 . . . . 10.0 109.366 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.53 140.32 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -159.36 -174.95 4.94 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.761 -1.212 . . . . 10.0 110.06 -171.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.13 -166.07 52.49 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 121.835 0.686 . . . . 10.0 111.641 169.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -148.47 161.8 40.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.512 1.125 . . . . 10.0 108.403 175.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.408 ' HA ' ' CE1' ' A' ' 53' ' ' HIS . 30.1 t -83.17 126.33 32.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -64.63 -26.97 68.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.119 0.568 . . . . 10.0 110.702 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.53 -30.17 46.89 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.529 -0.748 . . . . 10.0 112.487 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -130.15 -58.91 1.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.802 0.728 . . . . 10.0 112.396 -169.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 149.14 176.28 22.28 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 108.902 -1.679 . . . . 10.0 108.902 -170.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -57.13 134.53 64.84 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.572 2.182 . . . . 10.0 110.566 171.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.65 163.44 18.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 166.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -79.79 69.29 6.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.08 -1.822 . . . . 10.0 106.08 167.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -50.78 -30.09 13.25 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.211 1.404 . . . . 10.0 113.518 -168.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.69 70.89 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.289 0.95 . . . . 10.0 112.349 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.9 mt -64.32 -50.28 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.2 m -59.26 -46.5 88.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.61 -0.681 . . . . 10.0 111.96 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.9 p -63.94 -39.98 95.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.356 -0.83 . . . . 10.0 110.876 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.44 -40.17 92.94 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.307 0.958 . . . . 10.0 110.97 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -66.68 -44.23 82.36 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.755 -0.64 . . . . 10.0 110.436 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.7 mt -56.15 -52.44 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.003 -1.11 . . . . 10.0 108.003 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -59.55 -40.59 87.73 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.741 0.816 . . . . 10.0 111.54 -174.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.6 -41.08 98.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.704 0.802 . . . . 10.0 111.288 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt . . . . . 0 N--CA 1.467 0.416 0 CA-C-O 118.233 -0.889 . . . . 10.0 112.923 -177.386 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.235 0.3 0 N-CA-C 107.551 -1.277 . . . . 10.0 107.551 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.17 172.0 13.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.694 1.197 . . . . 10.0 109.163 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 44.0 p-90 -147.04 169.09 19.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.29 0.496 . . . . 10.0 111.179 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.149 0 C-N-CA 124.266 1.026 . . . . 10.0 109.997 171.864 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.243 0 N-CA-C 106.549 -1.649 . . . . 10.0 106.549 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -150.21 152.93 35.38 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 172.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.65 -21.8 61.01 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 118.381 -0.818 . . . . 10.0 113.161 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.7 -23.29 64.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.413 1.006 . . . . 10.0 112.688 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.9 mt -77.54 -8.65 58.13 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.661 0.784 . . . . 10.0 111.995 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.9 mt -112.76 128.45 25.56 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 106.479 -1.674 . . . . 10.0 106.479 -172.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.72 151.43 74.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.382 2.055 . . . . 10.0 110.755 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -67.63 -38.16 83.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.05 1.34 . . . . 10.0 112.817 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.55 138.66 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.145 -1.428 . . . . 10.0 107.145 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -155.04 97.7 1.95 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.438 -1.319 . . . . 10.0 107.438 -176.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.1 pt . . . . . 0 CA--C 1.533 0.308 0 C-N-CA 124.895 1.278 . . . . 10.0 108.211 -175.825 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.2 t . . . . . 0 CA--C 1.532 0.254 0 N-CA-C 108.748 -0.834 . . . . 10.0 108.748 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -145.42 146.16 31.42 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.711 -0.848 . . . . 10.0 108.711 172.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -61.84 157.65 17.72 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.367 0.667 . . . . 10.0 110.567 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -151.08 171.9 16.6 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.228 1.411 . . . . 10.0 108.242 169.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.4 152.61 29.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.707 1.203 . . . . 10.0 110.48 174.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.0 tp -102.95 117.68 35.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.086 -2.191 . . . . 10.0 105.086 167.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.78 134.69 62.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 105.731 -1.952 . . . . 10.0 105.731 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -85.79 135.14 33.85 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.381 -1.711 . . . . 10.0 106.381 167.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -120.88 142.3 37.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -122.66 133.21 54.52 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.368 1.867 . . . . 10.0 106.083 -174.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.6 p -66.83 143.55 56.81 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.649 -0.5 . . . . 10.0 109.649 172.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.12 59.35 3.64 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.214 1.006 . . . . 10.0 108.781 168.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -59.18 138.52 85.5 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.871 2.381 . . . . 10.0 109.522 -173.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 45.26 21.19 0.06 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.958 1.703 . . . . 10.0 114.482 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m 47.88 32.14 2.63 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.342 1.457 . . . . 10.0 113.125 -170.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.92 0.11 0.03 OUTLIER Glycine 0 CA--C 1.531 1.059 0 N-CA-C 115.929 1.131 . . . . 10.0 115.929 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.45 152.68 84.85 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 120.529 2.164 . . . . 10.0 110.509 171.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.69 52.63 3.75 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 124.123 3.215 . . . . 10.0 111.651 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.14 136.56 31.98 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.921 1.288 . . . . 10.0 108.333 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.15 30.56 0.7 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.244 1.418 . . . . 10.0 109.595 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -64.34 155.44 32.26 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -140.77 160.45 40.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.981 0.912 . . . . 10.0 110.702 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -149.78 172.64 14.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.177 0.991 . . . . 10.0 109.809 172.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.39 145.8 26.99 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 174.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.5 pt -135.74 148.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.585 1.554 . . . . 10.0 109.02 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.15 126.05 67.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.964 -1.495 . . . . 10.0 106.964 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -131.39 131.11 43.41 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 -174.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.04 55.01 0.36 Allowed Glycine 0 N--CA 1.464 0.527 0 CA-C-N 119.328 0.967 . . . . 10.0 111.398 -168.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -74.05 142.71 45.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.884 0.473 . . . . 10.0 111.15 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -63.53 -37.95 89.29 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 124.037 0.935 . . . . 10.0 112.551 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -66.33 -20.56 66.12 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 118.124 -0.941 . . . . 10.0 113.228 -172.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.37 134.38 51.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.768 0.713 . . . . 10.0 111.439 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -72.78 -34.42 66.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.552 0.691 . . . . 10.0 110.11 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -151.27 165.47 33.9 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 125.173 1.389 . . . . 10.0 109.238 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -48.88 -40.31 29.23 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.635 1.174 . . . . 10.0 112.516 169.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.24 73.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.52 -0.753 . . . . 10.0 112.184 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -70.19 -38.03 75.27 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.099 0.952 . . . . 10.0 109.793 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.22 -53.72 42.3 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 107.994 -1.113 . . . . 10.0 107.994 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -57.74 -45.24 86.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.323 -0.846 . . . . 10.0 111.504 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.04 -46.94 86.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.433 0.561 . . . . 10.0 111.538 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -63.22 -48.03 79.98 Favored 'General case' 0 C--N 1.342 0.274 0 O-C-N 121.604 -0.685 . . . . 10.0 109.756 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.08 -44.97 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 118.437 -0.792 . . . . 10.0 109.227 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.4 m -57.64 -42.26 83.07 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.497 1.044 . . . . 10.0 110.928 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.21 -45.49 95.9 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.577 -0.609 . . . . 10.0 111.577 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.33 -50.57 73.11 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.399 -1.06 . . . . 10.0 110.81 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -38.87 84.18 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 118.894 -0.574 . . . . 10.0 111.056 -178.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -63.94 -34.14 77.29 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.108 0.413 . . . . 10.0 110.837 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -71.57 -28.45 63.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 117.453 -1.26 . . . . 10.0 112.527 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -69.34 -59.86 2.72 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.727 1.149 . . . . 10.0 108.523 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.06 44.01 0.11 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.979 1.752 . . . . 10.0 109.169 -168.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.0 m -147.09 176.35 10.01 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.441 2.296 . . . . 10.0 107.346 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -148.46 165.9 29.76 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.02 -1.05 . . . . 10.0 108.923 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.8 m -131.04 159.8 36.47 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.602 1.092 . . . . 10.0 112.763 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -145.54 120.18 9.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.007 -1.849 . . . . 10.0 106.007 170.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.9 t -67.33 134.44 51.54 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.643 -1.285 . . . . 10.0 109.056 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 56.0 mt -91.64 -24.2 19.6 Favored 'General case' 0 C--O 1.226 -0.18 0 O-C-N 123.953 0.783 . . . . 10.0 110.646 171.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.92 164.78 21.01 Favored Glycine 0 C--N 1.337 0.587 0 O-C-N 121.216 -0.927 . . . . 10.0 111.233 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -125.61 163.15 19.69 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.263 -1.135 . . . . 10.0 110.263 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.29 -156.11 10.45 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.512 -1.835 . . . . 10.0 108.512 -171.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -139.35 153.59 47.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.059 1.744 . . . . 10.0 109.161 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.0 mm -119.98 145.89 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.327 -2.471 . . . . 10.0 104.327 168.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.4 m . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 168.469 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 mm . . . . . 0 C--O 1.237 0.44 0 N-CA-C 107.343 -1.355 . . . . 10.0 107.343 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -140.37 141.81 35.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.911 -1.144 . . . . 10.0 107.911 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.0 t -131.72 122.77 50.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.832 -1.544 . . . . 10.0 106.832 -169.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -158.28 -164.25 1.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.163 -0.961 . . . . 10.0 108.638 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.51 -173.27 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 118.65 0.659 . . . . 10.0 112.658 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -159.09 167.35 29.45 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.818 -1.178 . . . . 10.0 107.818 167.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.2 m -133.09 112.62 11.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 172.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -24.56 6.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.68 1.992 . . . . 10.0 114.101 -176.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.35 -25.31 65.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.745 0.818 . . . . 10.0 112.868 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.35 -41.68 0.14 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.0 0.818 . . . . 10.0 112.882 -174.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.29 -175.77 23.89 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.459 1.028 . . . . 10.0 110.765 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.19 148.16 68.12 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.264 2.643 . . . . 10.0 110.397 170.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.87 34.5 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.077 1.351 . . . . 10.0 113.176 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 35.28 59.31 0.77 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.277 2.231 . . . . 10.0 112.156 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -51.4 -25.14 5.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.327 2.251 . . . . 10.0 115.561 -164.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.77 92.47 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.764 1.165 . . . . 10.0 111.663 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.87 -54.01 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.027 -1.471 . . . . 10.0 107.027 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 m -63.34 -41.21 98.85 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.156 0.582 . . . . 10.0 112.516 -173.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.7 p -61.53 -47.14 86.93 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 118.628 0.649 . . . . 10.0 110.419 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -66.68 -36.74 83.25 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.22 0.464 . . . . 10.0 110.271 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -59.68 -50.79 72.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 118.847 -0.597 . . . . 10.0 110.794 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.54 -53.57 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.096 -1.076 . . . . 10.0 108.096 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -60.86 -37.97 83.96 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.039 1.335 . . . . 10.0 112.234 -173.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.48 -50.38 26.43 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.15 0.58 . . . . 10.0 110.389 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 tptt . . . . . 0 C--N 1.341 0.236 0 CA-C-O 118.625 -0.702 . . . . 10.0 111.444 -173.589 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.533 0.299 0 N-CA-C 104.032 -2.581 . . . . 10.0 104.032 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.1 p -111.94 167.15 10.61 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.832 0.853 . . . . 10.0 110.458 -170.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -145.43 166.75 24.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.487 0.921 . . . . 10.0 113.487 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 127.979 2.512 . . . . 10.0 107.93 170.911 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -151.72 149.54 29.18 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.938 -1.504 . . . . 10.0 106.938 171.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.75 -27.91 63.45 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.778 0.831 . . . . 10.0 112.933 -176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -25.96 68.01 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.773 0.715 . . . . 10.0 112.193 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.3 mt -76.34 -23.23 54.22 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.221 0.608 . . . . 10.0 111.191 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.9 mt -83.94 122.08 76.01 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 107.688 -1.227 . . . . 10.0 107.688 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.31 138.55 37.69 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.692 2.928 . . . . 10.0 110.909 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -85.25 -28.42 25.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.438 0.637 . . . . 10.0 112.104 -169.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.8 t -139.16 136.04 41.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 126.185 1.794 . . . . 10.0 106.193 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -149.5 98.79 2.82 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.8 pt . . . . . 0 CA--C 1.537 0.454 0 C-N-CA 125.665 1.586 . . . . 10.0 109.996 -169.647 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 CA--C 1.534 0.34 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -139.68 139.99 36.76 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.901 -1.148 . . . . 10.0 107.901 175.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -67.23 155.82 37.86 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.02 165.41 29.11 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.697 0.761 . . . . 10.0 109.108 172.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.5 140.09 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.318 1.447 . . . . 10.0 107.436 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -100.17 118.93 37.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.695 -2.335 . . . . 10.0 104.695 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.7 mt -123.29 135.97 61.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 -171.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -88.83 133.28 34.32 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.175 -1.787 . . . . 10.0 106.175 168.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -116.25 140.25 39.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.2 -1.778 . . . . 10.0 106.2 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -122.04 136.4 54.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.196 1.798 . . . . 10.0 106.997 -172.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 m -64.12 137.05 57.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.306 -0.628 . . . . 10.0 109.306 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.9 54.95 2.02 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.246 1.018 . . . . 10.0 108.957 166.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.85 131.49 33.25 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.895 2.397 . . . . 10.0 108.523 -169.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.304 4.6 ppt_? 41.12 29.25 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.386 1.874 . . . . 10.0 114.251 -169.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m 46.09 37.87 4.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.758 1.623 . . . . 10.0 113.489 -173.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.99 -1.95 0.03 OUTLIER Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.34 1.296 . . . . 10.0 116.34 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.29 152.38 63.76 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 120.478 2.139 . . . . 10.0 110.55 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.23 49.5 2.85 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.092 3.195 . . . . 10.0 111.892 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.82 128.0 18.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.964 1.306 . . . . 10.0 108.038 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.57 26.61 1.75 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.134 1.374 . . . . 10.0 109.948 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.86 160.05 21.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.6 0.76 . . . . 10.0 109.006 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -138.1 161.39 36.89 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.98 0.912 . . . . 10.0 110.797 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -144.59 173.13 12.08 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.221 1.008 . . . . 10.0 109.578 169.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -98.26 148.95 23.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 pt -137.24 154.17 30.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 125.736 1.615 . . . . 10.0 109.466 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.2 126.97 67.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.217 -1.772 . . . . 10.0 106.217 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -130.54 137.29 49.64 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.91 46.0 0.27 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.944 -0.862 . . . . 10.0 110.944 -169.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -66.16 136.61 56.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.064 0.546 . . . . 10.0 110.406 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -66.72 -27.96 68.05 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 113.667 0.988 . . . . 10.0 113.667 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.6 p-90 -68.3 -23.94 64.8 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.423 -0.798 . . . . 10.0 112.474 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.19 134.28 47.93 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.871 0.76 . . . . 10.0 110.778 -175.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.25 -35.37 71.4 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.366 0.666 . . . . 10.0 110.559 171.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -147.29 157.45 43.59 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.632 1.573 . . . . 10.0 109.084 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.88 -25.67 57.22 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.282 1.033 . . . . 10.0 112.387 172.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.77 -40.24 79.31 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.011 0.823 . . . . 10.0 112.03 169.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -71.54 -33.28 69.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.383 0.611 . . . . 10.0 110.125 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.0 -55.75 20.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 108.35 -0.982 . . . . 10.0 108.35 173.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -54.99 -42.16 72.11 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.956 -0.545 . . . . 10.0 111.305 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.93 -48.7 80.55 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.478 0.711 . . . . 10.0 111.261 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -44.89 72.07 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.486 -0.759 . . . . 10.0 110.29 -175.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.81 -46.06 95.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 C-N-CA 123.89 0.876 . . . . 10.0 109.172 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 m -58.4 -40.47 82.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.09 0.859 . . . . 10.0 111.242 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.09 -50.77 64.02 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.995 -0.842 . . . . 10.0 110.995 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.66 -47.91 84.15 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.073 0.937 . . . . 10.0 111.071 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -39.39 85.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.724 -0.61 . . . . 10.0 110.459 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -68.14 -33.37 74.36 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 118.829 0.741 . . . . 10.0 110.757 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.87 -39.7 94.83 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 116.575 -1.678 . . . . 10.0 111.029 169.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -67.7 -60.15 2.77 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 119.281 0.946 . . . . 10.0 108.788 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.08 44.28 0.08 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.283 1.42 . . . . 10.0 110.447 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.4 m -148.69 177.59 9.37 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.055 2.142 . . . . 10.0 108.052 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -148.21 165.99 29.27 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.503 1.121 . . . . 10.0 109.004 172.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.5 m -134.5 160.1 39.08 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.842 1.201 . . . . 10.0 113.375 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.17 139.32 19.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.512 1.925 . . . . 10.0 106.902 169.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.3 m -75.67 140.82 42.75 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.352 -0.843 . . . . 10.0 110.415 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.7 mt -96.24 -22.99 16.91 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.921 -0.487 . . . . 10.0 110.802 168.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.16 -173.59 39.35 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.979 -1.248 . . . . 10.0 109.979 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.05 -172.16 22.47 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 118.846 1.323 . . . . 10.0 111.911 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.65 -150.85 9.58 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 109.375 -1.49 . . . . 10.0 109.375 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -137.3 160.76 38.11 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.966 1.306 . . . . 10.0 109.117 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.5 mt -132.6 150.18 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 CA--C 1.532 0.268 0 C-N-CA 124.608 1.163 . . . . 10.0 109.441 171.619 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.9 mm . . . . . 0 C--O 1.238 0.484 0 N-CA-C 106.719 -1.586 . . . . 10.0 106.719 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -137.23 156.22 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 120.147 -1.596 . . . . 10.0 109.247 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.38 131.87 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.067 -1.457 . . . . 10.0 107.067 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.59 176.72 12.26 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.159 -0.963 . . . . 10.0 112.136 -169.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.71 -159.47 53.03 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.217 -0.753 . . . . 10.0 111.217 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -157.39 157.06 33.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.123 1.369 . . . . 10.0 108.829 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -73.79 127.98 34.28 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.003 -1.061 . . . . 10.0 108.236 170.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 96.7 mtp -75.44 -18.19 59.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.763 -0.637 . . . . 10.0 111.215 169.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.56 -32.01 53.53 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 118.429 0.559 . . . . 10.0 111.688 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -127.37 -49.29 1.42 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.685 0.394 . . . . 10.0 111.264 -171.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.47 177.59 15.76 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.391 -1.484 . . . . 10.0 109.391 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.27 131.15 41.82 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.943 2.429 . . . . 10.0 110.573 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.05 162.58 16.49 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.82 0.819 . . . . 10.0 109.113 166.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -79.17 68.15 5.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.598 -1.63 . . . . 10.0 106.598 167.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -49.81 -32.34 13.86 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.316 1.446 . . . . 10.0 113.321 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.65 -36.89 74.84 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.433 1.015 . . . . 10.0 112.563 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.5 mt -66.62 -49.23 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -58.13 -44.21 87.68 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 117.858 -1.068 . . . . 10.0 111.99 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 p -64.79 -38.06 89.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 120.235 1.38 . . . . 10.0 111.273 -177.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.66 -40.31 88.59 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.58 1.082 . . . . 10.0 110.672 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -65.53 -45.72 82.37 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.793 -0.567 . . . . 10.0 110.337 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.3 mt -59.66 -43.12 90.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 118.017 -0.992 . . . . 10.0 109.213 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -57.95 -41.76 83.52 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 119.024 0.829 . . . . 10.0 110.669 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.69 -44.01 87.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.394 0.543 . . . . 10.0 111.03 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.2 tptp . . . . . 0 CA--C 1.533 0.314 0 O-C-N 121.671 -0.643 . . . . 10.0 111.365 -174.876 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 105.444 -2.058 . . . . 10.0 105.444 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.3 p -133.22 173.43 11.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.61 0.641 . . . . 10.0 109.622 171.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -144.89 165.34 28.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.508 0.323 . . . . 10.0 111.039 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 C-N-CA 126.215 1.806 . . . . 10.0 108.38 171.841 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.267 0 N-CA-C 108.999 -0.741 . . . . 10.0 108.999 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -149.31 151.16 33.69 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.51 -25.42 62.38 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.399 -0.81 . . . . 10.0 113.07 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.03 -31.93 71.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.992 0.814 . . . . 10.0 112.034 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.06 -35.01 57.06 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.049 0.539 . . . . 10.0 110.118 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -65.61 119.77 62.96 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.271 1.028 . . . . 10.0 108.576 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.7 133.4 38.71 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.748 2.966 . . . . 10.0 111.167 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -84.69 -30.17 25.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.444 0.64 . . . . 10.0 111.929 -170.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -136.57 136.26 48.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 126.266 1.827 . . . . 10.0 106.07 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -149.48 101.54 3.11 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.205 -1.406 . . . . 10.0 107.205 170.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.2 pt . . . . . 0 CA--C 1.533 0.325 0 C-N-CA 125.495 1.518 . . . . 10.0 108.096 -174.944 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 107.691 -1.226 . . . . 10.0 107.691 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -142.53 138.01 30.59 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.668 0.787 . . . . 10.0 108.972 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -59.79 155.03 16.96 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.894 0.878 . . . . 10.0 109.733 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.12 166.47 27.75 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.173 0.989 . . . . 10.0 108.457 174.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.15 148.02 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.012 0.925 . . . . 10.0 108.599 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.9 tp -109.04 114.15 27.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 105.589 -2.004 . . . . 10.0 105.589 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.4 mt -119.18 133.92 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.045 -1.465 . . . . 10.0 107.045 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -88.5 135.05 33.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.93 133.62 53.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.537 -2.023 . . . . 10.0 105.537 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -111.69 128.33 56.04 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.009 -1.848 . . . . 10.0 106.009 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 p -78.66 146.12 34.21 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.009 0.433 . . . . 10.0 111.111 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.86 67.74 3.78 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 126.45 1.9 . . . . 10.0 106.448 167.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.14 -39.55 26.3 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.52 3.48 . . . . 10.0 114.2 -168.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.57 168.8 18.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.79 -1.559 . . . . 10.0 106.79 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -54.43 -21.48 9.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.419 1.888 . . . . 10.0 114.562 -170.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.41 32.12 1.77 Allowed Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.59 1.09 . . . . 10.0 111.699 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.91 146.23 95.53 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.145 0.972 . . . . 10.0 110.766 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -81.64 44.49 1.74 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 124.323 3.348 . . . . 10.0 112.391 -175.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.05 138.65 28.47 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.308 1.043 . . . . 10.0 109.572 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.55 27.98 0.64 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.515 1.526 . . . . 10.0 110.358 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.07 164.47 20.13 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.857 0.863 . . . . 10.0 109.527 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -139.54 160.17 40.47 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.909 0.884 . . . . 10.0 110.787 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -149.28 176.07 10.86 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.805 1.242 . . . . 10.0 109.506 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -102.97 154.18 19.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.81 -0.811 . . . . 10.0 108.81 169.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.2 pt -134.04 154.11 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 125.456 1.502 . . . . 10.0 109.583 170.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.42 127.87 62.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.284 -1.747 . . . . 10.0 106.284 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -131.16 134.97 47.03 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 107.863 -1.162 . . . . 10.0 107.863 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.18 49.59 0.31 Allowed Glycine 0 N--CA 1.46 0.258 0 N-CA-C 110.601 -1.0 . . . . 10.0 110.601 -170.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.33 132.5 46.51 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.465 -0.569 . . . . 10.0 109.465 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -65.45 -26.57 68.01 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 113.483 0.92 . . . . 10.0 113.483 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -67.6 -22.83 65.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.46 -0.781 . . . . 10.0 112.774 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.7 128.89 38.02 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.975 0.807 . . . . 10.0 110.462 -174.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -74.58 -24.75 58.96 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.288 0.566 . . . . 10.0 110.412 173.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -147.13 152.64 38.8 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 120.521 -1.362 . . . . 10.0 109.613 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -53.8 -37.39 63.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.133 0.973 . . . . 10.0 111.137 168.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.2 -31.26 71.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.523 -0.751 . . . . 10.0 112.58 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -69.31 -39.04 78.51 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.149 0.976 . . . . 10.0 109.602 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.74 -53.37 47.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 173.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.82 -46.42 74.55 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.727 -0.654 . . . . 10.0 111.135 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.32 -47.26 86.77 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.302 0.376 . . . . 10.0 111.407 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -65.89 -47.26 75.44 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 121.745 -0.597 . . . . 10.0 109.796 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.84 -39.26 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 118.193 -0.908 . . . . 10.0 110.131 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -59.77 -44.65 93.78 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.684 1.129 . . . . 10.0 110.678 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.92 -46.57 93.9 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.884 -0.887 . . . . 10.0 110.884 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.04 -48.24 81.16 Favored 'General case' 0 C--O 1.228 -0.066 0 CA-C-N 117.696 0.748 . . . . 10.0 110.851 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.0 mmt -60.08 -38.7 83.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.227 0.611 . . . . 10.0 111.18 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -63.68 -34.62 78.27 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.645 0.657 . . . . 10.0 110.601 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -70.0 -33.04 71.52 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.78 -1.105 . . . . 10.0 112.033 170.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -66.82 -53.18 35.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.444 1.02 . . . . 10.0 109.491 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 130.35 43.17 0.2 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.34 1.448 . . . . 10.0 110.177 -169.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.5 m -148.28 175.08 11.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.159 1.783 . . . . 10.0 108.461 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -145.27 166.16 26.31 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.265 1.026 . . . . 10.0 108.568 170.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.5 m -133.71 155.79 49.1 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.797 1.036 . . . . 10.0 113.797 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -147.54 142.59 27.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.552 1.941 . . . . 10.0 106.286 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.7 m -83.36 136.48 34.33 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.263 -0.898 . . . . 10.0 110.366 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.9 mt -87.66 -25.17 23.65 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.377 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.09 -178.7 41.68 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.929 -1.269 . . . . 10.0 109.929 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.93 -177.91 21.86 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 118.038 0.919 . . . . 10.0 111.928 170.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.87 -147.91 5.92 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 108.851 -1.7 . . . . 10.0 108.851 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.64 155.22 44.18 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.471 1.508 . . . . 10.0 107.906 170.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.1 155.91 18.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 104.517 -2.401 . . . . 10.0 104.517 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.452 -0.358 0 O-C-N 121.023 -1.048 . . . . 10.0 108.377 173.064 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt . . . . . 0 C--O 1.239 0.513 0 N-CA-C 108.214 -1.032 . . . . 10.0 108.214 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -135.31 155.03 51.28 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.477 1.511 . . . . 10.0 108.893 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.22 139.69 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.429 1.092 . . . . 10.0 108.439 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -159.37 -172.16 3.62 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.272 -0.893 . . . . 10.0 110.564 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.13 -173.42 36.07 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 121.553 0.53 . . . . 10.0 112.125 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -154.08 160.22 41.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.178 -1.415 . . . . 10.0 107.178 169.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.6 m -124.23 107.33 11.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.9 mtt -56.59 -23.64 42.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.989 1.316 . . . . 10.0 113.664 -169.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.75 -25.11 68.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.528 -0.749 . . . . 10.0 112.767 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -135.71 -50.48 0.72 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.712 0.805 . . . . 10.0 111.111 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.7 -177.94 20.09 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.941 1.734 . . . . 10.0 109.604 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.94 132.98 36.69 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.195 1.93 . . . . 10.0 109.175 169.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.18 152.57 37.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 167.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -78.28 73.09 4.84 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -51.1 -31.0 17.73 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 124.631 1.173 . . . . 10.0 113.258 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.66 -35.81 73.15 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.212 0.914 . . . . 10.0 112.405 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.6 mt -65.11 -51.81 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.208 -1.404 . . . . 10.0 107.208 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -57.63 -44.93 85.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.26 -0.876 . . . . 10.0 112.287 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 p -66.85 -38.65 86.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.704 1.138 . . . . 10.0 111.156 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.08 -39.14 89.8 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.941 0.792 . . . . 10.0 110.736 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -64.65 -46.68 81.46 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 122.056 -0.403 . . . . 10.0 110.683 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.43 -44.07 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -60.81 -42.01 96.82 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.256 0.934 . . . . 10.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.42 87.22 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.281 0.632 . . . . 10.0 111.724 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.1 tptp . . . . . 0 CA--C 1.541 0.63 0 CA-C-O 118.089 -0.958 . . . . 10.0 111.57 174.718 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 CA--C 1.534 0.357 0 N-CA-C 106.926 -1.509 . . . . 10.0 106.926 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.9 p -139.71 166.95 23.23 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 120.987 -1.07 . . . . 10.0 110.034 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -147.12 164.06 34.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.916 0.326 . . . . 10.0 111.134 169.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.371 0 C-N-CA 126.536 1.934 . . . . 10.0 108.532 174.64 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.365 0 CA-C-O 121.953 0.883 . . . . 10.0 111.399 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -147.62 151.44 36.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.3 -1.741 . . . . 10.0 106.3 170.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.5 mt -59.88 -22.55 62.49 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 117.602 -1.189 . . . . 10.0 113.947 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.5 -33.58 75.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.034 0.834 . . . . 10.0 111.615 172.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.16 -34.35 43.23 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.989 0.516 . . . . 10.0 110.299 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -65.21 125.03 88.54 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.799 -1.186 . . . . 10.0 107.799 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.35 139.86 61.51 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.326 2.018 . . . . 10.0 109.875 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.92 -31.5 51.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.036 0.935 . . . . 10.0 111.644 -171.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.5 t -140.41 136.17 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 105.129 -2.174 . . . . 10.0 105.129 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -150.77 102.34 2.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 172.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 pt . . . . . 0 CA--C 1.539 0.524 0 C-N-CA 124.967 1.307 . . . . 10.0 109.478 -168.355 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 37.5 t . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 108.025 -1.102 . . . . 10.0 108.025 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -152.49 148.55 27.54 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.575 1.179 . . . . 10.0 111.213 172.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -63.82 145.98 54.79 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.06 160.74 40.36 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.488 0.715 . . . . 10.0 110.159 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.95 146.42 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.576 1.55 . . . . 10.0 108.132 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 tt -106.49 122.22 45.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 105.438 -2.06 . . . . 10.0 105.438 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.8 mt -126.03 133.26 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.997 -1.483 . . . . 10.0 106.997 -171.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 ttm105 -85.47 139.0 31.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 167.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.27 140.58 41.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 124.579 1.152 . . . . 10.0 107.894 175.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -115.54 127.32 55.18 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.692 -1.966 . . . . 10.0 105.692 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.9 p -74.39 144.54 44.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.228 0.537 . . . . 10.0 111.399 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.0 71.07 4.65 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.795 2.038 . . . . 10.0 106.419 167.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.76 -38.92 47.75 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.69 2.927 . . . . 10.0 112.55 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -146.4 162.74 37.57 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 105.257 -2.127 . . . . 10.0 105.257 170.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -55.6 -23.21 26.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.508 1.299 . . . . 10.0 114.508 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -132.5 25.34 3.81 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.69 1.138 . . . . 10.0 111.865 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.86 149.83 89.0 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 118.679 1.24 . . . . 10.0 110.932 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.65 41.66 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.052 3.168 . . . . 10.0 112.03 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.1 135.09 22.59 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.267 1.027 . . . . 10.0 109.001 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.04 27.52 0.77 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.848 1.659 . . . . 10.0 109.579 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.69 166.46 17.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.302 1.041 . . . . 10.0 109.515 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.1 m -136.39 161.19 36.51 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.405 -0.81 . . . . 10.0 110.459 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -146.9 170.7 16.52 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.299 1.439 . . . . 10.0 107.664 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -122.48 140.95 52.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.261 -2.125 . . . . 10.0 105.261 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.2 pt -134.97 154.12 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.347 1.059 . . . . 10.0 110.123 -173.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.97 128.63 69.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -133.75 144.26 48.97 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.041 -1.466 . . . . 10.0 107.041 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.37 131.55 1.96 Allowed Glycine 0 CA--C 1.506 -0.493 0 CA-C-N 120.193 1.361 . . . . 10.0 111.033 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -147.22 139.29 24.43 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -70.84 -17.59 62.73 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 116.885 -1.531 . . . . 10.0 114.277 -173.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -68.52 -17.22 64.12 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 119.994 1.27 . . . . 10.0 112.012 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.81 127.39 31.72 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 119.856 1.207 . . . . 10.0 111.513 -172.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.79 -44.47 85.64 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.802 0.81 . . . . 10.0 109.068 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -146.51 168.83 20.25 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 127.183 2.193 . . . . 10.0 106.898 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -56.98 -36.13 69.97 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.997 -1.064 . . . . 10.0 112.403 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.27 -24.51 63.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.11 -0.947 . . . . 10.0 112.657 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -66.49 -36.34 82.49 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.903 1.335 . . . . 10.0 109.549 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -65.71 -53.78 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 120.471 -1.393 . . . . 10.0 108.505 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -54.73 -40.18 69.02 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.76 -1.114 . . . . 10.0 111.473 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.59 -46.24 90.69 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.347 0.976 . . . . 10.0 111.756 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -65.27 -48.15 74.22 Favored 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 121.002 -1.061 . . . . 10.0 109.718 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.07 -42.48 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.554 -0.535 . . . . 10.0 109.554 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 p -65.06 -34.46 78.47 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.576 1.08 . . . . 10.0 111.362 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.76 -47.93 81.66 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.08 -47.41 84.81 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 117.363 0.582 . . . . 10.0 111.115 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.7 mmt -60.7 -36.8 79.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.137 -0.935 . . . . 10.0 110.57 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.53 -39.85 94.53 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.39 0.996 . . . . 10.0 111.08 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -70.72 -27.19 63.79 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.759 1.163 . . . . 10.0 111.779 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -69.61 -55.64 9.51 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.335 0.97 . . . . 10.0 108.84 175.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.17 42.66 0.14 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.029 1.3 . . . . 10.0 111.553 -173.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 50.9 m -142.17 168.01 20.76 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.278 1.431 . . . . 10.0 109.508 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.73 160.71 30.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.156 1.782 . . . . 10.0 107.138 170.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.3 m -129.7 153.17 48.43 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.443 1.097 . . . . 10.0 112.663 -166.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -142.72 110.65 5.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.907 -1.886 . . . . 10.0 105.907 170.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.5 p -61.26 122.95 16.38 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.248 -0.908 . . . . 10.0 109.103 170.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.1 mt -86.37 -22.55 26.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.163 0.506 . . . . 10.0 110.558 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.84 -177.18 30.66 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 108.239 -1.945 . . . . 10.0 108.239 -172.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.32 -161.2 13.77 Favored Glycine 0 CA--C 1.52 0.371 0 O-C-N 121.016 -1.285 . . . . 10.0 110.714 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.97 -138.63 3.84 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.656 -1.778 . . . . 10.0 108.656 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -136.81 144.43 43.68 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.698 1.199 . . . . 10.0 107.884 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.84 151.55 8.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 104.656 -2.35 . . . . 10.0 104.656 169.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 177.008 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.8 mt . . . . . 0 C--O 1.239 0.518 0 N-CA-C 107.057 -1.46 . . . . 10.0 107.057 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -139.02 159.66 41.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.5 t -141.62 132.53 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.668 -1.234 . . . . 10.0 107.668 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.89 176.69 10.56 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.799 -1.188 . . . . 10.0 111.434 -171.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.27 -166.01 52.28 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 121.732 -0.605 . . . . 10.0 111.59 -176.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -150.52 160.2 43.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.504 1.122 . . . . 10.0 108.05 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.2 m -86.42 116.7 24.74 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.983 0.811 . . . . 10.0 109.594 172.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -58.56 -25.52 62.62 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 122.877 0.471 . . . . 10.0 110.537 170.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.28 -29.19 70.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.629 -1.177 . . . . 10.0 113.56 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.68 -55.63 0.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.924 1.238 . . . . 10.0 110.884 -176.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.11 -178.79 36.92 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.523 -1.031 . . . . 10.0 110.523 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.43 134.48 41.84 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.818 2.345 . . . . 10.0 109.909 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.09 162.17 28.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.816 0.817 . . . . 10.0 109.796 164.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -80.01 74.84 6.76 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.198 -1.408 . . . . 10.0 107.198 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -48.83 -31.36 6.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.225 1.41 . . . . 10.0 114.487 -170.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.89 72.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.135 0.88 . . . . 10.0 112.408 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.9 mt -63.48 -52.21 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -58.96 -44.77 91.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.305 -0.855 . . . . 10.0 111.355 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.8 p -65.24 -39.17 92.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.702 1.137 . . . . 10.0 111.679 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -65.4 -40.38 93.37 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.648 1.113 . . . . 10.0 109.832 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -66.76 -46.31 75.77 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.03 0.532 . . . . 10.0 110.114 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 72.6 mt -57.51 -45.65 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -61.11 -41.74 97.25 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.158 0.89 . . . . 10.0 110.825 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.77 -39.87 95.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.589 0.631 . . . . 10.0 111.195 174.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.239 0.537 0 CA-C-O 117.296 -1.335 . . . . 10.0 112.181 178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 106.744 -1.576 . . . . 10.0 106.744 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.1 p -142.86 170.82 14.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.855 1.262 . . . . 10.0 109.128 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -145.6 166.74 24.89 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 119.199 0.909 . . . . 10.0 111.346 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 127.369 2.268 . . . . 10.0 108.124 173.398 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.398 0 CA-C-O 121.382 0.611 . . . . 10.0 111.701 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -152.02 154.63 36.38 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.458 1.503 . . . . 10.0 107.203 173.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.77 -24.79 58.82 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.716 0.806 . . . . 10.0 112.81 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.16 -26.76 66.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.37 0.986 . . . . 10.0 112.368 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.2 mt -75.76 -25.08 56.17 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.033 0.533 . . . . 10.0 111.306 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.6 mt -84.16 127.49 66.39 Favored Pre-proline 0 C--O 1.237 0.436 0 N-CA-C 106.722 -1.584 . . . . 10.0 106.722 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.3 147.17 77.77 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.185 1.923 . . . . 10.0 109.769 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.04 -30.44 55.65 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.535 0.683 . . . . 10.0 112.052 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.83 134.86 45.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.14 -2.171 . . . . 10.0 105.14 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -151.2 114.39 4.79 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.305 -1.369 . . . . 10.0 107.305 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.8 pt . . . . . 0 C--N 1.328 -0.34 0 C-N-CA 126.132 1.773 . . . . 10.0 106.272 -175.601 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -147.6 154.56 40.83 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.197 0.999 . . . . 10.0 110.325 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -79.08 145.92 33.54 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.991 1.316 . . . . 10.0 109.017 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.2 162.25 39.28 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.993 0.425 . . . . 10.0 110.458 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.61 143.19 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 125.261 1.424 . . . . 10.0 107.565 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.72 125.37 47.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.328 -2.101 . . . . 10.0 105.328 171.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.3 mt -128.87 130.17 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.552 -1.647 . . . . 10.0 106.552 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -83.43 135.42 34.69 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.007 -1.849 . . . . 10.0 106.007 168.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 p -124.82 138.4 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.793 -1.558 . . . . 10.0 106.793 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -121.98 131.05 53.8 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.927 1.691 . . . . 10.0 106.647 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 p -67.65 140.23 56.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.783 0.325 . . . . 10.0 110.326 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.42 62.4 4.92 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.803 1.241 . . . . 10.0 108.557 168.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -53.96 -35.29 80.06 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.188 3.259 . . . . 10.0 113.503 -169.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -153.14 161.15 42.79 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.855 2.062 . . . . 10.0 105.738 172.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -55.99 -22.3 26.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.653 1.353 . . . . 10.0 114.653 -172.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.1 26.75 3.37 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.492 1.044 . . . . 10.0 112.045 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.96 148.88 91.52 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 118.039 0.92 . . . . 10.0 110.611 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -79.9 42.96 1.41 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 124.308 3.339 . . . . 10.0 111.999 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.28 139.31 28.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.379 1.072 . . . . 10.0 109.514 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.21 16.79 0.41 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.424 1.49 . . . . 10.0 111.797 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -63.33 160.03 16.8 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.274 1.43 . . . . 10.0 109.722 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.9 m -140.64 161.36 37.95 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.206 1.003 . . . . 10.0 110.66 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -146.99 179.33 7.68 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.967 1.307 . . . . 10.0 108.87 169.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -120.31 143.38 48.39 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.191 -1.041 . . . . 10.0 108.191 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.0 146.97 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.991 1.316 . . . . 10.0 110.289 -171.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.19 125.97 60.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.649 -1.611 . . . . 10.0 106.649 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -131.91 144.18 50.67 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.657 -1.609 . . . . 10.0 106.657 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.71 130.9 1.86 Allowed Glycine 0 C--N 1.329 0.156 0 CA-C-N 120.017 1.281 . . . . 10.0 112.868 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -150.91 142.38 23.46 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.218 1.007 . . . . 10.0 109.293 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -72.49 -16.89 61.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.118 1.155 . . . . 10.0 114.118 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -65.97 -21.37 66.41 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.69 1.132 . . . . 10.0 112.828 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.11 130.7 44.32 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 118.485 0.584 . . . . 10.0 110.804 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -67.8 -41.5 83.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -144.12 158.58 43.63 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 126.319 1.848 . . . . 10.0 107.169 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -56.27 -32.02 64.14 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.525 0.73 . . . . 10.0 112.853 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.09 -27.02 65.16 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.866 -0.588 . . . . 10.0 112.136 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.43 -35.9 78.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.503 0.592 . . . . 10.0 110.795 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.56 -50.85 69.4 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 107.683 -1.229 . . . . 10.0 107.683 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -55.28 -45.59 76.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.928 -0.558 . . . . 10.0 111.171 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.46 -45.27 88.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 118.541 0.61 . . . . 10.0 111.822 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -59.0 -50.1 75.36 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.562 0.745 . . . . 10.0 109.481 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.64 -46.11 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.521 0.728 . . . . 10.0 109.068 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 m -59.08 -36.03 74.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.352 0.978 . . . . 10.0 111.486 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.02 -49.32 76.48 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.531 -1.028 . . . . 10.0 110.531 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.01 -45.87 91.71 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 117.751 0.776 . . . . 10.0 111.283 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -36.43 82.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.776 -0.63 . . . . 10.0 111.057 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -65.05 -35.73 82.09 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.9 0.773 . . . . 10.0 110.942 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -66.36 -32.18 73.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.135 -0.936 . . . . 10.0 111.542 172.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -69.19 -60.47 2.33 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.913 0.779 . . . . 10.0 109.281 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.66 47.38 0.09 OUTLIER Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.826 1.679 . . . . 10.0 109.456 -169.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.9 m -146.79 172.43 13.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.263 1.825 . . . . 10.0 108.734 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -137.87 160.45 39.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.846 1.659 . . . . 10.0 108.361 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.4 m -134.54 154.39 51.48 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.118 0.967 . . . . 10.0 112.894 -168.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -144.78 109.93 5.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.588 1.955 . . . . 10.0 106.857 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -60.04 126.88 29.24 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.114 -0.991 . . . . 10.0 109.544 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.2 mt -91.69 -26.57 18.57 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.698 0.399 . . . . 10.0 110.351 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.33 169.58 31.95 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.641 -0.984 . . . . 10.0 110.641 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.96 166.51 22.01 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.952 1.263 . . . . 10.0 110.883 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.48 -161.56 23.91 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.529 -1.428 . . . . 10.0 109.529 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -138.24 156.66 47.47 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.09 -1.241 . . . . 10.0 108.972 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.9 mt -127.81 146.95 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 104.54 -2.393 . . . . 10.0 104.54 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 C--N 1.33 -0.273 0 N-CA-C 106.903 -1.518 . . . . 10.0 106.903 169.874 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.4 pt . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 108.122 -1.066 . . . . 10.0 108.122 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -149.25 156.6 42.37 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.223 -1.029 . . . . 10.0 108.223 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.31 137.7 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.09 0.956 . . . . 10.0 108.51 -169.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -160.17 -177.11 6.05 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.344 -0.847 . . . . 10.0 110.114 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.64 178.93 37.86 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.244 0.449 . . . . 10.0 112.218 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -153.61 -176.23 5.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.227 1.011 . . . . 10.0 108.815 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -137.06 111.14 8.32 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.4 mtt -61.11 -12.87 13.76 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.359 0.664 . . . . 10.0 112.639 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.06 -32.39 54.47 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.124 0.97 . . . . 10.0 112.428 170.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.56 -37.11 0.14 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.377 0.881 . . . . 10.0 113.377 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 141.82 -178.68 20.44 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.612 1.101 . . . . 10.0 110.654 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.22 143.79 78.71 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.219 2.613 . . . . 10.0 110.2 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.44 32.75 0.09 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.182 1.793 . . . . 10.0 113.737 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 37.66 55.45 1.5 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.093 2.557 . . . . 10.0 110.171 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -45.45 -26.84 0.61 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.771 2.428 . . . . 10.0 116.275 -166.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.02 83.2 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.567 1.53 . . . . 10.0 111.899 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.4 -55.03 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -63.93 -39.91 95.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.606 -0.712 . . . . 10.0 112.017 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.0 p -64.85 -38.61 91.56 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 119.417 1.008 . . . . 10.0 110.57 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.59 -41.41 96.27 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.673 1.124 . . . . 10.0 111.241 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -64.08 -47.89 78.34 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.819 -0.55 . . . . 10.0 110.663 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.85 -42.43 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.839 0.855 . . . . 10.0 108.828 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -60.31 -40.15 89.53 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.244 1.018 . . . . 10.0 111.206 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.0 96.43 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.162 0.437 . . . . 10.0 110.936 174.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? . . . . . 0 CA--C 1.535 0.396 0 CA-C-O 117.776 -1.106 . . . . 10.0 113.101 -171.603 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.239 0.546 0 N-CA-C 107.4 -1.333 . . . . 10.0 107.4 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.12 167.07 26.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.432 1.493 . . . . 10.0 107.5 -172.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -144.15 159.67 42.25 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.662 -0.496 . . . . 10.0 109.662 172.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -179.857 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 107.196 -1.409 . . . . 10.0 107.196 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -148.12 152.71 37.78 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.041 -1.096 . . . . 10.0 108.041 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.4 mt -54.91 -31.1 59.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.342 1.057 . . . . 10.0 112.637 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.59 -24.59 66.78 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.7 mt -76.32 -23.74 54.3 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.88 0.472 . . . . 10.0 111.203 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.5 mt -74.48 135.42 75.52 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.001 -1.481 . . . . 10.0 107.001 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.47 138.03 53.24 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.21 1.94 . . . . 10.0 109.062 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.72 -31.79 68.76 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.054 0.761 . . . . 10.0 113.054 -169.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -158.11 136.53 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 105.944 -1.873 . . . . 10.0 105.944 -174.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -157.34 112.72 2.81 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.577 -0.897 . . . . 10.0 108.577 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 pt . . . . . 0 CA--C 1.54 0.594 0 C-N-CA 125.487 1.515 . . . . 10.0 109.964 -176.082 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 C--O 1.24 0.585 0 N-CA-C 108.655 -0.869 . . . . 10.0 108.655 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -154.04 154.85 34.43 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.248 1.019 . . . . 10.0 110.019 168.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -77.75 151.02 34.3 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.112 0.965 . . . . 10.0 109.45 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.53 161.5 38.3 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.507 0.723 . . . . 10.0 109.75 176.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.51 152.69 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.091 1.356 . . . . 10.0 108.988 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -115.35 121.99 44.51 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.58 -2.007 . . . . 10.0 105.58 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 95.2 mt -130.71 134.24 62.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.408 -1.33 . . . . 10.0 107.408 -169.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -85.23 144.56 28.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.533 -1.654 . . . . 10.0 106.533 167.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.99 144.12 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -124.21 132.35 53.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.093 1.757 . . . . 10.0 106.449 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.2 p -64.39 139.86 58.81 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.973 -0.38 . . . . 10.0 109.973 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.48 62.17 2.83 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.854 1.262 . . . . 10.0 108.612 169.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -59.27 135.33 64.85 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.918 2.412 . . . . 10.0 109.499 -172.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 44.76 26.96 0.22 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.925 1.29 . . . . 10.0 113.601 -171.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m 51.54 29.66 5.66 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.22 1.408 . . . . 10.0 113.434 -176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.22 -7.41 0.02 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 116.58 1.392 . . . . 10.0 116.58 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 153.06 80.64 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 120.062 1.931 . . . . 10.0 110.476 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.18 64.06 7.81 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.26 3.306 . . . . 10.0 111.941 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.5 138.21 34.43 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.334 1.453 . . . . 10.0 108.317 172.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.1 25.17 0.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.757 1.223 . . . . 10.0 110.781 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.29 161.14 25.64 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 169.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -139.63 163.51 32.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.291 1.036 . . . . 10.0 110.996 -176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -151.43 166.95 29.49 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.947 2.099 . . . . 10.0 107.862 -170.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.3 mp0 -122.32 143.15 49.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 pt -136.77 155.36 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.441 1.896 . . . . 10.0 109.228 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.48 129.95 74.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -134.68 147.03 50.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.661 -1.607 . . . . 10.0 106.661 -172.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.78 124.17 1.0 Allowed Glycine 0 C--O 1.224 -0.497 0 CA-C-N 119.642 1.11 . . . . 10.0 110.644 172.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -144.52 138.12 27.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 123.846 0.38 . . . . 10.0 110.429 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -61.45 -29.78 70.17 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.22 1.008 . . . . 10.0 112.876 -175.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -64.07 -23.14 67.22 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.957 0.799 . . . . 10.0 112.97 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.37 118.7 14.5 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 119.26 0.936 . . . . 10.0 109.791 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -68.38 -34.16 75.55 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.878 0.471 . . . . 10.0 109.965 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -142.46 151.94 42.24 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.076 1.751 . . . . 10.0 107.894 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -57.17 -36.69 71.09 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.676 0.621 . . . . 10.0 112.676 -171.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.95 -27.06 63.06 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 124.0 0.812 . . . . 10.0 112.175 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.73 -35.36 79.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.26 0.482 . . . . 10.0 110.926 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -66.37 -54.83 22.22 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 N-CA-C 107.399 -1.334 . . . . 10.0 107.399 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -56.93 -41.95 79.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.944 -0.55 . . . . 10.0 111.55 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.33 -47.38 79.61 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.908 0.483 . . . . 10.0 111.632 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -60.97 -47.69 85.29 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 121.872 -0.518 . . . . 10.0 109.695 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.19 -47.57 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 118.475 -0.774 . . . . 10.0 108.996 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 m -57.82 -42.44 84.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.348 0.976 . . . . 10.0 110.897 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.63 -44.29 98.01 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.235 -0.746 . . . . 10.0 111.235 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.87 -48.01 72.99 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.111 0.955 . . . . 10.0 111.504 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -41.07 78.17 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 119.074 0.852 . . . . 10.0 110.121 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -62.69 -36.82 84.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.432 -0.794 . . . . 10.0 110.988 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.1 pttm -74.23 -25.42 59.65 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.468 -1.253 . . . . 10.0 112.652 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -68.31 -56.09 9.81 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.902 1.228 . . . . 10.0 109.151 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.13 45.28 0.14 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.522 1.534 . . . . 10.0 109.896 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.1 m -147.02 175.37 10.74 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.817 2.047 . . . . 10.0 107.875 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -145.64 165.27 29.21 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.892 -0.781 . . . . 10.0 108.892 169.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.94 164.13 19.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.771 1.026 . . . . 10.0 113.771 -168.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -147.07 112.84 5.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.9 2.48 . . . . 10.0 105.734 175.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.9 t -65.2 140.44 58.75 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.916 -1.115 . . . . 10.0 109.48 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.3 mt -106.14 -10.9 16.28 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.732 0.813 . . . . 10.0 111.047 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.31 -177.75 18.74 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.467 1.508 . . . . 10.0 109.723 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.59 -164.23 13.57 Favored Glycine 0 CA--C 1.522 0.519 0 O-C-N 121.472 -1.017 . . . . 10.0 112.04 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.28 -149.71 7.72 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 109.667 -1.373 . . . . 10.0 109.667 -172.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -143.06 155.96 44.72 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.602 1.161 . . . . 10.0 109.275 -174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.1 mt -136.43 153.97 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.529 -2.026 . . . . 10.0 105.529 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 169.879 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 pt . . . . . 0 C--O 1.238 0.462 0 CA-C-O 122.826 1.298 . . . . 10.0 110.917 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -134.77 154.45 51.59 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.663 1.985 . . . . 10.0 107.912 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 t -129.57 136.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -150.83 175.7 11.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.728 0.695 . . . . 10.0 111.816 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.84 -153.76 53.05 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.667 0.651 . . . . 10.0 112.981 170.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -150.6 -179.7 7.46 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.381 1.472 . . . . 10.0 109.601 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.9 m -114.94 122.89 47.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.805 0.842 . . . . 10.0 109.194 170.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -58.35 -29.23 65.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.352 1.061 . . . . 10.0 111.213 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.75 -25.41 66.48 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.737 1.014 . . . . 10.0 113.737 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -59.03 0.25 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.514 1.052 . . . . 10.0 111.271 -174.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.88 179.66 35.77 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.515 -1.034 . . . . 10.0 110.515 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -56.68 137.41 80.98 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.016 2.477 . . . . 10.0 111.138 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.55 165.81 21.92 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.603 0.715 . . . . 10.0 109.241 167.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -81.59 69.12 8.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.366 -1.716 . . . . 10.0 106.366 167.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -49.24 -30.19 6.82 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.663 1.585 . . . . 10.0 114.196 -169.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.15 -36.28 74.99 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.374 0.988 . . . . 10.0 112.266 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.7 mt -62.81 -50.45 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.052 -1.462 . . . . 10.0 107.052 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -58.55 -47.64 83.54 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.741 0.816 . . . . 10.0 111.822 -177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 p -65.39 -37.85 88.24 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.409 -0.805 . . . . 10.0 111.356 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -64.73 -42.67 95.03 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.362 0.983 . . . . 10.0 110.387 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -62.41 -47.95 81.88 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.682 -0.675 . . . . 10.0 110.085 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.62 -52.19 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -57.52 -38.06 74.04 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.349 1.06 . . . . 10.0 111.971 -174.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 -44.01 81.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.78 0.432 . . . . 10.0 111.309 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.7 mptt . . . . . 0 N--CA 1.469 0.476 0 CA-C-N 118.406 0.548 . . . . 10.0 111.853 -169.656 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 CA--C 1.537 0.456 0 N-CA-C 108.637 -0.875 . . . . 10.0 108.637 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.9 p -139.63 167.98 20.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.294 1.037 . . . . 10.0 110.149 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -150.63 167.85 26.07 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.961 -0.462 . . . . 10.0 110.957 170.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.236 0 C-N-CA 125.68 1.592 . . . . 10.0 108.513 169.617 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 106.808 -1.553 . . . . 10.0 106.808 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -150.3 150.69 31.83 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.75 -1.204 . . . . 10.0 107.75 173.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -59.15 -23.47 62.2 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 118.211 -0.9 . . . . 10.0 112.88 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.28 -26.41 67.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.473 1.033 . . . . 10.0 112.473 175.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -73.97 -26.25 60.37 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.111 0.564 . . . . 10.0 111.009 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.38 127.16 62.18 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 106.737 -1.579 . . . . 10.0 106.737 -174.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.62 149.03 79.23 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.226 1.951 . . . . 10.0 110.087 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.66 -33.68 60.43 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.47 1.108 . . . . 10.0 111.958 -178.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -136.92 135.12 48.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 104.843 -2.28 . . . . 10.0 104.843 176.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -150.5 118.07 6.12 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.069 -1.826 . . . . 10.0 106.069 171.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.8 pt . . . . . 0 C--N 1.33 -0.263 0 C-N-CA 124.353 1.061 . . . . 10.0 110.272 -169.806 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 108.966 -0.753 . . . . 10.0 108.966 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -150.69 147.64 27.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.869 1.268 . . . . 10.0 109.104 172.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -67.82 153.94 42.62 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.772 -0.58 . . . . 10.0 109.685 174.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.17 165.6 26.97 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.979 0.912 . . . . 10.0 109.366 170.549 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.6 147.72 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.428 1.491 . . . . 10.0 107.67 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tt -109.14 121.02 44.27 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 104.777 -2.305 . . . . 10.0 104.777 177.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.5 mt -128.74 140.53 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 -170.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -94.54 131.23 40.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 167.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.91 143.32 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -123.47 130.13 52.24 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.495 1.918 . . . . 10.0 105.857 -175.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.1 p -72.36 142.93 48.77 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.351 -0.241 . . . . 10.0 110.351 175.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.78 59.58 3.54 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.299 1.44 . . . . 10.0 108.205 168.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -58.67 141.41 97.61 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.019 2.48 . . . . 10.0 109.921 -171.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 52.2 16.73 0.61 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.448 1.099 . . . . 10.0 113.058 -177.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m 48.17 31.4 2.55 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.548 1.139 . . . . 10.0 112.897 -169.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.88 -1.71 0.02 OUTLIER Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.43 -1.206 . . . . 10.0 115.954 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 153.32 78.91 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 120.094 1.947 . . . . 10.0 110.448 174.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.87 55.29 5.2 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 124.256 3.304 . . . . 10.0 111.855 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.92 139.51 30.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.045 1.338 . . . . 10.0 108.653 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.75 30.09 0.66 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.188 1.395 . . . . 10.0 109.772 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -66.32 158.4 29.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 174.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 m -140.33 160.27 40.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.138 0.975 . . . . 10.0 110.326 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -150.22 169.57 21.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.132 0.973 . . . . 10.0 109.635 171.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -98.5 149.06 23.12 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.499 -0.926 . . . . 10.0 108.499 172.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.1 pt -138.9 154.43 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.055 1.742 . . . . 10.0 109.924 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.25 128.8 64.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.985 -1.487 . . . . 10.0 106.985 176.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 mmp_? -134.61 138.12 44.26 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.873 -1.529 . . . . 10.0 106.873 -178.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.38 122.91 0.92 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-N 119.725 1.148 . . . . 10.0 110.996 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -142.84 133.93 25.8 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 -172.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -59.55 -21.58 60.48 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 114.515 1.302 . . . . 10.0 114.515 -175.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -65.34 -25.33 67.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.377 1.444 . . . . 10.0 112.276 177.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.85 116.14 11.89 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.854 1.206 . . . . 10.0 110.371 -178.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.7 -29.89 65.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.311 0.645 . . . . 10.0 110.354 173.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -136.03 146.64 47.34 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.79 1.636 . . . . 10.0 107.422 178.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -60.77 -31.88 71.22 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.762 0.825 . . . . 10.0 111.755 -174.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.99 -26.35 67.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.343 0.657 . . . . 10.0 112.165 177.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.62 -32.69 74.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.357 0.598 . . . . 10.0 110.548 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.7 mt -67.48 -51.78 48.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 174.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -55.83 -41.97 75.04 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.462 -0.78 . . . . 10.0 111.141 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.79 -48.74 79.26 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.068 0.547 . . . . 10.0 111.461 177.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -47.27 86.05 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.368 -0.832 . . . . 10.0 110.33 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.56 -43.77 96.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 -177.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 m -62.99 -36.29 83.03 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.479 1.036 . . . . 10.0 111.029 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.33 52.95 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.34 -1.104 . . . . 10.0 110.34 173.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.08 -39.91 91.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.693 0.746 . . . . 10.0 111.686 -177.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.7 mmt -65.31 -39.14 92.09 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.724 -0.655 . . . . 10.0 111.086 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -64.85 -34.76 79.13 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.071 0.85 . . . . 10.0 110.533 176.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.67 -31.92 72.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.359 -1.305 . . . . 10.0 111.612 172.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -73.81 -54.6 7.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.534 1.061 . . . . 10.0 109.014 176.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.95 44.22 0.16 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.39 1.471 . . . . 10.0 109.881 -170.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.6 m -144.07 169.63 17.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.632 1.573 . . . . 10.0 109.308 -177.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -140.04 163.49 32.56 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.357 1.863 . . . . 10.0 108.397 178.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.0 m -139.1 156.38 47.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.67 1.123 . . . . 10.0 113.795 -167.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -139.82 130.15 25.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.872 1.669 . . . . 10.0 106.93 168.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.5 p -68.89 143.31 54.53 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.786 -1.196 . . . . 10.0 109.468 172.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.6 mt -105.1 -18.14 14.25 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.469 0.708 . . . . 10.0 110.906 171.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.96 -173.92 35.24 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.719 -1.352 . . . . 10.0 109.719 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.94 -174.5 28.73 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.248 -1.148 . . . . 10.0 112.006 172.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.44 -149.36 7.81 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.942 -1.663 . . . . 10.0 108.942 -173.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -133.48 154.51 50.75 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.652 1.181 . . . . 10.0 108.874 178.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.4 mt -125.31 152.02 31.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 104.994 -2.224 . . . . 10.0 104.994 173.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 C--N 1.327 -0.392 0 C-N-CA 124.904 1.282 . . . . 10.0 108.837 -176.856 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 C--O 1.236 0.343 0 N-CA-C 106.266 -1.753 . . . . 10.0 106.266 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -141.09 149.71 41.95 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.232 -1.025 . . . . 10.0 108.232 -168.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -135.04 139.42 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.458 -0.942 . . . . 10.0 108.458 -171.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.25 -176.0 3.88 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.457 1.103 . . . . 10.0 109.702 -178.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.08 -167.44 45.59 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 121.653 -0.654 . . . . 10.0 111.866 175.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -152.1 158.2 42.65 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 169.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.9 p -69.07 158.71 34.28 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.637 -0.664 . . . . 10.0 110.601 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 92.8 mtp -82.97 5.57 21.62 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 118.774 -0.632 . . . . 10.0 112.541 -174.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.15 -44.97 0.11 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.465 1.029 . . . . 10.0 113.533 176.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -74.11 -47.12 38.4 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.209 0.913 . . . . 10.0 111.003 -169.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.94 175.76 14.2 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.72 1.629 . . . . 10.0 110.375 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -54.34 130.0 37.59 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.585 2.19 . . . . 10.0 110.105 169.509 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.89 162.67 13.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.775 0.797 . . . . 10.0 109.244 167.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -79.01 70.01 5.27 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.092 -1.447 . . . . 10.0 107.092 169.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -49.72 -36.37 25.18 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.098 1.359 . . . . 10.0 113.217 -168.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.95 -32.79 73.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.084 0.856 . . . . 10.0 112.504 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.26 -50.59 50.98 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 107.428 -1.323 . . . . 10.0 107.428 175.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.3 m -56.53 -41.89 77.54 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.195 -0.907 . . . . 10.0 111.523 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.5 p -64.38 -43.5 94.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.43 1.014 . . . . 10.0 111.172 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -61.73 -38.88 89.53 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.193 1.36 . . . . 10.0 110.886 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -63.77 -50.24 69.8 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.574 0.35 . . . . 10.0 110.222 176.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.68 -47.15 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.615 -0.883 . . . . 10.0 108.615 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -54.61 -47.43 73.4 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.3 1.04 . . . . 10.0 110.244 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.75 -39.48 88.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.662 0.385 . . . . 10.0 111.572 -178.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt . . . . . 0 N--CA 1.463 0.217 0 CA-C-O 118.12 -0.943 . . . . 10.0 112.457 -175.054 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.541 0.63 0 N-CA-C 105.665 -1.976 . . . . 10.0 105.665 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.7 p -145.58 166.55 25.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.479 1.111 . . . . 10.0 108.893 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -153.41 165.53 35.52 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.548 -0.72 . . . . 10.0 111.075 167.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.254 0 C-N-CA 125.622 1.569 . . . . 10.0 108.931 174.202 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 tpt . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.5 154.53 50.71 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.962 1.305 . . . . 10.0 107.762 172.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 m -63.21 158.16 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.537 0.684 . . . . 10.0 109.602 170.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -124.23 172.92 8.69 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 125.437 1.495 . . . . 10.0 107.722 171.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -147.94 151.93 36.65 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.167 -1.42 . . . . 10.0 107.167 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.4 mt -60.41 -23.16 64.15 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 123.364 0.666 . . . . 10.0 112.713 -176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.84 -28.62 69.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.474 1.034 . . . . 10.0 112.292 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.8 mt -74.5 -29.56 61.46 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 122.95 0.5 . . . . 10.0 110.769 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.1 mt -75.98 126.0 87.43 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 106.984 -1.488 . . . . 10.0 106.984 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -63.68 142.07 81.9 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.156 1.904 . . . . 10.0 109.292 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -78.98 -29.86 44.07 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.681 0.753 . . . . 10.0 112.172 -170.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.47 135.62 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 104.083 -2.562 . . . . 10.0 104.083 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -149.2 107.76 3.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.609 -1.997 . . . . 10.0 105.609 173.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.8 pt -135.23 146.21 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 108.189 -1.041 . . . . 10.0 108.189 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -113.81 121.01 42.71 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 104.724 -2.325 . . . . 10.0 104.724 170.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.1 m -139.32 131.28 27.8 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.342 0.497 . . . . 10.0 112.342 -167.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -156.52 16.73 0.32 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.452 1.101 . . . . 10.0 111.815 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.3 -156.18 26.48 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 108.426 -1.87 . . . . 10.0 108.426 -172.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.9 t -75.14 140.03 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 169.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -157.57 153.11 26.37 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.64 1.176 . . . . 10.0 109.496 171.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -68.06 150.78 47.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 123.968 0.907 . . . . 10.0 110.28 175.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.46 163.65 35.0 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.72 0.808 . . . . 10.0 109.233 174.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.89 147.35 23.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.258 1.023 . . . . 10.0 108.705 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.8 tp -106.31 119.95 40.58 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 105.02 -2.215 . . . . 10.0 105.02 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.4 130.5 71.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.081 -1.452 . . . . 10.0 107.081 -169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -82.21 134.36 35.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.063 -2.199 . . . . 10.0 105.063 168.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.6 p -119.71 138.93 48.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 106.255 -1.757 . . . . 10.0 106.255 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -119.4 131.17 55.62 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.08 -1.822 . . . . 10.0 106.08 -175.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.3 p -73.51 145.78 45.36 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.867 0.758 . . . . 10.0 110.006 172.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.27 61.02 3.1 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 106.26 -1.756 . . . . 10.0 106.26 169.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -56.74 136.9 78.89 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.472 2.781 . . . . 10.0 110.955 -169.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 45.44 26.65 0.31 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.686 1.594 . . . . 10.0 113.829 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 m 55.04 26.01 7.61 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.27 1.428 . . . . 10.0 113.479 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.93 -1.34 0.03 OUTLIER Glycine 0 CA--C 1.532 1.101 0 N-CA-C 116.843 1.497 . . . . 10.0 116.843 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.11 152.5 84.01 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 120.114 1.957 . . . . 10.0 110.173 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -77.83 56.88 5.84 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 124.473 3.449 . . . . 10.0 111.874 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.38 137.37 30.4 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.139 1.376 . . . . 10.0 108.381 176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.03 32.46 0.6 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.321 1.449 . . . . 10.0 109.829 -176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.83 170.09 13.28 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.469 0.708 . . . . 10.0 109.297 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 m -147.03 159.97 42.94 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.622 -0.673 . . . . 10.0 110.417 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -147.59 175.36 10.92 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.087 1.355 . . . . 10.0 108.261 169.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.6 mp0 -105.33 150.74 24.94 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.628 -0.879 . . . . 10.0 108.628 170.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.2 pt -135.86 150.37 28.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 125.323 1.449 . . . . 10.0 109.49 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.31 126.98 64.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 106.388 -1.708 . . . . 10.0 106.388 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -132.48 139.15 47.83 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.96 113.88 0.5 Allowed Glycine 0 C--N 1.332 0.321 0 CA-C-N 119.473 1.033 . . . . 10.0 110.941 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -140.75 132.23 26.93 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.114 -0.699 . . . . 10.0 109.114 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -69.49 -14.81 63.07 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 114.048 1.129 . . . . 10.0 114.048 -171.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -66.58 -23.48 66.2 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.478 1.036 . . . . 10.0 111.943 175.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.79 127.64 33.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 119.236 0.926 . . . . 10.0 110.082 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.87 -39.23 73.0 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.541 -0.3 . . . . 10.0 110.284 173.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -140.5 160.6 39.64 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.663 1.585 . . . . 10.0 108.658 -177.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -56.45 -33.19 65.65 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.323 1.049 . . . . 10.0 112.09 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.7 -31.12 69.3 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.038 0.935 . . . . 10.0 112.209 178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -71.35 -36.07 71.38 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.998 0.817 . . . . 10.0 110.577 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 35.2 mt -65.49 -50.91 69.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 174.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -57.41 -45.1 84.96 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.418 -0.325 . . . . 10.0 110.554 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.41 -46.3 90.71 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.994 0.518 . . . . 10.0 111.851 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.2 mmtt -57.2 -49.49 75.84 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.016 0.371 . . . . 10.0 110.287 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.5 t -68.85 -46.39 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.8 m -58.37 -35.51 72.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.489 1.041 . . . . 10.0 111.509 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.4 -50.68 60.52 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.703 -0.959 . . . . 10.0 110.703 174.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -62.66 -44.84 95.24 Favored 'General case' 0 CA--C 1.524 -0.043 0 CA-C-N 117.539 0.67 . . . . 10.0 111.204 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.91 -37.22 81.48 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 118.673 -0.68 . . . . 10.0 110.887 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -65.25 -34.96 79.59 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.161 0.891 . . . . 10.0 111.19 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -64.9 -33.87 77.04 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.93 0.786 . . . . 10.0 111.658 171.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -70.6 -52.97 17.85 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.093 0.861 . . . . 10.0 110.165 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 127.82 43.77 0.23 Allowed Glycine 0 CA--C 1.529 0.91 0 C-N-CA 125.276 1.417 . . . . 10.0 110.204 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.8 m -144.24 172.29 13.13 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.015 1.726 . . . . 10.0 108.655 -175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -140.27 164.83 29.03 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.692 1.597 . . . . 10.0 108.228 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.0 m -133.3 159.55 39.91 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.048 0.939 . . . . 10.0 112.429 -169.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -148.48 117.45 6.75 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 126.253 1.821 . . . . 10.0 106.61 170.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.1 p -62.74 130.59 45.6 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.547 -0.721 . . . . 10.0 109.115 172.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.0 mt -90.78 -23.04 20.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.576 0.351 . . . . 10.0 110.481 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.77 179.35 29.1 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 108.43 -1.868 . . . . 10.0 108.43 -174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -159.46 -164.14 14.31 Favored Glycine 0 CA--C 1.518 0.266 0 N-CA-C 110.668 -0.973 . . . . 10.0 110.668 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.69 -139.48 4.28 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 108.508 -1.837 . . . . 10.0 108.508 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.1 mtm180 -139.87 157.71 45.26 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.985 1.314 . . . . 10.0 108.116 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.42 151.45 29.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.62 -2.363 . . . . 10.0 104.62 172.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.8 m -130.82 115.13 16.18 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 108.044 -1.095 . . . . 10.0 108.044 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -78.7 102.78 8.24 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 104.92 -2.252 . . . . 10.0 104.92 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -30.4 -53.01 0.17 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.126 2.171 . . . . 10.0 116.278 -169.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.1 m 45.52 25.09 0.21 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.179 1.792 . . . . 10.0 114.19 -176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -164.3 -56.11 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.722 1.209 . . . . 10.0 109.628 -171.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -144.5 110.47 5.4 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.397 1.258 . . . . 10.0 114.397 -169.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER 70.84 -79.58 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 119.105 3.002 . . . . 10.0 119.105 168.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.89 168.93 25.65 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 121.325 1.875 . . . . 10.0 115.333 -168.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 54.7 mt -54.3 137.93 14.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.206 1.402 . . . . 10.0 108.255 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -138.14 157.96 45.28 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.745 0.818 . . . . 10.0 109.083 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 25.5 t -137.48 135.49 46.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.582 1.153 . . . . 10.0 108.086 -170.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -163.1 -178.53 6.09 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.329 -0.857 . . . . 10.0 111.714 -171.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.77 -163.49 49.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 123.662 0.649 . . . . 10.0 111.617 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -150.65 178.86 8.69 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.943 1.297 . . . . 10.0 108.632 170.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m -103.28 124.79 49.31 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.285 -1.005 . . . . 10.0 108.285 169.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 59.6 mtt -58.73 -30.24 67.32 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 118.081 0.401 . . . . 10.0 110.716 169.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.46 -30.94 71.78 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.119 0.968 . . . . 10.0 113.475 -176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -141.01 -57.9 0.5 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.428 1.013 . . . . 10.0 110.676 -172.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.86 -178.69 35.84 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 109.596 -1.402 . . . . 10.0 109.596 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -62.6 138.2 68.66 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.163 1.909 . . . . 10.0 110.167 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.08 161.44 24.47 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.806 -1.183 . . . . 10.0 107.806 168.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -78.82 71.67 5.29 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.487 -2.042 . . . . 10.0 105.487 169.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.7 m80 -50.33 -30.85 13.0 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 125.045 1.338 . . . . 10.0 113.494 -169.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.4 -38.43 74.28 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.111 0.869 . . . . 10.0 112.061 176.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.3 mt -63.36 -51.22 73.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.404 -1.332 . . . . 10.0 107.404 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.3 m -58.06 -46.16 85.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.967 -0.539 . . . . 10.0 112.128 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 19.4 p -66.28 -41.01 90.46 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 119.394 0.997 . . . . 10.0 110.823 -177.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -64.86 -39.96 94.38 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 118.894 0.77 . . . . 10.0 110.641 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -62.76 -48.22 80.12 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 118.96 -0.543 . . . . 10.0 110.598 176.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.83 -45.74 91.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -62.2 -40.45 96.12 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.014 0.926 . . . . 10.0 111.589 -177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.86 -44.25 77.56 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.033 0.533 . . . . 10.0 110.819 177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -77.06 -38.44 52.61 Favored 'General case' 0 C--O 1.231 0.111 0 N-CA-C 112.669 0.618 . . . . 10.0 112.669 -172.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -110.22 143.98 29.16 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.352 0.661 . . . . 10.0 111.193 -168.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.56 -3.78 13.96 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.96 2.44 . . . . 10.0 113.652 -175.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -56.38 132.76 51.96 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.697 1.135 . . . . 10.0 109.032 175.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -58.14 -27.99 64.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.745 1.618 . . . . 10.0 115.196 -168.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -155.95 153.09 29.04 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.979 1.263 . . . . 10.0 110.979 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.06 133.93 17.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.772 -1.936 . . . . 10.0 105.772 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.9 p -134.82 169.91 16.65 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.518 0.727 . . . . 10.0 109.76 175.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -140.85 166.15 25.57 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 123.318 0.647 . . . . 10.0 110.467 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.34 172.51 14.79 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.526 1.53 . . . . 10.0 108.483 172.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -134.94 35.95 3.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.828 1.251 . . . . 10.0 108.606 175.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.0 -31.01 71.29 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.397 1.079 . . . . 10.0 113.621 -169.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 176.38 179.91 47.08 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 118.059 0.39 . . . . 10.0 112.563 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 15.3 t80 . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.409 1.484 . . . . 10.0 108.489 179.82 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 119.242 -0.408 . . . . 10.0 109.923 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.24 151.52 36.05 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 122.785 0.434 . . . . 10.0 111.115 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.4 m -67.37 164.71 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 123.689 0.796 . . . . 10.0 110.672 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -67.69 164.6 18.94 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.987 0.515 . . . . 10.0 111.236 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -152.5 146.64 25.42 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 106.61 -1.626 . . . . 10.0 106.61 170.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.46 -25.27 65.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 118.505 -0.759 . . . . 10.0 113.002 -174.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.4 -26.95 68.68 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.113 0.87 . . . . 10.0 112.034 175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 78.1 mt -75.76 -27.64 58.15 Favored 'General case' 0 C--N 1.341 0.219 0 C-N-CA 122.82 0.448 . . . . 10.0 110.709 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 82.6 mt -74.74 122.09 86.71 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -51.15 139.96 42.09 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.161 2.574 . . . . 10.0 110.594 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -80.27 -29.47 38.31 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 122.087 0.946 . . . . 10.0 111.605 -172.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -136.65 136.17 48.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 104.323 -2.473 . . . . 10.0 104.323 174.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -146.32 118.28 8.22 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.488 -1.301 . . . . 10.0 107.488 174.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.2 pt -142.2 144.96 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.028 1.731 . . . . 10.0 106.653 -174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -155.92 74.84 0.88 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 122.886 1.326 . . . . 10.0 108.35 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.5 m -156.56 173.37 17.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.987 1.715 . . . . 10.0 108.382 177.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -144.8 138.71 27.29 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 107.194 -1.41 . . . . 10.0 107.194 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 86.75 -153.02 25.48 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.591 -1.403 . . . . 10.0 109.591 -170.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.82 142.09 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 108.118 -1.067 . . . . 10.0 108.118 169.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -150.17 152.15 34.21 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.74 0.816 . . . . 10.0 110.766 169.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -70.76 150.11 46.22 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 123.898 0.879 . . . . 10.0 108.985 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.25 159.36 43.45 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.282 0.492 . . . . 10.0 110.899 172.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.3 p -138.39 145.32 28.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.684 1.594 . . . . 10.0 107.169 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 tt -106.48 122.04 45.49 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 104.971 -2.233 . . . . 10.0 104.971 175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 57.5 mt -124.94 130.15 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 106.884 -1.525 . . . . 10.0 106.884 -171.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -80.04 129.24 34.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 104.73 -2.322 . . . . 10.0 104.73 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -118.73 142.6 32.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -124.62 134.98 52.74 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.182 1.793 . . . . 10.0 106.785 -171.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.9 p -65.79 140.51 58.42 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 110.048 -0.353 . . . . 10.0 110.048 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.33 46.25 0.48 Allowed Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 125.184 1.393 . . . . 10.0 111.99 168.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -60.13 159.34 26.54 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.497 2.798 . . . . 10.0 110.785 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 52.29 20.66 1.43 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.872 1.269 . . . . 10.0 112.141 -175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m 52.1 22.69 1.97 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.582 1.553 . . . . 10.0 113.531 -171.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 155.34 32.94 0.03 OUTLIER Glycine 0 CA--C 1.529 0.928 0 O-C-N 121.29 -0.881 . . . . 10.0 113.826 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.08 157.74 20.54 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 118.617 1.208 . . . . 10.0 110.475 170.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.89 57.71 4.58 Favored 'Trans proline' 0 CA--C 1.544 1.013 0 C-N-CA 124.085 3.19 . . . . 10.0 111.434 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.32 145.54 34.06 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.937 1.695 . . . . 10.0 108.366 177.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.47 31.11 0.59 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.756 1.222 . . . . 10.0 110.267 -177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -63.99 153.25 37.8 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.436 -0.95 . . . . 10.0 108.436 172.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -144.55 161.82 38.13 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.658 1.183 . . . . 10.0 109.992 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.7 pttt -150.22 176.57 10.73 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.764 1.226 . . . . 10.0 109.712 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -102.14 146.88 27.33 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.871 -1.159 . . . . 10.0 107.871 171.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.3 pt -133.67 155.27 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 124.859 1.264 . . . . 10.0 110.407 172.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.95 130.4 66.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.788 -1.56 . . . . 10.0 106.788 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -132.25 143.91 50.25 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.056 -1.461 . . . . 10.0 107.056 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.56 129.84 1.88 Allowed Glycine 0 C--O 1.226 -0.391 0 CA-C-N 120.489 1.495 . . . . 10.0 113.305 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -151.31 148.27 27.96 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.516 1.126 . . . . 10.0 109.153 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -88.95 -6.72 57.06 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 117.385 -1.293 . . . . 10.0 114.196 -177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -63.99 -22.65 67.02 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 120.019 1.281 . . . . 10.0 111.805 172.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.85 124.11 22.81 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 123.345 0.658 . . . . 10.0 109.548 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.26 -35.92 80.52 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.275 0.559 . . . . 10.0 109.642 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -142.74 151.38 41.21 Favored 'General case' 0 C--O 1.226 -0.158 0 C-N-CA 126.411 1.885 . . . . 10.0 106.951 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -55.03 -35.7 64.72 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.37 0.668 . . . . 10.0 112.503 -174.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.08 -24.54 58.95 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 118.429 -0.796 . . . . 10.0 112.445 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -67.13 -36.64 82.31 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.735 0.698 . . . . 10.0 110.709 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.1 mt -65.25 -49.94 76.2 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 N-CA-C 107.787 -1.19 . . . . 10.0 107.787 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -56.1 -46.58 79.05 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 118.902 -0.571 . . . . 10.0 111.169 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.02 -45.16 86.65 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.189 0.595 . . . . 10.0 111.888 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -58.84 -49.4 77.89 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.42 0.688 . . . . 10.0 109.747 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 84.5 t -68.82 -42.19 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 -177.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.6 m -58.38 -35.63 72.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 119.591 1.087 . . . . 10.0 111.333 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.64 -48.33 82.32 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.781 -0.928 . . . . 10.0 110.781 172.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.34 -46.41 90.0 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 117.907 0.853 . . . . 10.0 111.272 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -36.57 83.22 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-O 118.643 -0.694 . . . . 10.0 110.888 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -64.5 -36.01 82.82 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.828 0.74 . . . . 10.0 110.879 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.46 -32.34 73.13 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 117.982 -1.008 . . . . 10.0 111.71 172.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -67.85 -57.06 6.89 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.152 0.887 . . . . 10.0 109.048 176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.59 47.04 0.16 Allowed Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.882 1.706 . . . . 10.0 109.163 -169.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.5 m -146.32 173.62 12.08 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.719 2.008 . . . . 10.0 108.379 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -141.03 162.86 34.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.513 1.525 . . . . 10.0 108.557 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.1 m -134.47 158.75 43.11 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.425 1.09 . . . . 10.0 112.398 -168.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -148.45 122.21 9.29 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.954 1.702 . . . . 10.0 106.944 170.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.7 p -64.56 128.54 36.22 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.772 -1.205 . . . . 10.0 109.368 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.9 mt -91.06 -25.97 19.39 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 110.382 -0.229 . . . . 10.0 110.382 171.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.14 -177.74 35.58 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 109.548 -1.421 . . . . 10.0 109.548 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -153.82 -174.67 24.27 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 118.222 1.011 . . . . 10.0 112.015 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.66 -145.96 5.35 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.12 -1.592 . . . . 10.0 109.12 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 85.8 mtm-85 -137.74 155.31 49.21 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.148 -1.207 . . . . 10.0 108.37 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 83.9 mt -122.63 148.73 26.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 105.024 -2.213 . . . . 10.0 105.024 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.9 p -148.71 161.12 42.39 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.006 1.322 . . . . 10.0 108.638 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -162.0 163.13 29.07 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.224 1.01 . . . . 10.0 108.47 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 45.3 tp60 -150.22 55.42 0.93 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 105.521 -2.029 . . . . 10.0 105.521 171.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.2 m -44.69 -26.41 0.38 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.028 2.531 . . . . 10.0 116.297 -167.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -59.0 -24.61 62.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 173.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -147.24 -25.19 0.39 Allowed 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.071 0.948 . . . . 10.0 113.458 -170.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -137.18 145.19 43.43 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 120.361 -1.462 . . . . 10.0 110.519 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 168.42 6.56 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.731 1.212 . . . . 10.0 112.447 176.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 51.5 mt -68.13 149.42 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.283 -1.377 . . . . 10.0 107.283 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -140.47 162.83 34.4 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.033 0.933 . . . . 10.0 109.672 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.3 144.35 37.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 106.12 -1.808 . . . . 10.0 106.12 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -161.19 179.15 8.6 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.283 -0.886 . . . . 10.0 110.218 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.26 -176.21 47.63 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 123.092 0.377 . . . . 10.0 112.651 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -155.77 134.71 12.01 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.757 0.823 . . . . 10.0 109.958 168.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 m -74.24 95.55 2.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.912 0.885 . . . . 10.0 109.785 177.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 76.9 mtm -57.62 -14.44 5.4 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.878 0.871 . . . . 10.0 112.602 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -55.34 -27.7 48.86 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.691 1.196 . . . . 10.0 113.121 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.75 -47.63 0.33 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 118.862 0.756 . . . . 10.0 110.882 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.8 173.85 23.35 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.28 1.419 . . . . 10.0 109.862 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -53.37 134.23 56.32 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.791 2.327 . . . . 10.0 111.071 169.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.41 162.06 21.29 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 167.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -78.99 71.2 5.43 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.134 -1.432 . . . . 10.0 107.134 169.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -54.42 -26.25 29.64 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.75 1.22 . . . . 10.0 113.376 -170.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.44 -38.86 92.76 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.476 1.035 . . . . 10.0 111.745 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.6 mt -67.47 -49.87 67.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 107.418 -1.327 . . . . 10.0 107.418 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 m -58.84 -44.54 90.98 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-O 118.863 -0.589 . . . . 10.0 112.06 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.0 p -64.95 -41.53 95.41 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.058 -0.972 . . . . 10.0 111.009 -177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -64.19 -39.33 93.76 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.384 0.993 . . . . 10.0 110.807 176.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 mttm -65.43 -48.22 73.54 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 121.926 -0.484 . . . . 10.0 110.67 177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.24 -42.94 92.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.298 -1.001 . . . . 10.0 108.298 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -59.49 -45.59 91.23 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.925 0.89 . . . . 10.0 110.41 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.18 -39.72 95.45 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.552 0.614 . . . . 10.0 111.396 177.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -68.23 -38.18 81.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 118.668 -0.682 . . . . 10.0 110.943 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -130.99 65.86 77.76 Favored Pre-proline 0 CA--C 1.541 0.601 0 C-N-CA 125.112 1.365 . . . . 10.0 109.995 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.45 -10.74 29.59 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.041 2.494 . . . . 10.0 113.569 -171.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.62 -12.38 52.8 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.912 0.885 . . . . 10.0 112.67 175.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -133.29 150.77 51.89 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 124.347 1.059 . . . . 10.0 109.907 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -75.1 159.31 31.82 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.899 -1.149 . . . . 10.0 107.899 168.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.04 135.64 33.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 172.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.6 p -139.73 172.24 13.07 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.208 1.403 . . . . 10.0 108.749 174.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -140.45 163.72 32.05 Favored 'General case' 0 C--O 1.227 -0.114 0 O-C-N 121.543 -0.723 . . . . 10.0 112.406 -176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.27 171.03 15.58 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.5 1.92 . . . . 10.0 108.504 172.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -146.64 27.65 1.09 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.852 1.261 . . . . 10.0 110.993 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -62.05 -22.27 65.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.818 1.247 . . . . 10.0 113.6 -170.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -160.74 176.66 37.34 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.623 -1.391 . . . . 10.0 109.623 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 25.2 p90 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 117.701 -1.142 . . . . 10.0 111.385 178.048 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.6 ttt . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.68 -173.87 4.39 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.454 1.102 . . . . 10.0 108.779 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.9 m -60.56 142.08 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 108.011 -1.107 . . . . 10.0 108.011 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.32 171.24 20.54 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.959 1.704 . . . . 10.0 107.118 -175.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -152.17 150.64 30.08 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 107.389 -1.337 . . . . 10.0 107.389 172.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.7 mt -59.4 -26.66 65.33 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.679 0.792 . . . . 10.0 112.832 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.94 -26.25 68.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 118.936 0.789 . . . . 10.0 112.159 176.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.1 mt -75.79 -25.27 56.25 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.034 0.534 . . . . 10.0 110.982 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 70.4 mt -78.68 122.82 85.29 Favored Pre-proline 0 C--O 1.241 0.606 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 -176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -50.74 133.53 39.23 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.499 2.8 . . . . 10.0 110.721 173.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -82.52 -28.65 30.94 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.504 0.668 . . . . 10.0 112.074 -170.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.7 t -137.08 134.91 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 104.893 -2.262 . . . . 10.0 104.893 176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -150.64 113.82 4.84 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.056 -1.831 . . . . 10.0 106.056 171.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.1 pt -135.61 170.88 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 124.681 1.192 . . . . 10.0 110.258 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -133.43 34.79 3.47 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.582 1.153 . . . . 10.0 111.921 -167.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.0 m -49.3 130.85 19.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.95 1.7 . . . . 10.0 112.314 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -165.86 -35.37 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.878 1.671 . . . . 10.0 109.743 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.61 -153.7 6.4 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 106.251 -2.74 . . . . 10.0 106.251 170.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.6 t -61.46 139.27 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 118.649 1.224 . . . . 10.0 108.089 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -146.35 147.06 30.93 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.855 0.862 . . . . 10.0 109.618 171.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -70.02 146.89 50.7 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.79 -0.818 . . . . 10.0 108.79 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.01 158.78 43.28 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.599 -0.889 . . . . 10.0 108.599 175.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.7 p -135.75 150.6 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 125.171 1.388 . . . . 10.0 107.698 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.6 tp -115.13 115.71 27.21 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 105.486 -2.042 . . . . 10.0 105.486 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 79.3 mt -124.9 138.29 54.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 106.759 -1.571 . . . . 10.0 106.759 -169.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -92.86 135.4 34.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 106.674 -1.602 . . . . 10.0 106.674 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.11 139.99 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 105.824 -1.917 . . . . 10.0 105.824 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -115.11 130.0 56.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.914 -1.884 . . . . 10.0 105.914 173.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.8 p -70.17 143.51 52.25 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.941 -0.392 . . . . 10.0 109.941 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.03 61.44 3.37 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.721 1.208 . . . . 10.0 108.325 169.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -58.93 152.25 59.41 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.247 2.631 . . . . 10.0 111.103 -169.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.4 ttp180 65.92 -61.38 0.27 Allowed 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 128.122 2.569 . . . . 10.0 112.135 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.2 p -171.11 -33.19 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.425 2.29 . . . . 10.0 108.864 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -174.66 42.63 0.13 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.05 1.31 . . . . 10.0 110.574 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -57.02 157.23 11.53 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.339 0.656 . . . . 10.0 110.262 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.52 59.46 5.54 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.181 3.254 . . . . 10.0 112.474 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.18 136.36 26.46 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.074 1.749 . . . . 10.0 107.297 171.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.38 30.21 0.85 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.775 1.23 . . . . 10.0 110.054 -177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -64.87 161.07 19.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.79 -0.819 . . . . 10.0 108.79 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.5 m -141.08 159.51 42.05 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.233 1.013 . . . . 10.0 110.009 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -149.83 170.19 19.35 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.503 1.121 . . . . 10.0 109.617 171.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -99.95 154.45 18.37 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.211 -0.663 . . . . 10.0 109.211 170.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 46.0 pt -137.12 154.03 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.291 1.436 . . . . 10.0 109.956 174.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.7 t -108.35 126.84 65.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.453 -1.684 . . . . 10.0 106.453 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -133.94 143.06 47.97 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 106.738 -1.579 . . . . 10.0 106.738 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.84 129.47 1.65 Allowed Glycine 0 C--O 1.227 -0.295 0 CA-C-N 120.259 1.39 . . . . 10.0 111.378 171.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -145.0 141.5 28.98 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.454 0.702 . . . . 10.0 110.432 -173.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -70.51 -21.98 62.68 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 118.358 -0.83 . . . . 10.0 113.195 -174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -66.44 -25.13 66.6 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.586 1.085 . . . . 10.0 112.629 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.67 126.32 29.61 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.252 0.933 . . . . 10.0 110.114 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.49 -31.96 65.81 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 122.621 0.368 . . . . 10.0 110.249 170.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -146.05 152.22 38.99 Favored 'General case' 0 C--N 1.339 0.113 0 C-N-CA 125.339 1.456 . . . . 10.0 109.13 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -56.93 -31.46 64.98 Favored 'General case' 0 N--CA 1.463 0.191 0 C-N-CA 125.004 1.322 . . . . 10.0 112.626 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.18 -31.55 69.1 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.674 -0.679 . . . . 10.0 112.047 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -68.74 -41.65 78.68 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 118.647 0.658 . . . . 10.0 110.107 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 28.3 mt -62.78 -50.74 78.52 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 108.312 -0.996 . . . . 10.0 108.312 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -55.34 -43.7 75.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.834 -0.603 . . . . 10.0 111.295 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.11 -46.59 83.51 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.609 0.64 . . . . 10.0 111.666 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.5 mmtp -57.61 -49.9 74.9 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.132 0.573 . . . . 10.0 109.643 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.51 -44.31 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.648 -0.871 . . . . 10.0 108.648 -172.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 m -56.61 -42.52 78.92 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 119.025 0.83 . . . . 10.0 110.9 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.52 -48.37 86.35 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.78 -0.928 . . . . 10.0 110.78 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -62.29 -47.38 84.55 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 118.16 0.98 . . . . 10.0 111.046 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -39.51 87.5 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 119.011 -0.518 . . . . 10.0 110.69 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -65.51 -33.76 76.68 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.567 0.621 . . . . 10.0 110.896 176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.08 -34.0 77.08 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 117.239 -1.362 . . . . 10.0 111.21 171.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 -69.47 -65.89 0.65 Allowed 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.292 0.951 . . . . 10.0 108.682 176.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.79 42.24 0.04 OUTLIER Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.371 1.462 . . . . 10.0 110.491 -169.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 86.1 m -146.38 176.11 10.03 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.596 1.958 . . . . 10.0 107.935 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -145.21 165.72 27.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.168 0.987 . . . . 10.0 108.764 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.9 m -130.15 155.08 46.81 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 119.289 0.949 . . . . 10.0 113.019 -169.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -141.57 136.97 31.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 126.074 1.749 . . . . 10.0 106.774 169.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 15.5 t -78.77 141.66 37.62 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.598 -0.689 . . . . 10.0 109.358 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 63.4 mt -103.48 -20.36 14.07 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 123.377 0.671 . . . . 10.0 111.146 171.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.71 -177.96 34.25 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 110.814 -0.914 . . . . 10.0 110.814 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.15 178.42 32.68 Favored Glycine 0 CA--C 1.521 0.427 0 O-C-N 121.631 -0.923 . . . . 10.0 112.356 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -175.97 -145.6 5.6 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 109.84 -1.304 . . . . 10.0 109.84 -172.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -142.55 161.72 37.32 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 126.894 2.078 . . . . 10.0 107.755 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.8 mt -132.29 145.32 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 105.929 -1.878 . . . . 10.0 105.929 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.0 p -154.12 174.52 14.61 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.431 1.092 . . . . 10.0 110.747 -175.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -149.61 152.41 35.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.797 2.039 . . . . 10.0 105.557 169.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -129.05 -12.05 4.68 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.886 0.474 . . . . 10.0 112.076 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.3 m 57.37 21.89 7.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.084 1.354 . . . . 10.0 113.796 177.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.33 -17.63 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.637 1.175 . . . . 10.0 113.059 -177.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -159.55 148.02 17.65 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.921 1.688 . . . . 10.0 106.539 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 53.8 -162.66 0.11 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.256 1.022 . . . . 10.0 110.462 -168.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -135.45 -144.81 0.21 Allowed 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.15 -1.426 . . . . 10.0 107.15 173.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 22.3 mm -63.19 113.38 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 101.676 -3.453 . . . . 10.0 101.676 167.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -117.53 145.63 44.11 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.5 -0.555 . . . . 10.0 109.5 -167.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 32.1 t -135.17 130.49 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 106.917 -1.512 . . . . 10.0 106.917 -170.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -166.86 169.46 13.17 Favored 'General case' 0 N--CA 1.465 0.281 0 O-C-N 121.135 -0.978 . . . . 10.0 109.47 -169.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 131.03 -174.63 19.84 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-N 119.272 0.942 . . . . 10.0 114.435 169.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -140.41 1.31 1.76 Allowed 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 114.413 1.264 . . . . 10.0 114.413 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.6 p 50.53 -25.55 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 129.707 3.203 . . . . 10.0 119.007 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 12.3 tmm? 66.58 -48.39 0.45 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.574 2.35 . . . . 10.0 111.009 -168.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.58 -33.74 70.3 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.363 1.465 . . . . 10.0 113.016 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -133.93 -50.25 0.82 Allowed 'General case' 0 C--N 1.341 0.237 0 CA-C-N 118.643 0.656 . . . . 10.0 111.747 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.02 170.96 12.31 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 109.37 -1.492 . . . . 10.0 109.37 -170.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.05 130.97 40.59 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.029 2.486 . . . . 10.0 111.8 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.66 158.88 28.92 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 168.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -77.1 73.34 3.68 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -54.61 -26.24 31.52 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.199 0.999 . . . . 10.0 112.835 -170.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.29 -41.06 98.17 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 119.261 0.937 . . . . 10.0 112.08 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 59.2 mt -64.52 -50.24 76.89 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 107.497 -1.298 . . . . 10.0 107.497 177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.7 m -60.09 -43.62 95.39 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 119.129 -0.462 . . . . 10.0 111.892 -178.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.9 p -66.58 -37.83 85.76 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 119.064 0.847 . . . . 10.0 111.547 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -64.89 -38.97 92.76 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.418 1.008 . . . . 10.0 110.796 175.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -66.66 -45.06 80.17 Favored 'General case' 0 N--CA 1.461 0.099 0 O-C-N 122.042 -0.411 . . . . 10.0 110.626 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 73.2 mt -56.86 -48.72 80.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -59.03 -40.02 83.75 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 119.158 0.89 . . . . 10.0 111.567 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.42 -32.33 72.28 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.992 0.815 . . . . 10.0 111.977 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -89.89 -12.6 38.46 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 118.534 -0.746 . . . . 10.0 112.822 174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 31.1 p90 38.25 57.59 5.03 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 127.541 2.336 . . . . 10.0 114.558 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -67.63 -16.31 46.48 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 121.737 1.625 . . . . 10.0 110.671 169.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -142.08 160.15 40.81 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 128.134 2.574 . . . . 10.0 105.681 169.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 27.8 p90 -76.56 -15.72 59.79 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.539 -0.743 . . . . 10.0 112.456 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -146.72 153.05 39.81 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 119.945 1.248 . . . . 10.0 110.588 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.6 t -143.01 154.55 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 125.382 1.473 . . . . 10.0 107.597 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.0 p -145.53 158.42 43.84 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.826 1.65 . . . . 10.0 108.926 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -151.22 164.23 37.05 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.838 0.681 . . . . 10.0 112.838 173.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.21 -174.08 4.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.606 1.962 . . . . 10.0 108.436 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.98 35.04 3.56 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.127 0.971 . . . . 10.0 109.258 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -152.07 157.39 41.57 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.819 1.648 . . . . 10.0 108.021 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 122.95 -26.84 6.06 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.461 1.505 . . . . 10.0 111.605 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--O 1.25 1.1 0 N-CA-C 104.41 -2.441 . . . . 10.0 104.41 -179.665 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 tpt . . . . . 0 N--CA 1.482 1.147 0 N-CA-C 110.028 -0.36 . . . . 10.0 110.028 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.38 150.59 31.6 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.403 1.081 . . . . 10.0 109.221 176.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.69 176.4 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 128.063 2.545 . . . . 10.0 107.564 -176.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -136.21 174.61 10.42 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.297 1.439 . . . . 10.0 108.498 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -151.05 152.05 32.89 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.016 -1.105 . . . . 10.0 108.016 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 mt -59.53 -22.4 61.61 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.937 0.895 . . . . 10.0 113.04 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.94 -24.56 66.15 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.637 1.108 . . . . 10.0 112.435 174.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.5 mt -78.96 -17.1 56.01 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.455 0.702 . . . . 10.0 111.745 -178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 25.8 mt -100.36 132.35 22.65 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 -169.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.46 142.33 64.98 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.388 2.058 . . . . 10.0 110.272 -178.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -78.51 -28.88 46.35 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.816 0.847 . . . . 10.0 112.163 -174.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.26 134.38 47.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 106.086 -1.82 . . . . 10.0 106.086 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -152.96 113.42 4.04 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 105.837 -1.912 . . . . 10.0 105.837 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 34.3 pt -139.07 160.78 29.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 124.56 1.144 . . . . 10.0 109.962 -169.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.13 175.49 2.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.191 0.996 . . . . 10.0 111.572 175.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.7 m -138.82 11.58 2.67 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.376 1.07 . . . . 10.0 112.55 -169.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -148.81 138.29 21.83 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.152 0.887 . . . . 10.0 110.419 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.24 -163.63 16.29 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.487 1.041 . . . . 10.0 113.139 171.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.6 t -75.84 142.49 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 169.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -150.37 147.84 28.08 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.986 0.914 . . . . 10.0 109.734 171.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -74.93 157.88 34.25 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.672 -0.862 . . . . 10.0 108.672 177.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.71 160.35 43.25 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 122.549 0.34 . . . . 10.0 110.458 173.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 t -133.57 141.89 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.453 1.501 . . . . 10.0 107.383 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 51.8 tp -98.63 115.84 29.54 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 104.654 -2.35 . . . . 10.0 104.654 169.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 47.3 mt -122.83 124.84 71.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 106.625 -1.62 . . . . 10.0 106.625 -167.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -82.53 140.16 33.46 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 168.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.2 t -133.13 142.65 41.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.446 -1.687 . . . . 10.0 106.446 -174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -126.29 136.96 53.41 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.509 1.524 . . . . 10.0 107.119 -173.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.9 m -67.56 140.44 56.95 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 175.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.36 57.31 2.77 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.399 1.479 . . . . 10.0 107.981 167.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -59.97 135.12 60.88 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 123.333 2.689 . . . . 10.0 109.834 -169.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 47.34 26.04 0.67 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.028 1.331 . . . . 10.0 112.956 -174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m 48.23 31.28 2.55 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.458 1.503 . . . . 10.0 113.655 -172.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -172.64 -3.39 0.03 OUTLIER Glycine 0 CA--C 1.531 1.051 0 N-CA-C 117.019 1.568 . . . . 10.0 117.019 -177.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.05 151.08 81.76 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 120.433 2.116 . . . . 10.0 110.556 175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.03 52.06 3.9 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.315 3.344 . . . . 10.0 111.54 177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.53 136.07 30.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.003 1.321 . . . . 10.0 108.723 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.7 31.5 1.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.327 1.451 . . . . 10.0 109.762 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -61.97 151.48 34.91 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.51 -0.922 . . . . 10.0 108.51 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.4 m -139.39 158.49 44.05 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.799 0.84 . . . . 10.0 110.686 -175.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -152.41 176.78 11.29 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.807 1.243 . . . . 10.0 109.247 171.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -117.0 142.82 46.47 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.0 pt -131.17 156.42 42.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 C-N-CA 124.623 1.169 . . . . 10.0 110.067 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.42 125.8 65.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.915 -1.883 . . . . 10.0 105.915 175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? -130.13 139.17 50.93 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 175.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -172.0 132.76 2.5 Favored Glycine 0 C--O 1.224 -0.527 0 CA-C-N 120.03 1.286 . . . . 10.0 111.817 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -144.75 144.18 31.06 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 122.888 0.475 . . . . 10.0 111.178 -169.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -64.58 -32.45 74.11 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.845 0.858 . . . . 10.0 112.248 -174.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -68.59 -16.69 63.94 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 117.912 -1.042 . . . . 10.0 113.008 -177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.8 119.31 6.91 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.631 1.105 . . . . 10.0 111.629 -172.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -68.13 -37.36 81.0 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.161 0.584 . . . . 10.0 110.18 177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -149.67 168.86 22.42 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 127.142 2.177 . . . . 10.0 107.598 178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -59.6 -29.37 67.94 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.135 -0.978 . . . . 10.0 111.805 173.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.82 -31.92 68.9 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.838 0.855 . . . . 10.0 112.359 172.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -66.39 -42.6 87.65 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.795 0.807 . . . . 10.0 109.802 -176.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 81.1 mt -64.78 -53.84 37.17 Favored 'Isoleucine or valine' 0 C--N 1.345 0.371 0 N-CA-C 108.214 -1.032 . . . . 10.0 108.214 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -59.14 -39.17 81.55 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 119.027 -0.511 . . . . 10.0 110.992 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.51 -46.02 90.35 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.445 0.566 . . . . 10.0 111.761 179.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -62.83 -49.16 75.99 Favored 'General case' 0 C--N 1.345 0.373 0 O-C-N 121.691 -0.63 . . . . 10.0 109.661 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.1 t -67.79 -43.73 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.301 -0.629 . . . . 10.0 109.301 -169.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.7 p -65.09 -34.05 77.49 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.251 0.932 . . . . 10.0 111.205 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.98 -51.21 60.02 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.393 -1.083 . . . . 10.0 110.393 173.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.98 -46.25 91.5 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 117.357 0.579 . . . . 10.0 110.792 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.9 mmt -61.84 -37.75 85.64 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.702 -0.624 . . . . 10.0 110.812 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -64.86 -36.49 84.52 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.997 0.817 . . . . 10.0 111.14 175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -66.61 -34.22 77.41 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.994 -1.003 . . . . 10.0 111.304 172.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -68.15 -54.22 19.53 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.841 0.746 . . . . 10.0 109.546 177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 129.52 44.04 0.2 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.453 1.502 . . . . 10.0 110.551 -171.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 84.4 m -144.91 171.68 14.1 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.229 1.812 . . . . 10.0 109.047 -175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -139.54 160.92 38.74 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.432 1.493 . . . . 10.0 108.709 174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 76.8 m -127.71 157.59 39.91 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.847 1.259 . . . . 10.0 112.98 -168.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -145.52 111.75 5.7 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 126.677 1.991 . . . . 10.0 106.283 174.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.6 p -63.42 118.9 8.75 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 120.97 -1.081 . . . . 10.0 108.775 171.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 60.8 mt -80.7 -29.02 36.49 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 110.171 -0.307 . . . . 10.0 110.171 173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.64 -178.43 39.84 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.157 -1.977 . . . . 10.0 108.157 -176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -156.99 -168.86 20.19 Favored Glycine 0 CA--C 1.519 0.314 0 O-C-N 121.398 -1.06 . . . . 10.0 110.851 175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.17 -151.41 9.07 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 108.358 -1.897 . . . . 10.0 108.358 -174.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -144.13 165.4 27.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.8 mt -134.32 151.46 32.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 104.835 -2.283 . . . . 10.0 104.835 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.3 p -132.37 118.73 19.76 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.985 -1.117 . . . . 10.0 107.985 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -78.53 91.0 4.52 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.091 -1.818 . . . . 10.0 106.091 168.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -82.54 63.7 6.82 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 121.655 0.741 . . . . 10.0 109.28 -174.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.6 m 49.08 32.19 3.88 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.431 2.292 . . . . 10.0 113.449 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . 0.276 5.5 pt20 51.48 -26.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 130.347 3.459 . . . . 10.0 116.792 -168.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -56.37 -30.28 62.49 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.721 1.609 . . . . 10.0 112.147 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -124.42 32.18 5.56 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.335 1.054 . . . . 10.0 110.25 177.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.332 0.0 OUTLIER 54.53 -179.86 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.037 2.935 . . . . 10.0 115.225 172.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.7 pt -86.5 102.48 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.865 -1.531 . . . . 10.0 106.865 169.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -99.79 126.69 45.91 Favored 'General case' 0 C--O 1.232 0.167 0 N-CA-C 108.199 -1.038 . . . . 10.0 108.199 -176.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 47.6 t -87.42 145.31 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 106.652 -1.61 . . . . 10.0 106.652 174.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -161.67 178.77 8.71 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.687 0.795 . . . . 10.0 110.182 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.89 -158.26 46.31 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-O 121.328 0.405 . . . . 10.0 112.92 172.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -158.67 158.03 32.98 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.557 1.943 . . . . 10.0 107.56 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.6 t -72.09 130.78 41.71 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.013 -1.106 . . . . 10.0 108.013 172.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 60.4 mtt -73.3 -19.32 61.07 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 123.604 0.565 . . . . 10.0 110.811 169.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -85.95 -31.32 22.18 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.536 -0.745 . . . . 10.0 112.077 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -128.17 -54.53 1.28 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 118.889 0.768 . . . . 10.0 111.297 -170.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.09 179.85 22.58 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.837 1.208 . . . . 10.0 110.165 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -55.39 133.42 58.0 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 123.113 2.542 . . . . 10.0 111.673 173.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.69 165.76 20.6 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.399 -0.963 . . . . 10.0 108.399 166.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -80.12 68.22 6.19 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 168.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -49.45 -33.03 13.12 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.463 1.505 . . . . 10.0 113.709 -169.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.5 77.18 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.993 0.815 . . . . 10.0 112.231 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.4 mt -65.72 -50.97 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 107.097 -1.445 . . . . 10.0 107.097 176.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -55.94 -46.52 78.48 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 118.468 -0.777 . . . . 10.0 112.137 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 18.6 p -64.99 -42.32 94.63 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 119.721 1.146 . . . . 10.0 111.034 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -65.87 -39.44 90.69 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 118.864 0.756 . . . . 10.0 110.979 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.9 mttm -59.83 -51.66 68.77 Favored 'General case' 0 CA--C 1.523 -0.094 0 CA-C-O 118.818 -0.61 . . . . 10.0 109.836 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.8 mt -56.47 -48.81 79.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 108.419 -0.956 . . . . 10.0 108.419 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -60.99 -40.75 94.66 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.693 0.797 . . . . 10.0 111.513 -175.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.57 -46.12 77.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.122 0.569 . . . . 10.0 110.842 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -79.5 -19.65 49.16 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 118.62 -0.705 . . . . 10.0 112.082 -173.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.84 77.48 72.15 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 126.136 1.774 . . . . 10.0 107.221 177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.22 51.4 3.47 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.624 3.549 . . . . 10.0 111.955 -174.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -146.54 166.78 25.45 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.041 1.737 . . . . 10.0 107.953 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 50.78 -140.87 0.8 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.922 1.289 . . . . 10.0 110.029 -169.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -147.54 162.88 38.2 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.98 -1.489 . . . . 10.0 106.98 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.96 132.5 16.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.138 -1.43 . . . . 10.0 107.138 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.6 p -142.44 170.65 15.31 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.646 1.178 . . . . 10.0 108.707 173.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 54.5 p-90 -138.75 163.28 32.6 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 122.851 0.46 . . . . 10.0 111.886 178.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.47 168.87 20.14 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.164 1.785 . . . . 10.0 108.727 169.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -147.98 23.69 1.07 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.157 0.983 . . . . 10.0 110.164 176.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.61 -25.88 68.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.106 0.962 . . . . 10.0 112.946 -175.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -169.44 178.54 42.47 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 108.639 -1.784 . . . . 10.0 108.639 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 68.2 t80 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.932 -0.556 . . . . 10.0 109.535 176.11 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 mpp? . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 118.554 -0.736 . . . . 10.0 109.75 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.66 24.04 6.66 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.86 1.264 . . . . 10.0 111.276 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.48 152.19 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 128.904 2.882 . . . . 10.0 105.323 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.43 167.1 20.33 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 123.479 0.487 . . . . 10.0 109.785 168.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -151.16 151.32 31.76 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.931 1.292 . . . . 10.0 107.542 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.8 mt -59.13 -24.06 62.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 118.237 -0.887 . . . . 10.0 112.886 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.88 -25.9 67.02 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.605 1.093 . . . . 10.0 112.451 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.2 mt -74.94 -23.77 58.37 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.123 0.569 . . . . 10.0 111.366 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 62.9 mt -89.2 128.97 49.51 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 107.071 -1.455 . . . . 10.0 107.071 -173.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.81 147.17 80.48 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.165 1.91 . . . . 10.0 110.67 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -70.92 -35.61 72.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.779 1.632 . . . . 10.0 111.603 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.9 t -141.64 133.26 27.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 104.625 -2.361 . . . . 10.0 104.625 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -150.32 114.3 5.07 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.063 -1.829 . . . . 10.0 106.063 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 41.3 pt -141.5 161.06 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 124.502 1.121 . . . . 10.0 109.525 -170.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -148.28 103.91 3.48 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 176.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.2 m -155.88 155.01 32.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.013 0.925 . . . . 10.0 109.07 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -149.84 25.41 0.84 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 123.121 1.439 . . . . 10.0 109.717 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.77 -168.55 41.43 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 107.905 -2.078 . . . . 10.0 107.905 -169.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.9 t -65.79 120.64 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 118.06 0.93 . . . . 10.0 108.576 174.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -146.82 151.16 36.65 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.694 0.797 . . . . 10.0 109.981 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -55.95 153.46 8.69 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.64 1.176 . . . . 10.0 111.629 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.51 160.9 43.08 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.074 0.95 . . . . 10.0 108.965 168.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.12 147.25 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.703 1.201 . . . . 10.0 108.911 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -107.77 117.99 35.56 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.566 -2.013 . . . . 10.0 105.566 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 32.3 mt -123.19 132.34 71.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.522 -1.659 . . . . 10.0 106.522 -170.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -85.32 125.3 32.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.537 -2.023 . . . . 10.0 105.537 167.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.38 141.17 24.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 106.604 -1.628 . . . . 10.0 106.604 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -121.6 130.1 53.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 105.976 -1.861 . . . . 10.0 105.976 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.6 p -71.03 144.32 50.45 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 109.958 -0.386 . . . . 10.0 109.958 175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.0 61.83 3.56 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 125.567 1.547 . . . . 10.0 107.603 166.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -58.08 143.9 95.76 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.944 2.429 . . . . 10.0 110.601 -169.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 48.18 23.72 0.57 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.842 1.257 . . . . 10.0 113.111 -174.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.2 m 49.05 30.95 3.09 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.225 1.41 . . . . 10.0 113.683 -172.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.62 -2.34 0.02 OUTLIER Glycine 0 CA--C 1.53 1.013 0 N-CA-C 116.762 1.465 . . . . 10.0 116.762 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.16 152.22 78.94 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 119.937 1.868 . . . . 10.0 110.657 175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.78 57.77 6.18 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 124.285 3.323 . . . . 10.0 112.098 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.24 136.91 30.32 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 125.073 1.349 . . . . 10.0 108.309 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.79 28.53 0.77 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.897 1.279 . . . . 10.0 110.448 -177.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.04 159.94 24.86 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 121.375 -0.828 . . . . 10.0 109.095 172.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.0 m -139.76 162.12 35.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.874 0.87 . . . . 10.0 110.694 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -149.29 174.88 11.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.647 1.179 . . . . 10.0 109.351 170.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -99.3 148.85 23.73 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.282 -1.007 . . . . 10.0 108.282 171.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.7 pt -136.53 148.62 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 125.604 1.562 . . . . 10.0 109.72 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.7 t -106.94 127.34 62.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.289 -1.375 . . . . 10.0 107.289 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -132.68 141.95 48.84 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.618 -1.253 . . . . 10.0 107.618 -176.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.06 107.21 0.23 Allowed Glycine 0 C--O 1.226 -0.359 0 N-CA-C 110.132 -1.187 . . . . 10.0 110.132 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -132.97 132.62 42.14 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 109.175 -0.676 . . . . 10.0 109.175 -171.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -59.55 -23.95 63.3 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.791 1.404 . . . . 10.0 114.791 -172.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.7 p-90 -67.39 -24.65 65.7 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.315 0.961 . . . . 10.0 112.425 177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.98 125.42 29.07 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 119.744 1.157 . . . . 10.0 109.799 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -74.29 -33.59 63.28 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.392 0.615 . . . . 10.0 109.855 171.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -143.71 155.91 44.36 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 125.15 1.38 . . . . 10.0 110.008 -172.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -58.66 -33.87 70.6 Favored 'General case' 0 C--N 1.333 -0.121 0 C-N-CA 125.415 1.486 . . . . 10.0 112.94 -171.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.94 -31.09 70.64 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 118.383 -0.818 . . . . 10.0 111.513 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -70.93 -38.54 72.91 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 118.86 0.755 . . . . 10.0 110.124 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 34.4 mt -63.88 -50.34 77.95 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -52.92 -48.26 67.39 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.427 -0.797 . . . . 10.0 111.123 176.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -63.2 -47.15 83.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.417 0.553 . . . . 10.0 111.255 -177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -59.48 -51.42 69.95 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 121.872 -0.518 . . . . 10.0 110.153 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.1 t -66.98 -41.26 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.678 -0.86 . . . . 10.0 108.678 -173.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.2 m -62.91 -36.04 82.06 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.629 1.104 . . . . 10.0 111.547 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.77 -51.13 59.45 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.163 -1.175 . . . . 10.0 110.163 173.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.29 -43.45 98.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 117.793 0.797 . . . . 10.0 111.016 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.1 mmt -62.32 -37.0 83.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 O-C-N 121.71 -0.619 . . . . 10.0 111.433 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -65.03 -36.17 83.52 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.009 0.822 . . . . 10.0 110.755 175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -65.78 -32.72 74.41 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 117.64 -1.172 . . . . 10.0 111.509 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.8 mm-40 -68.99 -52.16 31.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.718 1.144 . . . . 10.0 109.727 175.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 122.08 50.12 0.24 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 108.766 -1.734 . . . . 10.0 108.766 -169.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 64.0 m -147.69 170.65 17.08 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.532 1.933 . . . . 10.0 109.216 -177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -140.2 165.38 27.52 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.276 1.83 . . . . 10.0 108.48 179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 88.1 m -134.48 156.14 49.12 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 124.582 1.153 . . . . 10.0 112.358 -167.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -149.25 123.23 9.39 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 106.135 -1.802 . . . . 10.0 106.135 169.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 98.4 m -69.71 126.98 31.35 Favored 'General case' 0 C--O 1.226 -0.178 0 O-C-N 121.038 -1.039 . . . . 10.0 109.334 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.99 -27.33 35.97 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 122.097 -0.377 . . . . 10.0 110.306 170.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.1 -177.87 38.14 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 108.966 -1.654 . . . . 10.0 108.966 -178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -152.96 -173.01 21.87 Favored Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.5 -1.0 . . . . 10.0 111.48 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.51 -146.77 6.4 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 108.511 -1.836 . . . . 10.0 108.511 -173.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -147.71 159.91 43.28 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.601 1.161 . . . . 10.0 109.505 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.9 mt -128.7 149.32 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.513 -2.032 . . . . 10.0 105.513 -174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 96.2 p -125.74 164.45 20.62 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.245 1.018 . . . . 10.0 108.814 170.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -139.24 154.17 47.94 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.23 1.412 . . . . 10.0 108.12 -176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.4 pt20 -70.09 -2.93 14.32 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.216 1.191 . . . . 10.0 114.216 -172.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.2 m -47.65 -41.35 22.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.756 1.622 . . . . 10.0 112.444 168.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 -154.24 14.57 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.75 0.82 . . . . 10.0 111.953 -175.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -144.79 -162.15 1.43 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.978 1.311 . . . . 10.0 108.439 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -73.99 -176.4 2.5 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 120.875 -1.14 . . . . 10.0 109.656 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.57 163.66 0.27 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.904 -0.569 . . . . 10.0 110.63 165.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 28.0 mt -54.73 122.16 3.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 -171.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -136.38 147.14 47.18 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 107.415 -1.328 . . . . 10.0 107.415 -176.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -132.69 135.51 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.173 -1.417 . . . . 10.0 107.173 -172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -164.79 175.29 9.79 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 123.941 0.897 . . . . 10.0 109.695 -170.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.52 -174.19 20.87 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 121.722 0.624 . . . . 10.0 112.76 174.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -141.9 24.81 1.99 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.047 0.939 . . . . 10.0 111.862 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.7 p 59.46 -174.89 0.1 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.511 1.924 . . . . 10.0 112.832 -170.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 48.0 mtt -128.55 21.81 6.01 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.192 1.397 . . . . 10.0 109.039 167.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -145.24 -28.83 0.45 Allowed 'General case' 0 C--N 1.347 0.488 0 N-CA-C 115.172 1.545 . . . . 10.0 115.172 -169.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.89 -52.54 0.52 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 120.484 1.493 . . . . 10.0 111.554 -173.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 151.29 177.79 25.44 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.42 1.486 . . . . 10.0 109.646 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.3 134.45 45.31 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.759 2.306 . . . . 10.0 111.178 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.55 160.93 18.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.963 0.887 . . . . 10.0 109.085 165.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -80.33 75.4 7.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.724 -1.584 . . . . 10.0 106.724 169.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -54.53 -23.74 17.8 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.724 1.209 . . . . 10.0 113.546 -170.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.45 -40.37 94.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.703 1.138 . . . . 10.0 111.675 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 53.7 mt -65.16 -51.84 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.7 m -57.83 -45.42 86.22 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 118.712 -0.661 . . . . 10.0 112.003 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.0 p -68.74 -38.61 80.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 117.775 -1.107 . . . . 10.0 111.654 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -63.4 -40.29 96.82 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.076 1.307 . . . . 10.0 110.71 175.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.9 mttm -62.74 -50.43 71.09 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.133 -0.355 . . . . 10.0 110.064 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.2 -39.46 82.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 O-C-N 120.651 -1.281 . . . . 10.0 109.076 178.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -62.03 -41.55 98.21 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 119.624 1.102 . . . . 10.0 110.66 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.34 -41.3 96.84 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.315 0.961 . . . . 10.0 111.048 174.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -62.98 -33.2 74.89 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 118.252 -0.88 . . . . 10.0 110.66 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.4 t80 41.99 64.63 5.56 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 127.77 2.428 . . . . 10.0 111.764 -174.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -68.03 -24.37 39.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.033 1.822 . . . . 10.0 113.142 -174.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -156.09 -48.19 0.08 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 119.253 0.933 . . . . 10.0 112.525 175.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -160.01 -171.31 3.18 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 121.317 -0.865 . . . . 10.0 111.086 -169.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -47.06 147.97 1.26 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.62 2.368 . . . . 10.0 111.693 174.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 t -132.51 140.77 46.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.117 1.367 . . . . 10.0 108.644 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.63 169.27 21.97 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.569 1.548 . . . . 10.0 109.96 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 39.6 p-90 -145.63 166.18 26.54 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.755 1.162 . . . . 10.0 111.243 172.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.33 175.23 14.13 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.98 1.712 . . . . 10.0 108.236 169.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -137.76 36.66 2.41 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.201 1.0 . . . . 10.0 109.567 177.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.84 -26.3 68.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.354 1.061 . . . . 10.0 112.427 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.48 -174.87 42.43 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 109.258 -1.537 . . . . 10.0 109.258 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 58.6 t80 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.968 -0.539 . . . . 10.0 109.942 173.039 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 118.557 -0.735 . . . . 10.0 110.381 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.53 -177.58 4.81 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.875 0.87 . . . . 10.0 111.613 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.5 m -89.96 146.24 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.239 1.015 . . . . 10.0 109.218 168.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -161.7 -177.24 5.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.945 2.098 . . . . 10.0 106.753 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -144.89 147.05 32.33 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.382 -1.71 . . . . 10.0 106.382 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.5 mt -59.05 -26.21 64.39 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.54 -24.92 67.77 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.704 0.684 . . . . 10.0 112.713 176.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.83 -27.74 57.99 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 118.37 0.532 . . . . 10.0 110.61 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.6 mt -79.94 132.52 60.27 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 107.135 -1.431 . . . . 10.0 107.135 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.11 147.88 80.17 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.453 2.102 . . . . 10.0 109.531 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -78.49 -28.61 46.41 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.287 0.565 . . . . 10.0 112.131 -172.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -137.96 135.51 45.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.256 1.422 . . . . 10.0 107.173 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -147.84 99.8 3.13 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.541 -1.281 . . . . 10.0 107.541 172.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 39.6 pt -143.75 -179.02 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.656 1.583 . . . . 10.0 109.736 -169.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -138.58 163.5 31.87 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 106.071 -1.826 . . . . 10.0 106.071 167.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.5 m -152.89 22.82 0.58 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.771 1.229 . . . . 10.0 111.198 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -64.43 -18.21 64.52 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.583 -0.698 . . . . 10.0 112.463 169.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.04 -174.94 34.42 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.118 1.818 . . . . 10.0 109.101 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.9 t -64.62 130.88 30.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 108.283 -1.006 . . . . 10.0 108.283 169.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -141.94 148.67 39.02 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.059 1.344 . . . . 10.0 108.977 173.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -60.43 151.61 27.72 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.658 0.783 . . . . 10.0 109.187 173.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -152.08 162.07 41.66 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.633 -0.667 . . . . 10.0 110.563 170.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.84 152.86 31.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.889 1.276 . . . . 10.0 109.677 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 tp -102.63 114.3 28.41 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 104.654 -2.351 . . . . 10.0 104.654 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 77.4 mt -116.58 132.13 67.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.2 -1.778 . . . . 10.0 106.2 -170.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -88.51 139.51 30.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 106.437 -1.69 . . . . 10.0 106.437 168.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -128.98 142.43 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 106.076 -1.824 . . . . 10.0 106.076 -176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -120.6 133.57 55.36 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.189 -1.782 . . . . 10.0 106.189 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.7 p -65.8 140.65 58.42 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.766 -0.457 . . . . 10.0 109.766 173.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.9 60.2 2.89 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.24 1.416 . . . . 10.0 108.676 168.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.36 143.63 99.49 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.05 2.5 . . . . 10.0 108.941 -174.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 35.0 tpt85 53.12 16.17 0.73 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.637 1.175 . . . . 10.0 113.102 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.3 m 54.97 24.15 5.67 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.44 1.096 . . . . 10.0 113.222 -170.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.87 1.47 0.03 OUTLIER Glycine 0 CA--C 1.531 1.061 0 N-CA-C 116.652 1.421 . . . . 10.0 116.652 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.53 153.35 77.67 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 119.984 1.892 . . . . 10.0 110.252 173.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.95 64.42 7.7 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.315 3.344 . . . . 10.0 111.925 -177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.32 140.0 35.55 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.378 1.471 . . . . 10.0 108.346 172.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.36 26.17 0.78 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.806 1.242 . . . . 10.0 110.65 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -66.88 159.96 27.16 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.785 -0.82 . . . . 10.0 108.785 169.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 m -139.45 162.64 34.55 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.154 0.982 . . . . 10.0 111.135 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -152.43 145.3 24.4 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.318 1.847 . . . . 10.0 107.71 -170.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.2 144.03 28.08 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.249 -1.389 . . . . 10.0 107.249 169.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 47.8 pt -134.74 151.37 31.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.238 1.015 . . . . 10.0 109.965 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.4 t -102.29 127.12 56.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 105.875 -1.898 . . . . 10.0 105.875 175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.412 ' HG3' HG21 ' A' ' 60' ' ' VAL . 6.2 mmp_? -130.28 133.63 46.63 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 107.177 -1.416 . . . . 10.0 107.177 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.55 49.51 0.33 Allowed Glycine 0 C--O 1.227 -0.299 0 N-CA-C 111.068 -0.813 . . . . 10.0 111.068 -169.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -65.92 132.95 49.84 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.934 -0.395 . . . . 10.0 109.934 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -63.1 -27.12 69.17 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 113.924 1.083 . . . . 10.0 113.924 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -69.39 -20.61 63.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 117.958 -1.02 . . . . 10.0 112.641 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.44 133.93 52.37 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 119.29 0.95 . . . . 10.0 111.031 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -79.49 -35.61 39.9 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.509 0.671 . . . . 10.0 109.901 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -143.7 163.42 33.34 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.96 1.304 . . . . 10.0 110.109 -170.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 94' ' ' SER . 53.2 m80 -57.54 -40.87 79.81 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.921 0.888 . . . . 10.0 111.466 175.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.74 -25.25 66.42 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 118.674 -0.679 . . . . 10.0 112.4 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -67.3 -41.49 85.28 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 122.148 0.975 . . . . 10.0 109.149 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.5 mt -63.67 -55.26 23.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.13 -1.063 . . . . 10.0 108.13 173.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -57.6 -41.02 80.38 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 119.171 -0.443 . . . . 10.0 111.732 -173.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.68 -44.8 92.64 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 122.724 0.409 . . . . 10.0 111.612 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -60.39 -51.35 69.88 Favored 'General case' 0 C--N 1.345 0.385 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.412 HG21 ' HG3' ' A' ' 45' ' ' ARG . 93.4 t -62.44 -39.86 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 118.201 -0.904 . . . . 10.0 110.05 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.0 m -61.77 -46.34 90.01 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.275 0.943 . . . . 10.0 110.362 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.51 -44.62 94.91 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.006 -0.838 . . . . 10.0 111.006 178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -58.59 -52.8 64.12 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 125.07 1.348 . . . . 10.0 109.481 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 24.6 mmt -61.39 -37.81 84.77 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.253 0.621 . . . . 10.0 111.485 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -64.19 -37.83 88.89 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 119.224 0.92 . . . . 10.0 110.85 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.92 -37.53 87.37 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 117.702 -1.142 . . . . 10.0 110.942 171.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -67.55 -51.14 54.22 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.714 0.688 . . . . 10.0 109.727 -178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.11 41.16 0.29 Allowed Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.86 1.219 . . . . 10.0 110.789 -169.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 98.4 m -145.51 171.5 14.57 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.961 1.704 . . . . 10.0 108.742 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -140.11 164.49 29.89 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.81 1.644 . . . . 10.0 108.239 174.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 71.6 m -130.58 164.83 24.06 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.506 1.048 . . . . 10.0 113.401 -168.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.98 132.88 16.08 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.184 2.194 . . . . 10.0 105.203 168.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 8.3 t -80.61 132.05 35.57 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.785 -1.197 . . . . 10.0 108.138 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 45.5 mt -87.63 -21.54 25.25 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 119.263 -0.399 . . . . 10.0 110.625 171.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.86 -178.32 26.5 Favored Glycine 0 C--N 1.336 0.564 0 N-CA-C 109.148 -1.581 . . . . 10.0 109.148 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.08 -171.83 24.49 Favored Glycine 0 C--N 1.329 0.183 0 O-C-N 121.706 -0.879 . . . . 10.0 111.866 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.18 -140.6 4.7 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 107.364 -2.295 . . . . 10.0 107.364 -173.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.0 mtm180 -139.31 149.44 44.23 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.883 -1.155 . . . . 10.0 107.883 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -115.24 146.05 20.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 104.871 -2.27 . . . . 10.0 104.871 170.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -137.08 154.09 50.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.812 0.845 . . . . 10.0 111.173 -168.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -65.82 164.63 14.4 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.325 1.05 . . . . 10.0 110.703 173.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -71.61 56.26 0.26 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.434 1.894 . . . . 10.0 112.676 172.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.0 p -144.44 -37.17 0.31 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.777 2.031 . . . . 10.0 109.417 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.461 HE22 ' CD2' ' A' ' 89' ' ' HIS . 1.1 tm0? -63.78 -24.52 67.79 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.976 0.91 . . . . 10.0 110.621 168.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -155.58 171.73 19.46 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.468 2.307 . . . . 10.0 106.63 175.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -59.27 -18.08 34.32 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.652 1.181 . . . . 10.0 112.725 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -138.08 170.01 16.78 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.285 1.434 . . . . 10.0 108.72 -175.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 84.5 mt -55.91 127.88 15.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 105.247 -2.131 . . . . 10.0 105.247 169.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.461 ' CD2' HE22 ' A' ' 84' ' ' GLN . 12.2 t60 -132.76 164.71 26.19 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 123.992 0.808 . . . . 10.0 110.605 -166.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 10.5 t -133.51 130.61 56.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 C-N-CA 125.136 1.374 . . . . 10.0 107.767 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -158.11 178.17 10.49 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.568 0.747 . . . . 10.0 110.894 -176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.42 -175.95 45.61 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.661 -0.575 . . . . 10.0 111.661 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -142.84 152.26 41.98 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.086 1.354 . . . . 10.0 107.36 174.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.408 ' HA ' ' CE1' ' A' ' 53' ' ' HIS . 78.7 p -67.57 142.52 56.47 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.715 -0.616 . . . . 10.0 109.868 -178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 97.1 mtp -70.26 -29.65 66.48 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.759 -0.459 . . . . 10.0 109.759 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.29 -33.52 63.27 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 117.883 -1.056 . . . . 10.0 113.307 -174.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -136.32 -52.2 0.71 Allowed 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.588 1.085 . . . . 10.0 112.489 -169.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.45 -174.99 23.72 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.855 1.216 . . . . 10.0 110.248 -169.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.81 138.39 57.87 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.716 2.277 . . . . 10.0 111.249 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.2 167.6 20.0 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.996 -1.113 . . . . 10.0 107.996 165.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -80.23 79.06 6.86 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.368 -1.716 . . . . 10.0 106.368 168.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -56.11 -32.36 64.12 Favored 'General case' 0 C--O 1.222 -0.395 0 C-N-CA 124.133 0.973 . . . . 10.0 111.6 -173.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.97 -42.28 97.3 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.801 0.728 . . . . 10.0 112.214 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 65.2 mt -63.87 -46.93 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 107.212 -1.403 . . . . 10.0 107.212 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 14.5 m -57.12 -44.9 83.72 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.212 -0.899 . . . . 10.0 111.752 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.1 p -64.95 -38.03 89.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 120.463 1.483 . . . . 10.0 111.436 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.16 -40.22 95.67 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 119.317 0.962 . . . . 10.0 110.639 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.4 mttm -65.28 -47.36 76.92 Favored 'General case' 0 C--N 1.333 -0.116 0 O-C-N 121.611 -0.681 . . . . 10.0 110.451 177.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 60.6 mt -60.62 -45.34 97.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 178.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -53.12 -49.97 65.45 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.898 0.879 . . . . 10.0 110.092 176.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.87 -32.36 73.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.005 0.522 . . . . 10.0 112.399 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -62.89 -51.87 65.3 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 118.981 0.81 . . . . 10.0 109.981 -176.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -158.88 -52.62 0.01 OUTLIER Pre-proline 0 CA--C 1.538 0.505 0 CA-C-O 117.158 -1.401 . . . . 10.0 113.332 -177.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.94 65.64 4.08 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.779 2.986 . . . . 10.0 112.308 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -58.72 -31.03 67.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.723 1.209 . . . . 10.0 112.32 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -58.75 -56.08 26.87 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 123.049 0.54 . . . . 10.0 110.573 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -169.66 156.48 6.52 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-N 118.635 0.652 . . . . 10.0 111.247 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.9 t -147.73 139.95 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 129.099 2.96 . . . . 10.0 103.145 167.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.9 p -119.06 165.41 14.17 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.2 0.909 . . . . 10.0 110.76 -170.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -154.48 162.5 41.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 O-C-N 120.901 -1.124 . . . . 10.0 108.453 169.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -149.93 -32.08 0.2 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.8 0.667 . . . . 10.0 112.8 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 51.4 t30 38.98 62.69 1.04 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.233 1.413 . . . . 10.0 112.579 -171.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -59.19 -35.79 74.21 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.749 -0.66 . . . . 10.0 111.489 172.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.77 173.17 33.99 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.515 1.531 . . . . 10.0 110.282 172.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 64.0 t80 . . . . . 0 C--O 1.247 0.936 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 169.246 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ttt . . . . . 0 N--CA 1.484 1.25 0 N-CA-C 109.946 -0.39 . . . . 10.0 109.946 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.87 171.2 14.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.237 1.415 . . . . 10.0 109.078 176.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.2 m -67.28 165.79 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.647 0.737 . . . . 10.0 110.907 173.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -149.4 -179.24 6.92 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.451 2.3 . . . . 10.0 106.394 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -150.83 151.22 31.96 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.31 -23.81 64.49 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.566 0.746 . . . . 10.0 112.514 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.72 -32.12 67.42 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.224 0.92 . . . . 10.0 112.08 173.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 98.6 mt -76.51 -35.53 58.27 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 122.866 0.466 . . . . 10.0 109.837 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 47.5 mt -63.64 122.59 77.38 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.43 141.94 88.77 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.349 2.032 . . . . 10.0 109.531 -173.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -85.14 -32.18 22.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.192 0.52 . . . . 10.0 112.395 -169.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -139.61 134.06 38.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.599 -2.001 . . . . 10.0 105.599 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -149.61 98.96 2.83 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.599 -1.259 . . . . 10.0 107.599 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.8 pt -140.47 166.28 19.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.125 1.77 . . . . 10.0 107.959 -174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -136.01 34.97 2.83 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 122.699 1.238 . . . . 10.0 109.856 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 m -75.28 41.75 0.19 Allowed 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.685 1.994 . . . . 10.0 112.979 -174.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -63.08 -15.92 58.22 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.35 1.06 . . . . 10.0 111.817 169.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.07 -172.99 15.91 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 127.869 2.652 . . . . 10.0 107.486 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.51 126.0 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 117.854 0.827 . . . . 10.0 109.574 -177.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -157.32 147.86 21.18 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.287 0.635 . . . . 10.0 109.72 169.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -67.59 164.48 18.99 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.412 0.625 . . . . 10.0 111.276 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -151.61 166.61 30.69 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.603 0.761 . . . . 10.0 109.196 173.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -133.88 148.54 30.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.509 1.124 . . . . 10.0 108.538 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.1 tp -110.44 122.35 47.5 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.845 -1.909 . . . . 10.0 105.845 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.4 mt -129.08 136.95 58.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 106.472 -1.677 . . . . 10.0 106.472 -171.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.1 ttt85 -93.64 131.86 38.53 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.221 -1.77 . . . . 10.0 106.221 169.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.7 144.06 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 107.614 -1.254 . . . . 10.0 107.614 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -122.5 122.45 38.96 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 105.737 -1.949 . . . . 10.0 105.737 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.1 p -75.85 147.89 38.76 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.058 0.456 . . . . 10.0 111.475 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -160.57 65.46 2.29 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 127.31 2.244 . . . . 10.0 106.606 168.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -54.64 140.7 76.15 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.392 2.728 . . . . 10.0 111.211 -169.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 48.88 21.9 0.5 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.654 1.182 . . . . 10.0 113.295 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.3 m 48.79 35.69 6.84 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.098 1.359 . . . . 10.0 112.923 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -171.41 -12.03 0.02 OUTLIER Glycine 0 CA--C 1.531 1.047 0 N-CA-C 116.618 1.407 . . . . 10.0 116.618 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.03 150.12 92.48 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 120.006 1.903 . . . . 10.0 110.776 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.41 61.33 7.84 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 124.325 3.35 . . . . 10.0 111.695 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.86 140.02 34.54 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 124.886 1.275 . . . . 10.0 108.6 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.97 27.94 0.77 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.89 1.276 . . . . 10.0 110.931 -176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.84 165.37 19.9 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.426 0.69 . . . . 10.0 109.361 172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 12.9 m -139.31 159.93 41.0 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.225 1.01 . . . . 10.0 110.142 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -153.05 175.51 12.91 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.596 1.158 . . . . 10.0 109.584 170.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -96.43 159.62 14.84 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.06 -0.718 . . . . 10.0 109.06 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.1 pt -138.24 147.55 25.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 125.95 1.7 . . . . 10.0 108.425 169.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.1 t -108.27 124.95 64.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.02 -1.845 . . . . 10.0 106.02 177.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -131.01 136.89 48.9 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 124.077 0.951 . . . . 10.0 108.637 -173.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -162.38 47.82 0.34 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 109.687 -1.365 . . . . 10.0 109.687 -172.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -67.77 125.84 27.5 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.063 0.545 . . . . 10.0 111.041 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -59.3 -31.44 69.15 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.626 0.973 . . . . 10.0 113.626 -171.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 19.8 p-90 -69.01 -17.81 63.96 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 118.169 -0.919 . . . . 10.0 112.662 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.78 136.39 57.39 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 119.142 0.883 . . . . 10.0 111.538 -171.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.69 -38.54 80.39 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.728 -0.669 . . . . 10.0 110.388 173.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -154.77 169.7 23.33 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 126.22 1.808 . . . . 10.0 108.791 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -55.65 -32.36 63.14 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.098 0.959 . . . . 10.0 111.737 169.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.31 -36.01 80.83 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.121 0.568 . . . . 10.0 111.751 174.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -69.92 -39.2 76.27 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.447 -0.575 . . . . 10.0 109.447 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 62.0 mt -61.03 -57.28 12.88 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 108.458 -0.941 . . . . 10.0 108.458 173.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -58.93 -40.85 85.84 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 119.334 -0.365 . . . . 10.0 111.222 -172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -63.83 -46.72 83.81 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 122.54 0.336 . . . . 10.0 111.68 177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -64.28 -45.22 88.98 Favored 'General case' 0 C--N 1.344 0.327 0 O-C-N 121.785 -0.572 . . . . 10.0 109.907 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.09 -44.22 98.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 123.478 0.711 . . . . 10.0 109.093 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.7 m -60.95 -38.61 86.48 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.346 0.975 . . . . 10.0 111.092 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.17 -52.2 43.14 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.866 -0.894 . . . . 10.0 110.866 175.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.27 -42.4 99.13 Favored 'General case' 0 N--CA 1.461 0.104 0 CA-C-N 117.48 0.64 . . . . 10.0 111.366 -176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 25.4 mmt -62.51 -38.07 88.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 118.4 -0.81 . . . . 10.0 110.768 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -62.9 -36.04 82.05 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.581 1.082 . . . . 10.0 111.042 174.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -66.07 -33.43 75.78 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 118.098 -0.953 . . . . 10.0 111.685 172.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -70.76 -40.32 72.74 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.219 0.918 . . . . 10.0 110.679 176.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 106.51 53.07 0.73 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 108.768 -1.733 . . . . 10.0 108.768 -168.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.2 m -141.84 165.04 28.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.235 1.814 . . . . 10.0 107.855 171.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -128.31 161.87 28.4 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.581 1.553 . . . . 10.0 107.668 171.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 73.6 m -127.79 154.28 45.59 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 124.368 1.067 . . . . 10.0 112.576 -168.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -143.7 116.72 8.87 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.162 -1.792 . . . . 10.0 106.162 169.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.3 p -61.25 130.46 46.29 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.134 -0.979 . . . . 10.0 108.739 170.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 44.8 mt -90.66 -24.45 20.47 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 122.48 0.312 . . . . 10.0 110.21 172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.98 179.07 33.55 Favored Glycine 0 CA--C 1.522 0.518 0 N-CA-C 108.907 -1.677 . . . . 10.0 108.907 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.67 -179.33 22.72 Favored Glycine 0 CA--C 1.522 0.527 0 O-C-N 121.681 -0.894 . . . . 10.0 111.485 171.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.56 -149.98 7.05 Favored Glycine 0 C--O 1.241 0.563 0 N-CA-C 109.789 -1.324 . . . . 10.0 109.789 -170.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -147.43 165.13 31.16 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 124.794 1.238 . . . . 10.0 109.505 174.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.3 mt -133.82 149.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.484 -2.413 . . . . 10.0 104.484 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 31.1 m -147.0 160.77 41.97 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.516 0.726 . . . . 10.0 109.582 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -158.38 129.69 6.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 105.252 -2.129 . . . . 10.0 105.252 -174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 59.67 171.16 0.08 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.07 1.748 . . . . 10.0 111.928 -168.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.6 m 64.1 -20.72 0.07 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.874 2.07 . . . . 10.0 115.922 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -135.83 -29.91 1.01 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.59 1.956 . . . . 10.0 110.459 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -153.66 138.53 17.14 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.491 -1.3 . . . . 10.0 107.491 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -67.55 -13.38 62.0 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.103 -0.951 . . . . 10.0 113.229 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.68 170.37 15.91 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.931 1.292 . . . . 10.0 109.354 176.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 70.9 mt -57.61 136.5 20.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.526 0.679 . . . . 10.0 109.187 -176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -134.51 148.8 50.6 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.007 1.323 . . . . 10.0 108.076 172.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.7 138.62 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.751 1.621 . . . . 10.0 107.286 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -169.31 -167.13 0.68 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.212 1.405 . . . . 10.0 107.905 -171.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.05 -172.92 38.97 Favored Glycine 0 CA--C 1.525 0.702 0 O-C-N 121.361 -0.837 . . . . 10.0 112.738 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.69 174.31 11.91 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.951 0.9 . . . . 10.0 109.908 169.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 73.3 m -131.81 105.89 7.76 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 105.219 -2.141 . . . . 10.0 105.219 169.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.3 ttt -54.83 -28.71 51.61 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.303 1.041 . . . . 10.0 113.14 -169.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.0 -25.06 66.62 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.998 0.74 . . . . 10.0 112.998 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -128.87 -49.58 1.23 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.623 0.769 . . . . 10.0 110.407 -170.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.81 174.69 13.75 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 126.203 1.858 . . . . 10.0 108.917 -174.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -53.94 136.14 65.6 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.574 2.183 . . . . 10.0 110.895 169.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.93 159.29 25.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.697 0.761 . . . . 10.0 109.164 168.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -78.76 72.01 5.26 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 169.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -49.52 -32.89 13.27 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 125.26 1.424 . . . . 10.0 113.551 -169.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.02 -38.03 72.55 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.069 0.85 . . . . 10.0 112.426 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 50.9 mt -64.8 -51.38 67.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 106.992 -1.484 . . . . 10.0 106.992 177.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.2 m -59.95 -43.64 94.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 118.288 -0.863 . . . . 10.0 111.804 -178.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -63.42 -40.42 97.15 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 119.79 1.177 . . . . 10.0 111.002 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.97 -39.94 90.81 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.275 0.943 . . . . 10.0 110.674 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -66.32 -45.98 78.45 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.986 -0.446 . . . . 10.0 110.045 179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 66.0 mt -59.1 -41.89 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.516 -0.92 . . . . 10.0 108.516 173.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -64.18 -36.56 84.44 Favored 'General case' 0 C--O 1.223 -0.296 0 O-C-N 120.877 -1.14 . . . . 10.0 111.35 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.27 -42.51 93.16 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.514 0.597 . . . . 10.0 111.037 172.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -62.09 -29.62 70.44 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.421 0.689 . . . . 10.0 111.011 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 t80 49.45 53.49 14.51 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 127.294 2.238 . . . . 10.0 113.489 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.22 -14.28 25.69 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.151 1.901 . . . . 10.0 112.264 174.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -149.13 164.64 34.11 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.023 1.729 . . . . 10.0 108.292 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -59.88 -31.32 69.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.564 1.546 . . . . 10.0 113.092 -172.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -152.64 156.8 39.94 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.05 0.94 . . . . 10.0 108.553 -173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.5 t -143.0 139.15 27.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.781 -1.562 . . . . 10.0 106.781 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.2 p -147.52 165.45 30.29 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.388 1.075 . . . . 10.0 109.612 -175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 40.4 p-90 -145.75 162.09 38.42 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 118.285 0.493 . . . . 10.0 111.181 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -163.18 167.4 22.14 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 126.617 1.967 . . . . 10.0 107.361 169.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -78.36 48.26 0.75 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.414 0.685 . . . . 10.0 110.409 171.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -67.26 -19.25 65.48 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.565 1.146 . . . . 10.0 113.214 -169.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.67 -173.62 41.54 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.51 -1.436 . . . . 10.0 109.51 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 . . . . . 0 C--O 1.257 1.498 0 C-N-CA 125.604 1.561 . . . . 10.0 107.474 -174.703 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 110.24 -0.282 . . . . 10.0 110.24 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.55 165.94 30.7 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.512 1.525 . . . . 10.0 108.467 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.8 m -139.88 171.22 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 126.11 1.764 . . . . 10.0 109.045 -176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.0 177.47 8.34 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.343 1.857 . . . . 10.0 108.543 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.95 153.66 35.65 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.651 1.18 . . . . 10.0 108.107 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.3 mt -59.86 -20.39 56.82 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.902 0.881 . . . . 10.0 113.036 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.12 -23.59 63.98 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.605 1.093 . . . . 10.0 112.375 173.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.6 mt -78.36 -7.84 57.75 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.557 0.743 . . . . 10.0 111.943 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.2 mt -111.11 126.62 28.31 Favored Pre-proline 0 C--O 1.236 0.379 0 N-CA-C 106.168 -1.79 . . . . 10.0 106.168 -175.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -69.88 153.61 68.2 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.927 1.751 . . . . 10.0 109.992 177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -81.51 -27.56 34.42 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.385 1.474 . . . . 10.0 112.642 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 45.8 t -134.84 133.62 53.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 124.995 1.318 . . . . 10.0 107.471 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -149.2 103.88 3.36 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 106.755 -1.572 . . . . 10.0 106.755 169.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.0 pt -133.55 34.13 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.192 1.397 . . . . 10.0 110.108 -169.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -61.9 90.3 0.03 OUTLIER 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.441 1.496 . . . . 10.0 111.308 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.3 m -166.21 177.33 6.96 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.545 2.738 . . . . 10.0 108.301 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.19 143.35 30.26 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 124.87 1.268 . . . . 10.0 108.178 -173.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.57 -155.55 50.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.998 -1.241 . . . . 10.0 109.998 -174.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -65.29 137.86 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 O-C-N 121.391 -1.064 . . . . 10.0 108.997 173.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -151.87 152.38 32.51 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.139 0.976 . . . . 10.0 109.784 168.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -74.36 152.3 39.58 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.711 0.805 . . . . 10.0 109.079 176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.34 160.39 42.09 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.089 0.471 . . . . 10.0 110.308 173.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 t -134.22 141.67 43.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 106.548 -1.649 . . . . 10.0 106.548 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.7 tp -98.32 121.29 40.06 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 105.05 -2.204 . . . . 10.0 105.05 169.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.8 mt -129.33 135.57 61.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.582 -1.636 . . . . 10.0 106.582 -168.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -89.33 138.73 31.18 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.807 -1.923 . . . . 10.0 105.807 168.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.8 p -122.75 144.23 32.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.62 -1.622 . . . . 10.0 106.62 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -128.62 131.59 48.11 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 126.178 1.791 . . . . 10.0 106.713 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.5 p -78.17 140.11 38.98 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.824 0.284 . . . . 10.0 110.564 177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.05 66.45 4.41 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.979 1.712 . . . . 10.0 107.182 169.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.36 -26.4 71.19 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.386 2.724 . . . . 10.0 113.131 -168.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.6 ptt85 -153.11 167.65 28.54 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.795 1.638 . . . . 10.0 107.167 168.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.2 m -58.53 137.76 57.21 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 58.23 27.54 60.41 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.06 0.838 . . . . 10.0 113.876 178.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.49 149.81 87.28 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 118.556 1.178 . . . . 10.0 110.884 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -78.45 35.7 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.987 3.125 . . . . 10.0 111.872 173.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.67 132.81 15.34 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.631 1.573 . . . . 10.0 108.516 -174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.32 28.39 0.57 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.642 1.577 . . . . 10.0 109.547 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -67.21 157.15 34.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.953 0.901 . . . . 10.0 109.098 178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.0 m -141.91 159.63 41.84 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.685 1.194 . . . . 10.0 109.838 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -152.26 176.09 11.95 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.469 1.108 . . . . 10.0 109.807 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.2 mp0 -108.24 144.93 35.05 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.512 -0.921 . . . . 10.0 108.512 174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 41.3 pt -137.19 148.78 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 125.855 1.662 . . . . 10.0 109.629 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 49.6 t -107.94 122.58 62.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 105.977 -1.86 . . . . 10.0 105.977 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -127.6 137.47 52.57 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.588 -1.634 . . . . 10.0 106.588 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -167.51 133.67 2.98 Favored Glycine 0 C--O 1.225 -0.428 0 CA-C-N 119.822 1.192 . . . . 10.0 111.624 174.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -146.01 140.49 26.88 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.019 0.438 . . . . 10.0 110.992 -173.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -65.04 -28.31 69.39 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.242 1.017 . . . . 10.0 113.43 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -69.4 -16.41 63.5 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 118.502 -0.761 . . . . 10.0 112.386 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.67 122.35 15.08 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-N 118.869 0.759 . . . . 10.0 111.244 -173.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -69.55 -32.88 71.94 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.2 0.6 . . . . 10.0 110.201 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -148.47 163.64 36.55 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 126.668 1.987 . . . . 10.0 107.617 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -58.92 -38.07 78.12 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.653 -0.655 . . . . 10.0 110.697 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.56 -21.31 66.27 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.246 0.832 . . . . 10.0 113.246 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -67.31 -39.06 85.87 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.729 0.776 . . . . 10.0 109.477 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.42 -53.1 46.94 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 N-CA-C 107.716 -1.216 . . . . 10.0 107.716 173.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -58.3 -42.07 85.85 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 119.155 -0.45 . . . . 10.0 111.353 -173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.72 -45.58 85.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 118.287 0.494 . . . . 10.0 111.597 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -58.94 -49.55 77.41 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.377 0.671 . . . . 10.0 109.438 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.9 t -64.19 -47.47 89.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 123.873 0.869 . . . . 10.0 109.122 -178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -59.83 -35.09 74.02 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.264 0.938 . . . . 10.0 111.325 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.36 -49.31 75.39 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.646 -0.982 . . . . 10.0 110.646 173.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -61.48 -45.87 92.44 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 117.873 0.836 . . . . 10.0 111.329 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -37.43 83.34 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 118.635 -0.697 . . . . 10.0 110.863 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -64.56 -35.9 82.48 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.049 0.84 . . . . 10.0 110.962 176.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.97 -32.0 72.94 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.085 -0.959 . . . . 10.0 111.721 172.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -68.63 -57.99 4.92 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.079 0.854 . . . . 10.0 109.172 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 133.12 41.8 0.17 Allowed Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.43 1.49 . . . . 10.0 110.198 -169.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 95.7 m -142.87 171.69 13.71 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.679 1.592 . . . . 10.0 109.262 -172.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -140.23 164.07 31.04 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.043 1.737 . . . . 10.0 108.176 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 97.7 m -130.09 163.82 25.74 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.517 1.127 . . . . 10.0 112.299 -169.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -148.19 118.41 7.3 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 105.892 -1.892 . . . . 10.0 105.892 171.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.9 p -66.03 129.04 38.44 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 120.929 -1.107 . . . . 10.0 109.119 174.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 mt -93.13 -23.67 18.52 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 122.598 0.359 . . . . 10.0 110.461 172.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.3 -178.22 34.64 Favored Glycine 0 C--N 1.338 0.688 0 N-CA-C 109.388 -1.485 . . . . 10.0 109.388 177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.2 -177.74 22.78 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 118.233 1.017 . . . . 10.0 112.403 176.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -179.67 -159.35 23.45 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 108.7 -1.76 . . . . 10.0 108.7 -170.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.0 mtm105 -138.8 161.88 36.14 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.36 -1.082 . . . . 10.0 108.475 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 18.7 mt -136.22 146.42 29.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.66 -1.978 . . . . 10.0 105.66 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.1 t -151.64 174.16 13.8 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.023 0.929 . . . . 10.0 109.41 171.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -158.65 158.01 32.97 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.614 1.966 . . . . 10.0 107.462 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 47.81 45.82 18.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.01 1.324 . . . . 10.0 111.092 -176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.0 p -150.46 -93.63 0.06 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.923 0.889 . . . . 10.0 109.769 -169.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -67.11 -29.3 69.0 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.748 1.219 . . . . 10.0 110.208 172.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -152.44 164.35 37.71 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.679 1.991 . . . . 10.0 106.477 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -72.82 -60.79 2.06 Favored 'General case' 0 C--O 1.231 0.094 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.05 164.71 17.24 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 123.448 0.468 . . . . 10.0 110.576 176.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.6 mt -57.92 136.94 20.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -136.91 126.91 25.92 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 106.675 -1.602 . . . . 10.0 106.675 176.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 53.1 t -89.35 146.33 6.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 105.639 -1.985 . . . . 10.0 105.639 173.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -154.99 171.53 19.58 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.763 -1.21 . . . . 10.0 111.2 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.74 -160.5 54.07 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 121.535 0.519 . . . . 10.0 112.392 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -148.71 -177.41 5.77 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.625 1.57 . . . . 10.0 108.289 173.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.7 t -109.96 131.17 55.3 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 124.899 1.28 . . . . 10.0 107.865 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 64.3 mtt -72.58 -18.8 61.58 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 118.999 -0.524 . . . . 10.0 111.391 171.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.91 -35.8 72.44 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.909 0.777 . . . . 10.0 110.99 -177.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -132.97 -43.77 0.87 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.9 0.48 . . . . 10.0 112.103 -169.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.22 -178.36 18.84 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 109.013 -1.635 . . . . 10.0 109.013 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.01 136.65 62.3 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.307 2.005 . . . . 10.0 110.499 172.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.14 162.14 20.39 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 166.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -79.41 69.93 5.75 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.167 -1.79 . . . . 10.0 106.167 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -50.94 -31.0 16.36 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 125.467 1.507 . . . . 10.0 113.111 -168.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.7 -37.66 73.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.276 0.944 . . . . 10.0 112.326 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.73 -50.43 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 107.293 -1.373 . . . . 10.0 107.293 176.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -58.56 -45.78 88.25 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 118.553 -0.737 . . . . 10.0 111.792 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 17.9 p -63.79 -38.12 89.91 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 117.754 -1.117 . . . . 10.0 110.976 -176.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -65.13 -41.39 94.85 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 120.014 1.279 . . . . 10.0 111.227 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -65.11 -48.1 74.81 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 122.046 -0.409 . . . . 10.0 109.909 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 58.7 mt -61.38 -42.32 93.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -58.83 -37.88 77.41 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.328 1.051 . . . . 10.0 111.081 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.72 -39.76 89.79 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.687 0.676 . . . . 10.0 110.969 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -71.84 -44.38 63.94 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.746 0.703 . . . . 10.0 112.049 175.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.415 ' CD1' ' HD2' ' A' ' 114' ' ' PRO . 4.7 t80 -60.91 144.31 90.49 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.428 1.091 . . . . 10.0 110.088 -170.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HD2' ' CD1' ' A' ' 113' ' ' TYR . 93.8 Cg_endo -75.0 -1.8 11.7 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.751 2.301 . . . . 10.0 113.382 -173.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -139.93 153.91 47.07 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.028 1.331 . . . . 10.0 107.669 171.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -81.93 46.17 0.98 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.081 1.352 . . . . 10.0 111.474 -169.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -138.23 91.55 2.57 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.879 0.847 . . . . 10.0 110.878 -169.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 24.1 t -138.24 142.44 35.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.029 -2.211 . . . . 10.0 105.029 169.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 7.9 p -138.96 167.28 22.39 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.075 0.95 . . . . 10.0 109.928 -172.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -139.06 161.22 37.92 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 123.128 0.571 . . . . 10.0 110.882 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.72 163.21 38.01 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.588 1.555 . . . . 10.0 108.587 169.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -147.76 46.25 1.1 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.854 0.861 . . . . 10.0 109.617 176.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.66 -27.06 68.96 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.574 0.75 . . . . 10.0 112.621 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -174.68 179.95 45.67 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 126.472 1.986 . . . . 10.0 108.384 178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.5 t80 . . . . . 0 C--O 1.254 1.309 0 CA-C-O 116.573 -1.679 . . . . 10.0 109.36 176.418 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 118.854 -0.593 . . . . 10.0 110.302 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.27 165.33 36.06 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.495 1.518 . . . . 10.0 108.699 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 32.6 m -65.75 167.19 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 123.979 0.912 . . . . 10.0 110.609 172.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -65.87 169.39 6.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.008 0.523 . . . . 10.0 111.82 177.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -154.51 148.84 26.08 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.9 mt -58.13 -28.89 65.09 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.645 -0.659 . . . . 10.0 112.664 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.81 -26.47 68.35 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.93 0.786 . . . . 10.0 112.094 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 85.2 mt -78.23 -24.71 46.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.923 0.489 . . . . 10.0 110.897 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.99 122.18 86.21 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 106.804 -1.554 . . . . 10.0 106.804 176.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -50.28 133.16 35.84 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.106 2.537 . . . . 10.0 110.169 173.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -80.0 -29.25 39.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.677 0.751 . . . . 10.0 111.442 -172.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.3 t -137.74 135.9 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 127.176 2.19 . . . . 10.0 105.733 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -150.78 99.7 2.75 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.149 -1.426 . . . . 10.0 107.149 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.2 pt -131.38 36.59 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 125.055 1.342 . . . . 10.0 110.436 -168.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -66.56 81.74 0.1 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.471 1.508 . . . . 10.0 112.063 -176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.9 m -164.12 178.38 7.68 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.935 2.494 . . . . 10.0 108.332 174.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -147.98 158.51 44.09 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 124.602 1.161 . . . . 10.0 108.553 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.31 -162.64 51.32 Favored Glycine 0 CA--C 1.527 0.826 0 N-CA-C 109.587 -1.405 . . . . 10.0 109.587 -169.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.47 123.26 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 105.947 -1.871 . . . . 10.0 105.947 169.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -135.55 14.66 3.43 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.89 1.811 . . . . 10.0 115.89 -171.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.3 mttp 56.26 159.39 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.646 1.978 . . . . 10.0 112.89 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -160.52 158.19 28.78 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 120.493 -1.38 . . . . 10.0 109.481 169.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.1 p -138.01 148.8 24.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 124.735 1.214 . . . . 10.0 107.949 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.8 tp -109.73 118.88 37.7 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 105.574 -2.01 . . . . 10.0 105.574 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.0 mt -123.69 125.8 71.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 -169.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.6 tpp85 -76.97 131.72 38.64 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 168.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 p -119.88 135.22 60.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.864 -1.532 . . . . 10.0 106.864 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -114.65 150.67 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.448 1.899 . . . . 10.0 107.462 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.6 p -111.72 142.05 44.55 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.575 0.954 . . . . 10.0 113.575 -172.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.48 65.97 5.61 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 126.422 1.889 . . . . 10.0 106.594 168.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -41.48 133.27 3.5 Favored 'Trans proline' 0 C--N 1.35 0.613 1 C-N-CA 125.467 4.111 . . . . 10.0 114.201 -168.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.8 tpp180 50.3 23.88 1.34 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.39 1.476 . . . . 10.0 113.073 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.9 m 51.92 32.84 10.52 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.992 1.317 . . . . 10.0 111.871 -174.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.25 26.34 0.42 Allowed Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.455 -0.636 . . . . 10.0 112.827 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.77 131.27 9.93 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 107.949 -1.13 . . . . 10.0 107.949 172.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -86.54 32.99 0.44 Allowed 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 124.594 3.53 . . . . 10.0 112.747 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.01 83.81 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.623 0.769 . . . . 10.0 112.386 -168.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 49.11 28.46 2.12 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.543 1.937 . . . . 10.0 114.932 174.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -78.5 160.41 27.68 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 167.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 m -143.58 156.27 44.54 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.438 -0.789 . . . . 10.0 110.584 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.1 pttt -146.22 -175.47 4.78 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 124.989 1.316 . . . . 10.0 109.435 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -116.68 147.83 41.6 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.961 -1.126 . . . . 10.0 107.961 173.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.45 147.62 31.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.783 1.233 . . . . 10.0 110.111 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.0 t -107.66 125.91 64.05 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 106.79 -1.559 . . . . 10.0 106.79 -177.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -133.83 141.31 47.37 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 107.125 -1.435 . . . . 10.0 107.125 -173.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -171.48 124.86 1.14 Allowed Glycine 0 C--O 1.226 -0.382 0 CA-C-N 120.228 1.376 . . . . 10.0 111.52 173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -144.72 135.75 24.98 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 117.262 0.531 . . . . 10.0 110.938 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -66.0 -26.24 67.45 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 118.292 -0.861 . . . . 10.0 113.05 -170.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -63.55 -20.37 65.58 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 119.111 0.869 . . . . 10.0 112.715 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.98 120.64 14.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 119.212 0.915 . . . . 10.0 109.691 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.89 -34.24 77.35 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.01 0.524 . . . . 10.0 110.139 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -147.19 158.29 43.9 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 126.724 2.01 . . . . 10.0 107.196 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -58.53 -29.05 66.03 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.918 0.71 . . . . 10.0 112.918 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.67 -28.75 64.05 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 123.203 0.601 . . . . 10.0 112.545 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -74.18 -30.68 62.34 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.612 0.642 . . . . 10.0 110.973 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -65.76 -52.24 52.42 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 172.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -53.82 -43.27 69.27 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-O 118.629 -0.7 . . . . 10.0 111.16 177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.63 -44.44 93.86 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.728 0.695 . . . . 10.0 111.773 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -60.1 -51.55 69.13 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.141 -0.689 . . . . 10.0 109.141 176.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 81.4 t -68.96 -47.8 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 118.904 -0.57 . . . . 10.0 109.912 -170.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.8 p -60.59 -31.63 70.77 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.472 1.033 . . . . 10.0 111.527 177.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.34 -50.1 71.3 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.728 -0.949 . . . . 10.0 110.728 171.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.7 -44.52 93.41 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.668 0.734 . . . . 10.0 111.5 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -58.86 -40.01 83.04 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 118.685 0.675 . . . . 10.0 110.705 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -63.37 -35.66 81.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.16 0.891 . . . . 10.0 111.118 177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -65.67 -30.84 71.58 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 117.833 -1.079 . . . . 10.0 111.682 172.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -74.38 -38.12 63.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.797 1.181 . . . . 10.0 111.055 175.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 101.47 57.68 0.83 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 107.202 -2.359 . . . . 10.0 107.202 -168.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 65.0 m -146.07 169.14 19.29 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.262 1.825 . . . . 10.0 108.102 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -139.61 160.85 38.92 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.39 1.476 . . . . 10.0 108.635 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 96.0 m -131.19 155.09 47.65 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.496 1.118 . . . . 10.0 112.337 -168.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -149.86 118.86 6.69 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.884 1.674 . . . . 10.0 106.708 170.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.9 m -68.03 123.95 22.04 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.005 -1.059 . . . . 10.0 109.153 175.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.3 mt -81.08 -23.92 38.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.875 0.47 . . . . 10.0 110.726 174.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.98 176.72 36.92 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.204 -1.559 . . . . 10.0 109.204 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.05 178.5 23.72 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 118.223 1.011 . . . . 10.0 112.109 174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.23 -144.74 4.65 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 107.981 -2.048 . . . . 10.0 107.981 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.8 ptp85 -151.55 149.48 29.23 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 120.898 -1.354 . . . . 10.0 110.44 172.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 69.1 mt -108.56 148.04 12.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 105.121 -2.178 . . . . 10.0 105.121 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 t -151.65 -179.92 7.84 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.311 1.044 . . . . 10.0 109.121 171.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -114.17 116.56 29.27 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.408 1.483 . . . . 10.0 107.033 175.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -79.21 81.59 5.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.891 -1.522 . . . . 10.0 106.891 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 14.9 m -56.89 -28.66 62.17 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.465 0.706 . . . . 10.0 112.65 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -58.66 -19.96 43.91 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 113.585 0.957 . . . . 10.0 113.585 172.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -132.3 11.67 4.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.782 1.633 . . . . 10.0 110.912 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt 39.68 46.73 1.61 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.993 2.517 . . . . 10.0 113.709 -178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.2 pptp? -147.64 159.11 44.14 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 118.688 0.676 . . . . 10.0 111.619 177.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 38.5 pt -85.1 148.48 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.643 0.735 . . . . 10.0 110.735 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 54.5 t60 -149.13 163.36 37.81 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.105 0.962 . . . . 10.0 109.017 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -136.5 140.55 43.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 123.912 0.885 . . . . 10.0 108.66 -171.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -157.5 -175.34 5.34 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.962 0.905 . . . . 10.0 109.98 -178.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.63 -177.64 53.42 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 123.401 0.524 . . . . 10.0 113.012 171.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.31 -178.98 5.53 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 124.093 0.957 . . . . 10.0 110.184 169.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.8 m -133.52 107.43 8.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.212 -1.773 . . . . 10.0 106.212 174.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 77.2 mtm -59.74 -21.42 60.66 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.795 0.665 . . . . 10.0 112.795 -172.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.68 -26.36 67.05 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.802 0.841 . . . . 10.0 112.841 174.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -134.9 -50.68 0.77 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.489 0.716 . . . . 10.0 111.231 -169.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.08 175.32 13.79 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.198 1.856 . . . . 10.0 108.981 -174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -54.81 133.8 59.49 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.467 2.111 . . . . 10.0 110.271 169.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.08 156.07 29.41 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.526 1.155 . . . . 10.0 109.413 168.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -82.42 65.33 7.5 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.283 -1.747 . . . . 10.0 106.283 173.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 48.5 m80 -51.81 -24.66 6.36 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.374 1.87 . . . . 10.0 114.012 -168.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.88 -39.93 91.08 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 120.028 1.285 . . . . 10.0 111.392 175.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 62.3 mt -63.54 -50.91 76.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.6 m -61.51 -46.5 89.73 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.185 0.594 . . . . 10.0 111.874 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 9.5 p -65.37 -38.18 89.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 118.741 0.701 . . . . 10.0 110.966 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.02 -42.11 76.82 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.149 0.886 . . . . 10.0 110.985 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -59.96 -47.96 83.68 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 118.671 -0.681 . . . . 10.0 110.143 177.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.3 mt -56.93 -52.34 56.74 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 N-CA-C 108.112 -1.07 . . . . 10.0 108.112 175.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -56.2 -40.52 74.13 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 119.324 0.966 . . . . 10.0 111.25 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -68.43 -50.88 49.55 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.037 0.535 . . . . 10.0 111.82 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -86.94 -26.52 23.83 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 118.93 0.786 . . . . 10.0 112.749 -169.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -141.1 71.81 27.8 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.666 1.987 . . . . 10.0 107.165 -172.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -61.4 153.56 65.07 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.218 1.945 . . . . 10.0 111.142 -176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -149.97 179.89 7.69 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.878 1.671 . . . . 10.0 107.123 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -59.62 -39.4 84.15 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.192 0.905 . . . . 10.0 110.594 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -159.33 157.44 30.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.189 -1.412 . . . . 10.0 107.189 173.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.86 113.7 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 106.197 -1.779 . . . . 10.0 106.197 172.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 14.2 p -138.43 174.52 10.45 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.211 1.004 . . . . 10.0 109.421 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -142.76 159.7 41.74 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.251 0.62 . . . . 10.0 109.726 174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.21 162.67 36.28 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.433 1.493 . . . . 10.0 107.979 172.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.15 52.58 1.83 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.975 -0.75 . . . . 10.0 108.975 169.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -58.85 -25.7 63.5 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.36 1.064 . . . . 10.0 111.86 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.36 172.28 38.43 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 127.15 2.31 . . . . 10.0 107.388 169.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 117.862 -1.066 . . . . 10.0 108.865 172.083 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 118.371 -0.824 . . . . 10.0 109.955 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.08 168.86 26.21 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.369 1.868 . . . . 10.0 107.729 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.8 m -64.25 160.86 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.032 0.444 . . . . 10.0 110.487 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.34 177.64 10.65 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.347 1.859 . . . . 10.0 108.787 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -149.21 149.81 31.59 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.155 1.382 . . . . 10.0 107.872 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 75.5 mt -58.68 -25.51 62.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.364 1.066 . . . . 10.0 113.024 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.89 -24.23 65.81 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.64 0.655 . . . . 10.0 112.34 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.0 mt -75.47 -16.67 60.29 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.271 0.628 . . . . 10.0 111.494 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.5 mt -93.62 120.23 66.43 Favored Pre-proline 0 C--O 1.241 0.635 0 N-CA-C 107.0 -1.482 . . . . 10.0 107.0 -174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.35 136.24 39.46 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.497 2.798 . . . . 10.0 110.551 172.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -78.08 -28.16 48.72 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.392 0.615 . . . . 10.0 111.832 -171.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.2 t -139.22 135.11 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 104.262 -2.496 . . . . 10.0 104.262 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -153.39 119.93 5.58 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.608 -1.627 . . . . 10.0 106.608 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.9 pt -143.72 161.41 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.764 1.226 . . . . 10.0 109.171 -170.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -150.73 107.72 3.57 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.791 -1.559 . . . . 10.0 106.791 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.2 m -159.06 163.23 36.47 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.981 1.313 . . . . 10.0 109.536 -173.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -149.68 18.13 0.91 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 123.082 1.42 . . . . 10.0 110.708 -177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.42 -164.24 35.89 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 108.168 -1.973 . . . . 10.0 108.168 -171.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.6 t -62.45 120.47 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 117.922 0.861 . . . . 10.0 109.756 172.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -145.35 148.62 33.59 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.488 1.115 . . . . 10.0 109.265 169.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -63.65 150.9 43.18 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.017 0.927 . . . . 10.0 110.319 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.78 168.26 21.83 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 124.703 1.201 . . . . 10.0 109.037 178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.74 150.07 23.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.355 1.062 . . . . 10.0 108.661 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -114.16 121.92 45.25 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.375 -2.084 . . . . 10.0 105.375 177.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 62.5 mt -130.32 136.42 58.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 N-CA-C 107.202 -1.406 . . . . 10.0 107.202 -169.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -91.65 139.2 30.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.74 -1.578 . . . . 10.0 106.74 166.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.4 t -122.53 141.33 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.123 -1.806 . . . . 10.0 106.123 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -122.37 135.84 54.78 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.98 1.712 . . . . 10.0 107.217 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.2 m -63.12 135.17 57.03 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.008 -0.367 . . . . 10.0 110.008 174.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.41 52.7 1.0 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.348 1.459 . . . . 10.0 110.077 168.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -64.66 -13.07 36.87 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.188 3.258 . . . . 10.0 115.123 -167.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -139.52 13.72 2.55 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 120.719 -1.238 . . . . 10.0 110.755 174.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m 48.33 33.98 4.26 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.344 1.058 . . . . 10.0 112.018 -168.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.32 64.82 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 N-CA-C 108.132 -1.987 . . . . 10.0 108.132 -168.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.97 157.12 77.72 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 125.231 1.412 . . . . 10.0 108.964 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -75.92 39.53 0.66 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 124.309 3.339 . . . . 10.0 112.121 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.93 104.92 3.74 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.978 1.711 . . . . 10.0 107.014 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -140.81 28.92 1.92 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.488 1.515 . . . . 10.0 110.28 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.73 174.57 2.82 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.2 1.0 . . . . 10.0 109.911 173.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -152.39 159.71 43.38 Favored 'General case' 0 CA--C 1.529 0.156 0 O-C-N 120.193 -1.567 . . . . 10.0 110.423 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -149.63 168.52 23.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.647 1.179 . . . . 10.0 109.565 171.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -99.9 150.67 22.14 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.953 -0.758 . . . . 10.0 108.953 173.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.9 pt -138.9 156.04 27.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 125.795 1.638 . . . . 10.0 109.889 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.39 130.35 62.57 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -133.35 141.16 47.79 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.02 1.328 . . . . 10.0 107.952 177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.72 100.85 0.15 Allowed Glycine 0 C--O 1.227 -0.336 0 N-CA-C 110.029 -1.229 . . . . 10.0 110.029 -171.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -130.4 131.87 45.48 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 118.236 1.018 . . . . 10.0 110.371 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -59.56 -25.51 64.61 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.198 1.184 . . . . 10.0 114.198 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -68.32 -20.62 64.75 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.494 1.043 . . . . 10.0 112.279 177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.42 137.68 58.01 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.221 0.919 . . . . 10.0 111.428 -171.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.08 -40.95 87.11 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.679 -0.691 . . . . 10.0 109.231 170.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -155.92 170.67 21.57 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 126.125 1.77 . . . . 10.0 108.922 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -48.66 -36.31 15.73 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.977 1.311 . . . . 10.0 112.002 167.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.49 -28.02 66.66 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.948 0.721 . . . . 10.0 112.948 177.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -67.32 -41.94 84.45 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 122.18 0.991 . . . . 10.0 108.671 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.6 mt -62.0 -51.36 73.47 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 108.541 -0.911 . . . . 10.0 108.541 173.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -55.64 -43.49 76.25 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.679 -0.677 . . . . 10.0 111.598 -176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -62.58 -48.18 80.57 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.369 0.531 . . . . 10.0 111.726 178.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -60.54 -49.5 77.29 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.668 -0.645 . . . . 10.0 109.826 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.8 t -67.4 -42.65 87.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.609 -0.885 . . . . 10.0 108.609 -172.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.7 m -58.58 -36.38 73.88 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.558 1.072 . . . . 10.0 111.447 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.11 -47.09 91.33 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.803 -0.919 . . . . 10.0 110.803 172.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.09 -47.29 86.97 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 117.838 0.819 . . . . 10.0 111.459 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -36.72 82.01 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 118.338 -0.839 . . . . 10.0 110.74 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -64.35 -36.61 84.68 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.998 0.817 . . . . 10.0 111.004 175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.2 mtmt -67.96 -31.74 71.68 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 117.121 -1.419 . . . . 10.0 111.867 172.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.4 mm-40 -67.6 -56.79 8.03 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 119.294 0.952 . . . . 10.0 108.807 175.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.73 41.39 0.19 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.047 1.308 . . . . 10.0 110.528 -169.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 82.3 m -144.0 173.63 11.55 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.837 1.655 . . . . 10.0 109.325 -175.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -139.27 164.24 30.34 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.421 1.488 . . . . 10.0 108.205 173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 75.2 m -125.22 161.55 26.66 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.567 1.147 . . . . 10.0 112.382 -168.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -149.11 109.8 4.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.817 2.047 . . . . 10.0 105.755 176.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.2 p -61.45 136.85 58.18 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.031 -1.043 . . . . 10.0 109.627 172.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 57.9 mt -110.19 -12.2 14.5 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 123.425 0.69 . . . . 10.0 111.235 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.86 -178.51 29.94 Favored Glycine 0 CA--C 1.52 0.358 0 N-CA-C 110.2 -1.16 . . . . 10.0 110.2 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.05 -179.24 22.97 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.841 -0.904 . . . . 10.0 110.841 168.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.1 -153.48 9.89 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.492 -1.843 . . . . 10.0 108.492 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.0 mtm-85 -134.69 132.74 39.24 Favored 'General case' 0 CA--C 1.518 -0.287 0 C-N-CA 123.995 0.918 . . . . 10.0 108.61 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.2 mt -101.17 119.56 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 104.567 -2.382 . . . . 10.0 104.567 176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.8 m -84.23 83.95 7.79 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.266 -2.124 . . . . 10.0 105.266 167.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -64.61 163.75 13.14 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 122.085 -0.384 . . . . 10.0 110.786 -174.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -53.51 145.8 14.12 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.716 0.806 . . . . 10.0 109.354 169.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.4 p -149.61 -58.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.408 0.623 . . . . 10.0 110.911 -169.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -151.68 58.5 0.87 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.644 -1.243 . . . . 10.0 107.644 -173.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.6 t0 53.54 61.3 3.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.38 1.472 . . . . 10.0 111.652 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm -125.58 -5.76 7.0 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.101 1.36 . . . . 10.0 112.47 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . 0.332 0.0 OUTLIER 62.76 162.37 0.09 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 127.826 2.45 . . . . 10.0 112.934 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 71.8 mt -74.58 134.78 28.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.919 -1.141 . . . . 10.0 107.919 176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -133.51 159.59 39.96 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.163 -1.421 . . . . 10.0 107.163 169.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 t -140.38 140.69 34.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 O-C-N 120.749 -1.219 . . . . 10.0 107.939 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -156.32 -177.89 6.92 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.877 0.871 . . . . 10.0 110.908 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.61 -166.4 50.77 Favored Glycine 0 CA--C 1.521 0.454 0 N-CA-C 111.922 -0.471 . . . . 10.0 111.922 169.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -157.18 173.43 16.99 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.785 1.234 . . . . 10.0 108.972 174.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.6 m -128.39 104.06 7.5 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 107.592 -1.262 . . . . 10.0 107.592 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 66.8 mtt -57.24 -24.27 53.59 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.36 1.064 . . . . 10.0 113.565 -170.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.24 -29.94 70.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.6 -0.714 . . . . 10.0 112.427 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -129.17 -45.82 1.24 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 123.663 0.785 . . . . 10.0 110.716 -171.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.97 174.33 13.33 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.768 1.651 . . . . 10.0 109.595 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -56.36 124.36 16.06 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.337 2.024 . . . . 10.0 109.631 169.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.69 159.49 13.34 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.778 0.799 . . . . 10.0 109.178 168.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -84.83 72.04 10.8 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.953 -1.499 . . . . 10.0 106.953 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 61.6 m80 -52.37 -25.14 8.98 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.132 1.373 . . . . 10.0 114.133 -169.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.76 -41.76 99.36 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.96 1.255 . . . . 10.0 111.617 173.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 57.9 mt -63.75 -50.95 75.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 107.528 -1.286 . . . . 10.0 107.528 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -56.79 -48.47 77.85 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.29 0.636 . . . . 10.0 111.588 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.8 p -68.89 -37.25 78.88 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.01 -0.995 . . . . 10.0 111.688 -175.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -65.65 -39.79 91.79 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 119.499 1.045 . . . . 10.0 110.404 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -62.65 -48.7 78.17 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 119.16 -0.448 . . . . 10.0 110.103 175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 70.0 mt -57.79 -42.39 81.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-N 119.219 0.918 . . . . 10.0 108.584 175.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -64.03 -37.63 88.12 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-N 119.535 1.062 . . . . 10.0 111.22 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.46 -42.03 92.74 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.689 0.677 . . . . 10.0 111.067 173.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -62.16 -30.39 71.02 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.467 0.707 . . . . 10.0 111.073 173.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.8 t80 49.63 53.23 14.04 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 127.483 2.313 . . . . 10.0 113.426 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.24 -14.42 28.49 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.021 1.814 . . . . 10.0 112.295 174.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -149.62 164.92 33.82 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.198 1.799 . . . . 10.0 108.514 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -58.21 -34.82 70.81 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.433 1.493 . . . . 10.0 113.457 -175.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -151.94 155.72 38.63 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.892 0.769 . . . . 10.0 109.96 -172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 t -141.8 137.07 31.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 107.111 -1.441 . . . . 10.0 107.111 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.2 p -142.55 170.48 15.63 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.514 1.126 . . . . 10.0 109.832 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -147.84 166.67 26.9 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 118.236 0.471 . . . . 10.0 111.106 169.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.09 176.88 10.41 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 127.026 2.13 . . . . 10.0 107.563 169.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.26 37.68 0.7 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 120.862 -1.149 . . . . 10.0 111.919 175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.23 -26.57 64.98 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.392 1.077 . . . . 10.0 113.167 -176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -174.01 177.97 46.06 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.751 -0.939 . . . . 10.0 110.751 177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 60.7 t80 . . . . . 0 C--O 1.246 0.909 0 C-N-CA 124.01 0.924 . . . . 10.0 109.896 173.409 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 118.743 -0.646 . . . . 10.0 109.839 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.28 26.05 2.41 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.282 1.033 . . . . 10.0 112.269 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.9 m -69.94 173.99 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 125.12 1.368 . . . . 10.0 110.632 169.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.62 -178.05 6.04 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.934 1.694 . . . . 10.0 107.73 171.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -148.11 151.9 36.41 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.721 -1.214 . . . . 10.0 107.721 175.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -56.13 -30.16 61.73 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.618 0.767 . . . . 10.0 112.837 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.46 -28.45 69.67 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.704 0.683 . . . . 10.0 112.149 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.0 mt -77.41 -28.82 52.77 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 122.844 0.458 . . . . 10.0 110.621 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.3 mt -69.91 122.06 84.79 Favored Pre-proline 0 C--O 1.24 0.557 0 N-CA-C 107.519 -1.289 . . . . 10.0 107.519 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.2 135.79 38.22 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.315 2.677 . . . . 10.0 110.341 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -80.23 -29.54 38.46 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.529 0.681 . . . . 10.0 111.35 -173.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.6 t -137.8 136.77 45.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 104.707 -2.331 . . . . 10.0 104.707 172.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -152.03 122.68 7.4 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.247 -1.76 . . . . 10.0 106.247 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.5 pt -143.61 160.8 16.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 124.65 1.18 . . . . 10.0 109.393 -169.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -141.94 126.3 17.65 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.2 1.0 . . . . 10.0 108.372 171.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m -124.05 176.12 6.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.185 1.394 . . . . 10.0 111.381 -166.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -157.69 -36.71 0.07 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.479 1.512 . . . . 10.0 109.821 168.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.47 -48.18 0.03 OUTLIER Glycine 0 C--N 1.339 0.724 0 N-CA-C 109.896 -1.282 . . . . 10.0 109.896 173.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -128.37 142.68 43.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.047 2.139 . . . . 10.0 106.251 174.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -154.07 154.27 33.37 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.852 0.751 . . . . 10.0 110.66 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -86.96 151.22 23.48 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.508 1.123 . . . . 10.0 108.32 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -145.28 159.92 42.29 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 122.99 0.516 . . . . 10.0 110.479 178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.94 140.53 47.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 125.694 1.598 . . . . 10.0 107.746 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.5 tp -98.24 119.98 37.85 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 105.513 -2.032 . . . . 10.0 105.513 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 76.7 mt -124.08 132.99 70.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 106.52 -1.659 . . . . 10.0 106.52 -171.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -86.78 132.5 33.83 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 106.16 -1.793 . . . . 10.0 106.16 168.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -106.67 139.87 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 107.604 -1.258 . . . . 10.0 107.604 171.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -114.31 123.75 50.28 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.222 -2.14 . . . . 10.0 105.222 175.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.7 p -68.89 145.24 53.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 117.794 0.27 . . . . 10.0 110.49 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -159.35 67.81 3.09 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 126.206 1.802 . . . . 10.0 106.354 168.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -54.71 127.47 26.29 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.064 2.509 . . . . 10.0 110.872 -170.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 37.03 39.06 0.11 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.582 1.953 . . . . 10.0 113.407 -169.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.8 m 51.6 30.98 7.12 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.796 1.639 . . . . 10.0 113.696 177.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.2 -19.54 0.02 OUTLIER Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.242 -1.31 . . . . 10.0 116.26 -176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.94 149.83 95.99 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 120.277 2.039 . . . . 10.0 110.764 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.63 61.59 8.03 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 124.418 3.412 . . . . 10.0 111.657 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.49 139.11 35.06 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.854 1.262 . . . . 10.0 108.536 175.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.06 28.05 0.68 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.752 1.221 . . . . 10.0 110.98 -176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -67.98 164.51 19.83 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.421 -0.799 . . . . 10.0 109.232 171.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.6 m -139.61 159.22 42.67 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.899 0.88 . . . . 10.0 110.802 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -150.19 171.48 16.86 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.216 1.007 . . . . 10.0 109.907 169.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.29 150.23 21.77 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.345 -0.983 . . . . 10.0 108.345 172.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 34.3 pt -137.14 150.76 26.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 125.461 1.504 . . . . 10.0 109.559 173.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.5 t -107.09 126.15 63.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -132.92 134.97 45.26 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.29 117.45 0.65 Allowed Glycine 0 C--O 1.225 -0.462 0 CA-C-N 119.46 1.027 . . . . 10.0 110.866 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -138.38 132.03 30.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 -172.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -60.14 -18.16 45.57 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 114.67 1.359 . . . . 10.0 114.67 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.1 p-90 -67.1 -28.01 67.81 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 120.27 1.395 . . . . 10.0 112.139 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.71 153.93 30.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 119.712 1.142 . . . . 10.0 109.419 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.31 -6.91 2.61 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.553 0.741 . . . . 10.0 111.821 -178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -134.92 12.63 3.64 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 118.885 0.766 . . . . 10.0 112.767 -168.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 63.38 -46.57 0.23 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 128.285 2.634 . . . . 10.0 114.792 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.07 -30.17 67.86 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 124.024 0.929 . . . . 10.0 111.363 -178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.12 -32.74 74.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 117.938 0.335 . . . . 10.0 111.533 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.3 mt -67.91 -55.41 16.84 Favored 'Isoleucine or valine' 0 C--N 1.341 0.228 0 N-CA-C 107.326 -1.361 . . . . 10.0 107.326 174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -54.58 -39.42 67.78 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.256 0.622 . . . . 10.0 111.603 -177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -61.54 -50.75 71.41 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.304 1.041 . . . . 10.0 111.712 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -45.52 93.12 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 121.713 -0.617 . . . . 10.0 110.218 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 99.5 t -64.86 -46.04 93.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 108.507 -0.923 . . . . 10.0 108.507 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.8 m -59.1 -36.15 74.64 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.746 1.157 . . . . 10.0 111.377 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.62 -51.33 54.97 Favored Glycine 0 CA--C 1.529 0.951 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 174.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.24 -45.21 94.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.525 0.662 . . . . 10.0 111.349 -178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -34.67 78.87 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 118.136 -0.935 . . . . 10.0 110.719 -175.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -65.78 -37.38 86.17 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 119.613 1.097 . . . . 10.0 110.648 174.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -62.65 -37.17 85.31 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 117.681 -1.152 . . . . 10.0 110.919 171.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.0 mm-40 -66.78 -52.64 41.7 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.409 1.004 . . . . 10.0 109.646 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 121.04 51.12 0.25 Allowed Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.475 1.512 . . . . 10.0 109.403 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.3 m -143.68 167.71 21.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.814 1.646 . . . . 10.0 108.486 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -129.62 161.97 29.35 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 126.03 1.732 . . . . 10.0 107.141 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 81.2 m -125.34 160.04 30.31 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.669 1.187 . . . . 10.0 112.017 -168.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -148.83 115.38 5.92 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.866 -1.901 . . . . 10.0 105.866 170.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -66.83 115.11 6.24 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.904 -1.123 . . . . 10.0 108.466 172.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.7 mt -77.54 -29.26 52.23 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.821 -0.549 . . . . 10.0 110.355 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.76 -177.53 38.82 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 109.071 -1.611 . . . . 10.0 109.071 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.68 -178.18 29.63 Favored Glycine 0 CA--C 1.521 0.437 0 CA-C-N 118.259 1.029 . . . . 10.0 111.178 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.5 -158.37 17.59 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 109.531 -1.428 . . . . 10.0 109.531 -172.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.5 mtm180 -131.8 154.52 49.03 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.54 -0.976 . . . . 10.0 108.476 -177.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.9 mt -134.29 140.55 45.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 104.302 -2.481 . . . . 10.0 104.302 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.1 m -151.88 151.73 31.66 Favored 'General case' 0 C--N 1.329 -0.312 0 O-C-N 120.908 -1.12 . . . . 10.0 110.273 172.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 -77.92 123.28 26.58 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 106.057 -1.831 . . . . 10.0 106.057 168.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 50.73 54.13 11.75 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.188 0.995 . . . . 10.0 113.583 173.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.1 p -56.49 -54.44 45.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.496 0.665 . . . . 10.0 109.905 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -157.68 51.88 0.45 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.403 2.281 . . . . 10.0 105.291 171.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -150.4 166.45 30.05 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.88 1.272 . . . . 10.0 108.526 -167.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -80.35 -21.59 42.29 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.059 1.344 . . . . 10.0 111.51 171.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.92 -175.27 4.34 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.653 1.581 . . . . 10.0 109.775 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 35.2 pt -62.28 145.63 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 119.875 1.216 . . . . 10.0 110.848 177.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -140.2 147.87 40.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.368 -1.345 . . . . 10.0 107.368 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 58.5 t -117.84 134.77 60.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 107.415 -1.328 . . . . 10.0 107.415 -177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -159.27 -179.69 8.2 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.175 -0.953 . . . . 10.0 111.046 -168.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 72.8 -158.39 53.08 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 124.053 0.835 . . . . 10.0 112.981 170.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -150.72 167.82 26.23 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.594 1.158 . . . . 10.0 108.558 172.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.7 p -68.53 -28.67 67.19 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 113.409 0.892 . . . . 10.0 113.409 -174.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 43.6 ttm 53.93 29.53 10.13 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.206 0.603 . . . . 10.0 110.159 -167.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.29 -32.42 0.6 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.738 1.215 . . . . 10.0 111.876 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.38 -46.13 0.56 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.215 0.606 . . . . 10.0 110.205 177.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 158.41 177.16 31.24 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.111 1.815 . . . . 10.0 109.598 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.99 138.36 56.79 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.511 2.14 . . . . 10.0 110.458 172.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.71 160.97 24.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.574 -0.898 . . . . 10.0 108.574 166.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -81.31 75.54 8.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.682 -1.599 . . . . 10.0 106.682 169.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -54.48 -24.31 19.89 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.901 1.28 . . . . 10.0 113.528 -169.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.5 99.44 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.651 1.114 . . . . 10.0 111.705 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 52.1 mt -64.51 -52.07 59.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 106.988 -1.486 . . . . 10.0 106.988 177.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.8 m -57.46 -45.79 84.36 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 118.511 -0.757 . . . . 10.0 112.092 -178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 6.8 p -66.24 -37.82 86.41 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 117.722 -1.132 . . . . 10.0 111.721 -176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -64.45 -41.21 96.67 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 119.965 1.257 . . . . 10.0 110.6 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -63.89 -47.55 80.17 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.103 -0.373 . . . . 10.0 110.265 177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.31 -38.9 79.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.415 -0.957 . . . . 10.0 108.415 176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -62.32 -38.11 88.17 Favored 'General case' 0 C--O 1.223 -0.293 0 O-C-N 120.556 -1.34 . . . . 10.0 111.239 177.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.39 -31.02 71.91 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 118.713 0.688 . . . . 10.0 112.228 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.7 tptt -74.38 -21.93 59.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.327 1.051 . . . . 10.0 111.649 172.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.278 45.0 p90 43.76 48.09 3.85 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 128.318 2.647 . . . . 10.0 116.425 -177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.28 174.97 9.98 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.485 1.456 . . . . 10.0 109.724 167.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.7 t70 49.1 -120.91 1.46 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 117.501 -1.238 . . . . 10.0 110.331 177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -133.48 -35.48 1.01 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 120.346 1.43 . . . . 10.0 112.812 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -163.87 164.68 23.35 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 105.78 -1.933 . . . . 10.0 105.78 -173.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.61 135.05 39.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 119.343 0.974 . . . . 10.0 108.984 -174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 8.5 p -144.7 170.07 16.79 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.428 1.491 . . . . 10.0 109.041 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -143.98 168.89 18.91 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.175 0.59 . . . . 10.0 110.754 173.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.23 148.89 31.0 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.756 1.223 . . . . 10.0 108.998 173.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -84.17 57.63 4.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.635 1.174 . . . . 10.0 109.676 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -149.49 168.27 23.94 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.131 1.372 . . . . 10.0 109.275 -169.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.35 25.53 63.34 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.147 0.88 . . . . 10.0 113.279 174.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 C--O 1.247 0.967 0 C-N-CA 124.495 1.118 . . . . 10.0 109.459 178.226 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.2 mmt . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 119.381 -0.343 . . . . 10.0 110.236 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.36 172.31 12.86 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.754 1.222 . . . . 10.0 109.879 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -64.62 153.54 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.227 0.537 . . . . 10.0 109.966 169.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.45 179.36 9.2 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.906 2.082 . . . . 10.0 106.832 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -149.35 150.54 32.64 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.968 -1.123 . . . . 10.0 107.968 174.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.35 -26.42 60.95 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.372 1.069 . . . . 10.0 112.753 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.91 -25.51 67.62 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.876 0.762 . . . . 10.0 112.792 175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -74.2 -25.8 59.89 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.205 0.457 . . . . 10.0 111.042 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.96 130.68 69.23 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 106.467 -1.679 . . . . 10.0 106.467 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.19 146.14 68.94 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 121.989 1.792 . . . . 10.0 109.625 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -75.72 -30.06 59.12 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.605 0.762 . . . . 10.0 112.593 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.4 t -138.28 132.31 41.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 105.696 -1.964 . . . . 10.0 105.696 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -149.93 102.72 3.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 105.47 -2.048 . . . . 10.0 105.47 171.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.2 pt -136.62 158.83 37.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 124.672 1.189 . . . . 10.0 110.516 -168.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.46 173.97 6.31 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.18 0.992 . . . . 10.0 112.391 -176.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 m -142.65 27.04 1.71 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.556 1.542 . . . . 10.0 111.369 -169.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -131.81 45.65 2.75 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-O 122.394 1.092 . . . . 10.0 111.078 -172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.01 -132.85 11.49 Favored Glycine 0 C--N 1.342 0.903 0 O-C-N 120.081 -1.637 . . . . 10.0 110.595 173.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.25 140.12 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 O-C-N 121.924 -0.75 . . . . 10.0 109.202 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -154.4 148.69 26.02 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 124.437 1.095 . . . . 10.0 109.592 170.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -72.73 150.71 42.63 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.696 -0.854 . . . . 10.0 108.696 174.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.33 165.51 29.93 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.683 0.793 . . . . 10.0 109.561 -178.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.7 143.37 24.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.506 -1.294 . . . . 10.0 107.506 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 25.5 tp -99.8 126.43 45.89 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 105.49 -2.041 . . . . 10.0 105.49 170.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 98.2 mt -130.34 136.66 58.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -91.56 145.71 24.38 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.987 -1.486 . . . . 10.0 106.987 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.6 t -128.53 146.0 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.082 -1.821 . . . . 10.0 106.082 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 65.6 m-70 -127.25 132.27 50.41 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.295 -1.742 . . . . 10.0 106.295 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.1 p -71.59 147.43 47.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.827 0.74 . . . . 10.0 110.777 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.93 62.31 3.42 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 125.621 1.568 . . . . 10.0 107.797 168.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -58.86 145.33 97.14 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.215 2.61 . . . . 10.0 109.664 -172.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 51.66 19.34 0.87 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.291 1.036 . . . . 10.0 112.517 -176.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m 50.44 28.5 3.37 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.865 1.266 . . . . 10.0 113.332 -171.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -179.62 -0.69 0.02 OUTLIER Glycine 0 CA--C 1.532 1.1 0 N-CA-C 116.497 1.359 . . . . 10.0 116.497 -178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.72 152.28 75.99 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 119.879 1.839 . . . . 10.0 110.244 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -77.46 61.45 7.4 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 124.229 3.286 . . . . 10.0 111.751 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.24 141.74 33.98 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.105 1.362 . . . . 10.0 108.602 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.67 39.5 0.49 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.465 1.506 . . . . 10.0 109.168 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -70.76 175.14 5.21 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.713 0.805 . . . . 10.0 108.896 172.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.1 m -151.99 163.2 39.79 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 120.171 -1.58 . . . . 10.0 111.369 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -154.82 163.53 40.14 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 127.529 2.332 . . . . 10.0 107.416 -169.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -129.24 141.86 51.01 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 107.351 -1.351 . . . . 10.0 107.351 174.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.3 pt -138.19 154.9 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 124.599 1.16 . . . . 10.0 110.822 -169.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.6 t -107.97 125.45 64.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 106.657 -1.609 . . . . 10.0 106.657 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmp_? -132.22 142.99 49.63 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -176.27 131.59 1.91 Allowed Glycine 0 C--O 1.22 -0.761 0 CA-C-N 119.878 1.217 . . . . 10.0 111.349 171.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -142.35 138.56 31.31 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 124.174 0.573 . . . . 10.0 109.644 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -68.59 -23.58 64.49 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.672 0.789 . . . . 10.0 112.362 -171.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -66.18 -20.53 66.16 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 118.444 -0.789 . . . . 10.0 112.422 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.42 127.67 32.6 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 118.995 0.816 . . . . 10.0 110.75 -175.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -72.31 -35.73 68.72 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 121.489 0.661 . . . . 10.0 109.648 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -149.01 165.7 30.88 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 126.174 1.79 . . . . 10.0 108.55 -175.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -57.03 -38.75 73.63 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.988 0.423 . . . . 10.0 110.763 175.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.37 -24.63 67.47 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 123.925 0.89 . . . . 10.0 113.16 177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -66.96 -46.53 74.42 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 11.3 mt -62.46 -51.43 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -55.36 -41.32 72.39 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 118.615 -0.707 . . . . 10.0 111.628 -176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -64.7 -47.14 79.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.267 0.485 . . . . 10.0 111.86 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -58.59 -49.85 75.96 Favored 'General case' 0 C--N 1.348 0.512 0 N-CA-C 109.797 -0.446 . . . . 10.0 109.797 178.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.6 t -65.46 -45.29 93.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.459 -0.781 . . . . 10.0 109.181 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 m -57.58 -43.02 84.27 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.051 0.841 . . . . 10.0 110.821 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.79 -46.59 94.21 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.969 -0.853 . . . . 10.0 110.969 175.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -63.35 -48.55 77.51 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 118.226 1.013 . . . . 10.0 110.951 -177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -39.09 84.44 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.553 0.615 . . . . 10.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -63.11 -35.88 81.73 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.472 0.578 . . . . 10.0 110.833 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.22 -32.6 72.92 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 117.513 -1.232 . . . . 10.0 112.188 171.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 mm-40 -67.26 -53.08 33.19 Favored 'General case' 0 C--O 1.225 -0.236 0 CA-C-N 119.295 0.952 . . . . 10.0 109.327 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 128.1 44.26 0.22 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 125.274 1.416 . . . . 10.0 109.607 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.3 m -145.95 175.89 10.1 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.185 2.194 . . . . 10.0 107.755 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -144.81 164.6 30.55 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 123.528 0.731 . . . . 10.0 109.04 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 86.8 m -120.9 162.29 20.11 Favored 'General case' 0 C--O 1.222 -0.382 0 C-N-CA 124.599 1.16 . . . . 10.0 113.313 -168.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -147.57 112.49 5.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.32 2.248 . . . . 10.0 105.741 175.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 31.4 t -64.2 140.47 58.87 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.029 -1.045 . . . . 10.0 109.67 177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.9 mt -110.26 -9.67 14.65 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.17 0.988 . . . . 10.0 111.636 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.88 171.75 18.63 Favored Glycine 0 C--N 1.339 0.715 0 C-N-CA 124.434 1.016 . . . . 10.0 112.073 169.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -124.28 161.2 18.78 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.465 1.031 . . . . 10.0 110.828 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -174.85 -160.89 23.64 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 109.027 -1.629 . . . . 10.0 109.027 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -146.07 162.84 37.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 120.34 -1.682 . . . . 10.0 110.337 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -129.12 151.75 36.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 105.64 -1.985 . . . . 10.0 105.64 -177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 60.1 p -140.69 152.61 45.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.459 1.104 . . . . 10.0 109.292 175.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 28.8 p-80 -160.8 162.76 32.42 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.262 1.825 . . . . 10.0 107.698 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -149.35 162.26 40.42 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.707 2.003 . . . . 10.0 106.576 171.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.5 m -64.21 -28.37 69.7 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.397 0.888 . . . . 10.0 113.397 -174.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -145.98 163.1 36.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.197 1.399 . . . . 10.0 109.35 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.5 t70 49.91 34.65 8.16 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.908 1.683 . . . . 10.0 113.716 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -158.98 163.12 36.75 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 125.96 1.704 . . . . 10.0 107.184 -174.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 167.39 21.22 Favored 'General case' 0 C--O 1.252 1.209 0 C-N-CA 126.277 1.831 . . . . 10.0 107.197 170.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 80.1 mt -61.49 128.36 22.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.003 -1.48 . . . . 10.0 107.003 171.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -135.77 148.97 48.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.598 -0.89 . . . . 10.0 108.598 175.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.3 t -131.05 128.56 62.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 124.769 1.228 . . . . 10.0 107.916 -169.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -157.13 -164.97 1.71 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.564 0.746 . . . . 10.0 109.699 -172.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 75.39 -169.85 54.6 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 111.081 -0.807 . . . . 10.0 111.081 -173.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -161.29 -170.89 2.8 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 125.4 1.48 . . . . 10.0 107.572 169.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 48.3 t -135.04 135.54 41.38 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.719 -1.215 . . . . 10.0 107.719 172.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 79.2 mtm -77.26 -16.81 58.84 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 118.877 -0.583 . . . . 10.0 111.134 169.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.89 -26.07 63.07 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.717 0.69 . . . . 10.0 112.333 -175.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.43 -48.91 0.2 Allowed 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 123.177 0.591 . . . . 10.0 110.53 -179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 154.27 179.57 29.67 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.197 -1.561 . . . . 10.0 109.197 -176.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -61.66 150.11 87.0 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.395 2.063 . . . . 10.0 109.902 170.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -73.33 27.95 0.06 Allowed 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.232 1.413 . . . . 10.0 113.924 -178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 40.21 55.8 2.67 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 127.425 2.29 . . . . 10.0 109.57 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 17.9 m80 -43.99 -35.42 2.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.485 2.314 . . . . 10.0 114.603 -166.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -55.15 -37.12 66.57 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.368 0.986 . . . . 10.0 113.128 177.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.3 mt -63.66 -53.2 47.88 Favored 'Isoleucine or valine' 0 C--N 1.342 0.269 0 N-CA-C 107.247 -1.39 . . . . 10.0 107.247 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 6.6 m -61.71 -41.73 98.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.178 -0.915 . . . . 10.0 112.267 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 p -65.01 -39.61 93.68 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 119.725 1.148 . . . . 10.0 110.602 -176.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -63.77 -40.56 96.97 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 119.501 1.046 . . . . 10.0 110.937 176.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -62.98 -48.92 76.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.674 0.39 . . . . 10.0 110.59 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 76.8 mt -58.4 -45.75 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.259 -1.015 . . . . 10.0 108.259 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -62.41 -38.02 88.06 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 121.225 -0.922 . . . . 10.0 111.547 -177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.73 -34.29 75.55 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.202 0.601 . . . . 10.0 111.763 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -80.03 -20.02 46.31 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 117.718 -1.134 . . . . 10.0 112.433 173.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 33.4 p90 38.09 58.19 4.9 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 127.302 2.241 . . . . 10.0 114.597 -175.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -69.26 -13.78 36.52 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 121.951 1.767 . . . . 10.0 111.969 170.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -144.83 162.77 35.97 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 126.292 1.837 . . . . 10.0 107.555 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -69.62 -18.24 63.58 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.544 1.138 . . . . 10.0 113.324 -172.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -150.63 153.98 36.65 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.94 0.896 . . . . 10.0 108.911 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 t -143.71 135.15 22.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.299 0 N-CA-C 106.205 -1.776 . . . . 10.0 106.205 177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.4 p -142.18 170.17 16.22 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.257 1.023 . . . . 10.0 109.996 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.9 p-90 -143.7 166.19 25.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.279 0.562 . . . . 10.0 112.474 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.52 -178.46 6.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.787 2.835 . . . . 10.0 107.504 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -144.19 52.98 1.27 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 121.378 -0.826 . . . . 10.0 109.799 -175.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -149.92 159.49 44.34 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.867 1.267 . . . . 10.0 108.942 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 102.33 162.21 26.34 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.975 1.75 . . . . 10.0 110.975 -178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.6 t80 . . . . . 0 C--O 1.251 1.181 0 C-N-CA 125.314 1.446 . . . . 10.0 107.875 170.402 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tpt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 110.012 -0.366 . . . . 10.0 110.012 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.68 169.14 18.31 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.933 1.293 . . . . 10.0 109.506 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.5 m -71.22 165.52 2.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 123.636 0.775 . . . . 10.0 111.159 173.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -152.54 179.53 8.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 127.809 2.444 . . . . 10.0 106.5 169.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -152.41 151.53 30.92 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.85 -25.32 64.93 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.645 0.778 . . . . 10.0 112.859 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.89 -32.87 72.83 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.162 0.892 . . . . 10.0 111.63 174.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.59 -34.89 58.41 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.963 0.505 . . . . 10.0 110.032 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 50.5 mt -64.62 118.81 51.65 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.15 139.51 52.72 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.484 2.789 . . . . 10.0 111.36 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -83.72 -31.98 25.75 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.303 0.573 . . . . 10.0 111.915 -173.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.57 139.04 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 105.759 -1.941 . . . . 10.0 105.759 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -146.89 113.26 5.92 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 105.451 -2.055 . . . . 10.0 105.451 171.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.6 pt -135.85 174.24 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.513 1.125 . . . . 10.0 111.877 -168.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -137.56 49.96 1.97 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.751 1.22 . . . . 10.0 110.897 -167.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.3 m -61.76 16.58 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 127.784 2.434 . . . . 10.0 115.751 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -58.7 -24.85 62.17 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.618 1.567 . . . . 10.0 111.992 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.17 -157.4 14.8 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.76 -2.136 . . . . 10.0 107.76 177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t -59.24 141.83 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 169.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -145.27 151.34 38.21 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 123.208 0.603 . . . . 10.0 109.978 171.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -79.98 146.28 32.12 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.335 -1.357 . . . . 10.0 107.335 174.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.86 161.54 38.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 118.629 0.649 . . . . 10.0 110.962 -177.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -140.39 145.2 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.571 1.548 . . . . 10.0 107.574 -177.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.3 tp -104.97 123.68 48.21 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.197 -2.149 . . . . 10.0 105.197 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.13 129.47 65.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 -172.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -83.65 140.09 32.4 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.525 -1.657 . . . . 10.0 106.525 167.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.0 t -125.69 139.74 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 106.16 -1.793 . . . . 10.0 106.16 -177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -121.02 138.1 54.33 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.337 1.855 . . . . 10.0 106.623 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.3 p -97.03 138.42 34.59 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.247 0.546 . . . . 10.0 112.323 -170.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.37 68.11 7.72 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 125.155 1.382 . . . . 10.0 107.393 168.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -49.48 149.62 9.5 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.957 3.105 . . . . 10.0 111.917 -172.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 45.86 20.99 0.08 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.573 1.549 . . . . 10.0 114.632 -171.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 18.6 m 50.94 39.05 21.89 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.758 1.223 . . . . 10.0 111.878 -171.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -163.23 -28.87 0.02 OUTLIER Glycine 0 C--N 1.342 0.871 0 CA-C-O 118.977 -0.902 . . . . 10.0 114.72 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.24 131.2 93.48 Favored Pre-proline 0 CA--C 1.543 0.674 0 CA-C-N 119.572 1.686 . . . . 10.0 109.231 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -85.55 32.83 0.47 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.353 3.369 . . . . 10.0 112.88 -170.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.78 -49.25 78.36 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.637 0.775 . . . . 10.0 111.95 -169.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 48.82 26.74 1.37 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.82 2.048 . . . . 10.0 115.32 174.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -77.87 159.5 28.89 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 168.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.0 m -142.91 158.74 43.33 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.535 -0.728 . . . . 10.0 110.624 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -151.76 176.04 11.8 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.97 1.308 . . . . 10.0 109.356 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.6 mp0 -106.68 153.63 22.12 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.963 -0.755 . . . . 10.0 108.963 170.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.7 pt -137.75 151.81 26.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 125.338 1.455 . . . . 10.0 110.081 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.6 t -106.45 130.12 58.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 106.233 -1.765 . . . . 10.0 106.233 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -133.83 140.35 46.83 Favored 'General case' 0 CA--C 1.518 -0.251 0 N-CA-C 106.082 -1.821 . . . . 10.0 106.082 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.74 139.31 4.98 Favored Glycine 0 C--O 1.226 -0.404 0 CA-C-N 120.455 1.48 . . . . 10.0 113.019 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -149.25 144.85 26.77 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 123.809 0.843 . . . . 10.0 109.652 -175.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -72.58 -23.96 61.03 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 117.956 -1.021 . . . . 10.0 112.936 -172.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -68.03 -17.27 64.36 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.668 0.988 . . . . 10.0 113.668 -174.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.24 130.79 46.98 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 119.389 0.995 . . . . 10.0 110.103 -174.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -69.47 -37.5 77.32 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.925 -0.398 . . . . 10.0 109.925 176.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -149.53 160.38 43.53 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.098 2.159 . . . . 10.0 106.709 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 62.9 m80 -57.32 -33.13 67.39 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.902 0.881 . . . . 10.0 112.701 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.0 -25.54 65.35 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.384 0.674 . . . . 10.0 112.586 176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.08 -37.92 84.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 118.579 0.627 . . . . 10.0 110.36 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.7 mt -64.27 -50.85 74.72 Favored 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 107.748 -1.204 . . . . 10.0 107.748 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -55.73 -42.6 75.6 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 118.851 -0.595 . . . . 10.0 111.326 178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -63.09 -43.9 97.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.601 0.637 . . . . 10.0 111.989 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -61.3 -51.34 69.28 Favored 'General case' 0 C--N 1.344 0.35 0 O-C-N 121.63 -0.669 . . . . 10.0 109.434 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.3 t -66.17 -42.71 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 109.584 -0.525 . . . . 10.0 109.584 -170.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.4 p -66.45 -33.75 76.39 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.182 0.901 . . . . 10.0 111.472 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.3 -39.54 96.02 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 119.364 0.983 . . . . 10.0 111.034 173.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -69.11 -45.38 70.36 Favored 'General case' 0 C--O 1.223 -0.323 0 O-C-N 121.724 -0.868 . . . . 10.0 111.109 176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 27.2 mmt -61.13 -39.5 90.26 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 119.186 0.903 . . . . 10.0 110.597 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -60.55 -39.75 89.07 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 118.78 0.718 . . . . 10.0 110.903 175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 -20.48 59.81 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 117.874 -1.06 . . . . 10.0 112.887 175.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 68.0 mm-40 -72.95 -43.29 62.48 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.714 1.143 . . . . 10.0 110.423 169.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 112.71 49.71 0.58 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 109.217 -1.553 . . . . 10.0 109.217 -169.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.7 m -145.74 169.83 17.71 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.046 1.738 . . . . 10.0 108.206 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -136.24 161.51 35.54 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 125.637 1.575 . . . . 10.0 108.216 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 90.6 m -125.13 158.05 34.86 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.542 1.137 . . . . 10.0 112.693 -168.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -146.0 106.41 4.06 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.994 2.118 . . . . 10.0 105.597 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.8 p -61.46 131.51 50.41 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.281 -0.887 . . . . 10.0 109.192 174.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 41.1 mt -102.4 -21.77 14.21 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.008 0.523 . . . . 10.0 110.909 175.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.01 -178.48 32.52 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 109.937 -1.265 . . . . 10.0 109.937 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -154.94 -173.29 23.56 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 117.944 0.872 . . . . 10.0 111.215 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.23 -148.98 9.87 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 109.157 -1.577 . . . . 10.0 109.157 -171.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -139.46 160.44 39.83 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.765 1.226 . . . . 10.0 108.671 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.8 mt -136.58 149.17 26.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 106.333 -1.728 . . . . 10.0 106.333 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.3 p -135.41 164.72 27.13 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 125.333 1.453 . . . . 10.0 108.435 170.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -142.06 143.51 33.13 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 124.752 1.221 . . . . 10.0 107.943 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 52.01 35.9 17.28 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.504 1.522 . . . . 10.0 111.628 -172.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.4 m -68.75 -25.69 64.86 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.441 1.896 . . . . 10.0 113.119 -169.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -158.33 -33.76 0.07 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.175 1.39 . . . . 10.0 109.819 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -143.56 171.6 13.95 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 126.706 2.002 . . . . 10.0 106.315 174.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -66.38 73.03 0.08 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.011 1.724 . . . . 10.0 110.789 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -145.08 -172.74 3.92 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.725 1.61 . . . . 10.0 110.269 -175.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 98.0 mt -127.35 148.17 32.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 105.546 -2.02 . . . . 10.0 105.546 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -135.76 145.2 46.33 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 123.847 0.859 . . . . 10.0 108.912 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 61.3 t -133.81 130.49 55.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 107.326 -1.361 . . . . 10.0 107.326 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -158.66 179.49 9.06 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.346 -0.846 . . . . 10.0 111.714 -168.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.72 -159.01 34.22 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 123.762 0.696 . . . . 10.0 112.359 170.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -155.92 152.38 28.18 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.596 1.959 . . . . 10.0 106.494 173.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 p -69.82 152.15 44.9 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 119.017 0.826 . . . . 10.0 111.131 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 91.5 mtp -77.81 28.73 0.17 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.588 1.155 . . . . 10.0 110.161 169.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.36 -41.5 0.18 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.087 0.955 . . . . 10.0 112.585 -169.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -133.42 -51.28 0.87 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.314 0.961 . . . . 10.0 112.565 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.19 -177.67 23.47 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 110.806 -0.918 . . . . 10.0 110.806 -171.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.2 144.76 82.34 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.004 2.47 . . . . 10.0 110.725 179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.86 21.83 1.5 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -170.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 40.94 53.2 3.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.237 1.415 . . . . 10.0 110.065 -169.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 24.5 m80 -39.09 -30.91 0.06 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.95 2.9 . . . . 10.0 116.759 -166.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.65 60.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.814 1.188 . . . . 10.0 112.643 175.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 84.0 mt -60.77 -54.22 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.2 m -61.59 -41.29 97.22 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 117.915 -1.04 . . . . 10.0 111.867 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.7 p -64.69 -37.31 87.14 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 120.092 1.314 . . . . 10.0 111.431 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.2 -39.98 86.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.906 0.775 . . . . 10.0 110.729 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -64.8 -46.26 82.77 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 121.834 -0.541 . . . . 10.0 110.527 177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 67.0 mt -57.64 -47.16 86.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 175.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -58.42 -42.31 86.96 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.134 0.879 . . . . 10.0 111.239 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.81 -38.67 89.0 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.593 0.633 . . . . 10.0 111.559 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -89.66 -20.21 23.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.085 -0.96 . . . . 10.0 112.99 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -137.05 59.36 22.02 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 125.384 1.473 . . . . 10.0 109.933 -175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.83 -11.25 31.39 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.739 2.293 . . . . 10.0 113.29 -175.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -66.29 -12.04 54.12 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.334 1.053 . . . . 10.0 112.961 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -130.88 150.58 51.97 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 124.526 1.13 . . . . 10.0 109.515 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -70.38 157.93 36.89 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 169.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.8 t -136.35 139.35 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 176.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 23.6 p -138.0 167.31 22.04 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.456 1.102 . . . . 10.0 109.429 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 61.6 p-90 -145.01 165.3 28.57 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.13 0.419 . . . . 10.0 112.13 172.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.06 171.37 14.58 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.27 2.228 . . . . 10.0 108.286 172.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -144.21 37.94 1.27 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.183 0.993 . . . . 10.0 109.681 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -149.38 155.52 40.6 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.369 1.467 . . . . 10.0 108.768 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.97 171.84 38.28 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.443 1.02 . . . . 10.0 111.505 -173.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.244 0.815 0 C-N-CA 124.841 1.256 . . . . 10.0 108.542 176.235 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 tpt . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 119.021 -0.514 . . . . 10.0 109.84 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.85 157.69 43.23 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.899 1.28 . . . . 10.0 108.657 175.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.83 150.47 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 126.081 1.752 . . . . 10.0 108.149 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.03 170.87 15.14 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 109.671 -0.492 . . . . 10.0 109.671 169.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -151.79 149.64 29.25 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 172.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.01 -23.5 63.71 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.36 -29.29 69.43 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.139 0.882 . . . . 10.0 111.987 174.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.9 mt -75.37 -31.88 60.65 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.159 0.436 . . . . 10.0 110.408 -179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.0 mt -69.79 123.74 89.21 Favored Pre-proline 0 C--O 1.24 0.602 0 N-CA-C 107.629 -1.248 . . . . 10.0 107.629 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -49.13 135.05 30.51 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.639 2.893 . . . . 10.0 111.159 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -84.18 -28.47 27.33 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.299 0.571 . . . . 10.0 112.237 -171.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.5 p -150.19 134.69 9.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 C-N-CA 127.41 2.284 . . . . 10.0 104.895 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -156.2 98.77 1.89 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 106.208 -1.775 . . . . 10.0 106.208 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 10.5 pt -129.71 87.77 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 124.487 1.115 . . . . 10.0 109.633 -169.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -62.2 -26.11 68.17 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.311 -0.859 . . . . 10.0 110.236 166.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.8 m -68.05 60.95 0.08 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.659 1.584 . . . . 10.0 111.359 167.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -77.04 39.58 0.24 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.32 1.848 . . . . 10.0 110.751 175.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.36 -170.76 42.31 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 126.034 1.778 . . . . 10.0 109.129 -169.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.4 t -73.41 78.63 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 123.883 0.873 . . . . 10.0 110.036 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -139.32 19.57 2.58 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.505 1.122 . . . . 10.0 111.696 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.1 mttt 64.17 146.3 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 128.594 2.758 . . . . 10.0 113.093 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.47 157.05 43.7 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.749 1.22 . . . . 10.0 108.344 175.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.34 147.96 32.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 125.624 1.569 . . . . 10.0 108.161 -175.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.2 tp -109.46 120.2 41.77 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 105.666 -1.975 . . . . 10.0 105.666 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 67.8 mt -131.28 136.36 57.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 106.391 -1.707 . . . . 10.0 106.391 -168.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -88.45 143.8 26.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.799 -1.556 . . . . 10.0 106.799 168.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -126.78 141.64 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 106.565 -1.643 . . . . 10.0 106.565 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -124.83 129.53 50.6 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.352 1.861 . . . . 10.0 106.048 -174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.1 p -80.06 146.22 32.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.775 0.322 . . . . 10.0 111.201 -178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -155.72 62.15 3.08 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 126.38 1.872 . . . . 10.0 106.702 167.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -55.61 143.63 78.27 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.532 2.821 . . . . 10.0 111.078 -168.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.4 ttt85 47.69 25.38 0.68 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.947 1.299 . . . . 10.0 113.09 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.0 m 53.01 28.82 7.11 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.523 1.529 . . . . 10.0 113.632 -175.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.84 -1.8 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 N-CA-C 116.723 1.449 . . . . 10.0 116.723 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 152.13 82.44 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 120.168 1.984 . . . . 10.0 110.675 176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.85 59.14 6.76 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 124.291 3.327 . . . . 10.0 111.917 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.6 140.98 33.46 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.024 1.33 . . . . 10.0 108.516 175.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.06 29.77 0.72 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.176 1.391 . . . . 10.0 110.254 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -67.57 162.24 23.87 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.643 0.777 . . . . 10.0 108.918 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.6 m -140.2 160.29 40.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.026 0.93 . . . . 10.0 110.01 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -150.78 176.28 11.19 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.58 1.152 . . . . 10.0 109.627 170.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.4 mp0 -99.31 157.09 16.64 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.347 -0.982 . . . . 10.0 108.347 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.8 pt -141.72 149.35 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 126.387 1.875 . . . . 10.0 108.346 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.76 124.27 66.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 105.883 -1.895 . . . . 10.0 105.883 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -129.38 148.53 51.31 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 107.596 -1.261 . . . . 10.0 107.596 -175.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.32 124.08 0.97 Allowed Glycine 0 C--O 1.228 -0.255 0 N-CA-C 109.035 -1.626 . . . . 10.0 109.035 173.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -140.63 134.97 31.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 117.4 0.6 . . . . 10.0 110.501 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -74.69 -11.95 60.3 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 114.277 1.214 . . . . 10.0 114.277 -169.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 8.1 p-90 -66.11 -24.3 66.66 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 119.461 1.028 . . . . 10.0 111.575 173.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.33 163.19 28.38 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.85 0.75 . . . . 10.0 110.809 177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -119.18 -17.65 8.87 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.449 1.1 . . . . 10.0 110.367 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -146.95 152.49 38.74 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.421 1.488 . . . . 10.0 108.105 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 94' ' ' SER . 55.7 m80 -57.68 -31.85 66.76 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.399 1.079 . . . . 10.0 112.21 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.32 -33.2 72.05 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 118.187 -0.911 . . . . 10.0 112.607 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -72.0 -37.08 69.88 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.959 0.799 . . . . 10.0 110.437 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 72.4 mt -63.9 -52.23 59.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 N-CA-C 107.934 -1.135 . . . . 10.0 107.934 173.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -56.87 -43.19 80.96 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 119.09 -0.481 . . . . 10.0 111.494 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -63.32 -45.5 91.0 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.906 0.482 . . . . 10.0 111.181 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -60.92 -48.25 82.67 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 121.608 -0.682 . . . . 10.0 109.976 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.97 -43.89 98.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.659 0.783 . . . . 10.0 109.622 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.8 m -61.29 -43.88 98.14 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.046 0.839 . . . . 10.0 110.406 178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.78 -46.92 93.55 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.787 -0.925 . . . . 10.0 110.787 177.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.05 -44.8 95.92 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 117.741 0.77 . . . . 10.0 110.668 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.3 mmt -62.01 -37.18 83.91 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.923 -0.56 . . . . 10.0 111.101 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -63.65 -35.64 81.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.274 0.943 . . . . 10.0 110.816 175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.55 -31.97 72.42 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 117.924 -1.036 . . . . 10.0 111.597 171.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 64.5 mm-40 -69.63 -44.43 70.65 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.527 1.058 . . . . 10.0 110.039 177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 113.86 47.55 0.61 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 108.852 -1.699 . . . . 10.0 108.852 -169.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.5 m -146.66 169.64 18.59 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.321 1.848 . . . . 10.0 108.655 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -140.57 164.93 28.83 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.064 1.746 . . . . 10.0 108.138 176.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 78.5 m -126.17 164.89 19.95 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.199 1.0 . . . . 10.0 112.811 -168.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -149.3 113.08 5.09 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.317 2.247 . . . . 10.0 105.346 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.8 t -66.47 140.23 58.01 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.637 -1.29 . . . . 10.0 109.479 176.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 48.8 mt -108.22 -13.46 14.9 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.614 0.765 . . . . 10.0 111.228 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 144.06 -174.25 24.48 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.209 1.385 . . . . 10.0 110.573 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.06 -176.23 27.03 Favored Glycine 0 CA--C 1.524 0.647 0 O-C-N 121.44 -1.036 . . . . 10.0 111.495 174.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -172.29 -154.5 10.2 Favored Glycine 0 N--CA 1.448 -0.524 0 N-CA-C 109.131 -1.588 . . . . 10.0 109.131 -174.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.5 mtm180 -139.52 163.65 31.98 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.441 1.896 . . . . 10.0 107.905 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 21.7 mt -129.23 150.78 34.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 N-CA-C 106.495 -1.669 . . . . 10.0 106.495 -172.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.3 p -159.08 -169.66 2.74 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.257 1.423 . . . . 10.0 108.832 -174.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -132.66 151.93 51.82 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.087 -1.449 . . . . 10.0 107.087 169.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -144.32 164.17 31.56 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 124.166 0.986 . . . . 10.0 110.286 -175.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.0 m 64.94 166.53 0.17 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.855 2.062 . . . . 10.0 112.656 -177.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -62.14 -28.11 69.42 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.986 -0.446 . . . . 10.0 111.453 178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -71.69 -6.25 39.76 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.41 1.084 . . . . 10.0 112.278 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . 0.253 63.5 pttt 42.25 46.23 3.82 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.428 1.891 . . . . 10.0 112.294 -173.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.69 155.27 23.08 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.335 -0.617 . . . . 10.0 109.335 172.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 79.8 mt -69.47 144.76 13.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.582 -1.636 . . . . 10.0 106.582 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -137.44 157.01 47.49 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.526 0.731 . . . . 10.0 109.366 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.53 140.32 39.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -159.36 -174.95 4.94 Favored 'General case' 0 C--N 1.328 -0.329 0 O-C-N 120.761 -1.212 . . . . 10.0 110.06 -171.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.13 -166.07 52.49 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-O 121.835 0.686 . . . . 10.0 111.641 169.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -148.47 161.8 40.89 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.512 1.125 . . . . 10.0 108.403 175.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.408 ' HA ' ' CE1' ' A' ' 53' ' ' HIS . 30.1 t -83.17 126.33 32.5 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 169.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -64.63 -26.97 68.63 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.119 0.568 . . . . 10.0 110.702 169.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.53 -30.17 46.89 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.529 -0.748 . . . . 10.0 112.487 -178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -130.15 -58.91 1.06 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.802 0.728 . . . . 10.0 112.396 -169.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 149.14 176.28 22.28 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 108.902 -1.679 . . . . 10.0 108.902 -170.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -57.13 134.53 64.84 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.572 2.182 . . . . 10.0 110.566 171.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.65 163.44 18.94 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.924 -0.769 . . . . 10.0 108.924 166.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -79.79 69.29 6.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.08 -1.822 . . . . 10.0 106.08 167.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -50.78 -30.09 13.25 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.211 1.404 . . . . 10.0 113.518 -168.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -56.56 -37.69 70.89 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.289 0.95 . . . . 10.0 112.349 176.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.9 mt -64.32 -50.28 77.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.2 m -59.26 -46.5 88.35 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 121.61 -0.681 . . . . 10.0 111.96 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 24.9 p -63.94 -39.98 95.38 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.356 -0.83 . . . . 10.0 110.876 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.44 -40.17 92.94 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 119.307 0.958 . . . . 10.0 110.97 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp -66.68 -44.23 82.36 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 118.755 -0.64 . . . . 10.0 110.436 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 65.7 mt -56.15 -52.44 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.003 -1.11 . . . . 10.0 108.003 171.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 30.2 ttmt -59.55 -40.59 87.73 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.741 0.816 . . . . 10.0 111.54 -174.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.6 -41.08 98.76 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 123.704 0.802 . . . . 10.0 111.288 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -89.93 -19.05 24.99 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 118.233 -0.889 . . . . 10.0 112.923 -177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -130.96 57.75 34.05 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 124.797 1.239 . . . . 10.0 110.042 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.53 -11.07 30.9 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.108 2.539 . . . . 10.0 113.368 -173.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -63.18 -12.59 29.22 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.124 0.97 . . . . 10.0 112.33 172.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -126.46 144.18 50.94 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.594 1.158 . . . . 10.0 109.199 179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -78.03 153.33 32.42 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.276 -1.379 . . . . 10.0 107.276 168.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t -140.47 135.54 35.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 107.551 -1.277 . . . . 10.0 107.551 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.17 172.0 13.51 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.694 1.197 . . . . 10.0 109.163 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 44.0 p-90 -147.04 169.09 19.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.29 0.496 . . . . 10.0 111.179 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -144.92 148.93 34.42 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.266 1.026 . . . . 10.0 109.997 171.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -80.74 48.27 1.05 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.286 1.834 . . . . 10.0 110.406 173.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -139.99 166.39 24.77 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.741 1.216 . . . . 10.0 110.089 -169.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 66.42 28.85 73.98 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 124.959 1.266 . . . . 10.0 112.675 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 . . . . . 0 C--O 1.253 1.285 0 CA-C-O 115.641 -2.123 . . . . 10.0 109.028 178.315 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 tpt . . . . . 0 N--CA 1.48 1.033 0 CA-C-O 118.294 -0.86 . . . . 10.0 109.28 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.91 158.18 33.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.513 0.725 . . . . 10.0 112.227 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.31 161.79 4.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 123.692 0.797 . . . . 10.0 110.262 167.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.77 176.65 11.88 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.407 1.883 . . . . 10.0 106.549 173.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -150.21 152.93 35.38 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 107.45 -1.315 . . . . 10.0 107.45 172.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.65 -21.8 61.01 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 118.381 -0.818 . . . . 10.0 113.161 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.7 -23.29 64.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.413 1.006 . . . . 10.0 112.688 173.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.9 mt -77.54 -8.65 58.13 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.661 0.784 . . . . 10.0 111.995 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 91.9 mt -112.76 128.45 25.56 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 106.479 -1.674 . . . . 10.0 106.479 -172.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.72 151.43 74.62 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.382 2.055 . . . . 10.0 110.755 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -67.63 -38.16 83.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.05 1.34 . . . . 10.0 112.817 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -149.55 138.66 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 107.145 -1.428 . . . . 10.0 107.145 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -155.04 97.7 1.95 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.438 -1.319 . . . . 10.0 107.438 -176.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.1 pt -131.44 158.4 43.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.895 1.278 . . . . 10.0 108.211 -175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -140.25 24.01 2.33 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 123.339 1.542 . . . . 10.0 110.001 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.7 m -75.46 70.89 2.37 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.888 2.075 . . . . 10.0 112.528 -170.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -63.2 -12.73 30.44 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.704 1.201 . . . . 10.0 113.021 176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.23 -162.89 11.32 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.328 -1.909 . . . . 10.0 108.328 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.2 t -60.46 113.72 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.183 0.992 . . . . 10.0 108.748 174.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -145.42 146.16 31.42 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.711 -0.848 . . . . 10.0 108.711 172.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -61.84 157.65 17.72 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.367 0.667 . . . . 10.0 110.567 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -151.08 171.9 16.6 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.228 1.411 . . . . 10.0 108.242 169.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.4 152.61 29.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.707 1.203 . . . . 10.0 110.48 174.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 44.0 tp -102.95 117.68 35.14 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 105.086 -2.191 . . . . 10.0 105.086 167.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 81.9 mt -119.78 134.69 62.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 105.731 -1.952 . . . . 10.0 105.731 -171.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -85.79 135.14 33.85 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.381 -1.711 . . . . 10.0 106.381 167.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.8 p -120.88 142.3 37.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 78.3 m-70 -122.66 133.21 54.52 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.368 1.867 . . . . 10.0 106.083 -174.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.6 p -66.83 143.55 56.81 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.649 -0.5 . . . . 10.0 109.649 172.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.12 59.35 3.64 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.214 1.006 . . . . 10.0 108.781 168.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -59.18 138.52 85.5 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.871 2.381 . . . . 10.0 109.522 -173.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.0 ptt-85 45.26 21.19 0.06 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.958 1.703 . . . . 10.0 114.482 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 m 47.88 32.14 2.63 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.342 1.457 . . . . 10.0 113.125 -170.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.92 0.11 0.03 OUTLIER Glycine 0 CA--C 1.531 1.059 0 N-CA-C 115.929 1.131 . . . . 10.0 115.929 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.45 152.68 84.85 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 120.529 2.164 . . . . 10.0 110.509 171.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.69 52.63 3.75 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 124.123 3.215 . . . . 10.0 111.651 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.14 136.56 31.98 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.921 1.288 . . . . 10.0 108.333 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.15 30.56 0.7 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.244 1.418 . . . . 10.0 109.595 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -64.34 155.44 32.26 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.418 -0.956 . . . . 10.0 108.418 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -140.77 160.45 40.03 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.981 0.912 . . . . 10.0 110.702 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -149.78 172.64 14.79 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.177 0.991 . . . . 10.0 109.809 172.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.39 145.8 26.99 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.647 -1.242 . . . . 10.0 107.647 174.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 27.5 pt -135.74 148.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 125.585 1.554 . . . . 10.0 109.02 176.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 76.6 t -110.15 126.05 67.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.964 -1.495 . . . . 10.0 106.964 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -131.39 131.11 43.41 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 -174.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -159.04 55.01 0.36 Allowed Glycine 0 N--CA 1.464 0.527 0 CA-C-N 119.328 0.967 . . . . 10.0 111.398 -168.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -74.05 142.71 45.68 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.884 0.473 . . . . 10.0 111.15 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -63.53 -37.95 89.29 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 124.037 0.935 . . . . 10.0 112.551 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -66.33 -20.56 66.12 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 118.124 -0.941 . . . . 10.0 113.228 -172.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.37 134.38 51.37 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 118.768 0.713 . . . . 10.0 111.439 -174.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -72.78 -34.42 66.94 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.552 0.691 . . . . 10.0 110.11 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -151.27 165.47 33.9 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 125.173 1.389 . . . . 10.0 109.238 -175.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -48.88 -40.31 29.23 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 124.635 1.174 . . . . 10.0 112.516 169.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.78 -33.24 73.74 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 118.52 -0.753 . . . . 10.0 112.184 -179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -70.19 -38.03 75.27 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 122.099 0.952 . . . . 10.0 109.793 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.1 mt -63.22 -53.72 42.3 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 107.994 -1.113 . . . . 10.0 107.994 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -57.74 -45.24 86.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.323 -0.846 . . . . 10.0 111.504 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.04 -46.94 86.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 118.433 0.561 . . . . 10.0 111.538 177.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -63.22 -48.03 79.98 Favored 'General case' 0 C--N 1.342 0.274 0 O-C-N 121.604 -0.685 . . . . 10.0 109.756 -177.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.08 -44.97 97.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 118.437 -0.792 . . . . 10.0 109.227 -178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.4 m -57.64 -42.26 83.07 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.497 1.044 . . . . 10.0 110.928 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.21 -45.49 95.9 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.577 -0.609 . . . . 10.0 111.577 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -60.33 -50.57 73.11 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 121.399 -1.06 . . . . 10.0 110.81 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -38.87 84.18 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 118.894 -0.574 . . . . 10.0 111.056 -178.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -63.94 -34.14 77.29 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.108 0.413 . . . . 10.0 110.837 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -71.57 -28.45 63.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 117.453 -1.26 . . . . 10.0 112.527 171.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 59.7 mm-40 -69.34 -59.86 2.72 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 119.727 1.149 . . . . 10.0 108.523 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 135.06 44.01 0.11 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.979 1.752 . . . . 10.0 109.169 -168.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 93.0 m -147.09 176.35 10.01 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 127.441 2.296 . . . . 10.0 107.346 -178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -148.46 165.9 29.76 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.02 -1.05 . . . . 10.0 108.923 172.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 92.8 m -131.04 159.8 36.47 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.602 1.092 . . . . 10.0 112.763 -168.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -145.54 120.18 9.8 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 106.007 -1.849 . . . . 10.0 106.007 170.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 9.9 t -67.33 134.44 51.54 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 120.643 -1.285 . . . . 10.0 109.056 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 56.0 mt -91.64 -24.2 19.6 Favored 'General case' 0 C--O 1.226 -0.18 0 O-C-N 123.953 0.783 . . . . 10.0 110.646 171.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.92 164.78 21.01 Favored Glycine 0 C--N 1.337 0.587 0 O-C-N 121.216 -0.927 . . . . 10.0 111.233 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -125.61 163.15 19.69 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.263 -1.135 . . . . 10.0 110.263 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -169.29 -156.11 10.45 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.512 -1.835 . . . . 10.0 108.512 -171.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -139.35 153.59 47.72 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.059 1.744 . . . . 10.0 109.161 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.0 mm -119.98 145.89 25.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 104.327 -2.471 . . . . 10.0 104.327 168.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 37.4 m -153.51 149.95 28.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 168.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -79.7 -8.35 59.17 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.648 0.981 . . . . 10.0 113.648 -176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -157.64 154.92 29.18 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 128.678 2.791 . . . . 10.0 105.669 170.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.7 m -162.26 -94.84 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.989 1.316 . . . . 10.0 107.791 169.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.92 -13.07 60.01 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.403 0.681 . . . . 10.0 111.347 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -142.32 160.69 39.75 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 126.453 1.901 . . . . 10.0 106.066 169.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -79.6 46.73 0.78 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.27 1.028 . . . . 10.0 110.57 -176.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -148.35 167.02 26.33 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 124.12 0.968 . . . . 10.0 110.708 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 mm -53.56 127.88 12.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 107.343 -1.355 . . . . 10.0 107.343 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -140.37 141.81 35.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 107.911 -1.144 . . . . 10.0 107.911 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 48.0 t -131.72 122.77 50.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 106.832 -1.544 . . . . 10.0 106.832 -169.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -158.28 -164.25 1.45 Allowed 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.163 -0.961 . . . . 10.0 108.638 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.51 -173.27 45.66 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 118.65 0.659 . . . . 10.0 112.658 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 15.1 p90 -159.09 167.35 29.45 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.818 -1.178 . . . . 10.0 107.818 167.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.2 m -133.09 112.62 11.93 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 172.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.86 -24.56 6.36 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.68 1.992 . . . . 10.0 114.101 -176.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.35 -25.31 65.73 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.745 0.818 . . . . 10.0 112.868 177.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -149.35 -41.68 0.14 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.0 0.818 . . . . 10.0 112.882 -174.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 144.29 -175.77 23.89 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.459 1.028 . . . . 10.0 110.765 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.19 148.16 68.12 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.264 2.643 . . . . 10.0 110.397 170.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.87 34.5 0.15 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.077 1.351 . . . . 10.0 113.176 -178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 35.28 59.31 0.77 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.277 2.231 . . . . 10.0 112.156 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -51.4 -25.14 5.69 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.327 2.251 . . . . 10.0 115.561 -164.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.77 92.47 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.764 1.165 . . . . 10.0 111.663 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.87 -54.01 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 107.027 -1.471 . . . . 10.0 107.027 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.1 m -63.34 -41.21 98.85 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.156 0.582 . . . . 10.0 112.516 -173.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.7 p -61.53 -47.14 86.93 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-N 118.628 0.649 . . . . 10.0 110.419 179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -66.68 -36.74 83.25 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 118.22 0.464 . . . . 10.0 110.271 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -59.68 -50.79 72.47 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 118.847 -0.597 . . . . 10.0 110.794 174.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.6 mt -54.54 -53.57 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.096 -1.076 . . . . 10.0 108.096 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -60.86 -37.97 83.96 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.039 1.335 . . . . 10.0 112.234 -173.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -72.48 -50.38 26.43 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.15 0.58 . . . . 10.0 110.389 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -69.94 -34.22 73.16 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 118.625 -0.702 . . . . 10.0 111.444 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -128.05 101.3 22.82 Favored Pre-proline 0 CA--C 1.535 0.384 0 N-CA-C 106.867 -1.531 . . . . 10.0 106.867 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.17 128.4 22.69 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.615 1.543 . . . . 10.0 109.344 -177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -153.47 155.95 37.25 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.023 -1.473 . . . . 10.0 107.023 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -60.97 -39.71 90.63 Favored 'General case' 0 C--O 1.225 -0.203 0 C-N-CA 124.405 1.082 . . . . 10.0 111.869 -170.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -160.8 155.59 23.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.923 0.783 . . . . 10.0 109.985 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.39 122.79 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 104.032 -2.581 . . . . 10.0 104.032 168.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.1 p -111.94 167.15 10.61 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.832 0.853 . . . . 10.0 110.458 -170.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -145.43 166.75 24.74 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.487 0.921 . . . . 10.0 113.487 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.84 -175.42 4.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.979 2.512 . . . . 10.0 107.93 170.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -140.52 51.42 1.66 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.174 -0.953 . . . . 10.0 110.105 -176.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -146.89 155.22 42.14 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.52 1.528 . . . . 10.0 107.92 175.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.65 -150.22 19.23 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.056 -1.618 . . . . 10.0 109.056 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 3.3 t80 . . . . . 0 C--O 1.249 1.058 0 N-CA-C 107.14 -1.43 . . . . 10.0 107.14 169.379 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 118.879 -0.581 . . . . 10.0 110.901 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.31 -176.41 5.29 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.933 1.693 . . . . 10.0 107.278 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.9 m -67.98 143.94 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 108.25 -1.018 . . . . 10.0 108.25 166.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.78 174.28 15.54 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.899 1.279 . . . . 10.0 107.857 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -151.72 149.54 29.18 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 106.938 -1.504 . . . . 10.0 106.938 171.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -57.75 -27.91 63.45 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 123.778 0.831 . . . . 10.0 112.933 -176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.09 -25.96 68.01 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.773 0.715 . . . . 10.0 112.193 177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.3 mt -76.34 -23.23 54.22 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.221 0.608 . . . . 10.0 111.191 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.9 mt -83.94 122.08 76.01 Favored Pre-proline 0 C--O 1.242 0.663 0 N-CA-C 107.688 -1.227 . . . . 10.0 107.688 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.31 138.55 37.69 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.692 2.928 . . . . 10.0 110.909 174.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -85.25 -28.42 25.37 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.438 0.637 . . . . 10.0 112.104 -169.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.8 t -139.16 136.04 41.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 126.185 1.794 . . . . 10.0 106.193 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -149.5 98.79 2.82 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 107.463 -1.31 . . . . 10.0 107.463 171.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.8 pt -143.49 178.96 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.665 1.586 . . . . 10.0 109.996 -169.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -140.58 152.73 45.71 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 106.175 -1.787 . . . . 10.0 106.175 164.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.3 m -137.05 2.4 2.56 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.841 1.656 . . . . 10.0 111.608 -175.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -58.47 -19.06 33.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.15 0.976 . . . . 10.0 113.255 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -151.3 -174.36 22.08 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 107.242 -2.343 . . . . 10.0 107.242 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.2 t -63.72 125.51 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -139.68 139.99 36.76 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.901 -1.148 . . . . 10.0 107.901 175.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.8 mttp -67.23 155.82 37.86 Favored 'General case' 0 C--O 1.224 -0.273 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -146.02 165.41 29.11 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.697 0.761 . . . . 10.0 109.108 172.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.5 140.09 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.318 1.447 . . . . 10.0 107.436 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 tt -100.17 118.93 37.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.695 -2.335 . . . . 10.0 104.695 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 42.7 mt -123.29 135.97 61.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.845 -1.539 . . . . 10.0 106.845 -171.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -88.83 133.28 34.32 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.175 -1.787 . . . . 10.0 106.175 168.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 p -116.25 140.25 39.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 106.2 -1.778 . . . . 10.0 106.2 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -122.04 136.4 54.92 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.196 1.798 . . . . 10.0 106.997 -172.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 m -64.12 137.05 57.78 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.306 -0.628 . . . . 10.0 109.306 175.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.9 54.95 2.02 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.246 1.018 . . . . 10.0 108.957 166.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -62.85 131.49 33.25 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.895 2.397 . . . . 10.0 108.523 -169.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . 0.304 4.6 ppt_? 41.12 29.25 0.08 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.386 1.874 . . . . 10.0 114.251 -169.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m 46.09 37.87 4.26 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.758 1.623 . . . . 10.0 113.489 -173.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -175.99 -1.95 0.03 OUTLIER Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.34 1.296 . . . . 10.0 116.34 177.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.29 152.38 63.76 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 120.478 2.139 . . . . 10.0 110.55 174.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.23 49.5 2.85 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 124.092 3.195 . . . . 10.0 111.892 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.82 128.0 18.66 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.964 1.306 . . . . 10.0 108.038 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -142.57 26.61 1.75 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.134 1.374 . . . . 10.0 109.948 -178.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.86 160.05 21.29 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.6 0.76 . . . . 10.0 109.006 172.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -138.1 161.39 36.89 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.98 0.912 . . . . 10.0 110.797 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -144.59 173.13 12.08 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.221 1.008 . . . . 10.0 109.578 169.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -98.26 148.95 23.11 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 171.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 pt -137.24 154.17 30.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 125.736 1.615 . . . . 10.0 109.466 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.4 t -110.2 126.97 67.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 106.217 -1.772 . . . . 10.0 106.217 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -130.54 137.29 49.64 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -165.91 46.0 0.27 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 110.944 -0.862 . . . . 10.0 110.944 -169.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -66.16 136.61 56.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.064 0.546 . . . . 10.0 110.406 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -66.72 -27.96 68.05 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 113.667 0.988 . . . . 10.0 113.667 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 12.6 p-90 -68.3 -23.94 64.8 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 118.423 -0.798 . . . . 10.0 112.474 -177.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.19 134.28 47.93 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 118.871 0.76 . . . . 10.0 110.778 -175.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -71.25 -35.37 71.4 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.366 0.666 . . . . 10.0 110.559 171.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -147.29 157.45 43.59 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.632 1.573 . . . . 10.0 109.084 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.88 -25.67 57.22 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.282 1.033 . . . . 10.0 112.387 172.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.77 -40.24 79.31 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.011 0.823 . . . . 10.0 112.03 169.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -71.54 -33.28 69.02 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.383 0.611 . . . . 10.0 110.125 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 65.0 mt -64.0 -55.75 20.41 Favored 'Isoleucine or valine' 0 C--N 1.343 0.303 0 N-CA-C 108.35 -0.982 . . . . 10.0 108.35 173.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -54.99 -42.16 72.11 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 118.956 -0.545 . . . . 10.0 111.305 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -58.93 -48.7 80.55 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.478 0.711 . . . . 10.0 111.261 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 -44.89 72.07 Favored 'General case' 0 N--CA 1.463 0.196 0 O-C-N 121.486 -0.759 . . . . 10.0 110.29 -175.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.81 -46.06 95.42 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.428 0 C-N-CA 123.89 0.876 . . . . 10.0 109.172 -177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.0 m -58.4 -40.47 82.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.09 0.859 . . . . 10.0 111.242 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.09 -50.77 64.02 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.995 -0.842 . . . . 10.0 110.995 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -60.66 -47.91 84.15 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.073 0.937 . . . . 10.0 111.071 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -39.39 85.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 121.724 -0.61 . . . . 10.0 110.459 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -68.14 -33.37 74.36 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 118.829 0.741 . . . . 10.0 110.757 178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.87 -39.7 94.83 Favored 'General case' 0 C--N 1.342 0.258 0 CA-C-O 116.575 -1.678 . . . . 10.0 111.029 169.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -67.7 -60.15 2.77 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 119.281 0.946 . . . . 10.0 108.788 -178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.08 44.28 0.08 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.283 1.42 . . . . 10.0 110.447 -169.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 62.4 m -148.69 177.59 9.37 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.055 2.142 . . . . 10.0 108.052 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -148.21 165.99 29.27 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.503 1.121 . . . . 10.0 109.004 172.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 56.5 m -134.5 160.1 39.08 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 119.842 1.201 . . . . 10.0 113.375 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -152.17 139.32 19.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.512 1.925 . . . . 10.0 106.902 169.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 78.3 m -75.67 140.82 42.75 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.352 -0.843 . . . . 10.0 110.415 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 38.7 mt -96.24 -22.99 16.91 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.921 -0.487 . . . . 10.0 110.802 168.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 163.16 -173.59 39.35 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.979 -1.248 . . . . 10.0 109.979 178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -155.05 -172.16 22.47 Favored Glycine 0 CA--C 1.525 0.661 0 CA-C-N 118.846 1.323 . . . . 10.0 111.911 172.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 179.65 -150.85 9.58 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 109.375 -1.49 . . . . 10.0 109.375 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 90.4 mtm-85 -137.3 160.76 38.11 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.966 1.306 . . . . 10.0 109.117 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.5 mt -132.6 150.18 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 -178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.6 m -155.19 144.5 21.08 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.608 1.163 . . . . 10.0 109.441 171.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -78.37 137.99 38.3 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 168.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -65.01 145.77 55.9 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.582 -0.699 . . . . 10.0 109.925 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.8 p -69.9 -22.12 63.25 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -170.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -143.81 22.23 1.78 Allowed 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.851 0.86 . . . . 10.0 111.28 -170.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -150.34 151.83 33.49 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.362 -0.977 . . . . 10.0 108.362 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -56.46 -28.91 60.95 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 117.819 -1.086 . . . . 10.0 113.211 177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.8 164.42 6.31 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 122.57 1.176 . . . . 10.0 113.468 -168.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 46.9 mm -115.72 155.04 17.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 125.738 1.615 . . . . 10.0 106.719 173.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -137.23 156.22 48.56 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 120.147 -1.596 . . . . 10.0 109.247 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.38 131.87 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.067 -1.457 . . . . 10.0 107.067 -174.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.59 176.72 12.26 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.159 -0.963 . . . . 10.0 112.136 -169.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.71 -159.47 53.03 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.217 -0.753 . . . . 10.0 111.217 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -157.39 157.06 33.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.123 1.369 . . . . 10.0 108.829 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.8 t -73.79 127.98 34.28 Favored 'General case' 0 C--O 1.225 -0.229 0 O-C-N 121.003 -1.061 . . . . 10.0 108.236 170.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 96.7 mtp -75.44 -18.19 59.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 118.763 -0.637 . . . . 10.0 111.215 169.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.56 -32.01 53.53 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 118.429 0.559 . . . . 10.0 111.688 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -127.37 -49.29 1.42 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.685 0.394 . . . . 10.0 111.264 -171.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.47 177.59 15.76 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 109.391 -1.484 . . . . 10.0 109.391 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -53.27 131.15 41.82 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.943 2.429 . . . . 10.0 110.573 169.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.05 162.58 16.49 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 121.82 0.819 . . . . 10.0 109.113 166.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -79.17 68.15 5.07 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.598 -1.63 . . . . 10.0 106.598 167.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -49.81 -32.34 13.86 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 125.316 1.446 . . . . 10.0 113.321 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.65 -36.89 74.84 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 119.433 1.015 . . . . 10.0 112.563 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 46.5 mt -66.62 -49.23 76.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 4.0 m -58.13 -44.21 87.68 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 117.858 -1.068 . . . . 10.0 111.99 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.9 p -64.79 -38.06 89.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 120.235 1.38 . . . . 10.0 111.273 -177.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.66 -40.31 88.59 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.58 1.082 . . . . 10.0 110.672 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -65.53 -45.72 82.37 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.793 -0.567 . . . . 10.0 110.337 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.3 mt -59.66 -43.12 90.56 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.357 0 CA-C-O 118.017 -0.992 . . . . 10.0 109.213 175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -57.95 -41.76 83.52 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-N 119.024 0.829 . . . . 10.0 110.669 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.69 -44.01 87.49 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.394 0.543 . . . . 10.0 111.03 176.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -69.46 -53.86 17.13 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.671 -0.643 . . . . 10.0 111.365 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -69.78 148.97 96.7 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 124.527 1.131 . . . . 10.0 110.737 -168.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -59.43 -40.46 66.96 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.377 2.052 . . . . 10.0 113.818 177.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.16 151.61 23.99 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.144 -0.317 . . . . 10.0 110.144 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -111.31 18.09 19.58 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.631 0.772 . . . . 10.0 113.072 -168.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -111.43 121.34 44.94 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 123.252 1.501 . . . . 10.0 109.093 171.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.6 t -137.99 141.77 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.444 -2.058 . . . . 10.0 105.444 170.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.3 p -133.22 173.43 11.46 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 118.61 0.641 . . . . 10.0 109.622 171.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 59.7 p-90 -144.89 165.34 28.41 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.508 0.323 . . . . 10.0 111.039 174.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.76 163.17 37.55 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.215 1.806 . . . . 10.0 108.38 171.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -149.3 34.64 0.72 Allowed 'General case' 0 C--O 1.22 -0.485 0 C-N-CA 124.054 0.942 . . . . 10.0 109.199 178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.61 -27.26 68.53 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.079 0.951 . . . . 10.0 112.853 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.22 -177.69 44.49 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 108.897 -1.681 . . . . 10.0 108.897 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.6 t80 . . . . . 0 C--O 1.245 0.829 0 CA-C-O 118.082 -0.961 . . . . 10.0 109.293 171.836 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 tpp . . . . . 0 N--CA 1.483 1.178 0 CA-C-O 118.217 -0.897 . . . . 10.0 109.741 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.67 166.41 25.91 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.968 0.907 . . . . 10.0 111.122 -175.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -143.36 161.77 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 128.673 2.789 . . . . 10.0 106.709 174.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.67 -179.23 7.61 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.174 1.39 . . . . 10.0 108.999 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -149.31 151.16 33.69 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.869 -1.16 . . . . 10.0 107.869 175.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.51 -25.42 62.38 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.399 -0.81 . . . . 10.0 113.07 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.03 -31.93 71.94 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.992 0.814 . . . . 10.0 112.034 174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 86.1 mt -77.06 -35.01 57.06 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.049 0.539 . . . . 10.0 110.118 -178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.9 mt -65.61 119.77 62.96 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.271 1.028 . . . . 10.0 108.576 -176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.7 133.4 38.71 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 123.748 2.966 . . . . 10.0 111.167 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -84.69 -30.17 25.01 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.444 0.64 . . . . 10.0 111.929 -170.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.6 t -136.57 136.26 48.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 126.266 1.827 . . . . 10.0 106.07 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -149.48 101.54 3.11 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.205 -1.406 . . . . 10.0 107.205 170.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 35.2 pt -137.13 158.5 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.495 1.518 . . . . 10.0 108.096 -174.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -145.71 35.62 1.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 122.378 1.085 . . . . 10.0 109.83 173.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 m -75.17 51.2 0.52 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 127.527 2.331 . . . . 10.0 113.229 -169.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.23 40.64 0.16 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.318 1.847 . . . . 10.0 111.432 176.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.24 177.02 39.11 Favored Glycine 0 CA--C 1.525 0.699 0 C-N-CA 128.125 2.774 . . . . 10.0 106.975 -174.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.99 113.59 2.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 118.878 1.339 . . . . 10.0 107.691 172.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -142.53 138.01 30.59 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.668 0.787 . . . . 10.0 108.972 176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -59.79 155.03 16.96 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 123.894 0.878 . . . . 10.0 109.733 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.12 166.47 27.75 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.173 0.989 . . . . 10.0 108.457 174.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.5 p -140.15 148.02 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.012 0.925 . . . . 10.0 108.599 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.9 tp -109.04 114.15 27.64 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 105.589 -2.004 . . . . 10.0 105.589 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.4 mt -119.18 133.92 64.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.045 -1.465 . . . . 10.0 107.045 -168.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -88.5 135.05 33.67 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.726 -1.583 . . . . 10.0 106.726 168.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -108.93 133.62 53.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 105.537 -2.023 . . . . 10.0 105.537 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -111.69 128.33 56.04 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.009 -1.848 . . . . 10.0 106.009 174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 p -78.66 146.12 34.21 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.009 0.433 . . . . 10.0 111.111 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.86 67.74 3.78 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 126.45 1.9 . . . . 10.0 106.448 167.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_exo -47.14 -39.55 26.3 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 124.52 3.48 . . . . 10.0 114.2 -168.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.57 168.8 18.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.79 -1.559 . . . . 10.0 106.79 174.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m -54.43 -21.48 9.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.419 1.888 . . . . 10.0 114.562 -170.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -144.41 32.12 1.77 Allowed Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.59 1.09 . . . . 10.0 111.699 171.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.91 146.23 95.53 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-N 118.145 0.972 . . . . 10.0 110.766 178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -81.64 44.49 1.74 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 124.323 3.348 . . . . 10.0 112.391 -175.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.05 138.65 28.47 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.308 1.043 . . . . 10.0 109.572 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -151.55 27.98 0.64 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.515 1.526 . . . . 10.0 110.358 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.07 164.47 20.13 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.857 0.863 . . . . 10.0 109.527 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.8 m -139.54 160.17 40.47 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.909 0.884 . . . . 10.0 110.787 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -149.28 176.07 10.86 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.805 1.242 . . . . 10.0 109.506 170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.6 mp0 -102.97 154.18 19.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.81 -0.811 . . . . 10.0 108.81 169.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 49.2 pt -134.04 154.11 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 125.456 1.502 . . . . 10.0 109.583 170.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.9 t -107.42 127.87 62.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 106.284 -1.747 . . . . 10.0 106.284 177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -131.16 134.97 47.03 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 107.863 -1.162 . . . . 10.0 107.863 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -163.18 49.59 0.31 Allowed Glycine 0 N--CA 1.46 0.258 0 N-CA-C 110.601 -1.0 . . . . 10.0 110.601 -170.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -69.33 132.5 46.51 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.465 -0.569 . . . . 10.0 109.465 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -65.45 -26.57 68.01 Favored 'General case' 0 C--O 1.221 -0.417 0 N-CA-C 113.483 0.92 . . . . 10.0 113.483 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -67.6 -22.83 65.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 118.46 -0.781 . . . . 10.0 112.774 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.7 128.89 38.02 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.975 0.807 . . . . 10.0 110.462 -174.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -74.58 -24.75 58.96 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.288 0.566 . . . . 10.0 110.412 173.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -147.13 152.64 38.8 Favored 'General case' 0 C--O 1.223 -0.299 0 O-C-N 120.521 -1.362 . . . . 10.0 109.613 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -53.8 -37.39 63.45 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.133 0.973 . . . . 10.0 111.137 168.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.2 -31.26 71.76 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 118.523 -0.751 . . . . 10.0 112.58 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -69.31 -39.04 78.51 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 122.149 0.976 . . . . 10.0 109.602 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 59.5 mt -62.74 -53.37 47.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 N-CA-C 108.376 -0.972 . . . . 10.0 108.376 173.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -54.82 -46.42 74.55 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-O 118.727 -0.654 . . . . 10.0 111.135 -177.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -61.32 -47.26 86.77 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.302 0.376 . . . . 10.0 111.407 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -65.89 -47.26 75.44 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 121.745 -0.597 . . . . 10.0 109.796 -177.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.9 t -66.84 -39.26 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 118.193 -0.908 . . . . 10.0 110.131 -175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 39.3 m -59.77 -44.65 93.78 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.684 1.129 . . . . 10.0 110.678 174.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.92 -46.57 93.9 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.884 -0.887 . . . . 10.0 110.884 176.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -62.04 -48.24 81.16 Favored 'General case' 0 C--O 1.228 -0.066 0 CA-C-N 117.696 0.748 . . . . 10.0 110.851 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.0 mmt -60.08 -38.7 83.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.227 0.611 . . . . 10.0 111.18 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -63.68 -34.62 78.27 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.645 0.657 . . . . 10.0 110.601 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -70.0 -33.04 71.52 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 117.78 -1.105 . . . . 10.0 112.033 170.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 61.9 mm-40 -66.82 -53.18 35.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 119.444 1.02 . . . . 10.0 109.491 178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 130.35 43.17 0.2 Allowed Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.34 1.448 . . . . 10.0 110.177 -169.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.5 m -148.28 175.08 11.37 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.159 1.783 . . . . 10.0 108.461 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -145.27 166.16 26.31 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.265 1.026 . . . . 10.0 108.568 170.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.5 m -133.71 155.79 49.1 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 113.797 1.036 . . . . 10.0 113.797 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -147.54 142.59 27.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.552 1.941 . . . . 10.0 106.286 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 87.7 m -83.36 136.48 34.33 Favored 'General case' 0 C--N 1.331 -0.217 0 O-C-N 121.263 -0.898 . . . . 10.0 110.366 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.9 mt -87.66 -25.17 23.65 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.329 -0.396 . . . . 10.0 110.377 169.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.09 -178.7 41.68 Favored Glycine 0 C--N 1.339 0.7 0 N-CA-C 109.929 -1.269 . . . . 10.0 109.929 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -146.93 -177.91 21.86 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 118.038 0.919 . . . . 10.0 111.928 170.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.87 -147.91 5.92 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 108.851 -1.7 . . . . 10.0 108.851 -176.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.64 155.22 44.18 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.471 1.508 . . . . 10.0 107.906 170.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.0 mt -117.1 155.91 18.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 104.517 -2.401 . . . . 10.0 104.517 178.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 24.6 m -147.81 144.73 28.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 121.023 -1.048 . . . . 10.0 108.377 173.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -161.99 151.73 16.41 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.495 1.518 . . . . 10.0 107.281 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -151.42 102.42 2.9 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 104.1 -2.556 . . . . 10.0 104.1 169.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.0 m -57.3 -25.83 59.91 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.044 0.938 . . . . 10.0 113.037 -169.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -77.61 -7.68 56.73 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.398 1.479 . . . . 10.0 112.56 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -143.08 -39.57 0.33 Allowed 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.76 1.392 . . . . 10.0 114.76 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -150.8 147.93 27.89 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.291 -1.506 . . . . 10.0 112.637 -171.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 169.06 2.32 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.142 0.977 . . . . 10.0 110.942 168.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 78.8 mt -66.85 141.56 17.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.214 -1.032 . . . . 10.0 108.214 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -135.31 155.03 51.28 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.477 1.511 . . . . 10.0 108.893 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 13.9 t -140.22 139.69 35.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.429 1.092 . . . . 10.0 108.439 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -159.37 -172.16 3.62 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.272 -0.893 . . . . 10.0 110.564 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 92.13 -173.42 36.07 Favored Glycine 0 CA--C 1.524 0.616 0 CA-C-O 121.553 0.53 . . . . 10.0 112.125 170.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -154.08 160.22 41.87 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 107.178 -1.415 . . . . 10.0 107.178 169.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 72.6 m -124.23 107.33 11.08 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.9 mtt -56.59 -23.64 42.1 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.989 1.316 . . . . 10.0 113.664 -169.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.75 -25.11 68.04 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 118.528 -0.749 . . . . 10.0 112.767 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -135.71 -50.48 0.72 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.712 0.805 . . . . 10.0 111.111 -169.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 139.7 -177.94 20.09 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.941 1.734 . . . . 10.0 109.604 -176.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.94 132.98 36.69 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.195 1.93 . . . . 10.0 109.175 169.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.18 152.57 37.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 167.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -78.28 73.09 4.84 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 169.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -51.1 -31.0 17.73 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 124.631 1.173 . . . . 10.0 113.258 -169.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -58.66 -35.81 73.15 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.212 0.914 . . . . 10.0 112.405 177.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 56.6 mt -65.11 -51.81 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 107.208 -1.404 . . . . 10.0 107.208 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.9 m -57.63 -44.93 85.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.26 -0.876 . . . . 10.0 112.287 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 p -66.85 -38.65 86.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 119.704 1.138 . . . . 10.0 111.156 -176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.08 -39.14 89.8 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.941 0.792 . . . . 10.0 110.736 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.3 mttm -64.65 -46.68 81.46 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 122.056 -0.403 . . . . 10.0 110.683 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 75.4 mt -58.43 -44.07 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.443 -0.947 . . . . 10.0 108.443 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -60.81 -42.01 96.82 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.256 0.934 . . . . 10.0 110.563 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.42 87.22 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.281 0.632 . . . . 10.0 111.724 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -71.75 -29.99 65.11 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 118.089 -0.958 . . . . 10.0 111.57 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . 0.264 40.9 p90 36.83 60.63 3.55 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 127.804 2.442 . . . . 10.0 113.926 -169.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -62.07 -27.43 79.16 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 121.188 1.259 . . . . 10.0 110.486 168.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -148.74 154.14 39.18 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 128.509 2.723 . . . . 10.0 105.088 166.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -83.3 141.47 31.79 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.99 0.424 . . . . 10.0 110.431 -174.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 65.27 146.43 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.924 2.49 . . . . 10.0 113.286 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.8 t -146.31 148.54 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.533 1.533 . . . . 10.0 106.926 -176.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.9 p -139.71 166.95 23.23 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 120.987 -1.07 . . . . 10.0 110.034 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 54.9 p-90 -147.12 164.06 34.31 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.916 0.326 . . . . 10.0 111.134 169.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -150.54 176.54 10.87 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.536 1.934 . . . . 10.0 108.532 174.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -139.0 41.97 2.1 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.281 1.032 . . . . 10.0 109.09 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -61.58 -30.5 70.71 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.065 0.946 . . . . 10.0 113.063 -174.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.68 -179.46 46.84 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.09 -1.204 . . . . 10.0 110.09 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.6 t80 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 116.651 -1.642 . . . . 10.0 109.74 172.393 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 117.816 -1.088 . . . . 10.0 109.307 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.63 161.06 41.34 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.933 1.693 . . . . 10.0 107.879 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.37 147.24 11.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 O-C-N 124.294 0.996 . . . . 10.0 109.89 176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.49 178.56 8.28 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.953 0.883 . . . . 10.0 111.399 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -147.62 151.44 36.22 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.3 -1.741 . . . . 10.0 106.3 170.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.5 mt -59.88 -22.55 62.49 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 117.602 -1.189 . . . . 10.0 113.947 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.5 -33.58 75.37 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.034 0.834 . . . . 10.0 111.615 172.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.9 mt -79.16 -34.35 43.23 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 122.989 0.516 . . . . 10.0 110.299 -177.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.8 mt -65.21 125.03 88.54 Favored Pre-proline 0 CA--C 1.54 0.586 0 N-CA-C 107.799 -1.186 . . . . 10.0 107.799 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.35 139.86 61.51 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.326 2.018 . . . . 10.0 109.875 -177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.92 -31.5 51.14 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.036 0.935 . . . . 10.0 111.644 -171.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.5 t -140.41 136.17 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 105.129 -2.174 . . . . 10.0 105.129 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -150.77 102.34 2.99 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 172.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 31.4 pt -131.15 42.78 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.967 1.307 . . . . 10.0 109.478 -168.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -64.46 81.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.447 1.899 . . . . 10.0 111.737 -176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m -162.64 175.36 11.46 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.314 2.246 . . . . 10.0 108.18 172.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -147.63 155.39 41.74 Favored 'General case' 0 C--O 1.248 1.019 0 C-N-CA 125.286 1.434 . . . . 10.0 107.613 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.82 -162.15 48.5 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.102 -1.199 . . . . 10.0 110.102 -166.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 37.5 t -72.16 139.64 19.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 108.025 -1.102 . . . . 10.0 108.025 167.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -152.49 148.55 27.54 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.575 1.179 . . . . 10.0 111.213 172.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -63.82 145.98 54.79 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 108.713 -0.847 . . . . 10.0 108.713 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -144.06 160.74 40.36 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.488 0.715 . . . . 10.0 110.159 175.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.95 146.42 26.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.576 1.55 . . . . 10.0 108.132 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.0 tt -106.49 122.22 45.86 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 105.438 -2.06 . . . . 10.0 105.438 175.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 64.8 mt -126.03 133.26 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.997 -1.483 . . . . 10.0 106.997 -171.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 ttm105 -85.47 139.0 31.85 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 167.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -118.27 140.58 41.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 124.579 1.152 . . . . 10.0 107.894 175.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -115.54 127.32 55.18 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.692 -1.966 . . . . 10.0 105.692 174.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.9 p -74.39 144.54 44.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-O 121.228 0.537 . . . . 10.0 111.399 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -157.0 71.07 4.65 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 126.795 2.038 . . . . 10.0 106.419 167.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -49.76 -38.92 47.75 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.69 2.927 . . . . 10.0 112.55 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -146.4 162.74 37.57 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 105.257 -2.127 . . . . 10.0 105.257 170.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -55.6 -23.21 26.04 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.508 1.299 . . . . 10.0 114.508 -172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -132.5 25.34 3.81 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.69 1.138 . . . . 10.0 111.865 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.86 149.83 89.0 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 118.679 1.24 . . . . 10.0 110.932 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -79.65 41.66 1.15 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 124.052 3.168 . . . . 10.0 112.03 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.1 135.09 22.59 Favored 'General case' 0 N--CA 1.457 -0.106 0 C-N-CA 124.267 1.027 . . . . 10.0 109.001 -177.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.04 27.52 0.77 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.848 1.659 . . . . 10.0 109.579 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -68.69 166.46 17.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.302 1.041 . . . . 10.0 109.515 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.1 m -136.39 161.19 36.51 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.405 -0.81 . . . . 10.0 110.459 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -146.9 170.7 16.52 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.299 1.439 . . . . 10.0 107.664 177.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -122.48 140.95 52.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.261 -2.125 . . . . 10.0 105.261 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 35.2 pt -134.97 154.12 35.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.347 1.059 . . . . 10.0 110.123 -173.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.97 128.63 69.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -133.75 144.26 48.97 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.041 -1.466 . . . . 10.0 107.041 -178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -175.37 131.55 1.96 Allowed Glycine 0 CA--C 1.506 -0.493 0 CA-C-N 120.193 1.361 . . . . 10.0 111.033 172.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -147.22 139.29 24.43 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.537 -0.542 . . . . 10.0 109.537 -177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -70.84 -17.59 62.73 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 116.885 -1.531 . . . . 10.0 114.277 -173.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.9 p-90 -68.52 -17.22 64.12 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 119.994 1.27 . . . . 10.0 112.012 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.81 127.39 31.72 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 119.856 1.207 . . . . 10.0 111.513 -172.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.79 -44.47 85.64 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.802 0.81 . . . . 10.0 109.068 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -146.51 168.83 20.25 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 127.183 2.193 . . . . 10.0 106.898 172.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -56.98 -36.13 69.97 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 120.997 -1.064 . . . . 10.0 112.403 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.27 -24.51 63.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.11 -0.947 . . . . 10.0 112.657 177.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -66.49 -36.34 82.49 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.903 1.335 . . . . 10.0 109.549 177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -65.71 -53.78 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 120.471 -1.393 . . . . 10.0 108.505 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -54.73 -40.18 69.02 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 117.76 -1.114 . . . . 10.0 111.473 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -61.59 -46.24 90.69 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.347 0.976 . . . . 10.0 111.756 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -65.27 -48.15 74.22 Favored 'General case' 0 CA--C 1.517 -0.323 0 O-C-N 121.002 -1.061 . . . . 10.0 109.718 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.4 t -67.07 -42.48 88.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 109.554 -0.535 . . . . 10.0 109.554 -170.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.4 p -65.06 -34.46 78.47 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.576 1.08 . . . . 10.0 111.362 178.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.76 -47.93 81.66 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 110.725 -0.95 . . . . 10.0 110.725 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -62.08 -47.41 84.81 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-N 117.363 0.582 . . . . 10.0 111.115 177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.7 mmt -60.7 -36.8 79.7 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 118.137 -0.935 . . . . 10.0 110.57 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -64.53 -39.85 94.53 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.39 0.996 . . . . 10.0 111.08 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -70.72 -27.19 63.79 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.759 1.163 . . . . 10.0 111.779 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 77.0 mm-40 -69.61 -55.64 9.51 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.335 0.97 . . . . 10.0 108.84 175.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.17 42.66 0.14 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.029 1.3 . . . . 10.0 111.553 -173.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 50.9 m -142.17 168.01 20.76 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.278 1.431 . . . . 10.0 109.508 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -127.73 160.71 30.87 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.156 1.782 . . . . 10.0 107.138 170.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 99.3 m -129.7 153.17 48.43 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.443 1.097 . . . . 10.0 112.663 -166.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -142.72 110.65 5.93 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 105.907 -1.886 . . . . 10.0 105.907 170.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.5 p -61.26 122.95 16.38 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.248 -0.908 . . . . 10.0 109.103 170.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 30.1 mt -86.37 -22.55 26.58 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.163 0.506 . . . . 10.0 110.558 177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.84 -177.18 30.66 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 108.239 -1.945 . . . . 10.0 108.239 -172.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -165.32 -161.2 13.77 Favored Glycine 0 CA--C 1.52 0.371 0 O-C-N 121.016 -1.285 . . . . 10.0 110.714 173.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 177.97 -138.63 3.84 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 108.656 -1.778 . . . . 10.0 108.656 -174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -136.81 144.43 43.68 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.698 1.199 . . . . 10.0 107.884 177.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.84 151.55 8.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 104.656 -2.35 . . . . 10.0 104.656 169.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.1 m -131.84 131.39 42.79 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 107.242 -1.392 . . . . 10.0 107.242 177.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -141.58 147.35 37.53 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.444 -1.317 . . . . 10.0 107.444 -171.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -149.12 135.75 19.52 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 104.796 -2.298 . . . . 10.0 104.796 165.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 7.8 m -67.42 -18.87 65.28 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.838 1.051 . . . . 10.0 113.838 -169.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -145.02 166.62 24.8 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.775 1.63 . . . . 10.0 108.206 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 65.07 -7.45 0.28 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 127.701 2.4 . . . . 10.0 114.912 170.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -139.86 -179.8 6.15 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 118.991 -2.318 . . . . 10.0 108.235 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.58 169.97 11.94 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.749 1.62 . . . . 10.0 109.059 175.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.72 142.82 13.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.057 -1.46 . . . . 10.0 107.057 -177.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.3 t60 -139.02 159.66 41.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 174.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 11.5 t -141.62 132.53 26.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 N-CA-C 107.668 -1.234 . . . . 10.0 107.668 -176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -161.89 176.69 10.56 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.799 -1.188 . . . . 10.0 111.434 -171.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 78.27 -166.01 52.28 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 121.732 -0.605 . . . . 10.0 111.59 -176.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -150.52 160.2 43.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 124.504 1.122 . . . . 10.0 108.05 173.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.2 m -86.42 116.7 24.74 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.983 0.811 . . . . 10.0 109.594 172.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -58.56 -25.52 62.62 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 122.877 0.471 . . . . 10.0 110.537 170.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.28 -29.19 70.25 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 117.629 -1.177 . . . . 10.0 113.56 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.68 -55.63 0.26 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 119.924 1.238 . . . . 10.0 110.884 -176.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 161.11 -178.79 36.92 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.523 -1.031 . . . . 10.0 110.523 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.43 134.48 41.84 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.818 2.345 . . . . 10.0 109.909 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.09 162.17 28.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.816 0.817 . . . . 10.0 109.796 164.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -80.01 74.84 6.76 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 107.198 -1.408 . . . . 10.0 107.198 169.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -48.83 -31.36 6.99 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.225 1.41 . . . . 10.0 114.487 -170.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.89 72.79 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.135 0.88 . . . . 10.0 112.408 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.9 mt -63.48 -52.21 60.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -58.96 -44.77 91.53 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.305 -0.855 . . . . 10.0 111.355 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 23.8 p -65.24 -39.17 92.34 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 119.702 1.137 . . . . 10.0 111.679 -175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -65.4 -40.38 93.37 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.648 1.113 . . . . 10.0 109.832 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -66.76 -46.31 75.77 Favored 'General case' 0 N--CA 1.462 0.17 0 C-N-CA 123.03 0.532 . . . . 10.0 110.114 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 72.6 mt -57.51 -45.65 85.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 108.807 -0.812 . . . . 10.0 108.807 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -61.11 -41.74 97.25 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 119.158 0.89 . . . . 10.0 110.825 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -62.77 -39.87 95.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.589 0.631 . . . . 10.0 111.195 174.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HA ' ' HE2' ' A' ' 112' ' ' LYS . 0.6 OUTLIER -69.29 -31.89 70.69 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 117.296 -1.335 . . . . 10.0 112.181 178.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -134.48 67.25 71.74 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.362 1.065 . . . . 10.0 110.506 -173.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.45 -22.43 50.5 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.846 2.364 . . . . 10.0 114.922 -176.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -65.43 -12.37 51.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.754 1.222 . . . . 10.0 112.863 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -127.59 146.38 50.55 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 120.63 -1.294 . . . . 10.0 109.74 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -71.05 153.39 42.64 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.021 -1.104 . . . . 10.0 108.021 165.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.7 t -135.89 137.05 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 106.744 -1.576 . . . . 10.0 106.744 175.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.1 p -142.86 170.82 14.99 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.855 1.262 . . . . 10.0 109.128 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -145.6 166.74 24.89 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 119.199 0.909 . . . . 10.0 111.346 174.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -147.3 172.32 14.05 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.369 2.268 . . . . 10.0 108.124 173.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -145.33 20.27 1.55 Allowed 'General case' 0 C--O 1.221 -0.41 0 C-N-CA 123.712 0.805 . . . . 10.0 111.84 -175.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -57.34 -36.85 71.67 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.451 1.101 . . . . 10.0 112.615 -172.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 163.52 170.12 27.96 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.877 -0.889 . . . . 10.0 110.877 175.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 51.1 t80 . . . . . 0 C--O 1.254 1.293 0 CA-C-O 116.308 -1.806 . . . . 10.0 108.291 168.8 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.702 -0.481 . . . . 10.0 109.702 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.19 164.75 34.87 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.023 1.329 . . . . 10.0 109.014 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.3 m -64.54 160.92 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 123.994 0.918 . . . . 10.0 110.563 172.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.71 169.66 12.43 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.382 0.611 . . . . 10.0 111.701 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -152.02 154.63 36.38 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.458 1.503 . . . . 10.0 107.203 173.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.4 mt -57.77 -24.79 58.82 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.716 0.806 . . . . 10.0 112.81 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.16 -26.76 66.56 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.37 0.986 . . . . 10.0 112.368 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 79.2 mt -75.76 -25.08 56.17 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.033 0.533 . . . . 10.0 111.306 -179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 95.6 mt -84.16 127.49 66.39 Favored Pre-proline 0 C--O 1.237 0.436 0 N-CA-C 106.722 -1.584 . . . . 10.0 106.722 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -67.3 147.17 77.77 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.185 1.923 . . . . 10.0 109.769 177.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -77.04 -30.44 55.65 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.535 0.683 . . . . 10.0 112.052 -174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 46.5 t -137.83 134.86 45.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.14 -2.171 . . . . 10.0 105.14 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -151.2 114.39 4.79 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.305 -1.369 . . . . 10.0 107.305 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 22.8 pt -141.43 140.13 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.132 1.773 . . . . 10.0 106.272 -175.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -154.55 83.09 1.11 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.81 0.814 . . . . 10.0 108.827 -177.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 m -161.45 175.65 11.94 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.418 1.887 . . . . 10.0 108.572 179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -140.76 158.73 43.55 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 125.097 1.359 . . . . 10.0 108.066 177.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.74 -157.65 50.48 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 109.931 -1.268 . . . . 10.0 109.931 -169.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.18 139.71 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 108.227 -1.027 . . . . 10.0 108.227 169.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -147.6 154.56 40.83 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.197 0.999 . . . . 10.0 110.325 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -79.08 145.92 33.54 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 124.991 1.316 . . . . 10.0 109.017 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.2 162.25 39.28 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.993 0.425 . . . . 10.0 110.458 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.61 143.19 26.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 125.261 1.424 . . . . 10.0 107.565 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 63.3 tp -100.72 125.37 47.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 105.328 -2.101 . . . . 10.0 105.328 171.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 80.3 mt -128.87 130.17 68.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.552 -1.647 . . . . 10.0 106.552 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -83.43 135.42 34.69 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 106.007 -1.849 . . . . 10.0 106.007 168.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.1 p -124.82 138.4 54.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.793 -1.558 . . . . 10.0 106.793 -175.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -121.98 131.05 53.8 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.927 1.691 . . . . 10.0 106.647 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.9 p -67.65 140.23 56.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.783 0.325 . . . . 10.0 110.326 176.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.42 62.4 4.92 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.803 1.241 . . . . 10.0 108.557 168.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -53.96 -35.29 80.06 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.188 3.259 . . . . 10.0 113.503 -169.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -153.14 161.15 42.79 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.855 2.062 . . . . 10.0 105.738 172.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.0 m -55.99 -22.3 26.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.653 1.353 . . . . 10.0 114.653 -172.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -134.1 26.75 3.37 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 124.492 1.044 . . . . 10.0 112.045 177.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.96 148.88 91.52 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 118.039 0.92 . . . . 10.0 110.611 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -79.9 42.96 1.41 Allowed 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 124.308 3.339 . . . . 10.0 111.999 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -144.28 139.31 28.52 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.379 1.072 . . . . 10.0 109.514 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.21 16.79 0.41 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.424 1.49 . . . . 10.0 111.797 176.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -63.33 160.03 16.8 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.274 1.43 . . . . 10.0 109.722 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.9 m -140.64 161.36 37.95 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.206 1.003 . . . . 10.0 110.66 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 pttt -146.99 179.33 7.68 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.967 1.307 . . . . 10.0 108.87 169.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -120.31 143.38 48.39 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.191 -1.041 . . . . 10.0 108.191 177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.6 pt -135.0 146.97 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 C-N-CA 124.991 1.316 . . . . 10.0 110.289 -171.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.0 t -105.19 125.97 60.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 106.649 -1.611 . . . . 10.0 106.649 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -131.91 144.18 50.67 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.657 -1.609 . . . . 10.0 106.657 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.71 130.9 1.86 Allowed Glycine 0 C--N 1.329 0.156 0 CA-C-N 120.017 1.281 . . . . 10.0 112.868 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -150.91 142.38 23.46 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.218 1.007 . . . . 10.0 109.293 -177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -72.49 -16.89 61.79 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.118 1.155 . . . . 10.0 114.118 -174.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 5.5 p-90 -65.97 -21.37 66.41 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 119.69 1.132 . . . . 10.0 112.828 -177.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.11 130.7 44.32 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 118.485 0.584 . . . . 10.0 110.804 -175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -67.8 -41.5 83.04 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.396 -0.594 . . . . 10.0 109.396 174.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -144.12 158.58 43.63 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 126.319 1.848 . . . . 10.0 107.169 175.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -56.27 -32.02 64.14 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.525 0.73 . . . . 10.0 112.853 -175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.09 -27.02 65.16 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 118.866 -0.588 . . . . 10.0 112.136 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -68.43 -35.9 78.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.503 0.592 . . . . 10.0 110.795 176.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 21.2 mt -65.56 -50.85 69.4 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 N-CA-C 107.683 -1.229 . . . . 10.0 107.683 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -55.28 -45.59 76.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.928 -0.558 . . . . 10.0 111.171 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.46 -45.27 88.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 118.541 0.61 . . . . 10.0 111.822 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -59.0 -50.1 75.36 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.562 0.745 . . . . 10.0 109.481 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 82.3 t -63.64 -46.11 95.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.521 0.728 . . . . 10.0 109.068 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.8 m -59.08 -36.03 74.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.352 0.978 . . . . 10.0 111.486 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.02 -49.32 76.48 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.531 -1.028 . . . . 10.0 110.531 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -62.01 -45.87 91.71 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 117.751 0.776 . . . . 10.0 111.283 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -36.43 82.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.776 -0.63 . . . . 10.0 111.057 -178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -65.05 -35.73 82.09 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.9 0.773 . . . . 10.0 110.942 176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -66.36 -32.18 73.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 118.135 -0.936 . . . . 10.0 111.542 172.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 60.2 mm-40 -69.19 -60.47 2.33 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.913 0.779 . . . . 10.0 109.281 175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 134.66 47.38 0.09 OUTLIER Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.826 1.679 . . . . 10.0 109.456 -169.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 66.9 m -146.79 172.43 13.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.263 1.825 . . . . 10.0 108.734 -178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -137.87 160.45 39.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.846 1.659 . . . . 10.0 108.361 175.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 66.4 m -134.54 154.39 51.48 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.118 0.967 . . . . 10.0 112.894 -168.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -144.78 109.93 5.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 126.588 1.955 . . . . 10.0 106.857 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 p -60.04 126.88 29.24 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.114 -0.991 . . . . 10.0 109.544 172.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 53.2 mt -91.69 -26.57 18.57 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.698 0.399 . . . . 10.0 110.351 173.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.33 169.58 31.95 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.641 -0.984 . . . . 10.0 110.641 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -129.96 166.51 22.01 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.952 1.263 . . . . 10.0 110.883 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -173.48 -161.56 23.91 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.529 -1.428 . . . . 10.0 109.529 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 90.6 mtm-85 -138.24 156.66 47.47 Favored 'General case' 0 C--N 1.33 -0.262 0 O-C-N 121.09 -1.241 . . . . 10.0 108.972 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 39.9 mt -127.81 146.95 32.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 104.54 -2.393 . . . . 10.0 104.54 178.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.2 m -113.44 120.75 42.12 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.903 -1.518 . . . . 10.0 106.903 169.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -68.81 156.07 39.04 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.872 0.869 . . . . 10.0 110.845 -179.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -61.86 149.34 40.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.093 1.357 . . . . 10.0 110.157 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 18.9 m -139.79 25.02 2.38 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.718 1.207 . . . . 10.0 110.926 -176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 51.64 43.88 29.54 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.558 1.543 . . . . 10.0 109.476 -168.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -157.68 -43.3 0.06 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.408 0.683 . . . . 10.0 112.641 -170.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -145.85 137.09 24.79 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.597 1.159 . . . . 10.0 108.213 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.16 156.17 4.28 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.645 1.178 . . . . 10.0 112.817 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 18.4 pt -58.47 133.92 23.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.122 -1.066 . . . . 10.0 108.122 168.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 47.4 t60 -149.25 156.6 42.37 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.223 -1.029 . . . . 10.0 108.223 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.31 137.7 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 124.09 0.956 . . . . 10.0 108.51 -169.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -160.17 -177.11 6.05 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.344 -0.847 . . . . 10.0 110.114 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.64 178.93 37.86 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 123.244 0.449 . . . . 10.0 112.218 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -153.61 -176.23 5.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.227 1.011 . . . . 10.0 108.815 169.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 14.9 m -137.06 111.14 8.32 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 65.4 mtt -61.11 -12.87 13.76 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.359 0.664 . . . . 10.0 112.639 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.06 -32.39 54.47 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.124 0.97 . . . . 10.0 112.428 170.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.56 -37.11 0.14 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.377 0.881 . . . . 10.0 113.377 -178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 141.82 -178.68 20.44 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.612 1.101 . . . . 10.0 110.654 -174.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -65.22 143.79 78.71 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.219 2.613 . . . . 10.0 110.2 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.44 32.75 0.09 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.182 1.793 . . . . 10.0 113.737 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 37.66 55.45 1.5 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 128.093 2.557 . . . . 10.0 110.171 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -45.45 -26.84 0.61 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.771 2.428 . . . . 10.0 116.275 -166.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.7 -39.02 83.2 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 120.567 1.53 . . . . 10.0 111.899 173.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.4 -55.03 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.6 m -63.93 -39.91 95.23 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.606 -0.712 . . . . 10.0 112.017 -175.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 11.0 p -64.85 -38.61 91.56 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 119.417 1.008 . . . . 10.0 110.57 -177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.59 -41.41 96.27 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.673 1.124 . . . . 10.0 111.241 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -64.08 -47.89 78.34 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.819 -0.55 . . . . 10.0 110.663 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 69.0 mt -60.85 -42.43 92.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 123.839 0.855 . . . . 10.0 108.828 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -60.31 -40.15 89.53 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.244 1.018 . . . . 10.0 111.206 178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.64 -41.0 96.43 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.162 0.437 . . . . 10.0 110.936 174.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -77.57 -36.82 51.7 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 117.776 -1.106 . . . . 10.0 113.101 -171.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -121.88 148.38 51.02 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 119.942 1.246 . . . . 10.0 112.422 -168.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.25 -10.06 16.35 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.51 2.806 . . . . 10.0 114.111 -172.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -77.76 67.29 3.62 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 108.283 -1.006 . . . . 10.0 108.283 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -58.89 -16.45 17.61 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.543 1.537 . . . . 10.0 115.025 -168.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -77.94 31.77 0.17 Allowed 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 120.843 1.656 . . . . 10.0 112.144 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.97 127.58 15.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.4 -1.333 . . . . 10.0 107.4 170.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.12 167.07 26.91 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 125.432 1.493 . . . . 10.0 107.5 -172.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -144.15 159.67 42.25 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.662 -0.496 . . . . 10.0 109.662 172.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -143.89 -23.52 0.57 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.815 1.043 . . . . 10.0 113.815 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.0 t30 41.68 53.94 3.85 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.282 1.433 . . . . 10.0 112.46 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -63.88 -25.72 68.28 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.522 0.934 . . . . 10.0 113.522 -173.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -168.94 171.84 43.05 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.584 1.564 . . . . 10.0 109.403 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 29.0 t80 . . . . . 0 C--O 1.252 1.207 0 C-N-CA 124.314 1.045 . . . . 10.0 111.844 -174.282 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.484 -0.562 . . . . 10.0 109.484 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.68 167.78 17.89 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.346 0.658 . . . . 10.0 110.386 170.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.78 166.4 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.306 0.574 . . . . 10.0 110.637 169.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -147.61 179.19 7.87 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.552 1.941 . . . . 10.0 107.196 173.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -148.12 152.71 37.78 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.041 -1.096 . . . . 10.0 108.041 176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 76.4 mt -54.91 -31.1 59.83 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.342 1.057 . . . . 10.0 112.637 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.59 -24.59 66.78 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.909 0.707 . . . . 10.0 112.909 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 77.7 mt -76.32 -23.74 54.3 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.88 0.472 . . . . 10.0 111.203 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 97.5 mt -74.48 135.42 75.52 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 107.001 -1.481 . . . . 10.0 107.001 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.47 138.03 53.24 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.21 1.94 . . . . 10.0 109.062 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.72 -31.79 68.76 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 113.054 0.761 . . . . 10.0 113.054 -169.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -158.11 136.53 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 105.944 -1.873 . . . . 10.0 105.944 -174.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -157.34 112.72 2.81 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 108.577 -0.897 . . . . 10.0 108.577 -179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 pt -134.09 31.83 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 125.487 1.515 . . . . 10.0 109.964 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -60.41 101.21 0.12 Allowed 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.947 0.899 . . . . 10.0 111.467 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.0 m -167.55 177.27 6.01 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 127.949 2.5 . . . . 10.0 108.161 176.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -140.83 156.39 46.15 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 124.535 1.134 . . . . 10.0 108.796 -175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.95 -155.97 41.5 Favored Glycine 0 CA--C 1.529 0.93 0 N-CA-C 110.458 -1.057 . . . . 10.0 110.458 -169.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.8 t -69.28 141.47 17.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.655 -0.869 . . . . 10.0 108.655 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -154.04 154.85 34.43 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.248 1.019 . . . . 10.0 110.019 168.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -77.75 151.02 34.3 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 124.112 0.965 . . . . 10.0 109.45 177.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -143.53 161.5 38.3 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.507 0.723 . . . . 10.0 109.75 176.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.51 152.69 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.091 1.356 . . . . 10.0 108.988 -177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.4 tp -115.35 121.99 44.51 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.58 -2.007 . . . . 10.0 105.58 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 95.2 mt -130.71 134.24 62.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 107.408 -1.33 . . . . 10.0 107.408 -169.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.0 ttm180 -85.23 144.56 28.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.533 -1.654 . . . . 10.0 106.533 167.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 p -131.99 144.12 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 106.803 -1.554 . . . . 10.0 106.803 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -124.21 132.35 53.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 126.093 1.757 . . . . 10.0 106.449 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.2 p -64.39 139.86 58.81 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.973 -0.38 . . . . 10.0 109.973 174.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -156.48 62.17 2.83 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.854 1.262 . . . . 10.0 108.612 169.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -59.27 135.33 64.85 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.918 2.412 . . . . 10.0 109.499 -172.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 44.76 26.96 0.22 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.925 1.29 . . . . 10.0 113.601 -171.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m 51.54 29.66 5.66 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.22 1.408 . . . . 10.0 113.434 -176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -173.22 -7.41 0.02 OUTLIER Glycine 0 CA--C 1.53 1.014 0 N-CA-C 116.58 1.392 . . . . 10.0 116.58 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.78 153.06 80.64 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-N 120.062 1.931 . . . . 10.0 110.476 174.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.18 64.06 7.81 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 124.26 3.306 . . . . 10.0 111.941 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.5 138.21 34.43 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.334 1.453 . . . . 10.0 108.317 172.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.1 25.17 0.82 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.757 1.223 . . . . 10.0 110.781 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.29 161.14 25.64 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.835 -0.802 . . . . 10.0 108.835 169.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -139.63 163.51 32.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.291 1.036 . . . . 10.0 110.996 -176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -151.43 166.95 29.49 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.947 2.099 . . . . 10.0 107.862 -170.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.3 mp0 -122.32 143.15 49.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 108.012 -1.107 . . . . 10.0 108.012 172.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 33.8 pt -136.77 155.36 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 126.441 1.896 . . . . 10.0 109.228 -174.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.9 t -123.48 129.95 74.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -175.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -134.68 147.03 50.02 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.661 -1.607 . . . . 10.0 106.661 -172.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.78 124.17 1.0 Allowed Glycine 0 C--O 1.224 -0.497 0 CA-C-N 119.642 1.11 . . . . 10.0 110.644 172.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -144.52 138.12 27.34 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 123.846 0.38 . . . . 10.0 110.429 -173.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -61.45 -29.78 70.17 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 124.22 1.008 . . . . 10.0 112.876 -175.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -64.07 -23.14 67.22 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.957 0.799 . . . . 10.0 112.97 -176.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.37 118.7 14.5 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 119.26 0.936 . . . . 10.0 109.791 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -68.38 -34.16 75.55 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 122.878 0.471 . . . . 10.0 109.965 174.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -142.46 151.94 42.24 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 126.076 1.751 . . . . 10.0 107.894 -178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -57.17 -36.69 71.09 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.676 0.621 . . . . 10.0 112.676 -171.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.95 -27.06 63.06 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 124.0 0.812 . . . . 10.0 112.175 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.73 -35.36 79.94 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.26 0.482 . . . . 10.0 110.926 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 20.0 mt -66.37 -54.83 22.22 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 N-CA-C 107.399 -1.334 . . . . 10.0 107.399 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -56.93 -41.95 79.12 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.944 -0.55 . . . . 10.0 111.55 -176.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.33 -47.38 79.61 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.908 0.483 . . . . 10.0 111.632 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -60.97 -47.69 85.29 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 121.872 -0.518 . . . . 10.0 109.695 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.8 t -63.19 -47.57 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 118.475 -0.774 . . . . 10.0 108.996 -178.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.0 m -57.82 -42.44 84.31 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.348 0.976 . . . . 10.0 110.897 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.63 -44.29 98.01 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.235 -0.746 . . . . 10.0 111.235 176.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -65.87 -48.01 72.99 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 118.111 0.955 . . . . 10.0 111.504 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.08 -41.07 78.17 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 119.074 0.852 . . . . 10.0 110.121 178.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -62.69 -36.82 84.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.432 -0.794 . . . . 10.0 110.988 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.1 pttm -74.23 -25.42 59.65 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 117.468 -1.253 . . . . 10.0 112.652 173.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -68.31 -56.09 9.81 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.902 1.228 . . . . 10.0 109.151 172.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 132.13 45.28 0.14 Allowed Glycine 0 CA--C 1.525 0.661 0 C-N-CA 125.522 1.534 . . . . 10.0 109.896 -169.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 67.1 m -147.02 175.37 10.74 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.817 2.047 . . . . 10.0 107.875 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -145.64 165.27 29.21 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.892 -0.781 . . . . 10.0 108.892 169.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.94 164.13 19.07 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.771 1.026 . . . . 10.0 113.771 -168.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -147.07 112.84 5.71 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.9 2.48 . . . . 10.0 105.734 175.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 16.9 t -65.2 140.44 58.75 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.916 -1.115 . . . . 10.0 109.48 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 55.3 mt -106.14 -10.9 16.28 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.732 0.813 . . . . 10.0 111.047 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.31 -177.75 18.74 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 125.467 1.508 . . . . 10.0 109.723 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.59 -164.23 13.57 Favored Glycine 0 CA--C 1.522 0.519 0 O-C-N 121.472 -1.017 . . . . 10.0 112.04 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -176.28 -149.71 7.72 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 109.667 -1.373 . . . . 10.0 109.667 -172.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -143.06 155.96 44.72 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 124.602 1.161 . . . . 10.0 109.275 -174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 65.1 mt -136.43 153.97 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.529 -2.026 . . . . 10.0 105.529 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.6 m -129.24 117.27 20.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 169.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -57.11 133.87 55.37 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.564 -0.532 . . . . 10.0 109.564 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 43.58 59.83 2.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.052 1.341 . . . . 10.0 111.258 -172.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -52.61 -36.26 55.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.081 0.552 . . . . 10.0 110.86 174.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -126.35 170.03 12.34 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.019 1.727 . . . . 10.0 106.842 168.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -58.34 -22.86 54.94 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 114.292 1.219 . . . . 10.0 114.292 -169.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -127.49 -5.72 5.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 117.818 -1.087 . . . . 10.0 113.716 -175.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.38 169.16 24.88 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 120.35 1.432 . . . . 10.0 112.487 -172.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 pt -116.06 166.06 10.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 CA-C-O 122.826 1.298 . . . . 10.0 110.917 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 44.1 t60 -134.77 154.45 51.59 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 126.663 1.985 . . . . 10.0 107.912 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.1 t -129.57 136.94 58.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -150.83 175.7 11.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 118.728 0.695 . . . . 10.0 111.816 -169.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 68.84 -153.76 53.05 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.667 0.651 . . . . 10.0 112.981 170.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -150.6 -179.7 7.46 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 125.381 1.472 . . . . 10.0 109.601 -177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 64.9 m -114.94 122.89 47.65 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.805 0.842 . . . . 10.0 109.194 170.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -58.35 -29.23 65.8 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.352 1.061 . . . . 10.0 111.213 177.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -66.75 -25.41 66.48 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.737 1.014 . . . . 10.0 113.737 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.11 -59.03 0.25 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.514 1.052 . . . . 10.0 111.271 -174.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 160.88 179.66 35.77 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.515 -1.034 . . . . 10.0 110.515 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -56.68 137.41 80.98 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 123.016 2.477 . . . . 10.0 111.138 170.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.55 165.81 21.92 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.603 0.715 . . . . 10.0 109.241 167.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -81.59 69.12 8.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.366 -1.716 . . . . 10.0 106.366 167.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -49.24 -30.19 6.82 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.663 1.585 . . . . 10.0 114.196 -169.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.15 -36.28 74.99 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.374 0.988 . . . . 10.0 112.266 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 48.7 mt -62.81 -50.45 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.052 -1.462 . . . . 10.0 107.052 175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 3.4 m -58.55 -47.64 83.54 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.741 0.816 . . . . 10.0 111.822 -177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 22.3 p -65.39 -37.85 88.24 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.409 -0.805 . . . . 10.0 111.356 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -64.73 -42.67 95.03 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.362 0.983 . . . . 10.0 110.387 177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -62.41 -47.95 81.88 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 118.682 -0.675 . . . . 10.0 110.085 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 63.4 mt -57.62 -52.19 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -57.52 -38.06 74.04 Favored 'General case' 0 C--O 1.222 -0.359 0 C-N-CA 124.349 1.06 . . . . 10.0 111.971 -174.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.05 -44.01 81.24 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 122.78 0.432 . . . . 10.0 111.309 179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -90.99 -49.48 6.39 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 118.406 0.548 . . . . 10.0 111.853 -169.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -72.49 159.4 85.47 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 123.198 0.599 . . . . 10.0 110.195 -175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.3 -13.85 30.96 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.716 2.277 . . . . 10.0 112.671 175.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -70.0 115.76 9.59 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 108.266 -1.013 . . . . 10.0 108.266 169.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -107.41 13.63 26.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.48 1.112 . . . . 10.0 111.384 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -140.71 36.49 1.81 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.683 1.193 . . . . 10.0 109.687 -174.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.4 t -56.66 146.08 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 124.918 1.287 . . . . 10.0 108.637 173.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 11.9 p -139.63 167.98 20.86 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.294 1.037 . . . . 10.0 110.149 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 45.2 p-90 -150.63 167.85 26.07 Favored 'General case' 0 C--O 1.235 0.311 0 O-C-N 121.961 -0.462 . . . . 10.0 110.957 170.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -148.5 153.17 38.09 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.68 1.592 . . . . 10.0 108.513 169.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -72.37 -27.0 62.11 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 122.585 0.354 . . . . 10.0 111.662 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -60.85 165.37 4.08 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.374 1.469 . . . . 10.0 112.327 -178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.77 31.16 10.38 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.932 0.777 . . . . 10.0 112.309 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 . . . . . 0 C--O 1.245 0.861 0 C-N-CA 124.279 1.032 . . . . 10.0 110.147 174.974 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.1 tmm? . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 118.297 -0.858 . . . . 10.0 110.11 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.63 -175.76 5.6 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.366 1.467 . . . . 10.0 108.648 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -63.74 155.71 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 122.989 0.515 . . . . 10.0 110.275 169.035 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.45 ' H ' ' HB3' ' A' ' 31' ' ' PRO . . . -158.16 177.35 11.39 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.493 2.317 . . . . 10.0 106.808 176.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -150.3 150.69 31.83 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.75 -1.204 . . . . 10.0 107.75 173.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 77.4 mt -59.15 -23.47 62.2 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 118.211 -0.9 . . . . 10.0 112.88 -177.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.28 -26.41 67.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.473 1.033 . . . . 10.0 112.473 175.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.8 mt -73.97 -26.25 60.37 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.111 0.564 . . . . 10.0 111.009 -178.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.3 mt -86.38 127.16 62.18 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 106.737 -1.579 . . . . 10.0 106.737 -174.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.62 149.03 79.23 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.226 1.951 . . . . 10.0 110.087 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -75.66 -33.68 60.43 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.47 1.108 . . . . 10.0 111.958 -178.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -136.92 135.12 48.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 104.843 -2.28 . . . . 10.0 104.843 176.432 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -150.5 118.07 6.12 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.069 -1.826 . . . . 10.0 106.069 171.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.8 pt -142.01 158.04 20.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.353 1.061 . . . . 10.0 110.272 -169.806 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -144.34 129.39 18.56 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 124.786 1.235 . . . . 10.0 108.743 174.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.416 ' HB3' ' CE1' ' A' ' 20' ' ' PHE . 58.7 p -131.49 177.49 7.45 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.766 1.227 . . . . 10.0 112.297 -166.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -163.92 -35.34 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.363 1.865 . . . . 10.0 108.825 169.305 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.71 -129.23 1.41 Allowed Glycine 0 CA--C 1.525 0.685 0 N-CA-C 106.273 -2.731 . . . . 10.0 106.273 170.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.8 t -64.06 144.65 14.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 118.418 1.109 . . . . 10.0 108.966 168.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 16' ' ' SER . 24.8 p90 -150.69 147.64 27.61 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 124.869 1.268 . . . . 10.0 109.104 172.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -67.82 153.94 42.62 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.772 -0.58 . . . . 10.0 109.685 174.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.17 165.6 26.97 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.979 0.912 . . . . 10.0 109.366 170.549 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.6 147.72 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.428 1.491 . . . . 10.0 107.67 179.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 tt -109.14 121.02 44.27 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 104.777 -2.305 . . . . 10.0 104.777 177.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.5 mt -128.74 140.53 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.965 -1.494 . . . . 10.0 106.965 -170.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.6 ttm180 -94.54 131.23 40.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 167.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -110.91 143.32 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 177.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -123.47 130.13 52.24 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 126.495 1.918 . . . . 10.0 105.857 -175.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.1 p -72.36 142.93 48.77 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.351 -0.241 . . . . 10.0 110.351 175.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -150.78 59.58 3.54 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.299 1.44 . . . . 10.0 108.205 168.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HB3' ' H ' ' A' ' 4' ' ' ALA . 10.1 Cg_exo -58.67 141.41 97.61 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.019 2.48 . . . . 10.0 109.921 -171.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.6 tpt85 52.2 16.73 0.61 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.448 1.099 . . . . 10.0 113.058 -177.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.0 m 48.17 31.4 2.55 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.548 1.139 . . . . 10.0 112.897 -169.596 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -177.88 -1.71 0.02 OUTLIER Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.43 -1.206 . . . . 10.0 115.954 -177.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.68 153.32 78.91 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 120.094 1.947 . . . . 10.0 110.448 174.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.87 55.29 5.2 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 124.256 3.304 . . . . 10.0 111.855 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.92 139.51 30.78 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.045 1.338 . . . . 10.0 108.653 177.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -150.75 30.09 0.66 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.188 1.395 . . . . 10.0 109.772 -179.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -66.32 158.4 29.22 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 108.694 -0.854 . . . . 10.0 108.694 174.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.2 m -140.33 160.27 40.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.138 0.975 . . . . 10.0 110.326 -179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -150.22 169.57 21.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.132 0.973 . . . . 10.0 109.635 171.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -98.5 149.06 23.12 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.499 -0.926 . . . . 10.0 108.499 172.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.1 pt -138.9 154.43 26.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 126.055 1.742 . . . . 10.0 109.924 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.25 128.8 64.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 106.985 -1.487 . . . . 10.0 106.985 176.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.4 mmp_? -134.61 138.12 44.26 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 106.873 -1.529 . . . . 10.0 106.873 -178.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.38 122.91 0.92 Allowed Glycine 0 C--O 1.224 -0.47 0 CA-C-N 119.725 1.148 . . . . 10.0 110.996 179.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -142.84 133.93 25.8 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 -172.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -59.55 -21.58 60.48 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 114.515 1.302 . . . . 10.0 114.515 -175.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -65.34 -25.33 67.54 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 120.377 1.444 . . . . 10.0 112.276 177.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.85 116.14 11.89 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 119.854 1.206 . . . . 10.0 110.371 -178.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -71.7 -29.89 65.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.311 0.645 . . . . 10.0 110.354 173.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -136.03 146.64 47.34 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.79 1.636 . . . . 10.0 107.422 178.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -60.77 -31.88 71.22 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.762 0.825 . . . . 10.0 111.755 -174.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.99 -26.35 67.53 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.343 0.657 . . . . 10.0 112.165 177.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.62 -32.69 74.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.357 0.598 . . . . 10.0 110.548 176.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 16.7 mt -67.48 -51.78 48.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 174.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -55.83 -41.97 75.04 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 118.462 -0.78 . . . . 10.0 111.141 -178.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.79 -48.74 79.26 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.068 0.547 . . . . 10.0 111.461 177.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.71 -47.27 86.05 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 121.368 -0.832 . . . . 10.0 110.33 -179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.56 -43.77 96.8 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 N-CA-C 109.484 -0.561 . . . . 10.0 109.484 -177.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.5 m -62.99 -36.29 83.03 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.479 1.036 . . . . 10.0 111.029 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.59 -51.33 52.95 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.34 -1.104 . . . . 10.0 110.34 173.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.08 -39.91 91.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.693 0.746 . . . . 10.0 111.686 -177.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.7 mmt -65.31 -39.14 92.09 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.724 -0.655 . . . . 10.0 111.086 178.737 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -64.85 -34.76 79.13 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.071 0.85 . . . . 10.0 110.533 176.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.67 -31.92 72.89 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.359 -1.305 . . . . 10.0 111.612 172.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.5 mm-40 -73.81 -54.6 7.65 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 119.534 1.061 . . . . 10.0 109.014 176.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 131.95 44.22 0.16 Allowed Glycine 0 CA--C 1.529 0.937 0 C-N-CA 125.39 1.471 . . . . 10.0 109.881 -170.18 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.6 m -144.07 169.63 17.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.632 1.573 . . . . 10.0 109.308 -177.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -140.04 163.49 32.56 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.357 1.863 . . . . 10.0 108.397 178.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 98.0 m -139.1 156.38 47.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 119.67 1.123 . . . . 10.0 113.795 -167.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 26.9 pt-20 -139.82 130.15 25.37 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.872 1.669 . . . . 10.0 106.93 168.388 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 5.5 p -68.89 143.31 54.53 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 120.786 -1.196 . . . . 10.0 109.468 172.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 32.6 mt -105.1 -18.14 14.25 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.469 0.708 . . . . 10.0 110.906 171.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.96 -173.92 35.24 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 109.719 -1.352 . . . . 10.0 109.719 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.94 -174.5 28.73 Favored Glycine 0 CA--C 1.525 0.672 0 O-C-N 121.248 -1.148 . . . . 10.0 112.006 172.585 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.44 -149.36 7.81 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.942 -1.663 . . . . 10.0 108.942 -173.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -133.48 154.51 50.75 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.652 1.181 . . . . 10.0 108.874 178.416 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 78.4 mt -125.31 152.02 31.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 104.994 -2.224 . . . . 10.0 104.994 173.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 12.5 m -143.29 155.5 44.49 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.904 1.282 . . . . 10.0 108.837 -176.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -158.85 144.56 16.52 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.591 -1.633 . . . . 10.0 106.591 171.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -136.91 114.81 11.37 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 105.216 -2.142 . . . . 10.0 105.216 169.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -55.55 -13.6 1.64 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.521 1.928 . . . . 10.0 116.085 -168.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -131.44 9.47 4.72 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.765 1.226 . . . . 10.0 111.374 -177.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -144.91 -32.93 0.39 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.327 1.232 . . . . 10.0 114.327 -173.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -147.13 124.41 11.55 Favored 'General case' 0 C--O 1.235 0.339 0 O-C-N 120.389 -1.444 . . . . 10.0 110.304 -168.278 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -60.75 172.34 0.96 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.228 1.011 . . . . 10.0 111.267 171.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.7 mm -56.86 123.61 8.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.266 -1.753 . . . . 10.0 106.266 171.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -141.09 149.71 41.95 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.232 -1.025 . . . . 10.0 108.232 -168.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -135.04 139.42 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.458 -0.942 . . . . 10.0 108.458 -171.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -165.25 -176.0 3.88 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.457 1.103 . . . . 10.0 109.702 -178.094 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.08 -167.44 45.59 Favored Glycine 0 CA--C 1.525 0.677 0 O-C-N 121.653 -0.654 . . . . 10.0 111.866 175.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -152.1 158.2 42.65 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 169.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.9 p -69.07 158.71 34.28 Favored 'General case' 0 CA--C 1.528 0.124 0 O-C-N 121.637 -0.664 . . . . 10.0 110.601 177.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 92.8 mtp -82.97 5.57 21.62 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 118.774 -0.632 . . . . 10.0 112.541 -174.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.15 -44.97 0.11 Allowed 'General case' 0 C--N 1.345 0.383 0 CA-C-N 119.465 1.029 . . . . 10.0 113.533 176.443 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -74.11 -47.12 38.4 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.209 0.913 . . . . 10.0 111.003 -169.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.94 175.76 14.2 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.72 1.629 . . . . 10.0 110.375 178.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -54.34 130.0 37.59 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.585 2.19 . . . . 10.0 110.105 169.509 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -63.89 162.67 13.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.775 0.797 . . . . 10.0 109.244 167.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -79.01 70.01 5.27 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.092 -1.447 . . . . 10.0 107.092 169.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -49.72 -36.37 25.18 Favored 'General case' 0 C--O 1.224 -0.245 0 C-N-CA 125.098 1.359 . . . . 10.0 113.217 -168.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.95 -32.79 73.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.084 0.856 . . . . 10.0 112.504 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.26 -50.59 50.98 Favored 'Isoleucine or valine' 0 C--N 1.341 0.218 0 N-CA-C 107.428 -1.323 . . . . 10.0 107.428 175.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 5.3 m -56.53 -41.89 77.54 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.195 -0.907 . . . . 10.0 111.523 179.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 14.5 p -64.38 -43.5 94.31 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 119.43 1.014 . . . . 10.0 111.172 -179.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -61.73 -38.88 89.53 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.193 1.36 . . . . 10.0 110.886 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -63.77 -50.24 69.8 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.574 0.35 . . . . 10.0 110.222 176.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 64.3 mt -57.68 -47.15 86.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 108.615 -0.883 . . . . 10.0 108.615 178.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -54.61 -47.43 73.4 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.3 1.04 . . . . 10.0 110.244 179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.75 -39.48 88.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 122.662 0.385 . . . . 10.0 111.572 -178.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -88.05 -32.94 18.51 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 118.12 -0.943 . . . . 10.0 112.457 -175.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -66.12 133.03 94.62 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 119.577 1.081 . . . . 10.0 109.233 -178.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.72 -29.57 42.67 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 121.789 1.659 . . . . 10.0 113.269 -169.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -83.75 -2.36 56.12 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 118.869 0.759 . . . . 10.0 112.401 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 29.7 t80 52.04 54.57 10.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.153 1.381 . . . . 10.0 112.003 176.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -145.66 160.55 41.53 Favored 'General case' 0 C--O 1.234 0.271 0 O-C-N 121.098 -1.001 . . . . 10.0 109.256 170.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.9 p -165.64 166.85 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 127.218 2.207 . . . . 10.0 105.665 178.209 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.7 p -145.58 166.55 25.42 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.479 1.111 . . . . 10.0 108.893 169.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TRP . . . . . . . . . . . . . 43.0 p-90 -153.41 165.53 35.52 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.548 -0.72 . . . . 10.0 111.075 167.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -145.88 153.47 40.89 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.622 1.569 . . . . 10.0 108.931 174.202 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -87.39 7.52 28.62 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.585 0.754 . . . . 10.0 112.643 -173.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -57.5 144.58 36.31 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.25 0.62 . . . . 10.0 111.01 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.59 175.81 54.9 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.21 0.909 . . . . 10.0 113.132 -172.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.2 t80 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 117.42 -1.276 . . . . 10.0 109.255 174.806 . . . . . . . . 0 0 . 1 stop_ save_